data_2gv1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2gv1 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.0 t . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -61.29 127.59 32.26 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.901 1.68 . . . . 0.0 112.928 -176.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 p -132.45 90.59 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.186 0 C-N-CA 125.585 1.554 . . . . 0.0 108.505 -174.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.1 m -81.65 153.22 26.76 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.92 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.89 149.59 17.71 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -176.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.4 tt -114.86 124.93 72.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.061 0.945 . . . . 0.0 110.414 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -119.35 109.56 15.94 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.953 1.701 . . . . 0.0 110.395 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.5 m-90 -92.11 116.45 28.95 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 125.626 1.57 . . . . 0.0 110.49 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -101.33 121.65 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.048 0.939 . . . . 0.0 109.164 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -91.34 173.19 8.05 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.362 1.465 . . . . 0.0 110.865 176.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.86 -166.98 50.96 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.7 mtt-85 -83.82 86.0 7.22 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.248 0.619 . . . . 0.0 111.519 -172.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.3 t -117.53 -40.57 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 123.791 0.837 . . . . 0.0 110.311 -174.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -73.65 149.33 42.05 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.175 0.443 . . . . 0.0 110.295 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.94 -43.26 1.74 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.102 0.858 . . . . 0.0 112.39 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.1 p -69.59 -8.12 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 118.066 0.933 . . . . 0.0 111.786 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.26 47.14 38.11 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -50.64 -40.89 54.49 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 124.022 0.929 . . . . 0.0 110.944 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 -70.76 55.0 0.17 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.599 1.96 . . . . 0.0 113.074 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -103.56 -68.93 0.82 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.36 1.064 . . . . 0.0 109.125 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.0 t -73.26 -22.11 60.46 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.3 t -41.31 -40.05 1.56 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.819 1.247 . . . . 0.0 112.55 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -64.79 -60.52 3.0 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.003 1.321 . . . . 0.0 110.826 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -51.26 -57.04 9.9 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.76 0.824 . . . . 0.0 111.022 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.04 -50.18 67.28 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.641 0.776 . . . . 0.0 110.477 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.91 -33.96 39.37 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 122.987 0.515 . . . . 0.0 112.098 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt -67.92 -33.4 74.62 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.463 0.705 . . . . 0.0 111.851 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 -66.15 -41.79 89.92 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.827 0.851 . . . . 0.0 111.411 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.93 -30.9 31.57 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.308 0.643 . . . . 0.0 111.77 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.96 21.4 78.51 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.095 0.855 . . . . 0.0 112.74 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.23 174.69 11.29 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.861 0.865 . . . . 0.0 110.955 176.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 50.0 p -117.31 -161.39 0.81 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -175.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.81 -155.16 16.3 Favored Glycine 0 C--N 1.339 0.705 0 CA-C-N 118.463 0.574 . . . . 0.0 111.822 169.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -168.14 159.23 10.82 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 171.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.01 95.33 4.86 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.77 1.228 . . . . 0.0 110.106 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -98.97 171.21 8.19 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.151 0.981 . . . . 0.0 110.674 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -127.29 133.23 50.17 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 124.048 0.939 . . . . 0.0 109.686 -177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.2 mt -71.23 173.52 7.61 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.158 1.383 . . . . 0.0 111.128 176.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -96.27 13.38 27.74 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.016 1.327 . . . . 0.0 111.801 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -121.38 0.59 10.05 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.635 1.174 . . . . 0.0 112.481 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.43 3.32 27.42 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.157 1.36 . . . . 0.0 114.425 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.37 165.14 11.73 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.959 1.704 . . . . 0.0 112.052 -169.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.8 t -126.87 124.49 64.89 Favored 'Isoleucine or valine' 0 C--N 1.348 0.515 0 C-N-CA 124.513 1.125 . . . . 0.0 111.752 -174.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -100.28 116.51 32.43 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 125.43 1.492 . . . . 0.0 111.718 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.0 t -113.51 133.0 60.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 123.496 0.719 . . . . 0.0 109.787 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.8 t -128.63 145.18 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.783 0.833 . . . . 0.0 110.188 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.9 137.1 11.71 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-O 118.297 -0.859 . . . . 0.0 111.786 -174.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 67.3 m -104.24 178.44 4.56 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.514 1.526 . . . . 0.0 112.418 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.06 -158.1 19.57 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 124.613 1.101 . . . . 0.0 110.422 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -79.56 128.63 33.62 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.835 0.854 . . . . 0.0 109.388 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -44.83 -49.32 10.88 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.241 1.016 . . . . 0.0 111.768 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -49.55 -54.29 17.43 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.305 1.431 . . . . 0.0 112.989 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -59.54 -47.82 84.07 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 125.302 1.441 . . . . 0.0 110.419 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.36 -41.6 71.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 122.429 0.292 . . . . 0.0 110.799 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -64.08 -26.88 68.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.226 0.611 . . . . 0.0 112.589 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -55.03 -48.96 72.72 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.637 0.775 . . . . 0.0 111.036 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -76.95 -30.26 55.96 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 118.192 0.451 . . . . 0.0 111.499 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.6 mmm -66.14 -21.42 66.34 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.624 -0.703 . . . . 0.0 111.594 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -44.41 -46.3 9.44 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.738 0.699 . . . . 0.0 109.996 168.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -67.74 -41.01 84.11 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.871 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 mt . . . . . 0 C--N 1.346 0.448 0 C-N-CA 123.476 0.71 . . . . 0.0 110.611 175.748 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.5 t . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -77.16 -47.96 18.94 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.924 0.89 . . . . 0.0 111.17 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.7 mtm105 -156.73 163.27 39.45 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.926 1.29 . . . . 0.0 109.484 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.4 p -154.57 131.61 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 118.944 -0.55 . . . . 0.0 111.136 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tp -122.67 141.0 52.22 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.357 1.063 . . . . 0.0 112.556 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.43 142.77 50.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.115 1.366 . . . . 0.0 112.867 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -143.2 159.57 55.2 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 125.119 1.368 . . . . 0.0 111.262 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.38 137.5 28.33 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.747 2.965 . . . . 0.0 111.346 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -125.3 116.94 22.73 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.79 1.236 . . . . 0.0 110.296 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -121.86 74.76 36.87 Favored Pre-proline 0 CA--C 1.536 0.408 0 O-C-N 121.425 -0.797 . . . . 0.0 110.77 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.72 146.27 42.82 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.76 2.306 . . . . 0.0 110.523 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.3 p -71.22 140.57 50.48 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.502 0.721 . . . . 0.0 110.461 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.22 179.73 30.79 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 123.811 0.72 . . . . 0.0 112.048 -177.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -101.75 131.02 48.27 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.597 1.159 . . . . 0.0 108.593 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -70.06 150.8 46.22 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.725 1.21 . . . . 0.0 109.534 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -77.32 0.15 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.788 0.835 . . . . 0.0 108.755 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -137.94 166.16 24.74 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.121 0.968 . . . . 0.0 110.674 -174.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -75.59 146.38 40.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.122 0.569 . . . . 0.0 110.101 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -149.81 -168.19 3.04 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.53 0.732 . . . . 0.0 110.055 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.4 pt . . . . . 0 CA--C 1.532 0.271 0 C-N-CA 124.376 1.07 . . . . 0.0 109.938 -176.965 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.2 t . . . . . 0 CA--C 1.535 0.393 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.3 121.78 21.86 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.926 0.891 . . . . 0.0 111.374 -174.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.87 85.54 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.087 0 C-N-CA 125.273 1.429 . . . . 0.0 108.262 -172.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 m -78.86 150.32 32.26 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.114 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pp -129.88 162.1 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.3 tt -119.83 124.5 72.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.186 0.994 . . . . 0.0 109.038 173.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -117.39 99.89 7.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 126.237 1.815 . . . . 0.0 109.298 -173.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -83.4 131.85 35.02 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.612 0.765 . . . . 0.0 110.113 175.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.5 t -112.04 107.15 22.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.184 0.993 . . . . 0.0 109.113 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -73.77 165.87 24.34 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 123.445 0.698 . . . . 0.0 110.997 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.03 -179.44 53.61 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 123.811 0.719 . . . . 0.0 111.741 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.1 mtt-85 -87.8 78.58 8.36 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 122.971 0.508 . . . . 0.0 112.033 -165.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.3 t -105.51 -26.98 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.11 0.964 . . . . 0.0 111.94 -173.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -73.29 156.72 38.16 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.224 0.61 . . . . 0.0 112.181 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.89 25.41 75.81 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.296 0.951 . . . . 0.0 113.244 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.6 t -123.49 -39.09 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.027 1.331 . . . . 0.0 110.478 -177.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.96 34.4 2.58 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.922 1.249 . . . . 0.0 112.733 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -48.25 -35.48 12.1 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.82 1.248 . . . . 0.0 112.781 172.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.38 57.17 2.29 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.291 1.836 . . . . 0.0 110.564 -174.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -98.31 -72.21 0.66 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.591 0.756 . . . . 0.0 109.444 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -88.48 -7.09 57.12 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.077 0.951 . . . . 0.0 111.996 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.8 t -43.62 -46.01 7.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.884 0.874 . . . . 0.0 112.72 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -53.4 -61.43 2.31 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 126.043 1.737 . . . . 0.0 110.537 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.95 -54.67 26.81 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.002 1.321 . . . . 0.0 110.645 -177.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -55.3 -52.68 62.68 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.582 0.753 . . . . 0.0 110.542 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.18 -36.34 63.29 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.087 0.555 . . . . 0.0 111.864 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -65.12 -31.34 72.5 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.919 0.887 . . . . 0.0 112.18 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.6 mtp85 -67.66 -47.05 70.63 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.422 0.556 . . . . 0.0 110.214 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mp -74.32 -33.08 63.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.745 0.418 . . . . 0.0 110.727 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.63 18.43 66.01 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.377 0.989 . . . . 0.0 112.629 -177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.77 171.0 13.58 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 117.466 0.633 . . . . 0.0 111.411 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.6 p -111.47 -158.17 0.64 Allowed 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -171.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.69 -159.69 13.59 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 118.092 0.406 . . . . 0.0 112.219 167.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -165.85 155.16 11.94 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 174.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.93 95.68 5.44 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.386 1.475 . . . . 0.0 110.085 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -104.53 175.36 5.51 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.683 0.793 . . . . 0.0 110.838 176.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -123.89 136.36 54.3 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.169 0.988 . . . . 0.0 109.988 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.5 mt -70.67 173.67 6.88 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.158 1.383 . . . . 0.0 110.632 173.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -96.91 18.93 13.55 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.658 1.183 . . . . 0.0 111.574 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -121.96 -20.91 6.17 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 123.806 0.842 . . . . 0.0 112.851 -175.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.24 -7.37 4.04 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.727 1.156 . . . . 0.0 113.836 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.8 p -112.48 166.64 11.13 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.186 1.395 . . . . 0.0 111.816 -165.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.0 t -124.46 129.83 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.191 0.996 . . . . 0.0 111.528 -168.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -104.82 114.01 27.96 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.789 1.236 . . . . 0.0 111.465 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.2 t -113.41 130.94 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.66 0.784 . . . . 0.0 109.946 -177.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.35 144.27 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.981 0.912 . . . . 0.0 110.473 -175.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.01 130.73 4.89 Favored 'General case' 0 C--N 1.349 0.557 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.112 -172.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 99.4 m -95.54 -178.94 4.58 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.151 1.38 . . . . 0.0 112.337 177.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.24 -159.39 14.33 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -83.06 127.01 33.19 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 174.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -49.93 -46.05 51.71 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.471 1.108 . . . . 0.0 110.851 -174.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -44.88 -50.56 8.68 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.054 1.788 . . . . 0.0 113.015 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -69.13 -49.03 60.65 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.147 0.979 . . . . 0.0 110.939 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.9 t -53.08 -38.52 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.004 0.521 . . . . 0.0 111.391 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -63.3 -26.96 69.01 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -61.46 -44.98 96.14 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.092 0.557 . . . . 0.0 111.293 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.37 -30.26 63.17 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.379 0.536 . . . . 0.0 110.515 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.8 mmt -66.92 -24.79 66.13 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.168 -0.92 . . . . 0.0 112.176 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -42.22 -53.91 3.89 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 119.036 0.835 . . . . 0.0 109.016 166.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 32.3 t90 -63.61 -40.98 98.28 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 123.337 0.655 . . . . 0.0 112.235 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 N--CA 1.469 0.516 0 CA-C-N 119.312 0.96 . . . . 0.0 110.774 178.912 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.9 t . . . . . 0 N--CA 1.454 -0.237 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -58.54 -45.52 88.73 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.3 mtm-85 -173.23 166.59 4.87 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.572 1.549 . . . . 0.0 109.51 -175.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.6 t -135.83 131.21 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.152 0.981 . . . . 0.0 110.827 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 tp -117.04 124.64 49.78 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.118 1.367 . . . . 0.0 111.706 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.79 134.7 52.27 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.284 1.034 . . . . 0.0 111.688 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -140.35 157.09 69.3 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.144 1.378 . . . . 0.0 110.589 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.39 131.25 18.63 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.251 3.301 . . . . 0.0 111.648 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -122.72 116.41 23.71 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.197 0.999 . . . . 0.0 111.446 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -113.85 77.89 3.81 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 119.223 0.92 . . . . 0.0 111.781 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.6 145.9 38.07 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.145 2.563 . . . . 0.0 111.297 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.2 m -73.91 135.79 43.31 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.339 1.056 . . . . 0.0 110.782 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.16 -179.06 42.99 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 123.708 0.671 . . . . 0.0 111.57 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -103.24 126.36 50.37 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.895 0.878 . . . . 0.0 108.758 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -67.0 155.4 38.73 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.905 1.282 . . . . 0.0 110.02 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.5 m -83.2 -76.95 0.26 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -128.48 167.75 16.62 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.029 1.331 . . . . 0.0 109.952 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -77.73 151.0 34.34 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.285 1.034 . . . . 0.0 110.137 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -151.38 -175.57 5.23 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.353 0.661 . . . . 0.0 110.724 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.3 pt . . . . . 0 CA--C 1.532 0.28 0 C-N-CA 123.875 0.87 . . . . 0.0 110.318 -178.351 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.9 m . . . . . 0 CA--C 1.529 0.143 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -73.49 105.13 4.71 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.524 0.73 . . . . 0.0 109.684 -176.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.5 p -98.57 81.6 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.3 m -75.71 151.38 37.66 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.151 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.71 147.51 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.3 tt -110.12 98.81 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 C-N-CA 123.699 0.8 . . . . 0.0 109.108 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.77 97.23 10.87 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.134 0.974 . . . . 0.0 109.181 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -72.09 102.65 3.06 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 169.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.68 82.86 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 174.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -65.92 132.05 47.7 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.97 -177.32 28.18 Favored Glycine 0 N--CA 1.448 -0.543 0 O-C-N 123.443 0.464 . . . . 0.0 111.988 178.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -89.06 69.05 8.4 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 121.911 0.863 . . . . 0.0 109.421 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.3 t -108.61 -47.35 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.937 1.695 . . . . 0.0 109.181 -167.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -57.68 145.19 35.11 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.076 0.95 . . . . 0.0 109.817 166.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.75 -45.11 2.71 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.801 0.715 . . . . 0.0 111.368 -175.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.0 t -65.64 -33.71 65.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.675 0.79 . . . . 0.0 111.085 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.2 38.51 5.36 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.581 1.086 . . . . 0.0 111.651 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -52.07 -30.37 25.56 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 126.17 1.788 . . . . 0.0 113.181 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.0 54.54 0.67 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.008 1.323 . . . . 0.0 110.377 174.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -87.37 -74.61 0.43 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.658 1.183 . . . . 0.0 108.444 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -101.83 17.83 22.05 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.637 1.175 . . . . 0.0 110.994 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.6 t -61.81 -40.53 95.59 Favored 'General case' 0 C--N 1.344 0.363 0 O-C-N 121.856 -0.527 . . . . 0.0 111.111 171.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -60.18 -50.33 74.1 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.402 0.681 . . . . 0.0 110.916 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -52.24 -58.49 6.48 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 123.184 0.303 . . . . 0.0 110.303 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.18 -52.17 59.69 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.755 1.222 . . . . 0.0 110.872 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.16 -39.66 63.75 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.444 1.097 . . . . 0.0 111.843 177.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -72.08 -23.69 61.39 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.917 0.887 . . . . 0.0 112.104 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.3 mmm-85 -65.12 -47.16 78.15 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 118.854 0.752 . . . . 0.0 108.982 171.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.9 mt -75.09 -33.46 61.64 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.069 0.947 . . . . 0.0 111.213 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.62 45.55 52.53 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 124.748 1.166 . . . . 0.0 111.314 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.36 174.98 5.65 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.757 1.223 . . . . 0.0 112.605 -175.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.4 p -114.63 -171.72 1.98 Allowed 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -170.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.69 -144.37 17.58 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 170.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -171.72 153.56 3.39 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 176.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.94 83.87 2.29 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.638 1.175 . . . . 0.0 108.689 170.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt -83.64 165.22 19.16 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -126.99 134.66 50.31 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 47.6 mt -80.74 -175.27 5.2 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.584 0.754 . . . . 0.0 109.899 170.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -93.04 2.31 56.84 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.961 0.904 . . . . 0.0 111.164 168.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -79.6 -48.1 14.34 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.403 0.681 . . . . 0.0 109.418 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.46 -28.72 2.31 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -157.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.04 117.02 10.17 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.312 0.645 . . . . 0.0 111.364 -166.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 63.8 t -88.76 104.12 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 171.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -79.65 93.41 5.51 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.821 1.248 . . . . 0.0 108.753 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.1 t -91.21 114.94 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.03 130.42 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.31 1.044 . . . . 0.0 108.479 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.17 123.64 7.17 Favored 'General case' 0 N--CA 1.457 -0.113 0 O-C-N 124.377 1.048 . . . . 0.0 109.792 -166.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 91.4 m -95.7 176.66 6.06 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.064 0.946 . . . . 0.0 112.085 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.9 -155.11 16.29 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -72.76 150.59 42.68 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 172.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -58.58 -46.89 85.96 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -46.49 -45.24 16.92 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.137 1.827 . . . . 0.0 113.034 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -67.02 -51.61 52.74 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.578 0.689 . . . . 0.0 110.707 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.7 t -61.08 -32.48 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.876 0.87 . . . . 0.0 111.904 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -53.64 -40.98 66.27 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.415 0.686 . . . . 0.0 111.092 173.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -65.06 -30.76 71.74 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.145 0.884 . . . . 0.0 112.691 -169.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -78.46 -35.97 45.97 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.565 0.62 . . . . 0.0 110.929 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 54.0 mtm -64.17 -41.91 96.93 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.498 0.59 . . . . 0.0 111.197 175.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -51.96 -29.77 21.92 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.219 1.008 . . . . 0.0 112.386 172.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 12.8 t90 -83.65 -41.07 18.18 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 117.845 -1.074 . . . . 0.0 110.874 170.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 25.6 mt . . . . . 0 C--N 1.346 0.444 0 CA-C-N 120.098 1.317 . . . . 0.0 111.53 -174.362 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.6 t . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -70.55 -54.83 10.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.032 0.933 . . . . 0.0 110.945 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -151.54 150.05 29.9 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 123.652 0.781 . . . . 0.0 110.097 -174.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.0 t -127.6 102.08 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.844 1.258 . . . . 0.0 109.53 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.7 tp -105.37 114.2 28.23 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 123.586 0.754 . . . . 0.0 110.159 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.4 m -99.28 138.11 36.83 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.122 0.569 . . . . 0.0 109.902 170.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -130.04 148.85 71.32 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 125.67 1.588 . . . . 0.0 108.402 172.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.61 109.87 1.52 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.406 2.737 . . . . 0.0 109.936 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -89.5 113.16 24.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.859 1.264 . . . . 0.0 109.164 -174.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -110.88 72.37 0.78 Allowed Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 125.162 1.385 . . . . 0.0 110.454 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.45 135.73 24.89 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.642 2.228 . . . . 0.0 110.119 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.1 p -71.36 137.23 48.24 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.16 -160.16 50.97 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -173.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -137.24 145.63 43.81 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.233 1.013 . . . . 0.0 110.11 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.3 tp -100.33 137.5 38.66 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 171.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.1 m -66.17 -48.43 70.75 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.694 0.797 . . . . 0.0 111.801 -173.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -129.53 160.93 31.68 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.976 0.911 . . . . 0.0 111.866 -166.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -84.85 145.8 27.65 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.427 1.091 . . . . 0.0 109.315 166.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -145.73 173.41 12.12 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.792 0.837 . . . . 0.0 110.893 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.6 pt . . . . . 0 C--N 1.34 0.161 0 C-N-CA 123.827 0.851 . . . . 0.0 110.409 -174.672 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.3 m . . . . . 0 CA--C 1.531 0.212 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -67.96 107.68 2.76 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 121.091 0.472 . . . . 0.0 110.966 -177.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.39 80.47 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.733 1.613 . . . . 0.0 107.097 -173.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -76.72 148.01 37.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.537 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pp -120.03 164.26 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.6 tt -125.01 118.5 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 124.395 1.078 . . . . 0.0 108.867 170.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -115.27 107.84 15.79 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.784 1.234 . . . . 0.0 110.211 -176.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -86.1 121.56 28.87 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 172.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.6 t -100.44 94.18 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -63.76 152.55 39.04 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.916 0.886 . . . . 0.0 110.958 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.3 -178.64 26.72 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 124.389 0.995 . . . . 0.0 112.261 174.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -85.94 87.55 7.43 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 123.169 0.588 . . . . 0.0 110.647 -173.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.0 t -114.82 -40.04 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.771 1.228 . . . . 0.0 110.178 -174.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -65.56 152.34 44.31 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.629 0.772 . . . . 0.0 111.718 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.67 17.95 76.94 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.996 0.807 . . . . 0.0 113.543 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.69 -42.05 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.783 1.233 . . . . 0.0 109.257 175.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.26 32.08 1.89 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.687 1.613 . . . . 0.0 112.124 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -53.21 -29.1 30.26 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.541 1.537 . . . . 0.0 112.882 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -68.69 41.54 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.096 2.158 . . . . 0.0 113.5 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -85.8 -67.72 0.79 Allowed 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.508 -0.745 . . . . 0.0 110.029 -173.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.3 t -92.56 -9.77 40.0 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.888 0.875 . . . . 0.0 112.61 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.6 t -43.82 -48.54 8.26 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.06 0.944 . . . . 0.0 113.541 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -58.4 -57.16 14.13 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 124.653 1.181 . . . . 0.0 110.141 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -50.74 -55.66 15.65 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.499 1.12 . . . . 0.0 110.672 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.16 -54.2 39.32 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 124.596 1.159 . . . . 0.0 110.164 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.57 -36.83 64.79 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.658 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -68.51 -31.44 70.7 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.464 0.705 . . . . 0.0 112.125 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -60.92 -49.29 78.05 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.715 0.689 . . . . 0.0 110.282 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.3 mt -75.52 -31.03 59.98 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.392 0.277 . . . . 0.0 110.911 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.55 22.54 53.5 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.749 1.166 . . . . 0.0 112.593 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.94 169.26 10.41 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.658 0.783 . . . . 0.0 112.201 -177.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.6 p -112.27 -159.39 0.68 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.725 0.81 . . . . 0.0 109.352 -166.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.7 -154.77 16.68 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 170.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -169.47 160.68 9.33 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.05 78.97 1.39 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.738 1.215 . . . . 0.0 109.679 -174.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -85.01 166.34 16.79 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -126.86 129.82 49.0 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.6 mt -68.08 173.84 4.31 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.904 1.282 . . . . 0.0 110.781 177.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -89.44 13.77 12.93 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.953 0.901 . . . . 0.0 111.378 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -105.94 -51.14 3.03 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 123.894 0.878 . . . . 0.0 110.31 -176.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 161.02 -20.55 0.21 Allowed Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.446 1.022 . . . . 0.0 112.671 -167.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.2 p -105.26 159.14 16.11 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.078 0.951 . . . . 0.0 112.287 -162.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.2 t -116.22 126.49 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.248 1.019 . . . . 0.0 111.261 -169.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -100.33 105.55 17.09 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.644 1.577 . . . . 0.0 110.397 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.6 t -110.45 127.16 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 123.262 0.625 . . . . 0.0 109.818 -172.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.46 141.0 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 118.629 -0.7 . . . . 0.0 109.948 -171.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.52 128.16 4.46 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 118.163 -0.922 . . . . 0.0 112.329 -167.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 98.9 m -97.04 177.65 5.53 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 113.443 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.62 -172.8 16.31 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 125.054 1.311 . . . . 0.0 111.01 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -67.59 124.28 22.81 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -52.62 -40.45 62.76 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.175 1.39 . . . . 0.0 112.24 -168.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -43.96 -50.59 7.43 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.669 1.604 . . . . 0.0 112.379 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -65.07 -52.72 54.03 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 122.958 0.503 . . . . 0.0 110.516 176.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.2 t -46.43 -45.57 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.094 0.958 . . . . 0.0 111.626 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -64.21 -29.05 70.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.496 -0.764 . . . . 0.0 112.799 -175.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -54.63 -44.27 73.03 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 119.324 0.966 . . . . 0.0 111.197 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.2 -29.32 61.68 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.452 0.301 . . . . 0.0 111.169 177.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mtm -68.31 -25.74 65.28 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 118.692 -0.67 . . . . 0.0 112.033 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -48.64 -53.15 19.68 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 166.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -62.81 -40.96 99.01 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 118.534 -0.745 . . . . 0.0 112.17 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 mt . . . . . 0 N--CA 1.469 0.476 0 CA-C-N 119.779 1.172 . . . . 0.0 109.922 177.77 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.6 t . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -68.56 -48.7 63.58 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 119.055 -0.498 . . . . 0.0 111.221 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.2 mtm105 -167.05 163.85 15.85 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.801 0.841 . . . . 0.0 110.799 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -127.06 117.25 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.289 1.036 . . . . 0.0 109.926 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 tt -106.91 111.84 24.53 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.257 1.023 . . . . 0.0 110.022 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.5 m -103.9 137.39 41.96 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.348 0.659 . . . . 0.0 111.175 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -139.64 160.06 62.8 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 126.037 1.735 . . . . 0.0 109.759 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.73 129.54 12.7 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.346 2.697 . . . . 0.0 110.367 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 59.4 t60 -116.88 110.51 18.43 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.287 1.035 . . . . 0.0 109.607 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -108.18 80.53 1.11 Allowed Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 119.079 0.854 . . . . 0.0 111.055 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.15 160.92 46.11 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.99 2.46 . . . . 0.0 110.85 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 88.7 p -84.08 147.59 27.29 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.028 0.931 . . . . 0.0 110.473 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.22 -171.75 18.18 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.85 0.738 . . . . 0.0 112.298 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -105.29 136.11 45.43 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.121 0.968 . . . . 0.0 109.864 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 mp -81.72 147.11 29.64 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.307 1.043 . . . . 0.0 109.251 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 19.2 p -78.69 -66.04 0.91 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.624 1.17 . . . . 0.0 109.874 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -137.92 166.55 23.76 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.259 1.424 . . . . 0.0 110.693 -167.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -84.36 140.68 31.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 167.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -148.38 -172.43 4.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.014 0.526 . . . . 0.0 109.827 -174.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.3 tt . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -175.398 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 t . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 111.286 0.106 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -67.14 120.48 13.8 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.221 1.008 . . . . 0.0 111.471 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 p -127.64 85.04 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 125.578 1.551 . . . . 0.0 107.813 -173.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.57 148.68 31.65 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.853 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 pp -129.43 162.96 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.6 tt -121.66 125.77 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 124.026 0.931 . . . . 0.0 108.988 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -118.62 103.66 9.91 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.659 1.584 . . . . 0.0 109.832 -173.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.5 m-90 -85.65 117.66 24.68 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.23 0.612 . . . . 0.0 109.815 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.0 t -100.51 108.85 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 123.83 0.852 . . . . 0.0 108.978 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -78.86 164.78 24.2 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.122 0.569 . . . . 0.0 110.876 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.76 -177.88 42.13 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 124.061 0.839 . . . . 0.0 112.122 177.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -84.76 81.42 8.88 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.386 0.612 . . . . 0.0 111.066 -169.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.8 t -108.52 -44.42 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.478 1.511 . . . . 0.0 110.48 -173.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -65.9 153.8 41.02 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.117 0.567 . . . . 0.0 110.964 175.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 67.75 17.52 69.3 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 123.998 0.808 . . . . 0.0 113.722 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.6 t -104.04 -43.27 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.752 1.221 . . . . 0.0 108.828 172.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.63 32.76 2.61 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.904 1.716 . . . . 0.0 111.233 -176.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -53.5 -34.59 58.65 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.801 1.24 . . . . 0.0 112.356 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.3 53.89 0.68 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.438 1.495 . . . . 0.0 112.139 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -94.4 -75.05 0.52 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.497 1.119 . . . . 0.0 109.48 -176.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -79.99 -11.87 59.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.905 0.882 . . . . 0.0 112.016 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.6 t -44.18 -44.43 7.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.97 0.908 . . . . 0.0 112.719 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.4 mm-40 -56.41 -63.68 1.11 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.823 1.649 . . . . 0.0 110.166 172.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -50.85 -56.22 13.23 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.969 1.707 . . . . 0.0 111.75 -174.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -56.04 -54.59 43.14 Favored 'General case' 0 CA--C 1.527 0.064 0 C-N-CA 124.292 1.037 . . . . 0.0 109.852 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.47 -37.61 49.72 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.93 0.892 . . . . 0.0 111.888 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -65.32 -32.16 73.67 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.769 1.228 . . . . 0.0 112.474 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.2 mmm-85 -64.52 -45.14 88.47 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 118.464 0.574 . . . . 0.0 110.037 175.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.5 mt -73.23 -36.02 66.38 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.192 0.597 . . . . 0.0 111.311 -178.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.49 18.61 65.93 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.415 1.007 . . . . 0.0 112.475 -175.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.47 169.45 14.49 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.463 0.705 . . . . 0.0 110.713 177.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.2 p -111.87 -157.61 0.62 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -170.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.6 -155.21 16.34 Favored Glycine 0 C--N 1.339 0.711 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 166.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -166.66 154.78 10.02 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 173.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.12 96.17 5.79 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.237 1.415 . . . . 0.0 110.098 175.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -102.2 174.09 6.08 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.749 0.82 . . . . 0.0 111.321 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -125.28 132.38 52.92 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.109 0.964 . . . . 0.0 109.344 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.0 mt -71.48 171.96 10.39 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.14 1.376 . . . . 0.0 110.758 174.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -95.47 15.68 19.01 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.049 1.34 . . . . 0.0 111.763 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -117.2 -26.35 6.8 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.115 0.966 . . . . 0.0 112.043 -175.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.73 4.13 1.66 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.644 1.116 . . . . 0.0 114.307 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 p -121.11 167.51 12.56 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.002 1.321 . . . . 0.0 112.091 -165.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.7 t -123.9 128.24 74.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.578 1.151 . . . . 0.0 111.222 -170.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -101.89 111.46 23.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.165 1.386 . . . . 0.0 111.56 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.1 t -108.5 132.55 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 123.043 0.537 . . . . 0.0 110.235 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.53 143.62 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.873 0.869 . . . . 0.0 110.174 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.4 129.11 5.49 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 118.174 -0.917 . . . . 0.0 111.905 -172.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 80.8 m -95.6 -179.43 4.74 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.634 1.174 . . . . 0.0 112.441 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.43 -167.4 14.79 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 124.94 1.257 . . . . 0.0 109.978 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.98 139.79 46.92 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 170.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -53.79 -45.09 70.62 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.904 0.882 . . . . 0.0 110.587 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -42.47 -45.52 5.45 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.347 1.927 . . . . 0.0 113.202 174.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -74.21 -46.93 38.71 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.252 1.021 . . . . 0.0 111.592 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -53.34 -41.51 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.461 0.705 . . . . 0.0 110.69 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -65.14 -22.72 66.96 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.331 0.653 . . . . 0.0 112.67 -176.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -61.87 -45.23 94.67 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.366 0.53 . . . . 0.0 111.021 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.3 -28.07 61.01 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.392 0.542 . . . . 0.0 111.038 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -68.59 -26.13 65.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.695 -0.669 . . . . 0.0 111.277 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -44.0 -49.36 8.65 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 167.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -69.34 -37.21 77.57 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-O 118.426 -0.797 . . . . 0.0 111.69 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 N--CA 1.468 0.436 0 CA-C-N 118.972 0.806 . . . . 0.0 111.028 177.856 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.8 t . . . . . 0 N--CA 1.456 -0.148 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -73.12 -52.6 13.62 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.609 0.763 . . . . 0.0 111.407 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.2 mmm-85 -168.94 166.44 11.22 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.725 1.21 . . . . 0.0 109.433 -171.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.06 133.84 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 118.838 -0.601 . . . . 0.0 111.41 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.6 tp -124.69 125.68 44.49 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.077 0.951 . . . . 0.0 112.251 -175.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.95 135.1 49.09 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.273 1.029 . . . . 0.0 111.813 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -134.17 155.98 79.5 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 125.909 1.684 . . . . 0.0 110.203 -178.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.74 126.53 11.48 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 124.244 3.296 . . . . 0.0 111.078 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -119.21 107.49 13.5 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.147 0.979 . . . . 0.0 110.371 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -110.55 74.22 0.87 Allowed Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 119.228 0.922 . . . . 0.0 111.464 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -72.97 151.5 50.47 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.179 2.586 . . . . 0.0 111.44 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.4 p -79.19 140.69 37.65 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.123 0.969 . . . . 0.0 110.624 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.8 174.26 16.57 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.028 0.823 . . . . 0.0 111.89 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -92.04 142.66 27.28 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.758 0.823 . . . . 0.0 108.975 171.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -85.98 149.01 25.49 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.1 p -75.54 -75.95 0.16 Allowed 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -134.08 163.0 30.55 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.833 0.853 . . . . 0.0 110.847 -171.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -76.52 148.63 37.0 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.848 0.859 . . . . 0.0 109.829 172.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -150.95 -177.69 6.16 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.121 0.568 . . . . 0.0 109.948 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.9 pt . . . . . 0 C--O 1.231 0.105 0 C-N-CA 123.575 0.75 . . . . 0.0 109.615 178.232 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 CA--C 1.539 0.536 0 CA-C-O 119.909 -0.091 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -63.06 134.71 56.52 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.709 1.204 . . . . 0.0 112.132 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.0 p -139.95 92.86 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.294 0 C-N-CA 124.603 1.161 . . . . 0.0 109.027 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.8 m -86.67 156.65 19.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.469 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.5 pp -140.46 158.48 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.073 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 tt -119.01 109.82 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.123 0.969 . . . . 0.0 109.549 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -101.99 119.77 39.33 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.298 1.039 . . . . 0.0 110.157 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.0 m-90 -97.39 112.35 24.22 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.039 0.935 . . . . 0.0 110.493 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 t -91.78 123.78 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.93 0.892 . . . . 0.0 109.063 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -94.0 174.89 6.93 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.461 1.504 . . . . 0.0 111.202 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.12 -163.56 54.15 Favored Glycine 0 C--N 1.338 0.683 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -85.93 91.8 8.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.67 0.788 . . . . 0.0 111.514 -173.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.6 t -123.45 -44.31 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.171 0.988 . . . . 0.0 109.771 -175.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -71.27 143.05 50.49 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.29 0.636 . . . . 0.0 110.172 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.26 18.04 79.09 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 119.214 -0.77 . . . . 0.0 113.309 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.0 t -108.78 -43.19 5.92 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 124.331 1.052 . . . . 0.0 109.686 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 116.71 25.56 3.34 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 125.185 1.374 . . . . 0.0 111.639 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -51.24 -35.09 35.33 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.891 0.876 . . . . 0.0 111.105 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.5 mtp180 -74.9 59.86 0.93 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.243 1.417 . . . . 0.0 111.36 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -114.27 -73.51 0.65 Allowed 'General case' 0 C--N 1.339 0.139 0 C-N-CA 125.389 1.475 . . . . 0.0 108.807 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.3 t -73.69 -19.96 60.68 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.229 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.5 t -45.44 -36.96 4.72 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.937 0.895 . . . . 0.0 112.163 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -69.95 -59.21 3.06 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.508 1.123 . . . . 0.0 110.208 176.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -52.33 -53.98 37.49 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.534 1.134 . . . . 0.0 111.348 -175.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.58 -52.12 64.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.643 1.177 . . . . 0.0 110.214 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.87 -31.54 59.81 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.169 0.587 . . . . 0.0 112.408 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -65.02 -34.33 78.18 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.642 1.177 . . . . 0.0 111.597 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -69.92 -48.87 56.85 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.757 0.823 . . . . 0.0 110.34 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.7 mt -71.21 -34.24 70.66 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.917 0.487 . . . . 0.0 110.779 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.09 14.08 81.1 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.319 0.962 . . . . 0.0 112.671 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.55 178.14 5.54 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.533 0.733 . . . . 0.0 111.259 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.3 p -123.79 -174.91 3.09 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 136.61 -149.3 20.11 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 170.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -169.03 165.93 11.17 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 172.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.1 101.58 7.09 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.597 0.759 . . . . 0.0 112.031 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -97.99 175.28 6.18 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.444 1.098 . . . . 0.0 111.243 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -123.77 136.54 54.48 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.837 1.255 . . . . 0.0 109.973 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.6 mt -74.19 173.91 9.48 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.504 1.522 . . . . 0.0 109.981 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -97.58 13.47 29.96 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.151 0.98 . . . . 0.0 111.719 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -117.92 -11.01 10.32 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 124.044 0.938 . . . . 0.0 112.446 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.38 19.77 4.53 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 125.098 1.333 . . . . 0.0 114.061 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.1 m -118.14 166.25 12.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.546 1.538 . . . . 0.0 111.601 -171.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.2 t -129.35 118.25 45.31 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 C-N-CA 124.046 0.938 . . . . 0.0 110.575 -175.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -94.88 126.47 40.23 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.58 0.752 . . . . 0.0 110.554 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.8 t -120.38 133.95 65.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.687 0.795 . . . . 0.0 109.457 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.5 t -126.28 142.54 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 C-N-CA 124.425 1.09 . . . . 0.0 109.512 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.93 134.62 10.83 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-O 118.752 -0.642 . . . . 0.0 111.117 -173.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 51.8 m -99.77 178.44 4.83 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.211 1.404 . . . . 0.0 112.611 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.46 -153.19 20.15 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -83.77 126.63 33.12 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.832 1.253 . . . . 0.0 109.561 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -46.38 -51.48 14.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.723 1.209 . . . . 0.0 111.537 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -51.9 -44.88 56.12 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.223 1.392 . . . . 0.0 112.97 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -69.09 -44.22 72.92 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 117.33 0.565 . . . . 0.0 111.752 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.4 t -54.39 -32.66 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 122.749 0.419 . . . . 0.0 110.728 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.97 -29.97 69.98 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -57.66 -24.03 54.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.009 0.923 . . . . 0.0 112.608 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.68 -29.51 12.62 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-N 118.784 0.72 . . . . 0.0 111.483 171.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.3 mmm -65.79 -20.36 66.23 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.838 -0.601 . . . . 0.0 111.949 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -45.12 -58.18 3.39 Favored 'General case' 0 C--O 1.214 -0.791 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 172.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -62.76 -36.9 84.55 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.125 0.57 . . . . 0.0 111.833 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt . . . . . 0 C--N 1.345 0.386 0 C-N-CA 123.707 0.803 . . . . 0.0 110.375 178.284 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -55.31 -49.97 70.78 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 122.979 0.512 . . . . 0.0 111.21 176.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -171.26 171.13 5.75 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.67 1.188 . . . . 0.0 109.595 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.9 p -156.28 134.26 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.009 0.523 . . . . 0.0 110.212 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tp -113.91 149.63 34.9 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.989 0.916 . . . . 0.0 110.886 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.12 131.32 44.05 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.427 1.091 . . . . 0.0 111.344 -176.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -141.53 156.31 66.73 Favored Pre-proline 0 N--CA 1.468 0.431 0 C-N-CA 124.01 0.924 . . . . 0.0 111.622 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -68.63 125.28 12.53 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 124.213 3.275 . . . . 0.0 110.836 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -118.99 117.36 28.58 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.89 0.876 . . . . 0.0 109.878 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -109.34 77.67 0.97 Allowed Pre-proline 0 CA--C 1.539 0.53 0 O-C-N 121.498 -0.751 . . . . 0.0 110.344 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.63 126.58 12.23 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.656 2.904 . . . . 0.0 109.755 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.0 p -70.31 148.67 48.23 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.338 0.655 . . . . 0.0 110.688 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.25 176.7 8.84 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.973 0.796 . . . . 0.0 112.164 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -105.27 131.78 52.3 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.71 1.204 . . . . 0.0 108.872 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.2 tp -83.19 151.76 25.53 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.572 0.749 . . . . 0.0 109.55 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.5 m -74.74 -73.43 0.24 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -138.04 162.99 32.72 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.466 1.106 . . . . 0.0 110.369 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -71.83 147.21 47.4 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.673 0.789 . . . . 0.0 110.519 175.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -143.97 -177.35 5.39 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.64 1.176 . . . . 0.0 110.159 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.3 pt . . . . . 0 CA--C 1.533 0.316 0 C-N-CA 123.628 0.771 . . . . 0.0 109.102 -177.782 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 t . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 110.605 -0.146 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.67 152.85 44.59 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.285 1.034 . . . . 0.0 112.821 -177.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 p -138.49 88.43 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.262 1.025 . . . . 0.0 108.405 -174.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.5 m -79.55 150.49 31.1 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.68 157.17 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.9 tt -116.35 116.35 52.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.431 1.093 . . . . 0.0 109.609 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -111.41 103.21 11.55 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.674 1.59 . . . . 0.0 109.917 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.1 m-90 -83.68 115.59 22.25 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 123.783 0.833 . . . . 0.0 109.868 176.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.3 t -97.92 113.24 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -87.82 172.63 9.49 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 124.487 1.115 . . . . 0.0 111.175 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.03 -169.55 55.01 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 123.632 0.634 . . . . 0.0 111.821 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -83.39 85.33 7.25 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.02 0.528 . . . . 0.0 112.124 -167.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.4 t -117.7 -43.08 2.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.845 -173.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -68.23 148.34 50.96 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.683 0.674 . . . . 0.0 110.389 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.74 -31.01 8.32 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 118.918 -0.934 . . . . 0.0 113.426 174.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 m -74.34 -0.58 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 119.018 1.409 . . . . 0.0 112.448 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.01 36.83 73.22 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.199 0.904 . . . . 0.0 110.859 -170.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -51.25 -38.84 54.86 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 123.908 0.883 . . . . 0.0 111.157 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.16 55.97 0.6 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.511 1.524 . . . . 0.0 113.095 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -110.99 -72.42 0.72 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.402 1.081 . . . . 0.0 109.465 -177.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 t -73.77 -16.93 61.15 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.213 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.2 t -40.68 -42.09 1.66 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.141 1.376 . . . . 0.0 113.021 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -64.3 -61.46 2.22 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.632 1.173 . . . . 0.0 110.411 173.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -48.97 -54.38 15.83 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.604 1.562 . . . . 0.0 111.734 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -55.69 -45.82 77.75 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.355 1.462 . . . . 0.0 112.038 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.09 -30.38 71.32 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.092 0.557 . . . . 0.0 111.999 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.8 tttt -65.3 -35.44 81.01 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.831 0.853 . . . . 0.0 111.328 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -67.51 -49.46 63.31 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.294 0.638 . . . . 0.0 110.536 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.9 mt -73.55 -34.37 65.15 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.825 0.45 . . . . 0.0 110.74 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.08 13.24 72.05 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.208 0.909 . . . . 0.0 112.866 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.21 176.28 8.9 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.775 0.83 . . . . 0.0 111.506 178.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.7 p -115.61 -160.89 0.76 Allowed 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -172.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.2 -155.25 16.27 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 118.637 0.653 . . . . 0.0 112.751 169.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -168.99 159.37 9.27 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 174.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.22 91.38 3.44 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.579 1.152 . . . . 0.0 111.5 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -93.17 174.83 7.02 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.337 0.655 . . . . 0.0 110.357 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -123.19 133.99 54.19 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 124.191 0.996 . . . . 0.0 110.539 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 30.0 mt -74.67 169.32 18.05 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.77 1.628 . . . . 0.0 110.267 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -90.0 4.5 49.96 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.391 1.076 . . . . 0.0 112.113 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -107.83 -7.57 16.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.469 1.108 . . . . 0.0 112.093 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.56 12.69 11.33 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.085 1.326 . . . . 0.0 113.963 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.36 168.06 10.31 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.637 1.575 . . . . 0.0 112.003 -170.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.9 t -129.07 118.13 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.49 1.116 . . . . 0.0 110.894 -173.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -94.97 121.71 36.87 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.407 1.003 . . . . 0.0 111.234 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.5 t -119.05 134.07 63.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 117.966 0.348 . . . . 0.0 110.532 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.43 142.55 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.412 1.085 . . . . 0.0 109.704 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.08 133.24 7.69 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 118.637 -0.697 . . . . 0.0 111.569 -171.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 96.9 m -100.18 176.44 5.39 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.808 1.243 . . . . 0.0 112.785 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.18 -159.01 20.03 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.825 1.202 . . . . 0.0 110.317 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -73.36 134.24 44.03 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.21 0.604 . . . . 0.0 110.17 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -49.01 -49.46 40.87 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.447 1.099 . . . . 0.0 111.184 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -49.91 -53.3 22.86 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.097 1.332 . . . . 0.0 112.171 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -62.22 -43.61 98.44 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.469 0.708 . . . . 0.0 111.487 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.7 t -58.02 -40.0 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 122.611 0.364 . . . . 0.0 110.396 175.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.46 -26.4 68.71 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -176.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -55.47 -44.72 76.71 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.609 0.764 . . . . 0.0 110.897 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.26 -30.44 48.58 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 118.177 0.444 . . . . 0.0 111.632 175.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.3 mmt -68.38 -22.72 64.63 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 119.074 -0.489 . . . . 0.0 112.096 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -43.34 -51.13 6.54 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 167.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 18.7 t90 -64.25 -40.95 97.06 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.344 0.52 . . . . 0.0 111.989 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mt . . . . . 0 C--N 1.348 0.502 0 C-N-CA 123.661 0.785 . . . . 0.0 111.043 179.464 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.7 t . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -62.43 -56.84 14.32 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.856 0.862 . . . . 0.0 109.988 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -166.96 158.14 12.22 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.18 0.992 . . . . 0.0 109.424 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.3 135.78 57.44 Favored 'Isoleucine or valine' 0 C--N 1.342 0.24 0 C-N-CA 123.771 0.828 . . . . 0.0 110.031 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.9 tp -117.37 108.44 15.58 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.812 0.845 . . . . 0.0 110.789 -177.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.15 127.15 46.45 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.632 1.173 . . . . 0.0 111.52 -177.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -131.0 156.51 80.04 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 126.125 1.77 . . . . 0.0 110.673 -175.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -71.24 120.14 6.78 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.232 3.288 . . . . 0.0 111.495 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -109.44 109.04 19.77 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.485 0.714 . . . . 0.0 109.616 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -109.89 74.21 0.74 Allowed Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 123.945 0.898 . . . . 0.0 110.315 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.73 146.9 30.62 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.072 2.515 . . . . 0.0 110.511 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.7 p -72.72 141.17 48.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.424 0.69 . . . . 0.0 110.485 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.7 -178.63 35.53 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 123.871 0.748 . . . . 0.0 112.132 -177.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -104.12 130.84 51.86 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.333 1.053 . . . . 0.0 108.688 172.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mp -69.54 151.84 45.52 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.836 1.254 . . . . 0.0 109.713 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.59 -77.82 0.17 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.105 0.962 . . . . 0.0 109.008 178.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -137.37 167.0 22.48 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.343 1.057 . . . . 0.0 110.536 -173.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -73.74 143.22 46.18 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.598 173.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -130.93 174.63 9.79 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.414 0.686 . . . . 0.0 110.201 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.5 tp . . . . . 0 N--CA 1.449 -0.479 0 C-N-CA 122.76 0.424 . . . . 0.0 110.727 177.316 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.479 0 CA-C-O 120.265 0.079 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -61.19 135.73 57.84 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.745 1.618 . . . . 0.0 112.104 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.6 p -140.85 91.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 124.604 1.162 . . . . 0.0 108.368 -174.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.0 m -80.86 155.88 26.36 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.579 177.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 pp -143.58 158.2 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.4 tt -118.49 119.73 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 124.103 0.961 . . . . 0.0 109.329 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -109.2 106.43 16.29 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.996 1.318 . . . . 0.0 109.99 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -90.13 124.3 34.7 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.903 0.881 . . . . 0.0 110.251 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.4 t -101.51 104.3 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.11 0.964 . . . . 0.0 108.605 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -68.45 176.87 2.63 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 123.801 0.84 . . . . 0.0 111.69 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.72 -169.51 47.92 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -92.24 91.32 7.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.032 0.533 . . . . 0.0 110.853 -175.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.3 t -111.86 -31.75 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 124.106 0.962 . . . . 0.0 111.233 -178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -69.13 150.16 47.86 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.586 0.355 . . . . 0.0 110.557 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.46 17.55 66.16 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 123.918 0.77 . . . . 0.0 113.397 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.0 t -114.94 -45.56 4.35 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 C-N-CA 124.761 1.224 . . . . 0.0 109.367 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.32 31.93 1.59 Allowed Glycine 0 C--N 1.339 0.698 0 C-N-CA 125.197 1.38 . . . . 0.0 111.434 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -50.79 -36.12 35.44 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 117.664 0.732 . . . . 0.0 110.874 177.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -74.3 56.56 0.65 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.502 1.121 . . . . 0.0 112.741 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -97.42 -71.02 0.7 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.965 0.906 . . . . 0.0 109.264 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 t -89.35 -2.99 58.64 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.71 0.804 . . . . 0.0 111.69 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.8 t -45.98 -37.78 6.93 Favored 'General case' 0 C--N 1.345 0.397 0 C-N-CA 123.84 0.856 . . . . 0.0 112.099 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -69.84 -59.51 2.89 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 124.31 1.044 . . . . 0.0 109.949 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -49.48 -55.11 14.4 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.704 1.202 . . . . 0.0 111.29 -176.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -55.78 -57.5 11.76 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.021 0.928 . . . . 0.0 109.822 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.22 -34.29 31.54 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.926 0.891 . . . . 0.0 112.121 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -62.68 -38.89 92.14 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.438 1.095 . . . . 0.0 111.71 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -68.6 -38.4 80.6 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.017 0.927 . . . . 0.0 110.527 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.87 -32.34 57.43 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.676 0.791 . . . . 0.0 111.118 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.94 15.57 80.42 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.686 0.66 . . . . 0.0 112.82 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.18 179.76 7.63 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.965 0.906 . . . . 0.0 111.217 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 46.0 p -120.29 -162.43 0.94 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -176.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.1 -151.93 17.45 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 172.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -172.57 170.39 4.85 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.844 0.458 . . . . 0.0 112.085 175.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.56 88.19 2.7 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.43 0.692 . . . . 0.0 111.697 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -88.91 173.03 8.73 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.89 0.876 . . . . 0.0 110.18 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -124.01 138.56 54.44 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.699 1.2 . . . . 0.0 108.684 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.9 mt -74.58 178.63 5.21 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.09 1.356 . . . . 0.0 110.173 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -100.94 12.3 37.92 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.806 0.842 . . . . 0.0 111.327 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -117.08 -14.67 10.56 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.401 1.08 . . . . 0.0 112.497 -176.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.13 2.6 7.69 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.171 1.367 . . . . 0.0 114.12 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.1 m -104.34 167.19 9.91 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.855 1.262 . . . . 0.0 111.679 -171.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.9 t -125.4 127.66 72.02 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 C-N-CA 124.302 1.041 . . . . 0.0 109.979 -176.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -102.33 122.73 44.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.659 1.184 . . . . 0.0 110.96 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.76 135.67 57.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -131.2 145.07 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.941 0.897 . . . . 0.0 109.578 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.52 138.96 12.56 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.991 -173.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.3 m -108.98 -178.6 3.62 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.053 1.341 . . . . 0.0 112.298 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.46 -161.29 26.16 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.95 121.46 23.49 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.196 0.998 . . . . 0.0 110.944 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -49.69 -45.32 48.75 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.765 1.226 . . . . 0.0 110.941 -175.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -44.47 -43.74 7.82 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 126.424 1.964 . . . . 0.0 113.423 175.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -78.4 -49.03 14.27 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.689 0.795 . . . . 0.0 110.09 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.4 t -52.87 -32.71 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 122.727 0.411 . . . . 0.0 111.851 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -63.25 -32.0 73.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.255 1.422 . . . . 0.0 112.149 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? -61.89 -52.87 62.35 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-O 118.625 -0.703 . . . . 0.0 110.012 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.81 -29.78 68.47 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.215 0.916 . . . . 0.0 111.091 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.87 -22.67 66.54 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.412 -0.804 . . . . 0.0 111.518 177.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -48.14 -46.63 34.59 Favored 'General case' 0 C--N 1.343 0.326 0 CA-C-N 118.632 0.651 . . . . 0.0 109.951 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -70.46 -35.94 73.62 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.113 -177.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 mt . . . . . 0 CA--C 1.536 0.428 0 CA-C-N 118.634 0.652 . . . . 0.0 109.957 177.898 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.3 t . . . . . 0 CA--C 1.533 0.295 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -62.92 -58.03 8.76 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.208 0.603 . . . . 0.0 110.782 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.0 tpp180 -168.38 174.07 7.23 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.931 0.892 . . . . 0.0 109.592 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.0 t -140.68 127.61 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.751 0.821 . . . . 0.0 109.982 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.13 156.08 19.18 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.695 1.198 . . . . 0.0 111.086 176.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.12 134.11 34.23 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.5 1.12 . . . . 0.0 111.556 -177.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -141.26 155.37 67.96 Favored Pre-proline 0 N--CA 1.471 0.586 0 C-N-CA 123.897 0.879 . . . . 0.0 111.503 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.9 122.24 9.13 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 124.704 3.603 . . . . 0.0 111.047 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -114.69 135.71 53.86 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.113 0.965 . . . . 0.0 110.512 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -139.66 71.42 37.13 Favored Pre-proline 0 CA--C 1.534 0.356 0 O-C-N 121.659 -0.651 . . . . 0.0 110.481 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -68.28 136.33 36.89 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.394 2.73 . . . . 0.0 110.138 -174.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.5 p -64.63 144.13 57.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.453 0.701 . . . . 0.0 110.825 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.87 170.75 5.46 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.225 0.917 . . . . 0.0 112.041 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -86.59 137.15 32.73 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mp -77.9 150.23 34.13 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.458 0.703 . . . . 0.0 109.543 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.8 -79.26 0.14 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -145.67 163.8 33.75 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.376 0.671 . . . . 0.0 110.948 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -74.22 143.99 44.91 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.258 0.623 . . . . 0.0 110.652 177.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -158.4 -179.98 8.6 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.197 0.599 . . . . 0.0 110.429 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.229 0 C-N-CA 123.511 0.724 . . . . 0.0 109.296 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 CA--C 1.537 0.45 0 N-CA-C 110.691 -0.114 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.6 134.36 54.19 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.176 1.39 . . . . 0.0 112.064 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 p -139.32 90.84 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.242 0 C-N-CA 124.645 1.178 . . . . 0.0 108.63 -174.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.3 m -81.36 153.2 27.12 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.772 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pp -141.16 158.2 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.123 0.569 . . . . 0.0 109.875 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 tt -117.7 118.24 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.171 0.989 . . . . 0.0 109.724 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -107.32 108.15 19.4 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.852 1.661 . . . . 0.0 109.897 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -90.4 128.35 36.46 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 125.243 1.417 . . . . 0.0 110.296 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.4 t -114.45 122.44 68.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.329 1.052 . . . . 0.0 109.07 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -96.66 178.76 5.22 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.829 1.252 . . . . 0.0 110.858 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.72 -160.21 53.44 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.3 mtt-85 -85.17 92.09 8.31 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -171.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.9 t -131.52 -45.84 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.523 0.729 . . . . 0.0 110.487 -175.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -70.46 146.91 49.98 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 122.857 0.463 . . . . 0.0 110.539 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.23 14.72 82.27 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 119.152 -0.805 . . . . 0.0 113.373 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 75.2 t -107.79 -44.11 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.618 1.167 . . . . 0.0 109.424 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.49 28.76 2.25 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 125.194 1.378 . . . . 0.0 111.431 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -50.78 -37.61 43.3 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 123.85 0.86 . . . . 0.0 111.11 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.21 59.49 0.76 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.388 1.075 . . . . 0.0 112.621 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -111.76 -72.84 0.7 Allowed 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.108 1.363 . . . . 0.0 109.55 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.1 t -73.13 -18.13 61.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.86 -0.59 . . . . 0.0 111.45 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.2 t -45.29 -36.92 4.35 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.844 0.858 . . . . 0.0 112.009 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -71.13 -57.79 4.18 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.351 1.06 . . . . 0.0 110.317 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.15 -59.87 3.87 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.158 0.983 . . . . 0.0 110.649 -175.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -55.18 -46.17 75.8 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.368 1.067 . . . . 0.0 110.428 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.59 -36.17 71.38 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.0 tttt -62.25 -30.91 71.44 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.09 0.556 . . . . 0.0 111.572 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.2 mmm-85 -66.85 -49.54 65.39 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 122.964 0.505 . . . . 0.0 110.652 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.6 mt -77.16 -42.44 37.73 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 122.403 0.281 . . . . 0.0 110.855 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.9 9.36 58.51 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.551 1.072 . . . . 0.0 112.953 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.01 168.1 3.44 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 117.86 0.83 . . . . 0.0 112.015 175.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.5 p -127.3 151.03 49.29 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -176.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 161.9 -148.36 15.67 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -170.45 167.83 8.05 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 122.99 0.516 . . . . 0.0 111.777 173.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.41 99.68 5.5 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 118.679 -0.676 . . . . 0.0 111.345 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -100.93 176.83 5.14 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 124.68 1.192 . . . . 0.0 111.547 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 -127.11 137.98 53.1 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.074 1.35 . . . . 0.0 109.473 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.1 mt -75.01 174.24 9.61 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 125.075 1.35 . . . . 0.0 110.552 174.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -96.69 10.33 39.01 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.708 1.203 . . . . 0.0 111.529 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.68 -2.55 12.43 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.528 1.131 . . . . 0.0 112.018 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.94 25.77 6.65 Favored Glycine 0 C--N 1.342 0.871 0 C-N-CA 124.638 1.113 . . . . 0.0 113.776 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.16 162.22 19.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.006 1.322 . . . . 0.0 111.531 -175.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.0 t -122.05 120.85 62.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.409 1.484 . . . . 0.0 110.864 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -99.11 122.37 42.25 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.906 1.282 . . . . 0.0 111.06 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.56 136.87 55.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 C-N-CA 123.554 0.741 . . . . 0.0 109.511 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 t -127.36 143.33 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 124.237 1.015 . . . . 0.0 109.425 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.43 136.71 13.96 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-O 118.819 -0.61 . . . . 0.0 110.925 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 56.4 m -104.39 -179.53 3.97 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.698 1.599 . . . . 0.0 112.652 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.52 -154.57 22.25 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -80.09 129.07 34.22 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 123.222 0.609 . . . . 0.0 110.231 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -48.73 -52.43 23.68 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.908 1.283 . . . . 0.0 111.013 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.04 -45.88 62.03 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.343 1.449 . . . . 0.0 112.693 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -66.7 -46.86 74.22 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 117.479 0.639 . . . . 0.0 111.224 177.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.3 t -54.91 -30.9 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.135 0.574 . . . . 0.0 110.955 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -59.33 -31.39 69.13 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -55.05 -36.78 65.92 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.901 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.91 -31.62 23.58 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.138 0.881 . . . . 0.0 111.03 174.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.5 mmm -65.59 -19.78 66.06 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.14 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -46.31 -51.38 14.78 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -70.83 -34.04 71.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 mt . . . . . 0 C--N 1.351 0.647 0 C-N-CA 123.324 0.65 . . . . 0.0 109.983 176.838 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.6 t . . . . . 0 CA--C 1.532 0.272 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -55.75 -56.61 18.4 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 123.848 0.859 . . . . 0.0 110.775 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.8 mtm-85 -157.08 161.9 39.46 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.953 1.301 . . . . 0.0 110.001 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.06 131.03 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.353 1.061 . . . . 0.0 109.534 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 tp -113.87 148.4 36.77 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.905 1.282 . . . . 0.0 110.819 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.42 135.57 38.82 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.402 -177.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -142.64 156.69 63.01 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 123.523 0.729 . . . . 0.0 111.68 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.13 122.98 10.09 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.644 3.563 . . . . 0.0 110.737 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -110.96 113.06 25.33 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.723 0.809 . . . . 0.0 109.571 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -117.43 70.08 6.12 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 118.709 0.686 . . . . 0.0 111.171 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.91 146.34 47.33 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.249 2.633 . . . . 0.0 110.79 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.5 p -72.5 142.97 48.54 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.615 0.766 . . . . 0.0 110.726 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.79 169.65 4.78 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.362 0.982 . . . . 0.0 112.128 -176.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -95.51 135.48 37.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.5 tp -79.77 150.48 30.76 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -75.81 0.14 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.223 1.009 . . . . 0.0 108.58 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -140.97 163.64 32.43 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.341 1.056 . . . . 0.0 110.129 -173.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -69.94 146.77 50.93 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.286 0.634 . . . . 0.0 110.829 175.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -143.25 -169.81 3.13 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.672 0.789 . . . . 0.0 110.909 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.0 pt . . . . . 0 CA--C 1.529 0.145 0 C-N-CA 124.181 0.993 . . . . 0.0 109.109 176.765 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 111.198 0.073 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -66.48 129.48 39.97 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.449 1.5 . . . . 0.0 112.137 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 p -135.15 89.33 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.281 0 C-N-CA 125.179 1.392 . . . . 0.0 108.435 -174.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.2 m -79.96 153.94 28.58 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.558 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.51 159.28 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.0 tt -122.83 121.08 62.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.451 1.101 . . . . 0.0 110.204 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -116.09 115.74 26.62 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.747 1.619 . . . . 0.0 111.615 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.1 m-90 -93.82 120.45 34.1 Favored 'General case' 0 C--N 1.337 0.063 0 C-N-CA 125.724 1.61 . . . . 0.0 110.906 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.1 t -109.33 123.54 65.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 124.537 1.135 . . . . 0.0 108.937 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -101.32 178.58 4.61 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 124.277 1.031 . . . . 0.0 110.846 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.59 -160.11 48.79 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -85.09 96.08 9.32 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -171.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.4 t -128.56 -46.79 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 124.036 0.835 . . . . 0.0 109.853 -176.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -67.92 145.64 54.37 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 123.558 0.743 . . . . 0.0 111.269 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.26 25.58 72.74 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 123.914 0.769 . . . . 0.0 112.98 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.7 t -119.37 -48.24 3.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 124.865 1.266 . . . . 0.0 109.397 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.55 30.71 2.14 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.36 1.457 . . . . 0.0 111.392 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -55.14 -40.35 70.46 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 117.52 0.66 . . . . 0.0 109.913 173.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -89.57 23.68 2.54 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.756 1.222 . . . . 0.0 112.364 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -90.11 -57.61 2.79 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.794 0.838 . . . . 0.0 109.036 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 t -73.84 -13.82 60.99 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.003 0.921 . . . . 0.0 113.31 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.7 t -65.76 -26.77 67.87 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 118.399 0.545 . . . . 0.0 111.393 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -57.48 -53.96 52.22 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.099 0.96 . . . . 0.0 109.912 175.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.67 -49.64 72.39 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.129 0.972 . . . . 0.0 111.941 -175.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.59 -53.11 60.68 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.151 0.58 . . . . 0.0 110.835 174.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.23 -33.77 29.39 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.921 0.888 . . . . 0.0 112.647 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -63.88 -35.8 81.84 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.007 0.923 . . . . 0.0 111.72 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 -69.45 -43.73 72.71 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.694 0.797 . . . . 0.0 110.309 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.3 mt -74.7 -39.42 61.95 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.754 0.821 . . . . 0.0 111.144 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.02 16.21 72.89 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.29 0.947 . . . . 0.0 112.871 -177.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.13 172.85 10.31 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 117.575 0.688 . . . . 0.0 110.915 175.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.1 p -118.73 -162.76 0.92 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -174.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 124.18 -154.14 17.71 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 169.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -168.17 161.82 12.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.095 -0.553 . . . . 0.0 112.125 170.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.09 97.31 5.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.599 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.21 175.23 6.69 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.922 0.889 . . . . 0.0 110.603 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -123.73 138.01 54.59 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.208 1.003 . . . . 0.0 109.478 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.6 mt -76.5 172.57 12.75 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.081 1.352 . . . . 0.0 110.247 173.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -90.76 4.0 52.79 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.639 1.175 . . . . 0.0 112.184 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -108.88 -10.66 15.08 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.584 1.154 . . . . 0.0 112.397 -175.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.53 -4.44 12.04 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.274 1.416 . . . . 0.0 113.668 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.07 163.86 13.31 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.919 1.288 . . . . 0.0 111.96 -171.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.6 t -127.88 118.34 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.604 1.562 . . . . 0.0 110.723 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -100.66 119.83 39.16 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.919 0.888 . . . . 0.0 111.132 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.4 t -112.09 138.84 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.563 1.545 . . . . 0.0 109.316 -173.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 t -134.42 145.2 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.008 0.923 . . . . 0.0 109.895 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.58 137.9 12.76 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-O 118.513 -0.756 . . . . 0.0 111.604 -175.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 58.4 m -107.3 177.54 4.81 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.134 1.373 . . . . 0.0 112.442 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.31 -167.68 19.37 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -73.25 140.87 47.16 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.0 0.52 . . . . 0.0 109.741 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -53.3 -47.37 69.28 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.21 0.604 . . . . 0.0 109.799 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -46.02 -34.38 5.78 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 126.451 1.977 . . . . 0.0 114.63 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -84.61 -46.48 11.49 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.804 1.242 . . . . 0.0 111.135 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.5 t -59.02 -40.76 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 122.254 0.221 . . . . 0.0 110.667 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -61.51 -25.58 67.36 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.9 0.88 . . . . 0.0 111.91 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -57.41 -49.83 74.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.57 0.748 . . . . 0.0 110.998 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -73.98 -32.69 63.53 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 118.324 0.511 . . . . 0.0 110.615 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mmm -66.6 -23.03 66.13 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 118.742 -0.646 . . . . 0.0 111.341 -177.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -45.7 -49.66 14.38 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.877 0.762 . . . . 0.0 109.548 168.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -59.41 -43.98 92.93 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.461 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.345 0.401 0 CA-C-N 119.49 1.041 . . . . 0.0 111.533 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.2 t . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -64.42 -57.25 9.81 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.61 1.164 . . . . 0.0 110.979 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -154.07 153.31 31.66 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.789 0.836 . . . . 0.0 110.301 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.73 135.37 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 123.687 0.795 . . . . 0.0 111.097 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.5 tp -127.69 147.0 50.38 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.244 1.018 . . . . 0.0 112.506 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.32 141.24 50.6 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.416 1.087 . . . . 0.0 112.303 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -142.68 158.21 60.37 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 124.852 1.261 . . . . 0.0 111.922 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.51 129.47 16.86 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 124.28 3.32 . . . . 0.0 111.716 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -121.16 129.67 53.36 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.302 1.041 . . . . 0.0 110.684 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -131.81 71.77 80.33 Favored Pre-proline 0 CA--C 1.537 0.463 0 O-C-N 121.372 -0.83 . . . . 0.0 111.211 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.45 150.19 63.65 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.241 2.628 . . . . 0.0 111.11 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 75.4 p -73.73 140.23 45.84 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.681 0.792 . . . . 0.0 110.521 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.02 179.62 25.77 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 123.938 0.78 . . . . 0.0 112.131 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -98.28 131.28 44.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.938 0.895 . . . . 0.0 108.769 171.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tp -72.55 152.94 41.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.645 1.178 . . . . 0.0 109.514 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.45 -79.93 0.13 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.837 0.855 . . . . 0.0 108.998 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -134.8 163.71 29.2 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.161 0.984 . . . . 0.0 109.938 -171.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -73.62 146.61 44.49 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.196 0.598 . . . . 0.0 110.322 173.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -140.13 -171.05 3.1 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.039 0.936 . . . . 0.0 110.158 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.8 pt . . . . . 0 CA--C 1.534 0.349 0 C-N-CA 123.968 0.907 . . . . 0.0 109.956 179.699 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.531 0.214 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.89 111.17 4.19 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.747 0.819 . . . . 0.0 111.687 -170.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 p -112.78 79.46 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 125.708 1.603 . . . . 0.0 107.331 -174.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -76.0 144.66 40.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.474 -177.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 pp -117.0 163.01 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -178.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.5 tt -124.79 116.02 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 124.911 1.284 . . . . 0.0 108.228 170.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -116.04 102.51 9.7 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.633 1.173 . . . . 0.0 110.801 -173.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.2 m-90 -82.49 112.44 19.42 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.12 0.568 . . . . 0.0 109.478 176.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.6 t -91.74 106.9 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -63.75 -37.31 86.88 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.949 0.5 . . . . 0.0 111.773 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.04 165.27 7.19 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.001 1.286 . . . . 0.0 114.854 -174.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -79.87 72.4 6.61 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.522 1.129 . . . . 0.0 111.893 -174.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.3 t -100.5 -33.31 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 124.579 1.152 . . . . 0.0 111.223 -173.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -67.34 145.73 54.8 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.883 0.473 . . . . 0.0 110.693 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.62 24.49 72.45 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 123.993 0.806 . . . . 0.0 113.323 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.5 t -118.95 -40.78 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.416 1.086 . . . . 0.0 110.319 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.95 31.41 5.69 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.148 1.356 . . . . 0.0 112.05 -177.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -48.72 -33.01 9.36 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.388 1.875 . . . . 0.0 112.927 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -72.79 57.97 0.44 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.862 2.065 . . . . 0.0 111.95 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -108.22 -69.54 0.85 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.346 1.058 . . . . 0.0 109.542 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.6 t -96.22 5.57 50.73 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.342 1.057 . . . . 0.0 112.553 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.9 t -58.36 -35.62 72.23 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 122.008 -0.432 . . . . 0.0 111.31 170.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 -61.85 -58.91 6.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.445 1.098 . . . . 0.0 110.698 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -51.85 -55.35 20.51 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.69 0.796 . . . . 0.0 110.994 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -53.21 -54.43 36.18 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.536 0.734 . . . . 0.0 111.044 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.18 -32.92 56.84 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.915 0.886 . . . . 0.0 112.622 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -67.65 -32.92 73.94 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.961 0.504 . . . . 0.0 111.631 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 40.0 mtp85 -68.17 -48.12 66.16 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.386 0.539 . . . . 0.0 110.128 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.77 -30.54 59.16 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.289 0.636 . . . . 0.0 110.696 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.84 22.43 61.58 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.404 1.478 . . . . 0.0 113.352 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.43 167.21 19.64 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.0 p -127.84 140.78 51.82 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.477 1.511 . . . . 0.0 107.348 -171.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.04 -165.11 38.52 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.675 -1.25 . . . . 0.0 112.701 -165.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -169.34 156.44 6.87 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 171.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.61 84.6 2.05 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.646 1.178 . . . . 0.0 109.215 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -89.3 168.11 12.52 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 122.974 0.509 . . . . 0.0 110.339 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -127.31 133.36 50.13 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.646 0.778 . . . . 0.0 109.511 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.4 mt -71.2 168.21 17.74 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.12 0.968 . . . . 0.0 109.755 170.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -86.51 4.44 39.88 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.867 0.867 . . . . 0.0 111.593 175.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -90.52 -56.02 3.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.827 0.851 . . . . 0.0 109.225 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 162.64 -12.34 0.11 Allowed Glycine 0 CA--C 1.53 0.99 0 CA-C-N 114.827 -1.079 . . . . 0.0 113.192 -166.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.4 m -112.76 145.61 40.25 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.295 1.048 . . . . 0.0 112.388 -164.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 86.0 t -105.37 122.44 58.71 Favored 'Isoleucine or valine' 0 C--N 1.344 0.341 0 C-N-CA 124.759 1.224 . . . . 0.0 110.652 -173.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -94.64 103.17 15.11 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.547 1.539 . . . . 0.0 110.128 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.14 124.68 56.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.7 t -128.16 135.08 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.947 0.899 . . . . 0.0 109.428 -174.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.62 125.36 6.45 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.365 -169.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 95.2 m -88.86 -178.98 5.87 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.361 1.464 . . . . 0.0 112.018 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.15 -165.91 17.39 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -74.21 136.0 42.77 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -56.85 -46.09 82.0 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.294 0.638 . . . . 0.0 110.575 -174.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -47.28 -50.93 16.14 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.617 1.58 . . . . 0.0 112.56 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -62.2 -50.68 70.84 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.751 0.82 . . . . 0.0 111.294 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.3 t -55.44 -37.86 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.823 0.849 . . . . 0.0 111.12 178.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -59.11 -33.57 71.0 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.472 0.578 . . . . 0.0 111.942 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -58.12 -42.51 85.89 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.739 0.699 . . . . 0.0 112.469 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 pp -78.54 -28.19 46.04 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.928 0.785 . . . . 0.0 111.32 175.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 7.9 mmm -67.14 -34.18 77.03 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 118.425 -0.797 . . . . 0.0 111.021 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -42.25 -53.37 4.13 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 168.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -65.49 -39.97 92.55 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 118.647 -0.692 . . . . 0.0 112.261 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 42.8 mt . . . . . 0 C--N 1.35 0.616 0 CA-C-N 119.813 1.188 . . . . 0.0 109.72 178.653 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.8 t . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.12 -64.42 0.86 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.126 0.97 . . . . 0.0 110.5 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.53 155.84 17.82 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.532 1.133 . . . . 0.0 109.169 -173.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -129.62 123.1 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.995 1.318 . . . . 0.0 109.259 -176.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.3 tp -99.72 106.87 18.83 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.1 m -99.93 130.03 46.07 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.095 0.558 . . . . 0.0 111.401 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -130.62 164.53 40.87 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 127.585 2.354 . . . . 0.0 108.469 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.05 129.29 10.45 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.089 2.526 . . . . 0.0 111.111 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -110.4 106.66 16.09 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.741 1.216 . . . . 0.0 109.979 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -106.63 86.99 2.48 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 118.635 0.652 . . . . 0.0 111.296 177.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.91 167.29 22.33 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.107 2.538 . . . . 0.0 110.829 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.5 m -87.77 129.59 35.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.012 0.925 . . . . 0.0 109.498 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.09 -177.94 27.31 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.941 0.781 . . . . 0.0 112.509 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -100.9 126.73 47.54 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.645 1.178 . . . . 0.0 109.467 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.7 tp -72.74 143.13 48.11 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 170.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.6 p -73.43 -63.39 1.2 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.238 1.015 . . . . 0.0 111.444 -171.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -132.26 166.47 21.82 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.054 1.341 . . . . 0.0 110.087 -174.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -82.3 144.64 30.46 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.083 0.553 . . . . 0.0 109.744 168.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -155.37 178.91 9.68 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 123.069 0.547 . . . . 0.0 109.759 176.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.128 0 C-N-CA 123.106 0.562 . . . . 0.0 110.626 177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 110.785 -0.08 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.24 155.11 39.67 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.235 1.014 . . . . 0.0 113.054 -176.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.34 90.99 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.304 1.042 . . . . 0.0 108.304 -174.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.7 m -78.87 153.39 30.6 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.471 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.68 149.4 18.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -176.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 tt -107.54 128.2 62.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 123.771 0.828 . . . . 0.0 109.704 176.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -121.97 101.21 7.42 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.058 1.743 . . . . 0.0 109.895 -176.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -86.37 123.52 31.7 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 124.772 1.229 . . . . 0.0 110.459 177.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.12 119.6 59.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.296 1.038 . . . . 0.0 109.292 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -92.22 175.17 6.95 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.011 1.324 . . . . 0.0 110.712 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.17 -167.52 53.43 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -84.67 84.24 7.75 Favored 'General case' 0 CA--C 1.523 -0.089 0 C-N-CA 123.083 0.553 . . . . 0.0 111.723 -169.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.94 -46.92 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 124.034 0.934 . . . . 0.0 109.442 -174.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -69.25 146.79 52.02 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-O 121.007 0.432 . . . . 0.0 111.365 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.15 20.92 73.46 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.209 0.909 . . . . 0.0 113.354 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.1 t -105.32 -42.42 7.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 C-N-CA 124.48 1.112 . . . . 0.0 109.242 175.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.48 29.07 2.81 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.653 1.597 . . . . 0.0 111.202 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -51.84 -36.55 48.61 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.483 1.113 . . . . 0.0 111.597 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.88 58.2 0.83 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.306 1.442 . . . . 0.0 112.423 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -107.24 -74.58 0.65 Allowed 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.562 1.145 . . . . 0.0 109.39 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.6 t -74.84 -18.48 60.44 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.633 -0.699 . . . . 0.0 112.002 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.4 t -43.82 -40.96 4.74 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.925 0.89 . . . . 0.0 112.286 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -67.04 -59.02 3.83 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.753 1.221 . . . . 0.0 109.675 175.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -52.76 -57.18 10.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.597 1.159 . . . . 0.0 111.343 -175.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -55.86 -51.03 68.95 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.568 0.747 . . . . 0.0 110.497 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.74 -36.55 62.43 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.807 0.443 . . . . 0.0 111.985 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -64.34 -30.97 72.0 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.365 0.666 . . . . 0.0 111.895 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 mmm-85 -67.75 -50.52 56.78 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.119 0.568 . . . . 0.0 110.597 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.9 mp -70.99 -30.05 66.19 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.827 0.451 . . . . 0.0 110.665 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.78 18.43 78.91 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.054 0.835 . . . . 0.0 112.483 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.52 175.03 10.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.705 0.802 . . . . 0.0 110.991 176.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.3 p -117.45 -161.65 0.83 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -173.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.46 -155.54 16.49 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 169.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -169.73 160.05 8.48 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 172.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.84 94.39 4.38 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.826 1.251 . . . . 0.0 110.21 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.3 174.5 6.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.506 0.722 . . . . 0.0 111.355 176.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -122.6 139.41 53.95 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.044 0.938 . . . . 0.0 109.715 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.8 mt -76.0 174.64 9.73 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 125.468 1.507 . . . . 0.0 110.258 173.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -98.67 11.7 37.72 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.968 1.307 . . . . 0.0 111.593 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -118.19 -4.54 10.96 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.806 1.242 . . . . 0.0 111.868 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.96 14.15 9.53 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.947 1.26 . . . . 0.0 114.483 176.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.8 168.57 10.1 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.504 1.522 . . . . 0.0 111.937 -170.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 73.1 t -130.7 120.99 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.312 1.045 . . . . 0.0 111.44 -174.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -101.98 118.04 36.09 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.081 0.952 . . . . 0.0 110.997 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.5 t -112.47 137.6 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 123.631 0.773 . . . . 0.0 110.027 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.22 144.31 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.689 0.796 . . . . 0.0 109.886 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.06 132.05 8.92 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-O 118.52 -0.753 . . . . 0.0 111.294 -174.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 89.7 m -100.43 -179.56 4.14 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.804 1.242 . . . . 0.0 112.365 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.2 -161.8 20.81 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -75.05 126.36 30.85 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 122.793 0.437 . . . . 0.0 110.096 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -49.18 -50.63 37.07 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 124.142 0.977 . . . . 0.0 110.594 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -48.16 -40.21 21.08 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.92 1.724 . . . . 0.0 113.652 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -77.57 -48.54 16.7 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.776 0.83 . . . . 0.0 111.132 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.0 -39.94 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 122.715 0.406 . . . . 0.0 111.114 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -61.77 -27.27 68.62 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -59.25 -48.12 82.8 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.193 0.451 . . . . 0.0 110.469 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.46 -30.74 63.37 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.889 0.313 . . . . 0.0 111.302 178.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mmt -67.55 -20.07 65.36 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-O 118.913 -0.565 . . . . 0.0 112.415 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -46.13 -50.98 14.83 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 168.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -61.27 -41.85 97.65 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 C--N 1.344 0.35 0 C-N-CA 123.812 0.845 . . . . 0.0 110.6 -179.781 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.7 t . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -60.7 -65.58 0.67 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.089 0.556 . . . . 0.0 109.892 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.6 mtm-85 -150.56 156.29 41.11 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.539 1.135 . . . . 0.0 109.6 -176.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.3 t -137.82 130.15 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 123.715 0.806 . . . . 0.0 110.522 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tp -113.38 135.35 53.96 Favored 'General case' 0 C--N 1.346 0.448 0 C-N-CA 125.21 1.404 . . . . 0.0 112.058 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.55 137.31 54.93 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.314 1.045 . . . . 0.0 111.985 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -145.27 159.06 50.17 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.645 1.178 . . . . 0.0 111.68 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.92 136.53 25.22 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.967 3.111 . . . . 0.0 111.666 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -127.13 125.43 41.18 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.672 1.189 . . . . 0.0 111.106 -175.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -129.7 70.91 82.16 Favored Pre-proline 0 CA--C 1.535 0.403 0 O-C-N 121.696 -0.627 . . . . 0.0 111.37 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.63 142.31 35.9 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.894 2.396 . . . . 0.0 110.776 -176.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.5 p -70.82 140.97 51.35 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.663 0.785 . . . . 0.0 110.85 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.99 173.04 23.95 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.106 0.86 . . . . 0.0 111.638 -175.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -96.1 135.34 38.03 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -76.25 151.99 36.65 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.3 m -80.88 -76.73 0.23 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -177.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -134.47 165.76 24.45 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.717 1.207 . . . . 0.0 110.223 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -72.88 149.79 43.17 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.711 0.804 . . . . 0.0 110.353 172.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -151.24 -169.54 3.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.005 0.922 . . . . 0.0 110.002 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.8 pt . . . . . 0 CA--C 1.533 0.29 0 C-N-CA 124.271 1.028 . . . . 0.0 109.542 176.943 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.456 -0.174 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.05 144.22 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.909 1.684 . . . . 0.0 111.672 176.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 p -139.44 88.2 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.199 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.7 m -81.7 152.78 26.91 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.403 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.5 146.76 19.27 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -176.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 tt -109.36 122.29 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 124.271 1.029 . . . . 0.0 109.877 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.55 116.56 28.99 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.971 1.308 . . . . 0.0 111.024 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.7 m-90 -96.56 121.99 38.99 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.768 0.827 . . . . 0.0 110.16 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.6 t -104.5 115.32 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.397 1.079 . . . . 0.0 108.848 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -87.49 178.56 6.77 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.76 1.224 . . . . 0.0 111.453 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.29 -159.71 50.46 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -88.37 99.49 12.29 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.114 -174.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -130.74 -43.71 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 123.441 0.697 . . . . 0.0 109.756 -177.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -70.4 143.77 51.76 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.596 0.758 . . . . 0.0 109.969 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.6 18.61 79.7 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 119.26 -0.745 . . . . 0.0 113.31 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 83.5 t -107.52 -43.63 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.577 1.151 . . . . 0.0 109.527 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 116.35 28.5 2.56 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 125.187 1.375 . . . . 0.0 111.446 -177.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -50.93 -32.71 21.6 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 123.627 0.771 . . . . 0.0 111.192 176.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -76.51 58.71 1.38 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.838 0.855 . . . . 0.0 112.764 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -95.18 -70.32 0.72 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 t -92.85 -2.54 55.8 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.496 -0.764 . . . . 0.0 111.656 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 t -45.48 -36.93 4.81 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.095 0.861 . . . . 0.0 112.403 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -73.72 -60.31 2.31 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.266 1.026 . . . . 0.0 109.806 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -50.3 -59.14 4.26 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.271 1.028 . . . . 0.0 111.002 -175.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.9 -53.28 34.06 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 125.589 1.556 . . . . 0.0 110.057 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.49 -37.84 70.93 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.618 0.367 . . . . 0.0 111.732 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.3 tttm -61.87 -31.72 72.02 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.249 1.019 . . . . 0.0 111.7 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.26 -52.32 48.71 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.261 0.624 . . . . 0.0 110.946 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.6 mt -72.23 -31.11 65.54 Favored 'General case' 0 CA--C 1.528 0.124 0 O-C-N 122.849 0.093 . . . . 0.0 110.812 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.66 6.94 82.48 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.064 0.84 . . . . 0.0 112.596 -178.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.15 178.14 2.93 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.817 0.808 . . . . 0.0 111.326 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 43.7 p -125.79 -169.05 1.94 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -175.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 130.85 -151.49 19.62 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 171.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -170.91 167.48 7.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.438 -0.381 . . . . 0.0 111.421 173.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -131.69 97.07 4.11 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.793 0.683 . . . . 0.0 111.435 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.4 mttp -93.28 174.01 7.43 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.969 1.308 . . . . 0.0 110.142 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -124.24 135.25 53.28 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.431 1.092 . . . . 0.0 109.628 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.8 mt -74.95 171.82 13.38 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.077 1.351 . . . . 0.0 109.847 177.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -93.66 4.96 53.13 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.587 0.755 . . . . 0.0 111.571 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -107.25 -14.53 14.87 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.64 1.176 . . . . 0.0 111.724 -177.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.92 7.6 8.53 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.015 1.293 . . . . 0.0 113.91 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.9 168.68 8.97 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.946 1.298 . . . . 0.0 111.336 -172.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.0 t -129.01 120.25 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.391 1.077 . . . . 0.0 110.549 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -95.71 127.16 41.5 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.82 0.848 . . . . 0.0 110.232 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.27 136.22 58.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 124.389 1.075 . . . . 0.0 109.525 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.24 143.37 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 124.012 0.925 . . . . 0.0 109.356 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.69 138.23 15.98 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 118.856 -0.592 . . . . 0.0 110.668 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 61.5 m -103.0 178.5 4.54 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.867 1.267 . . . . 0.0 111.435 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.94 -159.82 18.03 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -78.76 132.54 36.97 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 124.965 1.306 . . . . 0.0 109.408 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -46.84 -55.9 7.18 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.491 1.116 . . . . 0.0 110.683 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -49.99 -43.87 40.84 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.238 1.399 . . . . 0.0 112.767 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -67.07 -46.43 74.35 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.295 1.038 . . . . 0.0 111.187 176.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 77.4 t -54.05 -41.17 49.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.163 0.585 . . . . 0.0 110.408 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.24 -26.97 68.11 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -59.77 -27.12 66.26 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.259 1.024 . . . . 0.0 112.712 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.02 -29.81 13.43 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.48 0.582 . . . . 0.0 110.774 172.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.2 mmt -62.72 -23.56 67.22 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-O 118.722 -0.656 . . . . 0.0 111.418 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.48 -57.62 3.97 Favored 'General case' 0 C--O 1.248 0.985 0 C-N-CA 122.966 0.506 . . . . 0.0 110.027 173.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -65.31 -32.34 73.94 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 118.656 0.662 . . . . 0.0 112.07 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 C--N 1.349 0.575 0 CA-C-N 119.054 0.843 . . . . 0.0 109.832 178.938 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 87.8 t . . . . . 0 CA--C 1.529 0.138 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -63.05 -61.75 2.17 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.378 0.671 . . . . 0.0 109.31 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.9 mmm-85 -152.19 161.53 42.48 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.046 1.339 . . . . 0.0 109.801 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.1 t -142.24 140.38 29.28 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 124.202 1.001 . . . . 0.0 109.754 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.4 tp -129.14 157.32 42.11 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.816 0.847 . . . . 0.0 111.108 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.91 129.77 26.38 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.079 0.951 . . . . 0.0 111.221 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.31 158.83 73.16 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.112 1.365 . . . . 0.0 110.424 -177.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -71.66 130.51 17.16 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.517 3.478 . . . . 0.0 110.834 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -119.24 117.52 28.83 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.626 1.17 . . . . 0.0 109.767 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -125.55 68.2 59.76 Favored Pre-proline 0 CA--C 1.535 0.367 0 O-C-N 121.873 -0.517 . . . . 0.0 110.546 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.47 140.99 37.56 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.411 2.741 . . . . 0.0 110.432 -175.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.6 p -72.4 145.07 47.94 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.427 0.691 . . . . 0.0 110.797 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.66 170.35 3.95 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.381 0.991 . . . . 0.0 112.131 -176.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -92.21 138.13 31.79 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.8 tp -80.96 152.13 28.17 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 99.5 m -75.26 -73.96 0.23 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -146.54 167.38 23.86 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.396 0.678 . . . . 0.0 110.859 -176.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -70.39 144.72 51.48 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.951 0.501 . . . . 0.0 110.388 176.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -145.48 -176.78 5.25 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 122.999 0.52 . . . . 0.0 110.562 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.5 tt . . . . . 0 N--CA 1.45 -0.441 0 C-N-CA 123.305 0.642 . . . . 0.0 109.362 -179.689 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.311 0 N-CA-C 110.608 -0.145 . . . . 0.0 110.608 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.6 159.08 13.82 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.427 1.091 . . . . 0.0 112.496 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.0 p -143.83 89.63 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.6 m -75.55 153.71 37.24 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.76 174.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pp -143.13 155.82 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 123.068 0.547 . . . . 0.0 110.064 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.5 tp -112.84 118.55 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 125.004 1.322 . . . . 0.0 108.739 177.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -113.36 111.09 21.41 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.09 0.956 . . . . 0.0 110.384 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -92.41 121.02 33.47 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.801 0.84 . . . . 0.0 110.287 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.0 t -104.98 120.03 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.436 1.095 . . . . 0.0 108.932 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -95.27 176.39 6.23 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.309 1.044 . . . . 0.0 111.559 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.25 -156.39 48.63 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.5 mtt-85 -87.96 93.16 9.39 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 123.417 0.687 . . . . 0.0 111.85 -173.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 t -127.41 -45.88 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.205 1.002 . . . . 0.0 109.974 -175.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -70.68 141.83 51.59 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.35 0.66 . . . . 0.0 110.1 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.67 15.09 80.2 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.104 -0.831 . . . . 0.0 113.371 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.1 t -111.98 -44.28 5.1 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 C-N-CA 124.561 1.145 . . . . 0.0 109.764 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.56 23.01 2.94 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.262 1.41 . . . . 0.0 111.893 -176.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -59.32 -25.34 64.08 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 117.785 0.792 . . . . 0.0 111.988 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.74 30.62 4.25 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.584 1.554 . . . . 0.0 111.687 175.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -94.46 -61.21 1.55 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.76 0.709 . . . . 0.0 109.383 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.9 t -78.21 -1.7 34.12 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 t -59.58 -26.74 65.67 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.057 0.543 . . . . 0.0 111.299 173.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -70.95 -55.64 7.93 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.224 0.61 . . . . 0.0 110.728 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -52.37 -57.03 11.07 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.027 0.531 . . . . 0.0 111.177 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -47.05 73.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.263 0.625 . . . . 0.0 110.414 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.43 -29.69 50.15 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.8 tttm -69.53 -31.53 69.81 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.231 1.012 . . . . 0.0 111.802 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.8 mmm-85 -72.84 -37.2 67.51 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.018 0.927 . . . . 0.0 111.06 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -85.9 -30.18 23.06 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.909 0.884 . . . . 0.0 111.506 178.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.67 21.21 79.63 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.47 0.557 . . . . 0.0 112.374 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.58 178.02 8.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.961 0.904 . . . . 0.0 111.111 177.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.3 p -123.18 -164.22 1.19 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -175.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.2 -151.53 18.14 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 171.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -169.22 162.91 10.83 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.05 99.79 6.41 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.1 0.96 . . . . 0.0 111.477 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -100.06 172.85 6.94 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.717 1.207 . . . . 0.0 110.936 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -124.12 135.17 53.34 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.796 1.239 . . . . 0.0 108.753 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.8 mt -75.64 173.0 11.63 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.015 1.326 . . . . 0.0 110.08 175.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -95.3 8.1 44.18 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.053 0.941 . . . . 0.0 111.729 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -111.58 -2.6 15.38 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.899 1.28 . . . . 0.0 112.137 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.99 7.21 31.42 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.94 1.257 . . . . 0.0 113.949 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 75.4 m -102.92 165.82 10.81 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.513 1.525 . . . . 0.0 111.127 -173.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 91.4 t -128.57 122.77 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.688 1.195 . . . . 0.0 110.524 -177.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -99.32 123.43 43.59 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 124.187 0.995 . . . . 0.0 110.947 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.9 t -121.23 133.44 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.182 0.593 . . . . 0.0 109.631 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.9 t -126.01 142.79 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 124.646 1.178 . . . . 0.0 109.45 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.36 132.86 12.04 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 118.607 -0.711 . . . . 0.0 111.158 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.42 178.64 4.69 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 175.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.96 -157.69 20.64 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.789 1.185 . . . . 0.0 110.201 178.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -75.94 122.43 24.16 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.67 1.188 . . . . 0.0 109.572 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -45.84 -51.82 12.32 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.472 1.109 . . . . 0.0 111.071 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.29 -47.35 56.12 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.483 1.516 . . . . 0.0 113.129 177.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -65.44 -47.76 75.06 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.395 0.598 . . . . 0.0 110.299 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.5 t -57.56 -33.06 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 122.723 0.409 . . . . 0.0 110.751 176.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.48 -32.28 73.16 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.941 0.896 . . . . 0.0 112.949 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -56.64 -27.48 58.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.004 0.922 . . . . 0.0 112.461 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.36 -30.97 13.1 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 118.622 0.646 . . . . 0.0 111.289 173.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.3 mmm -63.6 -22.45 66.9 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-O 118.624 -0.703 . . . . 0.0 112.444 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -44.27 -55.9 4.55 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.335 0.516 . . . . 0.0 110.254 173.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -61.92 -41.92 98.5 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.147 0.579 . . . . 0.0 111.782 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.4 mt . . . . . 0 C--N 1.346 0.422 0 C-N-CA 123.785 0.834 . . . . 0.0 109.707 -179.938 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.6 t . . . . . 0 CA--C 1.532 0.259 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.43 -50.89 71.57 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.251 0.621 . . . . 0.0 111.108 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -169.04 153.42 5.57 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 123.396 0.678 . . . . 0.0 109.623 -177.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.5 t -141.96 134.76 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.138 0.575 . . . . 0.0 109.537 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.5 tp -120.43 156.14 32.05 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.976 0.91 . . . . 0.0 110.928 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.12 129.5 27.68 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.853 0.861 . . . . 0.0 110.873 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -132.73 154.93 81.65 Favored Pre-proline 0 CA--C 1.539 0.558 0 C-N-CA 124.499 1.12 . . . . 0.0 110.14 -177.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.89 125.63 11.75 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 124.857 3.704 . . . . 0.0 111.067 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -117.16 127.31 54.0 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.721 0.809 . . . . 0.0 110.844 -178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -133.63 70.49 75.91 Favored Pre-proline 0 CA--C 1.536 0.42 0 O-C-N 121.526 -0.734 . . . . 0.0 110.495 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.15 136.88 35.8 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 124.057 3.171 . . . . 0.0 109.984 -177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.6 p -61.48 143.76 55.36 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.642 0.777 . . . . 0.0 111.101 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.95 171.02 5.69 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.079 0.847 . . . . 0.0 112.112 -175.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -89.0 135.74 33.39 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mp -74.13 150.09 40.67 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.303 0.641 . . . . 0.0 109.678 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.61 -77.96 0.2 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.349 1.059 . . . . 0.0 108.625 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -143.78 164.71 29.73 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.613 0.765 . . . . 0.0 110.944 -174.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -70.96 144.86 50.39 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.973 0.509 . . . . 0.0 110.357 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -137.81 -179.35 5.71 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 124.101 0.961 . . . . 0.0 110.403 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.9 tt . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -177.189 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.535 0.368 0 CA-C-O 119.821 -0.133 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.13 134.4 49.28 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.267 1.027 . . . . 0.0 111.557 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 p -140.63 94.98 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 C-N-CA 124.551 1.141 . . . . 0.0 108.484 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.4 m -92.75 153.88 18.64 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.933 -177.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pp -143.6 156.46 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -174.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 tt -116.37 119.26 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.148 0.979 . . . . 0.0 109.418 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -109.9 108.33 18.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.88 1.272 . . . . 0.0 109.951 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -91.76 123.04 34.85 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.991 0.916 . . . . 0.0 110.235 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.9 t -99.15 108.52 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.586 1.155 . . . . 0.0 108.768 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -73.26 177.49 5.1 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.815 0.846 . . . . 0.0 111.426 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.95 -169.4 42.66 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 177.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -92.01 92.04 8.11 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.798 0.439 . . . . 0.0 110.881 -175.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -114.28 -31.06 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.101 0.96 . . . . 0.0 110.909 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -70.67 148.43 48.05 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.895 0.316 . . . . 0.0 110.52 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.75 22.81 54.95 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 123.753 0.692 . . . . 0.0 112.954 176.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.8 t -116.06 -48.97 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 C-N-CA 124.884 1.273 . . . . 0.0 109.41 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.67 32.29 1.23 Allowed Glycine 0 C--N 1.339 0.714 0 C-N-CA 125.251 1.405 . . . . 0.0 111.512 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -50.44 -36.81 34.96 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 123.848 0.859 . . . . 0.0 111.434 177.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.05 55.3 0.71 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.64 1.176 . . . . 0.0 112.058 177.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -94.54 -73.64 0.57 Allowed 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.337 0.655 . . . . 0.0 109.277 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.9 t -89.0 -1.59 58.18 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.435 0.694 . . . . 0.0 111.642 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.9 t -47.51 -36.93 11.03 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.752 0.821 . . . . 0.0 112.294 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -71.8 -55.96 6.64 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.442 1.097 . . . . 0.0 110.508 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -53.79 -54.15 42.27 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.677 0.791 . . . . 0.0 110.678 -176.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.15 -48.13 68.21 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.233 1.013 . . . . 0.0 110.515 177.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.42 -26.44 53.54 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -73.55 -28.28 61.79 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.806 0.843 . . . . 0.0 111.942 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.9 mtp85 -71.91 -41.89 67.38 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.321 1.049 . . . . 0.0 110.119 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -86.51 -52.67 5.43 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.558 0.743 . . . . 0.0 111.413 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.54 8.51 46.14 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.206 0.907 . . . . 0.0 112.995 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.15 167.57 2.31 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.969 0.884 . . . . 0.0 111.674 174.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.7 p -128.09 155.37 44.51 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.87 -147.95 17.38 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -169.35 166.27 10.48 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 173.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.4 100.73 5.46 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.803 0.841 . . . . 0.0 111.678 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -105.44 179.26 4.32 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.612 1.165 . . . . 0.0 110.835 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -123.51 138.99 54.46 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.673 1.189 . . . . 0.0 109.089 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.79 177.84 4.58 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.424 1.09 . . . . 0.0 110.349 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -101.14 13.31 35.54 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.296 1.038 . . . . 0.0 111.18 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -117.53 -15.46 10.24 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.863 1.265 . . . . 0.0 111.891 -177.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.0 5.66 8.02 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.012 1.292 . . . . 0.0 114.215 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 m -106.17 169.6 8.41 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.535 1.534 . . . . 0.0 111.564 -172.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.7 t -126.8 127.31 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.952 0.901 . . . . 0.0 110.448 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -105.06 122.24 45.46 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 123.725 0.81 . . . . 0.0 110.951 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.73 139.05 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 123.116 0.566 . . . . 0.0 109.632 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.2 t -130.22 142.6 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 124.276 1.031 . . . . 0.0 109.234 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.33 139.92 20.65 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.465 -176.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -111.64 -179.63 3.76 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.15 1.78 . . . . 0.0 110.911 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.43 -155.05 24.69 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.85 130.57 35.12 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 117.593 0.696 . . . . 0.0 110.179 -178.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -48.63 -50.39 33.04 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.399 1.08 . . . . 0.0 111.006 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.95 -52.15 31.8 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.143 1.354 . . . . 0.0 112.335 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -61.94 -46.62 88.53 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.084 0.954 . . . . 0.0 110.601 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.9 t -56.79 -41.84 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 122.319 0.247 . . . . 0.0 110.868 176.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -60.69 -26.59 67.24 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -60.64 -28.7 68.76 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.046 0.939 . . . . 0.0 112.401 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.0 -29.7 13.5 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.001 0.521 . . . . 0.0 111.0 174.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.4 mmt -64.15 -21.42 66.55 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.99 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -46.9 -59.05 3.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 118.37 0.532 . . . . 0.0 110.167 173.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -63.02 -33.35 75.23 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.571 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt . . . . . 0 CA--C 1.535 0.4 0 CA-C-N 119.221 0.918 . . . . 0.0 110.035 178.242 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 64.6 t . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.35 -57.48 12.12 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.606 0.762 . . . . 0.0 110.027 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -165.66 172.88 11.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.286 1.034 . . . . 0.0 109.863 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.74 125.16 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.878 0.871 . . . . 0.0 109.663 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.86 155.85 18.91 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.609 1.163 . . . . 0.0 110.784 177.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.18 129.39 27.39 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.293 1.037 . . . . 0.0 111.113 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.37 156.59 79.61 Favored Pre-proline 0 N--CA 1.47 0.563 0 C-N-CA 124.714 1.206 . . . . 0.0 110.429 -177.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.87 124.41 11.01 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 124.873 3.715 . . . . 0.0 111.052 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -116.45 119.07 34.46 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.085 0.954 . . . . 0.0 110.895 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -124.9 69.68 57.93 Favored Pre-proline 0 CA--C 1.535 0.373 0 O-C-N 121.526 -0.733 . . . . 0.0 110.83 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.06 141.11 43.16 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.248 2.632 . . . . 0.0 110.492 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.4 m -69.81 143.36 52.94 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.587 0.755 . . . . 0.0 110.572 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.76 169.43 4.63 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.14 0.876 . . . . 0.0 112.041 -176.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -92.48 135.1 34.34 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.7 tp -78.87 150.49 32.2 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.75 -77.32 0.11 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -141.11 163.78 32.05 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.08 0.952 . . . . 0.0 110.023 -173.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -71.12 146.53 49.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.15 0.58 . . . . 0.0 110.767 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -140.56 -171.11 3.15 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.336 1.055 . . . . 0.0 110.437 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.8 pp . . . . . 0 CA--C 1.53 0.191 0 C-N-CA 124.55 1.14 . . . . 0.0 109.619 179.699 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.5 m . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 110.701 -0.111 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.26 136.03 56.11 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.84 1.256 . . . . 0.0 112.095 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 p -141.04 91.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.271 0 C-N-CA 124.576 1.151 . . . . 0.0 108.511 -174.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.4 m -81.58 156.48 25.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.7 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 pp -143.7 159.37 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 tt -118.45 118.04 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.665 1.186 . . . . 0.0 109.276 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -108.81 108.51 19.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.898 1.279 . . . . 0.0 110.341 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -90.77 124.3 35.02 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.908 0.883 . . . . 0.0 110.188 177.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.2 t -106.15 124.59 61.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.919 1.288 . . . . 0.0 108.379 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -96.32 179.8 4.91 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.134 1.374 . . . . 0.0 110.589 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.31 -166.09 51.01 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.1 mtt180 -86.72 93.64 9.3 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 122.696 0.398 . . . . 0.0 111.652 -171.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.4 t -123.25 -41.44 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 123.676 0.79 . . . . 0.0 110.398 -174.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -69.74 144.47 52.74 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.042 0.537 . . . . 0.0 109.902 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.9 12.72 83.13 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.949 -0.917 . . . . 0.0 113.578 178.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.5 t -108.76 -49.21 7.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 CA-C-N 118.374 1.087 . . . . 0.0 109.682 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.01 29.4 1.51 Allowed Glycine 0 C--N 1.338 0.663 0 C-N-CA 124.476 1.036 . . . . 0.0 112.031 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -51.66 -36.21 45.37 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.005 0.903 . . . . 0.0 111.183 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.47 56.08 0.66 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.028 1.331 . . . . 0.0 112.069 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -107.87 -71.54 0.75 Allowed 'General case' 0 C--N 1.34 0.174 0 C-N-CA 124.832 1.253 . . . . 0.0 109.47 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.6 t -70.95 -21.62 62.32 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.009 0.524 . . . . 0.0 111.486 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.4 t -47.1 -38.13 10.9 Favored 'General case' 0 C--N 1.345 0.408 0 C-N-CA 123.683 0.793 . . . . 0.0 111.695 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -69.93 -56.47 6.94 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.127 0.971 . . . . 0.0 110.189 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -51.99 -56.84 11.76 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.098 0.959 . . . . 0.0 111.018 -176.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -56.47 -51.54 68.07 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 123.367 0.667 . . . . 0.0 110.23 178.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.38 -30.13 50.97 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.088 0.555 . . . . 0.0 112.439 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -64.57 -36.57 84.67 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.649 0.779 . . . . 0.0 111.192 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -72.38 -48.92 37.84 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.334 1.054 . . . . 0.0 110.256 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.1 mp -67.88 -38.21 82.75 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.964 0.906 . . . . 0.0 110.746 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.23 12.85 83.51 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 123.874 0.749 . . . . 0.0 112.684 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.68 177.59 2.44 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.805 0.842 . . . . 0.0 110.92 176.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.0 p -121.91 -165.7 1.3 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.37 -151.92 16.9 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 171.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -171.77 164.65 6.56 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 123.817 0.363 . . . . 0.0 111.727 173.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.21 90.3 3.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.009 0.924 . . . . 0.0 111.898 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -92.38 178.64 5.77 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 124.534 1.134 . . . . 0.0 110.897 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -121.71 140.73 51.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.293 1.037 . . . . 0.0 110.029 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.7 mt -73.94 174.95 7.83 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.842 1.257 . . . . 0.0 110.304 174.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -99.76 13.12 34.8 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.394 1.078 . . . . 0.0 111.442 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -119.25 -9.05 10.02 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.339 1.056 . . . . 0.0 112.148 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.13 24.76 4.08 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.917 1.246 . . . . 0.0 114.159 176.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.89 170.4 11.12 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.247 1.419 . . . . 0.0 111.482 -172.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.1 t -129.79 127.31 63.95 Favored 'Isoleucine or valine' 0 C--N 1.346 0.443 0 C-N-CA 123.836 0.855 . . . . 0.0 110.6 -175.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -108.46 123.2 48.51 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.577 0.751 . . . . 0.0 110.031 -177.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.4 t -117.14 136.39 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 123.778 0.831 . . . . 0.0 109.11 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -129.53 144.26 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 124.221 1.009 . . . . 0.0 108.997 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.43 141.4 18.24 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 118.695 -0.669 . . . . 0.0 110.616 -176.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.6 m -111.47 179.88 3.9 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.868 1.267 . . . . 0.0 111.784 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.04 -161.32 23.43 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.79 123.64 25.95 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.152 0.981 . . . . 0.0 110.576 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.73 -46.55 59.14 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.038 0.935 . . . . 0.0 110.108 -176.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -44.61 -41.81 7.13 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 126.057 1.789 . . . . 0.0 113.332 177.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -78.78 -50.74 10.82 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.462 0.705 . . . . 0.0 110.651 174.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -49.96 -40.76 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 118.441 0.564 . . . . 0.0 111.747 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.16 -30.8 69.56 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.71 1.604 . . . . 0.0 112.178 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -56.4 -40.79 75.24 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 124.46 1.104 . . . . 0.0 110.819 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.36 -30.53 27.35 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.672 0.669 . . . . 0.0 111.093 175.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.5 mmt -63.91 -20.18 65.65 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 118.586 -0.721 . . . . 0.0 112.02 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -45.56 -51.61 11.67 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.504 0.593 . . . . 0.0 110.411 174.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -62.29 -40.39 96.09 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.855 0.862 . . . . 0.0 111.965 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.4 mt . . . . . 0 N--CA 1.467 0.41 0 C-N-CA 123.957 0.903 . . . . 0.0 110.377 178.388 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.4 t . . . . . 0 CA--C 1.531 0.227 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -69.71 -54.57 13.17 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.942 0.897 . . . . 0.0 110.195 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -156.81 163.67 38.95 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.65 0.78 . . . . 0.0 110.252 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.55 138.64 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.889 0.876 . . . . 0.0 109.835 -178.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.05 156.63 34.49 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.57 1.148 . . . . 0.0 110.991 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.51 129.14 26.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.035 0.934 . . . . 0.0 111.231 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.9 157.77 77.31 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 124.936 1.294 . . . . 0.0 110.491 -177.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -70.77 126.22 12.42 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 124.795 3.663 . . . . 0.0 111.003 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -118.63 135.47 54.43 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.017 0.927 . . . . 0.0 110.193 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -138.61 75.35 37.9 Favored Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 121.715 -0.616 . . . . 0.0 110.886 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.78 149.34 60.2 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.641 2.894 . . . . 0.0 110.674 -176.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.3 p -76.27 144.33 40.38 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.674 0.79 . . . . 0.0 110.597 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.3 169.99 4.41 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.401 1.0 . . . . 0.0 112.128 -176.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -88.65 137.01 32.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mp -79.02 150.55 31.89 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.527 0.731 . . . . 0.0 109.492 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -76.67 0.19 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.336 1.054 . . . . 0.0 108.448 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -143.03 162.43 35.5 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.587 0.755 . . . . 0.0 110.741 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -75.63 145.6 40.95 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.099 0.559 . . . . 0.0 110.429 177.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -144.98 148.29 33.62 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 123.713 0.805 . . . . 0.0 109.912 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.522 0 O-C-N 121.977 -0.452 . . . . 0.0 110.802 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 CA--C 1.527 0.079 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -71.91 105.75 3.95 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.572 0.701 . . . . 0.0 110.537 -173.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.7 p -98.64 77.9 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.7 m -73.22 144.92 46.56 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -176.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.0 pp -112.77 166.69 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.3 tt -125.89 99.44 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 166.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.29 98.16 9.45 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.416 1.087 . . . . 0.0 109.593 -174.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 20.9 m-90 -79.49 100.19 7.6 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -82.62 90.75 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -177.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -72.1 159.68 33.75 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.984 0.421 . . . . 0.0 112.002 -169.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.4 -164.85 19.14 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 124.418 1.009 . . . . 0.0 111.66 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -93.62 82.52 4.37 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.662 0.785 . . . . 0.0 110.403 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.4 t -108.63 -47.56 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.674 1.19 . . . . 0.0 111.156 -167.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -62.12 157.26 19.5 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.126 0.97 . . . . 0.0 111.958 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.64 -43.67 3.19 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.091 0.853 . . . . 0.0 112.178 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.3 t -60.17 -39.27 80.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.543 1.137 . . . . 0.0 111.356 -176.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.69 33.1 2.73 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.306 1.431 . . . . 0.0 111.458 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -47.16 -34.78 6.55 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 126.559 1.943 . . . . 0.0 112.831 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.15 36.04 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.656 1.582 . . . . 0.0 113.007 171.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -60.84 -59.41 5.42 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.973 0.909 . . . . 0.0 110.464 -170.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 t -124.58 12.0 8.6 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.785 1.234 . . . . 0.0 111.701 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.7 t -47.44 -43.46 23.99 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -62.39 -51.5 67.32 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.706 1.202 . . . . 0.0 110.702 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -53.03 -57.98 8.55 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.329 0.652 . . . . 0.0 110.322 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.32 -49.82 63.47 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.767 1.227 . . . . 0.0 110.784 178.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.25 -38.52 68.62 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.259 0.624 . . . . 0.0 111.787 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -68.44 -28.06 66.73 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.911 0.884 . . . . 0.0 111.949 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 -62.49 -47.68 82.89 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.632 0.651 . . . . 0.0 109.522 175.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 62.7 mt -77.76 -32.55 52.7 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.508 0.723 . . . . 0.0 111.05 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.47 30.99 61.46 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.986 1.279 . . . . 0.0 112.437 -176.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.61 169.2 17.33 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.499 0.72 . . . . 0.0 112.179 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.4 p -127.31 147.24 50.25 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.857 0.863 . . . . 0.0 109.232 -168.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.51 -145.26 15.24 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -171.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -176.26 155.49 1.5 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.314 0.645 . . . . 0.0 111.255 174.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.88 93.85 6.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.489 1.116 . . . . 0.0 109.056 166.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -93.06 173.45 7.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 170.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -124.84 148.2 48.35 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 123.727 0.811 . . . . 0.0 110.132 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 35.5 mt -84.53 175.21 9.43 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.349 1.06 . . . . 0.0 110.046 172.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -87.57 18.83 3.68 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.386 1.074 . . . . 0.0 110.632 169.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -96.1 -53.12 3.76 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 125.009 1.324 . . . . 0.0 109.499 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.87 -17.1 1.4 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.492 1.044 . . . . 0.0 112.08 -160.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.1 p -107.61 153.8 22.37 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.372 1.069 . . . . 0.0 112.427 -162.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.7 t -102.47 121.17 53.22 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 124.727 1.211 . . . . 0.0 109.237 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -90.32 97.15 11.02 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 173.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.2 t -90.51 119.79 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.5 t -114.0 126.81 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.81 114.34 5.98 Favored 'General case' 0 CA--C 1.522 -0.106 0 O-C-N 123.911 0.757 . . . . 0.0 110.822 -168.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 87.7 m -80.21 -176.43 5.58 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 124.659 1.184 . . . . 0.0 110.78 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.06 -176.2 21.8 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -177.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -74.87 150.09 39.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -53.82 -46.48 71.16 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.202 0.601 . . . . 0.0 110.414 -176.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -47.09 -48.89 19.32 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.062 1.792 . . . . 0.0 112.914 174.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -63.98 -54.23 37.76 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 117.501 0.65 . . . . 0.0 111.27 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.5 t -58.17 -34.77 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.132 0.973 . . . . 0.0 111.602 -177.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -53.46 -40.29 65.16 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.052 0.541 . . . . 0.0 111.101 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -65.87 -37.87 87.3 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.67 0.668 . . . . 0.0 112.347 -172.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -75.69 -35.24 60.38 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.484 0.584 . . . . 0.0 110.972 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 43.9 mtm -65.67 -39.41 91.31 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 176.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -47.93 -40.47 22.1 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.563 0.745 . . . . 0.0 111.571 173.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 28.9 t90 -78.62 -37.2 42.8 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.245 -0.884 . . . . 0.0 110.737 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.1 mt . . . . . 0 C--N 1.345 0.385 0 CA-C-N 119.813 1.188 . . . . 0.0 110.911 -179.591 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 66.7 t . . . . . 0 CA--C 1.53 0.195 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -64.84 -55.74 17.7 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.439 0.695 . . . . 0.0 111.568 -175.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -171.63 148.42 2.45 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 125.432 1.493 . . . . 0.0 107.141 -175.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 p -119.5 126.49 75.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 123.041 0.537 . . . . 0.0 110.27 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.4 tp -103.58 118.79 37.54 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 123.527 0.731 . . . . 0.0 109.175 173.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.4 m -101.74 138.34 38.86 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.621 0.769 . . . . 0.0 109.622 169.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -130.55 154.3 81.63 Favored Pre-proline 0 CA--C 1.53 0.192 0 C-N-CA 125.413 1.485 . . . . 0.0 108.525 171.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -70.51 104.24 1.41 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.212 2.608 . . . . 0.0 109.705 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -85.18 111.61 19.97 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.377 1.071 . . . . 0.0 109.482 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.71 86.71 1.02 Allowed Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 124.157 0.983 . . . . 0.0 109.754 175.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.22 165.33 32.92 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.231 1.954 . . . . 0.0 109.646 169.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.9 m -74.96 123.18 24.66 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.98 -151.91 47.13 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -173.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -126.02 147.53 49.53 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.965 1.306 . . . . 0.0 108.57 171.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 31.6 tp -72.59 156.44 38.99 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.6 p -66.05 -55.76 14.99 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.451 1.1 . . . . 0.0 111.585 -178.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -140.46 166.81 23.7 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.592 1.157 . . . . 0.0 111.547 -167.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -86.12 137.95 32.28 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 168.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -160.28 -170.63 2.88 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -167.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.1 mt . . . . . 0 CA--C 1.535 0.373 0 C-N-CA 126.638 1.975 . . . . 0.0 109.055 -169.746 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 119.903 -0.094 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -60.95 134.28 56.94 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.973 1.309 . . . . 0.0 112.351 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 p -138.92 91.51 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.272 0 C-N-CA 124.778 1.231 . . . . 0.0 108.707 -174.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.8 m -82.46 153.42 25.65 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.937 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.88 146.22 18.8 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -176.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.5 tt -109.22 124.11 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 124.171 0.989 . . . . 0.0 109.874 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.7 112.47 22.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.745 1.218 . . . . 0.0 110.373 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.7 m-90 -94.67 130.69 41.05 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.366 1.066 . . . . 0.0 110.289 178.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.9 t -111.31 101.57 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -177.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -68.16 176.63 2.61 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.611 0.765 . . . . 0.0 111.132 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.7 -162.11 54.3 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -93.34 91.71 7.33 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 123.804 0.842 . . . . 0.0 112.06 -172.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.9 t -122.63 -30.78 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 C-N-CA 123.991 0.916 . . . . 0.0 111.275 -175.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -72.22 148.88 45.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 121.944 -0.473 . . . . 0.0 110.018 175.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.29 -21.02 47.68 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.067 -0.851 . . . . 0.0 113.023 176.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 p -84.09 0.53 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 118.55 1.175 . . . . 0.0 112.39 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.44 52.28 54.12 Favored Glycine 0 C--N 1.34 0.791 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -176.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.36 -34.25 70.47 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.591 0.756 . . . . 0.0 111.102 176.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.84 53.95 0.78 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.905 1.682 . . . . 0.0 112.326 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -87.17 -67.61 0.81 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -177.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 t -101.81 1.9 37.69 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.17 0.988 . . . . 0.0 112.094 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.8 t -48.35 -33.82 9.62 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.421 0.688 . . . . 0.0 112.149 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -68.03 -55.19 13.49 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.965 1.306 . . . . 0.0 110.423 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -55.08 -55.3 32.62 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.749 0.819 . . . . 0.0 110.742 -175.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.22 -47.97 68.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.839 0.856 . . . . 0.0 110.3 176.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.29 -28.23 58.07 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.48 -31.14 68.15 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.024 0.929 . . . . 0.0 111.873 177.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.1 mmm-85 -67.95 -42.39 81.03 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.801 0.84 . . . . 0.0 110.869 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -84.4 -42.05 16.07 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 122.947 0.499 . . . . 0.0 111.498 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.44 6.94 63.91 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 123.932 0.777 . . . . 0.0 112.91 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.67 167.72 3.38 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.138 0.969 . . . . 0.0 111.743 174.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.7 p -131.0 156.07 45.76 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -177.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 162.51 -148.13 14.84 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -169.62 164.15 10.19 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.163 -0.519 . . . . 0.0 111.77 172.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.98 97.27 5.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.014 0.926 . . . . 0.0 111.521 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -97.12 173.09 7.43 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.399 1.08 . . . . 0.0 111.095 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -123.44 137.87 54.71 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.428 1.091 . . . . 0.0 109.219 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.1 mt -75.67 177.36 6.88 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.497 1.119 . . . . 0.0 110.447 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -101.08 9.88 41.61 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.52 1.128 . . . . 0.0 111.276 177.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -109.34 -14.12 14.5 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.528 1.131 . . . . 0.0 112.086 -176.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.61 10.65 10.11 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.17 1.366 . . . . 0.0 113.938 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.54 164.45 14.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.538 1.535 . . . . 0.0 111.537 -173.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.4 p -119.55 138.97 48.46 Favored 'Isoleucine or valine' 0 C--N 1.347 0.494 0 C-N-CA 123.674 0.79 . . . . 0.0 110.702 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -110.86 121.18 44.71 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.581 1.152 . . . . 0.0 110.823 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 64.0 t -116.17 136.55 52.78 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.17 144.01 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 124.235 1.014 . . . . 0.0 109.482 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.54 142.03 21.7 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.581 -176.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.3 m -110.73 -178.78 3.57 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 126.173 1.789 . . . . 0.0 112.471 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.47 -153.59 23.48 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.054 -1.219 . . . . 0.0 110.054 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -82.25 132.7 35.23 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.096 0.558 . . . . 0.0 109.508 -178.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -48.71 -49.89 35.97 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.25 1.02 . . . . 0.0 110.972 -178.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.83 -52.96 28.15 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.103 1.335 . . . . 0.0 112.129 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -60.85 -46.5 90.34 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 124.232 1.013 . . . . 0.0 110.771 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.6 t -55.73 -42.79 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 122.271 0.228 . . . . 0.0 110.716 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.56 -27.73 66.49 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -27.05 68.49 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.842 0.857 . . . . 0.0 112.436 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.37 -29.05 14.18 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.211 0.604 . . . . 0.0 110.829 174.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.2 mmm -64.23 -21.87 66.74 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-O 118.588 -0.72 . . . . 0.0 111.535 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -47.54 -57.76 5.03 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 118.527 0.603 . . . . 0.0 109.812 172.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 15.7 t90 -64.3 -29.31 70.4 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.649 0.78 . . . . 0.0 111.727 -178.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 21.1 mt . . . . . 0 C--N 1.347 0.489 0 O-C-N 121.101 -1.0 . . . . 0.0 110.083 177.159 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.7 t . . . . . 0 CA--C 1.534 0.357 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -58.89 -50.79 72.7 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.494 0.718 . . . . 0.0 111.301 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.9 ttm-85 -169.3 163.56 10.76 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.042 0.537 . . . . 0.0 110.377 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.5 t -133.35 110.33 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.763 0.825 . . . . 0.0 109.953 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.0 tp -100.61 152.4 20.48 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.36 1.064 . . . . 0.0 110.283 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.52 129.51 31.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.011 0.924 . . . . 0.0 111.518 -177.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.21 158.49 74.04 Favored Pre-proline 0 N--CA 1.469 0.501 0 C-N-CA 125.358 1.463 . . . . 0.0 110.544 -176.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.73 132.26 19.91 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 124.482 3.455 . . . . 0.0 110.987 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -120.68 114.93 22.39 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.617 1.167 . . . . 0.0 109.626 -177.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -121.8 64.97 18.23 Favored Pre-proline 0 CA--C 1.536 0.426 0 O-C-N 121.656 -0.653 . . . . 0.0 110.867 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.45 142.26 44.45 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.207 2.605 . . . . 0.0 110.471 -174.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.6 p -70.44 142.46 51.98 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.372 0.669 . . . . 0.0 110.729 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.86 170.62 5.37 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.25 0.929 . . . . 0.0 112.105 -176.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -93.26 135.15 34.74 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.8 tp -77.74 149.17 34.57 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -75.53 0.15 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.217 1.007 . . . . 0.0 108.483 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -141.15 162.95 34.26 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.135 0.974 . . . . 0.0 109.926 -173.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -71.17 145.61 49.61 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.876 0.47 . . . . 0.0 110.616 174.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -142.05 -169.97 3.05 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.122 0.969 . . . . 0.0 109.964 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.2 mt . . . . . 0 CA--C 1.535 0.386 0 C-N-CA 123.906 0.882 . . . . 0.0 108.706 -177.91 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.9 t . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 110.598 -0.149 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 152.97 41.95 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.145 0.978 . . . . 0.0 112.908 -176.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 p -138.78 90.88 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 124.505 1.122 . . . . 0.0 108.435 -173.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.0 m -78.61 153.37 31.16 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.665 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.99 148.99 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -176.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.8 tt -111.43 125.61 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.942 0.897 . . . . 0.0 109.947 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -120.21 101.85 8.1 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.823 1.649 . . . . 0.0 109.767 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 -87.15 112.7 22.21 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 124.618 1.167 . . . . 0.0 109.895 177.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.84 121.52 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.312 1.045 . . . . 0.0 108.662 -177.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -99.27 171.35 8.04 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.048 0.939 . . . . 0.0 110.684 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.72 -165.08 49.28 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 123.375 0.512 . . . . 0.0 112.095 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.9 mtt85 -84.86 83.6 7.99 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -166.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.7 t -119.49 -47.25 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.909 0.883 . . . . 0.0 110.378 -173.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -67.68 146.64 53.61 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 120.848 0.356 . . . . 0.0 110.862 177.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.18 17.93 76.22 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.128 0.87 . . . . 0.0 113.738 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 82.4 t -102.86 -43.06 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 124.673 1.189 . . . . 0.0 109.141 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.08 29.02 3.16 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 125.884 1.707 . . . . 0.0 110.996 -175.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -50.97 -37.58 45.55 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 124.509 1.124 . . . . 0.0 111.325 177.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.0 60.09 0.96 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.848 1.259 . . . . 0.0 112.689 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -109.75 -72.94 0.7 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.684 1.194 . . . . 0.0 108.789 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.3 t -72.19 -23.26 61.24 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 118.503 -0.761 . . . . 0.0 112.053 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.5 t -41.32 -39.81 1.51 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.468 1.107 . . . . 0.0 112.667 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -71.64 -59.84 2.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.364 1.065 . . . . 0.0 110.681 176.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -49.98 -58.08 6.2 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.139 0.976 . . . . 0.0 111.771 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -53.14 -51.15 62.9 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.588 1.155 . . . . 0.0 110.849 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.46 -33.2 53.31 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 122.78 0.432 . . . . 0.0 112.079 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -68.23 -28.54 67.32 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.212 1.005 . . . . 0.0 112.234 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.6 mtp85 -70.81 -47.04 61.58 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.895 0.878 . . . . 0.0 109.926 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.5 mt -78.33 -40.71 35.78 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.013 0.525 . . . . 0.0 111.004 -177.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.27 22.31 41.62 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.195 1.379 . . . . 0.0 112.952 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.72 174.89 11.12 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.713 0.805 . . . . 0.0 111.566 177.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 51.2 p -117.69 -163.39 0.93 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.59 -155.39 16.24 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 118.534 0.606 . . . . 0.0 112.144 171.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -169.88 162.26 9.28 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.72 84.81 2.32 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.443 1.097 . . . . 0.0 111.254 -174.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -92.61 173.01 8.0 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.851 0.86 . . . . 0.0 111.281 -177.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -125.07 131.57 53.31 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.336 1.054 . . . . 0.0 109.494 -177.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.4 mt -70.06 171.25 9.86 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 125.214 1.405 . . . . 0.0 110.897 175.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -93.82 7.33 45.33 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.872 1.269 . . . . 0.0 111.747 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -112.63 -16.83 12.74 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.515 1.126 . . . . 0.0 112.119 -175.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.6 13.97 2.98 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.122 1.344 . . . . 0.0 114.385 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.54 166.32 12.85 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.426 1.49 . . . . 0.0 111.958 -167.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.3 t -127.07 120.92 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.586 1.155 . . . . 0.0 111.404 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -98.02 115.28 27.88 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 125.168 1.387 . . . . 0.0 111.684 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.6 t -114.1 133.32 60.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 122.861 0.464 . . . . 0.0 110.43 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.33 143.26 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 123.993 0.917 . . . . 0.0 109.738 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.96 133.03 11.63 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.015 -173.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 93.7 m -101.58 179.97 4.19 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.667 1.187 . . . . 0.0 112.325 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.73 -162.6 21.34 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.337 0.97 . . . . 0.0 110.758 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -73.18 121.75 20.79 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 123.691 0.796 . . . . 0.0 109.974 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -46.88 -50.85 17.97 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.015 1.326 . . . . 0.0 111.346 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -51.96 -45.77 55.97 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.402 1.477 . . . . 0.0 112.355 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -66.7 -50.88 61.41 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 117.455 0.628 . . . . 0.0 110.714 176.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.1 t -51.39 -34.05 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 122.647 0.379 . . . . 0.0 111.055 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -57.71 -31.46 66.43 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.915 0.886 . . . . 0.0 113.192 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -54.31 -44.86 72.36 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.828 0.851 . . . . 0.0 110.766 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.63 -32.18 53.22 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 118.481 0.582 . . . . 0.0 112.118 175.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.3 mmt -67.37 -25.19 65.85 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 118.814 -0.612 . . . . 0.0 111.867 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -42.44 -49.66 5.23 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.166 0.586 . . . . 0.0 109.719 170.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -64.13 -41.86 97.06 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.7 mt . . . . . 0 N--CA 1.471 0.612 0 C-N-CA 123.667 0.787 . . . . 0.0 110.599 179.641 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 95.4 t . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -67.21 -55.38 14.3 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.745 0.418 . . . . 0.0 110.998 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -166.64 99.05 0.57 Allowed 'General case' 0 C--N 1.342 0.274 0 C-N-CA 122.485 0.314 . . . . 0.0 111.422 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.9 p -84.41 125.54 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.275 0.63 . . . . 0.0 111.469 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.97 137.86 45.23 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 125.694 1.598 . . . . 0.0 111.568 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.88 138.56 54.35 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.156 1.382 . . . . 0.0 112.41 -177.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -144.04 158.73 54.97 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 124.945 1.298 . . . . 0.0 111.39 -177.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.02 137.38 26.44 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 124.074 3.182 . . . . 0.0 111.792 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -128.06 124.46 37.1 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.537 1.135 . . . . 0.0 111.181 -175.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -129.02 70.01 81.32 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 121.698 -0.626 . . . . 0.0 111.431 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.2 142.63 38.12 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.864 2.376 . . . . 0.0 110.722 -176.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.3 m -66.45 140.18 58.01 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.799 0.84 . . . . 0.0 110.776 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.86 -177.91 40.85 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.755 0.693 . . . . 0.0 111.547 -176.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -108.35 131.31 54.87 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.179 0.991 . . . . 0.0 108.568 172.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -69.82 151.75 45.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.927 1.291 . . . . 0.0 109.359 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.71 -77.98 0.13 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.672 0.789 . . . . 0.0 108.943 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -137.99 161.1 37.58 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.27 1.028 . . . . 0.0 109.838 -171.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -69.19 147.82 50.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.903 0.481 . . . . 0.0 110.03 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -152.06 -167.74 2.86 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 122.905 0.482 . . . . 0.0 110.524 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.2 tt . . . . . 0 N--CA 1.451 -0.41 0 C-N-CA 123.792 0.837 . . . . 0.0 109.48 177.413 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.0 m . . . . . 0 CA--C 1.533 0.302 0 CA-C-O 119.826 -0.13 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 142.84 55.84 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -169.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.25 88.5 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -172.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.2 m -78.95 152.06 31.29 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.276 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.52 149.33 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -177.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.8 tt -110.52 122.78 65.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 O-C-N 123.81 0.693 . . . . 0.0 109.335 174.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -113.88 95.67 5.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.684 1.594 . . . . 0.0 108.873 -175.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -81.44 130.59 35.1 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.4 t -107.07 113.97 44.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.476 1.111 . . . . 0.0 109.355 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -84.47 163.71 19.28 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.698 0.799 . . . . 0.0 111.052 175.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.39 179.5 53.02 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 124.126 0.869 . . . . 0.0 111.076 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.5 mtt180 -86.5 73.61 10.07 Favored 'General case' 0 N--CA 1.457 -0.075 0 CA-C-O 121.053 0.454 . . . . 0.0 111.751 -164.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.7 t -104.73 -33.25 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.162 0.985 . . . . 0.0 112.081 -170.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -63.13 159.68 16.94 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.677 0.671 . . . . 0.0 110.851 171.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.78 -46.08 1.65 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 123.992 0.806 . . . . 0.0 111.569 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.9 p -69.63 -9.74 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 123.431 0.693 . . . . 0.0 112.817 -174.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.08 44.46 35.85 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.894 0.759 . . . . 0.0 111.306 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -48.61 -34.13 11.09 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 125.867 1.667 . . . . 0.0 112.952 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 -71.95 47.92 0.15 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.844 1.657 . . . . 0.0 112.85 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -89.34 -69.63 0.7 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.089 0.956 . . . . 0.0 109.001 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.0 t -99.84 12.29 37.08 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.203 1.401 . . . . 0.0 111.23 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.1 t -59.41 -39.75 84.46 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.027 0.376 . . . . 0.0 110.796 170.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 -53.47 -60.55 3.16 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.868 1.267 . . . . 0.0 109.852 173.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -54.8 -57.04 13.15 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.001 0.92 . . . . 0.0 110.693 -173.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -54.55 -55.22 31.52 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 123.902 0.751 . . . . 0.0 109.856 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.92 -33.95 65.14 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 118.798 -0.62 . . . . 0.0 111.958 -177.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -67.56 -36.49 81.05 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.886 -0.578 . . . . 0.0 112.191 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -60.11 -46.87 88.17 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.656 0.662 . . . . 0.0 110.861 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.63 -22.01 34.85 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.98 31.57 47.79 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.557 1.075 . . . . 0.0 113.131 -178.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.21 140.77 41.81 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 117.503 0.652 . . . . 0.0 110.294 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.2 p -96.16 -159.89 0.76 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.484 176.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.49 -149.22 16.69 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 119.212 0.915 . . . . 0.0 112.034 172.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -169.84 158.23 7.24 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 177.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.93 97.4 5.68 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.267 1.427 . . . . 0.0 110.416 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -107.62 170.22 8.11 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.697 0.799 . . . . 0.0 111.425 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -120.66 131.46 54.59 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.386 1.075 . . . . 0.0 108.994 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.7 mt -68.04 174.84 3.49 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.228 1.411 . . . . 0.0 110.679 175.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -97.48 15.52 22.96 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.772 1.229 . . . . 0.0 111.397 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -120.09 -14.47 8.86 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 123.942 0.897 . . . . 0.0 112.778 -173.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.22 11.35 4.26 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.073 1.32 . . . . 0.0 114.325 175.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 p -126.35 162.08 26.36 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.308 1.443 . . . . 0.0 111.807 -166.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.4 t -117.06 132.91 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.785 1.234 . . . . 0.0 111.112 -174.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -106.29 113.35 26.82 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.749 1.22 . . . . 0.0 110.606 178.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.1 t -112.29 135.39 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.785 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.7 142.76 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.765 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.7 119.21 6.04 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 117.945 -1.026 . . . . 0.0 111.901 -171.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 98.5 m -109.58 132.02 54.52 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 120.031 1.287 . . . . 0.0 113.376 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 156.33 -163.86 32.19 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -71.81 126.85 30.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.334 0.567 . . . . 0.0 110.406 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -54.24 -43.21 70.7 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.853 1.261 . . . . 0.0 111.668 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -42.25 -42.8 4.43 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 126.057 1.789 . . . . 0.0 112.886 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -80.76 -47.17 14.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.207 1.003 . . . . 0.0 111.476 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 77.0 t -42.75 -52.11 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 123.938 0.895 . . . . 0.0 110.892 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -54.01 -36.4 62.94 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.405 0.682 . . . . 0.0 112.163 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -61.29 -44.24 97.55 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.022 0.929 . . . . 0.0 110.771 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.48 -32.32 68.13 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 122.934 0.494 . . . . 0.0 110.289 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.2 mmt -66.86 -24.87 66.18 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.096 -0.954 . . . . 0.0 112.264 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -47.71 -48.42 29.47 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 119.536 1.062 . . . . 0.0 109.535 172.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -61.25 -39.05 88.9 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 118.848 -0.596 . . . . 0.0 112.205 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.347 0.5 0 CA-C-N 119.385 0.993 . . . . 0.0 111.558 177.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 CA--C 1.531 0.217 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -64.93 -51.31 62.55 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -167.61 168.7 12.5 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.482 1.113 . . . . 0.0 109.142 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.1 t -132.11 125.64 54.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.148 0.979 . . . . 0.0 109.265 174.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tp -103.81 120.64 41.4 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.397 1.079 . . . . 0.0 110.965 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.6 136.35 43.47 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.05 0.94 . . . . 0.0 110.678 178.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -140.83 153.55 67.75 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 124.836 1.254 . . . . 0.0 109.937 178.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.57 136.54 28.53 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.666 2.911 . . . . 0.0 110.984 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -126.44 118.82 25.75 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.89 1.276 . . . . 0.0 110.105 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -121.2 72.34 25.18 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 119.147 0.885 . . . . 0.0 111.498 177.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.27 140.32 44.21 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.011 2.474 . . . . 0.0 110.118 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 80.9 p -75.75 143.05 42.23 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.637 0.775 . . . . 0.0 110.753 -176.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.45 -179.93 42.48 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -103.68 126.76 51.02 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.621 1.168 . . . . 0.0 108.719 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 mp -71.24 151.64 44.1 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.063 0.945 . . . . 0.0 109.797 173.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.4 p -78.65 -79.65 0.13 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.891 0.876 . . . . 0.0 108.719 173.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -141.28 164.06 31.26 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 124.119 0.968 . . . . 0.0 111.187 -168.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -75.23 148.36 39.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.904 0.882 . . . . 0.0 110.002 175.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -149.83 -172.37 4.13 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.065 0.546 . . . . 0.0 110.022 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.457 -0.114 0 C-N-CA 123.872 0.869 . . . . 0.0 110.66 -174.138 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 mtm . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 111.419 0.155 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.0 t -145.15 -51.5 0.27 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.544 1.138 . . . . 0.0 110.364 177.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -61.29 127.59 32.26 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.901 1.68 . . . . 0.0 112.928 -176.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 p -132.45 90.59 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.186 0 C-N-CA 125.585 1.554 . . . . 0.0 108.505 -174.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.1 m -81.65 153.22 26.76 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.92 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.89 149.59 17.71 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -176.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.4 tt -114.86 124.93 72.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.061 0.945 . . . . 0.0 110.414 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -119.35 109.56 15.94 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.953 1.701 . . . . 0.0 110.395 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.5 m-90 -92.11 116.45 28.95 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 125.626 1.57 . . . . 0.0 110.49 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -101.33 121.65 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.048 0.939 . . . . 0.0 109.164 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -91.34 173.19 8.05 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.362 1.465 . . . . 0.0 110.865 176.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.86 -166.98 50.96 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.7 mtt-85 -83.82 86.0 7.22 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.248 0.619 . . . . 0.0 111.519 -172.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.3 t -117.53 -40.57 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 123.791 0.837 . . . . 0.0 110.311 -174.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -73.65 149.33 42.05 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.175 0.443 . . . . 0.0 110.295 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.94 -43.26 1.74 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.102 0.858 . . . . 0.0 112.39 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.1 p -69.59 -8.12 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 118.066 0.933 . . . . 0.0 111.786 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.26 47.14 38.11 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -50.64 -40.89 54.49 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 124.022 0.929 . . . . 0.0 110.944 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 -70.76 55.0 0.17 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.599 1.96 . . . . 0.0 113.074 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -103.56 -68.93 0.82 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.36 1.064 . . . . 0.0 109.125 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.0 t -73.26 -22.11 60.46 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.3 t -41.31 -40.05 1.56 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.819 1.247 . . . . 0.0 112.55 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -64.79 -60.52 3.0 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.003 1.321 . . . . 0.0 110.826 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -51.26 -57.04 9.9 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.76 0.824 . . . . 0.0 111.022 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.04 -50.18 67.28 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.641 0.776 . . . . 0.0 110.477 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.91 -33.96 39.37 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 122.987 0.515 . . . . 0.0 112.098 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt -67.92 -33.4 74.62 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.463 0.705 . . . . 0.0 111.851 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 -66.15 -41.79 89.92 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.827 0.851 . . . . 0.0 111.411 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.93 -30.9 31.57 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.308 0.643 . . . . 0.0 111.77 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.96 21.4 78.51 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.095 0.855 . . . . 0.0 112.74 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.23 174.69 11.29 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.861 0.865 . . . . 0.0 110.955 176.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 50.0 p -117.31 -161.39 0.81 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -175.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.81 -155.16 16.3 Favored Glycine 0 C--N 1.339 0.705 0 CA-C-N 118.463 0.574 . . . . 0.0 111.822 169.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -168.14 159.23 10.82 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 171.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.01 95.33 4.86 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.77 1.228 . . . . 0.0 110.106 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -98.97 171.21 8.19 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.151 0.981 . . . . 0.0 110.674 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -127.29 133.23 50.17 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 124.048 0.939 . . . . 0.0 109.686 -177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.2 mt -71.23 173.52 7.61 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.158 1.383 . . . . 0.0 111.128 176.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -96.27 13.38 27.74 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.016 1.327 . . . . 0.0 111.801 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -121.38 0.59 10.05 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.635 1.174 . . . . 0.0 112.481 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.43 3.32 27.42 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.157 1.36 . . . . 0.0 114.425 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.37 165.14 11.73 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.959 1.704 . . . . 0.0 112.052 -169.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.8 t -126.87 124.49 64.89 Favored 'Isoleucine or valine' 0 C--N 1.348 0.515 0 C-N-CA 124.513 1.125 . . . . 0.0 111.752 -174.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -100.28 116.51 32.43 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 125.43 1.492 . . . . 0.0 111.718 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.0 t -113.51 133.0 60.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 123.496 0.719 . . . . 0.0 109.787 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.8 t -128.63 145.18 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.783 0.833 . . . . 0.0 110.188 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.9 137.1 11.71 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-O 118.297 -0.859 . . . . 0.0 111.786 -174.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 67.3 m -104.24 178.44 4.56 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.514 1.526 . . . . 0.0 112.418 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.06 -158.1 19.57 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 124.613 1.101 . . . . 0.0 110.422 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -79.56 128.63 33.62 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.835 0.854 . . . . 0.0 109.388 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -44.83 -49.32 10.88 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.241 1.016 . . . . 0.0 111.768 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -49.55 -54.29 17.43 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.305 1.431 . . . . 0.0 112.989 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -59.54 -47.82 84.07 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 125.302 1.441 . . . . 0.0 110.419 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.36 -41.6 71.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 122.429 0.292 . . . . 0.0 110.799 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -64.08 -26.88 68.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.226 0.611 . . . . 0.0 112.589 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -55.03 -48.96 72.72 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.637 0.775 . . . . 0.0 111.036 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -76.95 -30.26 55.96 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 118.192 0.451 . . . . 0.0 111.499 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.6 mmm -66.14 -21.42 66.34 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.624 -0.703 . . . . 0.0 111.594 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -44.41 -46.3 9.44 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.738 0.699 . . . . 0.0 109.996 168.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -67.74 -41.01 84.11 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.871 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 mt -54.47 -53.08 58.99 Favored 'General case' 0 C--N 1.346 0.448 0 C-N-CA 123.476 0.71 . . . . 0.0 110.611 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.46 -2.39 28.53 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.0 t -94.32 -30.43 14.53 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 119.276 0.943 . . . . 0.0 110.848 174.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.11 62.72 3.41 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -45.84 -65.52 1.97 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.819 1.2 . . . . 0.0 113.176 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -73.37 104.64 1.83 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.762 2.308 . . . . 0.0 110.347 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -55.13 -25.0 28.96 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.381 1.472 . . . . 0.0 113.501 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.91 -32.27 70.6 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.563 0.745 . . . . 0.0 111.234 174.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.62 155.65 37.27 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.873 0.469 . . . . 0.0 110.75 175.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.67 82.73 2.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.36 95.27 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -77.16 -47.96 18.94 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.924 0.89 . . . . 0.0 111.17 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.7 mtm105 -156.73 163.27 39.45 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.926 1.29 . . . . 0.0 109.484 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.4 p -154.57 131.61 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 118.944 -0.55 . . . . 0.0 111.136 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tp -122.67 141.0 52.22 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.357 1.063 . . . . 0.0 112.556 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.43 142.77 50.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.115 1.366 . . . . 0.0 112.867 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -143.2 159.57 55.2 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 125.119 1.368 . . . . 0.0 111.262 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.38 137.5 28.33 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.747 2.965 . . . . 0.0 111.346 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -125.3 116.94 22.73 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.79 1.236 . . . . 0.0 110.296 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -121.86 74.76 36.87 Favored Pre-proline 0 CA--C 1.536 0.408 0 O-C-N 121.425 -0.797 . . . . 0.0 110.77 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.72 146.27 42.82 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.76 2.306 . . . . 0.0 110.523 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.3 p -71.22 140.57 50.48 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.502 0.721 . . . . 0.0 110.461 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.22 179.73 30.79 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 123.811 0.72 . . . . 0.0 112.048 -177.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -101.75 131.02 48.27 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.597 1.159 . . . . 0.0 108.593 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -70.06 150.8 46.22 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.725 1.21 . . . . 0.0 109.534 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -77.32 0.15 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.788 0.835 . . . . 0.0 108.755 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -137.94 166.16 24.74 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.121 0.968 . . . . 0.0 110.674 -174.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -75.59 146.38 40.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.122 0.569 . . . . 0.0 110.101 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -149.81 -168.19 3.04 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.53 0.732 . . . . 0.0 110.055 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.4 pt -139.62 174.5 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.376 1.07 . . . . 0.0 109.938 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.106 0 CA-C-O 116.793 -1.575 . . . . 0.0 112.113 175.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? . . . . . 0 N--CA 1.474 0.769 0 CA-C-O 119.142 -0.456 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.2 t -141.26 -49.68 0.42 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.238 0.615 . . . . 0.0 111.956 -175.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.3 121.78 21.86 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.926 0.891 . . . . 0.0 111.374 -174.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.87 85.54 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.087 0 C-N-CA 125.273 1.429 . . . . 0.0 108.262 -172.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 m -78.86 150.32 32.26 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.114 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pp -129.88 162.1 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.3 tt -119.83 124.5 72.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.186 0.994 . . . . 0.0 109.038 173.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -117.39 99.89 7.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 126.237 1.815 . . . . 0.0 109.298 -173.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -83.4 131.85 35.02 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.612 0.765 . . . . 0.0 110.113 175.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.5 t -112.04 107.15 22.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.184 0.993 . . . . 0.0 109.113 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -73.77 165.87 24.34 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 123.445 0.698 . . . . 0.0 110.997 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.03 -179.44 53.61 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 123.811 0.719 . . . . 0.0 111.741 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.1 mtt-85 -87.8 78.58 8.36 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 122.971 0.508 . . . . 0.0 112.033 -165.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.3 t -105.51 -26.98 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.11 0.964 . . . . 0.0 111.94 -173.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -73.29 156.72 38.16 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.224 0.61 . . . . 0.0 112.181 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.89 25.41 75.81 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.296 0.951 . . . . 0.0 113.244 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.6 t -123.49 -39.09 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.027 1.331 . . . . 0.0 110.478 -177.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.96 34.4 2.58 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.922 1.249 . . . . 0.0 112.733 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -48.25 -35.48 12.1 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.82 1.248 . . . . 0.0 112.781 172.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.38 57.17 2.29 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.291 1.836 . . . . 0.0 110.564 -174.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -98.31 -72.21 0.66 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.591 0.756 . . . . 0.0 109.444 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -88.48 -7.09 57.12 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.077 0.951 . . . . 0.0 111.996 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.8 t -43.62 -46.01 7.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.884 0.874 . . . . 0.0 112.72 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -53.4 -61.43 2.31 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 126.043 1.737 . . . . 0.0 110.537 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.95 -54.67 26.81 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.002 1.321 . . . . 0.0 110.645 -177.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -55.3 -52.68 62.68 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.582 0.753 . . . . 0.0 110.542 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.18 -36.34 63.29 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.087 0.555 . . . . 0.0 111.864 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -65.12 -31.34 72.5 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.919 0.887 . . . . 0.0 112.18 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.6 mtp85 -67.66 -47.05 70.63 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.422 0.556 . . . . 0.0 110.214 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mp -74.32 -33.08 63.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.745 0.418 . . . . 0.0 110.727 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.63 18.43 66.01 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.377 0.989 . . . . 0.0 112.629 -177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.77 171.0 13.58 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 117.466 0.633 . . . . 0.0 111.411 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.6 p -111.47 -158.17 0.64 Allowed 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -171.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.69 -159.69 13.59 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 118.092 0.406 . . . . 0.0 112.219 167.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -165.85 155.16 11.94 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 174.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.93 95.68 5.44 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.386 1.475 . . . . 0.0 110.085 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -104.53 175.36 5.51 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.683 0.793 . . . . 0.0 110.838 176.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -123.89 136.36 54.3 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.169 0.988 . . . . 0.0 109.988 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.5 mt -70.67 173.67 6.88 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.158 1.383 . . . . 0.0 110.632 173.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -96.91 18.93 13.55 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.658 1.183 . . . . 0.0 111.574 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -121.96 -20.91 6.17 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 123.806 0.842 . . . . 0.0 112.851 -175.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.24 -7.37 4.04 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.727 1.156 . . . . 0.0 113.836 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.8 p -112.48 166.64 11.13 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.186 1.395 . . . . 0.0 111.816 -165.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.0 t -124.46 129.83 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.191 0.996 . . . . 0.0 111.528 -168.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -104.82 114.01 27.96 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.789 1.236 . . . . 0.0 111.465 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.2 t -113.41 130.94 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.66 0.784 . . . . 0.0 109.946 -177.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.35 144.27 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.981 0.912 . . . . 0.0 110.473 -175.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.01 130.73 4.89 Favored 'General case' 0 C--N 1.349 0.557 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.112 -172.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 99.4 m -95.54 -178.94 4.58 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.151 1.38 . . . . 0.0 112.337 177.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.24 -159.39 14.33 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -83.06 127.01 33.19 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 174.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -49.93 -46.05 51.71 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.471 1.108 . . . . 0.0 110.851 -174.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -44.88 -50.56 8.68 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.054 1.788 . . . . 0.0 113.015 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -69.13 -49.03 60.65 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.147 0.979 . . . . 0.0 110.939 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.9 t -53.08 -38.52 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.004 0.521 . . . . 0.0 111.391 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -63.3 -26.96 69.01 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -61.46 -44.98 96.14 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.092 0.557 . . . . 0.0 111.293 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.37 -30.26 63.17 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.379 0.536 . . . . 0.0 110.515 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.8 mmt -66.92 -24.79 66.13 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.168 -0.92 . . . . 0.0 112.176 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -42.22 -53.91 3.89 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 119.036 0.835 . . . . 0.0 109.016 166.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 32.3 t90 -63.61 -40.98 98.28 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 123.337 0.655 . . . . 0.0 112.235 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt -55.7 -42.52 75.36 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.312 0.96 . . . . 0.0 110.774 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.75 -28.38 60.74 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.925 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.0 m -103.29 8.44 38.28 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.56 1.144 . . . . 0.0 111.997 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.88 -41.01 42.76 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -176.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -21.51 93.16 0.01 OUTLIER Glycine 0 CA--C 1.534 1.261 0 C-N-CA 128.389 2.9 . . . . 0.0 115.279 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.76 -175.22 2.2 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.092 2.528 . . . . 0.0 110.689 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -70.63 -44.44 67.18 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.306 1.043 . . . . 0.0 111.493 -170.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.5 p -67.25 -59.33 3.51 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 124.039 0.935 . . . . 0.0 110.643 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.88 155.99 32.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.863 0.865 . . . . 0.0 111.121 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -139.63 108.49 5.98 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.955 0.902 . . . . 0.0 109.029 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.9 t -77.36 94.25 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -58.54 -45.52 88.73 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.3 mtm-85 -173.23 166.59 4.87 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.572 1.549 . . . . 0.0 109.51 -175.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.6 t -135.83 131.21 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.152 0.981 . . . . 0.0 110.827 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 tp -117.04 124.64 49.78 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.118 1.367 . . . . 0.0 111.706 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.79 134.7 52.27 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.284 1.034 . . . . 0.0 111.688 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -140.35 157.09 69.3 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.144 1.378 . . . . 0.0 110.589 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.39 131.25 18.63 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.251 3.301 . . . . 0.0 111.648 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -122.72 116.41 23.71 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.197 0.999 . . . . 0.0 111.446 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -113.85 77.89 3.81 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 119.223 0.92 . . . . 0.0 111.781 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.6 145.9 38.07 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.145 2.563 . . . . 0.0 111.297 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.2 m -73.91 135.79 43.31 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.339 1.056 . . . . 0.0 110.782 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.16 -179.06 42.99 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 123.708 0.671 . . . . 0.0 111.57 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -103.24 126.36 50.37 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.895 0.878 . . . . 0.0 108.758 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -67.0 155.4 38.73 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.905 1.282 . . . . 0.0 110.02 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.5 m -83.2 -76.95 0.26 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -128.48 167.75 16.62 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.029 1.331 . . . . 0.0 109.952 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -77.73 151.0 34.34 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.285 1.034 . . . . 0.0 110.137 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -151.38 -175.57 5.23 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.353 0.661 . . . . 0.0 110.724 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.3 pt -138.26 176.39 6.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 123.875 0.87 . . . . 0.0 110.318 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 116.782 -1.58 . . . . 0.0 111.581 169.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ppp? . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.9 m -173.12 -53.6 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 126.18 1.792 . . . . 0.0 108.405 173.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -73.49 105.13 4.71 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.524 0.73 . . . . 0.0 109.684 -176.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.5 p -98.57 81.6 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.3 m -75.71 151.38 37.66 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.151 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.71 147.51 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.3 tt -110.12 98.81 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 C-N-CA 123.699 0.8 . . . . 0.0 109.108 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.77 97.23 10.87 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.134 0.974 . . . . 0.0 109.181 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -72.09 102.65 3.06 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 169.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.68 82.86 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 174.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -65.92 132.05 47.7 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.97 -177.32 28.18 Favored Glycine 0 N--CA 1.448 -0.543 0 O-C-N 123.443 0.464 . . . . 0.0 111.988 178.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -89.06 69.05 8.4 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 121.911 0.863 . . . . 0.0 109.421 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.3 t -108.61 -47.35 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.937 1.695 . . . . 0.0 109.181 -167.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -57.68 145.19 35.11 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.076 0.95 . . . . 0.0 109.817 166.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.75 -45.11 2.71 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.801 0.715 . . . . 0.0 111.368 -175.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.0 t -65.64 -33.71 65.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.675 0.79 . . . . 0.0 111.085 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.2 38.51 5.36 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.581 1.086 . . . . 0.0 111.651 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -52.07 -30.37 25.56 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 126.17 1.788 . . . . 0.0 113.181 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.0 54.54 0.67 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.008 1.323 . . . . 0.0 110.377 174.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -87.37 -74.61 0.43 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.658 1.183 . . . . 0.0 108.444 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -101.83 17.83 22.05 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.637 1.175 . . . . 0.0 110.994 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.6 t -61.81 -40.53 95.59 Favored 'General case' 0 C--N 1.344 0.363 0 O-C-N 121.856 -0.527 . . . . 0.0 111.111 171.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -60.18 -50.33 74.1 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.402 0.681 . . . . 0.0 110.916 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -52.24 -58.49 6.48 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 123.184 0.303 . . . . 0.0 110.303 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.18 -52.17 59.69 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.755 1.222 . . . . 0.0 110.872 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.16 -39.66 63.75 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.444 1.097 . . . . 0.0 111.843 177.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -72.08 -23.69 61.39 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.917 0.887 . . . . 0.0 112.104 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.3 mmm-85 -65.12 -47.16 78.15 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 118.854 0.752 . . . . 0.0 108.982 171.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.9 mt -75.09 -33.46 61.64 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.069 0.947 . . . . 0.0 111.213 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.62 45.55 52.53 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 124.748 1.166 . . . . 0.0 111.314 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.36 174.98 5.65 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.757 1.223 . . . . 0.0 112.605 -175.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.4 p -114.63 -171.72 1.98 Allowed 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -170.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.69 -144.37 17.58 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 170.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -171.72 153.56 3.39 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 176.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.94 83.87 2.29 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.638 1.175 . . . . 0.0 108.689 170.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt -83.64 165.22 19.16 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -126.99 134.66 50.31 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 47.6 mt -80.74 -175.27 5.2 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.584 0.754 . . . . 0.0 109.899 170.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -93.04 2.31 56.84 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.961 0.904 . . . . 0.0 111.164 168.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -79.6 -48.1 14.34 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.403 0.681 . . . . 0.0 109.418 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.46 -28.72 2.31 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -157.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.04 117.02 10.17 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.312 0.645 . . . . 0.0 111.364 -166.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 63.8 t -88.76 104.12 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 171.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -79.65 93.41 5.51 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.821 1.248 . . . . 0.0 108.753 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.1 t -91.21 114.94 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.03 130.42 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.31 1.044 . . . . 0.0 108.479 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.17 123.64 7.17 Favored 'General case' 0 N--CA 1.457 -0.113 0 O-C-N 124.377 1.048 . . . . 0.0 109.792 -166.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 91.4 m -95.7 176.66 6.06 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.064 0.946 . . . . 0.0 112.085 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.9 -155.11 16.29 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -72.76 150.59 42.68 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 172.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -58.58 -46.89 85.96 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -46.49 -45.24 16.92 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.137 1.827 . . . . 0.0 113.034 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -67.02 -51.61 52.74 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.578 0.689 . . . . 0.0 110.707 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.7 t -61.08 -32.48 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.876 0.87 . . . . 0.0 111.904 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -53.64 -40.98 66.27 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.415 0.686 . . . . 0.0 111.092 173.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -65.06 -30.76 71.74 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.145 0.884 . . . . 0.0 112.691 -169.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -78.46 -35.97 45.97 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.565 0.62 . . . . 0.0 110.929 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 54.0 mtm -64.17 -41.91 96.93 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.498 0.59 . . . . 0.0 111.197 175.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -51.96 -29.77 21.92 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.219 1.008 . . . . 0.0 112.386 172.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 12.8 t90 -83.65 -41.07 18.18 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 117.845 -1.074 . . . . 0.0 110.874 170.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 25.6 mt -53.42 -46.6 69.84 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 120.098 1.317 . . . . 0.0 111.53 -174.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -58.16 -24.79 60.19 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.9 t -106.4 -0.69 23.99 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.996 1.718 . . . . 0.0 111.63 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.74 -33.24 84.51 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.265 0.936 . . . . 0.0 111.997 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 175.83 67.34 0.06 OUTLIER Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.0 -0.889 . . . . 0.0 110.896 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.02 -45.06 13.58 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.351 2.701 . . . . 0.0 112.299 -172.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 53.0 ptt85 -69.37 -33.71 73.46 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.039 0.536 . . . . 0.0 112.248 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.8 p -84.69 -74.32 0.39 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.1 0.56 . . . . 0.0 110.168 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.8 108.92 2.28 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.168 0.987 . . . . 0.0 109.035 175.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -87.13 76.76 9.22 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -168.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.6 t -67.27 102.14 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.515 1.126 . . . . 0.0 109.519 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -70.55 -54.83 10.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.032 0.933 . . . . 0.0 110.945 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -151.54 150.05 29.9 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 123.652 0.781 . . . . 0.0 110.097 -174.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.0 t -127.6 102.08 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.844 1.258 . . . . 0.0 109.53 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.7 tp -105.37 114.2 28.23 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 123.586 0.754 . . . . 0.0 110.159 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.4 m -99.28 138.11 36.83 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.122 0.569 . . . . 0.0 109.902 170.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -130.04 148.85 71.32 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 125.67 1.588 . . . . 0.0 108.402 172.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.61 109.87 1.52 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.406 2.737 . . . . 0.0 109.936 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -89.5 113.16 24.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.859 1.264 . . . . 0.0 109.164 -174.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -110.88 72.37 0.78 Allowed Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 125.162 1.385 . . . . 0.0 110.454 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.45 135.73 24.89 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.642 2.228 . . . . 0.0 110.119 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.1 p -71.36 137.23 48.24 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.16 -160.16 50.97 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -173.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -137.24 145.63 43.81 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.233 1.013 . . . . 0.0 110.11 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.3 tp -100.33 137.5 38.66 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 171.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.1 m -66.17 -48.43 70.75 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.694 0.797 . . . . 0.0 111.801 -173.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -129.53 160.93 31.68 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.976 0.911 . . . . 0.0 111.866 -166.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -84.85 145.8 27.65 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.427 1.091 . . . . 0.0 109.315 166.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -145.73 173.41 12.12 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.792 0.837 . . . . 0.0 110.893 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.6 pt -140.19 155.27 23.65 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 C-N-CA 123.827 0.851 . . . . 0.0 110.409 -174.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 116.94 -1.505 . . . . 0.0 110.048 157.289 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.3 m -116.9 -39.2 3.29 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.329 1.052 . . . . 0.0 112.024 -171.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -67.96 107.68 2.76 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 121.091 0.472 . . . . 0.0 110.966 -177.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.39 80.47 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.733 1.613 . . . . 0.0 107.097 -173.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -76.72 148.01 37.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.537 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pp -120.03 164.26 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.6 tt -125.01 118.5 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 124.395 1.078 . . . . 0.0 108.867 170.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -115.27 107.84 15.79 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.784 1.234 . . . . 0.0 110.211 -176.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -86.1 121.56 28.87 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 172.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.6 t -100.44 94.18 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -63.76 152.55 39.04 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.916 0.886 . . . . 0.0 110.958 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.3 -178.64 26.72 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 124.389 0.995 . . . . 0.0 112.261 174.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -85.94 87.55 7.43 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 123.169 0.588 . . . . 0.0 110.647 -173.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.0 t -114.82 -40.04 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.771 1.228 . . . . 0.0 110.178 -174.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -65.56 152.34 44.31 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.629 0.772 . . . . 0.0 111.718 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.67 17.95 76.94 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.996 0.807 . . . . 0.0 113.543 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.69 -42.05 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.783 1.233 . . . . 0.0 109.257 175.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.26 32.08 1.89 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.687 1.613 . . . . 0.0 112.124 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -53.21 -29.1 30.26 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.541 1.537 . . . . 0.0 112.882 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -68.69 41.54 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.096 2.158 . . . . 0.0 113.5 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -85.8 -67.72 0.79 Allowed 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.508 -0.745 . . . . 0.0 110.029 -173.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.3 t -92.56 -9.77 40.0 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.888 0.875 . . . . 0.0 112.61 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.6 t -43.82 -48.54 8.26 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.06 0.944 . . . . 0.0 113.541 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -58.4 -57.16 14.13 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 124.653 1.181 . . . . 0.0 110.141 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -50.74 -55.66 15.65 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.499 1.12 . . . . 0.0 110.672 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.16 -54.2 39.32 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 124.596 1.159 . . . . 0.0 110.164 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.57 -36.83 64.79 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.658 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -68.51 -31.44 70.7 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.464 0.705 . . . . 0.0 112.125 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -60.92 -49.29 78.05 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.715 0.689 . . . . 0.0 110.282 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.3 mt -75.52 -31.03 59.98 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.392 0.277 . . . . 0.0 110.911 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.55 22.54 53.5 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.749 1.166 . . . . 0.0 112.593 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.94 169.26 10.41 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.658 0.783 . . . . 0.0 112.201 -177.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.6 p -112.27 -159.39 0.68 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.725 0.81 . . . . 0.0 109.352 -166.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.7 -154.77 16.68 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 170.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -169.47 160.68 9.33 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.05 78.97 1.39 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.738 1.215 . . . . 0.0 109.679 -174.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -85.01 166.34 16.79 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -126.86 129.82 49.0 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.6 mt -68.08 173.84 4.31 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.904 1.282 . . . . 0.0 110.781 177.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -89.44 13.77 12.93 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.953 0.901 . . . . 0.0 111.378 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -105.94 -51.14 3.03 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 123.894 0.878 . . . . 0.0 110.31 -176.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 161.02 -20.55 0.21 Allowed Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.446 1.022 . . . . 0.0 112.671 -167.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.2 p -105.26 159.14 16.11 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.078 0.951 . . . . 0.0 112.287 -162.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.2 t -116.22 126.49 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.248 1.019 . . . . 0.0 111.261 -169.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -100.33 105.55 17.09 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.644 1.577 . . . . 0.0 110.397 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.6 t -110.45 127.16 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 123.262 0.625 . . . . 0.0 109.818 -172.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.46 141.0 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 118.629 -0.7 . . . . 0.0 109.948 -171.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.52 128.16 4.46 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 118.163 -0.922 . . . . 0.0 112.329 -167.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 98.9 m -97.04 177.65 5.53 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 113.443 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.62 -172.8 16.31 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 125.054 1.311 . . . . 0.0 111.01 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -67.59 124.28 22.81 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -52.62 -40.45 62.76 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.175 1.39 . . . . 0.0 112.24 -168.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -43.96 -50.59 7.43 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.669 1.604 . . . . 0.0 112.379 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -65.07 -52.72 54.03 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 122.958 0.503 . . . . 0.0 110.516 176.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.2 t -46.43 -45.57 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.094 0.958 . . . . 0.0 111.626 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -64.21 -29.05 70.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.496 -0.764 . . . . 0.0 112.799 -175.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -54.63 -44.27 73.03 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 119.324 0.966 . . . . 0.0 111.197 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.2 -29.32 61.68 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.452 0.301 . . . . 0.0 111.169 177.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mtm -68.31 -25.74 65.28 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 118.692 -0.67 . . . . 0.0 112.033 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -48.64 -53.15 19.68 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 166.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -62.81 -40.96 99.01 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 118.534 -0.745 . . . . 0.0 112.17 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 mt -54.81 -53.37 56.15 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.779 1.172 . . . . 0.0 109.922 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -66.7 -19.28 65.72 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.571 0.748 . . . . 0.0 112.915 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -104.25 -11.47 17.19 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.743 1.217 . . . . 0.0 112.36 -178.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.83 -43.08 96.64 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 124.356 0.979 . . . . 0.0 111.324 -172.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -12.09 85.12 0.0 OUTLIER Glycine 0 CA--C 1.533 1.192 0 C-N-CA 128.796 3.093 . . . . 0.0 115.553 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.26 165.8 27.24 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.991 2.46 . . . . 0.0 110.53 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -53.82 -40.66 66.6 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.62 1.168 . . . . 0.0 113.336 -169.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.2 t -72.88 -37.59 67.28 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.355 1.062 . . . . 0.0 111.636 -173.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.8 160.52 29.89 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.221 1.008 . . . . 0.0 111.562 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -128.82 101.4 6.09 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.082 0.953 . . . . 0.0 108.535 172.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.6 t -82.58 93.75 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -68.56 -48.7 63.58 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 119.055 -0.498 . . . . 0.0 111.221 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.2 mtm105 -167.05 163.85 15.85 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.801 0.841 . . . . 0.0 110.799 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -127.06 117.25 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.289 1.036 . . . . 0.0 109.926 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 tt -106.91 111.84 24.53 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.257 1.023 . . . . 0.0 110.022 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.5 m -103.9 137.39 41.96 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.348 0.659 . . . . 0.0 111.175 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -139.64 160.06 62.8 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 126.037 1.735 . . . . 0.0 109.759 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.73 129.54 12.7 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.346 2.697 . . . . 0.0 110.367 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 59.4 t60 -116.88 110.51 18.43 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.287 1.035 . . . . 0.0 109.607 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -108.18 80.53 1.11 Allowed Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 119.079 0.854 . . . . 0.0 111.055 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.15 160.92 46.11 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.99 2.46 . . . . 0.0 110.85 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 88.7 p -84.08 147.59 27.29 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.028 0.931 . . . . 0.0 110.473 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.22 -171.75 18.18 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.85 0.738 . . . . 0.0 112.298 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -105.29 136.11 45.43 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.121 0.968 . . . . 0.0 109.864 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 mp -81.72 147.11 29.64 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.307 1.043 . . . . 0.0 109.251 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 19.2 p -78.69 -66.04 0.91 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.624 1.17 . . . . 0.0 109.874 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -137.92 166.55 23.76 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.259 1.424 . . . . 0.0 110.693 -167.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -84.36 140.68 31.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 167.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -148.38 -172.43 4.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.014 0.526 . . . . 0.0 109.827 -174.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.3 tt -163.29 160.07 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -175.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 . . . . . 0 C--O 1.252 1.205 0 C-N-CA 124.952 1.301 . . . . 0.0 111.118 167.317 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 ptp . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 119.828 -0.13 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 t -121.85 -37.41 2.87 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.667 1.187 . . . . 0.0 111.286 -176.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -67.14 120.48 13.8 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.221 1.008 . . . . 0.0 111.471 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 p -127.64 85.04 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 125.578 1.551 . . . . 0.0 107.813 -173.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.57 148.68 31.65 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.853 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 pp -129.43 162.96 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.6 tt -121.66 125.77 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 124.026 0.931 . . . . 0.0 108.988 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -118.62 103.66 9.91 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.659 1.584 . . . . 0.0 109.832 -173.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.5 m-90 -85.65 117.66 24.68 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.23 0.612 . . . . 0.0 109.815 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.0 t -100.51 108.85 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 123.83 0.852 . . . . 0.0 108.978 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -78.86 164.78 24.2 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.122 0.569 . . . . 0.0 110.876 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.76 -177.88 42.13 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 124.061 0.839 . . . . 0.0 112.122 177.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -84.76 81.42 8.88 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.386 0.612 . . . . 0.0 111.066 -169.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.8 t -108.52 -44.42 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.478 1.511 . . . . 0.0 110.48 -173.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -65.9 153.8 41.02 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.117 0.567 . . . . 0.0 110.964 175.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 67.75 17.52 69.3 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 123.998 0.808 . . . . 0.0 113.722 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.6 t -104.04 -43.27 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.752 1.221 . . . . 0.0 108.828 172.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.63 32.76 2.61 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.904 1.716 . . . . 0.0 111.233 -176.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -53.5 -34.59 58.65 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.801 1.24 . . . . 0.0 112.356 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.3 53.89 0.68 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.438 1.495 . . . . 0.0 112.139 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -94.4 -75.05 0.52 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.497 1.119 . . . . 0.0 109.48 -176.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -79.99 -11.87 59.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.905 0.882 . . . . 0.0 112.016 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.6 t -44.18 -44.43 7.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.97 0.908 . . . . 0.0 112.719 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.4 mm-40 -56.41 -63.68 1.11 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.823 1.649 . . . . 0.0 110.166 172.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -50.85 -56.22 13.23 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.969 1.707 . . . . 0.0 111.75 -174.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -56.04 -54.59 43.14 Favored 'General case' 0 CA--C 1.527 0.064 0 C-N-CA 124.292 1.037 . . . . 0.0 109.852 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.47 -37.61 49.72 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.93 0.892 . . . . 0.0 111.888 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -65.32 -32.16 73.67 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.769 1.228 . . . . 0.0 112.474 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.2 mmm-85 -64.52 -45.14 88.47 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 118.464 0.574 . . . . 0.0 110.037 175.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.5 mt -73.23 -36.02 66.38 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.192 0.597 . . . . 0.0 111.311 -178.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.49 18.61 65.93 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.415 1.007 . . . . 0.0 112.475 -175.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.47 169.45 14.49 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.463 0.705 . . . . 0.0 110.713 177.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.2 p -111.87 -157.61 0.62 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -170.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.6 -155.21 16.34 Favored Glycine 0 C--N 1.339 0.711 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 166.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -166.66 154.78 10.02 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 173.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.12 96.17 5.79 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.237 1.415 . . . . 0.0 110.098 175.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -102.2 174.09 6.08 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.749 0.82 . . . . 0.0 111.321 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -125.28 132.38 52.92 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.109 0.964 . . . . 0.0 109.344 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.0 mt -71.48 171.96 10.39 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.14 1.376 . . . . 0.0 110.758 174.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -95.47 15.68 19.01 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.049 1.34 . . . . 0.0 111.763 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -117.2 -26.35 6.8 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.115 0.966 . . . . 0.0 112.043 -175.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.73 4.13 1.66 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.644 1.116 . . . . 0.0 114.307 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 p -121.11 167.51 12.56 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.002 1.321 . . . . 0.0 112.091 -165.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.7 t -123.9 128.24 74.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.578 1.151 . . . . 0.0 111.222 -170.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -101.89 111.46 23.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.165 1.386 . . . . 0.0 111.56 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.1 t -108.5 132.55 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 123.043 0.537 . . . . 0.0 110.235 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.53 143.62 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.873 0.869 . . . . 0.0 110.174 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.4 129.11 5.49 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 118.174 -0.917 . . . . 0.0 111.905 -172.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 80.8 m -95.6 -179.43 4.74 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.634 1.174 . . . . 0.0 112.441 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.43 -167.4 14.79 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 124.94 1.257 . . . . 0.0 109.978 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.98 139.79 46.92 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 170.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -53.79 -45.09 70.62 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.904 0.882 . . . . 0.0 110.587 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -42.47 -45.52 5.45 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.347 1.927 . . . . 0.0 113.202 174.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -74.21 -46.93 38.71 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.252 1.021 . . . . 0.0 111.592 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -53.34 -41.51 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.461 0.705 . . . . 0.0 110.69 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -65.14 -22.72 66.96 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.331 0.653 . . . . 0.0 112.67 -176.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -61.87 -45.23 94.67 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.366 0.53 . . . . 0.0 111.021 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.3 -28.07 61.01 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.392 0.542 . . . . 0.0 111.038 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -68.59 -26.13 65.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.695 -0.669 . . . . 0.0 111.277 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -44.0 -49.36 8.65 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 167.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -69.34 -37.21 77.57 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-O 118.426 -0.797 . . . . 0.0 111.69 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 mt -51.36 -42.42 61.32 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.972 0.806 . . . . 0.0 111.028 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.42 -45.43 62.72 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.1 t -58.07 -29.87 65.75 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.741 0.816 . . . . 0.0 113.101 175.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.28 -3.88 77.75 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.996 1.284 . . . . 0.0 113.022 -177.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.7 -72.64 0.71 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-N 118.188 0.994 . . . . 0.0 112.607 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -77.84 74.77 5.08 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.934 3.09 . . . . 0.0 110.767 -172.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.76 -57.11 0.73 Allowed 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.062 1.345 . . . . 0.0 109.164 -175.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.79 -45.79 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.115 1.366 . . . . 0.0 109.347 -175.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.32 154.52 10.45 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.795 1.238 . . . . 0.0 111.118 173.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.0 ttm-85 -113.08 78.37 1.13 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -177.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.8 t -71.14 102.43 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.71 0.804 . . . . 0.0 109.17 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -73.12 -52.6 13.62 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.609 0.763 . . . . 0.0 111.407 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.2 mmm-85 -168.94 166.44 11.22 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.725 1.21 . . . . 0.0 109.433 -171.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.06 133.84 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 118.838 -0.601 . . . . 0.0 111.41 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.6 tp -124.69 125.68 44.49 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.077 0.951 . . . . 0.0 112.251 -175.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.95 135.1 49.09 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.273 1.029 . . . . 0.0 111.813 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -134.17 155.98 79.5 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 125.909 1.684 . . . . 0.0 110.203 -178.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.74 126.53 11.48 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 124.244 3.296 . . . . 0.0 111.078 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -119.21 107.49 13.5 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.147 0.979 . . . . 0.0 110.371 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -110.55 74.22 0.87 Allowed Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 119.228 0.922 . . . . 0.0 111.464 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -72.97 151.5 50.47 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.179 2.586 . . . . 0.0 111.44 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.4 p -79.19 140.69 37.65 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.123 0.969 . . . . 0.0 110.624 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.8 174.26 16.57 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.028 0.823 . . . . 0.0 111.89 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -92.04 142.66 27.28 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.758 0.823 . . . . 0.0 108.975 171.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -85.98 149.01 25.49 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.1 p -75.54 -75.95 0.16 Allowed 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -134.08 163.0 30.55 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.833 0.853 . . . . 0.0 110.847 -171.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -76.52 148.63 37.0 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.848 0.859 . . . . 0.0 109.829 172.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -150.95 -177.69 6.16 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.121 0.568 . . . . 0.0 109.948 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.9 pt -132.07 152.65 37.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 C-N-CA 123.575 0.75 . . . . 0.0 109.615 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.2 mtm180 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 125.362 1.465 . . . . 0.0 113.526 174.107 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 119.025 -0.512 . . . . 0.0 109.715 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 t -168.91 -53.77 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 117.895 0.316 . . . . 0.0 110.97 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -63.06 134.71 56.52 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.709 1.204 . . . . 0.0 112.132 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.0 p -139.95 92.86 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.294 0 C-N-CA 124.603 1.161 . . . . 0.0 109.027 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.8 m -86.67 156.65 19.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.469 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.5 pp -140.46 158.48 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.073 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 tt -119.01 109.82 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.123 0.969 . . . . 0.0 109.549 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -101.99 119.77 39.33 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.298 1.039 . . . . 0.0 110.157 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.0 m-90 -97.39 112.35 24.22 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.039 0.935 . . . . 0.0 110.493 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 t -91.78 123.78 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.93 0.892 . . . . 0.0 109.063 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -94.0 174.89 6.93 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.461 1.504 . . . . 0.0 111.202 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.12 -163.56 54.15 Favored Glycine 0 C--N 1.338 0.683 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -85.93 91.8 8.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.67 0.788 . . . . 0.0 111.514 -173.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.6 t -123.45 -44.31 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.171 0.988 . . . . 0.0 109.771 -175.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -71.27 143.05 50.49 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.29 0.636 . . . . 0.0 110.172 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.26 18.04 79.09 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 119.214 -0.77 . . . . 0.0 113.309 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.0 t -108.78 -43.19 5.92 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 124.331 1.052 . . . . 0.0 109.686 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 116.71 25.56 3.34 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 125.185 1.374 . . . . 0.0 111.639 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -51.24 -35.09 35.33 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.891 0.876 . . . . 0.0 111.105 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.5 mtp180 -74.9 59.86 0.93 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.243 1.417 . . . . 0.0 111.36 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -114.27 -73.51 0.65 Allowed 'General case' 0 C--N 1.339 0.139 0 C-N-CA 125.389 1.475 . . . . 0.0 108.807 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.3 t -73.69 -19.96 60.68 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.229 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.5 t -45.44 -36.96 4.72 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.937 0.895 . . . . 0.0 112.163 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -69.95 -59.21 3.06 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.508 1.123 . . . . 0.0 110.208 176.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -52.33 -53.98 37.49 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.534 1.134 . . . . 0.0 111.348 -175.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.58 -52.12 64.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.643 1.177 . . . . 0.0 110.214 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.87 -31.54 59.81 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.169 0.587 . . . . 0.0 112.408 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -65.02 -34.33 78.18 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.642 1.177 . . . . 0.0 111.597 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -69.92 -48.87 56.85 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.757 0.823 . . . . 0.0 110.34 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.7 mt -71.21 -34.24 70.66 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.917 0.487 . . . . 0.0 110.779 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.09 14.08 81.1 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.319 0.962 . . . . 0.0 112.671 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.55 178.14 5.54 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.533 0.733 . . . . 0.0 111.259 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.3 p -123.79 -174.91 3.09 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 136.61 -149.3 20.11 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 170.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -169.03 165.93 11.17 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 172.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.1 101.58 7.09 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.597 0.759 . . . . 0.0 112.031 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -97.99 175.28 6.18 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.444 1.098 . . . . 0.0 111.243 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -123.77 136.54 54.48 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.837 1.255 . . . . 0.0 109.973 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.6 mt -74.19 173.91 9.48 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.504 1.522 . . . . 0.0 109.981 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -97.58 13.47 29.96 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.151 0.98 . . . . 0.0 111.719 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -117.92 -11.01 10.32 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 124.044 0.938 . . . . 0.0 112.446 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.38 19.77 4.53 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 125.098 1.333 . . . . 0.0 114.061 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.1 m -118.14 166.25 12.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.546 1.538 . . . . 0.0 111.601 -171.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.2 t -129.35 118.25 45.31 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 C-N-CA 124.046 0.938 . . . . 0.0 110.575 -175.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -94.88 126.47 40.23 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.58 0.752 . . . . 0.0 110.554 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.8 t -120.38 133.95 65.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.687 0.795 . . . . 0.0 109.457 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.5 t -126.28 142.54 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 C-N-CA 124.425 1.09 . . . . 0.0 109.512 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.93 134.62 10.83 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-O 118.752 -0.642 . . . . 0.0 111.117 -173.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 51.8 m -99.77 178.44 4.83 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.211 1.404 . . . . 0.0 112.611 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.46 -153.19 20.15 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -83.77 126.63 33.12 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.832 1.253 . . . . 0.0 109.561 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -46.38 -51.48 14.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.723 1.209 . . . . 0.0 111.537 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -51.9 -44.88 56.12 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.223 1.392 . . . . 0.0 112.97 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -69.09 -44.22 72.92 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 117.33 0.565 . . . . 0.0 111.752 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.4 t -54.39 -32.66 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 122.749 0.419 . . . . 0.0 110.728 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.97 -29.97 69.98 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -57.66 -24.03 54.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.009 0.923 . . . . 0.0 112.608 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.68 -29.51 12.62 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-N 118.784 0.72 . . . . 0.0 111.483 171.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.3 mmm -65.79 -20.36 66.23 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.838 -0.601 . . . . 0.0 111.949 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -45.12 -58.18 3.39 Favored 'General case' 0 C--O 1.214 -0.791 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 172.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -62.76 -36.9 84.55 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.125 0.57 . . . . 0.0 111.833 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -58.16 -52.75 64.25 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 123.707 0.803 . . . . 0.0 110.375 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.13 -30.48 62.32 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.046 0.539 . . . . 0.0 112.234 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.7 m -75.8 -23.18 55.82 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.332 0.653 . . . . 0.0 111.946 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.79 8.85 78.27 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.38 -1.234 . . . . 0.0 113.18 -176.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.86 -103.63 0.06 OUTLIER Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.905 1.717 . . . . 0.0 112.725 -176.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.3 -174.76 1.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.838 3.025 . . . . 0.0 111.761 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -78.68 -32.89 47.26 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.688 0.795 . . . . 0.0 110.995 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.0 p -57.42 161.83 3.2 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.167 0.987 . . . . 0.0 111.155 175.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 69.79 159.46 0.19 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.32 1.448 . . . . 0.0 110.684 -171.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.82 107.94 10.3 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.5 t -88.38 80.54 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -55.31 -49.97 70.78 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 122.979 0.512 . . . . 0.0 111.21 176.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -171.26 171.13 5.75 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.67 1.188 . . . . 0.0 109.595 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.9 p -156.28 134.26 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.009 0.523 . . . . 0.0 110.212 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tp -113.91 149.63 34.9 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.989 0.916 . . . . 0.0 110.886 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.12 131.32 44.05 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.427 1.091 . . . . 0.0 111.344 -176.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -141.53 156.31 66.73 Favored Pre-proline 0 N--CA 1.468 0.431 0 C-N-CA 124.01 0.924 . . . . 0.0 111.622 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -68.63 125.28 12.53 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 124.213 3.275 . . . . 0.0 110.836 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -118.99 117.36 28.58 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.89 0.876 . . . . 0.0 109.878 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -109.34 77.67 0.97 Allowed Pre-proline 0 CA--C 1.539 0.53 0 O-C-N 121.498 -0.751 . . . . 0.0 110.344 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.63 126.58 12.23 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.656 2.904 . . . . 0.0 109.755 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.0 p -70.31 148.67 48.23 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.338 0.655 . . . . 0.0 110.688 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.25 176.7 8.84 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.973 0.796 . . . . 0.0 112.164 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -105.27 131.78 52.3 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.71 1.204 . . . . 0.0 108.872 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.2 tp -83.19 151.76 25.53 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.572 0.749 . . . . 0.0 109.55 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.5 m -74.74 -73.43 0.24 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -138.04 162.99 32.72 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.466 1.106 . . . . 0.0 110.369 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -71.83 147.21 47.4 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.673 0.789 . . . . 0.0 110.519 175.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -143.97 -177.35 5.39 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.64 1.176 . . . . 0.0 110.159 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.3 pt -146.12 78.33 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 123.628 0.771 . . . . 0.0 109.102 -177.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 35.7 mtp180 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 117.045 -1.455 . . . . 0.0 111.665 -179.647 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ptt? . . . . . 0 N--CA 1.474 0.758 0 CA-C-O 119.857 -0.116 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 t -138.17 -41.07 0.52 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.922 0.889 . . . . 0.0 110.605 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.67 152.85 44.59 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.285 1.034 . . . . 0.0 112.821 -177.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 p -138.49 88.43 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.262 1.025 . . . . 0.0 108.405 -174.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.5 m -79.55 150.49 31.1 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.68 157.17 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.9 tt -116.35 116.35 52.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.431 1.093 . . . . 0.0 109.609 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -111.41 103.21 11.55 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.674 1.59 . . . . 0.0 109.917 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.1 m-90 -83.68 115.59 22.25 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 123.783 0.833 . . . . 0.0 109.868 176.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.3 t -97.92 113.24 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -87.82 172.63 9.49 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 124.487 1.115 . . . . 0.0 111.175 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.03 -169.55 55.01 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 123.632 0.634 . . . . 0.0 111.821 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -83.39 85.33 7.25 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.02 0.528 . . . . 0.0 112.124 -167.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.4 t -117.7 -43.08 2.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.845 -173.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -68.23 148.34 50.96 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.683 0.674 . . . . 0.0 110.389 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.74 -31.01 8.32 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 118.918 -0.934 . . . . 0.0 113.426 174.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 m -74.34 -0.58 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 119.018 1.409 . . . . 0.0 112.448 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.01 36.83 73.22 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.199 0.904 . . . . 0.0 110.859 -170.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -51.25 -38.84 54.86 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 123.908 0.883 . . . . 0.0 111.157 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.16 55.97 0.6 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.511 1.524 . . . . 0.0 113.095 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -110.99 -72.42 0.72 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.402 1.081 . . . . 0.0 109.465 -177.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 t -73.77 -16.93 61.15 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.213 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.2 t -40.68 -42.09 1.66 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.141 1.376 . . . . 0.0 113.021 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -64.3 -61.46 2.22 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.632 1.173 . . . . 0.0 110.411 173.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -48.97 -54.38 15.83 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.604 1.562 . . . . 0.0 111.734 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -55.69 -45.82 77.75 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.355 1.462 . . . . 0.0 112.038 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.09 -30.38 71.32 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.092 0.557 . . . . 0.0 111.999 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.8 tttt -65.3 -35.44 81.01 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.831 0.853 . . . . 0.0 111.328 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -67.51 -49.46 63.31 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.294 0.638 . . . . 0.0 110.536 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.9 mt -73.55 -34.37 65.15 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.825 0.45 . . . . 0.0 110.74 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.08 13.24 72.05 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.208 0.909 . . . . 0.0 112.866 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.21 176.28 8.9 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.775 0.83 . . . . 0.0 111.506 178.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.7 p -115.61 -160.89 0.76 Allowed 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -172.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.2 -155.25 16.27 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 118.637 0.653 . . . . 0.0 112.751 169.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -168.99 159.37 9.27 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 174.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.22 91.38 3.44 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.579 1.152 . . . . 0.0 111.5 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -93.17 174.83 7.02 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.337 0.655 . . . . 0.0 110.357 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -123.19 133.99 54.19 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 124.191 0.996 . . . . 0.0 110.539 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 30.0 mt -74.67 169.32 18.05 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.77 1.628 . . . . 0.0 110.267 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -90.0 4.5 49.96 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.391 1.076 . . . . 0.0 112.113 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -107.83 -7.57 16.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.469 1.108 . . . . 0.0 112.093 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.56 12.69 11.33 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.085 1.326 . . . . 0.0 113.963 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.36 168.06 10.31 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.637 1.575 . . . . 0.0 112.003 -170.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.9 t -129.07 118.13 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.49 1.116 . . . . 0.0 110.894 -173.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -94.97 121.71 36.87 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.407 1.003 . . . . 0.0 111.234 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.5 t -119.05 134.07 63.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 117.966 0.348 . . . . 0.0 110.532 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.43 142.55 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.412 1.085 . . . . 0.0 109.704 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.08 133.24 7.69 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 118.637 -0.697 . . . . 0.0 111.569 -171.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 96.9 m -100.18 176.44 5.39 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.808 1.243 . . . . 0.0 112.785 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.18 -159.01 20.03 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.825 1.202 . . . . 0.0 110.317 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -73.36 134.24 44.03 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.21 0.604 . . . . 0.0 110.17 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -49.01 -49.46 40.87 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.447 1.099 . . . . 0.0 111.184 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -49.91 -53.3 22.86 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.097 1.332 . . . . 0.0 112.171 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -62.22 -43.61 98.44 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.469 0.708 . . . . 0.0 111.487 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.7 t -58.02 -40.0 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 122.611 0.364 . . . . 0.0 110.396 175.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.46 -26.4 68.71 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -176.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -55.47 -44.72 76.71 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.609 0.764 . . . . 0.0 110.897 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.26 -30.44 48.58 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 118.177 0.444 . . . . 0.0 111.632 175.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.3 mmt -68.38 -22.72 64.63 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 119.074 -0.489 . . . . 0.0 112.096 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -43.34 -51.13 6.54 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 167.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 18.7 t90 -64.25 -40.95 97.06 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.344 0.52 . . . . 0.0 111.989 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mt -56.03 -55.07 37.28 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 123.661 0.785 . . . . 0.0 111.043 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.26 -36.77 77.47 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.769 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.7 t -61.97 -33.24 73.94 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.454 0.57 . . . . 0.0 111.718 175.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.07 16.29 76.72 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 118.932 -0.927 . . . . 0.0 112.886 -176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.99 -105.69 0.12 Allowed Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.893 1.711 . . . . 0.0 112.471 -174.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.4 -177.39 2.06 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 124.142 3.228 . . . . 0.0 112.388 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -65.62 -29.06 69.6 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.453 0.701 . . . . 0.0 111.841 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.6 p -63.75 153.41 36.49 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.402 0.681 . . . . 0.0 110.353 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 77.67 148.5 0.1 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 127.02 2.128 . . . . 0.0 111.042 -168.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -128.74 79.47 1.91 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.7 t -67.54 94.32 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 124.901 1.28 . . . . 0.0 108.039 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -62.43 -56.84 14.32 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.856 0.862 . . . . 0.0 109.988 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -166.96 158.14 12.22 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.18 0.992 . . . . 0.0 109.424 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.3 135.78 57.44 Favored 'Isoleucine or valine' 0 C--N 1.342 0.24 0 C-N-CA 123.771 0.828 . . . . 0.0 110.031 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.9 tp -117.37 108.44 15.58 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.812 0.845 . . . . 0.0 110.789 -177.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.15 127.15 46.45 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.632 1.173 . . . . 0.0 111.52 -177.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -131.0 156.51 80.04 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 126.125 1.77 . . . . 0.0 110.673 -175.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -71.24 120.14 6.78 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.232 3.288 . . . . 0.0 111.495 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -109.44 109.04 19.77 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.485 0.714 . . . . 0.0 109.616 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -109.89 74.21 0.74 Allowed Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 123.945 0.898 . . . . 0.0 110.315 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.73 146.9 30.62 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.072 2.515 . . . . 0.0 110.511 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.7 p -72.72 141.17 48.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.424 0.69 . . . . 0.0 110.485 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.7 -178.63 35.53 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 123.871 0.748 . . . . 0.0 112.132 -177.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -104.12 130.84 51.86 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.333 1.053 . . . . 0.0 108.688 172.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mp -69.54 151.84 45.52 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.836 1.254 . . . . 0.0 109.713 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.59 -77.82 0.17 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.105 0.962 . . . . 0.0 109.008 178.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -137.37 167.0 22.48 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.343 1.057 . . . . 0.0 110.536 -173.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -73.74 143.22 46.18 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.598 173.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -130.93 174.63 9.79 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.414 0.686 . . . . 0.0 110.201 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.5 tp -147.93 152.7 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 122.76 0.424 . . . . 0.0 110.727 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.7 ptt85 . . . . . 0 C--O 1.252 1.185 0 CA-C-O 116.534 -1.698 . . . . 0.0 112.415 174.015 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mtp . . . . . 0 N--CA 1.474 0.76 0 CA-C-O 119.606 -0.235 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.25 -49.89 0.15 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.13 0.572 . . . . 0.0 111.038 -178.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -61.19 135.73 57.84 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.745 1.618 . . . . 0.0 112.104 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.6 p -140.85 91.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 124.604 1.162 . . . . 0.0 108.368 -174.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.0 m -80.86 155.88 26.36 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.579 177.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 pp -143.58 158.2 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.4 tt -118.49 119.73 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 124.103 0.961 . . . . 0.0 109.329 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -109.2 106.43 16.29 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.996 1.318 . . . . 0.0 109.99 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -90.13 124.3 34.7 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.903 0.881 . . . . 0.0 110.251 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.4 t -101.51 104.3 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.11 0.964 . . . . 0.0 108.605 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -68.45 176.87 2.63 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 123.801 0.84 . . . . 0.0 111.69 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.72 -169.51 47.92 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -92.24 91.32 7.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.032 0.533 . . . . 0.0 110.853 -175.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.3 t -111.86 -31.75 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 124.106 0.962 . . . . 0.0 111.233 -178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -69.13 150.16 47.86 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.586 0.355 . . . . 0.0 110.557 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.46 17.55 66.16 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 123.918 0.77 . . . . 0.0 113.397 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.0 t -114.94 -45.56 4.35 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 C-N-CA 124.761 1.224 . . . . 0.0 109.367 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.32 31.93 1.59 Allowed Glycine 0 C--N 1.339 0.698 0 C-N-CA 125.197 1.38 . . . . 0.0 111.434 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -50.79 -36.12 35.44 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 117.664 0.732 . . . . 0.0 110.874 177.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -74.3 56.56 0.65 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.502 1.121 . . . . 0.0 112.741 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -97.42 -71.02 0.7 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.965 0.906 . . . . 0.0 109.264 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 t -89.35 -2.99 58.64 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.71 0.804 . . . . 0.0 111.69 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.8 t -45.98 -37.78 6.93 Favored 'General case' 0 C--N 1.345 0.397 0 C-N-CA 123.84 0.856 . . . . 0.0 112.099 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -69.84 -59.51 2.89 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 124.31 1.044 . . . . 0.0 109.949 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -49.48 -55.11 14.4 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.704 1.202 . . . . 0.0 111.29 -176.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -55.78 -57.5 11.76 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.021 0.928 . . . . 0.0 109.822 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.22 -34.29 31.54 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.926 0.891 . . . . 0.0 112.121 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -62.68 -38.89 92.14 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.438 1.095 . . . . 0.0 111.71 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -68.6 -38.4 80.6 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.017 0.927 . . . . 0.0 110.527 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.87 -32.34 57.43 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.676 0.791 . . . . 0.0 111.118 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.94 15.57 80.42 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.686 0.66 . . . . 0.0 112.82 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.18 179.76 7.63 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.965 0.906 . . . . 0.0 111.217 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 46.0 p -120.29 -162.43 0.94 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -176.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.1 -151.93 17.45 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 172.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -172.57 170.39 4.85 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.844 0.458 . . . . 0.0 112.085 175.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.56 88.19 2.7 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.43 0.692 . . . . 0.0 111.697 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -88.91 173.03 8.73 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.89 0.876 . . . . 0.0 110.18 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -124.01 138.56 54.44 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.699 1.2 . . . . 0.0 108.684 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.9 mt -74.58 178.63 5.21 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.09 1.356 . . . . 0.0 110.173 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -100.94 12.3 37.92 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.806 0.842 . . . . 0.0 111.327 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -117.08 -14.67 10.56 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.401 1.08 . . . . 0.0 112.497 -176.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.13 2.6 7.69 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.171 1.367 . . . . 0.0 114.12 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.1 m -104.34 167.19 9.91 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.855 1.262 . . . . 0.0 111.679 -171.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.9 t -125.4 127.66 72.02 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 C-N-CA 124.302 1.041 . . . . 0.0 109.979 -176.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -102.33 122.73 44.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.659 1.184 . . . . 0.0 110.96 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.76 135.67 57.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -131.2 145.07 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.941 0.897 . . . . 0.0 109.578 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.52 138.96 12.56 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.991 -173.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.3 m -108.98 -178.6 3.62 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.053 1.341 . . . . 0.0 112.298 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.46 -161.29 26.16 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.95 121.46 23.49 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.196 0.998 . . . . 0.0 110.944 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -49.69 -45.32 48.75 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.765 1.226 . . . . 0.0 110.941 -175.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -44.47 -43.74 7.82 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 126.424 1.964 . . . . 0.0 113.423 175.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -78.4 -49.03 14.27 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.689 0.795 . . . . 0.0 110.09 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.4 t -52.87 -32.71 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 122.727 0.411 . . . . 0.0 111.851 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -63.25 -32.0 73.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.255 1.422 . . . . 0.0 112.149 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? -61.89 -52.87 62.35 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-O 118.625 -0.703 . . . . 0.0 110.012 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.81 -29.78 68.47 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.215 0.916 . . . . 0.0 111.091 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.87 -22.67 66.54 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.412 -0.804 . . . . 0.0 111.518 177.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -48.14 -46.63 34.59 Favored 'General case' 0 C--N 1.343 0.326 0 CA-C-N 118.632 0.651 . . . . 0.0 109.951 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -70.46 -35.94 73.62 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.113 -177.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 mt -57.96 -44.75 87.22 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.634 0.652 . . . . 0.0 109.957 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -86.67 0.44 54.57 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.0 t -115.71 -15.2 11.37 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.251 1.421 . . . . 0.0 111.367 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -56.76 -55.98 27.19 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 54.45 67.16 2.32 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.451 ' CG ' ' HB2' ' A' ' 70' ' ' ALA . 72.9 Cg_endo -69.07 136.36 34.61 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 124.686 3.59 . . . . 0.0 110.976 -174.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -80.26 -37.18 33.41 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.879 0.871 . . . . 0.0 111.717 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.39 -35.74 34.84 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.99 0.916 . . . . 0.0 110.918 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.451 ' HB2' ' CG ' ' A' ' 67' ' ' PRO . . . -80.89 167.62 19.67 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.844 1.258 . . . . 0.0 110.144 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.1 ttt85 -124.88 83.43 2.16 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.309 1.044 . . . . 0.0 108.57 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.3 t -70.15 90.84 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -62.92 -58.03 8.76 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.208 0.603 . . . . 0.0 110.782 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.0 tpp180 -168.38 174.07 7.23 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.931 0.892 . . . . 0.0 109.592 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.0 t -140.68 127.61 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.751 0.821 . . . . 0.0 109.982 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.13 156.08 19.18 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.695 1.198 . . . . 0.0 111.086 176.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.12 134.11 34.23 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.5 1.12 . . . . 0.0 111.556 -177.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -141.26 155.37 67.96 Favored Pre-proline 0 N--CA 1.471 0.586 0 C-N-CA 123.897 0.879 . . . . 0.0 111.503 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.9 122.24 9.13 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 124.704 3.603 . . . . 0.0 111.047 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -114.69 135.71 53.86 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.113 0.965 . . . . 0.0 110.512 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -139.66 71.42 37.13 Favored Pre-proline 0 CA--C 1.534 0.356 0 O-C-N 121.659 -0.651 . . . . 0.0 110.481 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -68.28 136.33 36.89 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.394 2.73 . . . . 0.0 110.138 -174.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.5 p -64.63 144.13 57.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.453 0.701 . . . . 0.0 110.825 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.87 170.75 5.46 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.225 0.917 . . . . 0.0 112.041 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -86.59 137.15 32.73 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mp -77.9 150.23 34.13 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.458 0.703 . . . . 0.0 109.543 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.8 -79.26 0.14 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -145.67 163.8 33.75 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.376 0.671 . . . . 0.0 110.948 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -74.22 143.99 44.91 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.258 0.623 . . . . 0.0 110.652 177.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -158.4 -179.98 8.6 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.197 0.599 . . . . 0.0 110.429 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.15 144.56 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.511 0.724 . . . . 0.0 109.296 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.103 0 CA-C-O 116.878 -1.535 . . . . 0.0 114.015 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ptm . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 119.846 -0.121 . . . . 0.0 111.321 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 m -136.42 -47.03 0.62 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.185 0.994 . . . . 0.0 110.691 -176.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.6 134.36 54.19 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.176 1.39 . . . . 0.0 112.064 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 p -139.32 90.84 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.242 0 C-N-CA 124.645 1.178 . . . . 0.0 108.63 -174.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.3 m -81.36 153.2 27.12 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.772 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pp -141.16 158.2 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.123 0.569 . . . . 0.0 109.875 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 tt -117.7 118.24 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.171 0.989 . . . . 0.0 109.724 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -107.32 108.15 19.4 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.852 1.661 . . . . 0.0 109.897 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -90.4 128.35 36.46 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 125.243 1.417 . . . . 0.0 110.296 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.4 t -114.45 122.44 68.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.329 1.052 . . . . 0.0 109.07 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -96.66 178.76 5.22 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.829 1.252 . . . . 0.0 110.858 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.72 -160.21 53.44 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.3 mtt-85 -85.17 92.09 8.31 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -171.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.9 t -131.52 -45.84 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.523 0.729 . . . . 0.0 110.487 -175.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -70.46 146.91 49.98 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 122.857 0.463 . . . . 0.0 110.539 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.23 14.72 82.27 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 119.152 -0.805 . . . . 0.0 113.373 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 75.2 t -107.79 -44.11 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.618 1.167 . . . . 0.0 109.424 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.49 28.76 2.25 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 125.194 1.378 . . . . 0.0 111.431 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -50.78 -37.61 43.3 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 123.85 0.86 . . . . 0.0 111.11 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.21 59.49 0.76 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.388 1.075 . . . . 0.0 112.621 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -111.76 -72.84 0.7 Allowed 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.108 1.363 . . . . 0.0 109.55 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.1 t -73.13 -18.13 61.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.86 -0.59 . . . . 0.0 111.45 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.2 t -45.29 -36.92 4.35 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.844 0.858 . . . . 0.0 112.009 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -71.13 -57.79 4.18 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.351 1.06 . . . . 0.0 110.317 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.15 -59.87 3.87 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.158 0.983 . . . . 0.0 110.649 -175.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -55.18 -46.17 75.8 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.368 1.067 . . . . 0.0 110.428 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.59 -36.17 71.38 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.0 tttt -62.25 -30.91 71.44 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.09 0.556 . . . . 0.0 111.572 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.2 mmm-85 -66.85 -49.54 65.39 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 122.964 0.505 . . . . 0.0 110.652 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.6 mt -77.16 -42.44 37.73 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 122.403 0.281 . . . . 0.0 110.855 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.9 9.36 58.51 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.551 1.072 . . . . 0.0 112.953 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.01 168.1 3.44 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 117.86 0.83 . . . . 0.0 112.015 175.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.5 p -127.3 151.03 49.29 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -176.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 161.9 -148.36 15.67 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -170.45 167.83 8.05 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 122.99 0.516 . . . . 0.0 111.777 173.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.41 99.68 5.5 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 118.679 -0.676 . . . . 0.0 111.345 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -100.93 176.83 5.14 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 124.68 1.192 . . . . 0.0 111.547 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 -127.11 137.98 53.1 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.074 1.35 . . . . 0.0 109.473 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.1 mt -75.01 174.24 9.61 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 125.075 1.35 . . . . 0.0 110.552 174.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -96.69 10.33 39.01 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.708 1.203 . . . . 0.0 111.529 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.68 -2.55 12.43 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.528 1.131 . . . . 0.0 112.018 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.94 25.77 6.65 Favored Glycine 0 C--N 1.342 0.871 0 C-N-CA 124.638 1.113 . . . . 0.0 113.776 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.16 162.22 19.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.006 1.322 . . . . 0.0 111.531 -175.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.0 t -122.05 120.85 62.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.409 1.484 . . . . 0.0 110.864 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -99.11 122.37 42.25 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.906 1.282 . . . . 0.0 111.06 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.56 136.87 55.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 C-N-CA 123.554 0.741 . . . . 0.0 109.511 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 t -127.36 143.33 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 124.237 1.015 . . . . 0.0 109.425 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.43 136.71 13.96 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-O 118.819 -0.61 . . . . 0.0 110.925 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 56.4 m -104.39 -179.53 3.97 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.698 1.599 . . . . 0.0 112.652 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.52 -154.57 22.25 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -80.09 129.07 34.22 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 123.222 0.609 . . . . 0.0 110.231 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -48.73 -52.43 23.68 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.908 1.283 . . . . 0.0 111.013 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.04 -45.88 62.03 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.343 1.449 . . . . 0.0 112.693 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -66.7 -46.86 74.22 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 117.479 0.639 . . . . 0.0 111.224 177.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.3 t -54.91 -30.9 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.135 0.574 . . . . 0.0 110.955 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -59.33 -31.39 69.13 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -55.05 -36.78 65.92 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.901 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.91 -31.62 23.58 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.138 0.881 . . . . 0.0 111.03 174.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.5 mmm -65.59 -19.78 66.06 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.14 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -46.31 -51.38 14.78 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -70.83 -34.04 71.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 mt -56.15 -54.21 47.85 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 123.324 0.65 . . . . 0.0 109.983 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.57 -31.21 71.98 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.948 0.499 . . . . 0.0 112.275 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.8 m -66.63 -15.03 63.17 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.696 0.68 . . . . 0.0 112.658 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.27 19.89 77.76 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 118.512 -1.16 . . . . 0.0 111.974 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.4 -103.05 0.04 OUTLIER Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.559 1.552 . . . . 0.0 112.678 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -72.28 -176.3 2.13 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.032 3.154 . . . . 0.0 111.927 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -91.33 -38.34 12.69 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.877 0.871 . . . . 0.0 110.755 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.86 -32.91 61.22 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.611 1.164 . . . . 0.0 112.056 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.18 126.75 28.42 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.621 0.768 . . . . 0.0 109.974 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -115.29 78.45 1.17 Allowed 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.6 t -71.19 92.38 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -55.75 -56.61 18.4 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 123.848 0.859 . . . . 0.0 110.775 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.8 mtm-85 -157.08 161.9 39.46 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.953 1.301 . . . . 0.0 110.001 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.06 131.03 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.353 1.061 . . . . 0.0 109.534 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 tp -113.87 148.4 36.77 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.905 1.282 . . . . 0.0 110.819 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.42 135.57 38.82 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.402 -177.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -142.64 156.69 63.01 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 123.523 0.729 . . . . 0.0 111.68 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.13 122.98 10.09 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.644 3.563 . . . . 0.0 110.737 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -110.96 113.06 25.33 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.723 0.809 . . . . 0.0 109.571 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -117.43 70.08 6.12 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 118.709 0.686 . . . . 0.0 111.171 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.91 146.34 47.33 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.249 2.633 . . . . 0.0 110.79 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.5 p -72.5 142.97 48.54 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.615 0.766 . . . . 0.0 110.726 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.79 169.65 4.78 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.362 0.982 . . . . 0.0 112.128 -176.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -95.51 135.48 37.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.5 tp -79.77 150.48 30.76 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -75.81 0.14 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.223 1.009 . . . . 0.0 108.58 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -140.97 163.64 32.43 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.341 1.056 . . . . 0.0 110.129 -173.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -69.94 146.77 50.93 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.286 0.634 . . . . 0.0 110.829 175.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -143.25 -169.81 3.13 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.672 0.789 . . . . 0.0 110.909 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.0 pt -130.65 -170.9 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 124.181 0.993 . . . . 0.0 109.109 176.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.2 mtm-85 . . . . . 0 C--O 1.251 1.165 0 C-N-CA 125.069 1.348 . . . . 0.0 112.585 178.35 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.691 0 CA-C-O 119.402 -0.333 . . . . 0.0 110.666 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 t -140.89 -52.54 0.47 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.896 0.878 . . . . 0.0 111.198 -175.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -66.48 129.48 39.97 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.449 1.5 . . . . 0.0 112.137 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 p -135.15 89.33 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.281 0 C-N-CA 125.179 1.392 . . . . 0.0 108.435 -174.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.2 m -79.96 153.94 28.58 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.558 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.51 159.28 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.0 tt -122.83 121.08 62.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.451 1.101 . . . . 0.0 110.204 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -116.09 115.74 26.62 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.747 1.619 . . . . 0.0 111.615 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.1 m-90 -93.82 120.45 34.1 Favored 'General case' 0 C--N 1.337 0.063 0 C-N-CA 125.724 1.61 . . . . 0.0 110.906 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.1 t -109.33 123.54 65.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 124.537 1.135 . . . . 0.0 108.937 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -101.32 178.58 4.61 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 124.277 1.031 . . . . 0.0 110.846 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.59 -160.11 48.79 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -85.09 96.08 9.32 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -171.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.4 t -128.56 -46.79 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 124.036 0.835 . . . . 0.0 109.853 -176.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -67.92 145.64 54.37 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 123.558 0.743 . . . . 0.0 111.269 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.26 25.58 72.74 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 123.914 0.769 . . . . 0.0 112.98 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.7 t -119.37 -48.24 3.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 124.865 1.266 . . . . 0.0 109.397 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.55 30.71 2.14 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.36 1.457 . . . . 0.0 111.392 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -55.14 -40.35 70.46 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 117.52 0.66 . . . . 0.0 109.913 173.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -89.57 23.68 2.54 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.756 1.222 . . . . 0.0 112.364 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -90.11 -57.61 2.79 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.794 0.838 . . . . 0.0 109.036 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 t -73.84 -13.82 60.99 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.003 0.921 . . . . 0.0 113.31 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.7 t -65.76 -26.77 67.87 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 118.399 0.545 . . . . 0.0 111.393 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -57.48 -53.96 52.22 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.099 0.96 . . . . 0.0 109.912 175.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.67 -49.64 72.39 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.129 0.972 . . . . 0.0 111.941 -175.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.59 -53.11 60.68 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.151 0.58 . . . . 0.0 110.835 174.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.23 -33.77 29.39 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.921 0.888 . . . . 0.0 112.647 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -63.88 -35.8 81.84 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.007 0.923 . . . . 0.0 111.72 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 -69.45 -43.73 72.71 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.694 0.797 . . . . 0.0 110.309 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.3 mt -74.7 -39.42 61.95 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.754 0.821 . . . . 0.0 111.144 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.02 16.21 72.89 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.29 0.947 . . . . 0.0 112.871 -177.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.13 172.85 10.31 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 117.575 0.688 . . . . 0.0 110.915 175.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.1 p -118.73 -162.76 0.92 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -174.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 124.18 -154.14 17.71 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 169.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -168.17 161.82 12.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.095 -0.553 . . . . 0.0 112.125 170.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.09 97.31 5.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.599 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.21 175.23 6.69 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.922 0.889 . . . . 0.0 110.603 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -123.73 138.01 54.59 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.208 1.003 . . . . 0.0 109.478 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.6 mt -76.5 172.57 12.75 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.081 1.352 . . . . 0.0 110.247 173.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -90.76 4.0 52.79 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.639 1.175 . . . . 0.0 112.184 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -108.88 -10.66 15.08 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.584 1.154 . . . . 0.0 112.397 -175.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.53 -4.44 12.04 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.274 1.416 . . . . 0.0 113.668 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.07 163.86 13.31 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.919 1.288 . . . . 0.0 111.96 -171.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.6 t -127.88 118.34 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.604 1.562 . . . . 0.0 110.723 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -100.66 119.83 39.16 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.919 0.888 . . . . 0.0 111.132 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.4 t -112.09 138.84 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.563 1.545 . . . . 0.0 109.316 -173.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 t -134.42 145.2 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.008 0.923 . . . . 0.0 109.895 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.58 137.9 12.76 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-O 118.513 -0.756 . . . . 0.0 111.604 -175.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 58.4 m -107.3 177.54 4.81 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.134 1.373 . . . . 0.0 112.442 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.31 -167.68 19.37 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -73.25 140.87 47.16 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.0 0.52 . . . . 0.0 109.741 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -53.3 -47.37 69.28 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.21 0.604 . . . . 0.0 109.799 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -46.02 -34.38 5.78 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 126.451 1.977 . . . . 0.0 114.63 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -84.61 -46.48 11.49 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.804 1.242 . . . . 0.0 111.135 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.5 t -59.02 -40.76 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 122.254 0.221 . . . . 0.0 110.667 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -61.51 -25.58 67.36 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.9 0.88 . . . . 0.0 111.91 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -57.41 -49.83 74.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.57 0.748 . . . . 0.0 110.998 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -73.98 -32.69 63.53 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 118.324 0.511 . . . . 0.0 110.615 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mmm -66.6 -23.03 66.13 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 118.742 -0.646 . . . . 0.0 111.341 -177.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -45.7 -49.66 14.38 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.877 0.762 . . . . 0.0 109.548 168.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -59.41 -43.98 92.93 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.461 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.77 -47.36 59.65 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 119.49 1.041 . . . . 0.0 111.533 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.83 -0.0 46.01 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.0 m -102.66 -38.04 7.66 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 124.053 0.941 . . . . 0.0 111.103 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.73 13.43 47.94 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 118.874 -0.959 . . . . 0.0 112.972 -177.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.63 -65.19 1.8 Allowed Glycine 0 CA--C 1.53 1.005 0 CA-C-N 118.647 1.223 . . . . 0.0 112.573 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.43 -13.67 25.21 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.913 2.409 . . . . 0.0 112.788 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 48.3 mtm180 -91.5 -54.58 3.84 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 123.744 0.818 . . . . 0.0 110.783 -176.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.7 148.09 38.74 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.269 1.427 . . . . 0.0 108.808 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 63.82 -168.82 0.2 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 122.915 0.486 . . . . 0.0 110.898 174.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -132.21 81.86 1.98 Allowed 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.247 0.93 . . . . 0.0 109.328 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.2 t -76.63 94.82 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 123.48 0.712 . . . . 0.0 109.153 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -64.42 -57.25 9.81 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.61 1.164 . . . . 0.0 110.979 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -154.07 153.31 31.66 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.789 0.836 . . . . 0.0 110.301 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.73 135.37 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 123.687 0.795 . . . . 0.0 111.097 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.5 tp -127.69 147.0 50.38 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.244 1.018 . . . . 0.0 112.506 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.32 141.24 50.6 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.416 1.087 . . . . 0.0 112.303 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -142.68 158.21 60.37 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 124.852 1.261 . . . . 0.0 111.922 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.51 129.47 16.86 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 124.28 3.32 . . . . 0.0 111.716 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -121.16 129.67 53.36 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.302 1.041 . . . . 0.0 110.684 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -131.81 71.77 80.33 Favored Pre-proline 0 CA--C 1.537 0.463 0 O-C-N 121.372 -0.83 . . . . 0.0 111.211 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.45 150.19 63.65 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.241 2.628 . . . . 0.0 111.11 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 75.4 p -73.73 140.23 45.84 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.681 0.792 . . . . 0.0 110.521 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.02 179.62 25.77 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 123.938 0.78 . . . . 0.0 112.131 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -98.28 131.28 44.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.938 0.895 . . . . 0.0 108.769 171.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tp -72.55 152.94 41.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.645 1.178 . . . . 0.0 109.514 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.45 -79.93 0.13 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.837 0.855 . . . . 0.0 108.998 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -134.8 163.71 29.2 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.161 0.984 . . . . 0.0 109.938 -171.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -73.62 146.61 44.49 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.196 0.598 . . . . 0.0 110.322 173.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -140.13 -171.05 3.1 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.039 0.936 . . . . 0.0 110.158 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.8 pt -131.15 -173.93 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.968 0.907 . . . . 0.0 109.956 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.187 0 C-N-CA 125.236 1.414 . . . . 0.0 112.297 172.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ptm . . . . . 0 N--CA 1.474 0.755 0 CA-C-O 119.263 -0.399 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 175.45 -59.2 0.01 OUTLIER 'General case' 0 C--N 1.342 0.28 0 C-N-CA 125.74 1.616 . . . . 0.0 108.927 173.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.89 111.17 4.19 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.747 0.819 . . . . 0.0 111.687 -170.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 p -112.78 79.46 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 125.708 1.603 . . . . 0.0 107.331 -174.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -76.0 144.66 40.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.474 -177.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 pp -117.0 163.01 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -178.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.5 tt -124.79 116.02 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 124.911 1.284 . . . . 0.0 108.228 170.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -116.04 102.51 9.7 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.633 1.173 . . . . 0.0 110.801 -173.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.2 m-90 -82.49 112.44 19.42 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.12 0.568 . . . . 0.0 109.478 176.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.6 t -91.74 106.9 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -63.75 -37.31 86.88 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.949 0.5 . . . . 0.0 111.773 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.04 165.27 7.19 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.001 1.286 . . . . 0.0 114.854 -174.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -79.87 72.4 6.61 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.522 1.129 . . . . 0.0 111.893 -174.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.3 t -100.5 -33.31 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 124.579 1.152 . . . . 0.0 111.223 -173.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -67.34 145.73 54.8 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.883 0.473 . . . . 0.0 110.693 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.62 24.49 72.45 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 123.993 0.806 . . . . 0.0 113.323 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.5 t -118.95 -40.78 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.416 1.086 . . . . 0.0 110.319 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.95 31.41 5.69 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.148 1.356 . . . . 0.0 112.05 -177.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -48.72 -33.01 9.36 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.388 1.875 . . . . 0.0 112.927 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -72.79 57.97 0.44 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.862 2.065 . . . . 0.0 111.95 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -108.22 -69.54 0.85 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.346 1.058 . . . . 0.0 109.542 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.6 t -96.22 5.57 50.73 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.342 1.057 . . . . 0.0 112.553 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.9 t -58.36 -35.62 72.23 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 122.008 -0.432 . . . . 0.0 111.31 170.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 -61.85 -58.91 6.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.445 1.098 . . . . 0.0 110.698 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -51.85 -55.35 20.51 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.69 0.796 . . . . 0.0 110.994 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -53.21 -54.43 36.18 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.536 0.734 . . . . 0.0 111.044 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.18 -32.92 56.84 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.915 0.886 . . . . 0.0 112.622 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -67.65 -32.92 73.94 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.961 0.504 . . . . 0.0 111.631 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 40.0 mtp85 -68.17 -48.12 66.16 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.386 0.539 . . . . 0.0 110.128 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.77 -30.54 59.16 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.289 0.636 . . . . 0.0 110.696 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.84 22.43 61.58 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.404 1.478 . . . . 0.0 113.352 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.43 167.21 19.64 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.0 p -127.84 140.78 51.82 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.477 1.511 . . . . 0.0 107.348 -171.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.04 -165.11 38.52 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.675 -1.25 . . . . 0.0 112.701 -165.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -169.34 156.44 6.87 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 171.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.61 84.6 2.05 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.646 1.178 . . . . 0.0 109.215 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -89.3 168.11 12.52 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 122.974 0.509 . . . . 0.0 110.339 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -127.31 133.36 50.13 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.646 0.778 . . . . 0.0 109.511 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.4 mt -71.2 168.21 17.74 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.12 0.968 . . . . 0.0 109.755 170.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -86.51 4.44 39.88 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.867 0.867 . . . . 0.0 111.593 175.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -90.52 -56.02 3.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.827 0.851 . . . . 0.0 109.225 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 162.64 -12.34 0.11 Allowed Glycine 0 CA--C 1.53 0.99 0 CA-C-N 114.827 -1.079 . . . . 0.0 113.192 -166.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.4 m -112.76 145.61 40.25 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.295 1.048 . . . . 0.0 112.388 -164.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 86.0 t -105.37 122.44 58.71 Favored 'Isoleucine or valine' 0 C--N 1.344 0.341 0 C-N-CA 124.759 1.224 . . . . 0.0 110.652 -173.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -94.64 103.17 15.11 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.547 1.539 . . . . 0.0 110.128 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.14 124.68 56.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.7 t -128.16 135.08 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.947 0.899 . . . . 0.0 109.428 -174.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.62 125.36 6.45 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.365 -169.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 95.2 m -88.86 -178.98 5.87 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.361 1.464 . . . . 0.0 112.018 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.15 -165.91 17.39 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -74.21 136.0 42.77 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -56.85 -46.09 82.0 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.294 0.638 . . . . 0.0 110.575 -174.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -47.28 -50.93 16.14 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.617 1.58 . . . . 0.0 112.56 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -62.2 -50.68 70.84 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.751 0.82 . . . . 0.0 111.294 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.3 t -55.44 -37.86 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.823 0.849 . . . . 0.0 111.12 178.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -59.11 -33.57 71.0 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.472 0.578 . . . . 0.0 111.942 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -58.12 -42.51 85.89 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.739 0.699 . . . . 0.0 112.469 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 pp -78.54 -28.19 46.04 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.928 0.785 . . . . 0.0 111.32 175.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 7.9 mmm -67.14 -34.18 77.03 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 118.425 -0.797 . . . . 0.0 111.021 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -42.25 -53.37 4.13 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 168.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -65.49 -39.97 92.55 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 118.647 -0.692 . . . . 0.0 112.261 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 42.8 mt -58.79 -49.05 79.13 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 119.813 1.188 . . . . 0.0 109.72 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -72.43 8.28 1.45 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.05 1.34 . . . . 0.0 112.751 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.6 m -146.98 29.96 0.97 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.174 1.389 . . . . 0.0 109.064 172.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.16 -46.87 4.89 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -168.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.54 116.15 8.04 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.861 -0.966 . . . . 0.0 111.074 -173.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -73.25 -47.79 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.498 2.132 . . . . 0.0 110.974 -176.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 48.5 mtt-85 -145.37 -61.44 0.34 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.214 1.006 . . . . 0.0 109.561 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.4 t -59.08 -65.82 0.61 Allowed 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.76 1.224 . . . . 0.0 111.613 -174.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.89 118.92 6.8 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.046 0.539 . . . . 0.0 109.89 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -111.6 93.08 4.29 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.466 1.106 . . . . 0.0 108.148 -173.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.8 t -76.99 94.44 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.356 1.062 . . . . 0.0 108.97 -178.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.12 -64.42 0.86 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.126 0.97 . . . . 0.0 110.5 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.53 155.84 17.82 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.532 1.133 . . . . 0.0 109.169 -173.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -129.62 123.1 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.995 1.318 . . . . 0.0 109.259 -176.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.3 tp -99.72 106.87 18.83 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.1 m -99.93 130.03 46.07 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.095 0.558 . . . . 0.0 111.401 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -130.62 164.53 40.87 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 127.585 2.354 . . . . 0.0 108.469 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.05 129.29 10.45 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.089 2.526 . . . . 0.0 111.111 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -110.4 106.66 16.09 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.741 1.216 . . . . 0.0 109.979 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -106.63 86.99 2.48 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 118.635 0.652 . . . . 0.0 111.296 177.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.91 167.29 22.33 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.107 2.538 . . . . 0.0 110.829 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.5 m -87.77 129.59 35.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.012 0.925 . . . . 0.0 109.498 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.09 -177.94 27.31 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.941 0.781 . . . . 0.0 112.509 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -100.9 126.73 47.54 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.645 1.178 . . . . 0.0 109.467 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.7 tp -72.74 143.13 48.11 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 170.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.6 p -73.43 -63.39 1.2 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.238 1.015 . . . . 0.0 111.444 -171.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -132.26 166.47 21.82 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.054 1.341 . . . . 0.0 110.087 -174.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -82.3 144.64 30.46 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.083 0.553 . . . . 0.0 109.744 168.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -155.37 178.91 9.68 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 123.069 0.547 . . . . 0.0 109.759 176.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.99 163.54 24.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 123.106 0.562 . . . . 0.0 110.626 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 116.713 -1.613 . . . . 0.0 111.287 173.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttm . . . . . 0 N--CA 1.473 0.715 0 CA-C-O 119.443 -0.313 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.4 t -137.03 -41.84 0.58 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.899 0.88 . . . . 0.0 110.785 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.24 155.11 39.67 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.235 1.014 . . . . 0.0 113.054 -176.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.34 90.99 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.304 1.042 . . . . 0.0 108.304 -174.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.7 m -78.87 153.39 30.6 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.471 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.68 149.4 18.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -176.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 tt -107.54 128.2 62.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 123.771 0.828 . . . . 0.0 109.704 176.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -121.97 101.21 7.42 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.058 1.743 . . . . 0.0 109.895 -176.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -86.37 123.52 31.7 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 124.772 1.229 . . . . 0.0 110.459 177.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.12 119.6 59.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.296 1.038 . . . . 0.0 109.292 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -92.22 175.17 6.95 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.011 1.324 . . . . 0.0 110.712 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.17 -167.52 53.43 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -84.67 84.24 7.75 Favored 'General case' 0 CA--C 1.523 -0.089 0 C-N-CA 123.083 0.553 . . . . 0.0 111.723 -169.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.94 -46.92 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 124.034 0.934 . . . . 0.0 109.442 -174.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -69.25 146.79 52.02 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-O 121.007 0.432 . . . . 0.0 111.365 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.15 20.92 73.46 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.209 0.909 . . . . 0.0 113.354 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.1 t -105.32 -42.42 7.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 C-N-CA 124.48 1.112 . . . . 0.0 109.242 175.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.48 29.07 2.81 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.653 1.597 . . . . 0.0 111.202 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -51.84 -36.55 48.61 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.483 1.113 . . . . 0.0 111.597 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.88 58.2 0.83 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.306 1.442 . . . . 0.0 112.423 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -107.24 -74.58 0.65 Allowed 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.562 1.145 . . . . 0.0 109.39 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.6 t -74.84 -18.48 60.44 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.633 -0.699 . . . . 0.0 112.002 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.4 t -43.82 -40.96 4.74 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.925 0.89 . . . . 0.0 112.286 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -67.04 -59.02 3.83 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.753 1.221 . . . . 0.0 109.675 175.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -52.76 -57.18 10.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.597 1.159 . . . . 0.0 111.343 -175.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -55.86 -51.03 68.95 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.568 0.747 . . . . 0.0 110.497 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.74 -36.55 62.43 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.807 0.443 . . . . 0.0 111.985 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -64.34 -30.97 72.0 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.365 0.666 . . . . 0.0 111.895 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 mmm-85 -67.75 -50.52 56.78 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.119 0.568 . . . . 0.0 110.597 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.9 mp -70.99 -30.05 66.19 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.827 0.451 . . . . 0.0 110.665 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.78 18.43 78.91 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.054 0.835 . . . . 0.0 112.483 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.52 175.03 10.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.705 0.802 . . . . 0.0 110.991 176.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.3 p -117.45 -161.65 0.83 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -173.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.46 -155.54 16.49 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 169.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -169.73 160.05 8.48 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 172.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.84 94.39 4.38 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.826 1.251 . . . . 0.0 110.21 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.3 174.5 6.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.506 0.722 . . . . 0.0 111.355 176.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -122.6 139.41 53.95 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.044 0.938 . . . . 0.0 109.715 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.8 mt -76.0 174.64 9.73 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 125.468 1.507 . . . . 0.0 110.258 173.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -98.67 11.7 37.72 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.968 1.307 . . . . 0.0 111.593 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -118.19 -4.54 10.96 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.806 1.242 . . . . 0.0 111.868 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.96 14.15 9.53 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.947 1.26 . . . . 0.0 114.483 176.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.8 168.57 10.1 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.504 1.522 . . . . 0.0 111.937 -170.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 73.1 t -130.7 120.99 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.312 1.045 . . . . 0.0 111.44 -174.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -101.98 118.04 36.09 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.081 0.952 . . . . 0.0 110.997 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.5 t -112.47 137.6 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 123.631 0.773 . . . . 0.0 110.027 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.22 144.31 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.689 0.796 . . . . 0.0 109.886 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.06 132.05 8.92 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-O 118.52 -0.753 . . . . 0.0 111.294 -174.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 89.7 m -100.43 -179.56 4.14 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.804 1.242 . . . . 0.0 112.365 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.2 -161.8 20.81 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -75.05 126.36 30.85 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 122.793 0.437 . . . . 0.0 110.096 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -49.18 -50.63 37.07 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 124.142 0.977 . . . . 0.0 110.594 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -48.16 -40.21 21.08 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.92 1.724 . . . . 0.0 113.652 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -77.57 -48.54 16.7 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.776 0.83 . . . . 0.0 111.132 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.0 -39.94 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 122.715 0.406 . . . . 0.0 111.114 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -61.77 -27.27 68.62 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -59.25 -48.12 82.8 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.193 0.451 . . . . 0.0 110.469 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.46 -30.74 63.37 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.889 0.313 . . . . 0.0 111.302 178.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mmt -67.55 -20.07 65.36 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-O 118.913 -0.565 . . . . 0.0 112.415 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -46.13 -50.98 14.83 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 168.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -61.27 -41.85 97.65 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.1 mt -54.39 -54.13 44.71 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 123.812 0.845 . . . . 0.0 110.6 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -70.26 -33.72 71.95 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 119.073 -0.489 . . . . 0.0 112.038 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.5 t -63.85 -31.61 72.84 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.761 0.71 . . . . 0.0 111.914 175.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.81 13.28 80.71 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 118.813 -0.993 . . . . 0.0 113.178 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.7 -105.39 0.1 OUTLIER Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.77 1.653 . . . . 0.0 112.55 -175.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -71.81 -178.88 3.36 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.133 3.222 . . . . 0.0 112.514 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -68.47 -28.32 66.93 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.436 0.694 . . . . 0.0 111.93 177.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.9 p -65.42 157.83 28.32 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.523 0.729 . . . . 0.0 110.938 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 74.25 158.4 0.21 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.518 1.927 . . . . 0.0 110.78 -166.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -129.45 107.94 9.88 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.7 t -92.65 88.3 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -60.7 -65.58 0.67 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.089 0.556 . . . . 0.0 109.892 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.6 mtm-85 -150.56 156.29 41.11 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.539 1.135 . . . . 0.0 109.6 -176.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.3 t -137.82 130.15 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 123.715 0.806 . . . . 0.0 110.522 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tp -113.38 135.35 53.96 Favored 'General case' 0 C--N 1.346 0.448 0 C-N-CA 125.21 1.404 . . . . 0.0 112.058 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.55 137.31 54.93 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.314 1.045 . . . . 0.0 111.985 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -145.27 159.06 50.17 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.645 1.178 . . . . 0.0 111.68 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.92 136.53 25.22 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.967 3.111 . . . . 0.0 111.666 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -127.13 125.43 41.18 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.672 1.189 . . . . 0.0 111.106 -175.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -129.7 70.91 82.16 Favored Pre-proline 0 CA--C 1.535 0.403 0 O-C-N 121.696 -0.627 . . . . 0.0 111.37 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.63 142.31 35.9 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.894 2.396 . . . . 0.0 110.776 -176.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.5 p -70.82 140.97 51.35 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.663 0.785 . . . . 0.0 110.85 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.99 173.04 23.95 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.106 0.86 . . . . 0.0 111.638 -175.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -96.1 135.34 38.03 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -76.25 151.99 36.65 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.3 m -80.88 -76.73 0.23 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -177.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -134.47 165.76 24.45 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.717 1.207 . . . . 0.0 110.223 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -72.88 149.79 43.17 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.711 0.804 . . . . 0.0 110.353 172.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -151.24 -169.54 3.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.005 0.922 . . . . 0.0 110.002 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.8 pt -130.77 -179.46 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.271 1.028 . . . . 0.0 109.542 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.18 0 CA-C-O 117.62 -1.181 . . . . 0.0 111.723 170.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t 79.66 -65.51 0.19 Allowed 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 125.435 1.494 . . . . 0.0 109.396 177.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.05 144.22 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.909 1.684 . . . . 0.0 111.672 176.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 p -139.44 88.2 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.199 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.7 m -81.7 152.78 26.91 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.403 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.5 146.76 19.27 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -176.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 tt -109.36 122.29 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 124.271 1.029 . . . . 0.0 109.877 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.55 116.56 28.99 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.971 1.308 . . . . 0.0 111.024 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.7 m-90 -96.56 121.99 38.99 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.768 0.827 . . . . 0.0 110.16 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.6 t -104.5 115.32 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.397 1.079 . . . . 0.0 108.848 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -87.49 178.56 6.77 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.76 1.224 . . . . 0.0 111.453 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.29 -159.71 50.46 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -88.37 99.49 12.29 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.114 -174.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -130.74 -43.71 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 123.441 0.697 . . . . 0.0 109.756 -177.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -70.4 143.77 51.76 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.596 0.758 . . . . 0.0 109.969 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.6 18.61 79.7 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 119.26 -0.745 . . . . 0.0 113.31 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 83.5 t -107.52 -43.63 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.577 1.151 . . . . 0.0 109.527 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 116.35 28.5 2.56 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 125.187 1.375 . . . . 0.0 111.446 -177.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -50.93 -32.71 21.6 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 123.627 0.771 . . . . 0.0 111.192 176.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -76.51 58.71 1.38 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.838 0.855 . . . . 0.0 112.764 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -95.18 -70.32 0.72 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 t -92.85 -2.54 55.8 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.496 -0.764 . . . . 0.0 111.656 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 t -45.48 -36.93 4.81 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.095 0.861 . . . . 0.0 112.403 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -73.72 -60.31 2.31 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.266 1.026 . . . . 0.0 109.806 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -50.3 -59.14 4.26 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.271 1.028 . . . . 0.0 111.002 -175.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.9 -53.28 34.06 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 125.589 1.556 . . . . 0.0 110.057 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.49 -37.84 70.93 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.618 0.367 . . . . 0.0 111.732 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.3 tttm -61.87 -31.72 72.02 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.249 1.019 . . . . 0.0 111.7 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.26 -52.32 48.71 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.261 0.624 . . . . 0.0 110.946 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.6 mt -72.23 -31.11 65.54 Favored 'General case' 0 CA--C 1.528 0.124 0 O-C-N 122.849 0.093 . . . . 0.0 110.812 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.66 6.94 82.48 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.064 0.84 . . . . 0.0 112.596 -178.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.15 178.14 2.93 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.817 0.808 . . . . 0.0 111.326 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 43.7 p -125.79 -169.05 1.94 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -175.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 130.85 -151.49 19.62 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 171.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -170.91 167.48 7.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.438 -0.381 . . . . 0.0 111.421 173.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -131.69 97.07 4.11 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.793 0.683 . . . . 0.0 111.435 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.4 mttp -93.28 174.01 7.43 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.969 1.308 . . . . 0.0 110.142 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -124.24 135.25 53.28 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.431 1.092 . . . . 0.0 109.628 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.8 mt -74.95 171.82 13.38 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.077 1.351 . . . . 0.0 109.847 177.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -93.66 4.96 53.13 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.587 0.755 . . . . 0.0 111.571 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -107.25 -14.53 14.87 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.64 1.176 . . . . 0.0 111.724 -177.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.92 7.6 8.53 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.015 1.293 . . . . 0.0 113.91 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.9 168.68 8.97 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.946 1.298 . . . . 0.0 111.336 -172.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.0 t -129.01 120.25 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.391 1.077 . . . . 0.0 110.549 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -95.71 127.16 41.5 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.82 0.848 . . . . 0.0 110.232 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.27 136.22 58.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 124.389 1.075 . . . . 0.0 109.525 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.24 143.37 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 124.012 0.925 . . . . 0.0 109.356 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.69 138.23 15.98 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 118.856 -0.592 . . . . 0.0 110.668 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 61.5 m -103.0 178.5 4.54 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.867 1.267 . . . . 0.0 111.435 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.94 -159.82 18.03 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -78.76 132.54 36.97 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 124.965 1.306 . . . . 0.0 109.408 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -46.84 -55.9 7.18 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.491 1.116 . . . . 0.0 110.683 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -49.99 -43.87 40.84 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.238 1.399 . . . . 0.0 112.767 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -67.07 -46.43 74.35 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.295 1.038 . . . . 0.0 111.187 176.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 77.4 t -54.05 -41.17 49.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.163 0.585 . . . . 0.0 110.408 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.24 -26.97 68.11 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -59.77 -27.12 66.26 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.259 1.024 . . . . 0.0 112.712 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.02 -29.81 13.43 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.48 0.582 . . . . 0.0 110.774 172.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.2 mmt -62.72 -23.56 67.22 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-O 118.722 -0.656 . . . . 0.0 111.418 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.48 -57.62 3.97 Favored 'General case' 0 C--O 1.248 0.985 0 C-N-CA 122.966 0.506 . . . . 0.0 110.027 173.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -65.31 -32.34 73.94 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 118.656 0.662 . . . . 0.0 112.07 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.7 mt -61.64 -51.85 66.75 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 119.054 0.843 . . . . 0.0 109.832 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -81.84 -0.05 41.7 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -178.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.6 t -108.86 -32.5 7.27 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 125.234 1.413 . . . . 0.0 110.36 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -94.62 19.85 51.58 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.391 0.996 . . . . 0.0 112.159 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.09 -78.78 0.83 Allowed Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 125.202 1.382 . . . . 0.0 110.867 175.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -67.63 -9.89 26.95 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.785 2.99 . . . . 0.0 112.634 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.01 -32.51 46.99 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.282 1.033 . . . . 0.0 112.293 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.04 -44.56 0.08 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.403 1.081 . . . . 0.0 110.275 -178.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.09 176.72 7.72 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.646 1.578 . . . . 0.0 110.509 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -122.16 74.6 1.17 Allowed 'General case' 0 C--N 1.341 0.22 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -175.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 87.8 t -70.9 96.42 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -63.05 -61.75 2.17 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.378 0.671 . . . . 0.0 109.31 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.9 mmm-85 -152.19 161.53 42.48 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.046 1.339 . . . . 0.0 109.801 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.1 t -142.24 140.38 29.28 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 124.202 1.001 . . . . 0.0 109.754 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.4 tp -129.14 157.32 42.11 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.816 0.847 . . . . 0.0 111.108 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.91 129.77 26.38 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.079 0.951 . . . . 0.0 111.221 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.31 158.83 73.16 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.112 1.365 . . . . 0.0 110.424 -177.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -71.66 130.51 17.16 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.517 3.478 . . . . 0.0 110.834 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -119.24 117.52 28.83 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.626 1.17 . . . . 0.0 109.767 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -125.55 68.2 59.76 Favored Pre-proline 0 CA--C 1.535 0.367 0 O-C-N 121.873 -0.517 . . . . 0.0 110.546 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.47 140.99 37.56 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.411 2.741 . . . . 0.0 110.432 -175.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.6 p -72.4 145.07 47.94 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.427 0.691 . . . . 0.0 110.797 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.66 170.35 3.95 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.381 0.991 . . . . 0.0 112.131 -176.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -92.21 138.13 31.79 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.8 tp -80.96 152.13 28.17 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 99.5 m -75.26 -73.96 0.23 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -146.54 167.38 23.86 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.396 0.678 . . . . 0.0 110.859 -176.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -70.39 144.72 51.48 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.951 0.501 . . . . 0.0 110.388 176.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -145.48 -176.78 5.25 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 122.999 0.52 . . . . 0.0 110.562 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.5 tt -168.65 139.8 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 123.305 0.642 . . . . 0.0 109.362 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.108 0 CA-C-O 117.158 -1.401 . . . . 0.0 110.328 174.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.09 -44.03 0.2 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.5 0.72 . . . . 0.0 110.608 -176.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.6 159.08 13.82 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.427 1.091 . . . . 0.0 112.496 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.0 p -143.83 89.63 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.6 m -75.55 153.71 37.24 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.76 174.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pp -143.13 155.82 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 123.068 0.547 . . . . 0.0 110.064 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.5 tp -112.84 118.55 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 125.004 1.322 . . . . 0.0 108.739 177.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -113.36 111.09 21.41 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.09 0.956 . . . . 0.0 110.384 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -92.41 121.02 33.47 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.801 0.84 . . . . 0.0 110.287 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.0 t -104.98 120.03 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.436 1.095 . . . . 0.0 108.932 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -95.27 176.39 6.23 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.309 1.044 . . . . 0.0 111.559 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.25 -156.39 48.63 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.5 mtt-85 -87.96 93.16 9.39 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 123.417 0.687 . . . . 0.0 111.85 -173.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 t -127.41 -45.88 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.205 1.002 . . . . 0.0 109.974 -175.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -70.68 141.83 51.59 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.35 0.66 . . . . 0.0 110.1 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.67 15.09 80.2 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.104 -0.831 . . . . 0.0 113.371 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.1 t -111.98 -44.28 5.1 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 C-N-CA 124.561 1.145 . . . . 0.0 109.764 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.56 23.01 2.94 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.262 1.41 . . . . 0.0 111.893 -176.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -59.32 -25.34 64.08 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 117.785 0.792 . . . . 0.0 111.988 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.74 30.62 4.25 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.584 1.554 . . . . 0.0 111.687 175.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -94.46 -61.21 1.55 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.76 0.709 . . . . 0.0 109.383 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.9 t -78.21 -1.7 34.12 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 t -59.58 -26.74 65.67 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.057 0.543 . . . . 0.0 111.299 173.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -70.95 -55.64 7.93 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.224 0.61 . . . . 0.0 110.728 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -52.37 -57.03 11.07 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.027 0.531 . . . . 0.0 111.177 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -47.05 73.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.263 0.625 . . . . 0.0 110.414 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.43 -29.69 50.15 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.8 tttm -69.53 -31.53 69.81 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.231 1.012 . . . . 0.0 111.802 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.8 mmm-85 -72.84 -37.2 67.51 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.018 0.927 . . . . 0.0 111.06 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -85.9 -30.18 23.06 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.909 0.884 . . . . 0.0 111.506 178.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.67 21.21 79.63 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.47 0.557 . . . . 0.0 112.374 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.58 178.02 8.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.961 0.904 . . . . 0.0 111.111 177.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.3 p -123.18 -164.22 1.19 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -175.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.2 -151.53 18.14 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 171.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -169.22 162.91 10.83 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.05 99.79 6.41 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.1 0.96 . . . . 0.0 111.477 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -100.06 172.85 6.94 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.717 1.207 . . . . 0.0 110.936 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -124.12 135.17 53.34 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.796 1.239 . . . . 0.0 108.753 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.8 mt -75.64 173.0 11.63 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.015 1.326 . . . . 0.0 110.08 175.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -95.3 8.1 44.18 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.053 0.941 . . . . 0.0 111.729 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -111.58 -2.6 15.38 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.899 1.28 . . . . 0.0 112.137 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.99 7.21 31.42 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.94 1.257 . . . . 0.0 113.949 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 75.4 m -102.92 165.82 10.81 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.513 1.525 . . . . 0.0 111.127 -173.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 91.4 t -128.57 122.77 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.688 1.195 . . . . 0.0 110.524 -177.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -99.32 123.43 43.59 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 124.187 0.995 . . . . 0.0 110.947 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.9 t -121.23 133.44 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.182 0.593 . . . . 0.0 109.631 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.9 t -126.01 142.79 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 124.646 1.178 . . . . 0.0 109.45 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.36 132.86 12.04 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 118.607 -0.711 . . . . 0.0 111.158 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.42 178.64 4.69 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 175.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.96 -157.69 20.64 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.789 1.185 . . . . 0.0 110.201 178.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -75.94 122.43 24.16 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.67 1.188 . . . . 0.0 109.572 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -45.84 -51.82 12.32 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.472 1.109 . . . . 0.0 111.071 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.29 -47.35 56.12 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.483 1.516 . . . . 0.0 113.129 177.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -65.44 -47.76 75.06 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.395 0.598 . . . . 0.0 110.299 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.5 t -57.56 -33.06 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 122.723 0.409 . . . . 0.0 110.751 176.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.48 -32.28 73.16 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.941 0.896 . . . . 0.0 112.949 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -56.64 -27.48 58.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.004 0.922 . . . . 0.0 112.461 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.36 -30.97 13.1 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 118.622 0.646 . . . . 0.0 111.289 173.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.3 mmm -63.6 -22.45 66.9 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-O 118.624 -0.703 . . . . 0.0 112.444 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -44.27 -55.9 4.55 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.335 0.516 . . . . 0.0 110.254 173.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -61.92 -41.92 98.5 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.147 0.579 . . . . 0.0 111.782 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.4 mt -57.14 -54.25 48.93 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 123.785 0.834 . . . . 0.0 109.707 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 mppp? -66.73 -29.32 69.27 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.533 0.733 . . . . 0.0 112.314 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 t -69.56 -17.1 63.54 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.448 0.567 . . . . 0.0 112.015 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.81 5.4 89.43 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-O 118.271 -1.294 . . . . 0.0 112.716 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 43.49 -103.84 0.05 OUTLIER Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.623 1.582 . . . . 0.0 112.846 -175.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -70.64 171.06 16.16 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.422 2.748 . . . . 0.0 111.762 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.2 mtp180 -87.43 -35.0 18.53 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.45 0.7 . . . . 0.0 110.849 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -33.24 64.19 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.74 1.216 . . . . 0.0 111.965 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.35 144.39 57.2 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.736 0.814 . . . . 0.0 110.301 176.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -119.32 88.68 2.98 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.6 t -75.42 81.91 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.43 -50.89 71.57 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.251 0.621 . . . . 0.0 111.108 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -169.04 153.42 5.57 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 123.396 0.678 . . . . 0.0 109.623 -177.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.5 t -141.96 134.76 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.138 0.575 . . . . 0.0 109.537 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.5 tp -120.43 156.14 32.05 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.976 0.91 . . . . 0.0 110.928 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.12 129.5 27.68 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.853 0.861 . . . . 0.0 110.873 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -132.73 154.93 81.65 Favored Pre-proline 0 CA--C 1.539 0.558 0 C-N-CA 124.499 1.12 . . . . 0.0 110.14 -177.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.89 125.63 11.75 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 124.857 3.704 . . . . 0.0 111.067 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -117.16 127.31 54.0 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.721 0.809 . . . . 0.0 110.844 -178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -133.63 70.49 75.91 Favored Pre-proline 0 CA--C 1.536 0.42 0 O-C-N 121.526 -0.734 . . . . 0.0 110.495 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.15 136.88 35.8 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 124.057 3.171 . . . . 0.0 109.984 -177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.6 p -61.48 143.76 55.36 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.642 0.777 . . . . 0.0 111.101 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.95 171.02 5.69 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.079 0.847 . . . . 0.0 112.112 -175.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -89.0 135.74 33.39 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mp -74.13 150.09 40.67 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.303 0.641 . . . . 0.0 109.678 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.61 -77.96 0.2 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.349 1.059 . . . . 0.0 108.625 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -143.78 164.71 29.73 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.613 0.765 . . . . 0.0 110.944 -174.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -70.96 144.86 50.39 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.973 0.509 . . . . 0.0 110.357 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -137.81 -179.35 5.71 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 124.101 0.961 . . . . 0.0 110.403 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.9 tt -142.39 153.01 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -177.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 116.598 -1.668 . . . . 0.0 111.86 177.384 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 ttm . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 110.703 -0.11 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.92 -41.77 6.04 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.579 1.152 . . . . 0.0 111.091 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.13 134.4 49.28 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.267 1.027 . . . . 0.0 111.557 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 p -140.63 94.98 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 C-N-CA 124.551 1.141 . . . . 0.0 108.484 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.4 m -92.75 153.88 18.64 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.933 -177.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pp -143.6 156.46 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -174.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 tt -116.37 119.26 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.148 0.979 . . . . 0.0 109.418 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -109.9 108.33 18.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.88 1.272 . . . . 0.0 109.951 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -91.76 123.04 34.85 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.991 0.916 . . . . 0.0 110.235 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.9 t -99.15 108.52 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.586 1.155 . . . . 0.0 108.768 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -73.26 177.49 5.1 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.815 0.846 . . . . 0.0 111.426 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.95 -169.4 42.66 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 177.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -92.01 92.04 8.11 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.798 0.439 . . . . 0.0 110.881 -175.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -114.28 -31.06 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.101 0.96 . . . . 0.0 110.909 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -70.67 148.43 48.05 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.895 0.316 . . . . 0.0 110.52 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.75 22.81 54.95 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 123.753 0.692 . . . . 0.0 112.954 176.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.8 t -116.06 -48.97 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 C-N-CA 124.884 1.273 . . . . 0.0 109.41 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.67 32.29 1.23 Allowed Glycine 0 C--N 1.339 0.714 0 C-N-CA 125.251 1.405 . . . . 0.0 111.512 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -50.44 -36.81 34.96 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 123.848 0.859 . . . . 0.0 111.434 177.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.05 55.3 0.71 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.64 1.176 . . . . 0.0 112.058 177.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -94.54 -73.64 0.57 Allowed 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.337 0.655 . . . . 0.0 109.277 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.9 t -89.0 -1.59 58.18 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.435 0.694 . . . . 0.0 111.642 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.9 t -47.51 -36.93 11.03 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.752 0.821 . . . . 0.0 112.294 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -71.8 -55.96 6.64 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.442 1.097 . . . . 0.0 110.508 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -53.79 -54.15 42.27 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.677 0.791 . . . . 0.0 110.678 -176.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.15 -48.13 68.21 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.233 1.013 . . . . 0.0 110.515 177.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.42 -26.44 53.54 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -73.55 -28.28 61.79 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.806 0.843 . . . . 0.0 111.942 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.9 mtp85 -71.91 -41.89 67.38 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.321 1.049 . . . . 0.0 110.119 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -86.51 -52.67 5.43 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.558 0.743 . . . . 0.0 111.413 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.54 8.51 46.14 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.206 0.907 . . . . 0.0 112.995 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.15 167.57 2.31 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.969 0.884 . . . . 0.0 111.674 174.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.7 p -128.09 155.37 44.51 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.87 -147.95 17.38 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -169.35 166.27 10.48 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 173.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.4 100.73 5.46 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.803 0.841 . . . . 0.0 111.678 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -105.44 179.26 4.32 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.612 1.165 . . . . 0.0 110.835 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -123.51 138.99 54.46 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.673 1.189 . . . . 0.0 109.089 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.79 177.84 4.58 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.424 1.09 . . . . 0.0 110.349 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -101.14 13.31 35.54 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.296 1.038 . . . . 0.0 111.18 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -117.53 -15.46 10.24 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.863 1.265 . . . . 0.0 111.891 -177.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.0 5.66 8.02 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.012 1.292 . . . . 0.0 114.215 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 m -106.17 169.6 8.41 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.535 1.534 . . . . 0.0 111.564 -172.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.7 t -126.8 127.31 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.952 0.901 . . . . 0.0 110.448 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -105.06 122.24 45.46 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 123.725 0.81 . . . . 0.0 110.951 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.73 139.05 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 123.116 0.566 . . . . 0.0 109.632 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.2 t -130.22 142.6 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 124.276 1.031 . . . . 0.0 109.234 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.33 139.92 20.65 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.465 -176.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -111.64 -179.63 3.76 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.15 1.78 . . . . 0.0 110.911 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.43 -155.05 24.69 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.85 130.57 35.12 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 117.593 0.696 . . . . 0.0 110.179 -178.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -48.63 -50.39 33.04 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.399 1.08 . . . . 0.0 111.006 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.95 -52.15 31.8 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.143 1.354 . . . . 0.0 112.335 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -61.94 -46.62 88.53 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.084 0.954 . . . . 0.0 110.601 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.9 t -56.79 -41.84 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 122.319 0.247 . . . . 0.0 110.868 176.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -60.69 -26.59 67.24 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -60.64 -28.7 68.76 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.046 0.939 . . . . 0.0 112.401 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.0 -29.7 13.5 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.001 0.521 . . . . 0.0 111.0 174.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.4 mmt -64.15 -21.42 66.55 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.99 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -46.9 -59.05 3.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 118.37 0.532 . . . . 0.0 110.167 173.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -63.02 -33.35 75.23 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.571 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt -62.49 -50.43 71.45 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.221 0.918 . . . . 0.0 110.035 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -69.65 -12.65 61.8 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.043 0.756 . . . . 0.0 113.043 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.1 m -123.36 21.13 9.58 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.317 1.047 . . . . 0.0 111.223 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -89.42 -29.25 17.3 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -176.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -39.78 101.0 0.01 OUTLIER Glycine 0 C--N 1.344 1.003 0 C-N-CA 126.857 2.17 . . . . 0.0 112.824 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.29 -176.75 2.61 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.251 1.967 . . . . 0.0 110.98 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -68.61 -34.16 75.29 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.008 0.523 . . . . 0.0 111.444 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.96 -56.24 5.18 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 123.834 0.854 . . . . 0.0 110.606 -174.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.28 153.65 9.22 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.728 1.211 . . . . 0.0 110.737 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.39 79.57 1.55 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -178.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 64.6 t -68.2 90.43 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.892 0.877 . . . . 0.0 108.665 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.35 -57.48 12.12 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.606 0.762 . . . . 0.0 110.027 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -165.66 172.88 11.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.286 1.034 . . . . 0.0 109.863 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.74 125.16 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.878 0.871 . . . . 0.0 109.663 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.86 155.85 18.91 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.609 1.163 . . . . 0.0 110.784 177.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.18 129.39 27.39 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.293 1.037 . . . . 0.0 111.113 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.37 156.59 79.61 Favored Pre-proline 0 N--CA 1.47 0.563 0 C-N-CA 124.714 1.206 . . . . 0.0 110.429 -177.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.87 124.41 11.01 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 124.873 3.715 . . . . 0.0 111.052 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -116.45 119.07 34.46 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.085 0.954 . . . . 0.0 110.895 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -124.9 69.68 57.93 Favored Pre-proline 0 CA--C 1.535 0.373 0 O-C-N 121.526 -0.733 . . . . 0.0 110.83 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.06 141.11 43.16 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.248 2.632 . . . . 0.0 110.492 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.4 m -69.81 143.36 52.94 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.587 0.755 . . . . 0.0 110.572 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.76 169.43 4.63 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.14 0.876 . . . . 0.0 112.041 -176.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -92.48 135.1 34.34 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.7 tp -78.87 150.49 32.2 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.75 -77.32 0.11 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -141.11 163.78 32.05 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.08 0.952 . . . . 0.0 110.023 -173.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -71.12 146.53 49.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.15 0.58 . . . . 0.0 110.767 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -140.56 -171.11 3.15 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.336 1.055 . . . . 0.0 110.437 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.8 pp -134.98 -175.26 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.55 1.14 . . . . 0.0 109.619 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 116.72 -1.61 . . . . 0.0 114.34 176.076 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 119.63 -0.224 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.5 m -140.61 -53.02 0.49 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.456 1.102 . . . . 0.0 110.701 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.26 136.03 56.11 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.84 1.256 . . . . 0.0 112.095 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 p -141.04 91.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.271 0 C-N-CA 124.576 1.151 . . . . 0.0 108.511 -174.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.4 m -81.58 156.48 25.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.7 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 pp -143.7 159.37 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 tt -118.45 118.04 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.665 1.186 . . . . 0.0 109.276 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -108.81 108.51 19.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.898 1.279 . . . . 0.0 110.341 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -90.77 124.3 35.02 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.908 0.883 . . . . 0.0 110.188 177.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.2 t -106.15 124.59 61.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.919 1.288 . . . . 0.0 108.379 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -96.32 179.8 4.91 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.134 1.374 . . . . 0.0 110.589 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.31 -166.09 51.01 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.1 mtt180 -86.72 93.64 9.3 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 122.696 0.398 . . . . 0.0 111.652 -171.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.4 t -123.25 -41.44 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 123.676 0.79 . . . . 0.0 110.398 -174.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -69.74 144.47 52.74 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.042 0.537 . . . . 0.0 109.902 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.9 12.72 83.13 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.949 -0.917 . . . . 0.0 113.578 178.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.5 t -108.76 -49.21 7.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 CA-C-N 118.374 1.087 . . . . 0.0 109.682 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.01 29.4 1.51 Allowed Glycine 0 C--N 1.338 0.663 0 C-N-CA 124.476 1.036 . . . . 0.0 112.031 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -51.66 -36.21 45.37 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.005 0.903 . . . . 0.0 111.183 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.47 56.08 0.66 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.028 1.331 . . . . 0.0 112.069 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -107.87 -71.54 0.75 Allowed 'General case' 0 C--N 1.34 0.174 0 C-N-CA 124.832 1.253 . . . . 0.0 109.47 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.6 t -70.95 -21.62 62.32 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.009 0.524 . . . . 0.0 111.486 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.4 t -47.1 -38.13 10.9 Favored 'General case' 0 C--N 1.345 0.408 0 C-N-CA 123.683 0.793 . . . . 0.0 111.695 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -69.93 -56.47 6.94 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.127 0.971 . . . . 0.0 110.189 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -51.99 -56.84 11.76 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.098 0.959 . . . . 0.0 111.018 -176.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -56.47 -51.54 68.07 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 123.367 0.667 . . . . 0.0 110.23 178.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.38 -30.13 50.97 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.088 0.555 . . . . 0.0 112.439 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -64.57 -36.57 84.67 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.649 0.779 . . . . 0.0 111.192 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -72.38 -48.92 37.84 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.334 1.054 . . . . 0.0 110.256 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.1 mp -67.88 -38.21 82.75 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.964 0.906 . . . . 0.0 110.746 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.23 12.85 83.51 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 123.874 0.749 . . . . 0.0 112.684 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.68 177.59 2.44 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.805 0.842 . . . . 0.0 110.92 176.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.0 p -121.91 -165.7 1.3 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.37 -151.92 16.9 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 171.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -171.77 164.65 6.56 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 123.817 0.363 . . . . 0.0 111.727 173.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.21 90.3 3.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.009 0.924 . . . . 0.0 111.898 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -92.38 178.64 5.77 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 124.534 1.134 . . . . 0.0 110.897 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -121.71 140.73 51.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.293 1.037 . . . . 0.0 110.029 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.7 mt -73.94 174.95 7.83 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.842 1.257 . . . . 0.0 110.304 174.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -99.76 13.12 34.8 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.394 1.078 . . . . 0.0 111.442 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -119.25 -9.05 10.02 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.339 1.056 . . . . 0.0 112.148 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.13 24.76 4.08 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.917 1.246 . . . . 0.0 114.159 176.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.89 170.4 11.12 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.247 1.419 . . . . 0.0 111.482 -172.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.1 t -129.79 127.31 63.95 Favored 'Isoleucine or valine' 0 C--N 1.346 0.443 0 C-N-CA 123.836 0.855 . . . . 0.0 110.6 -175.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -108.46 123.2 48.51 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.577 0.751 . . . . 0.0 110.031 -177.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.4 t -117.14 136.39 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 123.778 0.831 . . . . 0.0 109.11 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -129.53 144.26 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 124.221 1.009 . . . . 0.0 108.997 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.43 141.4 18.24 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 118.695 -0.669 . . . . 0.0 110.616 -176.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.6 m -111.47 179.88 3.9 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.868 1.267 . . . . 0.0 111.784 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.04 -161.32 23.43 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.79 123.64 25.95 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.152 0.981 . . . . 0.0 110.576 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.73 -46.55 59.14 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.038 0.935 . . . . 0.0 110.108 -176.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -44.61 -41.81 7.13 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 126.057 1.789 . . . . 0.0 113.332 177.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -78.78 -50.74 10.82 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.462 0.705 . . . . 0.0 110.651 174.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -49.96 -40.76 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 118.441 0.564 . . . . 0.0 111.747 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.16 -30.8 69.56 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.71 1.604 . . . . 0.0 112.178 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -56.4 -40.79 75.24 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 124.46 1.104 . . . . 0.0 110.819 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.36 -30.53 27.35 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.672 0.669 . . . . 0.0 111.093 175.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.5 mmt -63.91 -20.18 65.65 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 118.586 -0.721 . . . . 0.0 112.02 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -45.56 -51.61 11.67 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.504 0.593 . . . . 0.0 110.411 174.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -62.29 -40.39 96.09 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.855 0.862 . . . . 0.0 111.965 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.4 mt -60.31 -49.15 78.75 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.957 0.903 . . . . 0.0 110.377 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -57.41 -28.76 63.55 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.433 0.693 . . . . 0.0 112.527 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.16 -27.36 65.59 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.276 0.63 . . . . 0.0 110.983 177.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.56 30.61 64.01 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 123.858 0.742 . . . . 0.0 112.128 174.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.48 76.2 0.21 Allowed Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -69.72 -10.98 29.94 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.413 2.075 . . . . 0.0 112.12 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -101.63 -50.71 3.64 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.626 1.171 . . . . 0.0 111.022 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.8 p -133.72 165.77 24.18 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 125.97 1.708 . . . . 0.0 108.551 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 70.04 158.67 0.18 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.537 1.135 . . . . 0.0 111.008 -176.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -124.52 74.59 1.34 Allowed 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.802 0.841 . . . . 0.0 109.014 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.4 t -71.58 106.0 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -69.71 -54.57 13.17 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.942 0.897 . . . . 0.0 110.195 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -156.81 163.67 38.95 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.65 0.78 . . . . 0.0 110.252 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.55 138.64 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.889 0.876 . . . . 0.0 109.835 -178.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.05 156.63 34.49 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.57 1.148 . . . . 0.0 110.991 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.51 129.14 26.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.035 0.934 . . . . 0.0 111.231 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.9 157.77 77.31 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 124.936 1.294 . . . . 0.0 110.491 -177.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -70.77 126.22 12.42 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 124.795 3.663 . . . . 0.0 111.003 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -118.63 135.47 54.43 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.017 0.927 . . . . 0.0 110.193 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -138.61 75.35 37.9 Favored Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 121.715 -0.616 . . . . 0.0 110.886 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.78 149.34 60.2 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.641 2.894 . . . . 0.0 110.674 -176.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.3 p -76.27 144.33 40.38 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.674 0.79 . . . . 0.0 110.597 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.3 169.99 4.41 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.401 1.0 . . . . 0.0 112.128 -176.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -88.65 137.01 32.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mp -79.02 150.55 31.89 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.527 0.731 . . . . 0.0 109.492 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -76.67 0.19 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.336 1.054 . . . . 0.0 108.448 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -143.03 162.43 35.5 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.587 0.755 . . . . 0.0 110.741 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -75.63 145.6 40.95 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.099 0.559 . . . . 0.0 110.429 177.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -144.98 148.29 33.62 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 123.713 0.805 . . . . 0.0 109.912 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -174.72 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 O-C-N 121.977 -0.452 . . . . 0.0 110.802 176.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 116.327 -1.797 . . . . 0.0 113.297 173.649 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 t -138.44 -60.9 0.6 Allowed 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.631 0.772 . . . . 0.0 109.655 -174.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -71.91 105.75 3.95 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.572 0.701 . . . . 0.0 110.537 -173.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.7 p -98.64 77.9 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.7 m -73.22 144.92 46.56 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -176.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.0 pp -112.77 166.69 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.3 tt -125.89 99.44 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 166.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.29 98.16 9.45 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.416 1.087 . . . . 0.0 109.593 -174.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 20.9 m-90 -79.49 100.19 7.6 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -82.62 90.75 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -177.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -72.1 159.68 33.75 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.984 0.421 . . . . 0.0 112.002 -169.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.4 -164.85 19.14 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 124.418 1.009 . . . . 0.0 111.66 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -93.62 82.52 4.37 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.662 0.785 . . . . 0.0 110.403 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.4 t -108.63 -47.56 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.674 1.19 . . . . 0.0 111.156 -167.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -62.12 157.26 19.5 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.126 0.97 . . . . 0.0 111.958 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.64 -43.67 3.19 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.091 0.853 . . . . 0.0 112.178 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.3 t -60.17 -39.27 80.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.543 1.137 . . . . 0.0 111.356 -176.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.69 33.1 2.73 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.306 1.431 . . . . 0.0 111.458 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -47.16 -34.78 6.55 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 126.559 1.943 . . . . 0.0 112.831 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.15 36.04 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.656 1.582 . . . . 0.0 113.007 171.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -60.84 -59.41 5.42 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.973 0.909 . . . . 0.0 110.464 -170.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 t -124.58 12.0 8.6 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.785 1.234 . . . . 0.0 111.701 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.7 t -47.44 -43.46 23.99 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -62.39 -51.5 67.32 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.706 1.202 . . . . 0.0 110.702 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -53.03 -57.98 8.55 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.329 0.652 . . . . 0.0 110.322 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.32 -49.82 63.47 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.767 1.227 . . . . 0.0 110.784 178.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.25 -38.52 68.62 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.259 0.624 . . . . 0.0 111.787 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -68.44 -28.06 66.73 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.911 0.884 . . . . 0.0 111.949 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 -62.49 -47.68 82.89 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.632 0.651 . . . . 0.0 109.522 175.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 62.7 mt -77.76 -32.55 52.7 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.508 0.723 . . . . 0.0 111.05 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.47 30.99 61.46 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.986 1.279 . . . . 0.0 112.437 -176.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.61 169.2 17.33 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.499 0.72 . . . . 0.0 112.179 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.4 p -127.31 147.24 50.25 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.857 0.863 . . . . 0.0 109.232 -168.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.51 -145.26 15.24 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -171.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -176.26 155.49 1.5 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.314 0.645 . . . . 0.0 111.255 174.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.88 93.85 6.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.489 1.116 . . . . 0.0 109.056 166.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -93.06 173.45 7.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 170.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -124.84 148.2 48.35 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 123.727 0.811 . . . . 0.0 110.132 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 35.5 mt -84.53 175.21 9.43 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.349 1.06 . . . . 0.0 110.046 172.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -87.57 18.83 3.68 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.386 1.074 . . . . 0.0 110.632 169.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -96.1 -53.12 3.76 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 125.009 1.324 . . . . 0.0 109.499 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.87 -17.1 1.4 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.492 1.044 . . . . 0.0 112.08 -160.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.1 p -107.61 153.8 22.37 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.372 1.069 . . . . 0.0 112.427 -162.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.7 t -102.47 121.17 53.22 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 124.727 1.211 . . . . 0.0 109.237 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -90.32 97.15 11.02 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 173.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.2 t -90.51 119.79 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.5 t -114.0 126.81 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.81 114.34 5.98 Favored 'General case' 0 CA--C 1.522 -0.106 0 O-C-N 123.911 0.757 . . . . 0.0 110.822 -168.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 87.7 m -80.21 -176.43 5.58 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 124.659 1.184 . . . . 0.0 110.78 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.06 -176.2 21.8 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -177.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -74.87 150.09 39.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -53.82 -46.48 71.16 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.202 0.601 . . . . 0.0 110.414 -176.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -47.09 -48.89 19.32 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.062 1.792 . . . . 0.0 112.914 174.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -63.98 -54.23 37.76 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 117.501 0.65 . . . . 0.0 111.27 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.5 t -58.17 -34.77 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.132 0.973 . . . . 0.0 111.602 -177.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -53.46 -40.29 65.16 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.052 0.541 . . . . 0.0 111.101 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -65.87 -37.87 87.3 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.67 0.668 . . . . 0.0 112.347 -172.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -75.69 -35.24 60.38 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.484 0.584 . . . . 0.0 110.972 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 43.9 mtm -65.67 -39.41 91.31 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 176.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -47.93 -40.47 22.1 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.563 0.745 . . . . 0.0 111.571 173.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 28.9 t90 -78.62 -37.2 42.8 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.245 -0.884 . . . . 0.0 110.737 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.1 mt -59.41 -49.44 77.81 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 119.813 1.188 . . . . 0.0 110.911 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -71.6 4.57 3.02 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.3 t -127.79 17.87 6.79 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.249 1.419 . . . . 0.0 110.182 169.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.05 -41.8 9.24 Favored Glycine 0 C--N 1.341 0.849 0 C-N-CA 124.732 1.158 . . . . 0.0 110.867 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -124.27 72.07 0.43 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.959 1.266 . . . . 0.0 111.265 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.65 -64.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.021 2.48 . . . . 0.0 110.387 177.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -83.95 -65.4 1.01 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.232 1.013 . . . . 0.0 108.615 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 77.9 p -66.16 155.05 38.07 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.55 0.74 . . . . 0.0 110.442 173.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 57.9 171.27 0.05 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.846 1.258 . . . . 0.0 111.005 -166.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.62 81.45 2.0 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 174.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 66.7 t -72.58 91.56 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 176.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -64.84 -55.74 17.7 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.439 0.695 . . . . 0.0 111.568 -175.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -171.63 148.42 2.45 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 125.432 1.493 . . . . 0.0 107.141 -175.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 p -119.5 126.49 75.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 123.041 0.537 . . . . 0.0 110.27 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.4 tp -103.58 118.79 37.54 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 123.527 0.731 . . . . 0.0 109.175 173.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.4 m -101.74 138.34 38.86 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.621 0.769 . . . . 0.0 109.622 169.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -130.55 154.3 81.63 Favored Pre-proline 0 CA--C 1.53 0.192 0 C-N-CA 125.413 1.485 . . . . 0.0 108.525 171.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -70.51 104.24 1.41 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.212 2.608 . . . . 0.0 109.705 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -85.18 111.61 19.97 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.377 1.071 . . . . 0.0 109.482 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.71 86.71 1.02 Allowed Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 124.157 0.983 . . . . 0.0 109.754 175.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.22 165.33 32.92 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.231 1.954 . . . . 0.0 109.646 169.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.9 m -74.96 123.18 24.66 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.98 -151.91 47.13 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -173.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -126.02 147.53 49.53 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.965 1.306 . . . . 0.0 108.57 171.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 31.6 tp -72.59 156.44 38.99 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.6 p -66.05 -55.76 14.99 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.451 1.1 . . . . 0.0 111.585 -178.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -140.46 166.81 23.7 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.592 1.157 . . . . 0.0 111.547 -167.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -86.12 137.95 32.28 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 168.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -160.28 -170.63 2.88 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -167.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.1 mt 65.9 -120.12 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 126.638 1.975 . . . . 0.0 109.055 -169.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.6 mtp85 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 117.285 -1.341 . . . . 0.0 110.194 -175.394 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? . . . . . 0 N--CA 1.475 0.775 0 CA-C-O 119.258 -0.401 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 t -172.18 -42.45 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.477 0.711 . . . . 0.0 111.024 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -60.95 134.28 56.94 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.973 1.309 . . . . 0.0 112.351 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 p -138.92 91.51 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.272 0 C-N-CA 124.778 1.231 . . . . 0.0 108.707 -174.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.8 m -82.46 153.42 25.65 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.937 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.88 146.22 18.8 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -176.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.5 tt -109.22 124.11 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 124.171 0.989 . . . . 0.0 109.874 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.7 112.47 22.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.745 1.218 . . . . 0.0 110.373 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.7 m-90 -94.67 130.69 41.05 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.366 1.066 . . . . 0.0 110.289 178.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.9 t -111.31 101.57 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -177.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -68.16 176.63 2.61 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.611 0.765 . . . . 0.0 111.132 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.7 -162.11 54.3 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -93.34 91.71 7.33 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 123.804 0.842 . . . . 0.0 112.06 -172.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.9 t -122.63 -30.78 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 C-N-CA 123.991 0.916 . . . . 0.0 111.275 -175.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -72.22 148.88 45.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 121.944 -0.473 . . . . 0.0 110.018 175.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.29 -21.02 47.68 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.067 -0.851 . . . . 0.0 113.023 176.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 p -84.09 0.53 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 118.55 1.175 . . . . 0.0 112.39 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.44 52.28 54.12 Favored Glycine 0 C--N 1.34 0.791 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -176.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.36 -34.25 70.47 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.591 0.756 . . . . 0.0 111.102 176.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.84 53.95 0.78 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.905 1.682 . . . . 0.0 112.326 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -87.17 -67.61 0.81 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -177.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 t -101.81 1.9 37.69 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.17 0.988 . . . . 0.0 112.094 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.8 t -48.35 -33.82 9.62 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.421 0.688 . . . . 0.0 112.149 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -68.03 -55.19 13.49 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.965 1.306 . . . . 0.0 110.423 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -55.08 -55.3 32.62 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.749 0.819 . . . . 0.0 110.742 -175.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.22 -47.97 68.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.839 0.856 . . . . 0.0 110.3 176.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.29 -28.23 58.07 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.48 -31.14 68.15 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.024 0.929 . . . . 0.0 111.873 177.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.1 mmm-85 -67.95 -42.39 81.03 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.801 0.84 . . . . 0.0 110.869 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -84.4 -42.05 16.07 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 122.947 0.499 . . . . 0.0 111.498 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.44 6.94 63.91 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 123.932 0.777 . . . . 0.0 112.91 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.67 167.72 3.38 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.138 0.969 . . . . 0.0 111.743 174.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.7 p -131.0 156.07 45.76 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -177.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 162.51 -148.13 14.84 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -169.62 164.15 10.19 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.163 -0.519 . . . . 0.0 111.77 172.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.98 97.27 5.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.014 0.926 . . . . 0.0 111.521 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -97.12 173.09 7.43 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.399 1.08 . . . . 0.0 111.095 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -123.44 137.87 54.71 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.428 1.091 . . . . 0.0 109.219 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.1 mt -75.67 177.36 6.88 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.497 1.119 . . . . 0.0 110.447 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -101.08 9.88 41.61 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.52 1.128 . . . . 0.0 111.276 177.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -109.34 -14.12 14.5 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.528 1.131 . . . . 0.0 112.086 -176.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.61 10.65 10.11 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.17 1.366 . . . . 0.0 113.938 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.54 164.45 14.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.538 1.535 . . . . 0.0 111.537 -173.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.4 p -119.55 138.97 48.46 Favored 'Isoleucine or valine' 0 C--N 1.347 0.494 0 C-N-CA 123.674 0.79 . . . . 0.0 110.702 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -110.86 121.18 44.71 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.581 1.152 . . . . 0.0 110.823 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 64.0 t -116.17 136.55 52.78 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.17 144.01 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 124.235 1.014 . . . . 0.0 109.482 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.54 142.03 21.7 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.581 -176.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.3 m -110.73 -178.78 3.57 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 126.173 1.789 . . . . 0.0 112.471 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.47 -153.59 23.48 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.054 -1.219 . . . . 0.0 110.054 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -82.25 132.7 35.23 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.096 0.558 . . . . 0.0 109.508 -178.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -48.71 -49.89 35.97 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.25 1.02 . . . . 0.0 110.972 -178.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.83 -52.96 28.15 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.103 1.335 . . . . 0.0 112.129 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -60.85 -46.5 90.34 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 124.232 1.013 . . . . 0.0 110.771 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.6 t -55.73 -42.79 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 122.271 0.228 . . . . 0.0 110.716 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.56 -27.73 66.49 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -27.05 68.49 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.842 0.857 . . . . 0.0 112.436 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.37 -29.05 14.18 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.211 0.604 . . . . 0.0 110.829 174.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.2 mmm -64.23 -21.87 66.74 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-O 118.588 -0.72 . . . . 0.0 111.535 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -47.54 -57.76 5.03 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 118.527 0.603 . . . . 0.0 109.812 172.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 15.7 t90 -64.3 -29.31 70.4 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.649 0.78 . . . . 0.0 111.727 -178.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 21.1 mt -66.39 -49.14 67.82 Favored 'General case' 0 C--N 1.347 0.489 0 O-C-N 121.101 -1.0 . . . . 0.0 110.083 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.79 14.31 6.08 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.0 t -148.71 14.6 0.95 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.416 0.686 . . . . 0.0 111.23 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -72.81 -60.16 4.05 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -175.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.02 78.17 0.13 Allowed Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 176.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.89 -171.22 0.46 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.552 2.835 . . . . 0.0 111.068 -175.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -47.53 -37.14 11.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.45 1.1 . . . . 0.0 112.933 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.34 133.92 1.43 Allowed 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.686 0.794 . . . . 0.0 109.905 177.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -170.0 153.65 4.8 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.876 1.271 . . . . 0.0 109.027 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -122.97 73.3 1.14 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.7 t -69.41 90.68 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -58.89 -50.79 72.7 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.494 0.718 . . . . 0.0 111.301 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.9 ttm-85 -169.3 163.56 10.76 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.042 0.537 . . . . 0.0 110.377 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.5 t -133.35 110.33 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.763 0.825 . . . . 0.0 109.953 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.0 tp -100.61 152.4 20.48 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.36 1.064 . . . . 0.0 110.283 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.52 129.51 31.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.011 0.924 . . . . 0.0 111.518 -177.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.21 158.49 74.04 Favored Pre-proline 0 N--CA 1.469 0.501 0 C-N-CA 125.358 1.463 . . . . 0.0 110.544 -176.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.73 132.26 19.91 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 124.482 3.455 . . . . 0.0 110.987 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -120.68 114.93 22.39 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.617 1.167 . . . . 0.0 109.626 -177.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -121.8 64.97 18.23 Favored Pre-proline 0 CA--C 1.536 0.426 0 O-C-N 121.656 -0.653 . . . . 0.0 110.867 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.45 142.26 44.45 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.207 2.605 . . . . 0.0 110.471 -174.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.6 p -70.44 142.46 51.98 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.372 0.669 . . . . 0.0 110.729 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.86 170.62 5.37 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.25 0.929 . . . . 0.0 112.105 -176.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -93.26 135.15 34.74 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.8 tp -77.74 149.17 34.57 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -75.53 0.15 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.217 1.007 . . . . 0.0 108.483 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -141.15 162.95 34.26 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.135 0.974 . . . . 0.0 109.926 -173.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -71.17 145.61 49.61 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.876 0.47 . . . . 0.0 110.616 174.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -142.05 -169.97 3.05 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.122 0.969 . . . . 0.0 109.964 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.2 mt -141.97 168.01 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.906 0.882 . . . . 0.0 108.706 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.168 0 CA-C-O 116.709 -1.615 . . . . 0.0 112.562 174.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 111.423 0.157 . . . . 0.0 111.423 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.9 t -137.43 -40.52 0.57 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.545 1.138 . . . . 0.0 110.598 -175.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 152.97 41.95 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.145 0.978 . . . . 0.0 112.908 -176.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 p -138.78 90.88 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 124.505 1.122 . . . . 0.0 108.435 -173.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.0 m -78.61 153.37 31.16 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.665 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.99 148.99 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -176.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.8 tt -111.43 125.61 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.942 0.897 . . . . 0.0 109.947 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -120.21 101.85 8.1 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.823 1.649 . . . . 0.0 109.767 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 -87.15 112.7 22.21 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 124.618 1.167 . . . . 0.0 109.895 177.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.84 121.52 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.312 1.045 . . . . 0.0 108.662 -177.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -99.27 171.35 8.04 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.048 0.939 . . . . 0.0 110.684 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.72 -165.08 49.28 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 123.375 0.512 . . . . 0.0 112.095 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.9 mtt85 -84.86 83.6 7.99 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -166.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.7 t -119.49 -47.25 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.909 0.883 . . . . 0.0 110.378 -173.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -67.68 146.64 53.61 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 120.848 0.356 . . . . 0.0 110.862 177.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.18 17.93 76.22 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.128 0.87 . . . . 0.0 113.738 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 82.4 t -102.86 -43.06 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 124.673 1.189 . . . . 0.0 109.141 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.08 29.02 3.16 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 125.884 1.707 . . . . 0.0 110.996 -175.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -50.97 -37.58 45.55 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 124.509 1.124 . . . . 0.0 111.325 177.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.0 60.09 0.96 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.848 1.259 . . . . 0.0 112.689 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -109.75 -72.94 0.7 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.684 1.194 . . . . 0.0 108.789 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.3 t -72.19 -23.26 61.24 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 118.503 -0.761 . . . . 0.0 112.053 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.5 t -41.32 -39.81 1.51 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.468 1.107 . . . . 0.0 112.667 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -71.64 -59.84 2.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.364 1.065 . . . . 0.0 110.681 176.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -49.98 -58.08 6.2 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.139 0.976 . . . . 0.0 111.771 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -53.14 -51.15 62.9 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.588 1.155 . . . . 0.0 110.849 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.46 -33.2 53.31 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 122.78 0.432 . . . . 0.0 112.079 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -68.23 -28.54 67.32 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.212 1.005 . . . . 0.0 112.234 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.6 mtp85 -70.81 -47.04 61.58 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.895 0.878 . . . . 0.0 109.926 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.5 mt -78.33 -40.71 35.78 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.013 0.525 . . . . 0.0 111.004 -177.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.27 22.31 41.62 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.195 1.379 . . . . 0.0 112.952 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.72 174.89 11.12 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.713 0.805 . . . . 0.0 111.566 177.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 51.2 p -117.69 -163.39 0.93 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.59 -155.39 16.24 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 118.534 0.606 . . . . 0.0 112.144 171.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -169.88 162.26 9.28 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.72 84.81 2.32 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.443 1.097 . . . . 0.0 111.254 -174.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -92.61 173.01 8.0 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.851 0.86 . . . . 0.0 111.281 -177.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -125.07 131.57 53.31 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.336 1.054 . . . . 0.0 109.494 -177.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.4 mt -70.06 171.25 9.86 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 125.214 1.405 . . . . 0.0 110.897 175.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -93.82 7.33 45.33 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.872 1.269 . . . . 0.0 111.747 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -112.63 -16.83 12.74 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.515 1.126 . . . . 0.0 112.119 -175.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.6 13.97 2.98 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.122 1.344 . . . . 0.0 114.385 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.54 166.32 12.85 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.426 1.49 . . . . 0.0 111.958 -167.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.3 t -127.07 120.92 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.586 1.155 . . . . 0.0 111.404 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -98.02 115.28 27.88 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 125.168 1.387 . . . . 0.0 111.684 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.6 t -114.1 133.32 60.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 122.861 0.464 . . . . 0.0 110.43 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.33 143.26 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 123.993 0.917 . . . . 0.0 109.738 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.96 133.03 11.63 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.015 -173.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 93.7 m -101.58 179.97 4.19 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.667 1.187 . . . . 0.0 112.325 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.73 -162.6 21.34 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.337 0.97 . . . . 0.0 110.758 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -73.18 121.75 20.79 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 123.691 0.796 . . . . 0.0 109.974 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -46.88 -50.85 17.97 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.015 1.326 . . . . 0.0 111.346 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -51.96 -45.77 55.97 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.402 1.477 . . . . 0.0 112.355 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -66.7 -50.88 61.41 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 117.455 0.628 . . . . 0.0 110.714 176.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.1 t -51.39 -34.05 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 122.647 0.379 . . . . 0.0 111.055 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -57.71 -31.46 66.43 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.915 0.886 . . . . 0.0 113.192 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -54.31 -44.86 72.36 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.828 0.851 . . . . 0.0 110.766 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.63 -32.18 53.22 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 118.481 0.582 . . . . 0.0 112.118 175.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.3 mmt -67.37 -25.19 65.85 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 118.814 -0.612 . . . . 0.0 111.867 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -42.44 -49.66 5.23 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.166 0.586 . . . . 0.0 109.719 170.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -64.13 -41.86 97.06 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.7 mt -53.1 -52.94 57.01 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.667 0.787 . . . . 0.0 110.599 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -28.24 69.4 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 119.04 -0.505 . . . . 0.0 111.837 176.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 t -62.18 -31.48 72.0 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.672 0.669 . . . . 0.0 111.536 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.37 6.48 75.75 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.534 -0.592 . . . . 0.0 113.096 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.85 162.51 2.71 Favored Glycine 0 CA--C 1.539 1.56 0 C-N-CA 124.095 0.855 . . . . 0.0 112.087 -170.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.56 83.74 2.11 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.696 2.931 . . . . 0.0 110.667 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 64.75 83.07 0.17 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.787 1.235 . . . . 0.0 110.305 177.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.94 -48.0 0.1 Allowed 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.292 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.29 151.66 42.18 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.565 1.546 . . . . 0.0 110.061 -173.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -114.83 84.05 2.01 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 95.4 t -69.28 102.6 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -67.21 -55.38 14.3 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.745 0.418 . . . . 0.0 110.998 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -166.64 99.05 0.57 Allowed 'General case' 0 C--N 1.342 0.274 0 C-N-CA 122.485 0.314 . . . . 0.0 111.422 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.9 p -84.41 125.54 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.275 0.63 . . . . 0.0 111.469 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.97 137.86 45.23 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 125.694 1.598 . . . . 0.0 111.568 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.88 138.56 54.35 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.156 1.382 . . . . 0.0 112.41 -177.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -144.04 158.73 54.97 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 124.945 1.298 . . . . 0.0 111.39 -177.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.02 137.38 26.44 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 124.074 3.182 . . . . 0.0 111.792 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -128.06 124.46 37.1 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.537 1.135 . . . . 0.0 111.181 -175.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -129.02 70.01 81.32 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 121.698 -0.626 . . . . 0.0 111.431 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.2 142.63 38.12 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.864 2.376 . . . . 0.0 110.722 -176.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.3 m -66.45 140.18 58.01 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.799 0.84 . . . . 0.0 110.776 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.86 -177.91 40.85 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.755 0.693 . . . . 0.0 111.547 -176.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -108.35 131.31 54.87 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.179 0.991 . . . . 0.0 108.568 172.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -69.82 151.75 45.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.927 1.291 . . . . 0.0 109.359 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.71 -77.98 0.13 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.672 0.789 . . . . 0.0 108.943 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -137.99 161.1 37.58 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.27 1.028 . . . . 0.0 109.838 -171.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -69.19 147.82 50.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.903 0.481 . . . . 0.0 110.03 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -152.06 -167.74 2.86 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 122.905 0.482 . . . . 0.0 110.524 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.2 tt -160.29 155.21 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 123.792 0.837 . . . . 0.0 109.48 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 . . . . . 0 C--O 1.251 1.182 0 CA-C-O 116.341 -1.79 . . . . 0.0 113.088 173.72 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 mtt . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 119.934 -0.079 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.0 m -127.91 -44.05 1.49 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.062 1.345 . . . . 0.0 110.737 176.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 142.84 55.84 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -169.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.25 88.5 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -172.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.2 m -78.95 152.06 31.29 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.276 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.52 149.33 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -177.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.8 tt -110.52 122.78 65.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 O-C-N 123.81 0.693 . . . . 0.0 109.335 174.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -113.88 95.67 5.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.684 1.594 . . . . 0.0 108.873 -175.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -81.44 130.59 35.1 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.4 t -107.07 113.97 44.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.476 1.111 . . . . 0.0 109.355 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -84.47 163.71 19.28 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.698 0.799 . . . . 0.0 111.052 175.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.39 179.5 53.02 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 124.126 0.869 . . . . 0.0 111.076 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.5 mtt180 -86.5 73.61 10.07 Favored 'General case' 0 N--CA 1.457 -0.075 0 CA-C-O 121.053 0.454 . . . . 0.0 111.751 -164.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.7 t -104.73 -33.25 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.162 0.985 . . . . 0.0 112.081 -170.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -63.13 159.68 16.94 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.677 0.671 . . . . 0.0 110.851 171.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.78 -46.08 1.65 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 123.992 0.806 . . . . 0.0 111.569 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.9 p -69.63 -9.74 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 123.431 0.693 . . . . 0.0 112.817 -174.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.08 44.46 35.85 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.894 0.759 . . . . 0.0 111.306 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -48.61 -34.13 11.09 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 125.867 1.667 . . . . 0.0 112.952 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 -71.95 47.92 0.15 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.844 1.657 . . . . 0.0 112.85 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -89.34 -69.63 0.7 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.089 0.956 . . . . 0.0 109.001 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.0 t -99.84 12.29 37.08 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.203 1.401 . . . . 0.0 111.23 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.1 t -59.41 -39.75 84.46 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.027 0.376 . . . . 0.0 110.796 170.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 -53.47 -60.55 3.16 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.868 1.267 . . . . 0.0 109.852 173.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -54.8 -57.04 13.15 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.001 0.92 . . . . 0.0 110.693 -173.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -54.55 -55.22 31.52 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 123.902 0.751 . . . . 0.0 109.856 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.92 -33.95 65.14 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 118.798 -0.62 . . . . 0.0 111.958 -177.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -67.56 -36.49 81.05 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.886 -0.578 . . . . 0.0 112.191 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -60.11 -46.87 88.17 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.656 0.662 . . . . 0.0 110.861 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.63 -22.01 34.85 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.98 31.57 47.79 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.557 1.075 . . . . 0.0 113.131 -178.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.21 140.77 41.81 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 117.503 0.652 . . . . 0.0 110.294 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.2 p -96.16 -159.89 0.76 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.484 176.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.49 -149.22 16.69 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 119.212 0.915 . . . . 0.0 112.034 172.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -169.84 158.23 7.24 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 177.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.93 97.4 5.68 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.267 1.427 . . . . 0.0 110.416 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -107.62 170.22 8.11 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.697 0.799 . . . . 0.0 111.425 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -120.66 131.46 54.59 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.386 1.075 . . . . 0.0 108.994 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.7 mt -68.04 174.84 3.49 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.228 1.411 . . . . 0.0 110.679 175.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -97.48 15.52 22.96 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.772 1.229 . . . . 0.0 111.397 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -120.09 -14.47 8.86 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 123.942 0.897 . . . . 0.0 112.778 -173.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.22 11.35 4.26 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.073 1.32 . . . . 0.0 114.325 175.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 p -126.35 162.08 26.36 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.308 1.443 . . . . 0.0 111.807 -166.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.4 t -117.06 132.91 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.785 1.234 . . . . 0.0 111.112 -174.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -106.29 113.35 26.82 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.749 1.22 . . . . 0.0 110.606 178.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.1 t -112.29 135.39 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.785 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.7 142.76 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.765 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.7 119.21 6.04 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 117.945 -1.026 . . . . 0.0 111.901 -171.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 98.5 m -109.58 132.02 54.52 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 120.031 1.287 . . . . 0.0 113.376 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 156.33 -163.86 32.19 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -71.81 126.85 30.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.334 0.567 . . . . 0.0 110.406 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -54.24 -43.21 70.7 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.853 1.261 . . . . 0.0 111.668 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -42.25 -42.8 4.43 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 126.057 1.789 . . . . 0.0 112.886 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -80.76 -47.17 14.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.207 1.003 . . . . 0.0 111.476 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 77.0 t -42.75 -52.11 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 123.938 0.895 . . . . 0.0 110.892 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -54.01 -36.4 62.94 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.405 0.682 . . . . 0.0 112.163 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -61.29 -44.24 97.55 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.022 0.929 . . . . 0.0 110.771 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.48 -32.32 68.13 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 122.934 0.494 . . . . 0.0 110.289 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.2 mmt -66.86 -24.87 66.18 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.096 -0.954 . . . . 0.0 112.264 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -47.71 -48.42 29.47 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 119.536 1.062 . . . . 0.0 109.535 172.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -61.25 -39.05 88.9 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 118.848 -0.596 . . . . 0.0 112.205 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.94 -46.58 71.6 Favored 'General case' 0 C--N 1.347 0.5 0 CA-C-N 119.385 0.993 . . . . 0.0 111.558 177.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -12.38 56.94 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 176.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 m -124.9 20.98 8.32 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.957 1.303 . . . . 0.0 111.496 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -88.41 -34.54 9.36 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -177.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -53.87 115.74 5.32 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.127 1.346 . . . . 0.0 111.735 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -85.62 -152.27 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.029 3.153 . . . . 0.0 109.835 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -61.73 -45.51 93.65 Favored 'General case' 0 C--N 1.344 0.331 0 O-C-N 121.829 -0.545 . . . . 0.0 111.02 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.9 p -86.51 179.0 6.92 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.685 1.194 . . . . 0.0 109.686 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 73.69 131.45 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 126.329 1.852 . . . . 0.0 111.573 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -120.48 94.51 4.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.41 1.084 . . . . 0.0 108.446 -176.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.6 t -72.76 98.12 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 124.403 1.081 . . . . 0.0 108.586 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -64.93 -51.31 62.55 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -167.61 168.7 12.5 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.482 1.113 . . . . 0.0 109.142 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.1 t -132.11 125.64 54.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.148 0.979 . . . . 0.0 109.265 174.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tp -103.81 120.64 41.4 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.397 1.079 . . . . 0.0 110.965 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.6 136.35 43.47 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.05 0.94 . . . . 0.0 110.678 178.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -140.83 153.55 67.75 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 124.836 1.254 . . . . 0.0 109.937 178.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.57 136.54 28.53 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.666 2.911 . . . . 0.0 110.984 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -126.44 118.82 25.75 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.89 1.276 . . . . 0.0 110.105 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -121.2 72.34 25.18 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 119.147 0.885 . . . . 0.0 111.498 177.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.27 140.32 44.21 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.011 2.474 . . . . 0.0 110.118 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 80.9 p -75.75 143.05 42.23 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.637 0.775 . . . . 0.0 110.753 -176.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.45 -179.93 42.48 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -103.68 126.76 51.02 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.621 1.168 . . . . 0.0 108.719 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 mp -71.24 151.64 44.1 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.063 0.945 . . . . 0.0 109.797 173.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.4 p -78.65 -79.65 0.13 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.891 0.876 . . . . 0.0 108.719 173.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -141.28 164.06 31.26 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 124.119 0.968 . . . . 0.0 111.187 -168.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -75.23 148.36 39.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.904 0.882 . . . . 0.0 110.002 175.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -149.83 -172.37 4.13 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.065 0.546 . . . . 0.0 110.022 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.4 pp -129.88 173.85 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 C-N-CA 123.872 0.869 . . . . 0.0 110.66 -174.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 . . . . . 0 C--O 1.251 1.164 0 CA-C-O 116.477 -1.725 . . . . 0.0 113.563 179.582 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.0 t . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -61.29 127.59 32.26 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.901 1.68 . . . . 0.0 112.928 -176.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 p -132.45 90.59 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.186 0 C-N-CA 125.585 1.554 . . . . 0.0 108.505 -174.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.1 m -81.65 153.22 26.76 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.92 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.89 149.59 17.71 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -176.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.4 tt -114.86 124.93 72.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.061 0.945 . . . . 0.0 110.414 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -119.35 109.56 15.94 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.953 1.701 . . . . 0.0 110.395 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.5 m-90 -92.11 116.45 28.95 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 125.626 1.57 . . . . 0.0 110.49 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -101.33 121.65 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.048 0.939 . . . . 0.0 109.164 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -91.34 173.19 8.05 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.362 1.465 . . . . 0.0 110.865 176.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.86 -166.98 50.96 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.7 mtt-85 -83.82 86.0 7.22 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.248 0.619 . . . . 0.0 111.519 -172.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.3 t -117.53 -40.57 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 123.791 0.837 . . . . 0.0 110.311 -174.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -73.65 149.33 42.05 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.175 0.443 . . . . 0.0 110.295 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.94 -43.26 1.74 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.102 0.858 . . . . 0.0 112.39 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.1 p -69.59 -8.12 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 118.066 0.933 . . . . 0.0 111.786 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.26 47.14 38.11 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -50.64 -40.89 54.49 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 124.022 0.929 . . . . 0.0 110.944 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 -70.76 55.0 0.17 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.599 1.96 . . . . 0.0 113.074 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -103.56 -68.93 0.82 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.36 1.064 . . . . 0.0 109.125 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.0 t -73.26 -22.11 60.46 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.3 t -41.31 -40.05 1.56 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.819 1.247 . . . . 0.0 112.55 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -64.79 -60.52 3.0 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.003 1.321 . . . . 0.0 110.826 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -51.26 -57.04 9.9 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.76 0.824 . . . . 0.0 111.022 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.04 -50.18 67.28 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.641 0.776 . . . . 0.0 110.477 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.91 -33.96 39.37 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 122.987 0.515 . . . . 0.0 112.098 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt -67.92 -33.4 74.62 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.463 0.705 . . . . 0.0 111.851 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 -66.15 -41.79 89.92 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.827 0.851 . . . . 0.0 111.411 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.93 -30.9 31.57 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.308 0.643 . . . . 0.0 111.77 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.96 21.4 78.51 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.095 0.855 . . . . 0.0 112.74 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.49 HD12 ' HB1' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -81.23 174.69 11.29 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.861 0.865 . . . . 0.0 110.955 176.389 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 50.0 p -117.31 -161.39 0.81 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -175.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.81 -155.16 16.3 Favored Glycine 0 C--N 1.339 0.705 0 CA-C-N 118.463 0.574 . . . . 0.0 111.822 169.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -168.14 159.23 10.82 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 171.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.01 95.33 4.86 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.77 1.228 . . . . 0.0 110.106 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -98.97 171.21 8.19 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.151 0.981 . . . . 0.0 110.674 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -127.29 133.23 50.17 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 124.048 0.939 . . . . 0.0 109.686 -177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.2 mt -71.23 173.52 7.61 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.158 1.383 . . . . 0.0 111.128 176.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -96.27 13.38 27.74 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.016 1.327 . . . . 0.0 111.801 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -121.38 0.59 10.05 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.635 1.174 . . . . 0.0 112.481 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.43 3.32 27.42 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.157 1.36 . . . . 0.0 114.425 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.37 165.14 11.73 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.959 1.704 . . . . 0.0 112.052 -169.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.8 t -126.87 124.49 64.89 Favored 'Isoleucine or valine' 0 C--N 1.348 0.515 0 C-N-CA 124.513 1.125 . . . . 0.0 111.752 -174.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -100.28 116.51 32.43 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 125.43 1.492 . . . . 0.0 111.718 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.0 t -113.51 133.0 60.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 123.496 0.719 . . . . 0.0 109.787 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.8 t -128.63 145.18 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.783 0.833 . . . . 0.0 110.188 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.49 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -157.9 137.1 11.71 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-O 118.297 -0.859 . . . . 0.0 111.786 -174.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 67.3 m -104.24 178.44 4.56 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.514 1.526 . . . . 0.0 112.418 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.06 -158.1 19.57 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 124.613 1.101 . . . . 0.0 110.422 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -79.56 128.63 33.62 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.835 0.854 . . . . 0.0 109.388 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -44.83 -49.32 10.88 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.241 1.016 . . . . 0.0 111.768 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -49.55 -54.29 17.43 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.305 1.431 . . . . 0.0 112.989 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -59.54 -47.82 84.07 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 125.302 1.441 . . . . 0.0 110.419 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.36 -41.6 71.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 122.429 0.292 . . . . 0.0 110.799 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -64.08 -26.88 68.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.226 0.611 . . . . 0.0 112.589 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -55.03 -48.96 72.72 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.637 0.775 . . . . 0.0 111.036 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -76.95 -30.26 55.96 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 118.192 0.451 . . . . 0.0 111.499 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.6 mmm -66.14 -21.42 66.34 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.624 -0.703 . . . . 0.0 111.594 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -44.41 -46.3 9.44 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.738 0.699 . . . . 0.0 109.996 168.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -67.74 -41.01 84.11 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.871 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 mt . . . . . 0 C--N 1.346 0.448 0 C-N-CA 123.476 0.71 . . . . 0.0 110.611 175.748 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.5 t . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -77.16 -47.96 18.94 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.924 0.89 . . . . 0.0 111.17 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.7 mtm105 -156.73 163.27 39.45 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.926 1.29 . . . . 0.0 109.484 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.4 p -154.57 131.61 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 118.944 -0.55 . . . . 0.0 111.136 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tp -122.67 141.0 52.22 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.357 1.063 . . . . 0.0 112.556 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.43 142.77 50.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.115 1.366 . . . . 0.0 112.867 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -143.2 159.57 55.2 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 125.119 1.368 . . . . 0.0 111.262 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.38 137.5 28.33 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.747 2.965 . . . . 0.0 111.346 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -125.3 116.94 22.73 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.79 1.236 . . . . 0.0 110.296 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -121.86 74.76 36.87 Favored Pre-proline 0 CA--C 1.536 0.408 0 O-C-N 121.425 -0.797 . . . . 0.0 110.77 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.72 146.27 42.82 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.76 2.306 . . . . 0.0 110.523 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.3 p -71.22 140.57 50.48 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.502 0.721 . . . . 0.0 110.461 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.22 179.73 30.79 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 123.811 0.72 . . . . 0.0 112.048 -177.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -101.75 131.02 48.27 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.597 1.159 . . . . 0.0 108.593 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -70.06 150.8 46.22 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.725 1.21 . . . . 0.0 109.534 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -77.32 0.15 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.788 0.835 . . . . 0.0 108.755 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -137.94 166.16 24.74 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.121 0.968 . . . . 0.0 110.674 -174.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -75.59 146.38 40.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.122 0.569 . . . . 0.0 110.101 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -149.81 -168.19 3.04 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.53 0.732 . . . . 0.0 110.055 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.4 pt . . . . . 0 CA--C 1.532 0.271 0 C-N-CA 124.376 1.07 . . . . 0.0 109.938 -176.965 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.2 t . . . . . 0 CA--C 1.535 0.393 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.3 121.78 21.86 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.926 0.891 . . . . 0.0 111.374 -174.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.87 85.54 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.087 0 C-N-CA 125.273 1.429 . . . . 0.0 108.262 -172.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 m -78.86 150.32 32.26 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.114 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pp -129.88 162.1 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.3 tt -119.83 124.5 72.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.186 0.994 . . . . 0.0 109.038 173.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -117.39 99.89 7.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 126.237 1.815 . . . . 0.0 109.298 -173.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -83.4 131.85 35.02 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.612 0.765 . . . . 0.0 110.113 175.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.5 t -112.04 107.15 22.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.184 0.993 . . . . 0.0 109.113 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -73.77 165.87 24.34 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 123.445 0.698 . . . . 0.0 110.997 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.03 -179.44 53.61 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 123.811 0.719 . . . . 0.0 111.741 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.1 mtt-85 -87.8 78.58 8.36 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 122.971 0.508 . . . . 0.0 112.033 -165.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.3 t -105.51 -26.98 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.11 0.964 . . . . 0.0 111.94 -173.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -73.29 156.72 38.16 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.224 0.61 . . . . 0.0 112.181 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.89 25.41 75.81 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.296 0.951 . . . . 0.0 113.244 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.6 t -123.49 -39.09 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.027 1.331 . . . . 0.0 110.478 -177.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.96 34.4 2.58 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.922 1.249 . . . . 0.0 112.733 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -48.25 -35.48 12.1 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.82 1.248 . . . . 0.0 112.781 172.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.38 57.17 2.29 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.291 1.836 . . . . 0.0 110.564 -174.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -98.31 -72.21 0.66 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.591 0.756 . . . . 0.0 109.444 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -88.48 -7.09 57.12 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.077 0.951 . . . . 0.0 111.996 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.8 t -43.62 -46.01 7.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.884 0.874 . . . . 0.0 112.72 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -53.4 -61.43 2.31 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 126.043 1.737 . . . . 0.0 110.537 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.95 -54.67 26.81 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.002 1.321 . . . . 0.0 110.645 -177.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -55.3 -52.68 62.68 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.582 0.753 . . . . 0.0 110.542 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.18 -36.34 63.29 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.087 0.555 . . . . 0.0 111.864 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -65.12 -31.34 72.5 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.919 0.887 . . . . 0.0 112.18 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.6 mtp85 -67.66 -47.05 70.63 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.422 0.556 . . . . 0.0 110.214 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mp -74.32 -33.08 63.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.745 0.418 . . . . 0.0 110.727 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.63 18.43 66.01 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.377 0.989 . . . . 0.0 112.629 -177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.77 171.0 13.58 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 117.466 0.633 . . . . 0.0 111.411 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.6 p -111.47 -158.17 0.64 Allowed 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -171.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.69 -159.69 13.59 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 118.092 0.406 . . . . 0.0 112.219 167.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -165.85 155.16 11.94 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 174.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.93 95.68 5.44 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.386 1.475 . . . . 0.0 110.085 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -104.53 175.36 5.51 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.683 0.793 . . . . 0.0 110.838 176.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -123.89 136.36 54.3 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.169 0.988 . . . . 0.0 109.988 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.5 mt -70.67 173.67 6.88 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.158 1.383 . . . . 0.0 110.632 173.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -96.91 18.93 13.55 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.658 1.183 . . . . 0.0 111.574 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -121.96 -20.91 6.17 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 123.806 0.842 . . . . 0.0 112.851 -175.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.24 -7.37 4.04 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.727 1.156 . . . . 0.0 113.836 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.8 p -112.48 166.64 11.13 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.186 1.395 . . . . 0.0 111.816 -165.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.0 t -124.46 129.83 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.191 0.996 . . . . 0.0 111.528 -168.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -104.82 114.01 27.96 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.789 1.236 . . . . 0.0 111.465 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.2 t -113.41 130.94 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.66 0.784 . . . . 0.0 109.946 -177.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.35 144.27 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.981 0.912 . . . . 0.0 110.473 -175.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.01 130.73 4.89 Favored 'General case' 0 C--N 1.349 0.557 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.112 -172.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 99.4 m -95.54 -178.94 4.58 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.151 1.38 . . . . 0.0 112.337 177.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.24 -159.39 14.33 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -83.06 127.01 33.19 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 174.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -49.93 -46.05 51.71 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.471 1.108 . . . . 0.0 110.851 -174.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -44.88 -50.56 8.68 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.054 1.788 . . . . 0.0 113.015 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -69.13 -49.03 60.65 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.147 0.979 . . . . 0.0 110.939 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.9 t -53.08 -38.52 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.004 0.521 . . . . 0.0 111.391 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -63.3 -26.96 69.01 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -61.46 -44.98 96.14 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.092 0.557 . . . . 0.0 111.293 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.37 -30.26 63.17 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.379 0.536 . . . . 0.0 110.515 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.8 mmt -66.92 -24.79 66.13 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.168 -0.92 . . . . 0.0 112.176 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -42.22 -53.91 3.89 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 119.036 0.835 . . . . 0.0 109.016 166.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 32.3 t90 -63.61 -40.98 98.28 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 123.337 0.655 . . . . 0.0 112.235 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 N--CA 1.469 0.516 0 CA-C-N 119.312 0.96 . . . . 0.0 110.774 178.912 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.9 t . . . . . 0 N--CA 1.454 -0.237 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -58.54 -45.52 88.73 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.3 mtm-85 -173.23 166.59 4.87 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.572 1.549 . . . . 0.0 109.51 -175.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.6 t -135.83 131.21 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.152 0.981 . . . . 0.0 110.827 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 tp -117.04 124.64 49.78 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.118 1.367 . . . . 0.0 111.706 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.79 134.7 52.27 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.284 1.034 . . . . 0.0 111.688 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -140.35 157.09 69.3 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.144 1.378 . . . . 0.0 110.589 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.39 131.25 18.63 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.251 3.301 . . . . 0.0 111.648 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -122.72 116.41 23.71 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.197 0.999 . . . . 0.0 111.446 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -113.85 77.89 3.81 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 119.223 0.92 . . . . 0.0 111.781 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.6 145.9 38.07 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.145 2.563 . . . . 0.0 111.297 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.2 m -73.91 135.79 43.31 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.339 1.056 . . . . 0.0 110.782 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.16 -179.06 42.99 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 123.708 0.671 . . . . 0.0 111.57 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -103.24 126.36 50.37 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.895 0.878 . . . . 0.0 108.758 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -67.0 155.4 38.73 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.905 1.282 . . . . 0.0 110.02 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.5 m -83.2 -76.95 0.26 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -128.48 167.75 16.62 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.029 1.331 . . . . 0.0 109.952 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -77.73 151.0 34.34 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.285 1.034 . . . . 0.0 110.137 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -151.38 -175.57 5.23 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.353 0.661 . . . . 0.0 110.724 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.3 pt . . . . . 0 CA--C 1.532 0.28 0 C-N-CA 123.875 0.87 . . . . 0.0 110.318 -178.351 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.9 m . . . . . 0 CA--C 1.529 0.143 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -73.49 105.13 4.71 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.524 0.73 . . . . 0.0 109.684 -176.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.5 p -98.57 81.6 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.3 m -75.71 151.38 37.66 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.151 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.514 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -135.71 147.51 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.036 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.3 tt -110.12 98.81 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 C-N-CA 123.699 0.8 . . . . 0.0 109.108 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.77 97.23 10.87 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.134 0.974 . . . . 0.0 109.181 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -72.09 102.65 3.06 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 169.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.68 82.86 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 174.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -65.92 132.05 47.7 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.97 -177.32 28.18 Favored Glycine 0 N--CA 1.448 -0.543 0 O-C-N 123.443 0.464 . . . . 0.0 111.988 178.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -89.06 69.05 8.4 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 121.911 0.863 . . . . 0.0 109.421 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.3 t -108.61 -47.35 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.937 1.695 . . . . 0.0 109.181 -167.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -57.68 145.19 35.11 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.076 0.95 . . . . 0.0 109.817 166.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.75 -45.11 2.71 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.801 0.715 . . . . 0.0 111.368 -175.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.0 t -65.64 -33.71 65.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.675 0.79 . . . . 0.0 111.085 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.2 38.51 5.36 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.581 1.086 . . . . 0.0 111.651 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -52.07 -30.37 25.56 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 126.17 1.788 . . . . 0.0 113.181 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.0 54.54 0.67 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.008 1.323 . . . . 0.0 110.377 174.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -87.37 -74.61 0.43 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.658 1.183 . . . . 0.0 108.444 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -101.83 17.83 22.05 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.637 1.175 . . . . 0.0 110.994 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.6 t -61.81 -40.53 95.59 Favored 'General case' 0 C--N 1.344 0.363 0 O-C-N 121.856 -0.527 . . . . 0.0 111.111 171.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -60.18 -50.33 74.1 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.402 0.681 . . . . 0.0 110.916 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -52.24 -58.49 6.48 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 123.184 0.303 . . . . 0.0 110.303 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.18 -52.17 59.69 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.755 1.222 . . . . 0.0 110.872 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.16 -39.66 63.75 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.444 1.097 . . . . 0.0 111.843 177.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -72.08 -23.69 61.39 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.917 0.887 . . . . 0.0 112.104 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.3 mmm-85 -65.12 -47.16 78.15 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 118.854 0.752 . . . . 0.0 108.982 171.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.9 mt -75.09 -33.46 61.64 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.069 0.947 . . . . 0.0 111.213 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.62 45.55 52.53 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 124.748 1.166 . . . . 0.0 111.314 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.36 174.98 5.65 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.757 1.223 . . . . 0.0 112.605 -175.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.4 p -114.63 -171.72 1.98 Allowed 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -170.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.69 -144.37 17.58 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 170.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -171.72 153.56 3.39 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 176.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.94 83.87 2.29 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.638 1.175 . . . . 0.0 108.689 170.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt -83.64 165.22 19.16 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -126.99 134.66 50.31 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 47.6 mt -80.74 -175.27 5.2 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.584 0.754 . . . . 0.0 109.899 170.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -93.04 2.31 56.84 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.961 0.904 . . . . 0.0 111.164 168.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -79.6 -48.1 14.34 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.403 0.681 . . . . 0.0 109.418 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.46 -28.72 2.31 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -157.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.04 117.02 10.17 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.312 0.645 . . . . 0.0 111.364 -166.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 63.8 t -88.76 104.12 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 171.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -79.65 93.41 5.51 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.821 1.248 . . . . 0.0 108.753 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.1 t -91.21 114.94 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.03 130.42 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.31 1.044 . . . . 0.0 108.479 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.17 123.64 7.17 Favored 'General case' 0 N--CA 1.457 -0.113 0 O-C-N 124.377 1.048 . . . . 0.0 109.792 -166.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 91.4 m -95.7 176.66 6.06 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.064 0.946 . . . . 0.0 112.085 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.9 -155.11 16.29 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -72.76 150.59 42.68 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 172.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -58.58 -46.89 85.96 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -46.49 -45.24 16.92 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.137 1.827 . . . . 0.0 113.034 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -67.02 -51.61 52.74 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.578 0.689 . . . . 0.0 110.707 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.7 t -61.08 -32.48 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.876 0.87 . . . . 0.0 111.904 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -53.64 -40.98 66.27 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.415 0.686 . . . . 0.0 111.092 173.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -65.06 -30.76 71.74 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.145 0.884 . . . . 0.0 112.691 -169.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -78.46 -35.97 45.97 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.565 0.62 . . . . 0.0 110.929 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 54.0 mtm -64.17 -41.91 96.93 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.498 0.59 . . . . 0.0 111.197 175.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -51.96 -29.77 21.92 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.219 1.008 . . . . 0.0 112.386 172.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 12.8 t90 -83.65 -41.07 18.18 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 117.845 -1.074 . . . . 0.0 110.874 170.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 25.6 mt . . . . . 0 C--N 1.346 0.444 0 CA-C-N 120.098 1.317 . . . . 0.0 111.53 -174.362 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.6 t . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -70.55 -54.83 10.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.032 0.933 . . . . 0.0 110.945 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -151.54 150.05 29.9 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 123.652 0.781 . . . . 0.0 110.097 -174.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.0 t -127.6 102.08 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.844 1.258 . . . . 0.0 109.53 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.7 tp -105.37 114.2 28.23 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 123.586 0.754 . . . . 0.0 110.159 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.4 m -99.28 138.11 36.83 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.122 0.569 . . . . 0.0 109.902 170.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -130.04 148.85 71.32 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 125.67 1.588 . . . . 0.0 108.402 172.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.61 109.87 1.52 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.406 2.737 . . . . 0.0 109.936 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -89.5 113.16 24.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.859 1.264 . . . . 0.0 109.164 -174.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -110.88 72.37 0.78 Allowed Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 125.162 1.385 . . . . 0.0 110.454 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.45 135.73 24.89 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.642 2.228 . . . . 0.0 110.119 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.1 p -71.36 137.23 48.24 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.16 -160.16 50.97 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -173.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -137.24 145.63 43.81 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.233 1.013 . . . . 0.0 110.11 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.3 tp -100.33 137.5 38.66 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 171.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.1 m -66.17 -48.43 70.75 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.694 0.797 . . . . 0.0 111.801 -173.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -129.53 160.93 31.68 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.976 0.911 . . . . 0.0 111.866 -166.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -84.85 145.8 27.65 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.427 1.091 . . . . 0.0 109.315 166.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -145.73 173.41 12.12 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.792 0.837 . . . . 0.0 110.893 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.6 pt . . . . . 0 C--N 1.34 0.161 0 C-N-CA 123.827 0.851 . . . . 0.0 110.409 -174.672 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.3 m . . . . . 0 CA--C 1.531 0.212 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -67.96 107.68 2.76 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 121.091 0.472 . . . . 0.0 110.966 -177.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.39 80.47 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.733 1.613 . . . . 0.0 107.097 -173.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -76.72 148.01 37.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.537 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.445 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.2 pp -120.03 164.26 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.6 tt -125.01 118.5 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 124.395 1.078 . . . . 0.0 108.867 170.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -115.27 107.84 15.79 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.784 1.234 . . . . 0.0 110.211 -176.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -86.1 121.56 28.87 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 172.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.6 t -100.44 94.18 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -63.76 152.55 39.04 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.916 0.886 . . . . 0.0 110.958 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.3 -178.64 26.72 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 124.389 0.995 . . . . 0.0 112.261 174.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -85.94 87.55 7.43 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 123.169 0.588 . . . . 0.0 110.647 -173.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.0 t -114.82 -40.04 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.771 1.228 . . . . 0.0 110.178 -174.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -65.56 152.34 44.31 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.629 0.772 . . . . 0.0 111.718 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.67 17.95 76.94 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.996 0.807 . . . . 0.0 113.543 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.69 -42.05 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.783 1.233 . . . . 0.0 109.257 175.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.26 32.08 1.89 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.687 1.613 . . . . 0.0 112.124 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -53.21 -29.1 30.26 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.541 1.537 . . . . 0.0 112.882 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -68.69 41.54 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.096 2.158 . . . . 0.0 113.5 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -85.8 -67.72 0.79 Allowed 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.508 -0.745 . . . . 0.0 110.029 -173.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.3 t -92.56 -9.77 40.0 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.888 0.875 . . . . 0.0 112.61 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.6 t -43.82 -48.54 8.26 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.06 0.944 . . . . 0.0 113.541 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -58.4 -57.16 14.13 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 124.653 1.181 . . . . 0.0 110.141 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -50.74 -55.66 15.65 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.499 1.12 . . . . 0.0 110.672 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.16 -54.2 39.32 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 124.596 1.159 . . . . 0.0 110.164 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.57 -36.83 64.79 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.658 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -68.51 -31.44 70.7 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.464 0.705 . . . . 0.0 112.125 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -60.92 -49.29 78.05 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.715 0.689 . . . . 0.0 110.282 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.3 mt -75.52 -31.03 59.98 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.392 0.277 . . . . 0.0 110.911 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.55 22.54 53.5 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.749 1.166 . . . . 0.0 112.593 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.94 169.26 10.41 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.658 0.783 . . . . 0.0 112.201 -177.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.6 p -112.27 -159.39 0.68 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.725 0.81 . . . . 0.0 109.352 -166.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.7 -154.77 16.68 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 170.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -169.47 160.68 9.33 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.05 78.97 1.39 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.738 1.215 . . . . 0.0 109.679 -174.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -85.01 166.34 16.79 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -126.86 129.82 49.0 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.6 mt -68.08 173.84 4.31 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.904 1.282 . . . . 0.0 110.781 177.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -89.44 13.77 12.93 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.953 0.901 . . . . 0.0 111.378 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -105.94 -51.14 3.03 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 123.894 0.878 . . . . 0.0 110.31 -176.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 161.02 -20.55 0.21 Allowed Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.446 1.022 . . . . 0.0 112.671 -167.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.2 p -105.26 159.14 16.11 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.078 0.951 . . . . 0.0 112.287 -162.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.2 t -116.22 126.49 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.248 1.019 . . . . 0.0 111.261 -169.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -100.33 105.55 17.09 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.644 1.577 . . . . 0.0 110.397 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.6 t -110.45 127.16 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 123.262 0.625 . . . . 0.0 109.818 -172.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.46 141.0 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 118.629 -0.7 . . . . 0.0 109.948 -171.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.52 128.16 4.46 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 118.163 -0.922 . . . . 0.0 112.329 -167.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 98.9 m -97.04 177.65 5.53 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 113.443 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.62 -172.8 16.31 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 125.054 1.311 . . . . 0.0 111.01 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -67.59 124.28 22.81 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -52.62 -40.45 62.76 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.175 1.39 . . . . 0.0 112.24 -168.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -43.96 -50.59 7.43 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.669 1.604 . . . . 0.0 112.379 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -65.07 -52.72 54.03 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 122.958 0.503 . . . . 0.0 110.516 176.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.2 t -46.43 -45.57 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.094 0.958 . . . . 0.0 111.626 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -64.21 -29.05 70.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.496 -0.764 . . . . 0.0 112.799 -175.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -54.63 -44.27 73.03 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 119.324 0.966 . . . . 0.0 111.197 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.2 -29.32 61.68 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.452 0.301 . . . . 0.0 111.169 177.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mtm -68.31 -25.74 65.28 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 118.692 -0.67 . . . . 0.0 112.033 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -48.64 -53.15 19.68 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 166.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -62.81 -40.96 99.01 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 118.534 -0.745 . . . . 0.0 112.17 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 mt . . . . . 0 N--CA 1.469 0.476 0 CA-C-N 119.779 1.172 . . . . 0.0 109.922 177.77 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.6 t . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -68.56 -48.7 63.58 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 119.055 -0.498 . . . . 0.0 111.221 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.2 mtm105 -167.05 163.85 15.85 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.801 0.841 . . . . 0.0 110.799 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -127.06 117.25 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.289 1.036 . . . . 0.0 109.926 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 tt -106.91 111.84 24.53 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.257 1.023 . . . . 0.0 110.022 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.5 m -103.9 137.39 41.96 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.348 0.659 . . . . 0.0 111.175 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -139.64 160.06 62.8 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 126.037 1.735 . . . . 0.0 109.759 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.73 129.54 12.7 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.346 2.697 . . . . 0.0 110.367 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 59.4 t60 -116.88 110.51 18.43 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.287 1.035 . . . . 0.0 109.607 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -108.18 80.53 1.11 Allowed Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 119.079 0.854 . . . . 0.0 111.055 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.15 160.92 46.11 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.99 2.46 . . . . 0.0 110.85 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 88.7 p -84.08 147.59 27.29 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.028 0.931 . . . . 0.0 110.473 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.22 -171.75 18.18 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.85 0.738 . . . . 0.0 112.298 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -105.29 136.11 45.43 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.121 0.968 . . . . 0.0 109.864 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 mp -81.72 147.11 29.64 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.307 1.043 . . . . 0.0 109.251 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 19.2 p -78.69 -66.04 0.91 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.624 1.17 . . . . 0.0 109.874 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -137.92 166.55 23.76 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.259 1.424 . . . . 0.0 110.693 -167.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -84.36 140.68 31.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 167.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -148.38 -172.43 4.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.014 0.526 . . . . 0.0 109.827 -174.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.3 tt . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -175.398 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 t . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 111.286 0.106 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -67.14 120.48 13.8 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.221 1.008 . . . . 0.0 111.471 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 p -127.64 85.04 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 125.578 1.551 . . . . 0.0 107.813 -173.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.57 148.68 31.65 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.853 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.419 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.3 pp -129.43 162.96 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.6 tt -121.66 125.77 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 124.026 0.931 . . . . 0.0 108.988 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -118.62 103.66 9.91 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.659 1.584 . . . . 0.0 109.832 -173.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.5 m-90 -85.65 117.66 24.68 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.23 0.612 . . . . 0.0 109.815 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.0 t -100.51 108.85 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 123.83 0.852 . . . . 0.0 108.978 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -78.86 164.78 24.2 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.122 0.569 . . . . 0.0 110.876 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.76 -177.88 42.13 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 124.061 0.839 . . . . 0.0 112.122 177.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -84.76 81.42 8.88 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.386 0.612 . . . . 0.0 111.066 -169.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.8 t -108.52 -44.42 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.478 1.511 . . . . 0.0 110.48 -173.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -65.9 153.8 41.02 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.117 0.567 . . . . 0.0 110.964 175.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 67.75 17.52 69.3 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 123.998 0.808 . . . . 0.0 113.722 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.6 t -104.04 -43.27 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.752 1.221 . . . . 0.0 108.828 172.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.63 32.76 2.61 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.904 1.716 . . . . 0.0 111.233 -176.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -53.5 -34.59 58.65 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.801 1.24 . . . . 0.0 112.356 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.3 53.89 0.68 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.438 1.495 . . . . 0.0 112.139 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -94.4 -75.05 0.52 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.497 1.119 . . . . 0.0 109.48 -176.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -79.99 -11.87 59.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.905 0.882 . . . . 0.0 112.016 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.6 t -44.18 -44.43 7.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.97 0.908 . . . . 0.0 112.719 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.4 mm-40 -56.41 -63.68 1.11 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.823 1.649 . . . . 0.0 110.166 172.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -50.85 -56.22 13.23 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.969 1.707 . . . . 0.0 111.75 -174.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -56.04 -54.59 43.14 Favored 'General case' 0 CA--C 1.527 0.064 0 C-N-CA 124.292 1.037 . . . . 0.0 109.852 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.47 -37.61 49.72 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.93 0.892 . . . . 0.0 111.888 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -65.32 -32.16 73.67 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.769 1.228 . . . . 0.0 112.474 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.2 mmm-85 -64.52 -45.14 88.47 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 118.464 0.574 . . . . 0.0 110.037 175.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.5 mt -73.23 -36.02 66.38 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.192 0.597 . . . . 0.0 111.311 -178.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.49 18.61 65.93 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.415 1.007 . . . . 0.0 112.475 -175.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.47 169.45 14.49 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.463 0.705 . . . . 0.0 110.713 177.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.2 p -111.87 -157.61 0.62 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -170.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.6 -155.21 16.34 Favored Glycine 0 C--N 1.339 0.711 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 166.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -166.66 154.78 10.02 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 173.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.12 96.17 5.79 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.237 1.415 . . . . 0.0 110.098 175.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -102.2 174.09 6.08 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.749 0.82 . . . . 0.0 111.321 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -125.28 132.38 52.92 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.109 0.964 . . . . 0.0 109.344 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.0 mt -71.48 171.96 10.39 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.14 1.376 . . . . 0.0 110.758 174.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -95.47 15.68 19.01 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.049 1.34 . . . . 0.0 111.763 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -117.2 -26.35 6.8 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.115 0.966 . . . . 0.0 112.043 -175.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.73 4.13 1.66 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.644 1.116 . . . . 0.0 114.307 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 p -121.11 167.51 12.56 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.002 1.321 . . . . 0.0 112.091 -165.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.7 t -123.9 128.24 74.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.578 1.151 . . . . 0.0 111.222 -170.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -101.89 111.46 23.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.165 1.386 . . . . 0.0 111.56 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.1 t -108.5 132.55 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 123.043 0.537 . . . . 0.0 110.235 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.53 143.62 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.873 0.869 . . . . 0.0 110.174 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.4 129.11 5.49 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 118.174 -0.917 . . . . 0.0 111.905 -172.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 80.8 m -95.6 -179.43 4.74 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.634 1.174 . . . . 0.0 112.441 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.43 -167.4 14.79 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 124.94 1.257 . . . . 0.0 109.978 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.98 139.79 46.92 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 170.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -53.79 -45.09 70.62 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.904 0.882 . . . . 0.0 110.587 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -42.47 -45.52 5.45 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.347 1.927 . . . . 0.0 113.202 174.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -74.21 -46.93 38.71 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.252 1.021 . . . . 0.0 111.592 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -53.34 -41.51 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.461 0.705 . . . . 0.0 110.69 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -65.14 -22.72 66.96 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.331 0.653 . . . . 0.0 112.67 -176.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -61.87 -45.23 94.67 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.366 0.53 . . . . 0.0 111.021 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.3 -28.07 61.01 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.392 0.542 . . . . 0.0 111.038 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -68.59 -26.13 65.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.695 -0.669 . . . . 0.0 111.277 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -44.0 -49.36 8.65 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 167.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -69.34 -37.21 77.57 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-O 118.426 -0.797 . . . . 0.0 111.69 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 N--CA 1.468 0.436 0 CA-C-N 118.972 0.806 . . . . 0.0 111.028 177.856 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.8 t . . . . . 0 N--CA 1.456 -0.148 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -73.12 -52.6 13.62 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.609 0.763 . . . . 0.0 111.407 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.2 mmm-85 -168.94 166.44 11.22 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.725 1.21 . . . . 0.0 109.433 -171.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.06 133.84 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 118.838 -0.601 . . . . 0.0 111.41 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.6 tp -124.69 125.68 44.49 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.077 0.951 . . . . 0.0 112.251 -175.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.95 135.1 49.09 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.273 1.029 . . . . 0.0 111.813 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -134.17 155.98 79.5 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 125.909 1.684 . . . . 0.0 110.203 -178.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.74 126.53 11.48 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 124.244 3.296 . . . . 0.0 111.078 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -119.21 107.49 13.5 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.147 0.979 . . . . 0.0 110.371 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -110.55 74.22 0.87 Allowed Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 119.228 0.922 . . . . 0.0 111.464 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -72.97 151.5 50.47 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.179 2.586 . . . . 0.0 111.44 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.4 p -79.19 140.69 37.65 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.123 0.969 . . . . 0.0 110.624 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.8 174.26 16.57 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.028 0.823 . . . . 0.0 111.89 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -92.04 142.66 27.28 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.758 0.823 . . . . 0.0 108.975 171.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -85.98 149.01 25.49 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.1 p -75.54 -75.95 0.16 Allowed 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -134.08 163.0 30.55 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.833 0.853 . . . . 0.0 110.847 -171.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -76.52 148.63 37.0 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.848 0.859 . . . . 0.0 109.829 172.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -150.95 -177.69 6.16 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.121 0.568 . . . . 0.0 109.948 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.9 pt . . . . . 0 C--O 1.231 0.105 0 C-N-CA 123.575 0.75 . . . . 0.0 109.615 178.232 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 CA--C 1.539 0.536 0 CA-C-O 119.909 -0.091 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -63.06 134.71 56.52 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.709 1.204 . . . . 0.0 112.132 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.0 p -139.95 92.86 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.294 0 C-N-CA 124.603 1.161 . . . . 0.0 109.027 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.8 m -86.67 156.65 19.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.469 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.5 pp -140.46 158.48 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.073 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 tt -119.01 109.82 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.123 0.969 . . . . 0.0 109.549 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -101.99 119.77 39.33 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.298 1.039 . . . . 0.0 110.157 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.0 m-90 -97.39 112.35 24.22 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.039 0.935 . . . . 0.0 110.493 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.466 HG12 HG21 ' A' ' 14' ' ' VAL . 3.8 t -91.78 123.78 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.93 0.892 . . . . 0.0 109.063 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -94.0 174.89 6.93 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.461 1.504 . . . . 0.0 111.202 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.12 -163.56 54.15 Favored Glycine 0 C--N 1.338 0.683 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -85.93 91.8 8.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.67 0.788 . . . . 0.0 111.514 -173.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.466 HG21 HG12 ' A' ' 10' ' ' VAL . 17.6 t -123.45 -44.31 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.171 0.988 . . . . 0.0 109.771 -175.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -71.27 143.05 50.49 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.29 0.636 . . . . 0.0 110.172 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.26 18.04 79.09 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 119.214 -0.77 . . . . 0.0 113.309 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.0 t -108.78 -43.19 5.92 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 124.331 1.052 . . . . 0.0 109.686 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 116.71 25.56 3.34 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 125.185 1.374 . . . . 0.0 111.639 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -51.24 -35.09 35.33 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.891 0.876 . . . . 0.0 111.105 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.5 mtp180 -74.9 59.86 0.93 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.243 1.417 . . . . 0.0 111.36 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -114.27 -73.51 0.65 Allowed 'General case' 0 C--N 1.339 0.139 0 C-N-CA 125.389 1.475 . . . . 0.0 108.807 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.3 t -73.69 -19.96 60.68 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.229 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.5 t -45.44 -36.96 4.72 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.937 0.895 . . . . 0.0 112.163 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -69.95 -59.21 3.06 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.508 1.123 . . . . 0.0 110.208 176.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -52.33 -53.98 37.49 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.534 1.134 . . . . 0.0 111.348 -175.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.58 -52.12 64.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.643 1.177 . . . . 0.0 110.214 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.87 -31.54 59.81 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.169 0.587 . . . . 0.0 112.408 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -65.02 -34.33 78.18 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.642 1.177 . . . . 0.0 111.597 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -69.92 -48.87 56.85 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.757 0.823 . . . . 0.0 110.34 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.7 mt -71.21 -34.24 70.66 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.917 0.487 . . . . 0.0 110.779 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.09 14.08 81.1 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.319 0.962 . . . . 0.0 112.671 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.55 178.14 5.54 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.533 0.733 . . . . 0.0 111.259 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.3 p -123.79 -174.91 3.09 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 136.61 -149.3 20.11 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 170.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -169.03 165.93 11.17 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 172.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.1 101.58 7.09 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.597 0.759 . . . . 0.0 112.031 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -97.99 175.28 6.18 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.444 1.098 . . . . 0.0 111.243 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -123.77 136.54 54.48 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.837 1.255 . . . . 0.0 109.973 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.419 HD12 ' HB2' ' A' ' 43' ' ' SER . 18.6 mt -74.19 173.91 9.48 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.504 1.522 . . . . 0.0 109.981 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -97.58 13.47 29.96 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.151 0.98 . . . . 0.0 111.719 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -117.92 -11.01 10.32 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 124.044 0.938 . . . . 0.0 112.446 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.38 19.77 4.53 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 125.098 1.333 . . . . 0.0 114.061 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.419 ' HB2' HD12 ' A' ' 39' ' ' LEU . 17.1 m -118.14 166.25 12.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.546 1.538 . . . . 0.0 111.601 -171.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.2 t -129.35 118.25 45.31 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 C-N-CA 124.046 0.938 . . . . 0.0 110.575 -175.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -94.88 126.47 40.23 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.58 0.752 . . . . 0.0 110.554 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.8 t -120.38 133.95 65.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.687 0.795 . . . . 0.0 109.457 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.5 t -126.28 142.54 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 C-N-CA 124.425 1.09 . . . . 0.0 109.512 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.93 134.62 10.83 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-O 118.752 -0.642 . . . . 0.0 111.117 -173.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 51.8 m -99.77 178.44 4.83 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.211 1.404 . . . . 0.0 112.611 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.46 -153.19 20.15 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -83.77 126.63 33.12 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.832 1.253 . . . . 0.0 109.561 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -46.38 -51.48 14.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.723 1.209 . . . . 0.0 111.537 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -51.9 -44.88 56.12 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.223 1.392 . . . . 0.0 112.97 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -69.09 -44.22 72.92 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 117.33 0.565 . . . . 0.0 111.752 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.4 t -54.39 -32.66 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 122.749 0.419 . . . . 0.0 110.728 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.97 -29.97 69.98 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -57.66 -24.03 54.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.009 0.923 . . . . 0.0 112.608 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.68 -29.51 12.62 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-N 118.784 0.72 . . . . 0.0 111.483 171.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.3 mmm -65.79 -20.36 66.23 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.838 -0.601 . . . . 0.0 111.949 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -45.12 -58.18 3.39 Favored 'General case' 0 C--O 1.214 -0.791 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 172.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -62.76 -36.9 84.55 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.125 0.57 . . . . 0.0 111.833 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt . . . . . 0 C--N 1.345 0.386 0 C-N-CA 123.707 0.803 . . . . 0.0 110.375 178.284 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -55.31 -49.97 70.78 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 122.979 0.512 . . . . 0.0 111.21 176.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -171.26 171.13 5.75 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.67 1.188 . . . . 0.0 109.595 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.9 p -156.28 134.26 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.009 0.523 . . . . 0.0 110.212 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tp -113.91 149.63 34.9 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.989 0.916 . . . . 0.0 110.886 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.12 131.32 44.05 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.427 1.091 . . . . 0.0 111.344 -176.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -141.53 156.31 66.73 Favored Pre-proline 0 N--CA 1.468 0.431 0 C-N-CA 124.01 0.924 . . . . 0.0 111.622 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -68.63 125.28 12.53 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 124.213 3.275 . . . . 0.0 110.836 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -118.99 117.36 28.58 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.89 0.876 . . . . 0.0 109.878 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -109.34 77.67 0.97 Allowed Pre-proline 0 CA--C 1.539 0.53 0 O-C-N 121.498 -0.751 . . . . 0.0 110.344 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.63 126.58 12.23 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.656 2.904 . . . . 0.0 109.755 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.0 p -70.31 148.67 48.23 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.338 0.655 . . . . 0.0 110.688 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.25 176.7 8.84 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.973 0.796 . . . . 0.0 112.164 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -105.27 131.78 52.3 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.71 1.204 . . . . 0.0 108.872 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.2 tp -83.19 151.76 25.53 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.572 0.749 . . . . 0.0 109.55 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.5 m -74.74 -73.43 0.24 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -138.04 162.99 32.72 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.466 1.106 . . . . 0.0 110.369 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -71.83 147.21 47.4 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.673 0.789 . . . . 0.0 110.519 175.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -143.97 -177.35 5.39 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.64 1.176 . . . . 0.0 110.159 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.3 pt . . . . . 0 CA--C 1.533 0.316 0 C-N-CA 123.628 0.771 . . . . 0.0 109.102 -177.782 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 t . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 110.605 -0.146 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.67 152.85 44.59 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.285 1.034 . . . . 0.0 112.821 -177.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 p -138.49 88.43 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.262 1.025 . . . . 0.0 108.405 -174.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.5 m -79.55 150.49 31.1 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.584 HD11 HG11 ' A' ' 55' ' ' VAL . 1.4 pp -136.68 157.17 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.9 tt -116.35 116.35 52.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.431 1.093 . . . . 0.0 109.609 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -111.41 103.21 11.55 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.674 1.59 . . . . 0.0 109.917 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.1 m-90 -83.68 115.59 22.25 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 123.783 0.833 . . . . 0.0 109.868 176.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.466 HG13 HG22 ' A' ' 75' ' ' VAL . 4.3 t -97.92 113.24 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -87.82 172.63 9.49 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 124.487 1.115 . . . . 0.0 111.175 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.03 -169.55 55.01 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 123.632 0.634 . . . . 0.0 111.821 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -83.39 85.33 7.25 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.02 0.528 . . . . 0.0 112.124 -167.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.4 t -117.7 -43.08 2.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.845 -173.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -68.23 148.34 50.96 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.683 0.674 . . . . 0.0 110.389 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.74 -31.01 8.32 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 118.918 -0.934 . . . . 0.0 113.426 174.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 m -74.34 -0.58 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 119.018 1.409 . . . . 0.0 112.448 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.01 36.83 73.22 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.199 0.904 . . . . 0.0 110.859 -170.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -51.25 -38.84 54.86 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 123.908 0.883 . . . . 0.0 111.157 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.16 55.97 0.6 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.511 1.524 . . . . 0.0 113.095 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -110.99 -72.42 0.72 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.402 1.081 . . . . 0.0 109.465 -177.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 t -73.77 -16.93 61.15 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.213 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.2 t -40.68 -42.09 1.66 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.141 1.376 . . . . 0.0 113.021 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -64.3 -61.46 2.22 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.632 1.173 . . . . 0.0 110.411 173.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -48.97 -54.38 15.83 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.604 1.562 . . . . 0.0 111.734 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -55.69 -45.82 77.75 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.355 1.462 . . . . 0.0 112.038 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.09 -30.38 71.32 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.092 0.557 . . . . 0.0 111.999 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.8 tttt -65.3 -35.44 81.01 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.831 0.853 . . . . 0.0 111.328 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -67.51 -49.46 63.31 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.294 0.638 . . . . 0.0 110.536 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.9 mt -73.55 -34.37 65.15 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.825 0.45 . . . . 0.0 110.74 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.08 13.24 72.05 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.208 0.909 . . . . 0.0 112.866 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.21 176.28 8.9 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.775 0.83 . . . . 0.0 111.506 178.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.7 p -115.61 -160.89 0.76 Allowed 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -172.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.2 -155.25 16.27 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 118.637 0.653 . . . . 0.0 112.751 169.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -168.99 159.37 9.27 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 174.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.22 91.38 3.44 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.579 1.152 . . . . 0.0 111.5 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -93.17 174.83 7.02 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.337 0.655 . . . . 0.0 110.357 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -123.19 133.99 54.19 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 124.191 0.996 . . . . 0.0 110.539 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 30.0 mt -74.67 169.32 18.05 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.77 1.628 . . . . 0.0 110.267 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -90.0 4.5 49.96 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.391 1.076 . . . . 0.0 112.113 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -107.83 -7.57 16.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.469 1.108 . . . . 0.0 112.093 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.56 12.69 11.33 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.085 1.326 . . . . 0.0 113.963 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.36 168.06 10.31 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.637 1.575 . . . . 0.0 112.003 -170.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.9 t -129.07 118.13 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.49 1.116 . . . . 0.0 110.894 -173.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -94.97 121.71 36.87 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.407 1.003 . . . . 0.0 111.234 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.5 t -119.05 134.07 63.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 117.966 0.348 . . . . 0.0 110.532 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.43 142.55 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.412 1.085 . . . . 0.0 109.704 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.08 133.24 7.69 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 118.637 -0.697 . . . . 0.0 111.569 -171.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 96.9 m -100.18 176.44 5.39 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.808 1.243 . . . . 0.0 112.785 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.18 -159.01 20.03 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.825 1.202 . . . . 0.0 110.317 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -73.36 134.24 44.03 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.21 0.604 . . . . 0.0 110.17 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -49.01 -49.46 40.87 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.447 1.099 . . . . 0.0 111.184 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -49.91 -53.3 22.86 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.097 1.332 . . . . 0.0 112.171 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -62.22 -43.61 98.44 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.469 0.708 . . . . 0.0 111.487 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.584 HG11 HD11 ' A' ' 6' ' ' ILE . 80.7 t -58.02 -40.0 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 122.611 0.364 . . . . 0.0 110.396 175.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.46 -26.4 68.71 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -176.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -55.47 -44.72 76.71 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.609 0.764 . . . . 0.0 110.897 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.26 -30.44 48.58 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 118.177 0.444 . . . . 0.0 111.632 175.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.3 mmt -68.38 -22.72 64.63 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 119.074 -0.489 . . . . 0.0 112.096 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -43.34 -51.13 6.54 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 167.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 18.7 t90 -64.25 -40.95 97.06 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.344 0.52 . . . . 0.0 111.989 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mt . . . . . 0 C--N 1.348 0.502 0 C-N-CA 123.661 0.785 . . . . 0.0 111.043 179.464 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.7 t . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -62.43 -56.84 14.32 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.856 0.862 . . . . 0.0 109.988 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -166.96 158.14 12.22 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.18 0.992 . . . . 0.0 109.424 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.466 HG22 HG13 ' A' ' 10' ' ' VAL . 21.8 t -132.3 135.78 57.44 Favored 'Isoleucine or valine' 0 C--N 1.342 0.24 0 C-N-CA 123.771 0.828 . . . . 0.0 110.031 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.9 tp -117.37 108.44 15.58 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.812 0.845 . . . . 0.0 110.789 -177.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.15 127.15 46.45 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.632 1.173 . . . . 0.0 111.52 -177.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -131.0 156.51 80.04 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 126.125 1.77 . . . . 0.0 110.673 -175.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -71.24 120.14 6.78 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.232 3.288 . . . . 0.0 111.495 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -109.44 109.04 19.77 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.485 0.714 . . . . 0.0 109.616 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -109.89 74.21 0.74 Allowed Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 123.945 0.898 . . . . 0.0 110.315 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.73 146.9 30.62 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.072 2.515 . . . . 0.0 110.511 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.7 p -72.72 141.17 48.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.424 0.69 . . . . 0.0 110.485 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.7 -178.63 35.53 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 123.871 0.748 . . . . 0.0 112.132 -177.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -104.12 130.84 51.86 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.333 1.053 . . . . 0.0 108.688 172.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mp -69.54 151.84 45.52 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.836 1.254 . . . . 0.0 109.713 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.59 -77.82 0.17 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.105 0.962 . . . . 0.0 109.008 178.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -137.37 167.0 22.48 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.343 1.057 . . . . 0.0 110.536 -173.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -73.74 143.22 46.18 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.598 173.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -130.93 174.63 9.79 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.414 0.686 . . . . 0.0 110.201 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.5 tp . . . . . 0 N--CA 1.449 -0.479 0 C-N-CA 122.76 0.424 . . . . 0.0 110.727 177.316 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.479 0 CA-C-O 120.265 0.079 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -61.19 135.73 57.84 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.745 1.618 . . . . 0.0 112.104 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.6 p -140.85 91.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 124.604 1.162 . . . . 0.0 108.368 -174.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.0 m -80.86 155.88 26.36 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.579 177.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.411 HD11 HG11 ' A' ' 55' ' ' VAL . 1.3 pp -143.58 158.2 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.4 tt -118.49 119.73 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 124.103 0.961 . . . . 0.0 109.329 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -109.2 106.43 16.29 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.996 1.318 . . . . 0.0 109.99 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -90.13 124.3 34.7 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.903 0.881 . . . . 0.0 110.251 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.464 HG12 HG21 ' A' ' 14' ' ' VAL . 10.4 t -101.51 104.3 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.11 0.964 . . . . 0.0 108.605 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -68.45 176.87 2.63 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 123.801 0.84 . . . . 0.0 111.69 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.72 -169.51 47.92 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -92.24 91.32 7.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.032 0.533 . . . . 0.0 110.853 -175.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.464 HG21 HG12 ' A' ' 10' ' ' VAL . 57.3 t -111.86 -31.75 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 124.106 0.962 . . . . 0.0 111.233 -178.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -69.13 150.16 47.86 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.586 0.355 . . . . 0.0 110.557 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.46 17.55 66.16 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 123.918 0.77 . . . . 0.0 113.397 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.0 t -114.94 -45.56 4.35 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 C-N-CA 124.761 1.224 . . . . 0.0 109.367 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.32 31.93 1.59 Allowed Glycine 0 C--N 1.339 0.698 0 C-N-CA 125.197 1.38 . . . . 0.0 111.434 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -50.79 -36.12 35.44 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 117.664 0.732 . . . . 0.0 110.874 177.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -74.3 56.56 0.65 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.502 1.121 . . . . 0.0 112.741 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -97.42 -71.02 0.7 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.965 0.906 . . . . 0.0 109.264 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 t -89.35 -2.99 58.64 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.71 0.804 . . . . 0.0 111.69 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.8 t -45.98 -37.78 6.93 Favored 'General case' 0 C--N 1.345 0.397 0 C-N-CA 123.84 0.856 . . . . 0.0 112.099 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -69.84 -59.51 2.89 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 124.31 1.044 . . . . 0.0 109.949 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -49.48 -55.11 14.4 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.704 1.202 . . . . 0.0 111.29 -176.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -55.78 -57.5 11.76 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.021 0.928 . . . . 0.0 109.822 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.22 -34.29 31.54 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.926 0.891 . . . . 0.0 112.121 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -62.68 -38.89 92.14 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.438 1.095 . . . . 0.0 111.71 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -68.6 -38.4 80.6 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.017 0.927 . . . . 0.0 110.527 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.87 -32.34 57.43 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.676 0.791 . . . . 0.0 111.118 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.94 15.57 80.42 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.686 0.66 . . . . 0.0 112.82 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.447 HD12 ' HB1' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -83.18 179.76 7.63 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.965 0.906 . . . . 0.0 111.217 178.269 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 46.0 p -120.29 -162.43 0.94 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -176.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.1 -151.93 17.45 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 172.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -172.57 170.39 4.85 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.844 0.458 . . . . 0.0 112.085 175.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.56 88.19 2.7 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.43 0.692 . . . . 0.0 111.697 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -88.91 173.03 8.73 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.89 0.876 . . . . 0.0 110.18 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -124.01 138.56 54.44 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.699 1.2 . . . . 0.0 108.684 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.9 mt -74.58 178.63 5.21 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.09 1.356 . . . . 0.0 110.173 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -100.94 12.3 37.92 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.806 0.842 . . . . 0.0 111.327 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -117.08 -14.67 10.56 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.401 1.08 . . . . 0.0 112.497 -176.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.13 2.6 7.69 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.171 1.367 . . . . 0.0 114.12 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.1 m -104.34 167.19 9.91 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.855 1.262 . . . . 0.0 111.679 -171.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.9 t -125.4 127.66 72.02 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 C-N-CA 124.302 1.041 . . . . 0.0 109.979 -176.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -102.33 122.73 44.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.659 1.184 . . . . 0.0 110.96 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.76 135.67 57.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -131.2 145.07 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.941 0.897 . . . . 0.0 109.578 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.447 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -158.52 138.96 12.56 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.991 -173.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.3 m -108.98 -178.6 3.62 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.053 1.341 . . . . 0.0 112.298 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.46 -161.29 26.16 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.95 121.46 23.49 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.196 0.998 . . . . 0.0 110.944 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -49.69 -45.32 48.75 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.765 1.226 . . . . 0.0 110.941 -175.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -44.47 -43.74 7.82 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 126.424 1.964 . . . . 0.0 113.423 175.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -78.4 -49.03 14.27 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.689 0.795 . . . . 0.0 110.09 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.411 HG11 HD11 ' A' ' 6' ' ' ILE . 49.4 t -52.87 -32.71 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 122.727 0.411 . . . . 0.0 111.851 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -63.25 -32.0 73.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.255 1.422 . . . . 0.0 112.149 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? -61.89 -52.87 62.35 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-O 118.625 -0.703 . . . . 0.0 110.012 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.81 -29.78 68.47 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.215 0.916 . . . . 0.0 111.091 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.537 ' HA ' HD12 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -65.87 -22.67 66.54 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.412 -0.804 . . . . 0.0 111.518 177.854 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -48.14 -46.63 34.59 Favored 'General case' 0 C--N 1.343 0.326 0 CA-C-N 118.632 0.651 . . . . 0.0 109.951 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -70.46 -35.94 73.62 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.113 -177.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 59' ' ' MET . 5.2 mt . . . . . 0 CA--C 1.536 0.428 0 CA-C-N 118.634 0.652 . . . . 0.0 109.957 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.3 t . . . . . 0 CA--C 1.533 0.295 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -62.92 -58.03 8.76 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.208 0.603 . . . . 0.0 110.782 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.0 tpp180 -168.38 174.07 7.23 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.931 0.892 . . . . 0.0 109.592 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.0 t -140.68 127.61 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.751 0.821 . . . . 0.0 109.982 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.13 156.08 19.18 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.695 1.198 . . . . 0.0 111.086 176.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.12 134.11 34.23 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.5 1.12 . . . . 0.0 111.556 -177.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -141.26 155.37 67.96 Favored Pre-proline 0 N--CA 1.471 0.586 0 C-N-CA 123.897 0.879 . . . . 0.0 111.503 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.9 122.24 9.13 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 124.704 3.603 . . . . 0.0 111.047 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -114.69 135.71 53.86 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.113 0.965 . . . . 0.0 110.512 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -139.66 71.42 37.13 Favored Pre-proline 0 CA--C 1.534 0.356 0 O-C-N 121.659 -0.651 . . . . 0.0 110.481 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -68.28 136.33 36.89 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.394 2.73 . . . . 0.0 110.138 -174.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.5 p -64.63 144.13 57.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.453 0.701 . . . . 0.0 110.825 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.87 170.75 5.46 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.225 0.917 . . . . 0.0 112.041 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -86.59 137.15 32.73 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mp -77.9 150.23 34.13 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.458 0.703 . . . . 0.0 109.543 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.8 -79.26 0.14 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -145.67 163.8 33.75 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.376 0.671 . . . . 0.0 110.948 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -74.22 143.99 44.91 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.258 0.623 . . . . 0.0 110.652 177.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -158.4 -179.98 8.6 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.197 0.599 . . . . 0.0 110.429 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.229 0 C-N-CA 123.511 0.724 . . . . 0.0 109.296 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 CA--C 1.537 0.45 0 N-CA-C 110.691 -0.114 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.6 134.36 54.19 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.176 1.39 . . . . 0.0 112.064 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 p -139.32 90.84 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.242 0 C-N-CA 124.645 1.178 . . . . 0.0 108.63 -174.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.3 m -81.36 153.2 27.12 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.772 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pp -141.16 158.2 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.123 0.569 . . . . 0.0 109.875 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 tt -117.7 118.24 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.171 0.989 . . . . 0.0 109.724 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -107.32 108.15 19.4 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.852 1.661 . . . . 0.0 109.897 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -90.4 128.35 36.46 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 125.243 1.417 . . . . 0.0 110.296 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.463 HG12 HG21 ' A' ' 14' ' ' VAL . 10.4 t -114.45 122.44 68.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.329 1.052 . . . . 0.0 109.07 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -96.66 178.76 5.22 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.829 1.252 . . . . 0.0 110.858 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.72 -160.21 53.44 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.3 mtt-85 -85.17 92.09 8.31 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -171.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.463 HG21 HG12 ' A' ' 10' ' ' VAL . 20.9 t -131.52 -45.84 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.523 0.729 . . . . 0.0 110.487 -175.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -70.46 146.91 49.98 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 122.857 0.463 . . . . 0.0 110.539 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.23 14.72 82.27 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 119.152 -0.805 . . . . 0.0 113.373 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 75.2 t -107.79 -44.11 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.618 1.167 . . . . 0.0 109.424 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.49 28.76 2.25 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 125.194 1.378 . . . . 0.0 111.431 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -50.78 -37.61 43.3 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 123.85 0.86 . . . . 0.0 111.11 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.21 59.49 0.76 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.388 1.075 . . . . 0.0 112.621 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -111.76 -72.84 0.7 Allowed 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.108 1.363 . . . . 0.0 109.55 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.1 t -73.13 -18.13 61.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.86 -0.59 . . . . 0.0 111.45 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.2 t -45.29 -36.92 4.35 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.844 0.858 . . . . 0.0 112.009 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -71.13 -57.79 4.18 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.351 1.06 . . . . 0.0 110.317 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.15 -59.87 3.87 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.158 0.983 . . . . 0.0 110.649 -175.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -55.18 -46.17 75.8 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.368 1.067 . . . . 0.0 110.428 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.59 -36.17 71.38 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.0 tttt -62.25 -30.91 71.44 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.09 0.556 . . . . 0.0 111.572 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.2 mmm-85 -66.85 -49.54 65.39 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 122.964 0.505 . . . . 0.0 110.652 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.417 HD12 HD23 ' A' ' 58' ' ' LEU . 40.6 mt -77.16 -42.44 37.73 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 122.403 0.281 . . . . 0.0 110.855 -177.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.9 9.36 58.51 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.551 1.072 . . . . 0.0 112.953 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.01 168.1 3.44 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 117.86 0.83 . . . . 0.0 112.015 175.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.5 p -127.3 151.03 49.29 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -176.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 161.9 -148.36 15.67 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -170.45 167.83 8.05 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 122.99 0.516 . . . . 0.0 111.777 173.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.41 99.68 5.5 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 118.679 -0.676 . . . . 0.0 111.345 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -100.93 176.83 5.14 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 124.68 1.192 . . . . 0.0 111.547 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 -127.11 137.98 53.1 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.074 1.35 . . . . 0.0 109.473 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.1 mt -75.01 174.24 9.61 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 125.075 1.35 . . . . 0.0 110.552 174.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -96.69 10.33 39.01 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.708 1.203 . . . . 0.0 111.529 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.68 -2.55 12.43 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.528 1.131 . . . . 0.0 112.018 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.94 25.77 6.65 Favored Glycine 0 C--N 1.342 0.871 0 C-N-CA 124.638 1.113 . . . . 0.0 113.776 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.16 162.22 19.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.006 1.322 . . . . 0.0 111.531 -175.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.0 t -122.05 120.85 62.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.409 1.484 . . . . 0.0 110.864 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -99.11 122.37 42.25 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.906 1.282 . . . . 0.0 111.06 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.56 136.87 55.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 C-N-CA 123.554 0.741 . . . . 0.0 109.511 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 t -127.36 143.33 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 124.237 1.015 . . . . 0.0 109.425 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.43 136.71 13.96 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-O 118.819 -0.61 . . . . 0.0 110.925 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 56.4 m -104.39 -179.53 3.97 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.698 1.599 . . . . 0.0 112.652 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.52 -154.57 22.25 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -80.09 129.07 34.22 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 123.222 0.609 . . . . 0.0 110.231 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -48.73 -52.43 23.68 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.908 1.283 . . . . 0.0 111.013 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.04 -45.88 62.03 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.343 1.449 . . . . 0.0 112.693 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -66.7 -46.86 74.22 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 117.479 0.639 . . . . 0.0 111.224 177.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.3 t -54.91 -30.9 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.135 0.574 . . . . 0.0 110.955 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -59.33 -31.39 69.13 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -55.05 -36.78 65.92 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.901 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.417 HD23 HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -84.91 -31.62 23.58 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.138 0.881 . . . . 0.0 111.03 174.821 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.5 mmm -65.59 -19.78 66.06 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.14 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -46.31 -51.38 14.78 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -70.83 -34.04 71.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 mt . . . . . 0 C--N 1.351 0.647 0 C-N-CA 123.324 0.65 . . . . 0.0 109.983 176.838 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.6 t . . . . . 0 CA--C 1.532 0.272 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -55.75 -56.61 18.4 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 123.848 0.859 . . . . 0.0 110.775 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.8 mtm-85 -157.08 161.9 39.46 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.953 1.301 . . . . 0.0 110.001 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.06 131.03 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.353 1.061 . . . . 0.0 109.534 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 tp -113.87 148.4 36.77 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.905 1.282 . . . . 0.0 110.819 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.42 135.57 38.82 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.402 -177.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -142.64 156.69 63.01 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 123.523 0.729 . . . . 0.0 111.68 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.13 122.98 10.09 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.644 3.563 . . . . 0.0 110.737 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -110.96 113.06 25.33 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.723 0.809 . . . . 0.0 109.571 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -117.43 70.08 6.12 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 118.709 0.686 . . . . 0.0 111.171 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.91 146.34 47.33 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.249 2.633 . . . . 0.0 110.79 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.5 p -72.5 142.97 48.54 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.615 0.766 . . . . 0.0 110.726 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.79 169.65 4.78 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.362 0.982 . . . . 0.0 112.128 -176.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -95.51 135.48 37.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.5 tp -79.77 150.48 30.76 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -75.81 0.14 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.223 1.009 . . . . 0.0 108.58 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -140.97 163.64 32.43 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.341 1.056 . . . . 0.0 110.129 -173.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -69.94 146.77 50.93 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.286 0.634 . . . . 0.0 110.829 175.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -143.25 -169.81 3.13 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.672 0.789 . . . . 0.0 110.909 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.0 pt . . . . . 0 CA--C 1.529 0.145 0 C-N-CA 124.181 0.993 . . . . 0.0 109.109 176.765 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 111.198 0.073 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -66.48 129.48 39.97 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.449 1.5 . . . . 0.0 112.137 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 p -135.15 89.33 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.281 0 C-N-CA 125.179 1.392 . . . . 0.0 108.435 -174.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.2 m -79.96 153.94 28.58 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.558 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.422 HD11 HG11 ' A' ' 55' ' ' VAL . 1.3 pp -139.51 159.28 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.0 tt -122.83 121.08 62.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.451 1.101 . . . . 0.0 110.204 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -116.09 115.74 26.62 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.747 1.619 . . . . 0.0 111.615 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.1 m-90 -93.82 120.45 34.1 Favored 'General case' 0 C--N 1.337 0.063 0 C-N-CA 125.724 1.61 . . . . 0.0 110.906 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.1 t -109.33 123.54 65.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 124.537 1.135 . . . . 0.0 108.937 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -101.32 178.58 4.61 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 124.277 1.031 . . . . 0.0 110.846 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.59 -160.11 48.79 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -85.09 96.08 9.32 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -171.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.4 t -128.56 -46.79 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 124.036 0.835 . . . . 0.0 109.853 -176.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -67.92 145.64 54.37 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 123.558 0.743 . . . . 0.0 111.269 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.26 25.58 72.74 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 123.914 0.769 . . . . 0.0 112.98 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.7 t -119.37 -48.24 3.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 124.865 1.266 . . . . 0.0 109.397 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.55 30.71 2.14 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.36 1.457 . . . . 0.0 111.392 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -55.14 -40.35 70.46 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 117.52 0.66 . . . . 0.0 109.913 173.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -89.57 23.68 2.54 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.756 1.222 . . . . 0.0 112.364 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -90.11 -57.61 2.79 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.794 0.838 . . . . 0.0 109.036 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 t -73.84 -13.82 60.99 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.003 0.921 . . . . 0.0 113.31 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.7 t -65.76 -26.77 67.87 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 118.399 0.545 . . . . 0.0 111.393 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -57.48 -53.96 52.22 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.099 0.96 . . . . 0.0 109.912 175.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.67 -49.64 72.39 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.129 0.972 . . . . 0.0 111.941 -175.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.59 -53.11 60.68 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.151 0.58 . . . . 0.0 110.835 174.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.23 -33.77 29.39 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.921 0.888 . . . . 0.0 112.647 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -63.88 -35.8 81.84 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.007 0.923 . . . . 0.0 111.72 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 -69.45 -43.73 72.71 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.694 0.797 . . . . 0.0 110.309 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.3 mt -74.7 -39.42 61.95 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.754 0.821 . . . . 0.0 111.144 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.02 16.21 72.89 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.29 0.947 . . . . 0.0 112.871 -177.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.13 172.85 10.31 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 117.575 0.688 . . . . 0.0 110.915 175.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.1 p -118.73 -162.76 0.92 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -174.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 124.18 -154.14 17.71 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 169.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -168.17 161.82 12.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.095 -0.553 . . . . 0.0 112.125 170.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.09 97.31 5.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.599 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.21 175.23 6.69 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.922 0.889 . . . . 0.0 110.603 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -123.73 138.01 54.59 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.208 1.003 . . . . 0.0 109.478 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.6 mt -76.5 172.57 12.75 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.081 1.352 . . . . 0.0 110.247 173.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -90.76 4.0 52.79 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.639 1.175 . . . . 0.0 112.184 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -108.88 -10.66 15.08 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.584 1.154 . . . . 0.0 112.397 -175.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.53 -4.44 12.04 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.274 1.416 . . . . 0.0 113.668 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.07 163.86 13.31 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.919 1.288 . . . . 0.0 111.96 -171.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.6 t -127.88 118.34 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.604 1.562 . . . . 0.0 110.723 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -100.66 119.83 39.16 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.919 0.888 . . . . 0.0 111.132 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.4 t -112.09 138.84 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.563 1.545 . . . . 0.0 109.316 -173.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 t -134.42 145.2 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.008 0.923 . . . . 0.0 109.895 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.58 137.9 12.76 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-O 118.513 -0.756 . . . . 0.0 111.604 -175.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 58.4 m -107.3 177.54 4.81 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.134 1.373 . . . . 0.0 112.442 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.31 -167.68 19.37 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -73.25 140.87 47.16 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.0 0.52 . . . . 0.0 109.741 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -53.3 -47.37 69.28 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.21 0.604 . . . . 0.0 109.799 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -46.02 -34.38 5.78 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 126.451 1.977 . . . . 0.0 114.63 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -84.61 -46.48 11.49 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.804 1.242 . . . . 0.0 111.135 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.422 HG11 HD11 ' A' ' 6' ' ' ILE . 40.5 t -59.02 -40.76 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 122.254 0.221 . . . . 0.0 110.667 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -61.51 -25.58 67.36 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.9 0.88 . . . . 0.0 111.91 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -57.41 -49.83 74.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.57 0.748 . . . . 0.0 110.998 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -73.98 -32.69 63.53 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 118.324 0.511 . . . . 0.0 110.615 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mmm -66.6 -23.03 66.13 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 118.742 -0.646 . . . . 0.0 111.341 -177.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -45.7 -49.66 14.38 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.877 0.762 . . . . 0.0 109.548 168.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -59.41 -43.98 92.93 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.461 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.345 0.401 0 CA-C-N 119.49 1.041 . . . . 0.0 111.533 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.2 t . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -64.42 -57.25 9.81 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.61 1.164 . . . . 0.0 110.979 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -154.07 153.31 31.66 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.789 0.836 . . . . 0.0 110.301 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.73 135.37 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 123.687 0.795 . . . . 0.0 111.097 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.5 tp -127.69 147.0 50.38 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.244 1.018 . . . . 0.0 112.506 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.32 141.24 50.6 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.416 1.087 . . . . 0.0 112.303 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -142.68 158.21 60.37 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 124.852 1.261 . . . . 0.0 111.922 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.51 129.47 16.86 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 124.28 3.32 . . . . 0.0 111.716 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -121.16 129.67 53.36 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.302 1.041 . . . . 0.0 110.684 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -131.81 71.77 80.33 Favored Pre-proline 0 CA--C 1.537 0.463 0 O-C-N 121.372 -0.83 . . . . 0.0 111.211 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.45 150.19 63.65 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.241 2.628 . . . . 0.0 111.11 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 75.4 p -73.73 140.23 45.84 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.681 0.792 . . . . 0.0 110.521 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.02 179.62 25.77 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 123.938 0.78 . . . . 0.0 112.131 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -98.28 131.28 44.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.938 0.895 . . . . 0.0 108.769 171.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tp -72.55 152.94 41.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.645 1.178 . . . . 0.0 109.514 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.45 -79.93 0.13 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.837 0.855 . . . . 0.0 108.998 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -134.8 163.71 29.2 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.161 0.984 . . . . 0.0 109.938 -171.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -73.62 146.61 44.49 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.196 0.598 . . . . 0.0 110.322 173.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -140.13 -171.05 3.1 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.039 0.936 . . . . 0.0 110.158 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.8 pt . . . . . 0 CA--C 1.534 0.349 0 C-N-CA 123.968 0.907 . . . . 0.0 109.956 179.699 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.531 0.214 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.89 111.17 4.19 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.747 0.819 . . . . 0.0 111.687 -170.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 p -112.78 79.46 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 125.708 1.603 . . . . 0.0 107.331 -174.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -76.0 144.66 40.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.474 -177.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.436 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.6 pp -117.0 163.01 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.5 tt -124.79 116.02 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 124.911 1.284 . . . . 0.0 108.228 170.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -116.04 102.51 9.7 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.633 1.173 . . . . 0.0 110.801 -173.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.2 m-90 -82.49 112.44 19.42 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.12 0.568 . . . . 0.0 109.478 176.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.6 t -91.74 106.9 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -63.75 -37.31 86.88 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.949 0.5 . . . . 0.0 111.773 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.04 165.27 7.19 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.001 1.286 . . . . 0.0 114.854 -174.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -79.87 72.4 6.61 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.522 1.129 . . . . 0.0 111.893 -174.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.3 t -100.5 -33.31 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 124.579 1.152 . . . . 0.0 111.223 -173.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -67.34 145.73 54.8 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.883 0.473 . . . . 0.0 110.693 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.62 24.49 72.45 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 123.993 0.806 . . . . 0.0 113.323 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.5 t -118.95 -40.78 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.416 1.086 . . . . 0.0 110.319 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.95 31.41 5.69 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.148 1.356 . . . . 0.0 112.05 -177.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -48.72 -33.01 9.36 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.388 1.875 . . . . 0.0 112.927 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -72.79 57.97 0.44 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.862 2.065 . . . . 0.0 111.95 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -108.22 -69.54 0.85 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.346 1.058 . . . . 0.0 109.542 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.6 t -96.22 5.57 50.73 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.342 1.057 . . . . 0.0 112.553 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.9 t -58.36 -35.62 72.23 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 122.008 -0.432 . . . . 0.0 111.31 170.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 -61.85 -58.91 6.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.445 1.098 . . . . 0.0 110.698 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -51.85 -55.35 20.51 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.69 0.796 . . . . 0.0 110.994 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -53.21 -54.43 36.18 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.536 0.734 . . . . 0.0 111.044 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.18 -32.92 56.84 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.915 0.886 . . . . 0.0 112.622 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -67.65 -32.92 73.94 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.961 0.504 . . . . 0.0 111.631 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 40.0 mtp85 -68.17 -48.12 66.16 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.386 0.539 . . . . 0.0 110.128 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.77 -30.54 59.16 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.289 0.636 . . . . 0.0 110.696 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.84 22.43 61.58 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.404 1.478 . . . . 0.0 113.352 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.418 HD22 ' C ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -81.43 167.21 19.64 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.621 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.0 p -127.84 140.78 51.82 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.477 1.511 . . . . 0.0 107.348 -171.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.04 -165.11 38.52 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.675 -1.25 . . . . 0.0 112.701 -165.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -169.34 156.44 6.87 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 171.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.61 84.6 2.05 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.646 1.178 . . . . 0.0 109.215 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -89.3 168.11 12.52 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 122.974 0.509 . . . . 0.0 110.339 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -127.31 133.36 50.13 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.646 0.778 . . . . 0.0 109.511 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.4 mt -71.2 168.21 17.74 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.12 0.968 . . . . 0.0 109.755 170.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -86.51 4.44 39.88 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.867 0.867 . . . . 0.0 111.593 175.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -90.52 -56.02 3.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.827 0.851 . . . . 0.0 109.225 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 162.64 -12.34 0.11 Allowed Glycine 0 CA--C 1.53 0.99 0 CA-C-N 114.827 -1.079 . . . . 0.0 113.192 -166.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.4 m -112.76 145.61 40.25 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.295 1.048 . . . . 0.0 112.388 -164.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 86.0 t -105.37 122.44 58.71 Favored 'Isoleucine or valine' 0 C--N 1.344 0.341 0 C-N-CA 124.759 1.224 . . . . 0.0 110.652 -173.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -94.64 103.17 15.11 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.547 1.539 . . . . 0.0 110.128 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.14 124.68 56.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.7 t -128.16 135.08 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.947 0.899 . . . . 0.0 109.428 -174.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.62 125.36 6.45 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.365 -169.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 95.2 m -88.86 -178.98 5.87 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.361 1.464 . . . . 0.0 112.018 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.15 -165.91 17.39 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -74.21 136.0 42.77 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -56.85 -46.09 82.0 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.294 0.638 . . . . 0.0 110.575 -174.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -47.28 -50.93 16.14 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.617 1.58 . . . . 0.0 112.56 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -62.2 -50.68 70.84 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.751 0.82 . . . . 0.0 111.294 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.3 t -55.44 -37.86 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.823 0.849 . . . . 0.0 111.12 178.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -59.11 -33.57 71.0 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.472 0.578 . . . . 0.0 111.942 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -58.12 -42.51 85.89 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.739 0.699 . . . . 0.0 112.469 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 pp -78.54 -28.19 46.04 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.928 0.785 . . . . 0.0 111.32 175.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 7.9 mmm -67.14 -34.18 77.03 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 118.425 -0.797 . . . . 0.0 111.021 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -42.25 -53.37 4.13 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 168.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -65.49 -39.97 92.55 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 118.647 -0.692 . . . . 0.0 112.261 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 42.8 mt . . . . . 0 C--N 1.35 0.616 0 CA-C-N 119.813 1.188 . . . . 0.0 109.72 178.653 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.8 t . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.12 -64.42 0.86 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.126 0.97 . . . . 0.0 110.5 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.53 155.84 17.82 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.532 1.133 . . . . 0.0 109.169 -173.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -129.62 123.1 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.995 1.318 . . . . 0.0 109.259 -176.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.3 tp -99.72 106.87 18.83 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.1 m -99.93 130.03 46.07 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.095 0.558 . . . . 0.0 111.401 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -130.62 164.53 40.87 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 127.585 2.354 . . . . 0.0 108.469 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.05 129.29 10.45 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.089 2.526 . . . . 0.0 111.111 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -110.4 106.66 16.09 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.741 1.216 . . . . 0.0 109.979 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -106.63 86.99 2.48 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 118.635 0.652 . . . . 0.0 111.296 177.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.91 167.29 22.33 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.107 2.538 . . . . 0.0 110.829 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.5 m -87.77 129.59 35.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.012 0.925 . . . . 0.0 109.498 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.09 -177.94 27.31 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.941 0.781 . . . . 0.0 112.509 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -100.9 126.73 47.54 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.645 1.178 . . . . 0.0 109.467 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.7 tp -72.74 143.13 48.11 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 170.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.6 p -73.43 -63.39 1.2 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.238 1.015 . . . . 0.0 111.444 -171.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -132.26 166.47 21.82 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.054 1.341 . . . . 0.0 110.087 -174.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -82.3 144.64 30.46 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.083 0.553 . . . . 0.0 109.744 168.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -155.37 178.91 9.68 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 123.069 0.547 . . . . 0.0 109.759 176.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.128 0 C-N-CA 123.106 0.562 . . . . 0.0 110.626 177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 110.785 -0.08 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.24 155.11 39.67 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.235 1.014 . . . . 0.0 113.054 -176.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.34 90.99 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.304 1.042 . . . . 0.0 108.304 -174.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.7 m -78.87 153.39 30.6 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.471 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.68 149.4 18.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -176.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 tt -107.54 128.2 62.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 123.771 0.828 . . . . 0.0 109.704 176.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -121.97 101.21 7.42 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.058 1.743 . . . . 0.0 109.895 -176.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -86.37 123.52 31.7 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 124.772 1.229 . . . . 0.0 110.459 177.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.12 119.6 59.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.296 1.038 . . . . 0.0 109.292 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -92.22 175.17 6.95 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.011 1.324 . . . . 0.0 110.712 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.17 -167.52 53.43 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -84.67 84.24 7.75 Favored 'General case' 0 CA--C 1.523 -0.089 0 C-N-CA 123.083 0.553 . . . . 0.0 111.723 -169.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.94 -46.92 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 124.034 0.934 . . . . 0.0 109.442 -174.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -69.25 146.79 52.02 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-O 121.007 0.432 . . . . 0.0 111.365 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.15 20.92 73.46 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.209 0.909 . . . . 0.0 113.354 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.1 t -105.32 -42.42 7.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 C-N-CA 124.48 1.112 . . . . 0.0 109.242 175.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.48 29.07 2.81 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.653 1.597 . . . . 0.0 111.202 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -51.84 -36.55 48.61 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.483 1.113 . . . . 0.0 111.597 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.88 58.2 0.83 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.306 1.442 . . . . 0.0 112.423 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -107.24 -74.58 0.65 Allowed 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.562 1.145 . . . . 0.0 109.39 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.6 t -74.84 -18.48 60.44 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.633 -0.699 . . . . 0.0 112.002 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.4 t -43.82 -40.96 4.74 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.925 0.89 . . . . 0.0 112.286 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -67.04 -59.02 3.83 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.753 1.221 . . . . 0.0 109.675 175.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -52.76 -57.18 10.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.597 1.159 . . . . 0.0 111.343 -175.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -55.86 -51.03 68.95 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.568 0.747 . . . . 0.0 110.497 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.74 -36.55 62.43 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.807 0.443 . . . . 0.0 111.985 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -64.34 -30.97 72.0 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.365 0.666 . . . . 0.0 111.895 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 mmm-85 -67.75 -50.52 56.78 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.119 0.568 . . . . 0.0 110.597 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.9 mp -70.99 -30.05 66.19 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.827 0.451 . . . . 0.0 110.665 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.78 18.43 78.91 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.054 0.835 . . . . 0.0 112.483 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.52 175.03 10.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.705 0.802 . . . . 0.0 110.991 176.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.3 p -117.45 -161.65 0.83 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -173.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.46 -155.54 16.49 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 169.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -169.73 160.05 8.48 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 172.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.84 94.39 4.38 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.826 1.251 . . . . 0.0 110.21 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.3 174.5 6.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.506 0.722 . . . . 0.0 111.355 176.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -122.6 139.41 53.95 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.044 0.938 . . . . 0.0 109.715 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.8 mt -76.0 174.64 9.73 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 125.468 1.507 . . . . 0.0 110.258 173.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -98.67 11.7 37.72 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.968 1.307 . . . . 0.0 111.593 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -118.19 -4.54 10.96 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.806 1.242 . . . . 0.0 111.868 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.96 14.15 9.53 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.947 1.26 . . . . 0.0 114.483 176.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.8 168.57 10.1 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.504 1.522 . . . . 0.0 111.937 -170.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 73.1 t -130.7 120.99 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.312 1.045 . . . . 0.0 111.44 -174.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -101.98 118.04 36.09 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.081 0.952 . . . . 0.0 110.997 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.5 t -112.47 137.6 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 123.631 0.773 . . . . 0.0 110.027 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.22 144.31 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.689 0.796 . . . . 0.0 109.886 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.06 132.05 8.92 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-O 118.52 -0.753 . . . . 0.0 111.294 -174.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 89.7 m -100.43 -179.56 4.14 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.804 1.242 . . . . 0.0 112.365 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.2 -161.8 20.81 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -75.05 126.36 30.85 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 122.793 0.437 . . . . 0.0 110.096 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -49.18 -50.63 37.07 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 124.142 0.977 . . . . 0.0 110.594 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -48.16 -40.21 21.08 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.92 1.724 . . . . 0.0 113.652 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -77.57 -48.54 16.7 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.776 0.83 . . . . 0.0 111.132 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.0 -39.94 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 122.715 0.406 . . . . 0.0 111.114 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -61.77 -27.27 68.62 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -59.25 -48.12 82.8 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.193 0.451 . . . . 0.0 110.469 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.46 -30.74 63.37 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.889 0.313 . . . . 0.0 111.302 178.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mmt -67.55 -20.07 65.36 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-O 118.913 -0.565 . . . . 0.0 112.415 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -46.13 -50.98 14.83 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 168.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -61.27 -41.85 97.65 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 C--N 1.344 0.35 0 C-N-CA 123.812 0.845 . . . . 0.0 110.6 -179.781 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.7 t . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -60.7 -65.58 0.67 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.089 0.556 . . . . 0.0 109.892 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.6 mtm-85 -150.56 156.29 41.11 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.539 1.135 . . . . 0.0 109.6 -176.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.3 t -137.82 130.15 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 123.715 0.806 . . . . 0.0 110.522 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tp -113.38 135.35 53.96 Favored 'General case' 0 C--N 1.346 0.448 0 C-N-CA 125.21 1.404 . . . . 0.0 112.058 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.55 137.31 54.93 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.314 1.045 . . . . 0.0 111.985 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -145.27 159.06 50.17 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.645 1.178 . . . . 0.0 111.68 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.92 136.53 25.22 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.967 3.111 . . . . 0.0 111.666 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -127.13 125.43 41.18 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.672 1.189 . . . . 0.0 111.106 -175.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -129.7 70.91 82.16 Favored Pre-proline 0 CA--C 1.535 0.403 0 O-C-N 121.696 -0.627 . . . . 0.0 111.37 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.63 142.31 35.9 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.894 2.396 . . . . 0.0 110.776 -176.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.5 p -70.82 140.97 51.35 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.663 0.785 . . . . 0.0 110.85 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.99 173.04 23.95 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.106 0.86 . . . . 0.0 111.638 -175.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -96.1 135.34 38.03 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -76.25 151.99 36.65 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.3 m -80.88 -76.73 0.23 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -177.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -134.47 165.76 24.45 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.717 1.207 . . . . 0.0 110.223 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -72.88 149.79 43.17 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.711 0.804 . . . . 0.0 110.353 172.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -151.24 -169.54 3.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.005 0.922 . . . . 0.0 110.002 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.8 pt . . . . . 0 CA--C 1.533 0.29 0 C-N-CA 124.271 1.028 . . . . 0.0 109.542 176.943 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.456 -0.174 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.05 144.22 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.909 1.684 . . . . 0.0 111.672 176.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 p -139.44 88.2 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.199 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.7 m -81.7 152.78 26.91 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.403 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.5 146.76 19.27 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -176.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 tt -109.36 122.29 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 124.271 1.029 . . . . 0.0 109.877 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.55 116.56 28.99 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.971 1.308 . . . . 0.0 111.024 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.7 m-90 -96.56 121.99 38.99 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.768 0.827 . . . . 0.0 110.16 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.545 HG12 HG21 ' A' ' 14' ' ' VAL . 5.6 t -104.5 115.32 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.397 1.079 . . . . 0.0 108.848 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -87.49 178.56 6.77 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.76 1.224 . . . . 0.0 111.453 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.29 -159.71 50.46 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -88.37 99.49 12.29 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.114 -174.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.545 HG21 HG12 ' A' ' 10' ' ' VAL . 21.7 t -130.74 -43.71 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 123.441 0.697 . . . . 0.0 109.756 -177.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -70.4 143.77 51.76 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.596 0.758 . . . . 0.0 109.969 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.6 18.61 79.7 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 119.26 -0.745 . . . . 0.0 113.31 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 83.5 t -107.52 -43.63 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.577 1.151 . . . . 0.0 109.527 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 116.35 28.5 2.56 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 125.187 1.375 . . . . 0.0 111.446 -177.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -50.93 -32.71 21.6 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 123.627 0.771 . . . . 0.0 111.192 176.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -76.51 58.71 1.38 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.838 0.855 . . . . 0.0 112.764 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -95.18 -70.32 0.72 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 t -92.85 -2.54 55.8 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.496 -0.764 . . . . 0.0 111.656 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 t -45.48 -36.93 4.81 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.095 0.861 . . . . 0.0 112.403 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -73.72 -60.31 2.31 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.266 1.026 . . . . 0.0 109.806 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -50.3 -59.14 4.26 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.271 1.028 . . . . 0.0 111.002 -175.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.9 -53.28 34.06 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 125.589 1.556 . . . . 0.0 110.057 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.49 -37.84 70.93 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.618 0.367 . . . . 0.0 111.732 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.3 tttm -61.87 -31.72 72.02 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.249 1.019 . . . . 0.0 111.7 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.26 -52.32 48.71 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.261 0.624 . . . . 0.0 110.946 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 57' ' ' LYS . 34.6 mt -72.23 -31.11 65.54 Favored 'General case' 0 CA--C 1.528 0.124 0 O-C-N 122.849 0.093 . . . . 0.0 110.812 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.66 6.94 82.48 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.064 0.84 . . . . 0.0 112.596 -178.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.15 178.14 2.93 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.817 0.808 . . . . 0.0 111.326 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 43.7 p -125.79 -169.05 1.94 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -175.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 130.85 -151.49 19.62 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 171.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -170.91 167.48 7.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.438 -0.381 . . . . 0.0 111.421 173.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.46 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -131.69 97.07 4.11 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.793 0.683 . . . . 0.0 111.435 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.4 mttp -93.28 174.01 7.43 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.969 1.308 . . . . 0.0 110.142 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -124.24 135.25 53.28 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.431 1.092 . . . . 0.0 109.628 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.8 mt -74.95 171.82 13.38 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.077 1.351 . . . . 0.0 109.847 177.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -93.66 4.96 53.13 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.587 0.755 . . . . 0.0 111.571 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -107.25 -14.53 14.87 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.64 1.176 . . . . 0.0 111.724 -177.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.92 7.6 8.53 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.015 1.293 . . . . 0.0 113.91 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.9 168.68 8.97 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.946 1.298 . . . . 0.0 111.336 -172.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.0 t -129.01 120.25 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.391 1.077 . . . . 0.0 110.549 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -95.71 127.16 41.5 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.82 0.848 . . . . 0.0 110.232 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.27 136.22 58.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 124.389 1.075 . . . . 0.0 109.525 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.24 143.37 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 124.012 0.925 . . . . 0.0 109.356 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.69 138.23 15.98 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 118.856 -0.592 . . . . 0.0 110.668 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 61.5 m -103.0 178.5 4.54 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.867 1.267 . . . . 0.0 111.435 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.94 -159.82 18.03 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -78.76 132.54 36.97 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 124.965 1.306 . . . . 0.0 109.408 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -46.84 -55.9 7.18 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.491 1.116 . . . . 0.0 110.683 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -49.99 -43.87 40.84 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.238 1.399 . . . . 0.0 112.767 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -67.07 -46.43 74.35 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.295 1.038 . . . . 0.0 111.187 176.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 77.4 t -54.05 -41.17 49.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.163 0.585 . . . . 0.0 110.408 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.24 -26.97 68.11 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.418 ' HB2' HD21 ' A' ' 30' ' ' LEU . 29.4 mmmt -59.77 -27.12 66.26 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.259 1.024 . . . . 0.0 112.712 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.02 -29.81 13.43 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.48 0.582 . . . . 0.0 110.774 172.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.449 ' HA ' HD12 ' A' ' 62' ' ' LEU . 2.2 mmt -62.72 -23.56 67.22 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-O 118.722 -0.656 . . . . 0.0 111.418 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.48 -57.62 3.97 Favored 'General case' 0 C--O 1.248 0.985 0 C-N-CA 122.966 0.506 . . . . 0.0 110.027 173.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -65.31 -32.34 73.94 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 118.656 0.662 . . . . 0.0 112.07 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 59' ' ' MET . 12.7 mt . . . . . 0 C--N 1.349 0.575 0 CA-C-N 119.054 0.843 . . . . 0.0 109.832 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 87.8 t . . . . . 0 CA--C 1.529 0.138 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -63.05 -61.75 2.17 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.378 0.671 . . . . 0.0 109.31 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.9 mmm-85 -152.19 161.53 42.48 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.046 1.339 . . . . 0.0 109.801 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.1 t -142.24 140.38 29.28 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 124.202 1.001 . . . . 0.0 109.754 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.4 tp -129.14 157.32 42.11 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.816 0.847 . . . . 0.0 111.108 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.91 129.77 26.38 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.079 0.951 . . . . 0.0 111.221 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.31 158.83 73.16 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.112 1.365 . . . . 0.0 110.424 -177.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -71.66 130.51 17.16 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.517 3.478 . . . . 0.0 110.834 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -119.24 117.52 28.83 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.626 1.17 . . . . 0.0 109.767 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -125.55 68.2 59.76 Favored Pre-proline 0 CA--C 1.535 0.367 0 O-C-N 121.873 -0.517 . . . . 0.0 110.546 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.47 140.99 37.56 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.411 2.741 . . . . 0.0 110.432 -175.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.6 p -72.4 145.07 47.94 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.427 0.691 . . . . 0.0 110.797 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.66 170.35 3.95 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.381 0.991 . . . . 0.0 112.131 -176.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -92.21 138.13 31.79 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.8 tp -80.96 152.13 28.17 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 99.5 m -75.26 -73.96 0.23 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -146.54 167.38 23.86 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.396 0.678 . . . . 0.0 110.859 -176.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -70.39 144.72 51.48 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.951 0.501 . . . . 0.0 110.388 176.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -145.48 -176.78 5.25 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 122.999 0.52 . . . . 0.0 110.562 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.46 HD12 ' HB3' ' A' ' 36' ' ' ALA . 6.5 tt . . . . . 0 N--CA 1.45 -0.441 0 C-N-CA 123.305 0.642 . . . . 0.0 109.362 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.311 0 N-CA-C 110.608 -0.145 . . . . 0.0 110.608 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.6 159.08 13.82 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.427 1.091 . . . . 0.0 112.496 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.0 p -143.83 89.63 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.6 m -75.55 153.71 37.24 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.76 174.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pp -143.13 155.82 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 123.068 0.547 . . . . 0.0 110.064 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.5 tp -112.84 118.55 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 125.004 1.322 . . . . 0.0 108.739 177.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -113.36 111.09 21.41 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.09 0.956 . . . . 0.0 110.384 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -92.41 121.02 33.47 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.801 0.84 . . . . 0.0 110.287 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.538 HG12 HG21 ' A' ' 14' ' ' VAL . 3.0 t -104.98 120.03 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.436 1.095 . . . . 0.0 108.932 -177.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -95.27 176.39 6.23 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.309 1.044 . . . . 0.0 111.559 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.25 -156.39 48.63 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.5 mtt-85 -87.96 93.16 9.39 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 123.417 0.687 . . . . 0.0 111.85 -173.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.538 HG21 HG12 ' A' ' 10' ' ' VAL . 16.9 t -127.41 -45.88 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.205 1.002 . . . . 0.0 109.974 -175.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -70.68 141.83 51.59 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.35 0.66 . . . . 0.0 110.1 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.67 15.09 80.2 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.104 -0.831 . . . . 0.0 113.371 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.1 t -111.98 -44.28 5.1 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 C-N-CA 124.561 1.145 . . . . 0.0 109.764 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.56 23.01 2.94 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.262 1.41 . . . . 0.0 111.893 -176.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -59.32 -25.34 64.08 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 117.785 0.792 . . . . 0.0 111.988 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.74 30.62 4.25 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.584 1.554 . . . . 0.0 111.687 175.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -94.46 -61.21 1.55 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.76 0.709 . . . . 0.0 109.383 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.9 t -78.21 -1.7 34.12 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 t -59.58 -26.74 65.67 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.057 0.543 . . . . 0.0 111.299 173.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -70.95 -55.64 7.93 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.224 0.61 . . . . 0.0 110.728 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -52.37 -57.03 11.07 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.027 0.531 . . . . 0.0 111.177 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -47.05 73.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.263 0.625 . . . . 0.0 110.414 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.43 -29.69 50.15 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.8 tttm -69.53 -31.53 69.81 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.231 1.012 . . . . 0.0 111.802 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.8 mmm-85 -72.84 -37.2 67.51 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.018 0.927 . . . . 0.0 111.06 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -85.9 -30.18 23.06 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.909 0.884 . . . . 0.0 111.506 178.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.67 21.21 79.63 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.47 0.557 . . . . 0.0 112.374 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.45 HD12 ' HB1' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -79.58 178.02 8.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.961 0.904 . . . . 0.0 111.111 177.575 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.3 p -123.18 -164.22 1.19 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -175.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.2 -151.53 18.14 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 171.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -169.22 162.91 10.83 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.05 99.79 6.41 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.1 0.96 . . . . 0.0 111.477 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -100.06 172.85 6.94 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.717 1.207 . . . . 0.0 110.936 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -124.12 135.17 53.34 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.796 1.239 . . . . 0.0 108.753 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.443 HD12 ' HB2' ' A' ' 43' ' ' SER . 21.8 mt -75.64 173.0 11.63 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.015 1.326 . . . . 0.0 110.08 175.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -95.3 8.1 44.18 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.053 0.941 . . . . 0.0 111.729 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -111.58 -2.6 15.38 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.899 1.28 . . . . 0.0 112.137 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.99 7.21 31.42 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.94 1.257 . . . . 0.0 113.949 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.443 ' HB2' HD12 ' A' ' 39' ' ' LEU . 75.4 m -102.92 165.82 10.81 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.513 1.525 . . . . 0.0 111.127 -173.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 91.4 t -128.57 122.77 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.688 1.195 . . . . 0.0 110.524 -177.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -99.32 123.43 43.59 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 124.187 0.995 . . . . 0.0 110.947 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.9 t -121.23 133.44 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.182 0.593 . . . . 0.0 109.631 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.9 t -126.01 142.79 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 124.646 1.178 . . . . 0.0 109.45 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.45 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -154.36 132.86 12.04 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 118.607 -0.711 . . . . 0.0 111.158 -175.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.42 178.64 4.69 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 175.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.96 -157.69 20.64 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.789 1.185 . . . . 0.0 110.201 178.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -75.94 122.43 24.16 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.67 1.188 . . . . 0.0 109.572 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -45.84 -51.82 12.32 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.472 1.109 . . . . 0.0 111.071 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.29 -47.35 56.12 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.483 1.516 . . . . 0.0 113.129 177.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -65.44 -47.76 75.06 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.395 0.598 . . . . 0.0 110.299 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.5 t -57.56 -33.06 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 122.723 0.409 . . . . 0.0 110.751 176.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.48 -32.28 73.16 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.941 0.896 . . . . 0.0 112.949 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -56.64 -27.48 58.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.004 0.922 . . . . 0.0 112.461 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.36 -30.97 13.1 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 118.622 0.646 . . . . 0.0 111.289 173.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.479 ' HA ' HD12 ' A' ' 62' ' ' LEU . 2.3 mmm -63.6 -22.45 66.9 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-O 118.624 -0.703 . . . . 0.0 112.444 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -44.27 -55.9 4.55 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.335 0.516 . . . . 0.0 110.254 173.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -61.92 -41.92 98.5 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.147 0.579 . . . . 0.0 111.782 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 59' ' ' MET . 11.4 mt . . . . . 0 C--N 1.346 0.422 0 C-N-CA 123.785 0.834 . . . . 0.0 109.707 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.6 t . . . . . 0 CA--C 1.532 0.259 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.43 -50.89 71.57 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.251 0.621 . . . . 0.0 111.108 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -169.04 153.42 5.57 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 123.396 0.678 . . . . 0.0 109.623 -177.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.5 t -141.96 134.76 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.138 0.575 . . . . 0.0 109.537 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.5 tp -120.43 156.14 32.05 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.976 0.91 . . . . 0.0 110.928 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.12 129.5 27.68 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.853 0.861 . . . . 0.0 110.873 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -132.73 154.93 81.65 Favored Pre-proline 0 CA--C 1.539 0.558 0 C-N-CA 124.499 1.12 . . . . 0.0 110.14 -177.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.89 125.63 11.75 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 124.857 3.704 . . . . 0.0 111.067 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -117.16 127.31 54.0 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.721 0.809 . . . . 0.0 110.844 -178.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -133.63 70.49 75.91 Favored Pre-proline 0 CA--C 1.536 0.42 0 O-C-N 121.526 -0.734 . . . . 0.0 110.495 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.15 136.88 35.8 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 124.057 3.171 . . . . 0.0 109.984 -177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.6 p -61.48 143.76 55.36 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.642 0.777 . . . . 0.0 111.101 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.95 171.02 5.69 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.079 0.847 . . . . 0.0 112.112 -175.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -89.0 135.74 33.39 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mp -74.13 150.09 40.67 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.303 0.641 . . . . 0.0 109.678 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.61 -77.96 0.2 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.349 1.059 . . . . 0.0 108.625 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -143.78 164.71 29.73 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.613 0.765 . . . . 0.0 110.944 -174.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -70.96 144.86 50.39 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.973 0.509 . . . . 0.0 110.357 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -137.81 -179.35 5.71 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 124.101 0.961 . . . . 0.0 110.403 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.9 tt . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -177.189 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.535 0.368 0 CA-C-O 119.821 -0.133 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.13 134.4 49.28 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.267 1.027 . . . . 0.0 111.557 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 p -140.63 94.98 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 C-N-CA 124.551 1.141 . . . . 0.0 108.484 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.4 m -92.75 153.88 18.64 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.933 -177.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pp -143.6 156.46 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -174.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 tt -116.37 119.26 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.148 0.979 . . . . 0.0 109.418 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -109.9 108.33 18.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.88 1.272 . . . . 0.0 109.951 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -91.76 123.04 34.85 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.991 0.916 . . . . 0.0 110.235 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.421 HG12 HG21 ' A' ' 14' ' ' VAL . 12.9 t -99.15 108.52 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.586 1.155 . . . . 0.0 108.768 -178.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -73.26 177.49 5.1 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.815 0.846 . . . . 0.0 111.426 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.95 -169.4 42.66 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 177.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -92.01 92.04 8.11 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.798 0.439 . . . . 0.0 110.881 -175.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.421 HG21 HG12 ' A' ' 10' ' ' VAL . 58.8 t -114.28 -31.06 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.101 0.96 . . . . 0.0 110.909 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -70.67 148.43 48.05 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.895 0.316 . . . . 0.0 110.52 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.75 22.81 54.95 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 123.753 0.692 . . . . 0.0 112.954 176.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.8 t -116.06 -48.97 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 C-N-CA 124.884 1.273 . . . . 0.0 109.41 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.67 32.29 1.23 Allowed Glycine 0 C--N 1.339 0.714 0 C-N-CA 125.251 1.405 . . . . 0.0 111.512 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -50.44 -36.81 34.96 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 123.848 0.859 . . . . 0.0 111.434 177.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.05 55.3 0.71 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.64 1.176 . . . . 0.0 112.058 177.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -94.54 -73.64 0.57 Allowed 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.337 0.655 . . . . 0.0 109.277 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.9 t -89.0 -1.59 58.18 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.435 0.694 . . . . 0.0 111.642 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.9 t -47.51 -36.93 11.03 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.752 0.821 . . . . 0.0 112.294 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -55.96 6.64 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.442 1.097 . . . . 0.0 110.508 176.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -53.79 -54.15 42.27 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.677 0.791 . . . . 0.0 110.678 -176.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.15 -48.13 68.21 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.233 1.013 . . . . 0.0 110.515 177.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.42 -26.44 53.54 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -73.55 -28.28 61.79 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.806 0.843 . . . . 0.0 111.942 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.9 mtp85 -71.91 -41.89 67.38 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.321 1.049 . . . . 0.0 110.119 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -86.51 -52.67 5.43 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.558 0.743 . . . . 0.0 111.413 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.54 8.51 46.14 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.206 0.907 . . . . 0.0 112.995 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.15 167.57 2.31 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.969 0.884 . . . . 0.0 111.674 174.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.7 p -128.09 155.37 44.51 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.87 -147.95 17.38 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -169.35 166.27 10.48 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 173.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.4 100.73 5.46 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.803 0.841 . . . . 0.0 111.678 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -105.44 179.26 4.32 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.612 1.165 . . . . 0.0 110.835 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -123.51 138.99 54.46 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.673 1.189 . . . . 0.0 109.089 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.79 177.84 4.58 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.424 1.09 . . . . 0.0 110.349 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -101.14 13.31 35.54 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.296 1.038 . . . . 0.0 111.18 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -117.53 -15.46 10.24 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.863 1.265 . . . . 0.0 111.891 -177.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.0 5.66 8.02 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.012 1.292 . . . . 0.0 114.215 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 m -106.17 169.6 8.41 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.535 1.534 . . . . 0.0 111.564 -172.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.7 t -126.8 127.31 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.952 0.901 . . . . 0.0 110.448 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -105.06 122.24 45.46 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 123.725 0.81 . . . . 0.0 110.951 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.73 139.05 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 123.116 0.566 . . . . 0.0 109.632 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.2 t -130.22 142.6 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 124.276 1.031 . . . . 0.0 109.234 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.33 139.92 20.65 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.465 -176.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -111.64 -179.63 3.76 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.15 1.78 . . . . 0.0 110.911 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.43 -155.05 24.69 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.85 130.57 35.12 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 117.593 0.696 . . . . 0.0 110.179 -178.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -48.63 -50.39 33.04 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.399 1.08 . . . . 0.0 111.006 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.95 -52.15 31.8 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.143 1.354 . . . . 0.0 112.335 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -61.94 -46.62 88.53 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.084 0.954 . . . . 0.0 110.601 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.9 t -56.79 -41.84 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 122.319 0.247 . . . . 0.0 110.868 176.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -60.69 -26.59 67.24 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -60.64 -28.7 68.76 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.046 0.939 . . . . 0.0 112.401 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.0 -29.7 13.5 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.001 0.521 . . . . 0.0 111.0 174.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.4 mmt -64.15 -21.42 66.55 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.99 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -46.9 -59.05 3.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 118.37 0.532 . . . . 0.0 110.167 173.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -63.02 -33.35 75.23 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.571 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt . . . . . 0 CA--C 1.535 0.4 0 CA-C-N 119.221 0.918 . . . . 0.0 110.035 178.242 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 64.6 t . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.35 -57.48 12.12 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.606 0.762 . . . . 0.0 110.027 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -165.66 172.88 11.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.286 1.034 . . . . 0.0 109.863 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.74 125.16 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.878 0.871 . . . . 0.0 109.663 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.86 155.85 18.91 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.609 1.163 . . . . 0.0 110.784 177.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.18 129.39 27.39 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.293 1.037 . . . . 0.0 111.113 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.37 156.59 79.61 Favored Pre-proline 0 N--CA 1.47 0.563 0 C-N-CA 124.714 1.206 . . . . 0.0 110.429 -177.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.87 124.41 11.01 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 124.873 3.715 . . . . 0.0 111.052 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -116.45 119.07 34.46 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.085 0.954 . . . . 0.0 110.895 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -124.9 69.68 57.93 Favored Pre-proline 0 CA--C 1.535 0.373 0 O-C-N 121.526 -0.733 . . . . 0.0 110.83 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.06 141.11 43.16 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.248 2.632 . . . . 0.0 110.492 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.4 m -69.81 143.36 52.94 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.587 0.755 . . . . 0.0 110.572 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.76 169.43 4.63 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.14 0.876 . . . . 0.0 112.041 -176.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -92.48 135.1 34.34 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.7 tp -78.87 150.49 32.2 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.75 -77.32 0.11 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -141.11 163.78 32.05 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.08 0.952 . . . . 0.0 110.023 -173.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -71.12 146.53 49.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.15 0.58 . . . . 0.0 110.767 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -140.56 -171.11 3.15 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.336 1.055 . . . . 0.0 110.437 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.8 pp . . . . . 0 CA--C 1.53 0.191 0 C-N-CA 124.55 1.14 . . . . 0.0 109.619 179.699 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.5 m . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 110.701 -0.111 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.26 136.03 56.11 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.84 1.256 . . . . 0.0 112.095 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 p -141.04 91.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.271 0 C-N-CA 124.576 1.151 . . . . 0.0 108.511 -174.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.4 m -81.58 156.48 25.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.7 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.451 HD11 HG11 ' A' ' 55' ' ' VAL . 1.3 pp -143.7 159.37 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 tt -118.45 118.04 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.665 1.186 . . . . 0.0 109.276 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -108.81 108.51 19.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.898 1.279 . . . . 0.0 110.341 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -90.77 124.3 35.02 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.908 0.883 . . . . 0.0 110.188 177.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.451 HG12 HG21 ' A' ' 14' ' ' VAL . 4.2 t -106.15 124.59 61.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.919 1.288 . . . . 0.0 108.379 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -96.32 179.8 4.91 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.134 1.374 . . . . 0.0 110.589 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.31 -166.09 51.01 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.1 mtt180 -86.72 93.64 9.3 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 122.696 0.398 . . . . 0.0 111.652 -171.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.451 HG21 HG12 ' A' ' 10' ' ' VAL . 18.4 t -123.25 -41.44 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 123.676 0.79 . . . . 0.0 110.398 -174.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -69.74 144.47 52.74 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.042 0.537 . . . . 0.0 109.902 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.9 12.72 83.13 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.949 -0.917 . . . . 0.0 113.578 178.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.5 t -108.76 -49.21 7.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 CA-C-N 118.374 1.087 . . . . 0.0 109.682 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.01 29.4 1.51 Allowed Glycine 0 C--N 1.338 0.663 0 C-N-CA 124.476 1.036 . . . . 0.0 112.031 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -51.66 -36.21 45.37 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.005 0.903 . . . . 0.0 111.183 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.47 56.08 0.66 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.028 1.331 . . . . 0.0 112.069 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -107.87 -71.54 0.75 Allowed 'General case' 0 C--N 1.34 0.174 0 C-N-CA 124.832 1.253 . . . . 0.0 109.47 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.6 t -70.95 -21.62 62.32 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.009 0.524 . . . . 0.0 111.486 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.4 t -47.1 -38.13 10.9 Favored 'General case' 0 C--N 1.345 0.408 0 C-N-CA 123.683 0.793 . . . . 0.0 111.695 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -69.93 -56.47 6.94 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.127 0.971 . . . . 0.0 110.189 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -51.99 -56.84 11.76 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.098 0.959 . . . . 0.0 111.018 -176.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -56.47 -51.54 68.07 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 123.367 0.667 . . . . 0.0 110.23 178.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.38 -30.13 50.97 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.088 0.555 . . . . 0.0 112.439 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -64.57 -36.57 84.67 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.649 0.779 . . . . 0.0 111.192 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -72.38 -48.92 37.84 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.334 1.054 . . . . 0.0 110.256 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.1 mp -67.88 -38.21 82.75 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.964 0.906 . . . . 0.0 110.746 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.23 12.85 83.51 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 123.874 0.749 . . . . 0.0 112.684 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.421 HD12 ' HB1' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -68.68 177.59 2.44 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.805 0.842 . . . . 0.0 110.92 176.329 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.0 p -121.91 -165.7 1.3 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.37 -151.92 16.9 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 171.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -171.77 164.65 6.56 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 123.817 0.363 . . . . 0.0 111.727 173.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.21 90.3 3.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.009 0.924 . . . . 0.0 111.898 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -92.38 178.64 5.77 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 124.534 1.134 . . . . 0.0 110.897 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -121.71 140.73 51.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.293 1.037 . . . . 0.0 110.029 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.7 mt -73.94 174.95 7.83 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.842 1.257 . . . . 0.0 110.304 174.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -99.76 13.12 34.8 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.394 1.078 . . . . 0.0 111.442 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -119.25 -9.05 10.02 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.339 1.056 . . . . 0.0 112.148 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.13 24.76 4.08 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.917 1.246 . . . . 0.0 114.159 176.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.89 170.4 11.12 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.247 1.419 . . . . 0.0 111.482 -172.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.1 t -129.79 127.31 63.95 Favored 'Isoleucine or valine' 0 C--N 1.346 0.443 0 C-N-CA 123.836 0.855 . . . . 0.0 110.6 -175.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -108.46 123.2 48.51 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.577 0.751 . . . . 0.0 110.031 -177.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.4 t -117.14 136.39 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 123.778 0.831 . . . . 0.0 109.11 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -129.53 144.26 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 124.221 1.009 . . . . 0.0 108.997 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.421 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -155.43 141.4 18.24 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 118.695 -0.669 . . . . 0.0 110.616 -176.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.6 m -111.47 179.88 3.9 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.868 1.267 . . . . 0.0 111.784 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.04 -161.32 23.43 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.79 123.64 25.95 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.152 0.981 . . . . 0.0 110.576 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.73 -46.55 59.14 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.038 0.935 . . . . 0.0 110.108 -176.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -44.61 -41.81 7.13 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 126.057 1.789 . . . . 0.0 113.332 177.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -78.78 -50.74 10.82 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.462 0.705 . . . . 0.0 110.651 174.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 6' ' ' ILE . 59.8 t -49.96 -40.76 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 118.441 0.564 . . . . 0.0 111.747 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.16 -30.8 69.56 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.71 1.604 . . . . 0.0 112.178 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -56.4 -40.79 75.24 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 124.46 1.104 . . . . 0.0 110.819 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.36 -30.53 27.35 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.672 0.669 . . . . 0.0 111.093 175.152 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.5 mmt -63.91 -20.18 65.65 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 118.586 -0.721 . . . . 0.0 112.02 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -45.56 -51.61 11.67 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.504 0.593 . . . . 0.0 110.411 174.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -62.29 -40.39 96.09 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.855 0.862 . . . . 0.0 111.965 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.4 mt . . . . . 0 N--CA 1.467 0.41 0 C-N-CA 123.957 0.903 . . . . 0.0 110.377 178.388 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.4 t . . . . . 0 CA--C 1.531 0.227 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -69.71 -54.57 13.17 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.942 0.897 . . . . 0.0 110.195 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -156.81 163.67 38.95 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.65 0.78 . . . . 0.0 110.252 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.55 138.64 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.889 0.876 . . . . 0.0 109.835 -178.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.05 156.63 34.49 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.57 1.148 . . . . 0.0 110.991 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.51 129.14 26.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.035 0.934 . . . . 0.0 111.231 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.9 157.77 77.31 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 124.936 1.294 . . . . 0.0 110.491 -177.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -70.77 126.22 12.42 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 124.795 3.663 . . . . 0.0 111.003 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -118.63 135.47 54.43 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.017 0.927 . . . . 0.0 110.193 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -138.61 75.35 37.9 Favored Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 121.715 -0.616 . . . . 0.0 110.886 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.78 149.34 60.2 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.641 2.894 . . . . 0.0 110.674 -176.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.3 p -76.27 144.33 40.38 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.674 0.79 . . . . 0.0 110.597 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.3 169.99 4.41 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.401 1.0 . . . . 0.0 112.128 -176.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -88.65 137.01 32.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mp -79.02 150.55 31.89 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.527 0.731 . . . . 0.0 109.492 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -76.67 0.19 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.336 1.054 . . . . 0.0 108.448 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -143.03 162.43 35.5 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.587 0.755 . . . . 0.0 110.741 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -75.63 145.6 40.95 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.099 0.559 . . . . 0.0 110.429 177.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -144.98 148.29 33.62 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 123.713 0.805 . . . . 0.0 109.912 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.522 0 O-C-N 121.977 -0.452 . . . . 0.0 110.802 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 CA--C 1.527 0.079 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -71.91 105.75 3.95 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.572 0.701 . . . . 0.0 110.537 -173.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.7 p -98.64 77.9 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.7 m -73.22 144.92 46.56 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -176.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.494 HD12 ' C ' ' A' ' 6' ' ' ILE . 2.0 pp -112.77 166.69 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.3 tt -125.89 99.44 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 166.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.29 98.16 9.45 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.416 1.087 . . . . 0.0 109.593 -174.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 20.9 m-90 -79.49 100.19 7.6 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -82.62 90.75 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -177.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -72.1 159.68 33.75 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.984 0.421 . . . . 0.0 112.002 -169.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.4 -164.85 19.14 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 124.418 1.009 . . . . 0.0 111.66 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -93.62 82.52 4.37 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.662 0.785 . . . . 0.0 110.403 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.4 t -108.63 -47.56 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.674 1.19 . . . . 0.0 111.156 -167.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -62.12 157.26 19.5 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.126 0.97 . . . . 0.0 111.958 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.64 -43.67 3.19 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.091 0.853 . . . . 0.0 112.178 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.3 t -60.17 -39.27 80.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.543 1.137 . . . . 0.0 111.356 -176.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.69 33.1 2.73 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.306 1.431 . . . . 0.0 111.458 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -47.16 -34.78 6.55 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 126.559 1.943 . . . . 0.0 112.831 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.15 36.04 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.656 1.582 . . . . 0.0 113.007 171.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -60.84 -59.41 5.42 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.973 0.909 . . . . 0.0 110.464 -170.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 t -124.58 12.0 8.6 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.785 1.234 . . . . 0.0 111.701 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.7 t -47.44 -43.46 23.99 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -62.39 -51.5 67.32 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.706 1.202 . . . . 0.0 110.702 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -53.03 -57.98 8.55 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.329 0.652 . . . . 0.0 110.322 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.32 -49.82 63.47 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.767 1.227 . . . . 0.0 110.784 178.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.25 -38.52 68.62 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.259 0.624 . . . . 0.0 111.787 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -68.44 -28.06 66.73 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.911 0.884 . . . . 0.0 111.949 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 -62.49 -47.68 82.89 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.632 0.651 . . . . 0.0 109.522 175.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 62.7 mt -77.76 -32.55 52.7 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.508 0.723 . . . . 0.0 111.05 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.47 30.99 61.46 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.986 1.279 . . . . 0.0 112.437 -176.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.444 HD22 ' C ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -81.61 169.2 17.33 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.499 0.72 . . . . 0.0 112.179 -179.266 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.4 ' N ' HD22 ' A' ' 32' ' ' LEU . 21.4 p -127.31 147.24 50.25 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.857 0.863 . . . . 0.0 109.232 -168.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.51 -145.26 15.24 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -171.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -176.26 155.49 1.5 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.314 0.645 . . . . 0.0 111.255 174.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.88 93.85 6.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.489 1.116 . . . . 0.0 109.056 166.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -93.06 173.45 7.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 170.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -124.84 148.2 48.35 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 123.727 0.811 . . . . 0.0 110.132 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 35.5 mt -84.53 175.21 9.43 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.349 1.06 . . . . 0.0 110.046 172.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -87.57 18.83 3.68 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.386 1.074 . . . . 0.0 110.632 169.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -96.1 -53.12 3.76 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 125.009 1.324 . . . . 0.0 109.499 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.87 -17.1 1.4 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.492 1.044 . . . . 0.0 112.08 -160.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.1 p -107.61 153.8 22.37 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.372 1.069 . . . . 0.0 112.427 -162.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.7 t -102.47 121.17 53.22 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 124.727 1.211 . . . . 0.0 109.237 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -90.32 97.15 11.02 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 173.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.2 t -90.51 119.79 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.5 t -114.0 126.81 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.41 ' HA ' HD23 ' A' ' 32' ' ' LEU . . . -147.81 114.34 5.98 Favored 'General case' 0 CA--C 1.522 -0.106 0 O-C-N 123.911 0.757 . . . . 0.0 110.822 -168.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 87.7 m -80.21 -176.43 5.58 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 124.659 1.184 . . . . 0.0 110.78 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.06 -176.2 21.8 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -177.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -74.87 150.09 39.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -53.82 -46.48 71.16 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.202 0.601 . . . . 0.0 110.414 -176.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -47.09 -48.89 19.32 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.062 1.792 . . . . 0.0 112.914 174.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -63.98 -54.23 37.76 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 117.501 0.65 . . . . 0.0 111.27 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.5 t -58.17 -34.77 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.132 0.973 . . . . 0.0 111.602 -177.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -53.46 -40.29 65.16 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.052 0.541 . . . . 0.0 111.101 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -65.87 -37.87 87.3 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.67 0.668 . . . . 0.0 112.347 -172.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -75.69 -35.24 60.38 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.484 0.584 . . . . 0.0 110.972 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 43.9 mtm -65.67 -39.41 91.31 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 176.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -47.93 -40.47 22.1 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.563 0.745 . . . . 0.0 111.571 173.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 28.9 t90 -78.62 -37.2 42.8 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.245 -0.884 . . . . 0.0 110.737 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.1 mt . . . . . 0 C--N 1.345 0.385 0 CA-C-N 119.813 1.188 . . . . 0.0 110.911 -179.591 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 66.7 t . . . . . 0 CA--C 1.53 0.195 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -64.84 -55.74 17.7 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.439 0.695 . . . . 0.0 111.568 -175.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -171.63 148.42 2.45 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 125.432 1.493 . . . . 0.0 107.141 -175.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 p -119.5 126.49 75.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 123.041 0.537 . . . . 0.0 110.27 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.4 tp -103.58 118.79 37.54 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 123.527 0.731 . . . . 0.0 109.175 173.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.4 m -101.74 138.34 38.86 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.621 0.769 . . . . 0.0 109.622 169.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -130.55 154.3 81.63 Favored Pre-proline 0 CA--C 1.53 0.192 0 C-N-CA 125.413 1.485 . . . . 0.0 108.525 171.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -70.51 104.24 1.41 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.212 2.608 . . . . 0.0 109.705 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -85.18 111.61 19.97 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.377 1.071 . . . . 0.0 109.482 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.71 86.71 1.02 Allowed Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 124.157 0.983 . . . . 0.0 109.754 175.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.22 165.33 32.92 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.231 1.954 . . . . 0.0 109.646 169.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.9 m -74.96 123.18 24.66 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.98 -151.91 47.13 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -173.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -126.02 147.53 49.53 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.965 1.306 . . . . 0.0 108.57 171.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 31.6 tp -72.59 156.44 38.99 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.6 p -66.05 -55.76 14.99 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.451 1.1 . . . . 0.0 111.585 -178.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -140.46 166.81 23.7 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.592 1.157 . . . . 0.0 111.547 -167.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -86.12 137.95 32.28 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 168.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -160.28 -170.63 2.88 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -167.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.1 mt . . . . . 0 CA--C 1.535 0.373 0 C-N-CA 126.638 1.975 . . . . 0.0 109.055 -169.746 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 119.903 -0.094 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -60.95 134.28 56.94 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.973 1.309 . . . . 0.0 112.351 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 p -138.92 91.51 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.272 0 C-N-CA 124.778 1.231 . . . . 0.0 108.707 -174.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.8 m -82.46 153.42 25.65 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.937 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.88 146.22 18.8 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -176.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.5 tt -109.22 124.11 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 124.171 0.989 . . . . 0.0 109.874 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.7 112.47 22.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.745 1.218 . . . . 0.0 110.373 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.7 m-90 -94.67 130.69 41.05 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.366 1.066 . . . . 0.0 110.289 178.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.611 HG13 HG22 ' A' ' 75' ' ' VAL . 2.9 t -111.31 101.57 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -177.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -68.16 176.63 2.61 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.611 0.765 . . . . 0.0 111.132 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.7 -162.11 54.3 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -93.34 91.71 7.33 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 123.804 0.842 . . . . 0.0 112.06 -172.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.507 HG21 HG12 ' A' ' 10' ' ' VAL . 31.9 t -122.63 -30.78 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 C-N-CA 123.991 0.916 . . . . 0.0 111.275 -175.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -72.22 148.88 45.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 121.944 -0.473 . . . . 0.0 110.018 175.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.29 -21.02 47.68 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.067 -0.851 . . . . 0.0 113.023 176.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 p -84.09 0.53 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 118.55 1.175 . . . . 0.0 112.39 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.44 52.28 54.12 Favored Glycine 0 C--N 1.34 0.791 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -176.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.36 -34.25 70.47 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.591 0.756 . . . . 0.0 111.102 176.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.84 53.95 0.78 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.905 1.682 . . . . 0.0 112.326 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -87.17 -67.61 0.81 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -177.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 t -101.81 1.9 37.69 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.17 0.988 . . . . 0.0 112.094 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.8 t -48.35 -33.82 9.62 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.421 0.688 . . . . 0.0 112.149 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -68.03 -55.19 13.49 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.965 1.306 . . . . 0.0 110.423 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -55.08 -55.3 32.62 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.749 0.819 . . . . 0.0 110.742 -175.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.22 -47.97 68.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.839 0.856 . . . . 0.0 110.3 176.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.29 -28.23 58.07 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.48 -31.14 68.15 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.024 0.929 . . . . 0.0 111.873 177.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.1 mmm-85 -67.95 -42.39 81.03 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.801 0.84 . . . . 0.0 110.869 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -84.4 -42.05 16.07 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 122.947 0.499 . . . . 0.0 111.498 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.44 6.94 63.91 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 123.932 0.777 . . . . 0.0 112.91 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.67 167.72 3.38 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.138 0.969 . . . . 0.0 111.743 174.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.7 p -131.0 156.07 45.76 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -177.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 162.51 -148.13 14.84 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -169.62 164.15 10.19 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.163 -0.519 . . . . 0.0 111.77 172.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.98 97.27 5.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.014 0.926 . . . . 0.0 111.521 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -97.12 173.09 7.43 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.399 1.08 . . . . 0.0 111.095 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -123.44 137.87 54.71 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.428 1.091 . . . . 0.0 109.219 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.1 mt -75.67 177.36 6.88 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.497 1.119 . . . . 0.0 110.447 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -101.08 9.88 41.61 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.52 1.128 . . . . 0.0 111.276 177.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -109.34 -14.12 14.5 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.528 1.131 . . . . 0.0 112.086 -176.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.61 10.65 10.11 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.17 1.366 . . . . 0.0 113.938 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.54 164.45 14.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.538 1.535 . . . . 0.0 111.537 -173.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.4 p -119.55 138.97 48.46 Favored 'Isoleucine or valine' 0 C--N 1.347 0.494 0 C-N-CA 123.674 0.79 . . . . 0.0 110.702 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -110.86 121.18 44.71 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.581 1.152 . . . . 0.0 110.823 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 64.0 t -116.17 136.55 52.78 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.17 144.01 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 124.235 1.014 . . . . 0.0 109.482 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.54 142.03 21.7 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.581 -176.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.3 m -110.73 -178.78 3.57 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 126.173 1.789 . . . . 0.0 112.471 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.47 -153.59 23.48 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.054 -1.219 . . . . 0.0 110.054 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -82.25 132.7 35.23 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.096 0.558 . . . . 0.0 109.508 -178.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -48.71 -49.89 35.97 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.25 1.02 . . . . 0.0 110.972 -178.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.83 -52.96 28.15 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.103 1.335 . . . . 0.0 112.129 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -60.85 -46.5 90.34 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 124.232 1.013 . . . . 0.0 110.771 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.6 t -55.73 -42.79 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 122.271 0.228 . . . . 0.0 110.716 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.56 -27.73 66.49 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -27.05 68.49 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.842 0.857 . . . . 0.0 112.436 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.37 -29.05 14.18 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.211 0.604 . . . . 0.0 110.829 174.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.428 ' HA ' HD12 ' A' ' 62' ' ' LEU . 1.2 mmm -64.23 -21.87 66.74 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-O 118.588 -0.72 . . . . 0.0 111.535 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -47.54 -57.76 5.03 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 118.527 0.603 . . . . 0.0 109.812 172.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 15.7 t90 -64.3 -29.31 70.4 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.649 0.78 . . . . 0.0 111.727 -178.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 59' ' ' MET . 21.1 mt . . . . . 0 C--N 1.347 0.489 0 O-C-N 121.101 -1.0 . . . . 0.0 110.083 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.7 t . . . . . 0 CA--C 1.534 0.357 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -58.89 -50.79 72.7 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.494 0.718 . . . . 0.0 111.301 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.9 ttm-85 -169.3 163.56 10.76 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.042 0.537 . . . . 0.0 110.377 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.611 HG22 HG13 ' A' ' 10' ' ' VAL . 8.5 t -133.35 110.33 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.763 0.825 . . . . 0.0 109.953 -176.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.0 tp -100.61 152.4 20.48 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.36 1.064 . . . . 0.0 110.283 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.52 129.51 31.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.011 0.924 . . . . 0.0 111.518 -177.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.21 158.49 74.04 Favored Pre-proline 0 N--CA 1.469 0.501 0 C-N-CA 125.358 1.463 . . . . 0.0 110.544 -176.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.73 132.26 19.91 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 124.482 3.455 . . . . 0.0 110.987 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -120.68 114.93 22.39 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.617 1.167 . . . . 0.0 109.626 -177.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -121.8 64.97 18.23 Favored Pre-proline 0 CA--C 1.536 0.426 0 O-C-N 121.656 -0.653 . . . . 0.0 110.867 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.45 142.26 44.45 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.207 2.605 . . . . 0.0 110.471 -174.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.6 p -70.44 142.46 51.98 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.372 0.669 . . . . 0.0 110.729 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.86 170.62 5.37 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.25 0.929 . . . . 0.0 112.105 -176.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -93.26 135.15 34.74 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.8 tp -77.74 149.17 34.57 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -75.53 0.15 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.217 1.007 . . . . 0.0 108.483 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -141.15 162.95 34.26 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.135 0.974 . . . . 0.0 109.926 -173.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -71.17 145.61 49.61 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.876 0.47 . . . . 0.0 110.616 174.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -142.05 -169.97 3.05 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.122 0.969 . . . . 0.0 109.964 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.2 mt . . . . . 0 CA--C 1.535 0.386 0 C-N-CA 123.906 0.882 . . . . 0.0 108.706 -177.91 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.9 t . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 110.598 -0.149 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 152.97 41.95 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.145 0.978 . . . . 0.0 112.908 -176.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 p -138.78 90.88 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 124.505 1.122 . . . . 0.0 108.435 -173.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.0 m -78.61 153.37 31.16 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.665 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.99 148.99 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -176.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.8 tt -111.43 125.61 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.942 0.897 . . . . 0.0 109.947 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -120.21 101.85 8.1 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.823 1.649 . . . . 0.0 109.767 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 -87.15 112.7 22.21 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 124.618 1.167 . . . . 0.0 109.895 177.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.84 121.52 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.312 1.045 . . . . 0.0 108.662 -177.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -99.27 171.35 8.04 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.048 0.939 . . . . 0.0 110.684 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.72 -165.08 49.28 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 123.375 0.512 . . . . 0.0 112.095 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.9 mtt85 -84.86 83.6 7.99 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -166.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.7 t -119.49 -47.25 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.909 0.883 . . . . 0.0 110.378 -173.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -67.68 146.64 53.61 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 120.848 0.356 . . . . 0.0 110.862 177.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.18 17.93 76.22 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.128 0.87 . . . . 0.0 113.738 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 82.4 t -102.86 -43.06 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 124.673 1.189 . . . . 0.0 109.141 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.08 29.02 3.16 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 125.884 1.707 . . . . 0.0 110.996 -175.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -50.97 -37.58 45.55 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 124.509 1.124 . . . . 0.0 111.325 177.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.0 60.09 0.96 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.848 1.259 . . . . 0.0 112.689 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -109.75 -72.94 0.7 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.684 1.194 . . . . 0.0 108.789 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.3 t -72.19 -23.26 61.24 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 118.503 -0.761 . . . . 0.0 112.053 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.5 t -41.32 -39.81 1.51 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.468 1.107 . . . . 0.0 112.667 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -71.64 -59.84 2.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.364 1.065 . . . . 0.0 110.681 176.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -49.98 -58.08 6.2 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.139 0.976 . . . . 0.0 111.771 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -53.14 -51.15 62.9 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.588 1.155 . . . . 0.0 110.849 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.46 -33.2 53.31 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 122.78 0.432 . . . . 0.0 112.079 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -68.23 -28.54 67.32 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.212 1.005 . . . . 0.0 112.234 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.6 mtp85 -70.81 -47.04 61.58 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.895 0.878 . . . . 0.0 109.926 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.5 mt -78.33 -40.71 35.78 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.013 0.525 . . . . 0.0 111.004 -177.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.27 22.31 41.62 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.195 1.379 . . . . 0.0 112.952 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.72 174.89 11.12 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.713 0.805 . . . . 0.0 111.566 177.079 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 51.2 p -117.69 -163.39 0.93 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.59 -155.39 16.24 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 118.534 0.606 . . . . 0.0 112.144 171.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -169.88 162.26 9.28 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.72 84.81 2.32 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.443 1.097 . . . . 0.0 111.254 -174.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -92.61 173.01 8.0 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.851 0.86 . . . . 0.0 111.281 -177.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -125.07 131.57 53.31 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.336 1.054 . . . . 0.0 109.494 -177.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 39' ' ' LEU . 16.4 mt -70.06 171.25 9.86 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 125.214 1.405 . . . . 0.0 110.897 175.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -93.82 7.33 45.33 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.872 1.269 . . . . 0.0 111.747 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -112.63 -16.83 12.74 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.515 1.126 . . . . 0.0 112.119 -175.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.6 13.97 2.98 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.122 1.344 . . . . 0.0 114.385 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.54 166.32 12.85 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.426 1.49 . . . . 0.0 111.958 -167.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.3 t -127.07 120.92 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.586 1.155 . . . . 0.0 111.404 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -98.02 115.28 27.88 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 125.168 1.387 . . . . 0.0 111.684 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.6 t -114.1 133.32 60.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 122.861 0.464 . . . . 0.0 110.43 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.33 143.26 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 123.993 0.917 . . . . 0.0 109.738 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.96 133.03 11.63 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.015 -173.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 93.7 m -101.58 179.97 4.19 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.667 1.187 . . . . 0.0 112.325 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.73 -162.6 21.34 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.337 0.97 . . . . 0.0 110.758 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -73.18 121.75 20.79 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 123.691 0.796 . . . . 0.0 109.974 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -46.88 -50.85 17.97 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.015 1.326 . . . . 0.0 111.346 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -51.96 -45.77 55.97 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.402 1.477 . . . . 0.0 112.355 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -66.7 -50.88 61.41 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 117.455 0.628 . . . . 0.0 110.714 176.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.1 t -51.39 -34.05 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 122.647 0.379 . . . . 0.0 111.055 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -57.71 -31.46 66.43 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.915 0.886 . . . . 0.0 113.192 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -54.31 -44.86 72.36 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.828 0.851 . . . . 0.0 110.766 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.63 -32.18 53.22 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 118.481 0.582 . . . . 0.0 112.118 175.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.3 mmt -67.37 -25.19 65.85 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 118.814 -0.612 . . . . 0.0 111.867 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -42.44 -49.66 5.23 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.166 0.586 . . . . 0.0 109.719 170.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -64.13 -41.86 97.06 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.7 mt . . . . . 0 N--CA 1.471 0.612 0 C-N-CA 123.667 0.787 . . . . 0.0 110.599 179.641 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 95.4 t . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -67.21 -55.38 14.3 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.745 0.418 . . . . 0.0 110.998 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -166.64 99.05 0.57 Allowed 'General case' 0 C--N 1.342 0.274 0 C-N-CA 122.485 0.314 . . . . 0.0 111.422 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.9 p -84.41 125.54 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.275 0.63 . . . . 0.0 111.469 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.97 137.86 45.23 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 125.694 1.598 . . . . 0.0 111.568 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.88 138.56 54.35 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.156 1.382 . . . . 0.0 112.41 -177.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -144.04 158.73 54.97 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 124.945 1.298 . . . . 0.0 111.39 -177.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.02 137.38 26.44 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 124.074 3.182 . . . . 0.0 111.792 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -128.06 124.46 37.1 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.537 1.135 . . . . 0.0 111.181 -175.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -129.02 70.01 81.32 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 121.698 -0.626 . . . . 0.0 111.431 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.2 142.63 38.12 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.864 2.376 . . . . 0.0 110.722 -176.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.3 m -66.45 140.18 58.01 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.799 0.84 . . . . 0.0 110.776 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.86 -177.91 40.85 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.755 0.693 . . . . 0.0 111.547 -176.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -108.35 131.31 54.87 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.179 0.991 . . . . 0.0 108.568 172.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -69.82 151.75 45.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.927 1.291 . . . . 0.0 109.359 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.71 -77.98 0.13 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.672 0.789 . . . . 0.0 108.943 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -137.99 161.1 37.58 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.27 1.028 . . . . 0.0 109.838 -171.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -69.19 147.82 50.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.903 0.481 . . . . 0.0 110.03 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -152.06 -167.74 2.86 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 122.905 0.482 . . . . 0.0 110.524 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.2 tt . . . . . 0 N--CA 1.451 -0.41 0 C-N-CA 123.792 0.837 . . . . 0.0 109.48 177.413 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.0 m . . . . . 0 CA--C 1.533 0.302 0 CA-C-O 119.826 -0.13 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 142.84 55.84 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -169.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.25 88.5 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -172.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.2 m -78.95 152.06 31.29 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.276 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.416 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -141.52 149.33 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -177.105 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.8 tt -110.52 122.78 65.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 O-C-N 123.81 0.693 . . . . 0.0 109.335 174.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -113.88 95.67 5.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.684 1.594 . . . . 0.0 108.873 -175.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -81.44 130.59 35.1 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.4 t -107.07 113.97 44.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.476 1.111 . . . . 0.0 109.355 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -84.47 163.71 19.28 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.698 0.799 . . . . 0.0 111.052 175.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.39 179.5 53.02 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 124.126 0.869 . . . . 0.0 111.076 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.5 mtt180 -86.5 73.61 10.07 Favored 'General case' 0 N--CA 1.457 -0.075 0 CA-C-O 121.053 0.454 . . . . 0.0 111.751 -164.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.7 t -104.73 -33.25 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.162 0.985 . . . . 0.0 112.081 -170.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -63.13 159.68 16.94 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.677 0.671 . . . . 0.0 110.851 171.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.78 -46.08 1.65 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 123.992 0.806 . . . . 0.0 111.569 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.9 p -69.63 -9.74 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 123.431 0.693 . . . . 0.0 112.817 -174.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.08 44.46 35.85 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.894 0.759 . . . . 0.0 111.306 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -48.61 -34.13 11.09 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 125.867 1.667 . . . . 0.0 112.952 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 -71.95 47.92 0.15 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.844 1.657 . . . . 0.0 112.85 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -89.34 -69.63 0.7 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.089 0.956 . . . . 0.0 109.001 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.0 t -99.84 12.29 37.08 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.203 1.401 . . . . 0.0 111.23 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.1 t -59.41 -39.75 84.46 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.027 0.376 . . . . 0.0 110.796 170.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 -53.47 -60.55 3.16 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.868 1.267 . . . . 0.0 109.852 173.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -54.8 -57.04 13.15 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.001 0.92 . . . . 0.0 110.693 -173.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -54.55 -55.22 31.52 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 123.902 0.751 . . . . 0.0 109.856 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.92 -33.95 65.14 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 118.798 -0.62 . . . . 0.0 111.958 -177.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -67.56 -36.49 81.05 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.886 -0.578 . . . . 0.0 112.191 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -60.11 -46.87 88.17 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.656 0.662 . . . . 0.0 110.861 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.63 -22.01 34.85 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.98 31.57 47.79 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.557 1.075 . . . . 0.0 113.131 -178.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.597 HD13 ' O ' ' A' ' 49' ' ' CYS . 3.3 mm? -76.21 140.77 41.81 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 117.503 0.652 . . . . 0.0 110.294 176.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.2 p -96.16 -159.89 0.76 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.484 176.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.49 -149.22 16.69 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 119.212 0.915 . . . . 0.0 112.034 172.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -169.84 158.23 7.24 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 177.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.93 97.4 5.68 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.267 1.427 . . . . 0.0 110.416 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -107.62 170.22 8.11 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.697 0.799 . . . . 0.0 111.425 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -120.66 131.46 54.59 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.386 1.075 . . . . 0.0 108.994 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.7 mt -68.04 174.84 3.49 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.228 1.411 . . . . 0.0 110.679 175.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -97.48 15.52 22.96 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.772 1.229 . . . . 0.0 111.397 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -120.09 -14.47 8.86 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 123.942 0.897 . . . . 0.0 112.778 -173.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.22 11.35 4.26 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.073 1.32 . . . . 0.0 114.325 175.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 p -126.35 162.08 26.36 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.308 1.443 . . . . 0.0 111.807 -166.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.4 t -117.06 132.91 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.785 1.234 . . . . 0.0 111.112 -174.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -106.29 113.35 26.82 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.749 1.22 . . . . 0.0 110.606 178.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.1 t -112.29 135.39 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.785 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.7 142.76 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.765 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.53 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -151.7 119.21 6.04 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 117.945 -1.026 . . . . 0.0 111.901 -171.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.597 ' O ' HD13 ' A' ' 32' ' ' LEU . 98.5 m -109.58 132.02 54.52 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 120.031 1.287 . . . . 0.0 113.376 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 156.33 -163.86 32.19 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -71.81 126.85 30.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.334 0.567 . . . . 0.0 110.406 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -54.24 -43.21 70.7 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.853 1.261 . . . . 0.0 111.668 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -42.25 -42.8 4.43 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 126.057 1.789 . . . . 0.0 112.886 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -80.76 -47.17 14.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.207 1.003 . . . . 0.0 111.476 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.488 HG22 HD11 ' A' ' 32' ' ' LEU . 77.0 t -42.75 -52.11 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 123.938 0.895 . . . . 0.0 110.892 177.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -54.01 -36.4 62.94 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.405 0.682 . . . . 0.0 112.163 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -61.29 -44.24 97.55 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.022 0.929 . . . . 0.0 110.771 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.48 -32.32 68.13 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 122.934 0.494 . . . . 0.0 110.289 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.2 mmt -66.86 -24.87 66.18 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.096 -0.954 . . . . 0.0 112.264 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -47.71 -48.42 29.47 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 119.536 1.062 . . . . 0.0 109.535 172.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -61.25 -39.05 88.9 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 118.848 -0.596 . . . . 0.0 112.205 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.347 0.5 0 CA-C-N 119.385 0.993 . . . . 0.0 111.558 177.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 CA--C 1.531 0.217 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -64.93 -51.31 62.55 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -167.61 168.7 12.5 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.482 1.113 . . . . 0.0 109.142 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.1 t -132.11 125.64 54.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.148 0.979 . . . . 0.0 109.265 174.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tp -103.81 120.64 41.4 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.397 1.079 . . . . 0.0 110.965 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.6 136.35 43.47 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.05 0.94 . . . . 0.0 110.678 178.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -140.83 153.55 67.75 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 124.836 1.254 . . . . 0.0 109.937 178.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.57 136.54 28.53 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.666 2.911 . . . . 0.0 110.984 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -126.44 118.82 25.75 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.89 1.276 . . . . 0.0 110.105 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -121.2 72.34 25.18 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 119.147 0.885 . . . . 0.0 111.498 177.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.27 140.32 44.21 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.011 2.474 . . . . 0.0 110.118 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 80.9 p -75.75 143.05 42.23 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.637 0.775 . . . . 0.0 110.753 -176.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.45 -179.93 42.48 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -103.68 126.76 51.02 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.621 1.168 . . . . 0.0 108.719 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 mp -71.24 151.64 44.1 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.063 0.945 . . . . 0.0 109.797 173.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.4 p -78.65 -79.65 0.13 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.891 0.876 . . . . 0.0 108.719 173.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -141.28 164.06 31.26 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 124.119 0.968 . . . . 0.0 111.187 -168.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -75.23 148.36 39.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.904 0.882 . . . . 0.0 110.002 175.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -149.83 -172.37 4.13 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.065 0.546 . . . . 0.0 110.022 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.457 -0.114 0 C-N-CA 123.872 0.869 . . . . 0.0 110.66 -174.138 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 mtm . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 111.419 0.155 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.0 t -145.15 -51.5 0.27 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.544 1.138 . . . . 0.0 110.364 177.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -61.29 127.59 32.26 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.901 1.68 . . . . 0.0 112.928 -176.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 p -132.45 90.59 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.186 0 C-N-CA 125.585 1.554 . . . . 0.0 108.505 -174.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.1 m -81.65 153.22 26.76 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.92 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.89 149.59 17.71 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -176.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.4 tt -114.86 124.93 72.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.061 0.945 . . . . 0.0 110.414 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -119.35 109.56 15.94 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.953 1.701 . . . . 0.0 110.395 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.5 m-90 -92.11 116.45 28.95 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 125.626 1.57 . . . . 0.0 110.49 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -101.33 121.65 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.048 0.939 . . . . 0.0 109.164 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -91.34 173.19 8.05 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.362 1.465 . . . . 0.0 110.865 176.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.86 -166.98 50.96 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.7 mtt-85 -83.82 86.0 7.22 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.248 0.619 . . . . 0.0 111.519 -172.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.3 t -117.53 -40.57 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 123.791 0.837 . . . . 0.0 110.311 -174.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -73.65 149.33 42.05 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.175 0.443 . . . . 0.0 110.295 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.94 -43.26 1.74 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.102 0.858 . . . . 0.0 112.39 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.1 p -69.59 -8.12 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 118.066 0.933 . . . . 0.0 111.786 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.26 47.14 38.11 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -50.64 -40.89 54.49 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 124.022 0.929 . . . . 0.0 110.944 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 -70.76 55.0 0.17 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.599 1.96 . . . . 0.0 113.074 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -103.56 -68.93 0.82 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.36 1.064 . . . . 0.0 109.125 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.0 t -73.26 -22.11 60.46 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.3 t -41.31 -40.05 1.56 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.819 1.247 . . . . 0.0 112.55 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -64.79 -60.52 3.0 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.003 1.321 . . . . 0.0 110.826 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -51.26 -57.04 9.9 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.76 0.824 . . . . 0.0 111.022 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.04 -50.18 67.28 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.641 0.776 . . . . 0.0 110.477 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.91 -33.96 39.37 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 122.987 0.515 . . . . 0.0 112.098 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt -67.92 -33.4 74.62 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.463 0.705 . . . . 0.0 111.851 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 -66.15 -41.79 89.92 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.827 0.851 . . . . 0.0 111.411 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.93 -30.9 31.57 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.308 0.643 . . . . 0.0 111.77 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.96 21.4 78.51 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.095 0.855 . . . . 0.0 112.74 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.49 HD12 ' HB1' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -81.23 174.69 11.29 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.861 0.865 . . . . 0.0 110.955 176.389 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 50.0 p -117.31 -161.39 0.81 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -175.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.81 -155.16 16.3 Favored Glycine 0 C--N 1.339 0.705 0 CA-C-N 118.463 0.574 . . . . 0.0 111.822 169.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -168.14 159.23 10.82 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 171.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.01 95.33 4.86 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.77 1.228 . . . . 0.0 110.106 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -98.97 171.21 8.19 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.151 0.981 . . . . 0.0 110.674 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -127.29 133.23 50.17 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 124.048 0.939 . . . . 0.0 109.686 -177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.2 mt -71.23 173.52 7.61 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.158 1.383 . . . . 0.0 111.128 176.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -96.27 13.38 27.74 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.016 1.327 . . . . 0.0 111.801 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -121.38 0.59 10.05 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.635 1.174 . . . . 0.0 112.481 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.43 3.32 27.42 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.157 1.36 . . . . 0.0 114.425 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.37 165.14 11.73 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.959 1.704 . . . . 0.0 112.052 -169.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.8 t -126.87 124.49 64.89 Favored 'Isoleucine or valine' 0 C--N 1.348 0.515 0 C-N-CA 124.513 1.125 . . . . 0.0 111.752 -174.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -100.28 116.51 32.43 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 125.43 1.492 . . . . 0.0 111.718 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.0 t -113.51 133.0 60.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 123.496 0.719 . . . . 0.0 109.787 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.8 t -128.63 145.18 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.783 0.833 . . . . 0.0 110.188 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.49 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -157.9 137.1 11.71 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-O 118.297 -0.859 . . . . 0.0 111.786 -174.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 67.3 m -104.24 178.44 4.56 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.514 1.526 . . . . 0.0 112.418 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.06 -158.1 19.57 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 124.613 1.101 . . . . 0.0 110.422 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -79.56 128.63 33.62 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.835 0.854 . . . . 0.0 109.388 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -44.83 -49.32 10.88 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.241 1.016 . . . . 0.0 111.768 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -49.55 -54.29 17.43 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.305 1.431 . . . . 0.0 112.989 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -59.54 -47.82 84.07 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 125.302 1.441 . . . . 0.0 110.419 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.36 -41.6 71.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 122.429 0.292 . . . . 0.0 110.799 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -64.08 -26.88 68.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.226 0.611 . . . . 0.0 112.589 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -55.03 -48.96 72.72 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.637 0.775 . . . . 0.0 111.036 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -76.95 -30.26 55.96 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 118.192 0.451 . . . . 0.0 111.499 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.6 mmm -66.14 -21.42 66.34 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.624 -0.703 . . . . 0.0 111.594 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -44.41 -46.3 9.44 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.738 0.699 . . . . 0.0 109.996 168.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -67.74 -41.01 84.11 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.871 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 mt -54.47 -53.08 58.99 Favored 'General case' 0 C--N 1.346 0.448 0 C-N-CA 123.476 0.71 . . . . 0.0 110.611 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.46 -2.39 28.53 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.0 t -94.32 -30.43 14.53 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 119.276 0.943 . . . . 0.0 110.848 174.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.11 62.72 3.41 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -45.84 -65.52 1.97 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.819 1.2 . . . . 0.0 113.176 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -73.37 104.64 1.83 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.762 2.308 . . . . 0.0 110.347 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -55.13 -25.0 28.96 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.381 1.472 . . . . 0.0 113.501 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.91 -32.27 70.6 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.563 0.745 . . . . 0.0 111.234 174.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.62 155.65 37.27 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.873 0.469 . . . . 0.0 110.75 175.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.67 82.73 2.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.36 95.27 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -77.16 -47.96 18.94 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.924 0.89 . . . . 0.0 111.17 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.7 mtm105 -156.73 163.27 39.45 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.926 1.29 . . . . 0.0 109.484 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.4 p -154.57 131.61 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 118.944 -0.55 . . . . 0.0 111.136 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tp -122.67 141.0 52.22 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.357 1.063 . . . . 0.0 112.556 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.43 142.77 50.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.115 1.366 . . . . 0.0 112.867 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -143.2 159.57 55.2 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 125.119 1.368 . . . . 0.0 111.262 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.38 137.5 28.33 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.747 2.965 . . . . 0.0 111.346 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -125.3 116.94 22.73 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.79 1.236 . . . . 0.0 110.296 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -121.86 74.76 36.87 Favored Pre-proline 0 CA--C 1.536 0.408 0 O-C-N 121.425 -0.797 . . . . 0.0 110.77 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.72 146.27 42.82 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.76 2.306 . . . . 0.0 110.523 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.3 p -71.22 140.57 50.48 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.502 0.721 . . . . 0.0 110.461 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.22 179.73 30.79 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 123.811 0.72 . . . . 0.0 112.048 -177.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -101.75 131.02 48.27 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.597 1.159 . . . . 0.0 108.593 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -70.06 150.8 46.22 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.725 1.21 . . . . 0.0 109.534 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -77.32 0.15 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.788 0.835 . . . . 0.0 108.755 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -137.94 166.16 24.74 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.121 0.968 . . . . 0.0 110.674 -174.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -75.59 146.38 40.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.122 0.569 . . . . 0.0 110.101 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -149.81 -168.19 3.04 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.53 0.732 . . . . 0.0 110.055 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.4 pt -139.62 174.5 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.376 1.07 . . . . 0.0 109.938 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.106 0 CA-C-O 116.793 -1.575 . . . . 0.0 112.113 175.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? . . . . . 0 N--CA 1.474 0.769 0 CA-C-O 119.142 -0.456 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.2 t -141.26 -49.68 0.42 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.238 0.615 . . . . 0.0 111.956 -175.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.3 121.78 21.86 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.926 0.891 . . . . 0.0 111.374 -174.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.87 85.54 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.087 0 C-N-CA 125.273 1.429 . . . . 0.0 108.262 -172.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 m -78.86 150.32 32.26 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.114 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pp -129.88 162.1 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.3 tt -119.83 124.5 72.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.186 0.994 . . . . 0.0 109.038 173.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -117.39 99.89 7.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 126.237 1.815 . . . . 0.0 109.298 -173.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -83.4 131.85 35.02 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.612 0.765 . . . . 0.0 110.113 175.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.5 t -112.04 107.15 22.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.184 0.993 . . . . 0.0 109.113 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -73.77 165.87 24.34 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 123.445 0.698 . . . . 0.0 110.997 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.03 -179.44 53.61 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 123.811 0.719 . . . . 0.0 111.741 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.1 mtt-85 -87.8 78.58 8.36 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 122.971 0.508 . . . . 0.0 112.033 -165.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.3 t -105.51 -26.98 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.11 0.964 . . . . 0.0 111.94 -173.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -73.29 156.72 38.16 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.224 0.61 . . . . 0.0 112.181 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.89 25.41 75.81 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.296 0.951 . . . . 0.0 113.244 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.6 t -123.49 -39.09 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.027 1.331 . . . . 0.0 110.478 -177.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.96 34.4 2.58 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.922 1.249 . . . . 0.0 112.733 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -48.25 -35.48 12.1 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.82 1.248 . . . . 0.0 112.781 172.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.38 57.17 2.29 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.291 1.836 . . . . 0.0 110.564 -174.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -98.31 -72.21 0.66 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.591 0.756 . . . . 0.0 109.444 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -88.48 -7.09 57.12 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.077 0.951 . . . . 0.0 111.996 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.8 t -43.62 -46.01 7.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.884 0.874 . . . . 0.0 112.72 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -53.4 -61.43 2.31 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 126.043 1.737 . . . . 0.0 110.537 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.95 -54.67 26.81 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.002 1.321 . . . . 0.0 110.645 -177.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -55.3 -52.68 62.68 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.582 0.753 . . . . 0.0 110.542 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.18 -36.34 63.29 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.087 0.555 . . . . 0.0 111.864 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -65.12 -31.34 72.5 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.919 0.887 . . . . 0.0 112.18 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.6 mtp85 -67.66 -47.05 70.63 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.422 0.556 . . . . 0.0 110.214 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mp -74.32 -33.08 63.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.745 0.418 . . . . 0.0 110.727 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.63 18.43 66.01 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.377 0.989 . . . . 0.0 112.629 -177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.77 171.0 13.58 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 117.466 0.633 . . . . 0.0 111.411 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.6 p -111.47 -158.17 0.64 Allowed 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -171.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.69 -159.69 13.59 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 118.092 0.406 . . . . 0.0 112.219 167.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -165.85 155.16 11.94 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 174.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.93 95.68 5.44 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.386 1.475 . . . . 0.0 110.085 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -104.53 175.36 5.51 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.683 0.793 . . . . 0.0 110.838 176.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -123.89 136.36 54.3 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.169 0.988 . . . . 0.0 109.988 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.5 mt -70.67 173.67 6.88 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.158 1.383 . . . . 0.0 110.632 173.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -96.91 18.93 13.55 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.658 1.183 . . . . 0.0 111.574 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -121.96 -20.91 6.17 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 123.806 0.842 . . . . 0.0 112.851 -175.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.24 -7.37 4.04 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.727 1.156 . . . . 0.0 113.836 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.8 p -112.48 166.64 11.13 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.186 1.395 . . . . 0.0 111.816 -165.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.0 t -124.46 129.83 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.191 0.996 . . . . 0.0 111.528 -168.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -104.82 114.01 27.96 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.789 1.236 . . . . 0.0 111.465 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.2 t -113.41 130.94 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.66 0.784 . . . . 0.0 109.946 -177.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.35 144.27 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.981 0.912 . . . . 0.0 110.473 -175.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.01 130.73 4.89 Favored 'General case' 0 C--N 1.349 0.557 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.112 -172.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 99.4 m -95.54 -178.94 4.58 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.151 1.38 . . . . 0.0 112.337 177.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.24 -159.39 14.33 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -83.06 127.01 33.19 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 174.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -49.93 -46.05 51.71 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.471 1.108 . . . . 0.0 110.851 -174.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -44.88 -50.56 8.68 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.054 1.788 . . . . 0.0 113.015 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -69.13 -49.03 60.65 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.147 0.979 . . . . 0.0 110.939 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.9 t -53.08 -38.52 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.004 0.521 . . . . 0.0 111.391 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -63.3 -26.96 69.01 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -61.46 -44.98 96.14 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.092 0.557 . . . . 0.0 111.293 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.37 -30.26 63.17 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.379 0.536 . . . . 0.0 110.515 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.8 mmt -66.92 -24.79 66.13 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.168 -0.92 . . . . 0.0 112.176 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -42.22 -53.91 3.89 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 119.036 0.835 . . . . 0.0 109.016 166.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 32.3 t90 -63.61 -40.98 98.28 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 123.337 0.655 . . . . 0.0 112.235 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt -55.7 -42.52 75.36 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.312 0.96 . . . . 0.0 110.774 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.75 -28.38 60.74 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.925 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.0 m -103.29 8.44 38.28 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.56 1.144 . . . . 0.0 111.997 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.88 -41.01 42.76 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -176.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -21.51 93.16 0.01 OUTLIER Glycine 0 CA--C 1.534 1.261 0 C-N-CA 128.389 2.9 . . . . 0.0 115.279 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.76 -175.22 2.2 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.092 2.528 . . . . 0.0 110.689 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -70.63 -44.44 67.18 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.306 1.043 . . . . 0.0 111.493 -170.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.5 p -67.25 -59.33 3.51 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 124.039 0.935 . . . . 0.0 110.643 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.88 155.99 32.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.863 0.865 . . . . 0.0 111.121 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -139.63 108.49 5.98 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.955 0.902 . . . . 0.0 109.029 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.9 t -77.36 94.25 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -58.54 -45.52 88.73 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.3 mtm-85 -173.23 166.59 4.87 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.572 1.549 . . . . 0.0 109.51 -175.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.6 t -135.83 131.21 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.152 0.981 . . . . 0.0 110.827 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 tp -117.04 124.64 49.78 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.118 1.367 . . . . 0.0 111.706 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.79 134.7 52.27 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.284 1.034 . . . . 0.0 111.688 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -140.35 157.09 69.3 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.144 1.378 . . . . 0.0 110.589 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.39 131.25 18.63 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.251 3.301 . . . . 0.0 111.648 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -122.72 116.41 23.71 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.197 0.999 . . . . 0.0 111.446 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -113.85 77.89 3.81 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 119.223 0.92 . . . . 0.0 111.781 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.6 145.9 38.07 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.145 2.563 . . . . 0.0 111.297 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.2 m -73.91 135.79 43.31 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.339 1.056 . . . . 0.0 110.782 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.16 -179.06 42.99 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 123.708 0.671 . . . . 0.0 111.57 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -103.24 126.36 50.37 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.895 0.878 . . . . 0.0 108.758 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -67.0 155.4 38.73 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.905 1.282 . . . . 0.0 110.02 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.5 m -83.2 -76.95 0.26 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -128.48 167.75 16.62 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.029 1.331 . . . . 0.0 109.952 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -77.73 151.0 34.34 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.285 1.034 . . . . 0.0 110.137 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -151.38 -175.57 5.23 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.353 0.661 . . . . 0.0 110.724 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.3 pt -138.26 176.39 6.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 123.875 0.87 . . . . 0.0 110.318 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 116.782 -1.58 . . . . 0.0 111.581 169.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ppp? . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.9 m -173.12 -53.6 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 126.18 1.792 . . . . 0.0 108.405 173.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -73.49 105.13 4.71 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.524 0.73 . . . . 0.0 109.684 -176.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.5 p -98.57 81.6 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.3 m -75.71 151.38 37.66 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.151 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.514 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -135.71 147.51 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.036 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.3 tt -110.12 98.81 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 C-N-CA 123.699 0.8 . . . . 0.0 109.108 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.77 97.23 10.87 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.134 0.974 . . . . 0.0 109.181 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -72.09 102.65 3.06 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 169.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.68 82.86 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 174.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -65.92 132.05 47.7 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.97 -177.32 28.18 Favored Glycine 0 N--CA 1.448 -0.543 0 O-C-N 123.443 0.464 . . . . 0.0 111.988 178.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -89.06 69.05 8.4 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 121.911 0.863 . . . . 0.0 109.421 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.3 t -108.61 -47.35 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.937 1.695 . . . . 0.0 109.181 -167.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -57.68 145.19 35.11 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.076 0.95 . . . . 0.0 109.817 166.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.75 -45.11 2.71 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.801 0.715 . . . . 0.0 111.368 -175.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.0 t -65.64 -33.71 65.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.675 0.79 . . . . 0.0 111.085 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.2 38.51 5.36 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.581 1.086 . . . . 0.0 111.651 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -52.07 -30.37 25.56 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 126.17 1.788 . . . . 0.0 113.181 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.0 54.54 0.67 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.008 1.323 . . . . 0.0 110.377 174.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -87.37 -74.61 0.43 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.658 1.183 . . . . 0.0 108.444 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -101.83 17.83 22.05 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.637 1.175 . . . . 0.0 110.994 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.6 t -61.81 -40.53 95.59 Favored 'General case' 0 C--N 1.344 0.363 0 O-C-N 121.856 -0.527 . . . . 0.0 111.111 171.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -60.18 -50.33 74.1 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.402 0.681 . . . . 0.0 110.916 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -52.24 -58.49 6.48 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 123.184 0.303 . . . . 0.0 110.303 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.18 -52.17 59.69 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.755 1.222 . . . . 0.0 110.872 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.16 -39.66 63.75 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.444 1.097 . . . . 0.0 111.843 177.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -72.08 -23.69 61.39 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.917 0.887 . . . . 0.0 112.104 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.3 mmm-85 -65.12 -47.16 78.15 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 118.854 0.752 . . . . 0.0 108.982 171.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.9 mt -75.09 -33.46 61.64 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.069 0.947 . . . . 0.0 111.213 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.62 45.55 52.53 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 124.748 1.166 . . . . 0.0 111.314 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.36 174.98 5.65 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.757 1.223 . . . . 0.0 112.605 -175.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.4 p -114.63 -171.72 1.98 Allowed 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -170.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.69 -144.37 17.58 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 170.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -171.72 153.56 3.39 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 176.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.94 83.87 2.29 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.638 1.175 . . . . 0.0 108.689 170.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt -83.64 165.22 19.16 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -126.99 134.66 50.31 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 47.6 mt -80.74 -175.27 5.2 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.584 0.754 . . . . 0.0 109.899 170.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -93.04 2.31 56.84 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.961 0.904 . . . . 0.0 111.164 168.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -79.6 -48.1 14.34 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.403 0.681 . . . . 0.0 109.418 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.46 -28.72 2.31 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -157.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.04 117.02 10.17 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.312 0.645 . . . . 0.0 111.364 -166.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 63.8 t -88.76 104.12 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 171.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -79.65 93.41 5.51 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.821 1.248 . . . . 0.0 108.753 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.1 t -91.21 114.94 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.03 130.42 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.31 1.044 . . . . 0.0 108.479 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.17 123.64 7.17 Favored 'General case' 0 N--CA 1.457 -0.113 0 O-C-N 124.377 1.048 . . . . 0.0 109.792 -166.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 91.4 m -95.7 176.66 6.06 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.064 0.946 . . . . 0.0 112.085 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.9 -155.11 16.29 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -72.76 150.59 42.68 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 172.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -58.58 -46.89 85.96 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -46.49 -45.24 16.92 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.137 1.827 . . . . 0.0 113.034 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -67.02 -51.61 52.74 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.578 0.689 . . . . 0.0 110.707 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.7 t -61.08 -32.48 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.876 0.87 . . . . 0.0 111.904 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -53.64 -40.98 66.27 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.415 0.686 . . . . 0.0 111.092 173.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -65.06 -30.76 71.74 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.145 0.884 . . . . 0.0 112.691 -169.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -78.46 -35.97 45.97 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.565 0.62 . . . . 0.0 110.929 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 54.0 mtm -64.17 -41.91 96.93 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.498 0.59 . . . . 0.0 111.197 175.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -51.96 -29.77 21.92 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.219 1.008 . . . . 0.0 112.386 172.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 12.8 t90 -83.65 -41.07 18.18 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 117.845 -1.074 . . . . 0.0 110.874 170.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 25.6 mt -53.42 -46.6 69.84 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 120.098 1.317 . . . . 0.0 111.53 -174.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -58.16 -24.79 60.19 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.9 t -106.4 -0.69 23.99 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.996 1.718 . . . . 0.0 111.63 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.74 -33.24 84.51 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.265 0.936 . . . . 0.0 111.997 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 175.83 67.34 0.06 OUTLIER Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.0 -0.889 . . . . 0.0 110.896 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.02 -45.06 13.58 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.351 2.701 . . . . 0.0 112.299 -172.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 53.0 ptt85 -69.37 -33.71 73.46 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.039 0.536 . . . . 0.0 112.248 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.8 p -84.69 -74.32 0.39 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.1 0.56 . . . . 0.0 110.168 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.8 108.92 2.28 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.168 0.987 . . . . 0.0 109.035 175.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -87.13 76.76 9.22 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -168.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.6 t -67.27 102.14 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.515 1.126 . . . . 0.0 109.519 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -70.55 -54.83 10.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.032 0.933 . . . . 0.0 110.945 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -151.54 150.05 29.9 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 123.652 0.781 . . . . 0.0 110.097 -174.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.0 t -127.6 102.08 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.844 1.258 . . . . 0.0 109.53 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.7 tp -105.37 114.2 28.23 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 123.586 0.754 . . . . 0.0 110.159 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.4 m -99.28 138.11 36.83 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.122 0.569 . . . . 0.0 109.902 170.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -130.04 148.85 71.32 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 125.67 1.588 . . . . 0.0 108.402 172.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.61 109.87 1.52 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.406 2.737 . . . . 0.0 109.936 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -89.5 113.16 24.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.859 1.264 . . . . 0.0 109.164 -174.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -110.88 72.37 0.78 Allowed Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 125.162 1.385 . . . . 0.0 110.454 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.45 135.73 24.89 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.642 2.228 . . . . 0.0 110.119 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.1 p -71.36 137.23 48.24 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.16 -160.16 50.97 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -173.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -137.24 145.63 43.81 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.233 1.013 . . . . 0.0 110.11 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.3 tp -100.33 137.5 38.66 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 171.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.1 m -66.17 -48.43 70.75 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.694 0.797 . . . . 0.0 111.801 -173.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -129.53 160.93 31.68 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.976 0.911 . . . . 0.0 111.866 -166.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -84.85 145.8 27.65 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.427 1.091 . . . . 0.0 109.315 166.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -145.73 173.41 12.12 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.792 0.837 . . . . 0.0 110.893 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.6 pt -140.19 155.27 23.65 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 C-N-CA 123.827 0.851 . . . . 0.0 110.409 -174.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 116.94 -1.505 . . . . 0.0 110.048 157.289 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.3 m -116.9 -39.2 3.29 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.329 1.052 . . . . 0.0 112.024 -171.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -67.96 107.68 2.76 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 121.091 0.472 . . . . 0.0 110.966 -177.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.39 80.47 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.733 1.613 . . . . 0.0 107.097 -173.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -76.72 148.01 37.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.537 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.445 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.2 pp -120.03 164.26 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.6 tt -125.01 118.5 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 124.395 1.078 . . . . 0.0 108.867 170.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -115.27 107.84 15.79 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.784 1.234 . . . . 0.0 110.211 -176.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -86.1 121.56 28.87 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 172.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.6 t -100.44 94.18 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -63.76 152.55 39.04 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.916 0.886 . . . . 0.0 110.958 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.3 -178.64 26.72 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 124.389 0.995 . . . . 0.0 112.261 174.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -85.94 87.55 7.43 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 123.169 0.588 . . . . 0.0 110.647 -173.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.0 t -114.82 -40.04 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.771 1.228 . . . . 0.0 110.178 -174.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -65.56 152.34 44.31 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.629 0.772 . . . . 0.0 111.718 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.67 17.95 76.94 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.996 0.807 . . . . 0.0 113.543 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.69 -42.05 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.783 1.233 . . . . 0.0 109.257 175.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.26 32.08 1.89 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.687 1.613 . . . . 0.0 112.124 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -53.21 -29.1 30.26 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.541 1.537 . . . . 0.0 112.882 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -68.69 41.54 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.096 2.158 . . . . 0.0 113.5 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -85.8 -67.72 0.79 Allowed 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.508 -0.745 . . . . 0.0 110.029 -173.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.3 t -92.56 -9.77 40.0 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.888 0.875 . . . . 0.0 112.61 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.6 t -43.82 -48.54 8.26 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.06 0.944 . . . . 0.0 113.541 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -58.4 -57.16 14.13 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 124.653 1.181 . . . . 0.0 110.141 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -50.74 -55.66 15.65 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.499 1.12 . . . . 0.0 110.672 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.16 -54.2 39.32 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 124.596 1.159 . . . . 0.0 110.164 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.57 -36.83 64.79 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.658 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -68.51 -31.44 70.7 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.464 0.705 . . . . 0.0 112.125 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -60.92 -49.29 78.05 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.715 0.689 . . . . 0.0 110.282 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.3 mt -75.52 -31.03 59.98 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.392 0.277 . . . . 0.0 110.911 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.55 22.54 53.5 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.749 1.166 . . . . 0.0 112.593 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.94 169.26 10.41 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.658 0.783 . . . . 0.0 112.201 -177.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.6 p -112.27 -159.39 0.68 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.725 0.81 . . . . 0.0 109.352 -166.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.7 -154.77 16.68 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 170.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -169.47 160.68 9.33 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.05 78.97 1.39 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.738 1.215 . . . . 0.0 109.679 -174.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -85.01 166.34 16.79 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -126.86 129.82 49.0 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.6 mt -68.08 173.84 4.31 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.904 1.282 . . . . 0.0 110.781 177.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -89.44 13.77 12.93 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.953 0.901 . . . . 0.0 111.378 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -105.94 -51.14 3.03 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 123.894 0.878 . . . . 0.0 110.31 -176.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 161.02 -20.55 0.21 Allowed Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.446 1.022 . . . . 0.0 112.671 -167.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.2 p -105.26 159.14 16.11 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.078 0.951 . . . . 0.0 112.287 -162.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.2 t -116.22 126.49 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.248 1.019 . . . . 0.0 111.261 -169.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -100.33 105.55 17.09 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.644 1.577 . . . . 0.0 110.397 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.6 t -110.45 127.16 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 123.262 0.625 . . . . 0.0 109.818 -172.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.46 141.0 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 118.629 -0.7 . . . . 0.0 109.948 -171.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.52 128.16 4.46 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 118.163 -0.922 . . . . 0.0 112.329 -167.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 98.9 m -97.04 177.65 5.53 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 113.443 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.62 -172.8 16.31 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 125.054 1.311 . . . . 0.0 111.01 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -67.59 124.28 22.81 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -52.62 -40.45 62.76 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.175 1.39 . . . . 0.0 112.24 -168.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -43.96 -50.59 7.43 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.669 1.604 . . . . 0.0 112.379 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -65.07 -52.72 54.03 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 122.958 0.503 . . . . 0.0 110.516 176.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.2 t -46.43 -45.57 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.094 0.958 . . . . 0.0 111.626 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -64.21 -29.05 70.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.496 -0.764 . . . . 0.0 112.799 -175.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -54.63 -44.27 73.03 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 119.324 0.966 . . . . 0.0 111.197 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.2 -29.32 61.68 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.452 0.301 . . . . 0.0 111.169 177.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mtm -68.31 -25.74 65.28 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 118.692 -0.67 . . . . 0.0 112.033 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -48.64 -53.15 19.68 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 166.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -62.81 -40.96 99.01 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 118.534 -0.745 . . . . 0.0 112.17 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 mt -54.81 -53.37 56.15 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.779 1.172 . . . . 0.0 109.922 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -66.7 -19.28 65.72 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.571 0.748 . . . . 0.0 112.915 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -104.25 -11.47 17.19 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.743 1.217 . . . . 0.0 112.36 -178.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.83 -43.08 96.64 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 124.356 0.979 . . . . 0.0 111.324 -172.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -12.09 85.12 0.0 OUTLIER Glycine 0 CA--C 1.533 1.192 0 C-N-CA 128.796 3.093 . . . . 0.0 115.553 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.26 165.8 27.24 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.991 2.46 . . . . 0.0 110.53 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -53.82 -40.66 66.6 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.62 1.168 . . . . 0.0 113.336 -169.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.2 t -72.88 -37.59 67.28 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.355 1.062 . . . . 0.0 111.636 -173.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.8 160.52 29.89 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.221 1.008 . . . . 0.0 111.562 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -128.82 101.4 6.09 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.082 0.953 . . . . 0.0 108.535 172.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.6 t -82.58 93.75 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -68.56 -48.7 63.58 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 119.055 -0.498 . . . . 0.0 111.221 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.2 mtm105 -167.05 163.85 15.85 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.801 0.841 . . . . 0.0 110.799 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -127.06 117.25 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.289 1.036 . . . . 0.0 109.926 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 tt -106.91 111.84 24.53 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.257 1.023 . . . . 0.0 110.022 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.5 m -103.9 137.39 41.96 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.348 0.659 . . . . 0.0 111.175 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -139.64 160.06 62.8 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 126.037 1.735 . . . . 0.0 109.759 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.73 129.54 12.7 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.346 2.697 . . . . 0.0 110.367 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 59.4 t60 -116.88 110.51 18.43 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.287 1.035 . . . . 0.0 109.607 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -108.18 80.53 1.11 Allowed Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 119.079 0.854 . . . . 0.0 111.055 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.15 160.92 46.11 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.99 2.46 . . . . 0.0 110.85 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 88.7 p -84.08 147.59 27.29 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.028 0.931 . . . . 0.0 110.473 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.22 -171.75 18.18 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.85 0.738 . . . . 0.0 112.298 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -105.29 136.11 45.43 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.121 0.968 . . . . 0.0 109.864 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 mp -81.72 147.11 29.64 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.307 1.043 . . . . 0.0 109.251 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 19.2 p -78.69 -66.04 0.91 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.624 1.17 . . . . 0.0 109.874 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -137.92 166.55 23.76 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.259 1.424 . . . . 0.0 110.693 -167.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -84.36 140.68 31.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 167.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -148.38 -172.43 4.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.014 0.526 . . . . 0.0 109.827 -174.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.3 tt -163.29 160.07 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -175.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 . . . . . 0 C--O 1.252 1.205 0 C-N-CA 124.952 1.301 . . . . 0.0 111.118 167.317 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 ptp . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 119.828 -0.13 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 t -121.85 -37.41 2.87 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.667 1.187 . . . . 0.0 111.286 -176.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -67.14 120.48 13.8 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.221 1.008 . . . . 0.0 111.471 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 p -127.64 85.04 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 125.578 1.551 . . . . 0.0 107.813 -173.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.57 148.68 31.65 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.853 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.419 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.3 pp -129.43 162.96 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.6 tt -121.66 125.77 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 124.026 0.931 . . . . 0.0 108.988 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -118.62 103.66 9.91 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.659 1.584 . . . . 0.0 109.832 -173.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.5 m-90 -85.65 117.66 24.68 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.23 0.612 . . . . 0.0 109.815 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.0 t -100.51 108.85 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 123.83 0.852 . . . . 0.0 108.978 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -78.86 164.78 24.2 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.122 0.569 . . . . 0.0 110.876 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.76 -177.88 42.13 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 124.061 0.839 . . . . 0.0 112.122 177.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -84.76 81.42 8.88 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.386 0.612 . . . . 0.0 111.066 -169.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.8 t -108.52 -44.42 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.478 1.511 . . . . 0.0 110.48 -173.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -65.9 153.8 41.02 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.117 0.567 . . . . 0.0 110.964 175.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 67.75 17.52 69.3 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 123.998 0.808 . . . . 0.0 113.722 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.6 t -104.04 -43.27 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.752 1.221 . . . . 0.0 108.828 172.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.63 32.76 2.61 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.904 1.716 . . . . 0.0 111.233 -176.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -53.5 -34.59 58.65 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.801 1.24 . . . . 0.0 112.356 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.3 53.89 0.68 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.438 1.495 . . . . 0.0 112.139 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -94.4 -75.05 0.52 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.497 1.119 . . . . 0.0 109.48 -176.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -79.99 -11.87 59.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.905 0.882 . . . . 0.0 112.016 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.6 t -44.18 -44.43 7.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.97 0.908 . . . . 0.0 112.719 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.4 mm-40 -56.41 -63.68 1.11 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.823 1.649 . . . . 0.0 110.166 172.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -50.85 -56.22 13.23 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.969 1.707 . . . . 0.0 111.75 -174.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -56.04 -54.59 43.14 Favored 'General case' 0 CA--C 1.527 0.064 0 C-N-CA 124.292 1.037 . . . . 0.0 109.852 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.47 -37.61 49.72 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.93 0.892 . . . . 0.0 111.888 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -65.32 -32.16 73.67 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.769 1.228 . . . . 0.0 112.474 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.2 mmm-85 -64.52 -45.14 88.47 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 118.464 0.574 . . . . 0.0 110.037 175.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.5 mt -73.23 -36.02 66.38 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.192 0.597 . . . . 0.0 111.311 -178.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.49 18.61 65.93 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.415 1.007 . . . . 0.0 112.475 -175.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.47 169.45 14.49 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.463 0.705 . . . . 0.0 110.713 177.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.2 p -111.87 -157.61 0.62 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -170.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.6 -155.21 16.34 Favored Glycine 0 C--N 1.339 0.711 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 166.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -166.66 154.78 10.02 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 173.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.12 96.17 5.79 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.237 1.415 . . . . 0.0 110.098 175.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -102.2 174.09 6.08 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.749 0.82 . . . . 0.0 111.321 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -125.28 132.38 52.92 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.109 0.964 . . . . 0.0 109.344 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.0 mt -71.48 171.96 10.39 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.14 1.376 . . . . 0.0 110.758 174.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -95.47 15.68 19.01 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.049 1.34 . . . . 0.0 111.763 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -117.2 -26.35 6.8 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.115 0.966 . . . . 0.0 112.043 -175.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.73 4.13 1.66 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.644 1.116 . . . . 0.0 114.307 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 p -121.11 167.51 12.56 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.002 1.321 . . . . 0.0 112.091 -165.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.7 t -123.9 128.24 74.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.578 1.151 . . . . 0.0 111.222 -170.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -101.89 111.46 23.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.165 1.386 . . . . 0.0 111.56 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.1 t -108.5 132.55 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 123.043 0.537 . . . . 0.0 110.235 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.53 143.62 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.873 0.869 . . . . 0.0 110.174 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.4 129.11 5.49 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 118.174 -0.917 . . . . 0.0 111.905 -172.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 80.8 m -95.6 -179.43 4.74 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.634 1.174 . . . . 0.0 112.441 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.43 -167.4 14.79 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 124.94 1.257 . . . . 0.0 109.978 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.98 139.79 46.92 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 170.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -53.79 -45.09 70.62 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.904 0.882 . . . . 0.0 110.587 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -42.47 -45.52 5.45 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.347 1.927 . . . . 0.0 113.202 174.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -74.21 -46.93 38.71 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.252 1.021 . . . . 0.0 111.592 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -53.34 -41.51 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.461 0.705 . . . . 0.0 110.69 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -65.14 -22.72 66.96 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.331 0.653 . . . . 0.0 112.67 -176.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -61.87 -45.23 94.67 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.366 0.53 . . . . 0.0 111.021 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.3 -28.07 61.01 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.392 0.542 . . . . 0.0 111.038 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -68.59 -26.13 65.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.695 -0.669 . . . . 0.0 111.277 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -44.0 -49.36 8.65 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 167.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -69.34 -37.21 77.57 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-O 118.426 -0.797 . . . . 0.0 111.69 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 mt -51.36 -42.42 61.32 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.972 0.806 . . . . 0.0 111.028 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.42 -45.43 62.72 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.1 t -58.07 -29.87 65.75 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.741 0.816 . . . . 0.0 113.101 175.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.28 -3.88 77.75 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.996 1.284 . . . . 0.0 113.022 -177.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.7 -72.64 0.71 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-N 118.188 0.994 . . . . 0.0 112.607 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -77.84 74.77 5.08 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.934 3.09 . . . . 0.0 110.767 -172.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.76 -57.11 0.73 Allowed 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.062 1.345 . . . . 0.0 109.164 -175.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.79 -45.79 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.115 1.366 . . . . 0.0 109.347 -175.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.32 154.52 10.45 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.795 1.238 . . . . 0.0 111.118 173.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.0 ttm-85 -113.08 78.37 1.13 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -177.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.8 t -71.14 102.43 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.71 0.804 . . . . 0.0 109.17 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -73.12 -52.6 13.62 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.609 0.763 . . . . 0.0 111.407 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.2 mmm-85 -168.94 166.44 11.22 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.725 1.21 . . . . 0.0 109.433 -171.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.06 133.84 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 118.838 -0.601 . . . . 0.0 111.41 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.6 tp -124.69 125.68 44.49 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.077 0.951 . . . . 0.0 112.251 -175.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.95 135.1 49.09 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.273 1.029 . . . . 0.0 111.813 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -134.17 155.98 79.5 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 125.909 1.684 . . . . 0.0 110.203 -178.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.74 126.53 11.48 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 124.244 3.296 . . . . 0.0 111.078 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -119.21 107.49 13.5 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.147 0.979 . . . . 0.0 110.371 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -110.55 74.22 0.87 Allowed Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 119.228 0.922 . . . . 0.0 111.464 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -72.97 151.5 50.47 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.179 2.586 . . . . 0.0 111.44 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.4 p -79.19 140.69 37.65 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.123 0.969 . . . . 0.0 110.624 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.8 174.26 16.57 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.028 0.823 . . . . 0.0 111.89 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -92.04 142.66 27.28 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.758 0.823 . . . . 0.0 108.975 171.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -85.98 149.01 25.49 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.1 p -75.54 -75.95 0.16 Allowed 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -134.08 163.0 30.55 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.833 0.853 . . . . 0.0 110.847 -171.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -76.52 148.63 37.0 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.848 0.859 . . . . 0.0 109.829 172.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -150.95 -177.69 6.16 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.121 0.568 . . . . 0.0 109.948 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.9 pt -132.07 152.65 37.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 C-N-CA 123.575 0.75 . . . . 0.0 109.615 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.2 mtm180 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 125.362 1.465 . . . . 0.0 113.526 174.107 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 119.025 -0.512 . . . . 0.0 109.715 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 t -168.91 -53.77 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 117.895 0.316 . . . . 0.0 110.97 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -63.06 134.71 56.52 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.709 1.204 . . . . 0.0 112.132 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.0 p -139.95 92.86 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.294 0 C-N-CA 124.603 1.161 . . . . 0.0 109.027 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.8 m -86.67 156.65 19.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.469 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.5 pp -140.46 158.48 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.073 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 tt -119.01 109.82 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.123 0.969 . . . . 0.0 109.549 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -101.99 119.77 39.33 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.298 1.039 . . . . 0.0 110.157 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.0 m-90 -97.39 112.35 24.22 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.039 0.935 . . . . 0.0 110.493 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.466 HG12 HG21 ' A' ' 14' ' ' VAL . 3.8 t -91.78 123.78 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.93 0.892 . . . . 0.0 109.063 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -94.0 174.89 6.93 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.461 1.504 . . . . 0.0 111.202 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.12 -163.56 54.15 Favored Glycine 0 C--N 1.338 0.683 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -85.93 91.8 8.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.67 0.788 . . . . 0.0 111.514 -173.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.466 HG21 HG12 ' A' ' 10' ' ' VAL . 17.6 t -123.45 -44.31 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.171 0.988 . . . . 0.0 109.771 -175.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -71.27 143.05 50.49 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.29 0.636 . . . . 0.0 110.172 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.26 18.04 79.09 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 119.214 -0.77 . . . . 0.0 113.309 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.0 t -108.78 -43.19 5.92 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 124.331 1.052 . . . . 0.0 109.686 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 116.71 25.56 3.34 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 125.185 1.374 . . . . 0.0 111.639 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -51.24 -35.09 35.33 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.891 0.876 . . . . 0.0 111.105 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.5 mtp180 -74.9 59.86 0.93 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.243 1.417 . . . . 0.0 111.36 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -114.27 -73.51 0.65 Allowed 'General case' 0 C--N 1.339 0.139 0 C-N-CA 125.389 1.475 . . . . 0.0 108.807 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.3 t -73.69 -19.96 60.68 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.229 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.5 t -45.44 -36.96 4.72 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.937 0.895 . . . . 0.0 112.163 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -69.95 -59.21 3.06 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.508 1.123 . . . . 0.0 110.208 176.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -52.33 -53.98 37.49 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.534 1.134 . . . . 0.0 111.348 -175.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.58 -52.12 64.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.643 1.177 . . . . 0.0 110.214 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.87 -31.54 59.81 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.169 0.587 . . . . 0.0 112.408 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -65.02 -34.33 78.18 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.642 1.177 . . . . 0.0 111.597 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -69.92 -48.87 56.85 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.757 0.823 . . . . 0.0 110.34 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.7 mt -71.21 -34.24 70.66 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.917 0.487 . . . . 0.0 110.779 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.09 14.08 81.1 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.319 0.962 . . . . 0.0 112.671 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.55 178.14 5.54 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.533 0.733 . . . . 0.0 111.259 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.3 p -123.79 -174.91 3.09 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 136.61 -149.3 20.11 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 170.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -169.03 165.93 11.17 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 172.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.1 101.58 7.09 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.597 0.759 . . . . 0.0 112.031 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -97.99 175.28 6.18 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.444 1.098 . . . . 0.0 111.243 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -123.77 136.54 54.48 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.837 1.255 . . . . 0.0 109.973 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.419 HD12 ' HB2' ' A' ' 43' ' ' SER . 18.6 mt -74.19 173.91 9.48 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.504 1.522 . . . . 0.0 109.981 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -97.58 13.47 29.96 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.151 0.98 . . . . 0.0 111.719 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -117.92 -11.01 10.32 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 124.044 0.938 . . . . 0.0 112.446 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.38 19.77 4.53 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 125.098 1.333 . . . . 0.0 114.061 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.419 ' HB2' HD12 ' A' ' 39' ' ' LEU . 17.1 m -118.14 166.25 12.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.546 1.538 . . . . 0.0 111.601 -171.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.2 t -129.35 118.25 45.31 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 C-N-CA 124.046 0.938 . . . . 0.0 110.575 -175.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -94.88 126.47 40.23 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.58 0.752 . . . . 0.0 110.554 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.8 t -120.38 133.95 65.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.687 0.795 . . . . 0.0 109.457 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.5 t -126.28 142.54 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 C-N-CA 124.425 1.09 . . . . 0.0 109.512 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.93 134.62 10.83 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-O 118.752 -0.642 . . . . 0.0 111.117 -173.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 51.8 m -99.77 178.44 4.83 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.211 1.404 . . . . 0.0 112.611 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.46 -153.19 20.15 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -83.77 126.63 33.12 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.832 1.253 . . . . 0.0 109.561 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -46.38 -51.48 14.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.723 1.209 . . . . 0.0 111.537 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -51.9 -44.88 56.12 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.223 1.392 . . . . 0.0 112.97 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -69.09 -44.22 72.92 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 117.33 0.565 . . . . 0.0 111.752 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.4 t -54.39 -32.66 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 122.749 0.419 . . . . 0.0 110.728 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.97 -29.97 69.98 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -57.66 -24.03 54.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.009 0.923 . . . . 0.0 112.608 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.68 -29.51 12.62 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-N 118.784 0.72 . . . . 0.0 111.483 171.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.3 mmm -65.79 -20.36 66.23 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.838 -0.601 . . . . 0.0 111.949 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -45.12 -58.18 3.39 Favored 'General case' 0 C--O 1.214 -0.791 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 172.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -62.76 -36.9 84.55 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.125 0.57 . . . . 0.0 111.833 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -58.16 -52.75 64.25 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 123.707 0.803 . . . . 0.0 110.375 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.13 -30.48 62.32 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.046 0.539 . . . . 0.0 112.234 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.7 m -75.8 -23.18 55.82 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.332 0.653 . . . . 0.0 111.946 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.79 8.85 78.27 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.38 -1.234 . . . . 0.0 113.18 -176.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.86 -103.63 0.06 OUTLIER Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.905 1.717 . . . . 0.0 112.725 -176.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.3 -174.76 1.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.838 3.025 . . . . 0.0 111.761 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -78.68 -32.89 47.26 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.688 0.795 . . . . 0.0 110.995 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.0 p -57.42 161.83 3.2 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.167 0.987 . . . . 0.0 111.155 175.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 69.79 159.46 0.19 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.32 1.448 . . . . 0.0 110.684 -171.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.82 107.94 10.3 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.5 t -88.38 80.54 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -55.31 -49.97 70.78 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 122.979 0.512 . . . . 0.0 111.21 176.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -171.26 171.13 5.75 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.67 1.188 . . . . 0.0 109.595 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.9 p -156.28 134.26 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.009 0.523 . . . . 0.0 110.212 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tp -113.91 149.63 34.9 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.989 0.916 . . . . 0.0 110.886 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.12 131.32 44.05 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.427 1.091 . . . . 0.0 111.344 -176.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -141.53 156.31 66.73 Favored Pre-proline 0 N--CA 1.468 0.431 0 C-N-CA 124.01 0.924 . . . . 0.0 111.622 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -68.63 125.28 12.53 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 124.213 3.275 . . . . 0.0 110.836 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -118.99 117.36 28.58 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.89 0.876 . . . . 0.0 109.878 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -109.34 77.67 0.97 Allowed Pre-proline 0 CA--C 1.539 0.53 0 O-C-N 121.498 -0.751 . . . . 0.0 110.344 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.63 126.58 12.23 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.656 2.904 . . . . 0.0 109.755 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.0 p -70.31 148.67 48.23 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.338 0.655 . . . . 0.0 110.688 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.25 176.7 8.84 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.973 0.796 . . . . 0.0 112.164 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -105.27 131.78 52.3 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.71 1.204 . . . . 0.0 108.872 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.2 tp -83.19 151.76 25.53 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.572 0.749 . . . . 0.0 109.55 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.5 m -74.74 -73.43 0.24 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -138.04 162.99 32.72 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.466 1.106 . . . . 0.0 110.369 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -71.83 147.21 47.4 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.673 0.789 . . . . 0.0 110.519 175.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -143.97 -177.35 5.39 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.64 1.176 . . . . 0.0 110.159 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.3 pt -146.12 78.33 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 123.628 0.771 . . . . 0.0 109.102 -177.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 35.7 mtp180 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 117.045 -1.455 . . . . 0.0 111.665 -179.647 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ptt? . . . . . 0 N--CA 1.474 0.758 0 CA-C-O 119.857 -0.116 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 t -138.17 -41.07 0.52 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.922 0.889 . . . . 0.0 110.605 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.67 152.85 44.59 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.285 1.034 . . . . 0.0 112.821 -177.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 p -138.49 88.43 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.262 1.025 . . . . 0.0 108.405 -174.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.5 m -79.55 150.49 31.1 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.584 HD11 HG11 ' A' ' 55' ' ' VAL . 1.4 pp -136.68 157.17 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.9 tt -116.35 116.35 52.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.431 1.093 . . . . 0.0 109.609 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -111.41 103.21 11.55 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.674 1.59 . . . . 0.0 109.917 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.1 m-90 -83.68 115.59 22.25 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 123.783 0.833 . . . . 0.0 109.868 176.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.466 HG13 HG22 ' A' ' 75' ' ' VAL . 4.3 t -97.92 113.24 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -87.82 172.63 9.49 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 124.487 1.115 . . . . 0.0 111.175 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.03 -169.55 55.01 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 123.632 0.634 . . . . 0.0 111.821 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -83.39 85.33 7.25 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.02 0.528 . . . . 0.0 112.124 -167.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.4 t -117.7 -43.08 2.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.845 -173.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -68.23 148.34 50.96 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.683 0.674 . . . . 0.0 110.389 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.74 -31.01 8.32 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 118.918 -0.934 . . . . 0.0 113.426 174.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 m -74.34 -0.58 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 119.018 1.409 . . . . 0.0 112.448 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.01 36.83 73.22 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.199 0.904 . . . . 0.0 110.859 -170.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -51.25 -38.84 54.86 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 123.908 0.883 . . . . 0.0 111.157 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.16 55.97 0.6 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.511 1.524 . . . . 0.0 113.095 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -110.99 -72.42 0.72 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.402 1.081 . . . . 0.0 109.465 -177.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 t -73.77 -16.93 61.15 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.213 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.2 t -40.68 -42.09 1.66 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.141 1.376 . . . . 0.0 113.021 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -64.3 -61.46 2.22 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.632 1.173 . . . . 0.0 110.411 173.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -48.97 -54.38 15.83 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.604 1.562 . . . . 0.0 111.734 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -55.69 -45.82 77.75 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.355 1.462 . . . . 0.0 112.038 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.09 -30.38 71.32 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.092 0.557 . . . . 0.0 111.999 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.8 tttt -65.3 -35.44 81.01 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.831 0.853 . . . . 0.0 111.328 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -67.51 -49.46 63.31 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.294 0.638 . . . . 0.0 110.536 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.9 mt -73.55 -34.37 65.15 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.825 0.45 . . . . 0.0 110.74 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.08 13.24 72.05 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.208 0.909 . . . . 0.0 112.866 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.21 176.28 8.9 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.775 0.83 . . . . 0.0 111.506 178.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.7 p -115.61 -160.89 0.76 Allowed 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -172.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.2 -155.25 16.27 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 118.637 0.653 . . . . 0.0 112.751 169.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -168.99 159.37 9.27 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 174.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.22 91.38 3.44 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.579 1.152 . . . . 0.0 111.5 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -93.17 174.83 7.02 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.337 0.655 . . . . 0.0 110.357 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -123.19 133.99 54.19 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 124.191 0.996 . . . . 0.0 110.539 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 30.0 mt -74.67 169.32 18.05 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.77 1.628 . . . . 0.0 110.267 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -90.0 4.5 49.96 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.391 1.076 . . . . 0.0 112.113 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -107.83 -7.57 16.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.469 1.108 . . . . 0.0 112.093 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.56 12.69 11.33 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.085 1.326 . . . . 0.0 113.963 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.36 168.06 10.31 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.637 1.575 . . . . 0.0 112.003 -170.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.9 t -129.07 118.13 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.49 1.116 . . . . 0.0 110.894 -173.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -94.97 121.71 36.87 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.407 1.003 . . . . 0.0 111.234 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.5 t -119.05 134.07 63.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 117.966 0.348 . . . . 0.0 110.532 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.43 142.55 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.412 1.085 . . . . 0.0 109.704 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.08 133.24 7.69 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 118.637 -0.697 . . . . 0.0 111.569 -171.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 96.9 m -100.18 176.44 5.39 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.808 1.243 . . . . 0.0 112.785 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.18 -159.01 20.03 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.825 1.202 . . . . 0.0 110.317 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -73.36 134.24 44.03 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.21 0.604 . . . . 0.0 110.17 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -49.01 -49.46 40.87 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.447 1.099 . . . . 0.0 111.184 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -49.91 -53.3 22.86 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.097 1.332 . . . . 0.0 112.171 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -62.22 -43.61 98.44 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.469 0.708 . . . . 0.0 111.487 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.584 HG11 HD11 ' A' ' 6' ' ' ILE . 80.7 t -58.02 -40.0 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 122.611 0.364 . . . . 0.0 110.396 175.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.46 -26.4 68.71 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -176.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -55.47 -44.72 76.71 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.609 0.764 . . . . 0.0 110.897 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.26 -30.44 48.58 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 118.177 0.444 . . . . 0.0 111.632 175.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.3 mmt -68.38 -22.72 64.63 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 119.074 -0.489 . . . . 0.0 112.096 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -43.34 -51.13 6.54 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 167.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 18.7 t90 -64.25 -40.95 97.06 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.344 0.52 . . . . 0.0 111.989 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mt -56.03 -55.07 37.28 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 123.661 0.785 . . . . 0.0 111.043 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.26 -36.77 77.47 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.769 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.7 t -61.97 -33.24 73.94 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.454 0.57 . . . . 0.0 111.718 175.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.07 16.29 76.72 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 118.932 -0.927 . . . . 0.0 112.886 -176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.99 -105.69 0.12 Allowed Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.893 1.711 . . . . 0.0 112.471 -174.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.4 -177.39 2.06 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 124.142 3.228 . . . . 0.0 112.388 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -65.62 -29.06 69.6 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.453 0.701 . . . . 0.0 111.841 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.6 p -63.75 153.41 36.49 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.402 0.681 . . . . 0.0 110.353 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 77.67 148.5 0.1 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 127.02 2.128 . . . . 0.0 111.042 -168.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -128.74 79.47 1.91 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.7 t -67.54 94.32 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 124.901 1.28 . . . . 0.0 108.039 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -62.43 -56.84 14.32 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.856 0.862 . . . . 0.0 109.988 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -166.96 158.14 12.22 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.18 0.992 . . . . 0.0 109.424 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.466 HG22 HG13 ' A' ' 10' ' ' VAL . 21.8 t -132.3 135.78 57.44 Favored 'Isoleucine or valine' 0 C--N 1.342 0.24 0 C-N-CA 123.771 0.828 . . . . 0.0 110.031 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.9 tp -117.37 108.44 15.58 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.812 0.845 . . . . 0.0 110.789 -177.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.15 127.15 46.45 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.632 1.173 . . . . 0.0 111.52 -177.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -131.0 156.51 80.04 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 126.125 1.77 . . . . 0.0 110.673 -175.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -71.24 120.14 6.78 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.232 3.288 . . . . 0.0 111.495 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -109.44 109.04 19.77 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.485 0.714 . . . . 0.0 109.616 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -109.89 74.21 0.74 Allowed Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 123.945 0.898 . . . . 0.0 110.315 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.73 146.9 30.62 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.072 2.515 . . . . 0.0 110.511 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.7 p -72.72 141.17 48.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.424 0.69 . . . . 0.0 110.485 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.7 -178.63 35.53 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 123.871 0.748 . . . . 0.0 112.132 -177.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -104.12 130.84 51.86 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.333 1.053 . . . . 0.0 108.688 172.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mp -69.54 151.84 45.52 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.836 1.254 . . . . 0.0 109.713 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.59 -77.82 0.17 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.105 0.962 . . . . 0.0 109.008 178.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -137.37 167.0 22.48 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.343 1.057 . . . . 0.0 110.536 -173.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -73.74 143.22 46.18 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.598 173.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -130.93 174.63 9.79 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.414 0.686 . . . . 0.0 110.201 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.5 tp -147.93 152.7 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 122.76 0.424 . . . . 0.0 110.727 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.7 ptt85 . . . . . 0 C--O 1.252 1.185 0 CA-C-O 116.534 -1.698 . . . . 0.0 112.415 174.015 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mtp . . . . . 0 N--CA 1.474 0.76 0 CA-C-O 119.606 -0.235 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.25 -49.89 0.15 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.13 0.572 . . . . 0.0 111.038 -178.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -61.19 135.73 57.84 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.745 1.618 . . . . 0.0 112.104 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.6 p -140.85 91.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 124.604 1.162 . . . . 0.0 108.368 -174.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.0 m -80.86 155.88 26.36 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.579 177.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.411 HD11 HG11 ' A' ' 55' ' ' VAL . 1.3 pp -143.58 158.2 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.4 tt -118.49 119.73 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 124.103 0.961 . . . . 0.0 109.329 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -109.2 106.43 16.29 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.996 1.318 . . . . 0.0 109.99 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -90.13 124.3 34.7 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.903 0.881 . . . . 0.0 110.251 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.464 HG12 HG21 ' A' ' 14' ' ' VAL . 10.4 t -101.51 104.3 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.11 0.964 . . . . 0.0 108.605 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -68.45 176.87 2.63 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 123.801 0.84 . . . . 0.0 111.69 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.72 -169.51 47.92 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -92.24 91.32 7.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.032 0.533 . . . . 0.0 110.853 -175.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.464 HG21 HG12 ' A' ' 10' ' ' VAL . 57.3 t -111.86 -31.75 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 124.106 0.962 . . . . 0.0 111.233 -178.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -69.13 150.16 47.86 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.586 0.355 . . . . 0.0 110.557 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.46 17.55 66.16 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 123.918 0.77 . . . . 0.0 113.397 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.578 HG21 ' HB2' ' A' ' 70' ' ' ALA . 71.0 t -114.94 -45.56 4.35 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 C-N-CA 124.761 1.224 . . . . 0.0 109.367 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.32 31.93 1.59 Allowed Glycine 0 C--N 1.339 0.698 0 C-N-CA 125.197 1.38 . . . . 0.0 111.434 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -50.79 -36.12 35.44 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 117.664 0.732 . . . . 0.0 110.874 177.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -74.3 56.56 0.65 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.502 1.121 . . . . 0.0 112.741 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -97.42 -71.02 0.7 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.965 0.906 . . . . 0.0 109.264 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 t -89.35 -2.99 58.64 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.71 0.804 . . . . 0.0 111.69 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.8 t -45.98 -37.78 6.93 Favored 'General case' 0 C--N 1.345 0.397 0 C-N-CA 123.84 0.856 . . . . 0.0 112.099 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -69.84 -59.51 2.89 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 124.31 1.044 . . . . 0.0 109.949 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -49.48 -55.11 14.4 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.704 1.202 . . . . 0.0 111.29 -176.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -55.78 -57.5 11.76 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.021 0.928 . . . . 0.0 109.822 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.22 -34.29 31.54 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.926 0.891 . . . . 0.0 112.121 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -62.68 -38.89 92.14 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.438 1.095 . . . . 0.0 111.71 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -68.6 -38.4 80.6 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.017 0.927 . . . . 0.0 110.527 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.87 -32.34 57.43 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.676 0.791 . . . . 0.0 111.118 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.94 15.57 80.42 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.686 0.66 . . . . 0.0 112.82 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.447 HD12 ' HB1' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -83.18 179.76 7.63 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.965 0.906 . . . . 0.0 111.217 178.269 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 46.0 p -120.29 -162.43 0.94 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -176.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.1 -151.93 17.45 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 172.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -172.57 170.39 4.85 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.844 0.458 . . . . 0.0 112.085 175.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.56 88.19 2.7 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.43 0.692 . . . . 0.0 111.697 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -88.91 173.03 8.73 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.89 0.876 . . . . 0.0 110.18 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -124.01 138.56 54.44 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.699 1.2 . . . . 0.0 108.684 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.9 mt -74.58 178.63 5.21 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.09 1.356 . . . . 0.0 110.173 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -100.94 12.3 37.92 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.806 0.842 . . . . 0.0 111.327 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -117.08 -14.67 10.56 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.401 1.08 . . . . 0.0 112.497 -176.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.13 2.6 7.69 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.171 1.367 . . . . 0.0 114.12 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.1 m -104.34 167.19 9.91 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.855 1.262 . . . . 0.0 111.679 -171.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.9 t -125.4 127.66 72.02 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 C-N-CA 124.302 1.041 . . . . 0.0 109.979 -176.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -102.33 122.73 44.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.659 1.184 . . . . 0.0 110.96 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.76 135.67 57.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -131.2 145.07 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.941 0.897 . . . . 0.0 109.578 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.447 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -158.52 138.96 12.56 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.991 -173.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.3 m -108.98 -178.6 3.62 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.053 1.341 . . . . 0.0 112.298 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.46 -161.29 26.16 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.95 121.46 23.49 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.196 0.998 . . . . 0.0 110.944 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -49.69 -45.32 48.75 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.765 1.226 . . . . 0.0 110.941 -175.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -44.47 -43.74 7.82 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 126.424 1.964 . . . . 0.0 113.423 175.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -78.4 -49.03 14.27 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.689 0.795 . . . . 0.0 110.09 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.411 HG11 HD11 ' A' ' 6' ' ' ILE . 49.4 t -52.87 -32.71 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 122.727 0.411 . . . . 0.0 111.851 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -63.25 -32.0 73.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.255 1.422 . . . . 0.0 112.149 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? -61.89 -52.87 62.35 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-O 118.625 -0.703 . . . . 0.0 110.012 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.81 -29.78 68.47 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.215 0.916 . . . . 0.0 111.091 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.537 ' HA ' HD12 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -65.87 -22.67 66.54 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.412 -0.804 . . . . 0.0 111.518 177.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -48.14 -46.63 34.59 Favored 'General case' 0 C--N 1.343 0.326 0 CA-C-N 118.632 0.651 . . . . 0.0 109.951 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -70.46 -35.94 73.62 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.113 -177.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 59' ' ' MET . 5.2 mt -57.96 -44.75 87.22 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.634 0.652 . . . . 0.0 109.957 177.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -86.67 0.44 54.57 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.0 t -115.71 -15.2 11.37 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.251 1.421 . . . . 0.0 111.367 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -56.76 -55.98 27.19 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 54.45 67.16 2.32 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.548 ' CG ' ' HB3' ' A' ' 70' ' ' ALA . 72.9 Cg_endo -69.07 136.36 34.61 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 124.686 3.59 . . . . 0.0 110.976 -174.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -80.26 -37.18 33.41 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.879 0.871 . . . . 0.0 111.717 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.39 -35.74 34.84 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.99 0.916 . . . . 0.0 110.918 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.578 ' HB2' HG21 ' A' ' 17' ' ' VAL . . . -80.89 167.62 19.67 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.844 1.258 . . . . 0.0 110.144 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.1 ttt85 -124.88 83.43 2.16 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.309 1.044 . . . . 0.0 108.57 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.3 t -70.15 90.84 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -62.92 -58.03 8.76 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.208 0.603 . . . . 0.0 110.782 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.0 tpp180 -168.38 174.07 7.23 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.931 0.892 . . . . 0.0 109.592 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.0 t -140.68 127.61 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.751 0.821 . . . . 0.0 109.982 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.13 156.08 19.18 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.695 1.198 . . . . 0.0 111.086 176.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.12 134.11 34.23 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.5 1.12 . . . . 0.0 111.556 -177.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -141.26 155.37 67.96 Favored Pre-proline 0 N--CA 1.471 0.586 0 C-N-CA 123.897 0.879 . . . . 0.0 111.503 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.9 122.24 9.13 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 124.704 3.603 . . . . 0.0 111.047 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -114.69 135.71 53.86 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.113 0.965 . . . . 0.0 110.512 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -139.66 71.42 37.13 Favored Pre-proline 0 CA--C 1.534 0.356 0 O-C-N 121.659 -0.651 . . . . 0.0 110.481 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -68.28 136.33 36.89 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.394 2.73 . . . . 0.0 110.138 -174.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.5 p -64.63 144.13 57.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.453 0.701 . . . . 0.0 110.825 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.87 170.75 5.46 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.225 0.917 . . . . 0.0 112.041 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -86.59 137.15 32.73 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mp -77.9 150.23 34.13 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.458 0.703 . . . . 0.0 109.543 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.8 -79.26 0.14 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -145.67 163.8 33.75 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.376 0.671 . . . . 0.0 110.948 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -74.22 143.99 44.91 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.258 0.623 . . . . 0.0 110.652 177.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -158.4 -179.98 8.6 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.197 0.599 . . . . 0.0 110.429 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.15 144.56 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.511 0.724 . . . . 0.0 109.296 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.103 0 CA-C-O 116.878 -1.535 . . . . 0.0 114.015 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ptm . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 119.846 -0.121 . . . . 0.0 111.321 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 m -136.42 -47.03 0.62 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.185 0.994 . . . . 0.0 110.691 -176.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.6 134.36 54.19 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.176 1.39 . . . . 0.0 112.064 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 p -139.32 90.84 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.242 0 C-N-CA 124.645 1.178 . . . . 0.0 108.63 -174.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.3 m -81.36 153.2 27.12 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.772 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pp -141.16 158.2 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.123 0.569 . . . . 0.0 109.875 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 tt -117.7 118.24 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.171 0.989 . . . . 0.0 109.724 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -107.32 108.15 19.4 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.852 1.661 . . . . 0.0 109.897 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -90.4 128.35 36.46 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 125.243 1.417 . . . . 0.0 110.296 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.463 HG12 HG21 ' A' ' 14' ' ' VAL . 10.4 t -114.45 122.44 68.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.329 1.052 . . . . 0.0 109.07 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -96.66 178.76 5.22 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.829 1.252 . . . . 0.0 110.858 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.72 -160.21 53.44 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.3 mtt-85 -85.17 92.09 8.31 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -171.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.463 HG21 HG12 ' A' ' 10' ' ' VAL . 20.9 t -131.52 -45.84 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.523 0.729 . . . . 0.0 110.487 -175.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -70.46 146.91 49.98 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 122.857 0.463 . . . . 0.0 110.539 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.23 14.72 82.27 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 119.152 -0.805 . . . . 0.0 113.373 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 75.2 t -107.79 -44.11 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.618 1.167 . . . . 0.0 109.424 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.49 28.76 2.25 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 125.194 1.378 . . . . 0.0 111.431 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -50.78 -37.61 43.3 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 123.85 0.86 . . . . 0.0 111.11 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.21 59.49 0.76 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.388 1.075 . . . . 0.0 112.621 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -111.76 -72.84 0.7 Allowed 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.108 1.363 . . . . 0.0 109.55 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.1 t -73.13 -18.13 61.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.86 -0.59 . . . . 0.0 111.45 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.2 t -45.29 -36.92 4.35 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.844 0.858 . . . . 0.0 112.009 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -71.13 -57.79 4.18 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.351 1.06 . . . . 0.0 110.317 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.15 -59.87 3.87 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.158 0.983 . . . . 0.0 110.649 -175.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -55.18 -46.17 75.8 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.368 1.067 . . . . 0.0 110.428 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.59 -36.17 71.38 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.0 tttt -62.25 -30.91 71.44 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.09 0.556 . . . . 0.0 111.572 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.2 mmm-85 -66.85 -49.54 65.39 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 122.964 0.505 . . . . 0.0 110.652 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.417 HD12 HD23 ' A' ' 58' ' ' LEU . 40.6 mt -77.16 -42.44 37.73 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 122.403 0.281 . . . . 0.0 110.855 -177.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.9 9.36 58.51 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.551 1.072 . . . . 0.0 112.953 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.01 168.1 3.44 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 117.86 0.83 . . . . 0.0 112.015 175.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.5 p -127.3 151.03 49.29 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -176.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 161.9 -148.36 15.67 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -170.45 167.83 8.05 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 122.99 0.516 . . . . 0.0 111.777 173.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.41 99.68 5.5 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 118.679 -0.676 . . . . 0.0 111.345 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -100.93 176.83 5.14 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 124.68 1.192 . . . . 0.0 111.547 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 -127.11 137.98 53.1 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.074 1.35 . . . . 0.0 109.473 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.1 mt -75.01 174.24 9.61 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 125.075 1.35 . . . . 0.0 110.552 174.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -96.69 10.33 39.01 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.708 1.203 . . . . 0.0 111.529 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.68 -2.55 12.43 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.528 1.131 . . . . 0.0 112.018 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.94 25.77 6.65 Favored Glycine 0 C--N 1.342 0.871 0 C-N-CA 124.638 1.113 . . . . 0.0 113.776 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.16 162.22 19.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.006 1.322 . . . . 0.0 111.531 -175.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.0 t -122.05 120.85 62.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.409 1.484 . . . . 0.0 110.864 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -99.11 122.37 42.25 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.906 1.282 . . . . 0.0 111.06 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.56 136.87 55.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 C-N-CA 123.554 0.741 . . . . 0.0 109.511 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 t -127.36 143.33 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 124.237 1.015 . . . . 0.0 109.425 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.43 136.71 13.96 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-O 118.819 -0.61 . . . . 0.0 110.925 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 56.4 m -104.39 -179.53 3.97 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.698 1.599 . . . . 0.0 112.652 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.52 -154.57 22.25 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -80.09 129.07 34.22 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 123.222 0.609 . . . . 0.0 110.231 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -48.73 -52.43 23.68 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.908 1.283 . . . . 0.0 111.013 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.04 -45.88 62.03 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.343 1.449 . . . . 0.0 112.693 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -66.7 -46.86 74.22 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 117.479 0.639 . . . . 0.0 111.224 177.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.3 t -54.91 -30.9 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.135 0.574 . . . . 0.0 110.955 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -59.33 -31.39 69.13 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -55.05 -36.78 65.92 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.901 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.417 HD23 HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -84.91 -31.62 23.58 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.138 0.881 . . . . 0.0 111.03 174.821 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.5 mmm -65.59 -19.78 66.06 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.14 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -46.31 -51.38 14.78 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -70.83 -34.04 71.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 mt -56.15 -54.21 47.85 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 123.324 0.65 . . . . 0.0 109.983 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.57 -31.21 71.98 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.948 0.499 . . . . 0.0 112.275 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.8 m -66.63 -15.03 63.17 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.696 0.68 . . . . 0.0 112.658 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.27 19.89 77.76 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 118.512 -1.16 . . . . 0.0 111.974 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.4 -103.05 0.04 OUTLIER Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.559 1.552 . . . . 0.0 112.678 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -72.28 -176.3 2.13 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.032 3.154 . . . . 0.0 111.927 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -91.33 -38.34 12.69 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.877 0.871 . . . . 0.0 110.755 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.86 -32.91 61.22 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.611 1.164 . . . . 0.0 112.056 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.18 126.75 28.42 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.621 0.768 . . . . 0.0 109.974 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -115.29 78.45 1.17 Allowed 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.6 t -71.19 92.38 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -55.75 -56.61 18.4 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 123.848 0.859 . . . . 0.0 110.775 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.8 mtm-85 -157.08 161.9 39.46 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.953 1.301 . . . . 0.0 110.001 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.06 131.03 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.353 1.061 . . . . 0.0 109.534 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 tp -113.87 148.4 36.77 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.905 1.282 . . . . 0.0 110.819 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.42 135.57 38.82 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.402 -177.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -142.64 156.69 63.01 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 123.523 0.729 . . . . 0.0 111.68 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.13 122.98 10.09 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.644 3.563 . . . . 0.0 110.737 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -110.96 113.06 25.33 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.723 0.809 . . . . 0.0 109.571 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -117.43 70.08 6.12 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 118.709 0.686 . . . . 0.0 111.171 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.91 146.34 47.33 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.249 2.633 . . . . 0.0 110.79 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.5 p -72.5 142.97 48.54 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.615 0.766 . . . . 0.0 110.726 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.79 169.65 4.78 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.362 0.982 . . . . 0.0 112.128 -176.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -95.51 135.48 37.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.5 tp -79.77 150.48 30.76 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -75.81 0.14 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.223 1.009 . . . . 0.0 108.58 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -140.97 163.64 32.43 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.341 1.056 . . . . 0.0 110.129 -173.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -69.94 146.77 50.93 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.286 0.634 . . . . 0.0 110.829 175.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -143.25 -169.81 3.13 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.672 0.789 . . . . 0.0 110.909 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.0 pt -130.65 -170.9 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 124.181 0.993 . . . . 0.0 109.109 176.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.2 mtm-85 . . . . . 0 C--O 1.251 1.165 0 C-N-CA 125.069 1.348 . . . . 0.0 112.585 178.35 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.691 0 CA-C-O 119.402 -0.333 . . . . 0.0 110.666 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 t -140.89 -52.54 0.47 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.896 0.878 . . . . 0.0 111.198 -175.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -66.48 129.48 39.97 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.449 1.5 . . . . 0.0 112.137 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 p -135.15 89.33 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.281 0 C-N-CA 125.179 1.392 . . . . 0.0 108.435 -174.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.2 m -79.96 153.94 28.58 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.558 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.422 HD11 HG11 ' A' ' 55' ' ' VAL . 1.3 pp -139.51 159.28 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.0 tt -122.83 121.08 62.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.451 1.101 . . . . 0.0 110.204 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -116.09 115.74 26.62 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.747 1.619 . . . . 0.0 111.615 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.1 m-90 -93.82 120.45 34.1 Favored 'General case' 0 C--N 1.337 0.063 0 C-N-CA 125.724 1.61 . . . . 0.0 110.906 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.1 t -109.33 123.54 65.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 124.537 1.135 . . . . 0.0 108.937 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -101.32 178.58 4.61 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 124.277 1.031 . . . . 0.0 110.846 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.59 -160.11 48.79 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -85.09 96.08 9.32 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -171.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.4 t -128.56 -46.79 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 124.036 0.835 . . . . 0.0 109.853 -176.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -67.92 145.64 54.37 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 123.558 0.743 . . . . 0.0 111.269 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.26 25.58 72.74 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 123.914 0.769 . . . . 0.0 112.98 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.7 t -119.37 -48.24 3.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 124.865 1.266 . . . . 0.0 109.397 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.55 30.71 2.14 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.36 1.457 . . . . 0.0 111.392 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -55.14 -40.35 70.46 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 117.52 0.66 . . . . 0.0 109.913 173.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -89.57 23.68 2.54 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.756 1.222 . . . . 0.0 112.364 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -90.11 -57.61 2.79 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.794 0.838 . . . . 0.0 109.036 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 t -73.84 -13.82 60.99 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.003 0.921 . . . . 0.0 113.31 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.7 t -65.76 -26.77 67.87 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 118.399 0.545 . . . . 0.0 111.393 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -57.48 -53.96 52.22 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.099 0.96 . . . . 0.0 109.912 175.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.67 -49.64 72.39 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.129 0.972 . . . . 0.0 111.941 -175.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.59 -53.11 60.68 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.151 0.58 . . . . 0.0 110.835 174.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.23 -33.77 29.39 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.921 0.888 . . . . 0.0 112.647 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -63.88 -35.8 81.84 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.007 0.923 . . . . 0.0 111.72 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 -69.45 -43.73 72.71 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.694 0.797 . . . . 0.0 110.309 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.3 mt -74.7 -39.42 61.95 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.754 0.821 . . . . 0.0 111.144 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.02 16.21 72.89 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.29 0.947 . . . . 0.0 112.871 -177.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.13 172.85 10.31 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 117.575 0.688 . . . . 0.0 110.915 175.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.1 p -118.73 -162.76 0.92 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -174.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 124.18 -154.14 17.71 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 169.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -168.17 161.82 12.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.095 -0.553 . . . . 0.0 112.125 170.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.09 97.31 5.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.599 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.21 175.23 6.69 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.922 0.889 . . . . 0.0 110.603 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -123.73 138.01 54.59 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.208 1.003 . . . . 0.0 109.478 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.6 mt -76.5 172.57 12.75 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.081 1.352 . . . . 0.0 110.247 173.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -90.76 4.0 52.79 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.639 1.175 . . . . 0.0 112.184 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -108.88 -10.66 15.08 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.584 1.154 . . . . 0.0 112.397 -175.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.53 -4.44 12.04 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.274 1.416 . . . . 0.0 113.668 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.07 163.86 13.31 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.919 1.288 . . . . 0.0 111.96 -171.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.6 t -127.88 118.34 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.604 1.562 . . . . 0.0 110.723 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -100.66 119.83 39.16 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.919 0.888 . . . . 0.0 111.132 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.4 t -112.09 138.84 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.563 1.545 . . . . 0.0 109.316 -173.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 t -134.42 145.2 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.008 0.923 . . . . 0.0 109.895 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.58 137.9 12.76 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-O 118.513 -0.756 . . . . 0.0 111.604 -175.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 58.4 m -107.3 177.54 4.81 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.134 1.373 . . . . 0.0 112.442 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.31 -167.68 19.37 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -73.25 140.87 47.16 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.0 0.52 . . . . 0.0 109.741 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -53.3 -47.37 69.28 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.21 0.604 . . . . 0.0 109.799 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -46.02 -34.38 5.78 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 126.451 1.977 . . . . 0.0 114.63 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -84.61 -46.48 11.49 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.804 1.242 . . . . 0.0 111.135 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.422 HG11 HD11 ' A' ' 6' ' ' ILE . 40.5 t -59.02 -40.76 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 122.254 0.221 . . . . 0.0 110.667 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -61.51 -25.58 67.36 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.9 0.88 . . . . 0.0 111.91 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -57.41 -49.83 74.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.57 0.748 . . . . 0.0 110.998 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -73.98 -32.69 63.53 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 118.324 0.511 . . . . 0.0 110.615 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mmm -66.6 -23.03 66.13 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 118.742 -0.646 . . . . 0.0 111.341 -177.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -45.7 -49.66 14.38 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.877 0.762 . . . . 0.0 109.548 168.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -59.41 -43.98 92.93 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.461 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.77 -47.36 59.65 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 119.49 1.041 . . . . 0.0 111.533 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.83 -0.0 46.01 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.0 m -102.66 -38.04 7.66 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 124.053 0.941 . . . . 0.0 111.103 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.73 13.43 47.94 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 118.874 -0.959 . . . . 0.0 112.972 -177.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.63 -65.19 1.8 Allowed Glycine 0 CA--C 1.53 1.005 0 CA-C-N 118.647 1.223 . . . . 0.0 112.573 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.43 -13.67 25.21 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.913 2.409 . . . . 0.0 112.788 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 48.3 mtm180 -91.5 -54.58 3.84 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 123.744 0.818 . . . . 0.0 110.783 -176.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.7 148.09 38.74 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.269 1.427 . . . . 0.0 108.808 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 63.82 -168.82 0.2 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 122.915 0.486 . . . . 0.0 110.898 174.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -132.21 81.86 1.98 Allowed 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.247 0.93 . . . . 0.0 109.328 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.2 t -76.63 94.82 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 123.48 0.712 . . . . 0.0 109.153 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -64.42 -57.25 9.81 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.61 1.164 . . . . 0.0 110.979 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -154.07 153.31 31.66 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.789 0.836 . . . . 0.0 110.301 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.73 135.37 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 123.687 0.795 . . . . 0.0 111.097 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.5 tp -127.69 147.0 50.38 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.244 1.018 . . . . 0.0 112.506 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.32 141.24 50.6 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.416 1.087 . . . . 0.0 112.303 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -142.68 158.21 60.37 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 124.852 1.261 . . . . 0.0 111.922 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.51 129.47 16.86 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 124.28 3.32 . . . . 0.0 111.716 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -121.16 129.67 53.36 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.302 1.041 . . . . 0.0 110.684 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -131.81 71.77 80.33 Favored Pre-proline 0 CA--C 1.537 0.463 0 O-C-N 121.372 -0.83 . . . . 0.0 111.211 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.45 150.19 63.65 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.241 2.628 . . . . 0.0 111.11 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 75.4 p -73.73 140.23 45.84 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.681 0.792 . . . . 0.0 110.521 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.02 179.62 25.77 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 123.938 0.78 . . . . 0.0 112.131 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -98.28 131.28 44.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.938 0.895 . . . . 0.0 108.769 171.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tp -72.55 152.94 41.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.645 1.178 . . . . 0.0 109.514 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.45 -79.93 0.13 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.837 0.855 . . . . 0.0 108.998 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -134.8 163.71 29.2 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.161 0.984 . . . . 0.0 109.938 -171.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -73.62 146.61 44.49 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.196 0.598 . . . . 0.0 110.322 173.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -140.13 -171.05 3.1 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.039 0.936 . . . . 0.0 110.158 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.8 pt -131.15 -173.93 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.968 0.907 . . . . 0.0 109.956 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.187 0 C-N-CA 125.236 1.414 . . . . 0.0 112.297 172.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ptm . . . . . 0 N--CA 1.474 0.755 0 CA-C-O 119.263 -0.399 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 175.45 -59.2 0.01 OUTLIER 'General case' 0 C--N 1.342 0.28 0 C-N-CA 125.74 1.616 . . . . 0.0 108.927 173.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.89 111.17 4.19 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.747 0.819 . . . . 0.0 111.687 -170.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 p -112.78 79.46 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 125.708 1.603 . . . . 0.0 107.331 -174.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -76.0 144.66 40.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.474 -177.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.436 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.6 pp -117.0 163.01 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.5 tt -124.79 116.02 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 124.911 1.284 . . . . 0.0 108.228 170.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -116.04 102.51 9.7 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.633 1.173 . . . . 0.0 110.801 -173.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.2 m-90 -82.49 112.44 19.42 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.12 0.568 . . . . 0.0 109.478 176.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.6 t -91.74 106.9 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -63.75 -37.31 86.88 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.949 0.5 . . . . 0.0 111.773 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.04 165.27 7.19 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.001 1.286 . . . . 0.0 114.854 -174.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -79.87 72.4 6.61 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.522 1.129 . . . . 0.0 111.893 -174.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.3 t -100.5 -33.31 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 124.579 1.152 . . . . 0.0 111.223 -173.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -67.34 145.73 54.8 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.883 0.473 . . . . 0.0 110.693 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.62 24.49 72.45 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 123.993 0.806 . . . . 0.0 113.323 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.5 t -118.95 -40.78 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.416 1.086 . . . . 0.0 110.319 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.95 31.41 5.69 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.148 1.356 . . . . 0.0 112.05 -177.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -48.72 -33.01 9.36 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.388 1.875 . . . . 0.0 112.927 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -72.79 57.97 0.44 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.862 2.065 . . . . 0.0 111.95 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -108.22 -69.54 0.85 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.346 1.058 . . . . 0.0 109.542 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.6 t -96.22 5.57 50.73 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.342 1.057 . . . . 0.0 112.553 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.9 t -58.36 -35.62 72.23 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 122.008 -0.432 . . . . 0.0 111.31 170.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 -61.85 -58.91 6.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.445 1.098 . . . . 0.0 110.698 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -51.85 -55.35 20.51 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.69 0.796 . . . . 0.0 110.994 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -53.21 -54.43 36.18 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.536 0.734 . . . . 0.0 111.044 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.18 -32.92 56.84 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.915 0.886 . . . . 0.0 112.622 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -67.65 -32.92 73.94 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.961 0.504 . . . . 0.0 111.631 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 40.0 mtp85 -68.17 -48.12 66.16 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.386 0.539 . . . . 0.0 110.128 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.77 -30.54 59.16 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.289 0.636 . . . . 0.0 110.696 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.84 22.43 61.58 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.404 1.478 . . . . 0.0 113.352 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.418 HD22 ' C ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -81.43 167.21 19.64 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.621 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.0 p -127.84 140.78 51.82 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.477 1.511 . . . . 0.0 107.348 -171.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.04 -165.11 38.52 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.675 -1.25 . . . . 0.0 112.701 -165.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -169.34 156.44 6.87 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 171.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.61 84.6 2.05 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.646 1.178 . . . . 0.0 109.215 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -89.3 168.11 12.52 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 122.974 0.509 . . . . 0.0 110.339 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -127.31 133.36 50.13 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.646 0.778 . . . . 0.0 109.511 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.4 mt -71.2 168.21 17.74 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.12 0.968 . . . . 0.0 109.755 170.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -86.51 4.44 39.88 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.867 0.867 . . . . 0.0 111.593 175.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -90.52 -56.02 3.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.827 0.851 . . . . 0.0 109.225 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 162.64 -12.34 0.11 Allowed Glycine 0 CA--C 1.53 0.99 0 CA-C-N 114.827 -1.079 . . . . 0.0 113.192 -166.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.4 m -112.76 145.61 40.25 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.295 1.048 . . . . 0.0 112.388 -164.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 86.0 t -105.37 122.44 58.71 Favored 'Isoleucine or valine' 0 C--N 1.344 0.341 0 C-N-CA 124.759 1.224 . . . . 0.0 110.652 -173.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -94.64 103.17 15.11 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.547 1.539 . . . . 0.0 110.128 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.14 124.68 56.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.7 t -128.16 135.08 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.947 0.899 . . . . 0.0 109.428 -174.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.62 125.36 6.45 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.365 -169.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 95.2 m -88.86 -178.98 5.87 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.361 1.464 . . . . 0.0 112.018 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.15 -165.91 17.39 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -74.21 136.0 42.77 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -56.85 -46.09 82.0 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.294 0.638 . . . . 0.0 110.575 -174.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -47.28 -50.93 16.14 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.617 1.58 . . . . 0.0 112.56 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -62.2 -50.68 70.84 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.751 0.82 . . . . 0.0 111.294 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.3 t -55.44 -37.86 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.823 0.849 . . . . 0.0 111.12 178.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -59.11 -33.57 71.0 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.472 0.578 . . . . 0.0 111.942 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -58.12 -42.51 85.89 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.739 0.699 . . . . 0.0 112.469 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 pp -78.54 -28.19 46.04 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.928 0.785 . . . . 0.0 111.32 175.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 7.9 mmm -67.14 -34.18 77.03 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 118.425 -0.797 . . . . 0.0 111.021 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -42.25 -53.37 4.13 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 168.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -65.49 -39.97 92.55 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 118.647 -0.692 . . . . 0.0 112.261 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 42.8 mt -58.79 -49.05 79.13 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 119.813 1.188 . . . . 0.0 109.72 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -72.43 8.28 1.45 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.05 1.34 . . . . 0.0 112.751 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.6 m -146.98 29.96 0.97 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.174 1.389 . . . . 0.0 109.064 172.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.16 -46.87 4.89 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -168.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.54 116.15 8.04 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.861 -0.966 . . . . 0.0 111.074 -173.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -73.25 -47.79 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.498 2.132 . . . . 0.0 110.974 -176.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 48.5 mtt-85 -145.37 -61.44 0.34 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.214 1.006 . . . . 0.0 109.561 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.4 t -59.08 -65.82 0.61 Allowed 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.76 1.224 . . . . 0.0 111.613 -174.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.89 118.92 6.8 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.046 0.539 . . . . 0.0 109.89 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -111.6 93.08 4.29 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.466 1.106 . . . . 0.0 108.148 -173.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.8 t -76.99 94.44 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.356 1.062 . . . . 0.0 108.97 -178.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.12 -64.42 0.86 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.126 0.97 . . . . 0.0 110.5 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.53 155.84 17.82 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.532 1.133 . . . . 0.0 109.169 -173.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -129.62 123.1 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.995 1.318 . . . . 0.0 109.259 -176.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.3 tp -99.72 106.87 18.83 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.1 m -99.93 130.03 46.07 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.095 0.558 . . . . 0.0 111.401 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -130.62 164.53 40.87 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 127.585 2.354 . . . . 0.0 108.469 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.05 129.29 10.45 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.089 2.526 . . . . 0.0 111.111 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -110.4 106.66 16.09 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.741 1.216 . . . . 0.0 109.979 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -106.63 86.99 2.48 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 118.635 0.652 . . . . 0.0 111.296 177.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.91 167.29 22.33 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.107 2.538 . . . . 0.0 110.829 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.5 m -87.77 129.59 35.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.012 0.925 . . . . 0.0 109.498 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.09 -177.94 27.31 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.941 0.781 . . . . 0.0 112.509 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -100.9 126.73 47.54 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.645 1.178 . . . . 0.0 109.467 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.7 tp -72.74 143.13 48.11 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 170.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.6 p -73.43 -63.39 1.2 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.238 1.015 . . . . 0.0 111.444 -171.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -132.26 166.47 21.82 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.054 1.341 . . . . 0.0 110.087 -174.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -82.3 144.64 30.46 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.083 0.553 . . . . 0.0 109.744 168.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -155.37 178.91 9.68 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 123.069 0.547 . . . . 0.0 109.759 176.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.99 163.54 24.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 123.106 0.562 . . . . 0.0 110.626 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 116.713 -1.613 . . . . 0.0 111.287 173.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttm . . . . . 0 N--CA 1.473 0.715 0 CA-C-O 119.443 -0.313 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.4 t -137.03 -41.84 0.58 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.899 0.88 . . . . 0.0 110.785 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.24 155.11 39.67 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.235 1.014 . . . . 0.0 113.054 -176.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.34 90.99 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.304 1.042 . . . . 0.0 108.304 -174.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.7 m -78.87 153.39 30.6 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.471 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.68 149.4 18.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -176.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 tt -107.54 128.2 62.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 123.771 0.828 . . . . 0.0 109.704 176.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -121.97 101.21 7.42 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.058 1.743 . . . . 0.0 109.895 -176.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -86.37 123.52 31.7 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 124.772 1.229 . . . . 0.0 110.459 177.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.12 119.6 59.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.296 1.038 . . . . 0.0 109.292 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -92.22 175.17 6.95 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.011 1.324 . . . . 0.0 110.712 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.17 -167.52 53.43 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -84.67 84.24 7.75 Favored 'General case' 0 CA--C 1.523 -0.089 0 C-N-CA 123.083 0.553 . . . . 0.0 111.723 -169.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.94 -46.92 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 124.034 0.934 . . . . 0.0 109.442 -174.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -69.25 146.79 52.02 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-O 121.007 0.432 . . . . 0.0 111.365 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.15 20.92 73.46 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.209 0.909 . . . . 0.0 113.354 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.1 t -105.32 -42.42 7.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 C-N-CA 124.48 1.112 . . . . 0.0 109.242 175.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.48 29.07 2.81 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.653 1.597 . . . . 0.0 111.202 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -51.84 -36.55 48.61 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.483 1.113 . . . . 0.0 111.597 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.88 58.2 0.83 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.306 1.442 . . . . 0.0 112.423 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -107.24 -74.58 0.65 Allowed 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.562 1.145 . . . . 0.0 109.39 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.6 t -74.84 -18.48 60.44 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.633 -0.699 . . . . 0.0 112.002 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.4 t -43.82 -40.96 4.74 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.925 0.89 . . . . 0.0 112.286 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -67.04 -59.02 3.83 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.753 1.221 . . . . 0.0 109.675 175.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -52.76 -57.18 10.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.597 1.159 . . . . 0.0 111.343 -175.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -55.86 -51.03 68.95 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.568 0.747 . . . . 0.0 110.497 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.74 -36.55 62.43 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.807 0.443 . . . . 0.0 111.985 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -64.34 -30.97 72.0 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.365 0.666 . . . . 0.0 111.895 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 mmm-85 -67.75 -50.52 56.78 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.119 0.568 . . . . 0.0 110.597 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.9 mp -70.99 -30.05 66.19 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.827 0.451 . . . . 0.0 110.665 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.78 18.43 78.91 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.054 0.835 . . . . 0.0 112.483 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.52 175.03 10.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.705 0.802 . . . . 0.0 110.991 176.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.3 p -117.45 -161.65 0.83 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -173.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.46 -155.54 16.49 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 169.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -169.73 160.05 8.48 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 172.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.84 94.39 4.38 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.826 1.251 . . . . 0.0 110.21 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.3 174.5 6.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.506 0.722 . . . . 0.0 111.355 176.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -122.6 139.41 53.95 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.044 0.938 . . . . 0.0 109.715 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.8 mt -76.0 174.64 9.73 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 125.468 1.507 . . . . 0.0 110.258 173.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -98.67 11.7 37.72 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.968 1.307 . . . . 0.0 111.593 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -118.19 -4.54 10.96 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.806 1.242 . . . . 0.0 111.868 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.96 14.15 9.53 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.947 1.26 . . . . 0.0 114.483 176.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.8 168.57 10.1 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.504 1.522 . . . . 0.0 111.937 -170.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 73.1 t -130.7 120.99 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.312 1.045 . . . . 0.0 111.44 -174.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -101.98 118.04 36.09 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.081 0.952 . . . . 0.0 110.997 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.5 t -112.47 137.6 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 123.631 0.773 . . . . 0.0 110.027 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.22 144.31 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.689 0.796 . . . . 0.0 109.886 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.06 132.05 8.92 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-O 118.52 -0.753 . . . . 0.0 111.294 -174.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 89.7 m -100.43 -179.56 4.14 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.804 1.242 . . . . 0.0 112.365 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.2 -161.8 20.81 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -75.05 126.36 30.85 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 122.793 0.437 . . . . 0.0 110.096 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -49.18 -50.63 37.07 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 124.142 0.977 . . . . 0.0 110.594 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -48.16 -40.21 21.08 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.92 1.724 . . . . 0.0 113.652 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -77.57 -48.54 16.7 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.776 0.83 . . . . 0.0 111.132 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.0 -39.94 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 122.715 0.406 . . . . 0.0 111.114 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -61.77 -27.27 68.62 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -59.25 -48.12 82.8 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.193 0.451 . . . . 0.0 110.469 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.46 -30.74 63.37 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.889 0.313 . . . . 0.0 111.302 178.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mmt -67.55 -20.07 65.36 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-O 118.913 -0.565 . . . . 0.0 112.415 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -46.13 -50.98 14.83 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 168.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -61.27 -41.85 97.65 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.1 mt -54.39 -54.13 44.71 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 123.812 0.845 . . . . 0.0 110.6 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -70.26 -33.72 71.95 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 119.073 -0.489 . . . . 0.0 112.038 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.5 t -63.85 -31.61 72.84 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.761 0.71 . . . . 0.0 111.914 175.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.81 13.28 80.71 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 118.813 -0.993 . . . . 0.0 113.178 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.7 -105.39 0.1 OUTLIER Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.77 1.653 . . . . 0.0 112.55 -175.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -71.81 -178.88 3.36 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.133 3.222 . . . . 0.0 112.514 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -68.47 -28.32 66.93 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.436 0.694 . . . . 0.0 111.93 177.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.9 p -65.42 157.83 28.32 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.523 0.729 . . . . 0.0 110.938 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 74.25 158.4 0.21 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.518 1.927 . . . . 0.0 110.78 -166.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -129.45 107.94 9.88 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.7 t -92.65 88.3 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -60.7 -65.58 0.67 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.089 0.556 . . . . 0.0 109.892 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.6 mtm-85 -150.56 156.29 41.11 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.539 1.135 . . . . 0.0 109.6 -176.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.3 t -137.82 130.15 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 123.715 0.806 . . . . 0.0 110.522 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tp -113.38 135.35 53.96 Favored 'General case' 0 C--N 1.346 0.448 0 C-N-CA 125.21 1.404 . . . . 0.0 112.058 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.55 137.31 54.93 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.314 1.045 . . . . 0.0 111.985 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -145.27 159.06 50.17 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.645 1.178 . . . . 0.0 111.68 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.92 136.53 25.22 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.967 3.111 . . . . 0.0 111.666 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -127.13 125.43 41.18 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.672 1.189 . . . . 0.0 111.106 -175.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -129.7 70.91 82.16 Favored Pre-proline 0 CA--C 1.535 0.403 0 O-C-N 121.696 -0.627 . . . . 0.0 111.37 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.63 142.31 35.9 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.894 2.396 . . . . 0.0 110.776 -176.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.5 p -70.82 140.97 51.35 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.663 0.785 . . . . 0.0 110.85 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.99 173.04 23.95 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.106 0.86 . . . . 0.0 111.638 -175.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -96.1 135.34 38.03 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -76.25 151.99 36.65 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.3 m -80.88 -76.73 0.23 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -177.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -134.47 165.76 24.45 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.717 1.207 . . . . 0.0 110.223 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -72.88 149.79 43.17 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.711 0.804 . . . . 0.0 110.353 172.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -151.24 -169.54 3.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.005 0.922 . . . . 0.0 110.002 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.8 pt -130.77 -179.46 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.271 1.028 . . . . 0.0 109.542 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.18 0 CA-C-O 117.62 -1.181 . . . . 0.0 111.723 170.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t 79.66 -65.51 0.19 Allowed 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 125.435 1.494 . . . . 0.0 109.396 177.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.05 144.22 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.909 1.684 . . . . 0.0 111.672 176.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 p -139.44 88.2 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.199 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.7 m -81.7 152.78 26.91 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.403 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.5 146.76 19.27 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -176.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 tt -109.36 122.29 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 124.271 1.029 . . . . 0.0 109.877 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.55 116.56 28.99 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.971 1.308 . . . . 0.0 111.024 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.7 m-90 -96.56 121.99 38.99 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.768 0.827 . . . . 0.0 110.16 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.545 HG12 HG21 ' A' ' 14' ' ' VAL . 5.6 t -104.5 115.32 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.397 1.079 . . . . 0.0 108.848 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -87.49 178.56 6.77 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.76 1.224 . . . . 0.0 111.453 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.29 -159.71 50.46 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -88.37 99.49 12.29 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.114 -174.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.545 HG21 HG12 ' A' ' 10' ' ' VAL . 21.7 t -130.74 -43.71 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 123.441 0.697 . . . . 0.0 109.756 -177.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -70.4 143.77 51.76 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.596 0.758 . . . . 0.0 109.969 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.6 18.61 79.7 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 119.26 -0.745 . . . . 0.0 113.31 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 83.5 t -107.52 -43.63 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.577 1.151 . . . . 0.0 109.527 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 116.35 28.5 2.56 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 125.187 1.375 . . . . 0.0 111.446 -177.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -50.93 -32.71 21.6 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 123.627 0.771 . . . . 0.0 111.192 176.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -76.51 58.71 1.38 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.838 0.855 . . . . 0.0 112.764 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -95.18 -70.32 0.72 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 t -92.85 -2.54 55.8 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.496 -0.764 . . . . 0.0 111.656 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 t -45.48 -36.93 4.81 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.095 0.861 . . . . 0.0 112.403 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -73.72 -60.31 2.31 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.266 1.026 . . . . 0.0 109.806 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -50.3 -59.14 4.26 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.271 1.028 . . . . 0.0 111.002 -175.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.9 -53.28 34.06 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 125.589 1.556 . . . . 0.0 110.057 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.49 -37.84 70.93 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.618 0.367 . . . . 0.0 111.732 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.3 tttm -61.87 -31.72 72.02 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.249 1.019 . . . . 0.0 111.7 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.26 -52.32 48.71 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.261 0.624 . . . . 0.0 110.946 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 57' ' ' LYS . 34.6 mt -72.23 -31.11 65.54 Favored 'General case' 0 CA--C 1.528 0.124 0 O-C-N 122.849 0.093 . . . . 0.0 110.812 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.66 6.94 82.48 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.064 0.84 . . . . 0.0 112.596 -178.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.15 178.14 2.93 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.817 0.808 . . . . 0.0 111.326 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 43.7 p -125.79 -169.05 1.94 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -175.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 130.85 -151.49 19.62 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 171.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -170.91 167.48 7.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.438 -0.381 . . . . 0.0 111.421 173.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.46 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -131.69 97.07 4.11 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.793 0.683 . . . . 0.0 111.435 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.4 mttp -93.28 174.01 7.43 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.969 1.308 . . . . 0.0 110.142 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -124.24 135.25 53.28 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.431 1.092 . . . . 0.0 109.628 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.8 mt -74.95 171.82 13.38 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.077 1.351 . . . . 0.0 109.847 177.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -93.66 4.96 53.13 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.587 0.755 . . . . 0.0 111.571 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -107.25 -14.53 14.87 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.64 1.176 . . . . 0.0 111.724 -177.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.92 7.6 8.53 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.015 1.293 . . . . 0.0 113.91 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.9 168.68 8.97 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.946 1.298 . . . . 0.0 111.336 -172.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.0 t -129.01 120.25 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.391 1.077 . . . . 0.0 110.549 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -95.71 127.16 41.5 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.82 0.848 . . . . 0.0 110.232 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.27 136.22 58.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 124.389 1.075 . . . . 0.0 109.525 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.24 143.37 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 124.012 0.925 . . . . 0.0 109.356 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.69 138.23 15.98 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 118.856 -0.592 . . . . 0.0 110.668 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 61.5 m -103.0 178.5 4.54 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.867 1.267 . . . . 0.0 111.435 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.94 -159.82 18.03 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -78.76 132.54 36.97 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 124.965 1.306 . . . . 0.0 109.408 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -46.84 -55.9 7.18 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.491 1.116 . . . . 0.0 110.683 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -49.99 -43.87 40.84 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.238 1.399 . . . . 0.0 112.767 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -67.07 -46.43 74.35 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.295 1.038 . . . . 0.0 111.187 176.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 77.4 t -54.05 -41.17 49.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.163 0.585 . . . . 0.0 110.408 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.24 -26.97 68.11 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.418 ' HB2' HD21 ' A' ' 30' ' ' LEU . 29.4 mmmt -59.77 -27.12 66.26 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.259 1.024 . . . . 0.0 112.712 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.02 -29.81 13.43 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.48 0.582 . . . . 0.0 110.774 172.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.449 ' HA ' HD12 ' A' ' 62' ' ' LEU . 2.2 mmt -62.72 -23.56 67.22 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-O 118.722 -0.656 . . . . 0.0 111.418 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.48 -57.62 3.97 Favored 'General case' 0 C--O 1.248 0.985 0 C-N-CA 122.966 0.506 . . . . 0.0 110.027 173.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -65.31 -32.34 73.94 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 118.656 0.662 . . . . 0.0 112.07 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 59' ' ' MET . 12.7 mt -61.64 -51.85 66.75 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 119.054 0.843 . . . . 0.0 109.832 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -81.84 -0.05 41.7 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -178.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.6 t -108.86 -32.5 7.27 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 125.234 1.413 . . . . 0.0 110.36 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -94.62 19.85 51.58 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.391 0.996 . . . . 0.0 112.159 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.09 -78.78 0.83 Allowed Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 125.202 1.382 . . . . 0.0 110.867 175.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -67.63 -9.89 26.95 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.785 2.99 . . . . 0.0 112.634 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.01 -32.51 46.99 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.282 1.033 . . . . 0.0 112.293 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.04 -44.56 0.08 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.403 1.081 . . . . 0.0 110.275 -178.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.09 176.72 7.72 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.646 1.578 . . . . 0.0 110.509 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -122.16 74.6 1.17 Allowed 'General case' 0 C--N 1.341 0.22 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -175.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 87.8 t -70.9 96.42 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -63.05 -61.75 2.17 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.378 0.671 . . . . 0.0 109.31 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.9 mmm-85 -152.19 161.53 42.48 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.046 1.339 . . . . 0.0 109.801 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.1 t -142.24 140.38 29.28 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 124.202 1.001 . . . . 0.0 109.754 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.4 tp -129.14 157.32 42.11 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.816 0.847 . . . . 0.0 111.108 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.91 129.77 26.38 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.079 0.951 . . . . 0.0 111.221 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.31 158.83 73.16 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.112 1.365 . . . . 0.0 110.424 -177.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -71.66 130.51 17.16 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.517 3.478 . . . . 0.0 110.834 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -119.24 117.52 28.83 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.626 1.17 . . . . 0.0 109.767 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -125.55 68.2 59.76 Favored Pre-proline 0 CA--C 1.535 0.367 0 O-C-N 121.873 -0.517 . . . . 0.0 110.546 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.47 140.99 37.56 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.411 2.741 . . . . 0.0 110.432 -175.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.6 p -72.4 145.07 47.94 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.427 0.691 . . . . 0.0 110.797 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.66 170.35 3.95 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.381 0.991 . . . . 0.0 112.131 -176.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -92.21 138.13 31.79 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.8 tp -80.96 152.13 28.17 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 99.5 m -75.26 -73.96 0.23 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -146.54 167.38 23.86 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.396 0.678 . . . . 0.0 110.859 -176.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -70.39 144.72 51.48 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.951 0.501 . . . . 0.0 110.388 176.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -145.48 -176.78 5.25 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 122.999 0.52 . . . . 0.0 110.562 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.46 HD12 ' HB3' ' A' ' 36' ' ' ALA . 6.5 tt -168.65 139.8 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 123.305 0.642 . . . . 0.0 109.362 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.108 0 CA-C-O 117.158 -1.401 . . . . 0.0 110.328 174.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.09 -44.03 0.2 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.5 0.72 . . . . 0.0 110.608 -176.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.6 159.08 13.82 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.427 1.091 . . . . 0.0 112.496 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.0 p -143.83 89.63 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.6 m -75.55 153.71 37.24 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.76 174.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pp -143.13 155.82 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 123.068 0.547 . . . . 0.0 110.064 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.5 tp -112.84 118.55 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 125.004 1.322 . . . . 0.0 108.739 177.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -113.36 111.09 21.41 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.09 0.956 . . . . 0.0 110.384 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -92.41 121.02 33.47 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.801 0.84 . . . . 0.0 110.287 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.538 HG12 HG21 ' A' ' 14' ' ' VAL . 3.0 t -104.98 120.03 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.436 1.095 . . . . 0.0 108.932 -177.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -95.27 176.39 6.23 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.309 1.044 . . . . 0.0 111.559 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.25 -156.39 48.63 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.5 mtt-85 -87.96 93.16 9.39 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 123.417 0.687 . . . . 0.0 111.85 -173.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.538 HG21 HG12 ' A' ' 10' ' ' VAL . 16.9 t -127.41 -45.88 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.205 1.002 . . . . 0.0 109.974 -175.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -70.68 141.83 51.59 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.35 0.66 . . . . 0.0 110.1 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.67 15.09 80.2 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.104 -0.831 . . . . 0.0 113.371 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.1 t -111.98 -44.28 5.1 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 C-N-CA 124.561 1.145 . . . . 0.0 109.764 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.56 23.01 2.94 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.262 1.41 . . . . 0.0 111.893 -176.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -59.32 -25.34 64.08 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 117.785 0.792 . . . . 0.0 111.988 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.74 30.62 4.25 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.584 1.554 . . . . 0.0 111.687 175.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -94.46 -61.21 1.55 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.76 0.709 . . . . 0.0 109.383 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.9 t -78.21 -1.7 34.12 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 t -59.58 -26.74 65.67 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.057 0.543 . . . . 0.0 111.299 173.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -70.95 -55.64 7.93 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.224 0.61 . . . . 0.0 110.728 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -52.37 -57.03 11.07 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.027 0.531 . . . . 0.0 111.177 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -47.05 73.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.263 0.625 . . . . 0.0 110.414 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.43 -29.69 50.15 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.8 tttm -69.53 -31.53 69.81 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.231 1.012 . . . . 0.0 111.802 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.8 mmm-85 -72.84 -37.2 67.51 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.018 0.927 . . . . 0.0 111.06 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -85.9 -30.18 23.06 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.909 0.884 . . . . 0.0 111.506 178.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.67 21.21 79.63 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.47 0.557 . . . . 0.0 112.374 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.45 HD12 ' HB1' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -79.58 178.02 8.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.961 0.904 . . . . 0.0 111.111 177.575 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.3 p -123.18 -164.22 1.19 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -175.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.2 -151.53 18.14 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 171.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -169.22 162.91 10.83 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.05 99.79 6.41 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.1 0.96 . . . . 0.0 111.477 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -100.06 172.85 6.94 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.717 1.207 . . . . 0.0 110.936 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -124.12 135.17 53.34 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.796 1.239 . . . . 0.0 108.753 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.443 HD12 ' HB2' ' A' ' 43' ' ' SER . 21.8 mt -75.64 173.0 11.63 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.015 1.326 . . . . 0.0 110.08 175.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -95.3 8.1 44.18 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.053 0.941 . . . . 0.0 111.729 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -111.58 -2.6 15.38 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.899 1.28 . . . . 0.0 112.137 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.99 7.21 31.42 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.94 1.257 . . . . 0.0 113.949 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.443 ' HB2' HD12 ' A' ' 39' ' ' LEU . 75.4 m -102.92 165.82 10.81 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.513 1.525 . . . . 0.0 111.127 -173.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 91.4 t -128.57 122.77 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.688 1.195 . . . . 0.0 110.524 -177.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -99.32 123.43 43.59 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 124.187 0.995 . . . . 0.0 110.947 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.9 t -121.23 133.44 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.182 0.593 . . . . 0.0 109.631 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.9 t -126.01 142.79 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 124.646 1.178 . . . . 0.0 109.45 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.45 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -154.36 132.86 12.04 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 118.607 -0.711 . . . . 0.0 111.158 -175.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.42 178.64 4.69 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 175.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.96 -157.69 20.64 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.789 1.185 . . . . 0.0 110.201 178.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -75.94 122.43 24.16 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.67 1.188 . . . . 0.0 109.572 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -45.84 -51.82 12.32 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.472 1.109 . . . . 0.0 111.071 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.29 -47.35 56.12 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.483 1.516 . . . . 0.0 113.129 177.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -65.44 -47.76 75.06 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.395 0.598 . . . . 0.0 110.299 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.5 t -57.56 -33.06 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 122.723 0.409 . . . . 0.0 110.751 176.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.48 -32.28 73.16 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.941 0.896 . . . . 0.0 112.949 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -56.64 -27.48 58.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.004 0.922 . . . . 0.0 112.461 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.36 -30.97 13.1 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 118.622 0.646 . . . . 0.0 111.289 173.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.479 ' HA ' HD12 ' A' ' 62' ' ' LEU . 2.3 mmm -63.6 -22.45 66.9 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-O 118.624 -0.703 . . . . 0.0 112.444 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -44.27 -55.9 4.55 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.335 0.516 . . . . 0.0 110.254 173.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -61.92 -41.92 98.5 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.147 0.579 . . . . 0.0 111.782 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 59' ' ' MET . 11.4 mt -57.14 -54.25 48.93 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 123.785 0.834 . . . . 0.0 109.707 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 mppp? -66.73 -29.32 69.27 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.533 0.733 . . . . 0.0 112.314 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 t -69.56 -17.1 63.54 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.448 0.567 . . . . 0.0 112.015 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.81 5.4 89.43 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-O 118.271 -1.294 . . . . 0.0 112.716 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 43.49 -103.84 0.05 OUTLIER Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.623 1.582 . . . . 0.0 112.846 -175.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -70.64 171.06 16.16 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.422 2.748 . . . . 0.0 111.762 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.2 mtp180 -87.43 -35.0 18.53 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.45 0.7 . . . . 0.0 110.849 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -33.24 64.19 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.74 1.216 . . . . 0.0 111.965 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.35 144.39 57.2 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.736 0.814 . . . . 0.0 110.301 176.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -119.32 88.68 2.98 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.6 t -75.42 81.91 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.43 -50.89 71.57 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.251 0.621 . . . . 0.0 111.108 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -169.04 153.42 5.57 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 123.396 0.678 . . . . 0.0 109.623 -177.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.5 t -141.96 134.76 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.138 0.575 . . . . 0.0 109.537 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.5 tp -120.43 156.14 32.05 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.976 0.91 . . . . 0.0 110.928 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.12 129.5 27.68 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.853 0.861 . . . . 0.0 110.873 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -132.73 154.93 81.65 Favored Pre-proline 0 CA--C 1.539 0.558 0 C-N-CA 124.499 1.12 . . . . 0.0 110.14 -177.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.89 125.63 11.75 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 124.857 3.704 . . . . 0.0 111.067 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -117.16 127.31 54.0 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.721 0.809 . . . . 0.0 110.844 -178.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -133.63 70.49 75.91 Favored Pre-proline 0 CA--C 1.536 0.42 0 O-C-N 121.526 -0.734 . . . . 0.0 110.495 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.15 136.88 35.8 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 124.057 3.171 . . . . 0.0 109.984 -177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.6 p -61.48 143.76 55.36 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.642 0.777 . . . . 0.0 111.101 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.95 171.02 5.69 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.079 0.847 . . . . 0.0 112.112 -175.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -89.0 135.74 33.39 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mp -74.13 150.09 40.67 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.303 0.641 . . . . 0.0 109.678 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.61 -77.96 0.2 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.349 1.059 . . . . 0.0 108.625 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -143.78 164.71 29.73 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.613 0.765 . . . . 0.0 110.944 -174.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -70.96 144.86 50.39 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.973 0.509 . . . . 0.0 110.357 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -137.81 -179.35 5.71 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 124.101 0.961 . . . . 0.0 110.403 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.9 tt -142.39 153.01 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -177.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 116.598 -1.668 . . . . 0.0 111.86 177.384 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 ttm . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 110.703 -0.11 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.92 -41.77 6.04 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.579 1.152 . . . . 0.0 111.091 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.13 134.4 49.28 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.267 1.027 . . . . 0.0 111.557 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 p -140.63 94.98 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 C-N-CA 124.551 1.141 . . . . 0.0 108.484 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.4 m -92.75 153.88 18.64 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.933 -177.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pp -143.6 156.46 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -174.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 tt -116.37 119.26 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.148 0.979 . . . . 0.0 109.418 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -109.9 108.33 18.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.88 1.272 . . . . 0.0 109.951 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -91.76 123.04 34.85 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.991 0.916 . . . . 0.0 110.235 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.421 HG12 HG21 ' A' ' 14' ' ' VAL . 12.9 t -99.15 108.52 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.586 1.155 . . . . 0.0 108.768 -178.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -73.26 177.49 5.1 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.815 0.846 . . . . 0.0 111.426 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.95 -169.4 42.66 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 177.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -92.01 92.04 8.11 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.798 0.439 . . . . 0.0 110.881 -175.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.421 HG21 HG12 ' A' ' 10' ' ' VAL . 58.8 t -114.28 -31.06 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.101 0.96 . . . . 0.0 110.909 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -70.67 148.43 48.05 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.895 0.316 . . . . 0.0 110.52 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.75 22.81 54.95 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 123.753 0.692 . . . . 0.0 112.954 176.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.8 t -116.06 -48.97 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 C-N-CA 124.884 1.273 . . . . 0.0 109.41 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.67 32.29 1.23 Allowed Glycine 0 C--N 1.339 0.714 0 C-N-CA 125.251 1.405 . . . . 0.0 111.512 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -50.44 -36.81 34.96 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 123.848 0.859 . . . . 0.0 111.434 177.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.05 55.3 0.71 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.64 1.176 . . . . 0.0 112.058 177.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -94.54 -73.64 0.57 Allowed 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.337 0.655 . . . . 0.0 109.277 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.9 t -89.0 -1.59 58.18 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.435 0.694 . . . . 0.0 111.642 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.9 t -47.51 -36.93 11.03 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.752 0.821 . . . . 0.0 112.294 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -55.96 6.64 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.442 1.097 . . . . 0.0 110.508 176.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -53.79 -54.15 42.27 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.677 0.791 . . . . 0.0 110.678 -176.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.15 -48.13 68.21 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.233 1.013 . . . . 0.0 110.515 177.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.42 -26.44 53.54 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -73.55 -28.28 61.79 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.806 0.843 . . . . 0.0 111.942 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.9 mtp85 -71.91 -41.89 67.38 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.321 1.049 . . . . 0.0 110.119 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -86.51 -52.67 5.43 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.558 0.743 . . . . 0.0 111.413 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.54 8.51 46.14 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.206 0.907 . . . . 0.0 112.995 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.15 167.57 2.31 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.969 0.884 . . . . 0.0 111.674 174.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.7 p -128.09 155.37 44.51 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.87 -147.95 17.38 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -169.35 166.27 10.48 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 173.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.4 100.73 5.46 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.803 0.841 . . . . 0.0 111.678 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -105.44 179.26 4.32 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.612 1.165 . . . . 0.0 110.835 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -123.51 138.99 54.46 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.673 1.189 . . . . 0.0 109.089 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.79 177.84 4.58 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.424 1.09 . . . . 0.0 110.349 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -101.14 13.31 35.54 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.296 1.038 . . . . 0.0 111.18 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -117.53 -15.46 10.24 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.863 1.265 . . . . 0.0 111.891 -177.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.0 5.66 8.02 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.012 1.292 . . . . 0.0 114.215 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 m -106.17 169.6 8.41 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.535 1.534 . . . . 0.0 111.564 -172.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.7 t -126.8 127.31 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.952 0.901 . . . . 0.0 110.448 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -105.06 122.24 45.46 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 123.725 0.81 . . . . 0.0 110.951 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.73 139.05 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 123.116 0.566 . . . . 0.0 109.632 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.2 t -130.22 142.6 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 124.276 1.031 . . . . 0.0 109.234 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.33 139.92 20.65 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.465 -176.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -111.64 -179.63 3.76 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.15 1.78 . . . . 0.0 110.911 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.43 -155.05 24.69 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.85 130.57 35.12 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 117.593 0.696 . . . . 0.0 110.179 -178.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -48.63 -50.39 33.04 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.399 1.08 . . . . 0.0 111.006 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.95 -52.15 31.8 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.143 1.354 . . . . 0.0 112.335 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -61.94 -46.62 88.53 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.084 0.954 . . . . 0.0 110.601 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.9 t -56.79 -41.84 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 122.319 0.247 . . . . 0.0 110.868 176.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -60.69 -26.59 67.24 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -60.64 -28.7 68.76 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.046 0.939 . . . . 0.0 112.401 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.0 -29.7 13.5 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.001 0.521 . . . . 0.0 111.0 174.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.4 mmt -64.15 -21.42 66.55 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.99 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -46.9 -59.05 3.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 118.37 0.532 . . . . 0.0 110.167 173.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -63.02 -33.35 75.23 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.571 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt -62.49 -50.43 71.45 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.221 0.918 . . . . 0.0 110.035 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -69.65 -12.65 61.8 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.043 0.756 . . . . 0.0 113.043 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.1 m -123.36 21.13 9.58 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.317 1.047 . . . . 0.0 111.223 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -89.42 -29.25 17.3 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -176.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -39.78 101.0 0.01 OUTLIER Glycine 0 C--N 1.344 1.003 0 C-N-CA 126.857 2.17 . . . . 0.0 112.824 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.29 -176.75 2.61 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.251 1.967 . . . . 0.0 110.98 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -68.61 -34.16 75.29 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.008 0.523 . . . . 0.0 111.444 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.96 -56.24 5.18 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 123.834 0.854 . . . . 0.0 110.606 -174.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.28 153.65 9.22 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.728 1.211 . . . . 0.0 110.737 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.39 79.57 1.55 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -178.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 64.6 t -68.2 90.43 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.892 0.877 . . . . 0.0 108.665 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.35 -57.48 12.12 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.606 0.762 . . . . 0.0 110.027 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -165.66 172.88 11.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.286 1.034 . . . . 0.0 109.863 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.74 125.16 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.878 0.871 . . . . 0.0 109.663 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.86 155.85 18.91 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.609 1.163 . . . . 0.0 110.784 177.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.18 129.39 27.39 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.293 1.037 . . . . 0.0 111.113 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.37 156.59 79.61 Favored Pre-proline 0 N--CA 1.47 0.563 0 C-N-CA 124.714 1.206 . . . . 0.0 110.429 -177.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.87 124.41 11.01 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 124.873 3.715 . . . . 0.0 111.052 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -116.45 119.07 34.46 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.085 0.954 . . . . 0.0 110.895 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -124.9 69.68 57.93 Favored Pre-proline 0 CA--C 1.535 0.373 0 O-C-N 121.526 -0.733 . . . . 0.0 110.83 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.06 141.11 43.16 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.248 2.632 . . . . 0.0 110.492 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.4 m -69.81 143.36 52.94 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.587 0.755 . . . . 0.0 110.572 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.76 169.43 4.63 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.14 0.876 . . . . 0.0 112.041 -176.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -92.48 135.1 34.34 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.7 tp -78.87 150.49 32.2 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.75 -77.32 0.11 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -141.11 163.78 32.05 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.08 0.952 . . . . 0.0 110.023 -173.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -71.12 146.53 49.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.15 0.58 . . . . 0.0 110.767 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -140.56 -171.11 3.15 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.336 1.055 . . . . 0.0 110.437 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.8 pp -134.98 -175.26 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.55 1.14 . . . . 0.0 109.619 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 116.72 -1.61 . . . . 0.0 114.34 176.076 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 119.63 -0.224 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.5 m -140.61 -53.02 0.49 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.456 1.102 . . . . 0.0 110.701 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.26 136.03 56.11 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.84 1.256 . . . . 0.0 112.095 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 p -141.04 91.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.271 0 C-N-CA 124.576 1.151 . . . . 0.0 108.511 -174.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.4 m -81.58 156.48 25.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.7 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.451 HD11 HG11 ' A' ' 55' ' ' VAL . 1.3 pp -143.7 159.37 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 tt -118.45 118.04 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.665 1.186 . . . . 0.0 109.276 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -108.81 108.51 19.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.898 1.279 . . . . 0.0 110.341 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -90.77 124.3 35.02 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.908 0.883 . . . . 0.0 110.188 177.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.451 HG12 HG21 ' A' ' 14' ' ' VAL . 4.2 t -106.15 124.59 61.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.919 1.288 . . . . 0.0 108.379 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -96.32 179.8 4.91 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.134 1.374 . . . . 0.0 110.589 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.31 -166.09 51.01 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.1 mtt180 -86.72 93.64 9.3 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 122.696 0.398 . . . . 0.0 111.652 -171.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.451 HG21 HG12 ' A' ' 10' ' ' VAL . 18.4 t -123.25 -41.44 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 123.676 0.79 . . . . 0.0 110.398 -174.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -69.74 144.47 52.74 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.042 0.537 . . . . 0.0 109.902 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.9 12.72 83.13 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.949 -0.917 . . . . 0.0 113.578 178.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.5 t -108.76 -49.21 7.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 CA-C-N 118.374 1.087 . . . . 0.0 109.682 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.01 29.4 1.51 Allowed Glycine 0 C--N 1.338 0.663 0 C-N-CA 124.476 1.036 . . . . 0.0 112.031 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -51.66 -36.21 45.37 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.005 0.903 . . . . 0.0 111.183 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.47 56.08 0.66 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.028 1.331 . . . . 0.0 112.069 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -107.87 -71.54 0.75 Allowed 'General case' 0 C--N 1.34 0.174 0 C-N-CA 124.832 1.253 . . . . 0.0 109.47 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.6 t -70.95 -21.62 62.32 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.009 0.524 . . . . 0.0 111.486 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.4 t -47.1 -38.13 10.9 Favored 'General case' 0 C--N 1.345 0.408 0 C-N-CA 123.683 0.793 . . . . 0.0 111.695 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -69.93 -56.47 6.94 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.127 0.971 . . . . 0.0 110.189 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -51.99 -56.84 11.76 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.098 0.959 . . . . 0.0 111.018 -176.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -56.47 -51.54 68.07 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 123.367 0.667 . . . . 0.0 110.23 178.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.38 -30.13 50.97 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.088 0.555 . . . . 0.0 112.439 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -64.57 -36.57 84.67 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.649 0.779 . . . . 0.0 111.192 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -72.38 -48.92 37.84 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.334 1.054 . . . . 0.0 110.256 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.1 mp -67.88 -38.21 82.75 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.964 0.906 . . . . 0.0 110.746 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.23 12.85 83.51 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 123.874 0.749 . . . . 0.0 112.684 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.421 HD12 ' HB1' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -68.68 177.59 2.44 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.805 0.842 . . . . 0.0 110.92 176.329 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.0 p -121.91 -165.7 1.3 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.37 -151.92 16.9 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 171.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -171.77 164.65 6.56 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 123.817 0.363 . . . . 0.0 111.727 173.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.21 90.3 3.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.009 0.924 . . . . 0.0 111.898 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -92.38 178.64 5.77 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 124.534 1.134 . . . . 0.0 110.897 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -121.71 140.73 51.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.293 1.037 . . . . 0.0 110.029 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.7 mt -73.94 174.95 7.83 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.842 1.257 . . . . 0.0 110.304 174.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -99.76 13.12 34.8 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.394 1.078 . . . . 0.0 111.442 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -119.25 -9.05 10.02 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.339 1.056 . . . . 0.0 112.148 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.13 24.76 4.08 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.917 1.246 . . . . 0.0 114.159 176.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.89 170.4 11.12 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.247 1.419 . . . . 0.0 111.482 -172.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.1 t -129.79 127.31 63.95 Favored 'Isoleucine or valine' 0 C--N 1.346 0.443 0 C-N-CA 123.836 0.855 . . . . 0.0 110.6 -175.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -108.46 123.2 48.51 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.577 0.751 . . . . 0.0 110.031 -177.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.4 t -117.14 136.39 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 123.778 0.831 . . . . 0.0 109.11 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -129.53 144.26 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 124.221 1.009 . . . . 0.0 108.997 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.421 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -155.43 141.4 18.24 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 118.695 -0.669 . . . . 0.0 110.616 -176.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.6 m -111.47 179.88 3.9 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.868 1.267 . . . . 0.0 111.784 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.04 -161.32 23.43 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.79 123.64 25.95 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.152 0.981 . . . . 0.0 110.576 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.73 -46.55 59.14 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.038 0.935 . . . . 0.0 110.108 -176.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -44.61 -41.81 7.13 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 126.057 1.789 . . . . 0.0 113.332 177.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -78.78 -50.74 10.82 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.462 0.705 . . . . 0.0 110.651 174.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 6' ' ' ILE . 59.8 t -49.96 -40.76 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 118.441 0.564 . . . . 0.0 111.747 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.16 -30.8 69.56 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.71 1.604 . . . . 0.0 112.178 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -56.4 -40.79 75.24 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 124.46 1.104 . . . . 0.0 110.819 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.36 -30.53 27.35 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.672 0.669 . . . . 0.0 111.093 175.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.5 mmt -63.91 -20.18 65.65 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 118.586 -0.721 . . . . 0.0 112.02 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -45.56 -51.61 11.67 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.504 0.593 . . . . 0.0 110.411 174.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -62.29 -40.39 96.09 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.855 0.862 . . . . 0.0 111.965 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.4 mt -60.31 -49.15 78.75 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.957 0.903 . . . . 0.0 110.377 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -57.41 -28.76 63.55 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.433 0.693 . . . . 0.0 112.527 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.16 -27.36 65.59 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.276 0.63 . . . . 0.0 110.983 177.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.56 30.61 64.01 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 123.858 0.742 . . . . 0.0 112.128 174.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.48 76.2 0.21 Allowed Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -69.72 -10.98 29.94 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.413 2.075 . . . . 0.0 112.12 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -101.63 -50.71 3.64 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.626 1.171 . . . . 0.0 111.022 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.8 p -133.72 165.77 24.18 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 125.97 1.708 . . . . 0.0 108.551 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 70.04 158.67 0.18 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.537 1.135 . . . . 0.0 111.008 -176.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -124.52 74.59 1.34 Allowed 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.802 0.841 . . . . 0.0 109.014 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.4 t -71.58 106.0 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -69.71 -54.57 13.17 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.942 0.897 . . . . 0.0 110.195 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -156.81 163.67 38.95 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.65 0.78 . . . . 0.0 110.252 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.55 138.64 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.889 0.876 . . . . 0.0 109.835 -178.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.05 156.63 34.49 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.57 1.148 . . . . 0.0 110.991 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.51 129.14 26.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.035 0.934 . . . . 0.0 111.231 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.9 157.77 77.31 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 124.936 1.294 . . . . 0.0 110.491 -177.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -70.77 126.22 12.42 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 124.795 3.663 . . . . 0.0 111.003 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -118.63 135.47 54.43 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.017 0.927 . . . . 0.0 110.193 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -138.61 75.35 37.9 Favored Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 121.715 -0.616 . . . . 0.0 110.886 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.78 149.34 60.2 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.641 2.894 . . . . 0.0 110.674 -176.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.3 p -76.27 144.33 40.38 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.674 0.79 . . . . 0.0 110.597 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.3 169.99 4.41 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.401 1.0 . . . . 0.0 112.128 -176.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -88.65 137.01 32.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mp -79.02 150.55 31.89 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.527 0.731 . . . . 0.0 109.492 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -76.67 0.19 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.336 1.054 . . . . 0.0 108.448 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -143.03 162.43 35.5 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.587 0.755 . . . . 0.0 110.741 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -75.63 145.6 40.95 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.099 0.559 . . . . 0.0 110.429 177.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -144.98 148.29 33.62 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 123.713 0.805 . . . . 0.0 109.912 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -174.72 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 O-C-N 121.977 -0.452 . . . . 0.0 110.802 176.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 116.327 -1.797 . . . . 0.0 113.297 173.649 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 t -138.44 -60.9 0.6 Allowed 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.631 0.772 . . . . 0.0 109.655 -174.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -71.91 105.75 3.95 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.572 0.701 . . . . 0.0 110.537 -173.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.7 p -98.64 77.9 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.7 m -73.22 144.92 46.56 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -176.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.494 HD12 ' C ' ' A' ' 6' ' ' ILE . 2.0 pp -112.77 166.69 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.3 tt -125.89 99.44 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 166.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.29 98.16 9.45 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.416 1.087 . . . . 0.0 109.593 -174.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 20.9 m-90 -79.49 100.19 7.6 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -82.62 90.75 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -177.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -72.1 159.68 33.75 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.984 0.421 . . . . 0.0 112.002 -169.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.4 -164.85 19.14 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 124.418 1.009 . . . . 0.0 111.66 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -93.62 82.52 4.37 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.662 0.785 . . . . 0.0 110.403 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.4 t -108.63 -47.56 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.674 1.19 . . . . 0.0 111.156 -167.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -62.12 157.26 19.5 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.126 0.97 . . . . 0.0 111.958 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.64 -43.67 3.19 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.091 0.853 . . . . 0.0 112.178 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.3 t -60.17 -39.27 80.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.543 1.137 . . . . 0.0 111.356 -176.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.69 33.1 2.73 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.306 1.431 . . . . 0.0 111.458 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -47.16 -34.78 6.55 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 126.559 1.943 . . . . 0.0 112.831 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.15 36.04 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.656 1.582 . . . . 0.0 113.007 171.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -60.84 -59.41 5.42 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.973 0.909 . . . . 0.0 110.464 -170.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 t -124.58 12.0 8.6 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.785 1.234 . . . . 0.0 111.701 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.7 t -47.44 -43.46 23.99 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -62.39 -51.5 67.32 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.706 1.202 . . . . 0.0 110.702 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -53.03 -57.98 8.55 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.329 0.652 . . . . 0.0 110.322 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.32 -49.82 63.47 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.767 1.227 . . . . 0.0 110.784 178.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.25 -38.52 68.62 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.259 0.624 . . . . 0.0 111.787 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -68.44 -28.06 66.73 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.911 0.884 . . . . 0.0 111.949 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 -62.49 -47.68 82.89 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.632 0.651 . . . . 0.0 109.522 175.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 62.7 mt -77.76 -32.55 52.7 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.508 0.723 . . . . 0.0 111.05 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.47 30.99 61.46 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.986 1.279 . . . . 0.0 112.437 -176.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.444 HD22 ' C ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -81.61 169.2 17.33 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.499 0.72 . . . . 0.0 112.179 -179.266 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.4 ' N ' HD22 ' A' ' 32' ' ' LEU . 21.4 p -127.31 147.24 50.25 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.857 0.863 . . . . 0.0 109.232 -168.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.51 -145.26 15.24 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -171.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -176.26 155.49 1.5 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.314 0.645 . . . . 0.0 111.255 174.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.88 93.85 6.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.489 1.116 . . . . 0.0 109.056 166.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -93.06 173.45 7.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 170.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -124.84 148.2 48.35 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 123.727 0.811 . . . . 0.0 110.132 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 35.5 mt -84.53 175.21 9.43 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.349 1.06 . . . . 0.0 110.046 172.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -87.57 18.83 3.68 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.386 1.074 . . . . 0.0 110.632 169.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -96.1 -53.12 3.76 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 125.009 1.324 . . . . 0.0 109.499 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.87 -17.1 1.4 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.492 1.044 . . . . 0.0 112.08 -160.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.1 p -107.61 153.8 22.37 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.372 1.069 . . . . 0.0 112.427 -162.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.7 t -102.47 121.17 53.22 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 124.727 1.211 . . . . 0.0 109.237 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -90.32 97.15 11.02 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 173.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.2 t -90.51 119.79 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.5 t -114.0 126.81 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.41 ' HA ' HD23 ' A' ' 32' ' ' LEU . . . -147.81 114.34 5.98 Favored 'General case' 0 CA--C 1.522 -0.106 0 O-C-N 123.911 0.757 . . . . 0.0 110.822 -168.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 87.7 m -80.21 -176.43 5.58 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 124.659 1.184 . . . . 0.0 110.78 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.06 -176.2 21.8 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -177.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -74.87 150.09 39.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -53.82 -46.48 71.16 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.202 0.601 . . . . 0.0 110.414 -176.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -47.09 -48.89 19.32 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.062 1.792 . . . . 0.0 112.914 174.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -63.98 -54.23 37.76 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 117.501 0.65 . . . . 0.0 111.27 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.5 t -58.17 -34.77 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.132 0.973 . . . . 0.0 111.602 -177.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -53.46 -40.29 65.16 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.052 0.541 . . . . 0.0 111.101 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -65.87 -37.87 87.3 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.67 0.668 . . . . 0.0 112.347 -172.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -75.69 -35.24 60.38 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.484 0.584 . . . . 0.0 110.972 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 43.9 mtm -65.67 -39.41 91.31 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 176.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -47.93 -40.47 22.1 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.563 0.745 . . . . 0.0 111.571 173.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 28.9 t90 -78.62 -37.2 42.8 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.245 -0.884 . . . . 0.0 110.737 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.1 mt -59.41 -49.44 77.81 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 119.813 1.188 . . . . 0.0 110.911 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -71.6 4.57 3.02 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.3 t -127.79 17.87 6.79 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.249 1.419 . . . . 0.0 110.182 169.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.05 -41.8 9.24 Favored Glycine 0 C--N 1.341 0.849 0 C-N-CA 124.732 1.158 . . . . 0.0 110.867 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -124.27 72.07 0.43 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.959 1.266 . . . . 0.0 111.265 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.65 -64.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.021 2.48 . . . . 0.0 110.387 177.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -83.95 -65.4 1.01 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.232 1.013 . . . . 0.0 108.615 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 77.9 p -66.16 155.05 38.07 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.55 0.74 . . . . 0.0 110.442 173.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 57.9 171.27 0.05 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.846 1.258 . . . . 0.0 111.005 -166.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.62 81.45 2.0 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 174.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 66.7 t -72.58 91.56 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 176.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -64.84 -55.74 17.7 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.439 0.695 . . . . 0.0 111.568 -175.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -171.63 148.42 2.45 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 125.432 1.493 . . . . 0.0 107.141 -175.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 p -119.5 126.49 75.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 123.041 0.537 . . . . 0.0 110.27 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.4 tp -103.58 118.79 37.54 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 123.527 0.731 . . . . 0.0 109.175 173.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.4 m -101.74 138.34 38.86 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.621 0.769 . . . . 0.0 109.622 169.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -130.55 154.3 81.63 Favored Pre-proline 0 CA--C 1.53 0.192 0 C-N-CA 125.413 1.485 . . . . 0.0 108.525 171.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -70.51 104.24 1.41 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.212 2.608 . . . . 0.0 109.705 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -85.18 111.61 19.97 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.377 1.071 . . . . 0.0 109.482 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.71 86.71 1.02 Allowed Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 124.157 0.983 . . . . 0.0 109.754 175.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.22 165.33 32.92 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.231 1.954 . . . . 0.0 109.646 169.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.9 m -74.96 123.18 24.66 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.98 -151.91 47.13 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -173.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -126.02 147.53 49.53 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.965 1.306 . . . . 0.0 108.57 171.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 31.6 tp -72.59 156.44 38.99 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.6 p -66.05 -55.76 14.99 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.451 1.1 . . . . 0.0 111.585 -178.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -140.46 166.81 23.7 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.592 1.157 . . . . 0.0 111.547 -167.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -86.12 137.95 32.28 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 168.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -160.28 -170.63 2.88 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -167.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.1 mt 65.9 -120.12 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 126.638 1.975 . . . . 0.0 109.055 -169.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.6 mtp85 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 117.285 -1.341 . . . . 0.0 110.194 -175.394 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? . . . . . 0 N--CA 1.475 0.775 0 CA-C-O 119.258 -0.401 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 t -172.18 -42.45 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.477 0.711 . . . . 0.0 111.024 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -60.95 134.28 56.94 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.973 1.309 . . . . 0.0 112.351 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 p -138.92 91.51 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.272 0 C-N-CA 124.778 1.231 . . . . 0.0 108.707 -174.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.8 m -82.46 153.42 25.65 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.937 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.88 146.22 18.8 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -176.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.5 tt -109.22 124.11 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 124.171 0.989 . . . . 0.0 109.874 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.7 112.47 22.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.745 1.218 . . . . 0.0 110.373 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.7 m-90 -94.67 130.69 41.05 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.366 1.066 . . . . 0.0 110.289 178.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.611 HG13 HG22 ' A' ' 75' ' ' VAL . 2.9 t -111.31 101.57 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -177.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -68.16 176.63 2.61 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.611 0.765 . . . . 0.0 111.132 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.7 -162.11 54.3 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -93.34 91.71 7.33 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 123.804 0.842 . . . . 0.0 112.06 -172.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.507 HG21 HG12 ' A' ' 10' ' ' VAL . 31.9 t -122.63 -30.78 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 C-N-CA 123.991 0.916 . . . . 0.0 111.275 -175.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -72.22 148.88 45.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 121.944 -0.473 . . . . 0.0 110.018 175.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.29 -21.02 47.68 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.067 -0.851 . . . . 0.0 113.023 176.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 p -84.09 0.53 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 118.55 1.175 . . . . 0.0 112.39 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.44 52.28 54.12 Favored Glycine 0 C--N 1.34 0.791 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -176.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.36 -34.25 70.47 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.591 0.756 . . . . 0.0 111.102 176.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.84 53.95 0.78 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.905 1.682 . . . . 0.0 112.326 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -87.17 -67.61 0.81 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -177.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 t -101.81 1.9 37.69 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.17 0.988 . . . . 0.0 112.094 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.8 t -48.35 -33.82 9.62 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.421 0.688 . . . . 0.0 112.149 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -68.03 -55.19 13.49 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.965 1.306 . . . . 0.0 110.423 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -55.08 -55.3 32.62 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.749 0.819 . . . . 0.0 110.742 -175.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.22 -47.97 68.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.839 0.856 . . . . 0.0 110.3 176.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.29 -28.23 58.07 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.48 -31.14 68.15 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.024 0.929 . . . . 0.0 111.873 177.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.1 mmm-85 -67.95 -42.39 81.03 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.801 0.84 . . . . 0.0 110.869 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -84.4 -42.05 16.07 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 122.947 0.499 . . . . 0.0 111.498 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.44 6.94 63.91 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 123.932 0.777 . . . . 0.0 112.91 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.67 167.72 3.38 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.138 0.969 . . . . 0.0 111.743 174.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.7 p -131.0 156.07 45.76 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -177.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 162.51 -148.13 14.84 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -169.62 164.15 10.19 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.163 -0.519 . . . . 0.0 111.77 172.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.98 97.27 5.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.014 0.926 . . . . 0.0 111.521 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -97.12 173.09 7.43 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.399 1.08 . . . . 0.0 111.095 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -123.44 137.87 54.71 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.428 1.091 . . . . 0.0 109.219 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.1 mt -75.67 177.36 6.88 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.497 1.119 . . . . 0.0 110.447 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -101.08 9.88 41.61 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.52 1.128 . . . . 0.0 111.276 177.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -109.34 -14.12 14.5 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.528 1.131 . . . . 0.0 112.086 -176.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.61 10.65 10.11 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.17 1.366 . . . . 0.0 113.938 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.54 164.45 14.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.538 1.535 . . . . 0.0 111.537 -173.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.4 p -119.55 138.97 48.46 Favored 'Isoleucine or valine' 0 C--N 1.347 0.494 0 C-N-CA 123.674 0.79 . . . . 0.0 110.702 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -110.86 121.18 44.71 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.581 1.152 . . . . 0.0 110.823 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 64.0 t -116.17 136.55 52.78 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.17 144.01 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 124.235 1.014 . . . . 0.0 109.482 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.54 142.03 21.7 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.581 -176.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.3 m -110.73 -178.78 3.57 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 126.173 1.789 . . . . 0.0 112.471 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.47 -153.59 23.48 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.054 -1.219 . . . . 0.0 110.054 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -82.25 132.7 35.23 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.096 0.558 . . . . 0.0 109.508 -178.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -48.71 -49.89 35.97 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.25 1.02 . . . . 0.0 110.972 -178.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.83 -52.96 28.15 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.103 1.335 . . . . 0.0 112.129 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -60.85 -46.5 90.34 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 124.232 1.013 . . . . 0.0 110.771 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.6 t -55.73 -42.79 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 122.271 0.228 . . . . 0.0 110.716 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.56 -27.73 66.49 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -27.05 68.49 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.842 0.857 . . . . 0.0 112.436 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.37 -29.05 14.18 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.211 0.604 . . . . 0.0 110.829 174.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.428 ' HA ' HD12 ' A' ' 62' ' ' LEU . 1.2 mmm -64.23 -21.87 66.74 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-O 118.588 -0.72 . . . . 0.0 111.535 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -47.54 -57.76 5.03 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 118.527 0.603 . . . . 0.0 109.812 172.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 15.7 t90 -64.3 -29.31 70.4 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.649 0.78 . . . . 0.0 111.727 -178.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 59' ' ' MET . 21.1 mt -66.39 -49.14 67.82 Favored 'General case' 0 C--N 1.347 0.489 0 O-C-N 121.101 -1.0 . . . . 0.0 110.083 177.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.79 14.31 6.08 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.0 t -148.71 14.6 0.95 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.416 0.686 . . . . 0.0 111.23 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -72.81 -60.16 4.05 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -175.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.02 78.17 0.13 Allowed Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 176.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.89 -171.22 0.46 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.552 2.835 . . . . 0.0 111.068 -175.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -47.53 -37.14 11.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.45 1.1 . . . . 0.0 112.933 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.34 133.92 1.43 Allowed 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.686 0.794 . . . . 0.0 109.905 177.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -170.0 153.65 4.8 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.876 1.271 . . . . 0.0 109.027 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -122.97 73.3 1.14 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.7 t -69.41 90.68 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -58.89 -50.79 72.7 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.494 0.718 . . . . 0.0 111.301 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.9 ttm-85 -169.3 163.56 10.76 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.042 0.537 . . . . 0.0 110.377 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.611 HG22 HG13 ' A' ' 10' ' ' VAL . 8.5 t -133.35 110.33 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.763 0.825 . . . . 0.0 109.953 -176.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.0 tp -100.61 152.4 20.48 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.36 1.064 . . . . 0.0 110.283 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.52 129.51 31.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.011 0.924 . . . . 0.0 111.518 -177.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.21 158.49 74.04 Favored Pre-proline 0 N--CA 1.469 0.501 0 C-N-CA 125.358 1.463 . . . . 0.0 110.544 -176.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.73 132.26 19.91 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 124.482 3.455 . . . . 0.0 110.987 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -120.68 114.93 22.39 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.617 1.167 . . . . 0.0 109.626 -177.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -121.8 64.97 18.23 Favored Pre-proline 0 CA--C 1.536 0.426 0 O-C-N 121.656 -0.653 . . . . 0.0 110.867 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.45 142.26 44.45 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.207 2.605 . . . . 0.0 110.471 -174.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.6 p -70.44 142.46 51.98 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.372 0.669 . . . . 0.0 110.729 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.86 170.62 5.37 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.25 0.929 . . . . 0.0 112.105 -176.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -93.26 135.15 34.74 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.8 tp -77.74 149.17 34.57 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -75.53 0.15 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.217 1.007 . . . . 0.0 108.483 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -141.15 162.95 34.26 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.135 0.974 . . . . 0.0 109.926 -173.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -71.17 145.61 49.61 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.876 0.47 . . . . 0.0 110.616 174.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -142.05 -169.97 3.05 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.122 0.969 . . . . 0.0 109.964 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.2 mt -141.97 168.01 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.906 0.882 . . . . 0.0 108.706 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.168 0 CA-C-O 116.709 -1.615 . . . . 0.0 112.562 174.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 111.423 0.157 . . . . 0.0 111.423 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.9 t -137.43 -40.52 0.57 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.545 1.138 . . . . 0.0 110.598 -175.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 152.97 41.95 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.145 0.978 . . . . 0.0 112.908 -176.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 p -138.78 90.88 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 124.505 1.122 . . . . 0.0 108.435 -173.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.0 m -78.61 153.37 31.16 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.665 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.99 148.99 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -176.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.8 tt -111.43 125.61 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.942 0.897 . . . . 0.0 109.947 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -120.21 101.85 8.1 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.823 1.649 . . . . 0.0 109.767 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 -87.15 112.7 22.21 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 124.618 1.167 . . . . 0.0 109.895 177.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.84 121.52 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.312 1.045 . . . . 0.0 108.662 -177.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -99.27 171.35 8.04 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.048 0.939 . . . . 0.0 110.684 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.72 -165.08 49.28 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 123.375 0.512 . . . . 0.0 112.095 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.9 mtt85 -84.86 83.6 7.99 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -166.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.7 t -119.49 -47.25 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.909 0.883 . . . . 0.0 110.378 -173.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -67.68 146.64 53.61 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 120.848 0.356 . . . . 0.0 110.862 177.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.18 17.93 76.22 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.128 0.87 . . . . 0.0 113.738 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 82.4 t -102.86 -43.06 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 124.673 1.189 . . . . 0.0 109.141 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.08 29.02 3.16 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 125.884 1.707 . . . . 0.0 110.996 -175.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -50.97 -37.58 45.55 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 124.509 1.124 . . . . 0.0 111.325 177.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.0 60.09 0.96 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.848 1.259 . . . . 0.0 112.689 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -109.75 -72.94 0.7 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.684 1.194 . . . . 0.0 108.789 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.3 t -72.19 -23.26 61.24 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 118.503 -0.761 . . . . 0.0 112.053 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.5 t -41.32 -39.81 1.51 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.468 1.107 . . . . 0.0 112.667 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -71.64 -59.84 2.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.364 1.065 . . . . 0.0 110.681 176.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -49.98 -58.08 6.2 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.139 0.976 . . . . 0.0 111.771 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -53.14 -51.15 62.9 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.588 1.155 . . . . 0.0 110.849 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.46 -33.2 53.31 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 122.78 0.432 . . . . 0.0 112.079 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -68.23 -28.54 67.32 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.212 1.005 . . . . 0.0 112.234 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.6 mtp85 -70.81 -47.04 61.58 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.895 0.878 . . . . 0.0 109.926 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.5 mt -78.33 -40.71 35.78 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.013 0.525 . . . . 0.0 111.004 -177.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.27 22.31 41.62 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.195 1.379 . . . . 0.0 112.952 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.72 174.89 11.12 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.713 0.805 . . . . 0.0 111.566 177.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 51.2 p -117.69 -163.39 0.93 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.59 -155.39 16.24 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 118.534 0.606 . . . . 0.0 112.144 171.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -169.88 162.26 9.28 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.72 84.81 2.32 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.443 1.097 . . . . 0.0 111.254 -174.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -92.61 173.01 8.0 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.851 0.86 . . . . 0.0 111.281 -177.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -125.07 131.57 53.31 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.336 1.054 . . . . 0.0 109.494 -177.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 39' ' ' LEU . 16.4 mt -70.06 171.25 9.86 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 125.214 1.405 . . . . 0.0 110.897 175.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -93.82 7.33 45.33 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.872 1.269 . . . . 0.0 111.747 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -112.63 -16.83 12.74 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.515 1.126 . . . . 0.0 112.119 -175.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.6 13.97 2.98 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.122 1.344 . . . . 0.0 114.385 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.54 166.32 12.85 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.426 1.49 . . . . 0.0 111.958 -167.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.3 t -127.07 120.92 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.586 1.155 . . . . 0.0 111.404 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -98.02 115.28 27.88 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 125.168 1.387 . . . . 0.0 111.684 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.6 t -114.1 133.32 60.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 122.861 0.464 . . . . 0.0 110.43 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.33 143.26 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 123.993 0.917 . . . . 0.0 109.738 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.96 133.03 11.63 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.015 -173.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 93.7 m -101.58 179.97 4.19 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.667 1.187 . . . . 0.0 112.325 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.73 -162.6 21.34 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.337 0.97 . . . . 0.0 110.758 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -73.18 121.75 20.79 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 123.691 0.796 . . . . 0.0 109.974 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -46.88 -50.85 17.97 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.015 1.326 . . . . 0.0 111.346 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -51.96 -45.77 55.97 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.402 1.477 . . . . 0.0 112.355 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -66.7 -50.88 61.41 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 117.455 0.628 . . . . 0.0 110.714 176.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.1 t -51.39 -34.05 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 122.647 0.379 . . . . 0.0 111.055 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -57.71 -31.46 66.43 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.915 0.886 . . . . 0.0 113.192 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -54.31 -44.86 72.36 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.828 0.851 . . . . 0.0 110.766 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.63 -32.18 53.22 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 118.481 0.582 . . . . 0.0 112.118 175.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.3 mmt -67.37 -25.19 65.85 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 118.814 -0.612 . . . . 0.0 111.867 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -42.44 -49.66 5.23 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.166 0.586 . . . . 0.0 109.719 170.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -64.13 -41.86 97.06 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.7 mt -53.1 -52.94 57.01 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.667 0.787 . . . . 0.0 110.599 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -28.24 69.4 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 119.04 -0.505 . . . . 0.0 111.837 176.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 t -62.18 -31.48 72.0 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.672 0.669 . . . . 0.0 111.536 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.37 6.48 75.75 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.534 -0.592 . . . . 0.0 113.096 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.85 162.51 2.71 Favored Glycine 0 CA--C 1.539 1.56 0 C-N-CA 124.095 0.855 . . . . 0.0 112.087 -170.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.56 83.74 2.11 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.696 2.931 . . . . 0.0 110.667 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 64.75 83.07 0.17 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.787 1.235 . . . . 0.0 110.305 177.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.94 -48.0 0.1 Allowed 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.292 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.29 151.66 42.18 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.565 1.546 . . . . 0.0 110.061 -173.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -114.83 84.05 2.01 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 95.4 t -69.28 102.6 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -67.21 -55.38 14.3 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.745 0.418 . . . . 0.0 110.998 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -166.64 99.05 0.57 Allowed 'General case' 0 C--N 1.342 0.274 0 C-N-CA 122.485 0.314 . . . . 0.0 111.422 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.9 p -84.41 125.54 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.275 0.63 . . . . 0.0 111.469 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.97 137.86 45.23 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 125.694 1.598 . . . . 0.0 111.568 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.88 138.56 54.35 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.156 1.382 . . . . 0.0 112.41 -177.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -144.04 158.73 54.97 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 124.945 1.298 . . . . 0.0 111.39 -177.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.02 137.38 26.44 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 124.074 3.182 . . . . 0.0 111.792 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -128.06 124.46 37.1 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.537 1.135 . . . . 0.0 111.181 -175.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -129.02 70.01 81.32 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 121.698 -0.626 . . . . 0.0 111.431 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.2 142.63 38.12 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.864 2.376 . . . . 0.0 110.722 -176.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.3 m -66.45 140.18 58.01 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.799 0.84 . . . . 0.0 110.776 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.86 -177.91 40.85 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.755 0.693 . . . . 0.0 111.547 -176.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -108.35 131.31 54.87 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.179 0.991 . . . . 0.0 108.568 172.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -69.82 151.75 45.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.927 1.291 . . . . 0.0 109.359 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.71 -77.98 0.13 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.672 0.789 . . . . 0.0 108.943 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -137.99 161.1 37.58 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.27 1.028 . . . . 0.0 109.838 -171.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -69.19 147.82 50.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.903 0.481 . . . . 0.0 110.03 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -152.06 -167.74 2.86 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 122.905 0.482 . . . . 0.0 110.524 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.2 tt -160.29 155.21 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 123.792 0.837 . . . . 0.0 109.48 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 . . . . . 0 C--O 1.251 1.182 0 CA-C-O 116.341 -1.79 . . . . 0.0 113.088 173.72 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 mtt . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 119.934 -0.079 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.0 m -127.91 -44.05 1.49 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.062 1.345 . . . . 0.0 110.737 176.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 142.84 55.84 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -169.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.25 88.5 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -172.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.2 m -78.95 152.06 31.29 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.276 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.416 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -141.52 149.33 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -177.105 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.8 tt -110.52 122.78 65.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 O-C-N 123.81 0.693 . . . . 0.0 109.335 174.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -113.88 95.67 5.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.684 1.594 . . . . 0.0 108.873 -175.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -81.44 130.59 35.1 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.4 t -107.07 113.97 44.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.476 1.111 . . . . 0.0 109.355 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -84.47 163.71 19.28 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.698 0.799 . . . . 0.0 111.052 175.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.39 179.5 53.02 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 124.126 0.869 . . . . 0.0 111.076 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.5 mtt180 -86.5 73.61 10.07 Favored 'General case' 0 N--CA 1.457 -0.075 0 CA-C-O 121.053 0.454 . . . . 0.0 111.751 -164.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.7 t -104.73 -33.25 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.162 0.985 . . . . 0.0 112.081 -170.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -63.13 159.68 16.94 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.677 0.671 . . . . 0.0 110.851 171.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.78 -46.08 1.65 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 123.992 0.806 . . . . 0.0 111.569 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.9 p -69.63 -9.74 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 123.431 0.693 . . . . 0.0 112.817 -174.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.08 44.46 35.85 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.894 0.759 . . . . 0.0 111.306 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -48.61 -34.13 11.09 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 125.867 1.667 . . . . 0.0 112.952 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 -71.95 47.92 0.15 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.844 1.657 . . . . 0.0 112.85 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -89.34 -69.63 0.7 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.089 0.956 . . . . 0.0 109.001 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.0 t -99.84 12.29 37.08 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.203 1.401 . . . . 0.0 111.23 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.1 t -59.41 -39.75 84.46 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.027 0.376 . . . . 0.0 110.796 170.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 -53.47 -60.55 3.16 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.868 1.267 . . . . 0.0 109.852 173.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -54.8 -57.04 13.15 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.001 0.92 . . . . 0.0 110.693 -173.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -54.55 -55.22 31.52 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 123.902 0.751 . . . . 0.0 109.856 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.92 -33.95 65.14 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 118.798 -0.62 . . . . 0.0 111.958 -177.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -67.56 -36.49 81.05 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.886 -0.578 . . . . 0.0 112.191 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -60.11 -46.87 88.17 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.656 0.662 . . . . 0.0 110.861 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.63 -22.01 34.85 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.98 31.57 47.79 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.557 1.075 . . . . 0.0 113.131 -178.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.597 HD13 ' O ' ' A' ' 49' ' ' CYS . 3.3 mm? -76.21 140.77 41.81 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 117.503 0.652 . . . . 0.0 110.294 176.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.2 p -96.16 -159.89 0.76 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.484 176.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.49 -149.22 16.69 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 119.212 0.915 . . . . 0.0 112.034 172.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -169.84 158.23 7.24 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 177.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.93 97.4 5.68 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.267 1.427 . . . . 0.0 110.416 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -107.62 170.22 8.11 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.697 0.799 . . . . 0.0 111.425 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -120.66 131.46 54.59 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.386 1.075 . . . . 0.0 108.994 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.7 mt -68.04 174.84 3.49 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.228 1.411 . . . . 0.0 110.679 175.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -97.48 15.52 22.96 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.772 1.229 . . . . 0.0 111.397 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -120.09 -14.47 8.86 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 123.942 0.897 . . . . 0.0 112.778 -173.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.22 11.35 4.26 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.073 1.32 . . . . 0.0 114.325 175.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 p -126.35 162.08 26.36 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.308 1.443 . . . . 0.0 111.807 -166.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.4 t -117.06 132.91 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.785 1.234 . . . . 0.0 111.112 -174.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -106.29 113.35 26.82 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.749 1.22 . . . . 0.0 110.606 178.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.1 t -112.29 135.39 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.785 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.7 142.76 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.765 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.53 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -151.7 119.21 6.04 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 117.945 -1.026 . . . . 0.0 111.901 -171.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.597 ' O ' HD13 ' A' ' 32' ' ' LEU . 98.5 m -109.58 132.02 54.52 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 120.031 1.287 . . . . 0.0 113.376 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 156.33 -163.86 32.19 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -71.81 126.85 30.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.334 0.567 . . . . 0.0 110.406 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -54.24 -43.21 70.7 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.853 1.261 . . . . 0.0 111.668 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -42.25 -42.8 4.43 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 126.057 1.789 . . . . 0.0 112.886 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -80.76 -47.17 14.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.207 1.003 . . . . 0.0 111.476 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.488 HG22 HD11 ' A' ' 32' ' ' LEU . 77.0 t -42.75 -52.11 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 123.938 0.895 . . . . 0.0 110.892 177.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -54.01 -36.4 62.94 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.405 0.682 . . . . 0.0 112.163 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -61.29 -44.24 97.55 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.022 0.929 . . . . 0.0 110.771 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.48 -32.32 68.13 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 122.934 0.494 . . . . 0.0 110.289 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.2 mmt -66.86 -24.87 66.18 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.096 -0.954 . . . . 0.0 112.264 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -47.71 -48.42 29.47 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 119.536 1.062 . . . . 0.0 109.535 172.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -61.25 -39.05 88.9 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 118.848 -0.596 . . . . 0.0 112.205 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.94 -46.58 71.6 Favored 'General case' 0 C--N 1.347 0.5 0 CA-C-N 119.385 0.993 . . . . 0.0 111.558 177.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -12.38 56.94 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 176.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 m -124.9 20.98 8.32 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.957 1.303 . . . . 0.0 111.496 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -88.41 -34.54 9.36 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -177.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -53.87 115.74 5.32 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.127 1.346 . . . . 0.0 111.735 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -85.62 -152.27 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.029 3.153 . . . . 0.0 109.835 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -61.73 -45.51 93.65 Favored 'General case' 0 C--N 1.344 0.331 0 O-C-N 121.829 -0.545 . . . . 0.0 111.02 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.9 p -86.51 179.0 6.92 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.685 1.194 . . . . 0.0 109.686 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 73.69 131.45 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 126.329 1.852 . . . . 0.0 111.573 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -120.48 94.51 4.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.41 1.084 . . . . 0.0 108.446 -176.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.6 t -72.76 98.12 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 124.403 1.081 . . . . 0.0 108.586 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -64.93 -51.31 62.55 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -167.61 168.7 12.5 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.482 1.113 . . . . 0.0 109.142 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.1 t -132.11 125.64 54.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.148 0.979 . . . . 0.0 109.265 174.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tp -103.81 120.64 41.4 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.397 1.079 . . . . 0.0 110.965 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.6 136.35 43.47 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.05 0.94 . . . . 0.0 110.678 178.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -140.83 153.55 67.75 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 124.836 1.254 . . . . 0.0 109.937 178.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.57 136.54 28.53 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.666 2.911 . . . . 0.0 110.984 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -126.44 118.82 25.75 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.89 1.276 . . . . 0.0 110.105 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -121.2 72.34 25.18 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 119.147 0.885 . . . . 0.0 111.498 177.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.27 140.32 44.21 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.011 2.474 . . . . 0.0 110.118 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 80.9 p -75.75 143.05 42.23 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.637 0.775 . . . . 0.0 110.753 -176.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.45 -179.93 42.48 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -103.68 126.76 51.02 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.621 1.168 . . . . 0.0 108.719 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 mp -71.24 151.64 44.1 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.063 0.945 . . . . 0.0 109.797 173.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.4 p -78.65 -79.65 0.13 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.891 0.876 . . . . 0.0 108.719 173.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -141.28 164.06 31.26 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 124.119 0.968 . . . . 0.0 111.187 -168.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -75.23 148.36 39.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.904 0.882 . . . . 0.0 110.002 175.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -149.83 -172.37 4.13 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.065 0.546 . . . . 0.0 110.022 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.4 pp -129.88 173.85 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 C-N-CA 123.872 0.869 . . . . 0.0 110.66 -174.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 . . . . . 0 C--O 1.251 1.164 0 CA-C-O 116.477 -1.725 . . . . 0.0 113.563 179.582 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.0 t . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -61.29 127.59 32.26 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.901 1.68 . . . . 0.0 112.928 -176.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 p -132.45 90.59 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.186 0 C-N-CA 125.585 1.554 . . . . 0.0 108.505 -174.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.1 m -81.65 153.22 26.76 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.92 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.89 149.59 17.71 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -176.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.4 tt -114.86 124.93 72.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.061 0.945 . . . . 0.0 110.414 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -119.35 109.56 15.94 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.953 1.701 . . . . 0.0 110.395 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.5 m-90 -92.11 116.45 28.95 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 125.626 1.57 . . . . 0.0 110.49 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -101.33 121.65 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.048 0.939 . . . . 0.0 109.164 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -91.34 173.19 8.05 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.362 1.465 . . . . 0.0 110.865 176.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.86 -166.98 50.96 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.7 mtt-85 -83.82 86.0 7.22 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.248 0.619 . . . . 0.0 111.519 -172.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.3 t -117.53 -40.57 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 123.791 0.837 . . . . 0.0 110.311 -174.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -73.65 149.33 42.05 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.175 0.443 . . . . 0.0 110.295 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.94 -43.26 1.74 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.102 0.858 . . . . 0.0 112.39 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.1 p -69.59 -8.12 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 118.066 0.933 . . . . 0.0 111.786 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.26 47.14 38.11 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -50.64 -40.89 54.49 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 124.022 0.929 . . . . 0.0 110.944 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 -70.76 55.0 0.17 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.599 1.96 . . . . 0.0 113.074 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -103.56 -68.93 0.82 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.36 1.064 . . . . 0.0 109.125 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.0 t -73.26 -22.11 60.46 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.3 t -41.31 -40.05 1.56 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.819 1.247 . . . . 0.0 112.55 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -64.79 -60.52 3.0 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.003 1.321 . . . . 0.0 110.826 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -51.26 -57.04 9.9 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.76 0.824 . . . . 0.0 111.022 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.04 -50.18 67.28 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.641 0.776 . . . . 0.0 110.477 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.91 -33.96 39.37 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 122.987 0.515 . . . . 0.0 112.098 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt -67.92 -33.4 74.62 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.463 0.705 . . . . 0.0 111.851 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 -66.15 -41.79 89.92 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.827 0.851 . . . . 0.0 111.411 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.93 -30.9 31.57 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.308 0.643 . . . . 0.0 111.77 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.96 21.4 78.51 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.095 0.855 . . . . 0.0 112.74 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.49 HD12 ' HB1' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -81.23 174.69 11.29 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.861 0.865 . . . . 0.0 110.955 176.389 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 50.0 p -117.31 -161.39 0.81 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -175.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.81 -155.16 16.3 Favored Glycine 0 C--N 1.339 0.705 0 CA-C-N 118.463 0.574 . . . . 0.0 111.822 169.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -168.14 159.23 10.82 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 171.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.01 95.33 4.86 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.77 1.228 . . . . 0.0 110.106 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -98.97 171.21 8.19 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.151 0.981 . . . . 0.0 110.674 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -127.29 133.23 50.17 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 124.048 0.939 . . . . 0.0 109.686 -177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.2 mt -71.23 173.52 7.61 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.158 1.383 . . . . 0.0 111.128 176.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -96.27 13.38 27.74 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.016 1.327 . . . . 0.0 111.801 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -121.38 0.59 10.05 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.635 1.174 . . . . 0.0 112.481 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.43 3.32 27.42 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.157 1.36 . . . . 0.0 114.425 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.37 165.14 11.73 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.959 1.704 . . . . 0.0 112.052 -169.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.8 t -126.87 124.49 64.89 Favored 'Isoleucine or valine' 0 C--N 1.348 0.515 0 C-N-CA 124.513 1.125 . . . . 0.0 111.752 -174.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -100.28 116.51 32.43 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 125.43 1.492 . . . . 0.0 111.718 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.0 t -113.51 133.0 60.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 123.496 0.719 . . . . 0.0 109.787 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.8 t -128.63 145.18 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.783 0.833 . . . . 0.0 110.188 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.49 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -157.9 137.1 11.71 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-O 118.297 -0.859 . . . . 0.0 111.786 -174.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 67.3 m -104.24 178.44 4.56 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.514 1.526 . . . . 0.0 112.418 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.06 -158.1 19.57 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 124.613 1.101 . . . . 0.0 110.422 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -79.56 128.63 33.62 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.835 0.854 . . . . 0.0 109.388 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -44.83 -49.32 10.88 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.241 1.016 . . . . 0.0 111.768 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -49.55 -54.29 17.43 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.305 1.431 . . . . 0.0 112.989 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -59.54 -47.82 84.07 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 125.302 1.441 . . . . 0.0 110.419 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.36 -41.6 71.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 122.429 0.292 . . . . 0.0 110.799 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -64.08 -26.88 68.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.226 0.611 . . . . 0.0 112.589 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -55.03 -48.96 72.72 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.637 0.775 . . . . 0.0 111.036 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -76.95 -30.26 55.96 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 118.192 0.451 . . . . 0.0 111.499 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.6 mmm -66.14 -21.42 66.34 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.624 -0.703 . . . . 0.0 111.594 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -44.41 -46.3 9.44 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.738 0.699 . . . . 0.0 109.996 168.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -67.74 -41.01 84.11 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.871 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 mt . . . . . 0 C--N 1.346 0.448 0 C-N-CA 123.476 0.71 . . . . 0.0 110.611 175.748 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.5 t . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -77.16 -47.96 18.94 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.924 0.89 . . . . 0.0 111.17 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.7 mtm105 -156.73 163.27 39.45 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.926 1.29 . . . . 0.0 109.484 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.4 p -154.57 131.61 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 118.944 -0.55 . . . . 0.0 111.136 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tp -122.67 141.0 52.22 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.357 1.063 . . . . 0.0 112.556 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.43 142.77 50.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.115 1.366 . . . . 0.0 112.867 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -143.2 159.57 55.2 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 125.119 1.368 . . . . 0.0 111.262 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.38 137.5 28.33 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.747 2.965 . . . . 0.0 111.346 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -125.3 116.94 22.73 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.79 1.236 . . . . 0.0 110.296 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -121.86 74.76 36.87 Favored Pre-proline 0 CA--C 1.536 0.408 0 O-C-N 121.425 -0.797 . . . . 0.0 110.77 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.72 146.27 42.82 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.76 2.306 . . . . 0.0 110.523 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.3 p -71.22 140.57 50.48 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.502 0.721 . . . . 0.0 110.461 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.22 179.73 30.79 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 123.811 0.72 . . . . 0.0 112.048 -177.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -101.75 131.02 48.27 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.597 1.159 . . . . 0.0 108.593 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -70.06 150.8 46.22 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.725 1.21 . . . . 0.0 109.534 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -77.32 0.15 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.788 0.835 . . . . 0.0 108.755 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -137.94 166.16 24.74 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.121 0.968 . . . . 0.0 110.674 -174.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -75.59 146.38 40.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.122 0.569 . . . . 0.0 110.101 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -149.81 -168.19 3.04 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.53 0.732 . . . . 0.0 110.055 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.4 pt . . . . . 0 CA--C 1.532 0.271 0 C-N-CA 124.376 1.07 . . . . 0.0 109.938 -176.965 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.2 t . . . . . 0 CA--C 1.535 0.393 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.3 121.78 21.86 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.926 0.891 . . . . 0.0 111.374 -174.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.87 85.54 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.087 0 C-N-CA 125.273 1.429 . . . . 0.0 108.262 -172.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 m -78.86 150.32 32.26 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.114 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pp -129.88 162.1 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.3 tt -119.83 124.5 72.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.186 0.994 . . . . 0.0 109.038 173.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -117.39 99.89 7.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 126.237 1.815 . . . . 0.0 109.298 -173.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -83.4 131.85 35.02 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.612 0.765 . . . . 0.0 110.113 175.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.5 t -112.04 107.15 22.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.184 0.993 . . . . 0.0 109.113 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -73.77 165.87 24.34 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 123.445 0.698 . . . . 0.0 110.997 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.03 -179.44 53.61 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 123.811 0.719 . . . . 0.0 111.741 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.1 mtt-85 -87.8 78.58 8.36 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 122.971 0.508 . . . . 0.0 112.033 -165.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.3 t -105.51 -26.98 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.11 0.964 . . . . 0.0 111.94 -173.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -73.29 156.72 38.16 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.224 0.61 . . . . 0.0 112.181 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.89 25.41 75.81 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.296 0.951 . . . . 0.0 113.244 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.6 t -123.49 -39.09 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.027 1.331 . . . . 0.0 110.478 -177.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.96 34.4 2.58 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.922 1.249 . . . . 0.0 112.733 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -48.25 -35.48 12.1 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.82 1.248 . . . . 0.0 112.781 172.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.38 57.17 2.29 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.291 1.836 . . . . 0.0 110.564 -174.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -98.31 -72.21 0.66 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.591 0.756 . . . . 0.0 109.444 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -88.48 -7.09 57.12 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.077 0.951 . . . . 0.0 111.996 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.8 t -43.62 -46.01 7.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.884 0.874 . . . . 0.0 112.72 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -53.4 -61.43 2.31 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 126.043 1.737 . . . . 0.0 110.537 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.95 -54.67 26.81 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.002 1.321 . . . . 0.0 110.645 -177.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -55.3 -52.68 62.68 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.582 0.753 . . . . 0.0 110.542 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.18 -36.34 63.29 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.087 0.555 . . . . 0.0 111.864 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -65.12 -31.34 72.5 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.919 0.887 . . . . 0.0 112.18 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.6 mtp85 -67.66 -47.05 70.63 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.422 0.556 . . . . 0.0 110.214 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mp -74.32 -33.08 63.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.745 0.418 . . . . 0.0 110.727 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.63 18.43 66.01 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.377 0.989 . . . . 0.0 112.629 -177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.77 171.0 13.58 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 117.466 0.633 . . . . 0.0 111.411 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.6 p -111.47 -158.17 0.64 Allowed 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -171.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.69 -159.69 13.59 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 118.092 0.406 . . . . 0.0 112.219 167.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -165.85 155.16 11.94 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 174.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.93 95.68 5.44 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.386 1.475 . . . . 0.0 110.085 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -104.53 175.36 5.51 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.683 0.793 . . . . 0.0 110.838 176.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -123.89 136.36 54.3 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.169 0.988 . . . . 0.0 109.988 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.5 mt -70.67 173.67 6.88 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.158 1.383 . . . . 0.0 110.632 173.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -96.91 18.93 13.55 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.658 1.183 . . . . 0.0 111.574 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -121.96 -20.91 6.17 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 123.806 0.842 . . . . 0.0 112.851 -175.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.24 -7.37 4.04 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.727 1.156 . . . . 0.0 113.836 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.8 p -112.48 166.64 11.13 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.186 1.395 . . . . 0.0 111.816 -165.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.0 t -124.46 129.83 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.191 0.996 . . . . 0.0 111.528 -168.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -104.82 114.01 27.96 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.789 1.236 . . . . 0.0 111.465 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.2 t -113.41 130.94 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.66 0.784 . . . . 0.0 109.946 -177.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.35 144.27 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.981 0.912 . . . . 0.0 110.473 -175.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.01 130.73 4.89 Favored 'General case' 0 C--N 1.349 0.557 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.112 -172.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 99.4 m -95.54 -178.94 4.58 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.151 1.38 . . . . 0.0 112.337 177.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.24 -159.39 14.33 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -83.06 127.01 33.19 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 174.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -49.93 -46.05 51.71 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.471 1.108 . . . . 0.0 110.851 -174.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -44.88 -50.56 8.68 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.054 1.788 . . . . 0.0 113.015 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -69.13 -49.03 60.65 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.147 0.979 . . . . 0.0 110.939 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.9 t -53.08 -38.52 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.004 0.521 . . . . 0.0 111.391 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -63.3 -26.96 69.01 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -61.46 -44.98 96.14 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.092 0.557 . . . . 0.0 111.293 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.37 -30.26 63.17 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.379 0.536 . . . . 0.0 110.515 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.8 mmt -66.92 -24.79 66.13 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.168 -0.92 . . . . 0.0 112.176 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -42.22 -53.91 3.89 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 119.036 0.835 . . . . 0.0 109.016 166.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 32.3 t90 -63.61 -40.98 98.28 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 123.337 0.655 . . . . 0.0 112.235 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 N--CA 1.469 0.516 0 CA-C-N 119.312 0.96 . . . . 0.0 110.774 178.912 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.9 t . . . . . 0 N--CA 1.454 -0.237 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -58.54 -45.52 88.73 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.3 mtm-85 -173.23 166.59 4.87 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.572 1.549 . . . . 0.0 109.51 -175.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.6 t -135.83 131.21 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.152 0.981 . . . . 0.0 110.827 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 tp -117.04 124.64 49.78 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.118 1.367 . . . . 0.0 111.706 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.79 134.7 52.27 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.284 1.034 . . . . 0.0 111.688 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -140.35 157.09 69.3 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.144 1.378 . . . . 0.0 110.589 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.39 131.25 18.63 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.251 3.301 . . . . 0.0 111.648 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -122.72 116.41 23.71 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.197 0.999 . . . . 0.0 111.446 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -113.85 77.89 3.81 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 119.223 0.92 . . . . 0.0 111.781 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.6 145.9 38.07 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.145 2.563 . . . . 0.0 111.297 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.2 m -73.91 135.79 43.31 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.339 1.056 . . . . 0.0 110.782 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.16 -179.06 42.99 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 123.708 0.671 . . . . 0.0 111.57 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -103.24 126.36 50.37 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.895 0.878 . . . . 0.0 108.758 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -67.0 155.4 38.73 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.905 1.282 . . . . 0.0 110.02 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.5 m -83.2 -76.95 0.26 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -128.48 167.75 16.62 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.029 1.331 . . . . 0.0 109.952 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -77.73 151.0 34.34 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.285 1.034 . . . . 0.0 110.137 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -151.38 -175.57 5.23 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.353 0.661 . . . . 0.0 110.724 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.3 pt . . . . . 0 CA--C 1.532 0.28 0 C-N-CA 123.875 0.87 . . . . 0.0 110.318 -178.351 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.9 m . . . . . 0 CA--C 1.529 0.143 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -73.49 105.13 4.71 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.524 0.73 . . . . 0.0 109.684 -176.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.5 p -98.57 81.6 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.3 m -75.71 151.38 37.66 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.151 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.514 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -135.71 147.51 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.036 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.3 tt -110.12 98.81 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 C-N-CA 123.699 0.8 . . . . 0.0 109.108 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.77 97.23 10.87 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.134 0.974 . . . . 0.0 109.181 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -72.09 102.65 3.06 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 169.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.68 82.86 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 174.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -65.92 132.05 47.7 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.97 -177.32 28.18 Favored Glycine 0 N--CA 1.448 -0.543 0 O-C-N 123.443 0.464 . . . . 0.0 111.988 178.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -89.06 69.05 8.4 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 121.911 0.863 . . . . 0.0 109.421 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.3 t -108.61 -47.35 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.937 1.695 . . . . 0.0 109.181 -167.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -57.68 145.19 35.11 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.076 0.95 . . . . 0.0 109.817 166.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.75 -45.11 2.71 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.801 0.715 . . . . 0.0 111.368 -175.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.0 t -65.64 -33.71 65.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.675 0.79 . . . . 0.0 111.085 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.2 38.51 5.36 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.581 1.086 . . . . 0.0 111.651 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -52.07 -30.37 25.56 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 126.17 1.788 . . . . 0.0 113.181 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.0 54.54 0.67 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.008 1.323 . . . . 0.0 110.377 174.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -87.37 -74.61 0.43 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.658 1.183 . . . . 0.0 108.444 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -101.83 17.83 22.05 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.637 1.175 . . . . 0.0 110.994 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.6 t -61.81 -40.53 95.59 Favored 'General case' 0 C--N 1.344 0.363 0 O-C-N 121.856 -0.527 . . . . 0.0 111.111 171.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -60.18 -50.33 74.1 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.402 0.681 . . . . 0.0 110.916 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -52.24 -58.49 6.48 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 123.184 0.303 . . . . 0.0 110.303 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.18 -52.17 59.69 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.755 1.222 . . . . 0.0 110.872 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.16 -39.66 63.75 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.444 1.097 . . . . 0.0 111.843 177.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -72.08 -23.69 61.39 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.917 0.887 . . . . 0.0 112.104 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.3 mmm-85 -65.12 -47.16 78.15 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 118.854 0.752 . . . . 0.0 108.982 171.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.9 mt -75.09 -33.46 61.64 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.069 0.947 . . . . 0.0 111.213 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.62 45.55 52.53 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 124.748 1.166 . . . . 0.0 111.314 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.36 174.98 5.65 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.757 1.223 . . . . 0.0 112.605 -175.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.4 p -114.63 -171.72 1.98 Allowed 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -170.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.69 -144.37 17.58 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 170.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -171.72 153.56 3.39 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 176.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.94 83.87 2.29 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.638 1.175 . . . . 0.0 108.689 170.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt -83.64 165.22 19.16 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -126.99 134.66 50.31 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 47.6 mt -80.74 -175.27 5.2 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.584 0.754 . . . . 0.0 109.899 170.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -93.04 2.31 56.84 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.961 0.904 . . . . 0.0 111.164 168.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -79.6 -48.1 14.34 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.403 0.681 . . . . 0.0 109.418 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.46 -28.72 2.31 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -157.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.04 117.02 10.17 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.312 0.645 . . . . 0.0 111.364 -166.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 63.8 t -88.76 104.12 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 171.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -79.65 93.41 5.51 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.821 1.248 . . . . 0.0 108.753 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.1 t -91.21 114.94 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.03 130.42 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.31 1.044 . . . . 0.0 108.479 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.17 123.64 7.17 Favored 'General case' 0 N--CA 1.457 -0.113 0 O-C-N 124.377 1.048 . . . . 0.0 109.792 -166.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 91.4 m -95.7 176.66 6.06 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.064 0.946 . . . . 0.0 112.085 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.9 -155.11 16.29 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -72.76 150.59 42.68 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 172.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -58.58 -46.89 85.96 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -46.49 -45.24 16.92 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.137 1.827 . . . . 0.0 113.034 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -67.02 -51.61 52.74 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.578 0.689 . . . . 0.0 110.707 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.7 t -61.08 -32.48 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.876 0.87 . . . . 0.0 111.904 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -53.64 -40.98 66.27 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.415 0.686 . . . . 0.0 111.092 173.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -65.06 -30.76 71.74 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.145 0.884 . . . . 0.0 112.691 -169.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -78.46 -35.97 45.97 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.565 0.62 . . . . 0.0 110.929 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 54.0 mtm -64.17 -41.91 96.93 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.498 0.59 . . . . 0.0 111.197 175.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -51.96 -29.77 21.92 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.219 1.008 . . . . 0.0 112.386 172.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 12.8 t90 -83.65 -41.07 18.18 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 117.845 -1.074 . . . . 0.0 110.874 170.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 25.6 mt . . . . . 0 C--N 1.346 0.444 0 CA-C-N 120.098 1.317 . . . . 0.0 111.53 -174.362 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.6 t . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -70.55 -54.83 10.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.032 0.933 . . . . 0.0 110.945 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -151.54 150.05 29.9 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 123.652 0.781 . . . . 0.0 110.097 -174.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.0 t -127.6 102.08 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.844 1.258 . . . . 0.0 109.53 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.7 tp -105.37 114.2 28.23 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 123.586 0.754 . . . . 0.0 110.159 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.4 m -99.28 138.11 36.83 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.122 0.569 . . . . 0.0 109.902 170.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -130.04 148.85 71.32 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 125.67 1.588 . . . . 0.0 108.402 172.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.61 109.87 1.52 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.406 2.737 . . . . 0.0 109.936 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -89.5 113.16 24.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.859 1.264 . . . . 0.0 109.164 -174.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -110.88 72.37 0.78 Allowed Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 125.162 1.385 . . . . 0.0 110.454 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.45 135.73 24.89 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.642 2.228 . . . . 0.0 110.119 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.1 p -71.36 137.23 48.24 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.16 -160.16 50.97 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -173.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -137.24 145.63 43.81 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.233 1.013 . . . . 0.0 110.11 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.3 tp -100.33 137.5 38.66 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 171.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.1 m -66.17 -48.43 70.75 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.694 0.797 . . . . 0.0 111.801 -173.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -129.53 160.93 31.68 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.976 0.911 . . . . 0.0 111.866 -166.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -84.85 145.8 27.65 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.427 1.091 . . . . 0.0 109.315 166.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -145.73 173.41 12.12 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.792 0.837 . . . . 0.0 110.893 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.6 pt . . . . . 0 C--N 1.34 0.161 0 C-N-CA 123.827 0.851 . . . . 0.0 110.409 -174.672 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.3 m . . . . . 0 CA--C 1.531 0.212 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -67.96 107.68 2.76 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 121.091 0.472 . . . . 0.0 110.966 -177.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.39 80.47 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.733 1.613 . . . . 0.0 107.097 -173.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -76.72 148.01 37.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.537 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.445 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.2 pp -120.03 164.26 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.6 tt -125.01 118.5 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 124.395 1.078 . . . . 0.0 108.867 170.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -115.27 107.84 15.79 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.784 1.234 . . . . 0.0 110.211 -176.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -86.1 121.56 28.87 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 172.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.6 t -100.44 94.18 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -63.76 152.55 39.04 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.916 0.886 . . . . 0.0 110.958 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.3 -178.64 26.72 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 124.389 0.995 . . . . 0.0 112.261 174.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -85.94 87.55 7.43 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 123.169 0.588 . . . . 0.0 110.647 -173.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.0 t -114.82 -40.04 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.771 1.228 . . . . 0.0 110.178 -174.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -65.56 152.34 44.31 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.629 0.772 . . . . 0.0 111.718 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.67 17.95 76.94 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.996 0.807 . . . . 0.0 113.543 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.69 -42.05 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.783 1.233 . . . . 0.0 109.257 175.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.26 32.08 1.89 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.687 1.613 . . . . 0.0 112.124 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -53.21 -29.1 30.26 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.541 1.537 . . . . 0.0 112.882 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -68.69 41.54 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.096 2.158 . . . . 0.0 113.5 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -85.8 -67.72 0.79 Allowed 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.508 -0.745 . . . . 0.0 110.029 -173.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.3 t -92.56 -9.77 40.0 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.888 0.875 . . . . 0.0 112.61 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.6 t -43.82 -48.54 8.26 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.06 0.944 . . . . 0.0 113.541 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -58.4 -57.16 14.13 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 124.653 1.181 . . . . 0.0 110.141 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -50.74 -55.66 15.65 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.499 1.12 . . . . 0.0 110.672 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.16 -54.2 39.32 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 124.596 1.159 . . . . 0.0 110.164 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.57 -36.83 64.79 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.658 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -68.51 -31.44 70.7 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.464 0.705 . . . . 0.0 112.125 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -60.92 -49.29 78.05 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.715 0.689 . . . . 0.0 110.282 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.3 mt -75.52 -31.03 59.98 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.392 0.277 . . . . 0.0 110.911 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.55 22.54 53.5 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.749 1.166 . . . . 0.0 112.593 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.94 169.26 10.41 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.658 0.783 . . . . 0.0 112.201 -177.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.6 p -112.27 -159.39 0.68 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.725 0.81 . . . . 0.0 109.352 -166.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.7 -154.77 16.68 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 170.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -169.47 160.68 9.33 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.05 78.97 1.39 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.738 1.215 . . . . 0.0 109.679 -174.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -85.01 166.34 16.79 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -126.86 129.82 49.0 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.6 mt -68.08 173.84 4.31 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.904 1.282 . . . . 0.0 110.781 177.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -89.44 13.77 12.93 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.953 0.901 . . . . 0.0 111.378 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -105.94 -51.14 3.03 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 123.894 0.878 . . . . 0.0 110.31 -176.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 161.02 -20.55 0.21 Allowed Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.446 1.022 . . . . 0.0 112.671 -167.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.2 p -105.26 159.14 16.11 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.078 0.951 . . . . 0.0 112.287 -162.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.2 t -116.22 126.49 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.248 1.019 . . . . 0.0 111.261 -169.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -100.33 105.55 17.09 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.644 1.577 . . . . 0.0 110.397 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.6 t -110.45 127.16 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 123.262 0.625 . . . . 0.0 109.818 -172.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.46 141.0 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 118.629 -0.7 . . . . 0.0 109.948 -171.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.52 128.16 4.46 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 118.163 -0.922 . . . . 0.0 112.329 -167.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 98.9 m -97.04 177.65 5.53 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 113.443 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.62 -172.8 16.31 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 125.054 1.311 . . . . 0.0 111.01 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -67.59 124.28 22.81 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -52.62 -40.45 62.76 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.175 1.39 . . . . 0.0 112.24 -168.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -43.96 -50.59 7.43 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.669 1.604 . . . . 0.0 112.379 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -65.07 -52.72 54.03 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 122.958 0.503 . . . . 0.0 110.516 176.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.2 t -46.43 -45.57 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.094 0.958 . . . . 0.0 111.626 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -64.21 -29.05 70.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.496 -0.764 . . . . 0.0 112.799 -175.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -54.63 -44.27 73.03 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 119.324 0.966 . . . . 0.0 111.197 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.2 -29.32 61.68 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.452 0.301 . . . . 0.0 111.169 177.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mtm -68.31 -25.74 65.28 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 118.692 -0.67 . . . . 0.0 112.033 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -48.64 -53.15 19.68 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 166.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -62.81 -40.96 99.01 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 118.534 -0.745 . . . . 0.0 112.17 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 mt . . . . . 0 N--CA 1.469 0.476 0 CA-C-N 119.779 1.172 . . . . 0.0 109.922 177.77 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.6 t . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -68.56 -48.7 63.58 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 119.055 -0.498 . . . . 0.0 111.221 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.2 mtm105 -167.05 163.85 15.85 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.801 0.841 . . . . 0.0 110.799 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -127.06 117.25 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.289 1.036 . . . . 0.0 109.926 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 tt -106.91 111.84 24.53 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.257 1.023 . . . . 0.0 110.022 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.5 m -103.9 137.39 41.96 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.348 0.659 . . . . 0.0 111.175 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -139.64 160.06 62.8 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 126.037 1.735 . . . . 0.0 109.759 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.73 129.54 12.7 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.346 2.697 . . . . 0.0 110.367 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 59.4 t60 -116.88 110.51 18.43 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.287 1.035 . . . . 0.0 109.607 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -108.18 80.53 1.11 Allowed Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 119.079 0.854 . . . . 0.0 111.055 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.15 160.92 46.11 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.99 2.46 . . . . 0.0 110.85 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 88.7 p -84.08 147.59 27.29 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.028 0.931 . . . . 0.0 110.473 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.22 -171.75 18.18 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.85 0.738 . . . . 0.0 112.298 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -105.29 136.11 45.43 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.121 0.968 . . . . 0.0 109.864 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 mp -81.72 147.11 29.64 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.307 1.043 . . . . 0.0 109.251 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 19.2 p -78.69 -66.04 0.91 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.624 1.17 . . . . 0.0 109.874 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -137.92 166.55 23.76 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.259 1.424 . . . . 0.0 110.693 -167.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -84.36 140.68 31.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 167.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -148.38 -172.43 4.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.014 0.526 . . . . 0.0 109.827 -174.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.3 tt . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -175.398 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 t . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 111.286 0.106 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -67.14 120.48 13.8 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.221 1.008 . . . . 0.0 111.471 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 p -127.64 85.04 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 125.578 1.551 . . . . 0.0 107.813 -173.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.57 148.68 31.65 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.853 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.419 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.3 pp -129.43 162.96 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.6 tt -121.66 125.77 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 124.026 0.931 . . . . 0.0 108.988 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -118.62 103.66 9.91 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.659 1.584 . . . . 0.0 109.832 -173.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.5 m-90 -85.65 117.66 24.68 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.23 0.612 . . . . 0.0 109.815 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.0 t -100.51 108.85 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 123.83 0.852 . . . . 0.0 108.978 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -78.86 164.78 24.2 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.122 0.569 . . . . 0.0 110.876 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.76 -177.88 42.13 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 124.061 0.839 . . . . 0.0 112.122 177.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -84.76 81.42 8.88 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.386 0.612 . . . . 0.0 111.066 -169.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.8 t -108.52 -44.42 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.478 1.511 . . . . 0.0 110.48 -173.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -65.9 153.8 41.02 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.117 0.567 . . . . 0.0 110.964 175.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 67.75 17.52 69.3 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 123.998 0.808 . . . . 0.0 113.722 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.6 t -104.04 -43.27 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.752 1.221 . . . . 0.0 108.828 172.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.63 32.76 2.61 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.904 1.716 . . . . 0.0 111.233 -176.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -53.5 -34.59 58.65 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.801 1.24 . . . . 0.0 112.356 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.3 53.89 0.68 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.438 1.495 . . . . 0.0 112.139 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -94.4 -75.05 0.52 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.497 1.119 . . . . 0.0 109.48 -176.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -79.99 -11.87 59.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.905 0.882 . . . . 0.0 112.016 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.6 t -44.18 -44.43 7.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.97 0.908 . . . . 0.0 112.719 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.4 mm-40 -56.41 -63.68 1.11 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.823 1.649 . . . . 0.0 110.166 172.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -50.85 -56.22 13.23 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.969 1.707 . . . . 0.0 111.75 -174.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -56.04 -54.59 43.14 Favored 'General case' 0 CA--C 1.527 0.064 0 C-N-CA 124.292 1.037 . . . . 0.0 109.852 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.47 -37.61 49.72 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.93 0.892 . . . . 0.0 111.888 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -65.32 -32.16 73.67 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.769 1.228 . . . . 0.0 112.474 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.2 mmm-85 -64.52 -45.14 88.47 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 118.464 0.574 . . . . 0.0 110.037 175.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.5 mt -73.23 -36.02 66.38 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.192 0.597 . . . . 0.0 111.311 -178.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.49 18.61 65.93 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.415 1.007 . . . . 0.0 112.475 -175.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.47 169.45 14.49 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.463 0.705 . . . . 0.0 110.713 177.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.2 p -111.87 -157.61 0.62 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -170.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.6 -155.21 16.34 Favored Glycine 0 C--N 1.339 0.711 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 166.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -166.66 154.78 10.02 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 173.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.12 96.17 5.79 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.237 1.415 . . . . 0.0 110.098 175.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -102.2 174.09 6.08 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.749 0.82 . . . . 0.0 111.321 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -125.28 132.38 52.92 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.109 0.964 . . . . 0.0 109.344 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.0 mt -71.48 171.96 10.39 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.14 1.376 . . . . 0.0 110.758 174.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -95.47 15.68 19.01 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.049 1.34 . . . . 0.0 111.763 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -117.2 -26.35 6.8 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.115 0.966 . . . . 0.0 112.043 -175.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.73 4.13 1.66 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.644 1.116 . . . . 0.0 114.307 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 p -121.11 167.51 12.56 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.002 1.321 . . . . 0.0 112.091 -165.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.7 t -123.9 128.24 74.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.578 1.151 . . . . 0.0 111.222 -170.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -101.89 111.46 23.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.165 1.386 . . . . 0.0 111.56 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.1 t -108.5 132.55 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 123.043 0.537 . . . . 0.0 110.235 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.53 143.62 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.873 0.869 . . . . 0.0 110.174 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.4 129.11 5.49 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 118.174 -0.917 . . . . 0.0 111.905 -172.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 80.8 m -95.6 -179.43 4.74 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.634 1.174 . . . . 0.0 112.441 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.43 -167.4 14.79 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 124.94 1.257 . . . . 0.0 109.978 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.98 139.79 46.92 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 170.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -53.79 -45.09 70.62 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.904 0.882 . . . . 0.0 110.587 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -42.47 -45.52 5.45 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.347 1.927 . . . . 0.0 113.202 174.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -74.21 -46.93 38.71 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.252 1.021 . . . . 0.0 111.592 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -53.34 -41.51 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.461 0.705 . . . . 0.0 110.69 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -65.14 -22.72 66.96 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.331 0.653 . . . . 0.0 112.67 -176.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -61.87 -45.23 94.67 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.366 0.53 . . . . 0.0 111.021 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.3 -28.07 61.01 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.392 0.542 . . . . 0.0 111.038 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -68.59 -26.13 65.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.695 -0.669 . . . . 0.0 111.277 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -44.0 -49.36 8.65 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 167.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -69.34 -37.21 77.57 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-O 118.426 -0.797 . . . . 0.0 111.69 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 N--CA 1.468 0.436 0 CA-C-N 118.972 0.806 . . . . 0.0 111.028 177.856 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.8 t . . . . . 0 N--CA 1.456 -0.148 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -73.12 -52.6 13.62 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.609 0.763 . . . . 0.0 111.407 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.2 mmm-85 -168.94 166.44 11.22 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.725 1.21 . . . . 0.0 109.433 -171.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.06 133.84 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 118.838 -0.601 . . . . 0.0 111.41 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.6 tp -124.69 125.68 44.49 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.077 0.951 . . . . 0.0 112.251 -175.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.95 135.1 49.09 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.273 1.029 . . . . 0.0 111.813 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -134.17 155.98 79.5 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 125.909 1.684 . . . . 0.0 110.203 -178.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.74 126.53 11.48 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 124.244 3.296 . . . . 0.0 111.078 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -119.21 107.49 13.5 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.147 0.979 . . . . 0.0 110.371 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -110.55 74.22 0.87 Allowed Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 119.228 0.922 . . . . 0.0 111.464 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -72.97 151.5 50.47 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.179 2.586 . . . . 0.0 111.44 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.4 p -79.19 140.69 37.65 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.123 0.969 . . . . 0.0 110.624 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.8 174.26 16.57 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.028 0.823 . . . . 0.0 111.89 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -92.04 142.66 27.28 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.758 0.823 . . . . 0.0 108.975 171.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -85.98 149.01 25.49 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.1 p -75.54 -75.95 0.16 Allowed 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -134.08 163.0 30.55 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.833 0.853 . . . . 0.0 110.847 -171.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -76.52 148.63 37.0 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.848 0.859 . . . . 0.0 109.829 172.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -150.95 -177.69 6.16 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.121 0.568 . . . . 0.0 109.948 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.9 pt . . . . . 0 C--O 1.231 0.105 0 C-N-CA 123.575 0.75 . . . . 0.0 109.615 178.232 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 CA--C 1.539 0.536 0 CA-C-O 119.909 -0.091 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -63.06 134.71 56.52 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.709 1.204 . . . . 0.0 112.132 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.0 p -139.95 92.86 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.294 0 C-N-CA 124.603 1.161 . . . . 0.0 109.027 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.8 m -86.67 156.65 19.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.469 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.5 pp -140.46 158.48 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.073 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 tt -119.01 109.82 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.123 0.969 . . . . 0.0 109.549 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -101.99 119.77 39.33 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.298 1.039 . . . . 0.0 110.157 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.0 m-90 -97.39 112.35 24.22 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.039 0.935 . . . . 0.0 110.493 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.466 HG12 HG21 ' A' ' 14' ' ' VAL . 3.8 t -91.78 123.78 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.93 0.892 . . . . 0.0 109.063 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -94.0 174.89 6.93 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.461 1.504 . . . . 0.0 111.202 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.12 -163.56 54.15 Favored Glycine 0 C--N 1.338 0.683 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -85.93 91.8 8.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.67 0.788 . . . . 0.0 111.514 -173.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.466 HG21 HG12 ' A' ' 10' ' ' VAL . 17.6 t -123.45 -44.31 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.171 0.988 . . . . 0.0 109.771 -175.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -71.27 143.05 50.49 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.29 0.636 . . . . 0.0 110.172 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.26 18.04 79.09 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 119.214 -0.77 . . . . 0.0 113.309 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.0 t -108.78 -43.19 5.92 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 124.331 1.052 . . . . 0.0 109.686 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 116.71 25.56 3.34 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 125.185 1.374 . . . . 0.0 111.639 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -51.24 -35.09 35.33 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.891 0.876 . . . . 0.0 111.105 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.5 mtp180 -74.9 59.86 0.93 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.243 1.417 . . . . 0.0 111.36 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -114.27 -73.51 0.65 Allowed 'General case' 0 C--N 1.339 0.139 0 C-N-CA 125.389 1.475 . . . . 0.0 108.807 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.3 t -73.69 -19.96 60.68 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.229 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.5 t -45.44 -36.96 4.72 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.937 0.895 . . . . 0.0 112.163 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -69.95 -59.21 3.06 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.508 1.123 . . . . 0.0 110.208 176.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -52.33 -53.98 37.49 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.534 1.134 . . . . 0.0 111.348 -175.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.58 -52.12 64.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.643 1.177 . . . . 0.0 110.214 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.87 -31.54 59.81 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.169 0.587 . . . . 0.0 112.408 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -65.02 -34.33 78.18 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.642 1.177 . . . . 0.0 111.597 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -69.92 -48.87 56.85 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.757 0.823 . . . . 0.0 110.34 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.7 mt -71.21 -34.24 70.66 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.917 0.487 . . . . 0.0 110.779 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.09 14.08 81.1 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.319 0.962 . . . . 0.0 112.671 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.55 178.14 5.54 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.533 0.733 . . . . 0.0 111.259 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.3 p -123.79 -174.91 3.09 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 136.61 -149.3 20.11 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 170.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -169.03 165.93 11.17 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 172.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.1 101.58 7.09 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.597 0.759 . . . . 0.0 112.031 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -97.99 175.28 6.18 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.444 1.098 . . . . 0.0 111.243 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -123.77 136.54 54.48 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.837 1.255 . . . . 0.0 109.973 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.419 HD12 ' HB2' ' A' ' 43' ' ' SER . 18.6 mt -74.19 173.91 9.48 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.504 1.522 . . . . 0.0 109.981 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -97.58 13.47 29.96 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.151 0.98 . . . . 0.0 111.719 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -117.92 -11.01 10.32 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 124.044 0.938 . . . . 0.0 112.446 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.38 19.77 4.53 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 125.098 1.333 . . . . 0.0 114.061 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.419 ' HB2' HD12 ' A' ' 39' ' ' LEU . 17.1 m -118.14 166.25 12.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.546 1.538 . . . . 0.0 111.601 -171.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.2 t -129.35 118.25 45.31 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 C-N-CA 124.046 0.938 . . . . 0.0 110.575 -175.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -94.88 126.47 40.23 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.58 0.752 . . . . 0.0 110.554 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.8 t -120.38 133.95 65.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.687 0.795 . . . . 0.0 109.457 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.5 t -126.28 142.54 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 C-N-CA 124.425 1.09 . . . . 0.0 109.512 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.93 134.62 10.83 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-O 118.752 -0.642 . . . . 0.0 111.117 -173.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 51.8 m -99.77 178.44 4.83 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.211 1.404 . . . . 0.0 112.611 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.46 -153.19 20.15 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -83.77 126.63 33.12 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.832 1.253 . . . . 0.0 109.561 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -46.38 -51.48 14.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.723 1.209 . . . . 0.0 111.537 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -51.9 -44.88 56.12 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.223 1.392 . . . . 0.0 112.97 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -69.09 -44.22 72.92 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 117.33 0.565 . . . . 0.0 111.752 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.4 t -54.39 -32.66 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 122.749 0.419 . . . . 0.0 110.728 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.97 -29.97 69.98 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -57.66 -24.03 54.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.009 0.923 . . . . 0.0 112.608 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.68 -29.51 12.62 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-N 118.784 0.72 . . . . 0.0 111.483 171.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.3 mmm -65.79 -20.36 66.23 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.838 -0.601 . . . . 0.0 111.949 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -45.12 -58.18 3.39 Favored 'General case' 0 C--O 1.214 -0.791 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 172.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -62.76 -36.9 84.55 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.125 0.57 . . . . 0.0 111.833 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt . . . . . 0 C--N 1.345 0.386 0 C-N-CA 123.707 0.803 . . . . 0.0 110.375 178.284 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -55.31 -49.97 70.78 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 122.979 0.512 . . . . 0.0 111.21 176.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -171.26 171.13 5.75 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.67 1.188 . . . . 0.0 109.595 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.9 p -156.28 134.26 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.009 0.523 . . . . 0.0 110.212 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tp -113.91 149.63 34.9 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.989 0.916 . . . . 0.0 110.886 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.12 131.32 44.05 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.427 1.091 . . . . 0.0 111.344 -176.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -141.53 156.31 66.73 Favored Pre-proline 0 N--CA 1.468 0.431 0 C-N-CA 124.01 0.924 . . . . 0.0 111.622 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -68.63 125.28 12.53 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 124.213 3.275 . . . . 0.0 110.836 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -118.99 117.36 28.58 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.89 0.876 . . . . 0.0 109.878 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -109.34 77.67 0.97 Allowed Pre-proline 0 CA--C 1.539 0.53 0 O-C-N 121.498 -0.751 . . . . 0.0 110.344 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.63 126.58 12.23 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.656 2.904 . . . . 0.0 109.755 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.0 p -70.31 148.67 48.23 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.338 0.655 . . . . 0.0 110.688 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.25 176.7 8.84 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.973 0.796 . . . . 0.0 112.164 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -105.27 131.78 52.3 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.71 1.204 . . . . 0.0 108.872 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.2 tp -83.19 151.76 25.53 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.572 0.749 . . . . 0.0 109.55 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.5 m -74.74 -73.43 0.24 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -138.04 162.99 32.72 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.466 1.106 . . . . 0.0 110.369 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -71.83 147.21 47.4 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.673 0.789 . . . . 0.0 110.519 175.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -143.97 -177.35 5.39 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.64 1.176 . . . . 0.0 110.159 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.3 pt . . . . . 0 CA--C 1.533 0.316 0 C-N-CA 123.628 0.771 . . . . 0.0 109.102 -177.782 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 t . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 110.605 -0.146 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.67 152.85 44.59 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.285 1.034 . . . . 0.0 112.821 -177.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 p -138.49 88.43 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.262 1.025 . . . . 0.0 108.405 -174.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.5 m -79.55 150.49 31.1 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.584 HD11 HG11 ' A' ' 55' ' ' VAL . 1.4 pp -136.68 157.17 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.9 tt -116.35 116.35 52.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.431 1.093 . . . . 0.0 109.609 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -111.41 103.21 11.55 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.674 1.59 . . . . 0.0 109.917 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.1 m-90 -83.68 115.59 22.25 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 123.783 0.833 . . . . 0.0 109.868 176.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.466 HG13 HG22 ' A' ' 75' ' ' VAL . 4.3 t -97.92 113.24 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -87.82 172.63 9.49 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 124.487 1.115 . . . . 0.0 111.175 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.03 -169.55 55.01 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 123.632 0.634 . . . . 0.0 111.821 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -83.39 85.33 7.25 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.02 0.528 . . . . 0.0 112.124 -167.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.4 t -117.7 -43.08 2.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.845 -173.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -68.23 148.34 50.96 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.683 0.674 . . . . 0.0 110.389 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.74 -31.01 8.32 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 118.918 -0.934 . . . . 0.0 113.426 174.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 m -74.34 -0.58 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 119.018 1.409 . . . . 0.0 112.448 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.01 36.83 73.22 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.199 0.904 . . . . 0.0 110.859 -170.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -51.25 -38.84 54.86 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 123.908 0.883 . . . . 0.0 111.157 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.16 55.97 0.6 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.511 1.524 . . . . 0.0 113.095 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -110.99 -72.42 0.72 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.402 1.081 . . . . 0.0 109.465 -177.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 t -73.77 -16.93 61.15 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.213 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.2 t -40.68 -42.09 1.66 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.141 1.376 . . . . 0.0 113.021 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -64.3 -61.46 2.22 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.632 1.173 . . . . 0.0 110.411 173.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -48.97 -54.38 15.83 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.604 1.562 . . . . 0.0 111.734 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -55.69 -45.82 77.75 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.355 1.462 . . . . 0.0 112.038 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.09 -30.38 71.32 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.092 0.557 . . . . 0.0 111.999 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.8 tttt -65.3 -35.44 81.01 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.831 0.853 . . . . 0.0 111.328 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -67.51 -49.46 63.31 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.294 0.638 . . . . 0.0 110.536 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.9 mt -73.55 -34.37 65.15 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.825 0.45 . . . . 0.0 110.74 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.08 13.24 72.05 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.208 0.909 . . . . 0.0 112.866 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.21 176.28 8.9 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.775 0.83 . . . . 0.0 111.506 178.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.7 p -115.61 -160.89 0.76 Allowed 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -172.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.2 -155.25 16.27 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 118.637 0.653 . . . . 0.0 112.751 169.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -168.99 159.37 9.27 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 174.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.22 91.38 3.44 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.579 1.152 . . . . 0.0 111.5 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -93.17 174.83 7.02 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.337 0.655 . . . . 0.0 110.357 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -123.19 133.99 54.19 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 124.191 0.996 . . . . 0.0 110.539 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 30.0 mt -74.67 169.32 18.05 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.77 1.628 . . . . 0.0 110.267 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -90.0 4.5 49.96 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.391 1.076 . . . . 0.0 112.113 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -107.83 -7.57 16.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.469 1.108 . . . . 0.0 112.093 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.56 12.69 11.33 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.085 1.326 . . . . 0.0 113.963 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.36 168.06 10.31 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.637 1.575 . . . . 0.0 112.003 -170.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.9 t -129.07 118.13 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.49 1.116 . . . . 0.0 110.894 -173.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -94.97 121.71 36.87 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.407 1.003 . . . . 0.0 111.234 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.5 t -119.05 134.07 63.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 117.966 0.348 . . . . 0.0 110.532 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.43 142.55 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.412 1.085 . . . . 0.0 109.704 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.08 133.24 7.69 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 118.637 -0.697 . . . . 0.0 111.569 -171.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 96.9 m -100.18 176.44 5.39 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.808 1.243 . . . . 0.0 112.785 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.18 -159.01 20.03 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.825 1.202 . . . . 0.0 110.317 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -73.36 134.24 44.03 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.21 0.604 . . . . 0.0 110.17 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -49.01 -49.46 40.87 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.447 1.099 . . . . 0.0 111.184 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -49.91 -53.3 22.86 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.097 1.332 . . . . 0.0 112.171 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -62.22 -43.61 98.44 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.469 0.708 . . . . 0.0 111.487 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.584 HG11 HD11 ' A' ' 6' ' ' ILE . 80.7 t -58.02 -40.0 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 122.611 0.364 . . . . 0.0 110.396 175.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.46 -26.4 68.71 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -176.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -55.47 -44.72 76.71 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.609 0.764 . . . . 0.0 110.897 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.26 -30.44 48.58 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 118.177 0.444 . . . . 0.0 111.632 175.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.3 mmt -68.38 -22.72 64.63 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 119.074 -0.489 . . . . 0.0 112.096 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -43.34 -51.13 6.54 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 167.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 18.7 t90 -64.25 -40.95 97.06 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.344 0.52 . . . . 0.0 111.989 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mt . . . . . 0 C--N 1.348 0.502 0 C-N-CA 123.661 0.785 . . . . 0.0 111.043 179.464 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.7 t . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -62.43 -56.84 14.32 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.856 0.862 . . . . 0.0 109.988 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -166.96 158.14 12.22 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.18 0.992 . . . . 0.0 109.424 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.466 HG22 HG13 ' A' ' 10' ' ' VAL . 21.8 t -132.3 135.78 57.44 Favored 'Isoleucine or valine' 0 C--N 1.342 0.24 0 C-N-CA 123.771 0.828 . . . . 0.0 110.031 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.9 tp -117.37 108.44 15.58 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.812 0.845 . . . . 0.0 110.789 -177.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.15 127.15 46.45 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.632 1.173 . . . . 0.0 111.52 -177.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -131.0 156.51 80.04 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 126.125 1.77 . . . . 0.0 110.673 -175.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -71.24 120.14 6.78 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.232 3.288 . . . . 0.0 111.495 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -109.44 109.04 19.77 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.485 0.714 . . . . 0.0 109.616 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -109.89 74.21 0.74 Allowed Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 123.945 0.898 . . . . 0.0 110.315 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.73 146.9 30.62 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.072 2.515 . . . . 0.0 110.511 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.7 p -72.72 141.17 48.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.424 0.69 . . . . 0.0 110.485 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.7 -178.63 35.53 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 123.871 0.748 . . . . 0.0 112.132 -177.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -104.12 130.84 51.86 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.333 1.053 . . . . 0.0 108.688 172.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mp -69.54 151.84 45.52 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.836 1.254 . . . . 0.0 109.713 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.59 -77.82 0.17 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.105 0.962 . . . . 0.0 109.008 178.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -137.37 167.0 22.48 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.343 1.057 . . . . 0.0 110.536 -173.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -73.74 143.22 46.18 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.598 173.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -130.93 174.63 9.79 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.414 0.686 . . . . 0.0 110.201 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.5 tp . . . . . 0 N--CA 1.449 -0.479 0 C-N-CA 122.76 0.424 . . . . 0.0 110.727 177.316 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.479 0 CA-C-O 120.265 0.079 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -61.19 135.73 57.84 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.745 1.618 . . . . 0.0 112.104 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.6 p -140.85 91.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 124.604 1.162 . . . . 0.0 108.368 -174.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.0 m -80.86 155.88 26.36 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.579 177.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.411 HD11 HG11 ' A' ' 55' ' ' VAL . 1.3 pp -143.58 158.2 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.4 tt -118.49 119.73 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 124.103 0.961 . . . . 0.0 109.329 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -109.2 106.43 16.29 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.996 1.318 . . . . 0.0 109.99 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -90.13 124.3 34.7 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.903 0.881 . . . . 0.0 110.251 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.464 HG12 HG21 ' A' ' 14' ' ' VAL . 10.4 t -101.51 104.3 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.11 0.964 . . . . 0.0 108.605 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -68.45 176.87 2.63 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 123.801 0.84 . . . . 0.0 111.69 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.72 -169.51 47.92 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -92.24 91.32 7.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.032 0.533 . . . . 0.0 110.853 -175.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.464 HG21 HG12 ' A' ' 10' ' ' VAL . 57.3 t -111.86 -31.75 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 124.106 0.962 . . . . 0.0 111.233 -178.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -69.13 150.16 47.86 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.586 0.355 . . . . 0.0 110.557 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.46 17.55 66.16 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 123.918 0.77 . . . . 0.0 113.397 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.0 t -114.94 -45.56 4.35 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 C-N-CA 124.761 1.224 . . . . 0.0 109.367 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.32 31.93 1.59 Allowed Glycine 0 C--N 1.339 0.698 0 C-N-CA 125.197 1.38 . . . . 0.0 111.434 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -50.79 -36.12 35.44 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 117.664 0.732 . . . . 0.0 110.874 177.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -74.3 56.56 0.65 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.502 1.121 . . . . 0.0 112.741 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -97.42 -71.02 0.7 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.965 0.906 . . . . 0.0 109.264 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 t -89.35 -2.99 58.64 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.71 0.804 . . . . 0.0 111.69 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.8 t -45.98 -37.78 6.93 Favored 'General case' 0 C--N 1.345 0.397 0 C-N-CA 123.84 0.856 . . . . 0.0 112.099 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -69.84 -59.51 2.89 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 124.31 1.044 . . . . 0.0 109.949 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -49.48 -55.11 14.4 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.704 1.202 . . . . 0.0 111.29 -176.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -55.78 -57.5 11.76 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.021 0.928 . . . . 0.0 109.822 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.22 -34.29 31.54 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.926 0.891 . . . . 0.0 112.121 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -62.68 -38.89 92.14 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.438 1.095 . . . . 0.0 111.71 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -68.6 -38.4 80.6 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.017 0.927 . . . . 0.0 110.527 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.87 -32.34 57.43 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.676 0.791 . . . . 0.0 111.118 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.94 15.57 80.42 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.686 0.66 . . . . 0.0 112.82 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.447 HD12 ' HB1' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -83.18 179.76 7.63 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.965 0.906 . . . . 0.0 111.217 178.269 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 46.0 p -120.29 -162.43 0.94 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -176.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.1 -151.93 17.45 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 172.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -172.57 170.39 4.85 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.844 0.458 . . . . 0.0 112.085 175.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.56 88.19 2.7 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.43 0.692 . . . . 0.0 111.697 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -88.91 173.03 8.73 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.89 0.876 . . . . 0.0 110.18 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -124.01 138.56 54.44 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.699 1.2 . . . . 0.0 108.684 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.9 mt -74.58 178.63 5.21 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.09 1.356 . . . . 0.0 110.173 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -100.94 12.3 37.92 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.806 0.842 . . . . 0.0 111.327 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -117.08 -14.67 10.56 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.401 1.08 . . . . 0.0 112.497 -176.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.13 2.6 7.69 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.171 1.367 . . . . 0.0 114.12 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.1 m -104.34 167.19 9.91 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.855 1.262 . . . . 0.0 111.679 -171.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.9 t -125.4 127.66 72.02 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 C-N-CA 124.302 1.041 . . . . 0.0 109.979 -176.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -102.33 122.73 44.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.659 1.184 . . . . 0.0 110.96 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.76 135.67 57.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -131.2 145.07 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.941 0.897 . . . . 0.0 109.578 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.447 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -158.52 138.96 12.56 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.991 -173.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.3 m -108.98 -178.6 3.62 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.053 1.341 . . . . 0.0 112.298 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.46 -161.29 26.16 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.95 121.46 23.49 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.196 0.998 . . . . 0.0 110.944 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -49.69 -45.32 48.75 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.765 1.226 . . . . 0.0 110.941 -175.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -44.47 -43.74 7.82 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 126.424 1.964 . . . . 0.0 113.423 175.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -78.4 -49.03 14.27 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.689 0.795 . . . . 0.0 110.09 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.411 HG11 HD11 ' A' ' 6' ' ' ILE . 49.4 t -52.87 -32.71 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 122.727 0.411 . . . . 0.0 111.851 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -63.25 -32.0 73.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.255 1.422 . . . . 0.0 112.149 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? -61.89 -52.87 62.35 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-O 118.625 -0.703 . . . . 0.0 110.012 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.81 -29.78 68.47 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.215 0.916 . . . . 0.0 111.091 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.537 ' HA ' HD12 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -65.87 -22.67 66.54 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.412 -0.804 . . . . 0.0 111.518 177.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -48.14 -46.63 34.59 Favored 'General case' 0 C--N 1.343 0.326 0 CA-C-N 118.632 0.651 . . . . 0.0 109.951 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -70.46 -35.94 73.62 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.113 -177.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 59' ' ' MET . 5.2 mt . . . . . 0 CA--C 1.536 0.428 0 CA-C-N 118.634 0.652 . . . . 0.0 109.957 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.3 t . . . . . 0 CA--C 1.533 0.295 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -62.92 -58.03 8.76 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.208 0.603 . . . . 0.0 110.782 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.0 tpp180 -168.38 174.07 7.23 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.931 0.892 . . . . 0.0 109.592 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.0 t -140.68 127.61 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.751 0.821 . . . . 0.0 109.982 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.13 156.08 19.18 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.695 1.198 . . . . 0.0 111.086 176.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.12 134.11 34.23 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.5 1.12 . . . . 0.0 111.556 -177.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -141.26 155.37 67.96 Favored Pre-proline 0 N--CA 1.471 0.586 0 C-N-CA 123.897 0.879 . . . . 0.0 111.503 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.9 122.24 9.13 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 124.704 3.603 . . . . 0.0 111.047 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -114.69 135.71 53.86 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.113 0.965 . . . . 0.0 110.512 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -139.66 71.42 37.13 Favored Pre-proline 0 CA--C 1.534 0.356 0 O-C-N 121.659 -0.651 . . . . 0.0 110.481 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -68.28 136.33 36.89 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.394 2.73 . . . . 0.0 110.138 -174.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.5 p -64.63 144.13 57.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.453 0.701 . . . . 0.0 110.825 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.87 170.75 5.46 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.225 0.917 . . . . 0.0 112.041 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -86.59 137.15 32.73 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mp -77.9 150.23 34.13 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.458 0.703 . . . . 0.0 109.543 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.8 -79.26 0.14 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -145.67 163.8 33.75 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.376 0.671 . . . . 0.0 110.948 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -74.22 143.99 44.91 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.258 0.623 . . . . 0.0 110.652 177.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -158.4 -179.98 8.6 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.197 0.599 . . . . 0.0 110.429 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.229 0 C-N-CA 123.511 0.724 . . . . 0.0 109.296 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 CA--C 1.537 0.45 0 N-CA-C 110.691 -0.114 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.6 134.36 54.19 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.176 1.39 . . . . 0.0 112.064 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 p -139.32 90.84 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.242 0 C-N-CA 124.645 1.178 . . . . 0.0 108.63 -174.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.3 m -81.36 153.2 27.12 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.772 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pp -141.16 158.2 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.123 0.569 . . . . 0.0 109.875 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 tt -117.7 118.24 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.171 0.989 . . . . 0.0 109.724 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -107.32 108.15 19.4 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.852 1.661 . . . . 0.0 109.897 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -90.4 128.35 36.46 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 125.243 1.417 . . . . 0.0 110.296 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.463 HG12 HG21 ' A' ' 14' ' ' VAL . 10.4 t -114.45 122.44 68.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.329 1.052 . . . . 0.0 109.07 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -96.66 178.76 5.22 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.829 1.252 . . . . 0.0 110.858 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.72 -160.21 53.44 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.3 mtt-85 -85.17 92.09 8.31 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -171.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.463 HG21 HG12 ' A' ' 10' ' ' VAL . 20.9 t -131.52 -45.84 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.523 0.729 . . . . 0.0 110.487 -175.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -70.46 146.91 49.98 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 122.857 0.463 . . . . 0.0 110.539 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.23 14.72 82.27 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 119.152 -0.805 . . . . 0.0 113.373 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 75.2 t -107.79 -44.11 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.618 1.167 . . . . 0.0 109.424 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.49 28.76 2.25 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 125.194 1.378 . . . . 0.0 111.431 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -50.78 -37.61 43.3 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 123.85 0.86 . . . . 0.0 111.11 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.21 59.49 0.76 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.388 1.075 . . . . 0.0 112.621 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -111.76 -72.84 0.7 Allowed 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.108 1.363 . . . . 0.0 109.55 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.1 t -73.13 -18.13 61.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.86 -0.59 . . . . 0.0 111.45 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.2 t -45.29 -36.92 4.35 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.844 0.858 . . . . 0.0 112.009 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -71.13 -57.79 4.18 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.351 1.06 . . . . 0.0 110.317 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.15 -59.87 3.87 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.158 0.983 . . . . 0.0 110.649 -175.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -55.18 -46.17 75.8 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.368 1.067 . . . . 0.0 110.428 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.59 -36.17 71.38 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.0 tttt -62.25 -30.91 71.44 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.09 0.556 . . . . 0.0 111.572 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.2 mmm-85 -66.85 -49.54 65.39 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 122.964 0.505 . . . . 0.0 110.652 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.417 HD12 HD23 ' A' ' 58' ' ' LEU . 40.6 mt -77.16 -42.44 37.73 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 122.403 0.281 . . . . 0.0 110.855 -177.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.9 9.36 58.51 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.551 1.072 . . . . 0.0 112.953 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.01 168.1 3.44 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 117.86 0.83 . . . . 0.0 112.015 175.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.5 p -127.3 151.03 49.29 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -176.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 161.9 -148.36 15.67 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -170.45 167.83 8.05 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 122.99 0.516 . . . . 0.0 111.777 173.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.41 99.68 5.5 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 118.679 -0.676 . . . . 0.0 111.345 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -100.93 176.83 5.14 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 124.68 1.192 . . . . 0.0 111.547 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 -127.11 137.98 53.1 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.074 1.35 . . . . 0.0 109.473 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.1 mt -75.01 174.24 9.61 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 125.075 1.35 . . . . 0.0 110.552 174.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -96.69 10.33 39.01 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.708 1.203 . . . . 0.0 111.529 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.68 -2.55 12.43 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.528 1.131 . . . . 0.0 112.018 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.94 25.77 6.65 Favored Glycine 0 C--N 1.342 0.871 0 C-N-CA 124.638 1.113 . . . . 0.0 113.776 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.16 162.22 19.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.006 1.322 . . . . 0.0 111.531 -175.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.0 t -122.05 120.85 62.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.409 1.484 . . . . 0.0 110.864 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -99.11 122.37 42.25 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.906 1.282 . . . . 0.0 111.06 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.56 136.87 55.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 C-N-CA 123.554 0.741 . . . . 0.0 109.511 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 t -127.36 143.33 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 124.237 1.015 . . . . 0.0 109.425 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.43 136.71 13.96 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-O 118.819 -0.61 . . . . 0.0 110.925 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 56.4 m -104.39 -179.53 3.97 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.698 1.599 . . . . 0.0 112.652 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.52 -154.57 22.25 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -80.09 129.07 34.22 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 123.222 0.609 . . . . 0.0 110.231 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -48.73 -52.43 23.68 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.908 1.283 . . . . 0.0 111.013 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.04 -45.88 62.03 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.343 1.449 . . . . 0.0 112.693 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -66.7 -46.86 74.22 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 117.479 0.639 . . . . 0.0 111.224 177.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.3 t -54.91 -30.9 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.135 0.574 . . . . 0.0 110.955 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -59.33 -31.39 69.13 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -55.05 -36.78 65.92 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.901 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.417 HD23 HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -84.91 -31.62 23.58 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.138 0.881 . . . . 0.0 111.03 174.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.5 mmm -65.59 -19.78 66.06 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.14 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -46.31 -51.38 14.78 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -70.83 -34.04 71.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 mt . . . . . 0 C--N 1.351 0.647 0 C-N-CA 123.324 0.65 . . . . 0.0 109.983 176.838 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.6 t . . . . . 0 CA--C 1.532 0.272 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -55.75 -56.61 18.4 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 123.848 0.859 . . . . 0.0 110.775 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.8 mtm-85 -157.08 161.9 39.46 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.953 1.301 . . . . 0.0 110.001 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.06 131.03 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.353 1.061 . . . . 0.0 109.534 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 tp -113.87 148.4 36.77 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.905 1.282 . . . . 0.0 110.819 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.42 135.57 38.82 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.402 -177.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -142.64 156.69 63.01 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 123.523 0.729 . . . . 0.0 111.68 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.13 122.98 10.09 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.644 3.563 . . . . 0.0 110.737 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -110.96 113.06 25.33 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.723 0.809 . . . . 0.0 109.571 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -117.43 70.08 6.12 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 118.709 0.686 . . . . 0.0 111.171 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.91 146.34 47.33 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.249 2.633 . . . . 0.0 110.79 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.5 p -72.5 142.97 48.54 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.615 0.766 . . . . 0.0 110.726 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.79 169.65 4.78 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.362 0.982 . . . . 0.0 112.128 -176.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -95.51 135.48 37.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.5 tp -79.77 150.48 30.76 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -75.81 0.14 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.223 1.009 . . . . 0.0 108.58 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -140.97 163.64 32.43 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.341 1.056 . . . . 0.0 110.129 -173.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -69.94 146.77 50.93 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.286 0.634 . . . . 0.0 110.829 175.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -143.25 -169.81 3.13 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.672 0.789 . . . . 0.0 110.909 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.0 pt . . . . . 0 CA--C 1.529 0.145 0 C-N-CA 124.181 0.993 . . . . 0.0 109.109 176.765 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 111.198 0.073 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -66.48 129.48 39.97 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.449 1.5 . . . . 0.0 112.137 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 p -135.15 89.33 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.281 0 C-N-CA 125.179 1.392 . . . . 0.0 108.435 -174.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.2 m -79.96 153.94 28.58 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.558 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.422 HD11 HG11 ' A' ' 55' ' ' VAL . 1.3 pp -139.51 159.28 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.0 tt -122.83 121.08 62.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.451 1.101 . . . . 0.0 110.204 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -116.09 115.74 26.62 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.747 1.619 . . . . 0.0 111.615 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.1 m-90 -93.82 120.45 34.1 Favored 'General case' 0 C--N 1.337 0.063 0 C-N-CA 125.724 1.61 . . . . 0.0 110.906 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.1 t -109.33 123.54 65.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 124.537 1.135 . . . . 0.0 108.937 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -101.32 178.58 4.61 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 124.277 1.031 . . . . 0.0 110.846 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.59 -160.11 48.79 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -85.09 96.08 9.32 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -171.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.4 t -128.56 -46.79 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 124.036 0.835 . . . . 0.0 109.853 -176.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -67.92 145.64 54.37 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 123.558 0.743 . . . . 0.0 111.269 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.26 25.58 72.74 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 123.914 0.769 . . . . 0.0 112.98 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.7 t -119.37 -48.24 3.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 124.865 1.266 . . . . 0.0 109.397 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.55 30.71 2.14 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.36 1.457 . . . . 0.0 111.392 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -55.14 -40.35 70.46 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 117.52 0.66 . . . . 0.0 109.913 173.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -89.57 23.68 2.54 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.756 1.222 . . . . 0.0 112.364 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -90.11 -57.61 2.79 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.794 0.838 . . . . 0.0 109.036 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 t -73.84 -13.82 60.99 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.003 0.921 . . . . 0.0 113.31 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.7 t -65.76 -26.77 67.87 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 118.399 0.545 . . . . 0.0 111.393 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -57.48 -53.96 52.22 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.099 0.96 . . . . 0.0 109.912 175.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.67 -49.64 72.39 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.129 0.972 . . . . 0.0 111.941 -175.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.59 -53.11 60.68 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.151 0.58 . . . . 0.0 110.835 174.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.23 -33.77 29.39 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.921 0.888 . . . . 0.0 112.647 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -63.88 -35.8 81.84 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.007 0.923 . . . . 0.0 111.72 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 -69.45 -43.73 72.71 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.694 0.797 . . . . 0.0 110.309 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.3 mt -74.7 -39.42 61.95 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.754 0.821 . . . . 0.0 111.144 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.02 16.21 72.89 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.29 0.947 . . . . 0.0 112.871 -177.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.13 172.85 10.31 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 117.575 0.688 . . . . 0.0 110.915 175.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.1 p -118.73 -162.76 0.92 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -174.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 124.18 -154.14 17.71 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 169.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -168.17 161.82 12.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.095 -0.553 . . . . 0.0 112.125 170.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.09 97.31 5.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.599 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.21 175.23 6.69 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.922 0.889 . . . . 0.0 110.603 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -123.73 138.01 54.59 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.208 1.003 . . . . 0.0 109.478 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.6 mt -76.5 172.57 12.75 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.081 1.352 . . . . 0.0 110.247 173.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -90.76 4.0 52.79 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.639 1.175 . . . . 0.0 112.184 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -108.88 -10.66 15.08 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.584 1.154 . . . . 0.0 112.397 -175.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.53 -4.44 12.04 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.274 1.416 . . . . 0.0 113.668 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.07 163.86 13.31 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.919 1.288 . . . . 0.0 111.96 -171.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.6 t -127.88 118.34 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.604 1.562 . . . . 0.0 110.723 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -100.66 119.83 39.16 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.919 0.888 . . . . 0.0 111.132 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.4 t -112.09 138.84 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.563 1.545 . . . . 0.0 109.316 -173.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 t -134.42 145.2 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.008 0.923 . . . . 0.0 109.895 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.58 137.9 12.76 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-O 118.513 -0.756 . . . . 0.0 111.604 -175.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 58.4 m -107.3 177.54 4.81 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.134 1.373 . . . . 0.0 112.442 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.31 -167.68 19.37 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -73.25 140.87 47.16 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.0 0.52 . . . . 0.0 109.741 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -53.3 -47.37 69.28 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.21 0.604 . . . . 0.0 109.799 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -46.02 -34.38 5.78 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 126.451 1.977 . . . . 0.0 114.63 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -84.61 -46.48 11.49 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.804 1.242 . . . . 0.0 111.135 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.422 HG11 HD11 ' A' ' 6' ' ' ILE . 40.5 t -59.02 -40.76 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 122.254 0.221 . . . . 0.0 110.667 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -61.51 -25.58 67.36 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.9 0.88 . . . . 0.0 111.91 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -57.41 -49.83 74.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.57 0.748 . . . . 0.0 110.998 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -73.98 -32.69 63.53 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 118.324 0.511 . . . . 0.0 110.615 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mmm -66.6 -23.03 66.13 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 118.742 -0.646 . . . . 0.0 111.341 -177.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -45.7 -49.66 14.38 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.877 0.762 . . . . 0.0 109.548 168.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -59.41 -43.98 92.93 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.461 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.345 0.401 0 CA-C-N 119.49 1.041 . . . . 0.0 111.533 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.2 t . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -64.42 -57.25 9.81 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.61 1.164 . . . . 0.0 110.979 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -154.07 153.31 31.66 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.789 0.836 . . . . 0.0 110.301 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.73 135.37 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 123.687 0.795 . . . . 0.0 111.097 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.5 tp -127.69 147.0 50.38 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.244 1.018 . . . . 0.0 112.506 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.32 141.24 50.6 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.416 1.087 . . . . 0.0 112.303 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -142.68 158.21 60.37 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 124.852 1.261 . . . . 0.0 111.922 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.51 129.47 16.86 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 124.28 3.32 . . . . 0.0 111.716 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -121.16 129.67 53.36 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.302 1.041 . . . . 0.0 110.684 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -131.81 71.77 80.33 Favored Pre-proline 0 CA--C 1.537 0.463 0 O-C-N 121.372 -0.83 . . . . 0.0 111.211 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.45 150.19 63.65 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.241 2.628 . . . . 0.0 111.11 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 75.4 p -73.73 140.23 45.84 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.681 0.792 . . . . 0.0 110.521 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.02 179.62 25.77 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 123.938 0.78 . . . . 0.0 112.131 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -98.28 131.28 44.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.938 0.895 . . . . 0.0 108.769 171.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tp -72.55 152.94 41.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.645 1.178 . . . . 0.0 109.514 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.45 -79.93 0.13 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.837 0.855 . . . . 0.0 108.998 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -134.8 163.71 29.2 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.161 0.984 . . . . 0.0 109.938 -171.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -73.62 146.61 44.49 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.196 0.598 . . . . 0.0 110.322 173.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -140.13 -171.05 3.1 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.039 0.936 . . . . 0.0 110.158 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.8 pt . . . . . 0 CA--C 1.534 0.349 0 C-N-CA 123.968 0.907 . . . . 0.0 109.956 179.699 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.531 0.214 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.89 111.17 4.19 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.747 0.819 . . . . 0.0 111.687 -170.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 p -112.78 79.46 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 125.708 1.603 . . . . 0.0 107.331 -174.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -76.0 144.66 40.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.474 -177.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.436 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.6 pp -117.0 163.01 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.5 tt -124.79 116.02 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 124.911 1.284 . . . . 0.0 108.228 170.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -116.04 102.51 9.7 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.633 1.173 . . . . 0.0 110.801 -173.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.2 m-90 -82.49 112.44 19.42 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.12 0.568 . . . . 0.0 109.478 176.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.6 t -91.74 106.9 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -63.75 -37.31 86.88 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.949 0.5 . . . . 0.0 111.773 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.04 165.27 7.19 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.001 1.286 . . . . 0.0 114.854 -174.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -79.87 72.4 6.61 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.522 1.129 . . . . 0.0 111.893 -174.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.3 t -100.5 -33.31 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 124.579 1.152 . . . . 0.0 111.223 -173.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -67.34 145.73 54.8 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.883 0.473 . . . . 0.0 110.693 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.62 24.49 72.45 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 123.993 0.806 . . . . 0.0 113.323 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.5 t -118.95 -40.78 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.416 1.086 . . . . 0.0 110.319 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.95 31.41 5.69 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.148 1.356 . . . . 0.0 112.05 -177.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -48.72 -33.01 9.36 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.388 1.875 . . . . 0.0 112.927 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -72.79 57.97 0.44 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.862 2.065 . . . . 0.0 111.95 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -108.22 -69.54 0.85 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.346 1.058 . . . . 0.0 109.542 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.6 t -96.22 5.57 50.73 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.342 1.057 . . . . 0.0 112.553 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.9 t -58.36 -35.62 72.23 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 122.008 -0.432 . . . . 0.0 111.31 170.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 -61.85 -58.91 6.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.445 1.098 . . . . 0.0 110.698 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -51.85 -55.35 20.51 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.69 0.796 . . . . 0.0 110.994 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -53.21 -54.43 36.18 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.536 0.734 . . . . 0.0 111.044 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.18 -32.92 56.84 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.915 0.886 . . . . 0.0 112.622 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -67.65 -32.92 73.94 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.961 0.504 . . . . 0.0 111.631 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 40.0 mtp85 -68.17 -48.12 66.16 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.386 0.539 . . . . 0.0 110.128 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.77 -30.54 59.16 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.289 0.636 . . . . 0.0 110.696 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.84 22.43 61.58 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.404 1.478 . . . . 0.0 113.352 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.418 HD22 ' C ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -81.43 167.21 19.64 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.621 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.0 p -127.84 140.78 51.82 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.477 1.511 . . . . 0.0 107.348 -171.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.04 -165.11 38.52 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.675 -1.25 . . . . 0.0 112.701 -165.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -169.34 156.44 6.87 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 171.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.61 84.6 2.05 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.646 1.178 . . . . 0.0 109.215 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -89.3 168.11 12.52 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 122.974 0.509 . . . . 0.0 110.339 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -127.31 133.36 50.13 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.646 0.778 . . . . 0.0 109.511 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.4 mt -71.2 168.21 17.74 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.12 0.968 . . . . 0.0 109.755 170.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -86.51 4.44 39.88 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.867 0.867 . . . . 0.0 111.593 175.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -90.52 -56.02 3.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.827 0.851 . . . . 0.0 109.225 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 162.64 -12.34 0.11 Allowed Glycine 0 CA--C 1.53 0.99 0 CA-C-N 114.827 -1.079 . . . . 0.0 113.192 -166.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.4 m -112.76 145.61 40.25 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.295 1.048 . . . . 0.0 112.388 -164.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 86.0 t -105.37 122.44 58.71 Favored 'Isoleucine or valine' 0 C--N 1.344 0.341 0 C-N-CA 124.759 1.224 . . . . 0.0 110.652 -173.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -94.64 103.17 15.11 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.547 1.539 . . . . 0.0 110.128 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.14 124.68 56.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.7 t -128.16 135.08 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.947 0.899 . . . . 0.0 109.428 -174.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.62 125.36 6.45 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.365 -169.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 95.2 m -88.86 -178.98 5.87 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.361 1.464 . . . . 0.0 112.018 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.15 -165.91 17.39 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -74.21 136.0 42.77 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -56.85 -46.09 82.0 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.294 0.638 . . . . 0.0 110.575 -174.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -47.28 -50.93 16.14 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.617 1.58 . . . . 0.0 112.56 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -62.2 -50.68 70.84 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.751 0.82 . . . . 0.0 111.294 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.3 t -55.44 -37.86 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.823 0.849 . . . . 0.0 111.12 178.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -59.11 -33.57 71.0 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.472 0.578 . . . . 0.0 111.942 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -58.12 -42.51 85.89 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.739 0.699 . . . . 0.0 112.469 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 pp -78.54 -28.19 46.04 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.928 0.785 . . . . 0.0 111.32 175.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 7.9 mmm -67.14 -34.18 77.03 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 118.425 -0.797 . . . . 0.0 111.021 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -42.25 -53.37 4.13 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 168.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -65.49 -39.97 92.55 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 118.647 -0.692 . . . . 0.0 112.261 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 42.8 mt . . . . . 0 C--N 1.35 0.616 0 CA-C-N 119.813 1.188 . . . . 0.0 109.72 178.653 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.8 t . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.12 -64.42 0.86 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.126 0.97 . . . . 0.0 110.5 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.53 155.84 17.82 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.532 1.133 . . . . 0.0 109.169 -173.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -129.62 123.1 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.995 1.318 . . . . 0.0 109.259 -176.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.3 tp -99.72 106.87 18.83 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.1 m -99.93 130.03 46.07 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.095 0.558 . . . . 0.0 111.401 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -130.62 164.53 40.87 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 127.585 2.354 . . . . 0.0 108.469 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.05 129.29 10.45 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.089 2.526 . . . . 0.0 111.111 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -110.4 106.66 16.09 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.741 1.216 . . . . 0.0 109.979 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -106.63 86.99 2.48 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 118.635 0.652 . . . . 0.0 111.296 177.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.91 167.29 22.33 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.107 2.538 . . . . 0.0 110.829 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.5 m -87.77 129.59 35.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.012 0.925 . . . . 0.0 109.498 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.09 -177.94 27.31 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.941 0.781 . . . . 0.0 112.509 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -100.9 126.73 47.54 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.645 1.178 . . . . 0.0 109.467 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.7 tp -72.74 143.13 48.11 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 170.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.6 p -73.43 -63.39 1.2 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.238 1.015 . . . . 0.0 111.444 -171.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -132.26 166.47 21.82 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.054 1.341 . . . . 0.0 110.087 -174.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -82.3 144.64 30.46 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.083 0.553 . . . . 0.0 109.744 168.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -155.37 178.91 9.68 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 123.069 0.547 . . . . 0.0 109.759 176.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.128 0 C-N-CA 123.106 0.562 . . . . 0.0 110.626 177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 110.785 -0.08 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.24 155.11 39.67 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.235 1.014 . . . . 0.0 113.054 -176.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.34 90.99 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.304 1.042 . . . . 0.0 108.304 -174.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.7 m -78.87 153.39 30.6 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.471 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.68 149.4 18.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -176.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 tt -107.54 128.2 62.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 123.771 0.828 . . . . 0.0 109.704 176.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -121.97 101.21 7.42 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.058 1.743 . . . . 0.0 109.895 -176.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -86.37 123.52 31.7 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 124.772 1.229 . . . . 0.0 110.459 177.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.12 119.6 59.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.296 1.038 . . . . 0.0 109.292 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -92.22 175.17 6.95 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.011 1.324 . . . . 0.0 110.712 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.17 -167.52 53.43 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -84.67 84.24 7.75 Favored 'General case' 0 CA--C 1.523 -0.089 0 C-N-CA 123.083 0.553 . . . . 0.0 111.723 -169.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.94 -46.92 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 124.034 0.934 . . . . 0.0 109.442 -174.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -69.25 146.79 52.02 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-O 121.007 0.432 . . . . 0.0 111.365 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.15 20.92 73.46 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.209 0.909 . . . . 0.0 113.354 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.1 t -105.32 -42.42 7.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 C-N-CA 124.48 1.112 . . . . 0.0 109.242 175.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.48 29.07 2.81 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.653 1.597 . . . . 0.0 111.202 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -51.84 -36.55 48.61 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.483 1.113 . . . . 0.0 111.597 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.88 58.2 0.83 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.306 1.442 . . . . 0.0 112.423 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -107.24 -74.58 0.65 Allowed 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.562 1.145 . . . . 0.0 109.39 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.6 t -74.84 -18.48 60.44 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.633 -0.699 . . . . 0.0 112.002 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.4 t -43.82 -40.96 4.74 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.925 0.89 . . . . 0.0 112.286 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -67.04 -59.02 3.83 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.753 1.221 . . . . 0.0 109.675 175.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -52.76 -57.18 10.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.597 1.159 . . . . 0.0 111.343 -175.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -55.86 -51.03 68.95 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.568 0.747 . . . . 0.0 110.497 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.74 -36.55 62.43 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.807 0.443 . . . . 0.0 111.985 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -64.34 -30.97 72.0 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.365 0.666 . . . . 0.0 111.895 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 mmm-85 -67.75 -50.52 56.78 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.119 0.568 . . . . 0.0 110.597 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.9 mp -70.99 -30.05 66.19 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.827 0.451 . . . . 0.0 110.665 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.78 18.43 78.91 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.054 0.835 . . . . 0.0 112.483 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.52 175.03 10.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.705 0.802 . . . . 0.0 110.991 176.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.3 p -117.45 -161.65 0.83 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -173.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.46 -155.54 16.49 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 169.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -169.73 160.05 8.48 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 172.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.84 94.39 4.38 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.826 1.251 . . . . 0.0 110.21 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.3 174.5 6.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.506 0.722 . . . . 0.0 111.355 176.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -122.6 139.41 53.95 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.044 0.938 . . . . 0.0 109.715 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.8 mt -76.0 174.64 9.73 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 125.468 1.507 . . . . 0.0 110.258 173.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -98.67 11.7 37.72 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.968 1.307 . . . . 0.0 111.593 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -118.19 -4.54 10.96 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.806 1.242 . . . . 0.0 111.868 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.96 14.15 9.53 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.947 1.26 . . . . 0.0 114.483 176.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.8 168.57 10.1 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.504 1.522 . . . . 0.0 111.937 -170.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 73.1 t -130.7 120.99 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.312 1.045 . . . . 0.0 111.44 -174.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -101.98 118.04 36.09 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.081 0.952 . . . . 0.0 110.997 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.5 t -112.47 137.6 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 123.631 0.773 . . . . 0.0 110.027 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.22 144.31 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.689 0.796 . . . . 0.0 109.886 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.06 132.05 8.92 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-O 118.52 -0.753 . . . . 0.0 111.294 -174.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 89.7 m -100.43 -179.56 4.14 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.804 1.242 . . . . 0.0 112.365 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.2 -161.8 20.81 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -75.05 126.36 30.85 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 122.793 0.437 . . . . 0.0 110.096 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -49.18 -50.63 37.07 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 124.142 0.977 . . . . 0.0 110.594 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -48.16 -40.21 21.08 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.92 1.724 . . . . 0.0 113.652 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -77.57 -48.54 16.7 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.776 0.83 . . . . 0.0 111.132 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.0 -39.94 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 122.715 0.406 . . . . 0.0 111.114 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -61.77 -27.27 68.62 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -59.25 -48.12 82.8 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.193 0.451 . . . . 0.0 110.469 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.46 -30.74 63.37 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.889 0.313 . . . . 0.0 111.302 178.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mmt -67.55 -20.07 65.36 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-O 118.913 -0.565 . . . . 0.0 112.415 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -46.13 -50.98 14.83 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 168.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -61.27 -41.85 97.65 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 C--N 1.344 0.35 0 C-N-CA 123.812 0.845 . . . . 0.0 110.6 -179.781 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.7 t . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -60.7 -65.58 0.67 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.089 0.556 . . . . 0.0 109.892 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.6 mtm-85 -150.56 156.29 41.11 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.539 1.135 . . . . 0.0 109.6 -176.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.3 t -137.82 130.15 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 123.715 0.806 . . . . 0.0 110.522 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tp -113.38 135.35 53.96 Favored 'General case' 0 C--N 1.346 0.448 0 C-N-CA 125.21 1.404 . . . . 0.0 112.058 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.55 137.31 54.93 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.314 1.045 . . . . 0.0 111.985 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -145.27 159.06 50.17 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.645 1.178 . . . . 0.0 111.68 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.92 136.53 25.22 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.967 3.111 . . . . 0.0 111.666 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -127.13 125.43 41.18 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.672 1.189 . . . . 0.0 111.106 -175.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -129.7 70.91 82.16 Favored Pre-proline 0 CA--C 1.535 0.403 0 O-C-N 121.696 -0.627 . . . . 0.0 111.37 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.63 142.31 35.9 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.894 2.396 . . . . 0.0 110.776 -176.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.5 p -70.82 140.97 51.35 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.663 0.785 . . . . 0.0 110.85 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.99 173.04 23.95 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.106 0.86 . . . . 0.0 111.638 -175.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -96.1 135.34 38.03 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -76.25 151.99 36.65 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.3 m -80.88 -76.73 0.23 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -177.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -134.47 165.76 24.45 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.717 1.207 . . . . 0.0 110.223 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -72.88 149.79 43.17 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.711 0.804 . . . . 0.0 110.353 172.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -151.24 -169.54 3.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.005 0.922 . . . . 0.0 110.002 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.8 pt . . . . . 0 CA--C 1.533 0.29 0 C-N-CA 124.271 1.028 . . . . 0.0 109.542 176.943 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.456 -0.174 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.05 144.22 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.909 1.684 . . . . 0.0 111.672 176.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 p -139.44 88.2 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.199 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.7 m -81.7 152.78 26.91 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.403 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.5 146.76 19.27 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -176.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 tt -109.36 122.29 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 124.271 1.029 . . . . 0.0 109.877 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.55 116.56 28.99 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.971 1.308 . . . . 0.0 111.024 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.7 m-90 -96.56 121.99 38.99 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.768 0.827 . . . . 0.0 110.16 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.545 HG12 HG21 ' A' ' 14' ' ' VAL . 5.6 t -104.5 115.32 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.397 1.079 . . . . 0.0 108.848 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -87.49 178.56 6.77 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.76 1.224 . . . . 0.0 111.453 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.29 -159.71 50.46 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -88.37 99.49 12.29 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.114 -174.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.545 HG21 HG12 ' A' ' 10' ' ' VAL . 21.7 t -130.74 -43.71 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 123.441 0.697 . . . . 0.0 109.756 -177.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -70.4 143.77 51.76 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.596 0.758 . . . . 0.0 109.969 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.6 18.61 79.7 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 119.26 -0.745 . . . . 0.0 113.31 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 83.5 t -107.52 -43.63 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.577 1.151 . . . . 0.0 109.527 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 116.35 28.5 2.56 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 125.187 1.375 . . . . 0.0 111.446 -177.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -50.93 -32.71 21.6 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 123.627 0.771 . . . . 0.0 111.192 176.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -76.51 58.71 1.38 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.838 0.855 . . . . 0.0 112.764 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -95.18 -70.32 0.72 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 t -92.85 -2.54 55.8 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.496 -0.764 . . . . 0.0 111.656 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 t -45.48 -36.93 4.81 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.095 0.861 . . . . 0.0 112.403 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -73.72 -60.31 2.31 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.266 1.026 . . . . 0.0 109.806 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -50.3 -59.14 4.26 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.271 1.028 . . . . 0.0 111.002 -175.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.9 -53.28 34.06 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 125.589 1.556 . . . . 0.0 110.057 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.49 -37.84 70.93 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.618 0.367 . . . . 0.0 111.732 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.3 tttm -61.87 -31.72 72.02 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.249 1.019 . . . . 0.0 111.7 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.26 -52.32 48.71 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.261 0.624 . . . . 0.0 110.946 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 57' ' ' LYS . 34.6 mt -72.23 -31.11 65.54 Favored 'General case' 0 CA--C 1.528 0.124 0 O-C-N 122.849 0.093 . . . . 0.0 110.812 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.66 6.94 82.48 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.064 0.84 . . . . 0.0 112.596 -178.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.15 178.14 2.93 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.817 0.808 . . . . 0.0 111.326 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 43.7 p -125.79 -169.05 1.94 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -175.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 130.85 -151.49 19.62 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 171.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -170.91 167.48 7.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.438 -0.381 . . . . 0.0 111.421 173.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.46 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -131.69 97.07 4.11 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.793 0.683 . . . . 0.0 111.435 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.4 mttp -93.28 174.01 7.43 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.969 1.308 . . . . 0.0 110.142 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -124.24 135.25 53.28 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.431 1.092 . . . . 0.0 109.628 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.8 mt -74.95 171.82 13.38 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.077 1.351 . . . . 0.0 109.847 177.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -93.66 4.96 53.13 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.587 0.755 . . . . 0.0 111.571 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -107.25 -14.53 14.87 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.64 1.176 . . . . 0.0 111.724 -177.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.92 7.6 8.53 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.015 1.293 . . . . 0.0 113.91 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.9 168.68 8.97 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.946 1.298 . . . . 0.0 111.336 -172.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.0 t -129.01 120.25 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.391 1.077 . . . . 0.0 110.549 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -95.71 127.16 41.5 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.82 0.848 . . . . 0.0 110.232 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.27 136.22 58.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 124.389 1.075 . . . . 0.0 109.525 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.24 143.37 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 124.012 0.925 . . . . 0.0 109.356 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.69 138.23 15.98 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 118.856 -0.592 . . . . 0.0 110.668 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 61.5 m -103.0 178.5 4.54 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.867 1.267 . . . . 0.0 111.435 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.94 -159.82 18.03 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -78.76 132.54 36.97 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 124.965 1.306 . . . . 0.0 109.408 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -46.84 -55.9 7.18 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.491 1.116 . . . . 0.0 110.683 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -49.99 -43.87 40.84 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.238 1.399 . . . . 0.0 112.767 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -67.07 -46.43 74.35 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.295 1.038 . . . . 0.0 111.187 176.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 77.4 t -54.05 -41.17 49.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.163 0.585 . . . . 0.0 110.408 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.24 -26.97 68.11 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.418 ' HB2' HD21 ' A' ' 30' ' ' LEU . 29.4 mmmt -59.77 -27.12 66.26 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.259 1.024 . . . . 0.0 112.712 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.02 -29.81 13.43 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.48 0.582 . . . . 0.0 110.774 172.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.449 ' HA ' HD12 ' A' ' 62' ' ' LEU . 2.2 mmt -62.72 -23.56 67.22 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-O 118.722 -0.656 . . . . 0.0 111.418 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.48 -57.62 3.97 Favored 'General case' 0 C--O 1.248 0.985 0 C-N-CA 122.966 0.506 . . . . 0.0 110.027 173.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -65.31 -32.34 73.94 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 118.656 0.662 . . . . 0.0 112.07 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 59' ' ' MET . 12.7 mt . . . . . 0 C--N 1.349 0.575 0 CA-C-N 119.054 0.843 . . . . 0.0 109.832 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 87.8 t . . . . . 0 CA--C 1.529 0.138 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -63.05 -61.75 2.17 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.378 0.671 . . . . 0.0 109.31 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.9 mmm-85 -152.19 161.53 42.48 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.046 1.339 . . . . 0.0 109.801 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.1 t -142.24 140.38 29.28 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 124.202 1.001 . . . . 0.0 109.754 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.4 tp -129.14 157.32 42.11 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.816 0.847 . . . . 0.0 111.108 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.91 129.77 26.38 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.079 0.951 . . . . 0.0 111.221 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.31 158.83 73.16 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.112 1.365 . . . . 0.0 110.424 -177.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -71.66 130.51 17.16 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.517 3.478 . . . . 0.0 110.834 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -119.24 117.52 28.83 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.626 1.17 . . . . 0.0 109.767 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -125.55 68.2 59.76 Favored Pre-proline 0 CA--C 1.535 0.367 0 O-C-N 121.873 -0.517 . . . . 0.0 110.546 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.47 140.99 37.56 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.411 2.741 . . . . 0.0 110.432 -175.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.6 p -72.4 145.07 47.94 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.427 0.691 . . . . 0.0 110.797 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.66 170.35 3.95 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.381 0.991 . . . . 0.0 112.131 -176.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -92.21 138.13 31.79 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.8 tp -80.96 152.13 28.17 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 99.5 m -75.26 -73.96 0.23 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -146.54 167.38 23.86 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.396 0.678 . . . . 0.0 110.859 -176.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -70.39 144.72 51.48 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.951 0.501 . . . . 0.0 110.388 176.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -145.48 -176.78 5.25 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 122.999 0.52 . . . . 0.0 110.562 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.46 HD12 ' HB3' ' A' ' 36' ' ' ALA . 6.5 tt . . . . . 0 N--CA 1.45 -0.441 0 C-N-CA 123.305 0.642 . . . . 0.0 109.362 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.311 0 N-CA-C 110.608 -0.145 . . . . 0.0 110.608 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.6 159.08 13.82 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.427 1.091 . . . . 0.0 112.496 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.0 p -143.83 89.63 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.6 m -75.55 153.71 37.24 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.76 174.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pp -143.13 155.82 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 123.068 0.547 . . . . 0.0 110.064 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.5 tp -112.84 118.55 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 125.004 1.322 . . . . 0.0 108.739 177.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -113.36 111.09 21.41 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.09 0.956 . . . . 0.0 110.384 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -92.41 121.02 33.47 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.801 0.84 . . . . 0.0 110.287 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.538 HG12 HG21 ' A' ' 14' ' ' VAL . 3.0 t -104.98 120.03 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.436 1.095 . . . . 0.0 108.932 -177.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -95.27 176.39 6.23 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.309 1.044 . . . . 0.0 111.559 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.25 -156.39 48.63 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.5 mtt-85 -87.96 93.16 9.39 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 123.417 0.687 . . . . 0.0 111.85 -173.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.538 HG21 HG12 ' A' ' 10' ' ' VAL . 16.9 t -127.41 -45.88 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.205 1.002 . . . . 0.0 109.974 -175.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -70.68 141.83 51.59 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.35 0.66 . . . . 0.0 110.1 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.67 15.09 80.2 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.104 -0.831 . . . . 0.0 113.371 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.1 t -111.98 -44.28 5.1 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 C-N-CA 124.561 1.145 . . . . 0.0 109.764 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.56 23.01 2.94 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.262 1.41 . . . . 0.0 111.893 -176.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -59.32 -25.34 64.08 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 117.785 0.792 . . . . 0.0 111.988 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.74 30.62 4.25 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.584 1.554 . . . . 0.0 111.687 175.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -94.46 -61.21 1.55 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.76 0.709 . . . . 0.0 109.383 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.9 t -78.21 -1.7 34.12 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 t -59.58 -26.74 65.67 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.057 0.543 . . . . 0.0 111.299 173.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -70.95 -55.64 7.93 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.224 0.61 . . . . 0.0 110.728 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -52.37 -57.03 11.07 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.027 0.531 . . . . 0.0 111.177 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -47.05 73.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.263 0.625 . . . . 0.0 110.414 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.43 -29.69 50.15 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.8 tttm -69.53 -31.53 69.81 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.231 1.012 . . . . 0.0 111.802 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.8 mmm-85 -72.84 -37.2 67.51 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.018 0.927 . . . . 0.0 111.06 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -85.9 -30.18 23.06 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.909 0.884 . . . . 0.0 111.506 178.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.67 21.21 79.63 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.47 0.557 . . . . 0.0 112.374 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.45 HD12 ' HB1' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -79.58 178.02 8.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.961 0.904 . . . . 0.0 111.111 177.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.3 p -123.18 -164.22 1.19 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -175.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.2 -151.53 18.14 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 171.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -169.22 162.91 10.83 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.05 99.79 6.41 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.1 0.96 . . . . 0.0 111.477 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -100.06 172.85 6.94 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.717 1.207 . . . . 0.0 110.936 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -124.12 135.17 53.34 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.796 1.239 . . . . 0.0 108.753 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.443 HD12 ' HB2' ' A' ' 43' ' ' SER . 21.8 mt -75.64 173.0 11.63 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.015 1.326 . . . . 0.0 110.08 175.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -95.3 8.1 44.18 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.053 0.941 . . . . 0.0 111.729 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -111.58 -2.6 15.38 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.899 1.28 . . . . 0.0 112.137 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.99 7.21 31.42 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.94 1.257 . . . . 0.0 113.949 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.443 ' HB2' HD12 ' A' ' 39' ' ' LEU . 75.4 m -102.92 165.82 10.81 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.513 1.525 . . . . 0.0 111.127 -173.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 91.4 t -128.57 122.77 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.688 1.195 . . . . 0.0 110.524 -177.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -99.32 123.43 43.59 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 124.187 0.995 . . . . 0.0 110.947 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.9 t -121.23 133.44 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.182 0.593 . . . . 0.0 109.631 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.9 t -126.01 142.79 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 124.646 1.178 . . . . 0.0 109.45 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.45 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -154.36 132.86 12.04 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 118.607 -0.711 . . . . 0.0 111.158 -175.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.42 178.64 4.69 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 175.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.96 -157.69 20.64 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.789 1.185 . . . . 0.0 110.201 178.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -75.94 122.43 24.16 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.67 1.188 . . . . 0.0 109.572 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -45.84 -51.82 12.32 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.472 1.109 . . . . 0.0 111.071 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.29 -47.35 56.12 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.483 1.516 . . . . 0.0 113.129 177.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -65.44 -47.76 75.06 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.395 0.598 . . . . 0.0 110.299 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.5 t -57.56 -33.06 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 122.723 0.409 . . . . 0.0 110.751 176.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.48 -32.28 73.16 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.941 0.896 . . . . 0.0 112.949 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -56.64 -27.48 58.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.004 0.922 . . . . 0.0 112.461 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.36 -30.97 13.1 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 118.622 0.646 . . . . 0.0 111.289 173.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.479 ' HA ' HD12 ' A' ' 62' ' ' LEU . 2.3 mmm -63.6 -22.45 66.9 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-O 118.624 -0.703 . . . . 0.0 112.444 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -44.27 -55.9 4.55 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.335 0.516 . . . . 0.0 110.254 173.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -61.92 -41.92 98.5 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.147 0.579 . . . . 0.0 111.782 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 59' ' ' MET . 11.4 mt . . . . . 0 C--N 1.346 0.422 0 C-N-CA 123.785 0.834 . . . . 0.0 109.707 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.6 t . . . . . 0 CA--C 1.532 0.259 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.43 -50.89 71.57 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.251 0.621 . . . . 0.0 111.108 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -169.04 153.42 5.57 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 123.396 0.678 . . . . 0.0 109.623 -177.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.5 t -141.96 134.76 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.138 0.575 . . . . 0.0 109.537 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.5 tp -120.43 156.14 32.05 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.976 0.91 . . . . 0.0 110.928 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.12 129.5 27.68 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.853 0.861 . . . . 0.0 110.873 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -132.73 154.93 81.65 Favored Pre-proline 0 CA--C 1.539 0.558 0 C-N-CA 124.499 1.12 . . . . 0.0 110.14 -177.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.89 125.63 11.75 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 124.857 3.704 . . . . 0.0 111.067 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -117.16 127.31 54.0 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.721 0.809 . . . . 0.0 110.844 -178.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -133.63 70.49 75.91 Favored Pre-proline 0 CA--C 1.536 0.42 0 O-C-N 121.526 -0.734 . . . . 0.0 110.495 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.15 136.88 35.8 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 124.057 3.171 . . . . 0.0 109.984 -177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.6 p -61.48 143.76 55.36 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.642 0.777 . . . . 0.0 111.101 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.95 171.02 5.69 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.079 0.847 . . . . 0.0 112.112 -175.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -89.0 135.74 33.39 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mp -74.13 150.09 40.67 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.303 0.641 . . . . 0.0 109.678 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.61 -77.96 0.2 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.349 1.059 . . . . 0.0 108.625 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -143.78 164.71 29.73 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.613 0.765 . . . . 0.0 110.944 -174.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -70.96 144.86 50.39 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.973 0.509 . . . . 0.0 110.357 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -137.81 -179.35 5.71 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 124.101 0.961 . . . . 0.0 110.403 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.9 tt . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -177.189 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.535 0.368 0 CA-C-O 119.821 -0.133 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.13 134.4 49.28 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.267 1.027 . . . . 0.0 111.557 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 p -140.63 94.98 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 C-N-CA 124.551 1.141 . . . . 0.0 108.484 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.4 m -92.75 153.88 18.64 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.933 -177.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pp -143.6 156.46 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -174.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 tt -116.37 119.26 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.148 0.979 . . . . 0.0 109.418 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -109.9 108.33 18.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.88 1.272 . . . . 0.0 109.951 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -91.76 123.04 34.85 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.991 0.916 . . . . 0.0 110.235 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.421 HG12 HG21 ' A' ' 14' ' ' VAL . 12.9 t -99.15 108.52 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.586 1.155 . . . . 0.0 108.768 -178.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -73.26 177.49 5.1 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.815 0.846 . . . . 0.0 111.426 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.95 -169.4 42.66 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 177.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -92.01 92.04 8.11 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.798 0.439 . . . . 0.0 110.881 -175.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.421 HG21 HG12 ' A' ' 10' ' ' VAL . 58.8 t -114.28 -31.06 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.101 0.96 . . . . 0.0 110.909 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -70.67 148.43 48.05 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.895 0.316 . . . . 0.0 110.52 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.75 22.81 54.95 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 123.753 0.692 . . . . 0.0 112.954 176.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.8 t -116.06 -48.97 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 C-N-CA 124.884 1.273 . . . . 0.0 109.41 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.67 32.29 1.23 Allowed Glycine 0 C--N 1.339 0.714 0 C-N-CA 125.251 1.405 . . . . 0.0 111.512 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -50.44 -36.81 34.96 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 123.848 0.859 . . . . 0.0 111.434 177.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.05 55.3 0.71 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.64 1.176 . . . . 0.0 112.058 177.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -94.54 -73.64 0.57 Allowed 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.337 0.655 . . . . 0.0 109.277 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.9 t -89.0 -1.59 58.18 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.435 0.694 . . . . 0.0 111.642 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.9 t -47.51 -36.93 11.03 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.752 0.821 . . . . 0.0 112.294 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -71.8 -55.96 6.64 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.442 1.097 . . . . 0.0 110.508 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -53.79 -54.15 42.27 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.677 0.791 . . . . 0.0 110.678 -176.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.15 -48.13 68.21 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.233 1.013 . . . . 0.0 110.515 177.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.42 -26.44 53.54 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -73.55 -28.28 61.79 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.806 0.843 . . . . 0.0 111.942 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.9 mtp85 -71.91 -41.89 67.38 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.321 1.049 . . . . 0.0 110.119 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -86.51 -52.67 5.43 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.558 0.743 . . . . 0.0 111.413 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.54 8.51 46.14 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.206 0.907 . . . . 0.0 112.995 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.15 167.57 2.31 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.969 0.884 . . . . 0.0 111.674 174.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.7 p -128.09 155.37 44.51 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.87 -147.95 17.38 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -169.35 166.27 10.48 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 173.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.4 100.73 5.46 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.803 0.841 . . . . 0.0 111.678 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -105.44 179.26 4.32 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.612 1.165 . . . . 0.0 110.835 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -123.51 138.99 54.46 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.673 1.189 . . . . 0.0 109.089 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.79 177.84 4.58 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.424 1.09 . . . . 0.0 110.349 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -101.14 13.31 35.54 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.296 1.038 . . . . 0.0 111.18 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -117.53 -15.46 10.24 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.863 1.265 . . . . 0.0 111.891 -177.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.0 5.66 8.02 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.012 1.292 . . . . 0.0 114.215 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 m -106.17 169.6 8.41 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.535 1.534 . . . . 0.0 111.564 -172.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.7 t -126.8 127.31 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.952 0.901 . . . . 0.0 110.448 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -105.06 122.24 45.46 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 123.725 0.81 . . . . 0.0 110.951 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.73 139.05 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 123.116 0.566 . . . . 0.0 109.632 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.2 t -130.22 142.6 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 124.276 1.031 . . . . 0.0 109.234 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.33 139.92 20.65 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.465 -176.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -111.64 -179.63 3.76 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.15 1.78 . . . . 0.0 110.911 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.43 -155.05 24.69 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.85 130.57 35.12 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 117.593 0.696 . . . . 0.0 110.179 -178.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -48.63 -50.39 33.04 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.399 1.08 . . . . 0.0 111.006 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.95 -52.15 31.8 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.143 1.354 . . . . 0.0 112.335 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -61.94 -46.62 88.53 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.084 0.954 . . . . 0.0 110.601 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.9 t -56.79 -41.84 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 122.319 0.247 . . . . 0.0 110.868 176.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -60.69 -26.59 67.24 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -60.64 -28.7 68.76 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.046 0.939 . . . . 0.0 112.401 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.0 -29.7 13.5 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.001 0.521 . . . . 0.0 111.0 174.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.4 mmt -64.15 -21.42 66.55 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.99 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -46.9 -59.05 3.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 118.37 0.532 . . . . 0.0 110.167 173.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -63.02 -33.35 75.23 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.571 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt . . . . . 0 CA--C 1.535 0.4 0 CA-C-N 119.221 0.918 . . . . 0.0 110.035 178.242 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 64.6 t . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.35 -57.48 12.12 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.606 0.762 . . . . 0.0 110.027 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -165.66 172.88 11.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.286 1.034 . . . . 0.0 109.863 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.74 125.16 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.878 0.871 . . . . 0.0 109.663 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.86 155.85 18.91 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.609 1.163 . . . . 0.0 110.784 177.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.18 129.39 27.39 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.293 1.037 . . . . 0.0 111.113 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.37 156.59 79.61 Favored Pre-proline 0 N--CA 1.47 0.563 0 C-N-CA 124.714 1.206 . . . . 0.0 110.429 -177.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.87 124.41 11.01 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 124.873 3.715 . . . . 0.0 111.052 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -116.45 119.07 34.46 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.085 0.954 . . . . 0.0 110.895 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -124.9 69.68 57.93 Favored Pre-proline 0 CA--C 1.535 0.373 0 O-C-N 121.526 -0.733 . . . . 0.0 110.83 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.06 141.11 43.16 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.248 2.632 . . . . 0.0 110.492 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.4 m -69.81 143.36 52.94 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.587 0.755 . . . . 0.0 110.572 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.76 169.43 4.63 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.14 0.876 . . . . 0.0 112.041 -176.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -92.48 135.1 34.34 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.7 tp -78.87 150.49 32.2 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.75 -77.32 0.11 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -141.11 163.78 32.05 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.08 0.952 . . . . 0.0 110.023 -173.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -71.12 146.53 49.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.15 0.58 . . . . 0.0 110.767 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -140.56 -171.11 3.15 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.336 1.055 . . . . 0.0 110.437 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.8 pp . . . . . 0 CA--C 1.53 0.191 0 C-N-CA 124.55 1.14 . . . . 0.0 109.619 179.699 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.5 m . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 110.701 -0.111 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.26 136.03 56.11 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.84 1.256 . . . . 0.0 112.095 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 p -141.04 91.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.271 0 C-N-CA 124.576 1.151 . . . . 0.0 108.511 -174.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.4 m -81.58 156.48 25.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.7 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.451 HD11 HG11 ' A' ' 55' ' ' VAL . 1.3 pp -143.7 159.37 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 tt -118.45 118.04 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.665 1.186 . . . . 0.0 109.276 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -108.81 108.51 19.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.898 1.279 . . . . 0.0 110.341 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -90.77 124.3 35.02 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.908 0.883 . . . . 0.0 110.188 177.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.451 HG12 HG21 ' A' ' 14' ' ' VAL . 4.2 t -106.15 124.59 61.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.919 1.288 . . . . 0.0 108.379 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -96.32 179.8 4.91 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.134 1.374 . . . . 0.0 110.589 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.31 -166.09 51.01 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.1 mtt180 -86.72 93.64 9.3 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 122.696 0.398 . . . . 0.0 111.652 -171.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.451 HG21 HG12 ' A' ' 10' ' ' VAL . 18.4 t -123.25 -41.44 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 123.676 0.79 . . . . 0.0 110.398 -174.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -69.74 144.47 52.74 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.042 0.537 . . . . 0.0 109.902 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.9 12.72 83.13 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.949 -0.917 . . . . 0.0 113.578 178.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.5 t -108.76 -49.21 7.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 CA-C-N 118.374 1.087 . . . . 0.0 109.682 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.01 29.4 1.51 Allowed Glycine 0 C--N 1.338 0.663 0 C-N-CA 124.476 1.036 . . . . 0.0 112.031 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -51.66 -36.21 45.37 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.005 0.903 . . . . 0.0 111.183 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.47 56.08 0.66 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.028 1.331 . . . . 0.0 112.069 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -107.87 -71.54 0.75 Allowed 'General case' 0 C--N 1.34 0.174 0 C-N-CA 124.832 1.253 . . . . 0.0 109.47 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.6 t -70.95 -21.62 62.32 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.009 0.524 . . . . 0.0 111.486 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.4 t -47.1 -38.13 10.9 Favored 'General case' 0 C--N 1.345 0.408 0 C-N-CA 123.683 0.793 . . . . 0.0 111.695 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -69.93 -56.47 6.94 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.127 0.971 . . . . 0.0 110.189 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -51.99 -56.84 11.76 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.098 0.959 . . . . 0.0 111.018 -176.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -56.47 -51.54 68.07 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 123.367 0.667 . . . . 0.0 110.23 178.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.38 -30.13 50.97 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.088 0.555 . . . . 0.0 112.439 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -64.57 -36.57 84.67 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.649 0.779 . . . . 0.0 111.192 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -72.38 -48.92 37.84 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.334 1.054 . . . . 0.0 110.256 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.1 mp -67.88 -38.21 82.75 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.964 0.906 . . . . 0.0 110.746 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.23 12.85 83.51 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 123.874 0.749 . . . . 0.0 112.684 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.421 HD12 ' HB1' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -68.68 177.59 2.44 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.805 0.842 . . . . 0.0 110.92 176.329 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.0 p -121.91 -165.7 1.3 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.37 -151.92 16.9 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 171.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -171.77 164.65 6.56 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 123.817 0.363 . . . . 0.0 111.727 173.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.21 90.3 3.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.009 0.924 . . . . 0.0 111.898 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -92.38 178.64 5.77 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 124.534 1.134 . . . . 0.0 110.897 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -121.71 140.73 51.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.293 1.037 . . . . 0.0 110.029 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.7 mt -73.94 174.95 7.83 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.842 1.257 . . . . 0.0 110.304 174.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -99.76 13.12 34.8 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.394 1.078 . . . . 0.0 111.442 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -119.25 -9.05 10.02 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.339 1.056 . . . . 0.0 112.148 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.13 24.76 4.08 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.917 1.246 . . . . 0.0 114.159 176.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.89 170.4 11.12 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.247 1.419 . . . . 0.0 111.482 -172.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.1 t -129.79 127.31 63.95 Favored 'Isoleucine or valine' 0 C--N 1.346 0.443 0 C-N-CA 123.836 0.855 . . . . 0.0 110.6 -175.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -108.46 123.2 48.51 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.577 0.751 . . . . 0.0 110.031 -177.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.4 t -117.14 136.39 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 123.778 0.831 . . . . 0.0 109.11 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -129.53 144.26 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 124.221 1.009 . . . . 0.0 108.997 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.421 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -155.43 141.4 18.24 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 118.695 -0.669 . . . . 0.0 110.616 -176.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.6 m -111.47 179.88 3.9 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.868 1.267 . . . . 0.0 111.784 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.04 -161.32 23.43 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.79 123.64 25.95 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.152 0.981 . . . . 0.0 110.576 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.73 -46.55 59.14 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.038 0.935 . . . . 0.0 110.108 -176.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -44.61 -41.81 7.13 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 126.057 1.789 . . . . 0.0 113.332 177.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -78.78 -50.74 10.82 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.462 0.705 . . . . 0.0 110.651 174.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 6' ' ' ILE . 59.8 t -49.96 -40.76 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 118.441 0.564 . . . . 0.0 111.747 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.16 -30.8 69.56 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.71 1.604 . . . . 0.0 112.178 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -56.4 -40.79 75.24 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 124.46 1.104 . . . . 0.0 110.819 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.36 -30.53 27.35 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.672 0.669 . . . . 0.0 111.093 175.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.5 mmt -63.91 -20.18 65.65 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 118.586 -0.721 . . . . 0.0 112.02 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -45.56 -51.61 11.67 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.504 0.593 . . . . 0.0 110.411 174.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -62.29 -40.39 96.09 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.855 0.862 . . . . 0.0 111.965 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.4 mt . . . . . 0 N--CA 1.467 0.41 0 C-N-CA 123.957 0.903 . . . . 0.0 110.377 178.388 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.4 t . . . . . 0 CA--C 1.531 0.227 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -69.71 -54.57 13.17 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.942 0.897 . . . . 0.0 110.195 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -156.81 163.67 38.95 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.65 0.78 . . . . 0.0 110.252 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.55 138.64 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.889 0.876 . . . . 0.0 109.835 -178.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.05 156.63 34.49 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.57 1.148 . . . . 0.0 110.991 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.51 129.14 26.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.035 0.934 . . . . 0.0 111.231 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.9 157.77 77.31 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 124.936 1.294 . . . . 0.0 110.491 -177.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -70.77 126.22 12.42 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 124.795 3.663 . . . . 0.0 111.003 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -118.63 135.47 54.43 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.017 0.927 . . . . 0.0 110.193 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -138.61 75.35 37.9 Favored Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 121.715 -0.616 . . . . 0.0 110.886 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.78 149.34 60.2 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.641 2.894 . . . . 0.0 110.674 -176.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.3 p -76.27 144.33 40.38 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.674 0.79 . . . . 0.0 110.597 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.3 169.99 4.41 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.401 1.0 . . . . 0.0 112.128 -176.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -88.65 137.01 32.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mp -79.02 150.55 31.89 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.527 0.731 . . . . 0.0 109.492 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -76.67 0.19 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.336 1.054 . . . . 0.0 108.448 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -143.03 162.43 35.5 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.587 0.755 . . . . 0.0 110.741 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -75.63 145.6 40.95 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.099 0.559 . . . . 0.0 110.429 177.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -144.98 148.29 33.62 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 123.713 0.805 . . . . 0.0 109.912 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.522 0 O-C-N 121.977 -0.452 . . . . 0.0 110.802 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 CA--C 1.527 0.079 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -71.91 105.75 3.95 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.572 0.701 . . . . 0.0 110.537 -173.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.7 p -98.64 77.9 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.7 m -73.22 144.92 46.56 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -176.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.494 HD12 ' C ' ' A' ' 6' ' ' ILE . 2.0 pp -112.77 166.69 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.3 tt -125.89 99.44 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 166.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.29 98.16 9.45 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.416 1.087 . . . . 0.0 109.593 -174.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 20.9 m-90 -79.49 100.19 7.6 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -82.62 90.75 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -177.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -72.1 159.68 33.75 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.984 0.421 . . . . 0.0 112.002 -169.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.4 -164.85 19.14 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 124.418 1.009 . . . . 0.0 111.66 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -93.62 82.52 4.37 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.662 0.785 . . . . 0.0 110.403 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.4 t -108.63 -47.56 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.674 1.19 . . . . 0.0 111.156 -167.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -62.12 157.26 19.5 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.126 0.97 . . . . 0.0 111.958 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.64 -43.67 3.19 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.091 0.853 . . . . 0.0 112.178 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.3 t -60.17 -39.27 80.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.543 1.137 . . . . 0.0 111.356 -176.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.69 33.1 2.73 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.306 1.431 . . . . 0.0 111.458 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -47.16 -34.78 6.55 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 126.559 1.943 . . . . 0.0 112.831 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.15 36.04 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.656 1.582 . . . . 0.0 113.007 171.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -60.84 -59.41 5.42 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.973 0.909 . . . . 0.0 110.464 -170.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 t -124.58 12.0 8.6 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.785 1.234 . . . . 0.0 111.701 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.7 t -47.44 -43.46 23.99 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -62.39 -51.5 67.32 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.706 1.202 . . . . 0.0 110.702 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -53.03 -57.98 8.55 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.329 0.652 . . . . 0.0 110.322 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.32 -49.82 63.47 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.767 1.227 . . . . 0.0 110.784 178.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.25 -38.52 68.62 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.259 0.624 . . . . 0.0 111.787 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -68.44 -28.06 66.73 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.911 0.884 . . . . 0.0 111.949 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 -62.49 -47.68 82.89 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.632 0.651 . . . . 0.0 109.522 175.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 62.7 mt -77.76 -32.55 52.7 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.508 0.723 . . . . 0.0 111.05 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.47 30.99 61.46 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.986 1.279 . . . . 0.0 112.437 -176.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.444 HD22 ' C ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -81.61 169.2 17.33 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.499 0.72 . . . . 0.0 112.179 -179.266 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.4 ' N ' HD22 ' A' ' 32' ' ' LEU . 21.4 p -127.31 147.24 50.25 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.857 0.863 . . . . 0.0 109.232 -168.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.51 -145.26 15.24 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -171.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -176.26 155.49 1.5 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.314 0.645 . . . . 0.0 111.255 174.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.88 93.85 6.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.489 1.116 . . . . 0.0 109.056 166.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -93.06 173.45 7.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 170.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -124.84 148.2 48.35 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 123.727 0.811 . . . . 0.0 110.132 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 35.5 mt -84.53 175.21 9.43 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.349 1.06 . . . . 0.0 110.046 172.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -87.57 18.83 3.68 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.386 1.074 . . . . 0.0 110.632 169.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -96.1 -53.12 3.76 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 125.009 1.324 . . . . 0.0 109.499 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.87 -17.1 1.4 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.492 1.044 . . . . 0.0 112.08 -160.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.1 p -107.61 153.8 22.37 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.372 1.069 . . . . 0.0 112.427 -162.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.7 t -102.47 121.17 53.22 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 124.727 1.211 . . . . 0.0 109.237 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -90.32 97.15 11.02 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 173.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.2 t -90.51 119.79 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.5 t -114.0 126.81 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.41 ' HA ' HD23 ' A' ' 32' ' ' LEU . . . -147.81 114.34 5.98 Favored 'General case' 0 CA--C 1.522 -0.106 0 O-C-N 123.911 0.757 . . . . 0.0 110.822 -168.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 87.7 m -80.21 -176.43 5.58 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 124.659 1.184 . . . . 0.0 110.78 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.06 -176.2 21.8 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -177.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -74.87 150.09 39.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -53.82 -46.48 71.16 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.202 0.601 . . . . 0.0 110.414 -176.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -47.09 -48.89 19.32 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.062 1.792 . . . . 0.0 112.914 174.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -63.98 -54.23 37.76 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 117.501 0.65 . . . . 0.0 111.27 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.5 t -58.17 -34.77 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.132 0.973 . . . . 0.0 111.602 -177.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -53.46 -40.29 65.16 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.052 0.541 . . . . 0.0 111.101 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -65.87 -37.87 87.3 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.67 0.668 . . . . 0.0 112.347 -172.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -75.69 -35.24 60.38 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.484 0.584 . . . . 0.0 110.972 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 43.9 mtm -65.67 -39.41 91.31 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 176.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -47.93 -40.47 22.1 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.563 0.745 . . . . 0.0 111.571 173.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 28.9 t90 -78.62 -37.2 42.8 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.245 -0.884 . . . . 0.0 110.737 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.1 mt . . . . . 0 C--N 1.345 0.385 0 CA-C-N 119.813 1.188 . . . . 0.0 110.911 -179.591 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 66.7 t . . . . . 0 CA--C 1.53 0.195 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -64.84 -55.74 17.7 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.439 0.695 . . . . 0.0 111.568 -175.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -171.63 148.42 2.45 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 125.432 1.493 . . . . 0.0 107.141 -175.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 p -119.5 126.49 75.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 123.041 0.537 . . . . 0.0 110.27 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.4 tp -103.58 118.79 37.54 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 123.527 0.731 . . . . 0.0 109.175 173.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.4 m -101.74 138.34 38.86 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.621 0.769 . . . . 0.0 109.622 169.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -130.55 154.3 81.63 Favored Pre-proline 0 CA--C 1.53 0.192 0 C-N-CA 125.413 1.485 . . . . 0.0 108.525 171.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -70.51 104.24 1.41 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.212 2.608 . . . . 0.0 109.705 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -85.18 111.61 19.97 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.377 1.071 . . . . 0.0 109.482 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.71 86.71 1.02 Allowed Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 124.157 0.983 . . . . 0.0 109.754 175.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.22 165.33 32.92 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.231 1.954 . . . . 0.0 109.646 169.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.9 m -74.96 123.18 24.66 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.98 -151.91 47.13 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -173.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -126.02 147.53 49.53 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.965 1.306 . . . . 0.0 108.57 171.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 31.6 tp -72.59 156.44 38.99 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.6 p -66.05 -55.76 14.99 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.451 1.1 . . . . 0.0 111.585 -178.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -140.46 166.81 23.7 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.592 1.157 . . . . 0.0 111.547 -167.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -86.12 137.95 32.28 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 168.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -160.28 -170.63 2.88 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -167.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.1 mt . . . . . 0 CA--C 1.535 0.373 0 C-N-CA 126.638 1.975 . . . . 0.0 109.055 -169.746 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 119.903 -0.094 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -60.95 134.28 56.94 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.973 1.309 . . . . 0.0 112.351 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 p -138.92 91.51 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.272 0 C-N-CA 124.778 1.231 . . . . 0.0 108.707 -174.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.8 m -82.46 153.42 25.65 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.937 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.88 146.22 18.8 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -176.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.5 tt -109.22 124.11 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 124.171 0.989 . . . . 0.0 109.874 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.7 112.47 22.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.745 1.218 . . . . 0.0 110.373 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.7 m-90 -94.67 130.69 41.05 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.366 1.066 . . . . 0.0 110.289 178.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.611 HG13 HG22 ' A' ' 75' ' ' VAL . 2.9 t -111.31 101.57 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -177.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -68.16 176.63 2.61 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.611 0.765 . . . . 0.0 111.132 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.7 -162.11 54.3 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -93.34 91.71 7.33 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 123.804 0.842 . . . . 0.0 112.06 -172.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.507 HG21 HG12 ' A' ' 10' ' ' VAL . 31.9 t -122.63 -30.78 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 C-N-CA 123.991 0.916 . . . . 0.0 111.275 -175.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -72.22 148.88 45.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 121.944 -0.473 . . . . 0.0 110.018 175.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.29 -21.02 47.68 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.067 -0.851 . . . . 0.0 113.023 176.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 p -84.09 0.53 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 118.55 1.175 . . . . 0.0 112.39 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.44 52.28 54.12 Favored Glycine 0 C--N 1.34 0.791 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -176.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.36 -34.25 70.47 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.591 0.756 . . . . 0.0 111.102 176.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.84 53.95 0.78 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.905 1.682 . . . . 0.0 112.326 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -87.17 -67.61 0.81 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -177.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 t -101.81 1.9 37.69 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.17 0.988 . . . . 0.0 112.094 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.8 t -48.35 -33.82 9.62 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.421 0.688 . . . . 0.0 112.149 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -68.03 -55.19 13.49 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.965 1.306 . . . . 0.0 110.423 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -55.08 -55.3 32.62 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.749 0.819 . . . . 0.0 110.742 -175.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.22 -47.97 68.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.839 0.856 . . . . 0.0 110.3 176.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.29 -28.23 58.07 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.48 -31.14 68.15 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.024 0.929 . . . . 0.0 111.873 177.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.1 mmm-85 -67.95 -42.39 81.03 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.801 0.84 . . . . 0.0 110.869 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -84.4 -42.05 16.07 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 122.947 0.499 . . . . 0.0 111.498 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.44 6.94 63.91 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 123.932 0.777 . . . . 0.0 112.91 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.67 167.72 3.38 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.138 0.969 . . . . 0.0 111.743 174.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.7 p -131.0 156.07 45.76 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -177.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 162.51 -148.13 14.84 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -169.62 164.15 10.19 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.163 -0.519 . . . . 0.0 111.77 172.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.98 97.27 5.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.014 0.926 . . . . 0.0 111.521 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -97.12 173.09 7.43 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.399 1.08 . . . . 0.0 111.095 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -123.44 137.87 54.71 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.428 1.091 . . . . 0.0 109.219 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.1 mt -75.67 177.36 6.88 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.497 1.119 . . . . 0.0 110.447 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -101.08 9.88 41.61 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.52 1.128 . . . . 0.0 111.276 177.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -109.34 -14.12 14.5 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.528 1.131 . . . . 0.0 112.086 -176.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.61 10.65 10.11 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.17 1.366 . . . . 0.0 113.938 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.54 164.45 14.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.538 1.535 . . . . 0.0 111.537 -173.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.4 p -119.55 138.97 48.46 Favored 'Isoleucine or valine' 0 C--N 1.347 0.494 0 C-N-CA 123.674 0.79 . . . . 0.0 110.702 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -110.86 121.18 44.71 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.581 1.152 . . . . 0.0 110.823 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 64.0 t -116.17 136.55 52.78 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.17 144.01 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 124.235 1.014 . . . . 0.0 109.482 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.54 142.03 21.7 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.581 -176.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.3 m -110.73 -178.78 3.57 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 126.173 1.789 . . . . 0.0 112.471 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.47 -153.59 23.48 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.054 -1.219 . . . . 0.0 110.054 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -82.25 132.7 35.23 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.096 0.558 . . . . 0.0 109.508 -178.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -48.71 -49.89 35.97 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.25 1.02 . . . . 0.0 110.972 -178.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.83 -52.96 28.15 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.103 1.335 . . . . 0.0 112.129 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -60.85 -46.5 90.34 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 124.232 1.013 . . . . 0.0 110.771 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.6 t -55.73 -42.79 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 122.271 0.228 . . . . 0.0 110.716 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.56 -27.73 66.49 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -27.05 68.49 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.842 0.857 . . . . 0.0 112.436 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.37 -29.05 14.18 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.211 0.604 . . . . 0.0 110.829 174.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.428 ' HA ' HD12 ' A' ' 62' ' ' LEU . 1.2 mmm -64.23 -21.87 66.74 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-O 118.588 -0.72 . . . . 0.0 111.535 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -47.54 -57.76 5.03 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 118.527 0.603 . . . . 0.0 109.812 172.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 15.7 t90 -64.3 -29.31 70.4 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.649 0.78 . . . . 0.0 111.727 -178.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 59' ' ' MET . 21.1 mt . . . . . 0 C--N 1.347 0.489 0 O-C-N 121.101 -1.0 . . . . 0.0 110.083 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.7 t . . . . . 0 CA--C 1.534 0.357 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -58.89 -50.79 72.7 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.494 0.718 . . . . 0.0 111.301 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.9 ttm-85 -169.3 163.56 10.76 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.042 0.537 . . . . 0.0 110.377 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.611 HG22 HG13 ' A' ' 10' ' ' VAL . 8.5 t -133.35 110.33 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.763 0.825 . . . . 0.0 109.953 -176.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.0 tp -100.61 152.4 20.48 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.36 1.064 . . . . 0.0 110.283 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.52 129.51 31.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.011 0.924 . . . . 0.0 111.518 -177.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.21 158.49 74.04 Favored Pre-proline 0 N--CA 1.469 0.501 0 C-N-CA 125.358 1.463 . . . . 0.0 110.544 -176.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.73 132.26 19.91 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 124.482 3.455 . . . . 0.0 110.987 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -120.68 114.93 22.39 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.617 1.167 . . . . 0.0 109.626 -177.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -121.8 64.97 18.23 Favored Pre-proline 0 CA--C 1.536 0.426 0 O-C-N 121.656 -0.653 . . . . 0.0 110.867 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.45 142.26 44.45 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.207 2.605 . . . . 0.0 110.471 -174.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.6 p -70.44 142.46 51.98 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.372 0.669 . . . . 0.0 110.729 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.86 170.62 5.37 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.25 0.929 . . . . 0.0 112.105 -176.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -93.26 135.15 34.74 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.8 tp -77.74 149.17 34.57 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -75.53 0.15 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.217 1.007 . . . . 0.0 108.483 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -141.15 162.95 34.26 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.135 0.974 . . . . 0.0 109.926 -173.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -71.17 145.61 49.61 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.876 0.47 . . . . 0.0 110.616 174.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -142.05 -169.97 3.05 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.122 0.969 . . . . 0.0 109.964 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.2 mt . . . . . 0 CA--C 1.535 0.386 0 C-N-CA 123.906 0.882 . . . . 0.0 108.706 -177.91 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.9 t . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 110.598 -0.149 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 152.97 41.95 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.145 0.978 . . . . 0.0 112.908 -176.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 p -138.78 90.88 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 124.505 1.122 . . . . 0.0 108.435 -173.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.0 m -78.61 153.37 31.16 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.665 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.99 148.99 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -176.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.8 tt -111.43 125.61 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.942 0.897 . . . . 0.0 109.947 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -120.21 101.85 8.1 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.823 1.649 . . . . 0.0 109.767 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 -87.15 112.7 22.21 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 124.618 1.167 . . . . 0.0 109.895 177.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.84 121.52 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.312 1.045 . . . . 0.0 108.662 -177.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -99.27 171.35 8.04 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.048 0.939 . . . . 0.0 110.684 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.72 -165.08 49.28 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 123.375 0.512 . . . . 0.0 112.095 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.9 mtt85 -84.86 83.6 7.99 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -166.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.7 t -119.49 -47.25 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.909 0.883 . . . . 0.0 110.378 -173.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -67.68 146.64 53.61 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 120.848 0.356 . . . . 0.0 110.862 177.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.18 17.93 76.22 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.128 0.87 . . . . 0.0 113.738 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 82.4 t -102.86 -43.06 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 124.673 1.189 . . . . 0.0 109.141 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.08 29.02 3.16 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 125.884 1.707 . . . . 0.0 110.996 -175.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -50.97 -37.58 45.55 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 124.509 1.124 . . . . 0.0 111.325 177.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.0 60.09 0.96 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.848 1.259 . . . . 0.0 112.689 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -109.75 -72.94 0.7 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.684 1.194 . . . . 0.0 108.789 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.3 t -72.19 -23.26 61.24 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 118.503 -0.761 . . . . 0.0 112.053 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.5 t -41.32 -39.81 1.51 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.468 1.107 . . . . 0.0 112.667 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -71.64 -59.84 2.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.364 1.065 . . . . 0.0 110.681 176.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -49.98 -58.08 6.2 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.139 0.976 . . . . 0.0 111.771 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -53.14 -51.15 62.9 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.588 1.155 . . . . 0.0 110.849 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.46 -33.2 53.31 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 122.78 0.432 . . . . 0.0 112.079 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -68.23 -28.54 67.32 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.212 1.005 . . . . 0.0 112.234 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.6 mtp85 -70.81 -47.04 61.58 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.895 0.878 . . . . 0.0 109.926 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.5 mt -78.33 -40.71 35.78 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.013 0.525 . . . . 0.0 111.004 -177.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.27 22.31 41.62 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.195 1.379 . . . . 0.0 112.952 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.72 174.89 11.12 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.713 0.805 . . . . 0.0 111.566 177.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 51.2 p -117.69 -163.39 0.93 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.59 -155.39 16.24 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 118.534 0.606 . . . . 0.0 112.144 171.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -169.88 162.26 9.28 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.72 84.81 2.32 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.443 1.097 . . . . 0.0 111.254 -174.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -92.61 173.01 8.0 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.851 0.86 . . . . 0.0 111.281 -177.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -125.07 131.57 53.31 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.336 1.054 . . . . 0.0 109.494 -177.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 39' ' ' LEU . 16.4 mt -70.06 171.25 9.86 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 125.214 1.405 . . . . 0.0 110.897 175.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -93.82 7.33 45.33 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.872 1.269 . . . . 0.0 111.747 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -112.63 -16.83 12.74 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.515 1.126 . . . . 0.0 112.119 -175.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.6 13.97 2.98 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.122 1.344 . . . . 0.0 114.385 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.54 166.32 12.85 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.426 1.49 . . . . 0.0 111.958 -167.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.3 t -127.07 120.92 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.586 1.155 . . . . 0.0 111.404 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -98.02 115.28 27.88 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 125.168 1.387 . . . . 0.0 111.684 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.6 t -114.1 133.32 60.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 122.861 0.464 . . . . 0.0 110.43 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.33 143.26 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 123.993 0.917 . . . . 0.0 109.738 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.96 133.03 11.63 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.015 -173.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 93.7 m -101.58 179.97 4.19 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.667 1.187 . . . . 0.0 112.325 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.73 -162.6 21.34 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.337 0.97 . . . . 0.0 110.758 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -73.18 121.75 20.79 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 123.691 0.796 . . . . 0.0 109.974 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -46.88 -50.85 17.97 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.015 1.326 . . . . 0.0 111.346 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -51.96 -45.77 55.97 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.402 1.477 . . . . 0.0 112.355 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -66.7 -50.88 61.41 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 117.455 0.628 . . . . 0.0 110.714 176.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.1 t -51.39 -34.05 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 122.647 0.379 . . . . 0.0 111.055 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -57.71 -31.46 66.43 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.915 0.886 . . . . 0.0 113.192 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -54.31 -44.86 72.36 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.828 0.851 . . . . 0.0 110.766 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.63 -32.18 53.22 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 118.481 0.582 . . . . 0.0 112.118 175.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.3 mmt -67.37 -25.19 65.85 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 118.814 -0.612 . . . . 0.0 111.867 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -42.44 -49.66 5.23 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.166 0.586 . . . . 0.0 109.719 170.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -64.13 -41.86 97.06 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.7 mt . . . . . 0 N--CA 1.471 0.612 0 C-N-CA 123.667 0.787 . . . . 0.0 110.599 179.641 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 95.4 t . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -67.21 -55.38 14.3 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.745 0.418 . . . . 0.0 110.998 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -166.64 99.05 0.57 Allowed 'General case' 0 C--N 1.342 0.274 0 C-N-CA 122.485 0.314 . . . . 0.0 111.422 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.9 p -84.41 125.54 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.275 0.63 . . . . 0.0 111.469 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.97 137.86 45.23 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 125.694 1.598 . . . . 0.0 111.568 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.88 138.56 54.35 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.156 1.382 . . . . 0.0 112.41 -177.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -144.04 158.73 54.97 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 124.945 1.298 . . . . 0.0 111.39 -177.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.02 137.38 26.44 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 124.074 3.182 . . . . 0.0 111.792 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -128.06 124.46 37.1 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.537 1.135 . . . . 0.0 111.181 -175.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -129.02 70.01 81.32 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 121.698 -0.626 . . . . 0.0 111.431 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.2 142.63 38.12 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.864 2.376 . . . . 0.0 110.722 -176.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.3 m -66.45 140.18 58.01 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.799 0.84 . . . . 0.0 110.776 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.86 -177.91 40.85 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.755 0.693 . . . . 0.0 111.547 -176.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -108.35 131.31 54.87 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.179 0.991 . . . . 0.0 108.568 172.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -69.82 151.75 45.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.927 1.291 . . . . 0.0 109.359 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.71 -77.98 0.13 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.672 0.789 . . . . 0.0 108.943 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -137.99 161.1 37.58 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.27 1.028 . . . . 0.0 109.838 -171.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -69.19 147.82 50.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.903 0.481 . . . . 0.0 110.03 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -152.06 -167.74 2.86 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 122.905 0.482 . . . . 0.0 110.524 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.2 tt . . . . . 0 N--CA 1.451 -0.41 0 C-N-CA 123.792 0.837 . . . . 0.0 109.48 177.413 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.0 m . . . . . 0 CA--C 1.533 0.302 0 CA-C-O 119.826 -0.13 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 142.84 55.84 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -169.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.25 88.5 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -172.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.2 m -78.95 152.06 31.29 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.276 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.416 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -141.52 149.33 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -177.105 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.8 tt -110.52 122.78 65.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 O-C-N 123.81 0.693 . . . . 0.0 109.335 174.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -113.88 95.67 5.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.684 1.594 . . . . 0.0 108.873 -175.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -81.44 130.59 35.1 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.4 t -107.07 113.97 44.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.476 1.111 . . . . 0.0 109.355 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -84.47 163.71 19.28 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.698 0.799 . . . . 0.0 111.052 175.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.39 179.5 53.02 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 124.126 0.869 . . . . 0.0 111.076 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.5 mtt180 -86.5 73.61 10.07 Favored 'General case' 0 N--CA 1.457 -0.075 0 CA-C-O 121.053 0.454 . . . . 0.0 111.751 -164.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.7 t -104.73 -33.25 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.162 0.985 . . . . 0.0 112.081 -170.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -63.13 159.68 16.94 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.677 0.671 . . . . 0.0 110.851 171.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.78 -46.08 1.65 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 123.992 0.806 . . . . 0.0 111.569 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.9 p -69.63 -9.74 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 123.431 0.693 . . . . 0.0 112.817 -174.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.08 44.46 35.85 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.894 0.759 . . . . 0.0 111.306 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -48.61 -34.13 11.09 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 125.867 1.667 . . . . 0.0 112.952 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 -71.95 47.92 0.15 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.844 1.657 . . . . 0.0 112.85 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -89.34 -69.63 0.7 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.089 0.956 . . . . 0.0 109.001 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.0 t -99.84 12.29 37.08 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.203 1.401 . . . . 0.0 111.23 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.1 t -59.41 -39.75 84.46 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.027 0.376 . . . . 0.0 110.796 170.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 -53.47 -60.55 3.16 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.868 1.267 . . . . 0.0 109.852 173.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -54.8 -57.04 13.15 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.001 0.92 . . . . 0.0 110.693 -173.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -54.55 -55.22 31.52 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 123.902 0.751 . . . . 0.0 109.856 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.92 -33.95 65.14 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 118.798 -0.62 . . . . 0.0 111.958 -177.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -67.56 -36.49 81.05 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.886 -0.578 . . . . 0.0 112.191 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -60.11 -46.87 88.17 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.656 0.662 . . . . 0.0 110.861 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.63 -22.01 34.85 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.98 31.57 47.79 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.557 1.075 . . . . 0.0 113.131 -178.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.597 HD13 ' O ' ' A' ' 49' ' ' CYS . 3.3 mm? -76.21 140.77 41.81 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 117.503 0.652 . . . . 0.0 110.294 176.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.2 p -96.16 -159.89 0.76 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.484 176.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.49 -149.22 16.69 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 119.212 0.915 . . . . 0.0 112.034 172.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -169.84 158.23 7.24 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 177.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.93 97.4 5.68 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.267 1.427 . . . . 0.0 110.416 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -107.62 170.22 8.11 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.697 0.799 . . . . 0.0 111.425 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -120.66 131.46 54.59 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.386 1.075 . . . . 0.0 108.994 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.7 mt -68.04 174.84 3.49 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.228 1.411 . . . . 0.0 110.679 175.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -97.48 15.52 22.96 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.772 1.229 . . . . 0.0 111.397 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -120.09 -14.47 8.86 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 123.942 0.897 . . . . 0.0 112.778 -173.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.22 11.35 4.26 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.073 1.32 . . . . 0.0 114.325 175.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 p -126.35 162.08 26.36 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.308 1.443 . . . . 0.0 111.807 -166.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.4 t -117.06 132.91 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.785 1.234 . . . . 0.0 111.112 -174.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -106.29 113.35 26.82 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.749 1.22 . . . . 0.0 110.606 178.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.1 t -112.29 135.39 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.785 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.7 142.76 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.765 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.53 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -151.7 119.21 6.04 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 117.945 -1.026 . . . . 0.0 111.901 -171.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.597 ' O ' HD13 ' A' ' 32' ' ' LEU . 98.5 m -109.58 132.02 54.52 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 120.031 1.287 . . . . 0.0 113.376 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 156.33 -163.86 32.19 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -71.81 126.85 30.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.334 0.567 . . . . 0.0 110.406 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -54.24 -43.21 70.7 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.853 1.261 . . . . 0.0 111.668 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -42.25 -42.8 4.43 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 126.057 1.789 . . . . 0.0 112.886 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -80.76 -47.17 14.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.207 1.003 . . . . 0.0 111.476 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.488 HG22 HD11 ' A' ' 32' ' ' LEU . 77.0 t -42.75 -52.11 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 123.938 0.895 . . . . 0.0 110.892 177.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -54.01 -36.4 62.94 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.405 0.682 . . . . 0.0 112.163 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -61.29 -44.24 97.55 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.022 0.929 . . . . 0.0 110.771 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.48 -32.32 68.13 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 122.934 0.494 . . . . 0.0 110.289 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.2 mmt -66.86 -24.87 66.18 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.096 -0.954 . . . . 0.0 112.264 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -47.71 -48.42 29.47 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 119.536 1.062 . . . . 0.0 109.535 172.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -61.25 -39.05 88.9 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 118.848 -0.596 . . . . 0.0 112.205 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.347 0.5 0 CA-C-N 119.385 0.993 . . . . 0.0 111.558 177.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 CA--C 1.531 0.217 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -64.93 -51.31 62.55 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -167.61 168.7 12.5 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.482 1.113 . . . . 0.0 109.142 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.1 t -132.11 125.64 54.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.148 0.979 . . . . 0.0 109.265 174.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tp -103.81 120.64 41.4 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.397 1.079 . . . . 0.0 110.965 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.6 136.35 43.47 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.05 0.94 . . . . 0.0 110.678 178.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -140.83 153.55 67.75 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 124.836 1.254 . . . . 0.0 109.937 178.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.57 136.54 28.53 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.666 2.911 . . . . 0.0 110.984 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -126.44 118.82 25.75 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.89 1.276 . . . . 0.0 110.105 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -121.2 72.34 25.18 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 119.147 0.885 . . . . 0.0 111.498 177.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.27 140.32 44.21 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.011 2.474 . . . . 0.0 110.118 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 80.9 p -75.75 143.05 42.23 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.637 0.775 . . . . 0.0 110.753 -176.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.45 -179.93 42.48 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -103.68 126.76 51.02 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.621 1.168 . . . . 0.0 108.719 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 mp -71.24 151.64 44.1 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.063 0.945 . . . . 0.0 109.797 173.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.4 p -78.65 -79.65 0.13 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.891 0.876 . . . . 0.0 108.719 173.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -141.28 164.06 31.26 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 124.119 0.968 . . . . 0.0 111.187 -168.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -75.23 148.36 39.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.904 0.882 . . . . 0.0 110.002 175.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -149.83 -172.37 4.13 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.065 0.546 . . . . 0.0 110.022 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.457 -0.114 0 C-N-CA 123.872 0.869 . . . . 0.0 110.66 -174.138 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 mtm . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 111.419 0.155 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.0 t -145.15 -51.5 0.27 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.544 1.138 . . . . 0.0 110.364 177.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -61.29 127.59 32.26 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.901 1.68 . . . . 0.0 112.928 -176.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 p -132.45 90.59 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.186 0 C-N-CA 125.585 1.554 . . . . 0.0 108.505 -174.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.1 m -81.65 153.22 26.76 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.92 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.89 149.59 17.71 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -176.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.4 tt -114.86 124.93 72.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.061 0.945 . . . . 0.0 110.414 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -119.35 109.56 15.94 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.953 1.701 . . . . 0.0 110.395 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.5 m-90 -92.11 116.45 28.95 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 125.626 1.57 . . . . 0.0 110.49 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -101.33 121.65 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.048 0.939 . . . . 0.0 109.164 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -91.34 173.19 8.05 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.362 1.465 . . . . 0.0 110.865 176.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.86 -166.98 50.96 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.7 mtt-85 -83.82 86.0 7.22 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.248 0.619 . . . . 0.0 111.519 -172.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.3 t -117.53 -40.57 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 123.791 0.837 . . . . 0.0 110.311 -174.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -73.65 149.33 42.05 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.175 0.443 . . . . 0.0 110.295 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.94 -43.26 1.74 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.102 0.858 . . . . 0.0 112.39 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.1 p -69.59 -8.12 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 118.066 0.933 . . . . 0.0 111.786 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.26 47.14 38.11 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -50.64 -40.89 54.49 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 124.022 0.929 . . . . 0.0 110.944 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 -70.76 55.0 0.17 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.599 1.96 . . . . 0.0 113.074 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -103.56 -68.93 0.82 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.36 1.064 . . . . 0.0 109.125 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.0 t -73.26 -22.11 60.46 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.3 t -41.31 -40.05 1.56 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.819 1.247 . . . . 0.0 112.55 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -64.79 -60.52 3.0 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.003 1.321 . . . . 0.0 110.826 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -51.26 -57.04 9.9 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.76 0.824 . . . . 0.0 111.022 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.04 -50.18 67.28 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.641 0.776 . . . . 0.0 110.477 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.91 -33.96 39.37 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 122.987 0.515 . . . . 0.0 112.098 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt -67.92 -33.4 74.62 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.463 0.705 . . . . 0.0 111.851 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 -66.15 -41.79 89.92 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.827 0.851 . . . . 0.0 111.411 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.93 -30.9 31.57 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.308 0.643 . . . . 0.0 111.77 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.96 21.4 78.51 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.095 0.855 . . . . 0.0 112.74 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.49 HD12 ' HB1' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -81.23 174.69 11.29 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.861 0.865 . . . . 0.0 110.955 176.389 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 50.0 p -117.31 -161.39 0.81 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -175.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.81 -155.16 16.3 Favored Glycine 0 C--N 1.339 0.705 0 CA-C-N 118.463 0.574 . . . . 0.0 111.822 169.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -168.14 159.23 10.82 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 171.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.01 95.33 4.86 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.77 1.228 . . . . 0.0 110.106 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -98.97 171.21 8.19 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.151 0.981 . . . . 0.0 110.674 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -127.29 133.23 50.17 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 124.048 0.939 . . . . 0.0 109.686 -177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.2 mt -71.23 173.52 7.61 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.158 1.383 . . . . 0.0 111.128 176.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -96.27 13.38 27.74 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.016 1.327 . . . . 0.0 111.801 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -121.38 0.59 10.05 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.635 1.174 . . . . 0.0 112.481 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.43 3.32 27.42 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.157 1.36 . . . . 0.0 114.425 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.37 165.14 11.73 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.959 1.704 . . . . 0.0 112.052 -169.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.8 t -126.87 124.49 64.89 Favored 'Isoleucine or valine' 0 C--N 1.348 0.515 0 C-N-CA 124.513 1.125 . . . . 0.0 111.752 -174.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -100.28 116.51 32.43 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 125.43 1.492 . . . . 0.0 111.718 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.0 t -113.51 133.0 60.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 123.496 0.719 . . . . 0.0 109.787 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.8 t -128.63 145.18 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.783 0.833 . . . . 0.0 110.188 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.49 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -157.9 137.1 11.71 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-O 118.297 -0.859 . . . . 0.0 111.786 -174.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 67.3 m -104.24 178.44 4.56 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.514 1.526 . . . . 0.0 112.418 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.06 -158.1 19.57 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 124.613 1.101 . . . . 0.0 110.422 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -79.56 128.63 33.62 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.835 0.854 . . . . 0.0 109.388 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -44.83 -49.32 10.88 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.241 1.016 . . . . 0.0 111.768 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -49.55 -54.29 17.43 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.305 1.431 . . . . 0.0 112.989 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -59.54 -47.82 84.07 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 125.302 1.441 . . . . 0.0 110.419 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.36 -41.6 71.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 122.429 0.292 . . . . 0.0 110.799 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -64.08 -26.88 68.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.226 0.611 . . . . 0.0 112.589 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -55.03 -48.96 72.72 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.637 0.775 . . . . 0.0 111.036 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -76.95 -30.26 55.96 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 118.192 0.451 . . . . 0.0 111.499 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.6 mmm -66.14 -21.42 66.34 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.624 -0.703 . . . . 0.0 111.594 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -44.41 -46.3 9.44 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.738 0.699 . . . . 0.0 109.996 168.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -67.74 -41.01 84.11 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.871 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 mt -54.47 -53.08 58.99 Favored 'General case' 0 C--N 1.346 0.448 0 C-N-CA 123.476 0.71 . . . . 0.0 110.611 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.46 -2.39 28.53 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.0 t -94.32 -30.43 14.53 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 119.276 0.943 . . . . 0.0 110.848 174.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.11 62.72 3.41 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -45.84 -65.52 1.97 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.819 1.2 . . . . 0.0 113.176 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -73.37 104.64 1.83 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.762 2.308 . . . . 0.0 110.347 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -55.13 -25.0 28.96 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.381 1.472 . . . . 0.0 113.501 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.91 -32.27 70.6 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.563 0.745 . . . . 0.0 111.234 174.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.62 155.65 37.27 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.873 0.469 . . . . 0.0 110.75 175.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.67 82.73 2.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.36 95.27 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -77.16 -47.96 18.94 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.924 0.89 . . . . 0.0 111.17 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.7 mtm105 -156.73 163.27 39.45 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.926 1.29 . . . . 0.0 109.484 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.4 p -154.57 131.61 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 118.944 -0.55 . . . . 0.0 111.136 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tp -122.67 141.0 52.22 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.357 1.063 . . . . 0.0 112.556 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.43 142.77 50.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.115 1.366 . . . . 0.0 112.867 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -143.2 159.57 55.2 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 125.119 1.368 . . . . 0.0 111.262 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.38 137.5 28.33 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.747 2.965 . . . . 0.0 111.346 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -125.3 116.94 22.73 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.79 1.236 . . . . 0.0 110.296 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -121.86 74.76 36.87 Favored Pre-proline 0 CA--C 1.536 0.408 0 O-C-N 121.425 -0.797 . . . . 0.0 110.77 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.72 146.27 42.82 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.76 2.306 . . . . 0.0 110.523 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.3 p -71.22 140.57 50.48 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.502 0.721 . . . . 0.0 110.461 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.22 179.73 30.79 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 123.811 0.72 . . . . 0.0 112.048 -177.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -101.75 131.02 48.27 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.597 1.159 . . . . 0.0 108.593 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -70.06 150.8 46.22 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.725 1.21 . . . . 0.0 109.534 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -77.32 0.15 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.788 0.835 . . . . 0.0 108.755 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -137.94 166.16 24.74 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.121 0.968 . . . . 0.0 110.674 -174.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -75.59 146.38 40.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.122 0.569 . . . . 0.0 110.101 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -149.81 -168.19 3.04 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.53 0.732 . . . . 0.0 110.055 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.4 pt -139.62 174.5 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.376 1.07 . . . . 0.0 109.938 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.106 0 CA-C-O 116.793 -1.575 . . . . 0.0 112.113 175.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? . . . . . 0 N--CA 1.474 0.769 0 CA-C-O 119.142 -0.456 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.2 t -141.26 -49.68 0.42 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.238 0.615 . . . . 0.0 111.956 -175.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.3 121.78 21.86 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.926 0.891 . . . . 0.0 111.374 -174.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.87 85.54 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.087 0 C-N-CA 125.273 1.429 . . . . 0.0 108.262 -172.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 m -78.86 150.32 32.26 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.114 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pp -129.88 162.1 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.3 tt -119.83 124.5 72.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.186 0.994 . . . . 0.0 109.038 173.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -117.39 99.89 7.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 126.237 1.815 . . . . 0.0 109.298 -173.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -83.4 131.85 35.02 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.612 0.765 . . . . 0.0 110.113 175.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.5 t -112.04 107.15 22.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.184 0.993 . . . . 0.0 109.113 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -73.77 165.87 24.34 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 123.445 0.698 . . . . 0.0 110.997 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.03 -179.44 53.61 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 123.811 0.719 . . . . 0.0 111.741 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.1 mtt-85 -87.8 78.58 8.36 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 122.971 0.508 . . . . 0.0 112.033 -165.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.3 t -105.51 -26.98 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.11 0.964 . . . . 0.0 111.94 -173.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -73.29 156.72 38.16 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.224 0.61 . . . . 0.0 112.181 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.89 25.41 75.81 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.296 0.951 . . . . 0.0 113.244 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.6 t -123.49 -39.09 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.027 1.331 . . . . 0.0 110.478 -177.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.96 34.4 2.58 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.922 1.249 . . . . 0.0 112.733 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -48.25 -35.48 12.1 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.82 1.248 . . . . 0.0 112.781 172.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.38 57.17 2.29 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.291 1.836 . . . . 0.0 110.564 -174.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -98.31 -72.21 0.66 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.591 0.756 . . . . 0.0 109.444 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -88.48 -7.09 57.12 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.077 0.951 . . . . 0.0 111.996 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.8 t -43.62 -46.01 7.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.884 0.874 . . . . 0.0 112.72 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -53.4 -61.43 2.31 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 126.043 1.737 . . . . 0.0 110.537 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.95 -54.67 26.81 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.002 1.321 . . . . 0.0 110.645 -177.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -55.3 -52.68 62.68 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.582 0.753 . . . . 0.0 110.542 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.18 -36.34 63.29 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.087 0.555 . . . . 0.0 111.864 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -65.12 -31.34 72.5 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.919 0.887 . . . . 0.0 112.18 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.6 mtp85 -67.66 -47.05 70.63 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.422 0.556 . . . . 0.0 110.214 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mp -74.32 -33.08 63.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.745 0.418 . . . . 0.0 110.727 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.63 18.43 66.01 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.377 0.989 . . . . 0.0 112.629 -177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.77 171.0 13.58 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 117.466 0.633 . . . . 0.0 111.411 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.6 p -111.47 -158.17 0.64 Allowed 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -171.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.69 -159.69 13.59 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 118.092 0.406 . . . . 0.0 112.219 167.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -165.85 155.16 11.94 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 174.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.93 95.68 5.44 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.386 1.475 . . . . 0.0 110.085 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -104.53 175.36 5.51 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.683 0.793 . . . . 0.0 110.838 176.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -123.89 136.36 54.3 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.169 0.988 . . . . 0.0 109.988 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.5 mt -70.67 173.67 6.88 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.158 1.383 . . . . 0.0 110.632 173.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -96.91 18.93 13.55 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.658 1.183 . . . . 0.0 111.574 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -121.96 -20.91 6.17 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 123.806 0.842 . . . . 0.0 112.851 -175.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.24 -7.37 4.04 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.727 1.156 . . . . 0.0 113.836 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.8 p -112.48 166.64 11.13 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.186 1.395 . . . . 0.0 111.816 -165.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.0 t -124.46 129.83 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.191 0.996 . . . . 0.0 111.528 -168.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -104.82 114.01 27.96 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.789 1.236 . . . . 0.0 111.465 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.2 t -113.41 130.94 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.66 0.784 . . . . 0.0 109.946 -177.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.35 144.27 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.981 0.912 . . . . 0.0 110.473 -175.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.01 130.73 4.89 Favored 'General case' 0 C--N 1.349 0.557 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.112 -172.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 99.4 m -95.54 -178.94 4.58 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.151 1.38 . . . . 0.0 112.337 177.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.24 -159.39 14.33 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -83.06 127.01 33.19 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 174.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -49.93 -46.05 51.71 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.471 1.108 . . . . 0.0 110.851 -174.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -44.88 -50.56 8.68 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.054 1.788 . . . . 0.0 113.015 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -69.13 -49.03 60.65 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.147 0.979 . . . . 0.0 110.939 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.9 t -53.08 -38.52 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.004 0.521 . . . . 0.0 111.391 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -63.3 -26.96 69.01 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -61.46 -44.98 96.14 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.092 0.557 . . . . 0.0 111.293 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.37 -30.26 63.17 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.379 0.536 . . . . 0.0 110.515 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.8 mmt -66.92 -24.79 66.13 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.168 -0.92 . . . . 0.0 112.176 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -42.22 -53.91 3.89 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 119.036 0.835 . . . . 0.0 109.016 166.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 32.3 t90 -63.61 -40.98 98.28 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 123.337 0.655 . . . . 0.0 112.235 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt -55.7 -42.52 75.36 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.312 0.96 . . . . 0.0 110.774 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.75 -28.38 60.74 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.925 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.0 m -103.29 8.44 38.28 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.56 1.144 . . . . 0.0 111.997 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.88 -41.01 42.76 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -176.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -21.51 93.16 0.01 OUTLIER Glycine 0 CA--C 1.534 1.261 0 C-N-CA 128.389 2.9 . . . . 0.0 115.279 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.76 -175.22 2.2 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.092 2.528 . . . . 0.0 110.689 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -70.63 -44.44 67.18 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.306 1.043 . . . . 0.0 111.493 -170.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.5 p -67.25 -59.33 3.51 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 124.039 0.935 . . . . 0.0 110.643 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.88 155.99 32.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.863 0.865 . . . . 0.0 111.121 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -139.63 108.49 5.98 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.955 0.902 . . . . 0.0 109.029 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.9 t -77.36 94.25 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -58.54 -45.52 88.73 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.3 mtm-85 -173.23 166.59 4.87 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.572 1.549 . . . . 0.0 109.51 -175.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.6 t -135.83 131.21 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.152 0.981 . . . . 0.0 110.827 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 tp -117.04 124.64 49.78 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.118 1.367 . . . . 0.0 111.706 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.79 134.7 52.27 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.284 1.034 . . . . 0.0 111.688 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -140.35 157.09 69.3 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.144 1.378 . . . . 0.0 110.589 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.39 131.25 18.63 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.251 3.301 . . . . 0.0 111.648 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -122.72 116.41 23.71 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.197 0.999 . . . . 0.0 111.446 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -113.85 77.89 3.81 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 119.223 0.92 . . . . 0.0 111.781 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.6 145.9 38.07 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.145 2.563 . . . . 0.0 111.297 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.2 m -73.91 135.79 43.31 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.339 1.056 . . . . 0.0 110.782 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.16 -179.06 42.99 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 123.708 0.671 . . . . 0.0 111.57 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -103.24 126.36 50.37 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.895 0.878 . . . . 0.0 108.758 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -67.0 155.4 38.73 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.905 1.282 . . . . 0.0 110.02 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.5 m -83.2 -76.95 0.26 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -128.48 167.75 16.62 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.029 1.331 . . . . 0.0 109.952 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -77.73 151.0 34.34 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.285 1.034 . . . . 0.0 110.137 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -151.38 -175.57 5.23 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.353 0.661 . . . . 0.0 110.724 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.3 pt -138.26 176.39 6.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 123.875 0.87 . . . . 0.0 110.318 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 116.782 -1.58 . . . . 0.0 111.581 169.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ppp? . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.9 m -173.12 -53.6 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 126.18 1.792 . . . . 0.0 108.405 173.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -73.49 105.13 4.71 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.524 0.73 . . . . 0.0 109.684 -176.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.5 p -98.57 81.6 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.3 m -75.71 151.38 37.66 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.151 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.514 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -135.71 147.51 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.036 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.3 tt -110.12 98.81 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 C-N-CA 123.699 0.8 . . . . 0.0 109.108 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.77 97.23 10.87 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.134 0.974 . . . . 0.0 109.181 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -72.09 102.65 3.06 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 169.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.68 82.86 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 174.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -65.92 132.05 47.7 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.97 -177.32 28.18 Favored Glycine 0 N--CA 1.448 -0.543 0 O-C-N 123.443 0.464 . . . . 0.0 111.988 178.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -89.06 69.05 8.4 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 121.911 0.863 . . . . 0.0 109.421 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.3 t -108.61 -47.35 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.937 1.695 . . . . 0.0 109.181 -167.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -57.68 145.19 35.11 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.076 0.95 . . . . 0.0 109.817 166.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.75 -45.11 2.71 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.801 0.715 . . . . 0.0 111.368 -175.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.0 t -65.64 -33.71 65.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.675 0.79 . . . . 0.0 111.085 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.2 38.51 5.36 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.581 1.086 . . . . 0.0 111.651 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -52.07 -30.37 25.56 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 126.17 1.788 . . . . 0.0 113.181 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.0 54.54 0.67 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.008 1.323 . . . . 0.0 110.377 174.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -87.37 -74.61 0.43 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.658 1.183 . . . . 0.0 108.444 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -101.83 17.83 22.05 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.637 1.175 . . . . 0.0 110.994 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.6 t -61.81 -40.53 95.59 Favored 'General case' 0 C--N 1.344 0.363 0 O-C-N 121.856 -0.527 . . . . 0.0 111.111 171.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -60.18 -50.33 74.1 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.402 0.681 . . . . 0.0 110.916 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -52.24 -58.49 6.48 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 123.184 0.303 . . . . 0.0 110.303 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.18 -52.17 59.69 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.755 1.222 . . . . 0.0 110.872 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.16 -39.66 63.75 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.444 1.097 . . . . 0.0 111.843 177.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -72.08 -23.69 61.39 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.917 0.887 . . . . 0.0 112.104 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.3 mmm-85 -65.12 -47.16 78.15 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 118.854 0.752 . . . . 0.0 108.982 171.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.9 mt -75.09 -33.46 61.64 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.069 0.947 . . . . 0.0 111.213 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.62 45.55 52.53 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 124.748 1.166 . . . . 0.0 111.314 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.36 174.98 5.65 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.757 1.223 . . . . 0.0 112.605 -175.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.4 p -114.63 -171.72 1.98 Allowed 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -170.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.69 -144.37 17.58 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 170.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -171.72 153.56 3.39 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 176.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.94 83.87 2.29 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.638 1.175 . . . . 0.0 108.689 170.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt -83.64 165.22 19.16 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -126.99 134.66 50.31 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 47.6 mt -80.74 -175.27 5.2 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.584 0.754 . . . . 0.0 109.899 170.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -93.04 2.31 56.84 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.961 0.904 . . . . 0.0 111.164 168.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -79.6 -48.1 14.34 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.403 0.681 . . . . 0.0 109.418 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.46 -28.72 2.31 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -157.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.04 117.02 10.17 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.312 0.645 . . . . 0.0 111.364 -166.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 63.8 t -88.76 104.12 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 171.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -79.65 93.41 5.51 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.821 1.248 . . . . 0.0 108.753 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.1 t -91.21 114.94 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.03 130.42 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.31 1.044 . . . . 0.0 108.479 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.17 123.64 7.17 Favored 'General case' 0 N--CA 1.457 -0.113 0 O-C-N 124.377 1.048 . . . . 0.0 109.792 -166.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 91.4 m -95.7 176.66 6.06 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.064 0.946 . . . . 0.0 112.085 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.9 -155.11 16.29 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -72.76 150.59 42.68 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 172.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -58.58 -46.89 85.96 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -46.49 -45.24 16.92 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.137 1.827 . . . . 0.0 113.034 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -67.02 -51.61 52.74 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.578 0.689 . . . . 0.0 110.707 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.7 t -61.08 -32.48 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.876 0.87 . . . . 0.0 111.904 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -53.64 -40.98 66.27 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.415 0.686 . . . . 0.0 111.092 173.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -65.06 -30.76 71.74 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.145 0.884 . . . . 0.0 112.691 -169.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -78.46 -35.97 45.97 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.565 0.62 . . . . 0.0 110.929 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 54.0 mtm -64.17 -41.91 96.93 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.498 0.59 . . . . 0.0 111.197 175.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -51.96 -29.77 21.92 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.219 1.008 . . . . 0.0 112.386 172.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 12.8 t90 -83.65 -41.07 18.18 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 117.845 -1.074 . . . . 0.0 110.874 170.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 25.6 mt -53.42 -46.6 69.84 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 120.098 1.317 . . . . 0.0 111.53 -174.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -58.16 -24.79 60.19 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.9 t -106.4 -0.69 23.99 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.996 1.718 . . . . 0.0 111.63 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.74 -33.24 84.51 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.265 0.936 . . . . 0.0 111.997 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 175.83 67.34 0.06 OUTLIER Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.0 -0.889 . . . . 0.0 110.896 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.02 -45.06 13.58 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.351 2.701 . . . . 0.0 112.299 -172.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 53.0 ptt85 -69.37 -33.71 73.46 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.039 0.536 . . . . 0.0 112.248 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.8 p -84.69 -74.32 0.39 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.1 0.56 . . . . 0.0 110.168 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.8 108.92 2.28 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.168 0.987 . . . . 0.0 109.035 175.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -87.13 76.76 9.22 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -168.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.6 t -67.27 102.14 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.515 1.126 . . . . 0.0 109.519 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -70.55 -54.83 10.57 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.032 0.933 . . . . 0.0 110.945 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -151.54 150.05 29.9 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 123.652 0.781 . . . . 0.0 110.097 -174.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.0 t -127.6 102.08 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.844 1.258 . . . . 0.0 109.53 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.7 tp -105.37 114.2 28.23 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 123.586 0.754 . . . . 0.0 110.159 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.4 m -99.28 138.11 36.83 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.122 0.569 . . . . 0.0 109.902 170.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -130.04 148.85 71.32 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 125.67 1.588 . . . . 0.0 108.402 172.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.61 109.87 1.52 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.406 2.737 . . . . 0.0 109.936 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -89.5 113.16 24.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.859 1.264 . . . . 0.0 109.164 -174.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -110.88 72.37 0.78 Allowed Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 125.162 1.385 . . . . 0.0 110.454 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.45 135.73 24.89 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.642 2.228 . . . . 0.0 110.119 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.1 p -71.36 137.23 48.24 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.16 -160.16 50.97 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -173.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -137.24 145.63 43.81 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.233 1.013 . . . . 0.0 110.11 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.3 tp -100.33 137.5 38.66 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 171.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.1 m -66.17 -48.43 70.75 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.694 0.797 . . . . 0.0 111.801 -173.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -129.53 160.93 31.68 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.976 0.911 . . . . 0.0 111.866 -166.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -84.85 145.8 27.65 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.427 1.091 . . . . 0.0 109.315 166.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -145.73 173.41 12.12 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.792 0.837 . . . . 0.0 110.893 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.6 pt -140.19 155.27 23.65 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 C-N-CA 123.827 0.851 . . . . 0.0 110.409 -174.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 116.94 -1.505 . . . . 0.0 110.048 157.289 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.3 m -116.9 -39.2 3.29 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.329 1.052 . . . . 0.0 112.024 -171.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -67.96 107.68 2.76 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 121.091 0.472 . . . . 0.0 110.966 -177.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.39 80.47 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.733 1.613 . . . . 0.0 107.097 -173.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -76.72 148.01 37.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.537 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.445 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.2 pp -120.03 164.26 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.6 tt -125.01 118.5 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 124.395 1.078 . . . . 0.0 108.867 170.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -115.27 107.84 15.79 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.784 1.234 . . . . 0.0 110.211 -176.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -86.1 121.56 28.87 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 172.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.6 t -100.44 94.18 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -63.76 152.55 39.04 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.916 0.886 . . . . 0.0 110.958 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.3 -178.64 26.72 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 124.389 0.995 . . . . 0.0 112.261 174.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -85.94 87.55 7.43 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 123.169 0.588 . . . . 0.0 110.647 -173.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.0 t -114.82 -40.04 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.771 1.228 . . . . 0.0 110.178 -174.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -65.56 152.34 44.31 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.629 0.772 . . . . 0.0 111.718 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.67 17.95 76.94 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.996 0.807 . . . . 0.0 113.543 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.69 -42.05 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.783 1.233 . . . . 0.0 109.257 175.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.26 32.08 1.89 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.687 1.613 . . . . 0.0 112.124 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -53.21 -29.1 30.26 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.541 1.537 . . . . 0.0 112.882 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -68.69 41.54 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.096 2.158 . . . . 0.0 113.5 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -85.8 -67.72 0.79 Allowed 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.508 -0.745 . . . . 0.0 110.029 -173.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.3 t -92.56 -9.77 40.0 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.888 0.875 . . . . 0.0 112.61 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.6 t -43.82 -48.54 8.26 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.06 0.944 . . . . 0.0 113.541 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -58.4 -57.16 14.13 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 124.653 1.181 . . . . 0.0 110.141 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -50.74 -55.66 15.65 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.499 1.12 . . . . 0.0 110.672 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.16 -54.2 39.32 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 124.596 1.159 . . . . 0.0 110.164 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.57 -36.83 64.79 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.658 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -68.51 -31.44 70.7 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.464 0.705 . . . . 0.0 112.125 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -60.92 -49.29 78.05 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.715 0.689 . . . . 0.0 110.282 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.3 mt -75.52 -31.03 59.98 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.392 0.277 . . . . 0.0 110.911 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.55 22.54 53.5 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.749 1.166 . . . . 0.0 112.593 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.94 169.26 10.41 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.658 0.783 . . . . 0.0 112.201 -177.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.6 p -112.27 -159.39 0.68 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.725 0.81 . . . . 0.0 109.352 -166.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.7 -154.77 16.68 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 170.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -169.47 160.68 9.33 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.05 78.97 1.39 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.738 1.215 . . . . 0.0 109.679 -174.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -85.01 166.34 16.79 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -126.86 129.82 49.0 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.6 mt -68.08 173.84 4.31 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.904 1.282 . . . . 0.0 110.781 177.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -89.44 13.77 12.93 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.953 0.901 . . . . 0.0 111.378 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -105.94 -51.14 3.03 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 123.894 0.878 . . . . 0.0 110.31 -176.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 161.02 -20.55 0.21 Allowed Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.446 1.022 . . . . 0.0 112.671 -167.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.2 p -105.26 159.14 16.11 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.078 0.951 . . . . 0.0 112.287 -162.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.2 t -116.22 126.49 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.248 1.019 . . . . 0.0 111.261 -169.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -100.33 105.55 17.09 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.644 1.577 . . . . 0.0 110.397 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.6 t -110.45 127.16 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 123.262 0.625 . . . . 0.0 109.818 -172.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.46 141.0 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 118.629 -0.7 . . . . 0.0 109.948 -171.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.52 128.16 4.46 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 118.163 -0.922 . . . . 0.0 112.329 -167.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 98.9 m -97.04 177.65 5.53 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 113.443 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.62 -172.8 16.31 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 125.054 1.311 . . . . 0.0 111.01 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -67.59 124.28 22.81 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -52.62 -40.45 62.76 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.175 1.39 . . . . 0.0 112.24 -168.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -43.96 -50.59 7.43 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.669 1.604 . . . . 0.0 112.379 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -65.07 -52.72 54.03 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 122.958 0.503 . . . . 0.0 110.516 176.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.2 t -46.43 -45.57 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.094 0.958 . . . . 0.0 111.626 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -64.21 -29.05 70.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.496 -0.764 . . . . 0.0 112.799 -175.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -54.63 -44.27 73.03 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 119.324 0.966 . . . . 0.0 111.197 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.2 -29.32 61.68 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.452 0.301 . . . . 0.0 111.169 177.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mtm -68.31 -25.74 65.28 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 118.692 -0.67 . . . . 0.0 112.033 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -48.64 -53.15 19.68 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 166.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -62.81 -40.96 99.01 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 118.534 -0.745 . . . . 0.0 112.17 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 mt -54.81 -53.37 56.15 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.779 1.172 . . . . 0.0 109.922 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -66.7 -19.28 65.72 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.571 0.748 . . . . 0.0 112.915 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -104.25 -11.47 17.19 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.743 1.217 . . . . 0.0 112.36 -178.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.83 -43.08 96.64 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 124.356 0.979 . . . . 0.0 111.324 -172.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -12.09 85.12 0.0 OUTLIER Glycine 0 CA--C 1.533 1.192 0 C-N-CA 128.796 3.093 . . . . 0.0 115.553 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.26 165.8 27.24 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.991 2.46 . . . . 0.0 110.53 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -53.82 -40.66 66.6 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.62 1.168 . . . . 0.0 113.336 -169.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.2 t -72.88 -37.59 67.28 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.355 1.062 . . . . 0.0 111.636 -173.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.8 160.52 29.89 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.221 1.008 . . . . 0.0 111.562 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -128.82 101.4 6.09 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.082 0.953 . . . . 0.0 108.535 172.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.6 t -82.58 93.75 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -68.56 -48.7 63.58 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 119.055 -0.498 . . . . 0.0 111.221 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.2 mtm105 -167.05 163.85 15.85 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.801 0.841 . . . . 0.0 110.799 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -127.06 117.25 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.289 1.036 . . . . 0.0 109.926 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 tt -106.91 111.84 24.53 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.257 1.023 . . . . 0.0 110.022 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.5 m -103.9 137.39 41.96 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.348 0.659 . . . . 0.0 111.175 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -139.64 160.06 62.8 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 126.037 1.735 . . . . 0.0 109.759 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.73 129.54 12.7 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.346 2.697 . . . . 0.0 110.367 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 59.4 t60 -116.88 110.51 18.43 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.287 1.035 . . . . 0.0 109.607 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -108.18 80.53 1.11 Allowed Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 119.079 0.854 . . . . 0.0 111.055 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.15 160.92 46.11 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.99 2.46 . . . . 0.0 110.85 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 88.7 p -84.08 147.59 27.29 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.028 0.931 . . . . 0.0 110.473 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.22 -171.75 18.18 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.85 0.738 . . . . 0.0 112.298 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -105.29 136.11 45.43 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.121 0.968 . . . . 0.0 109.864 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 mp -81.72 147.11 29.64 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.307 1.043 . . . . 0.0 109.251 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 19.2 p -78.69 -66.04 0.91 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.624 1.17 . . . . 0.0 109.874 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -137.92 166.55 23.76 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.259 1.424 . . . . 0.0 110.693 -167.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -84.36 140.68 31.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 167.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -148.38 -172.43 4.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.014 0.526 . . . . 0.0 109.827 -174.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.3 tt -163.29 160.07 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -175.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 . . . . . 0 C--O 1.252 1.205 0 C-N-CA 124.952 1.301 . . . . 0.0 111.118 167.317 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 ptp . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 119.828 -0.13 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 t -121.85 -37.41 2.87 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.667 1.187 . . . . 0.0 111.286 -176.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -67.14 120.48 13.8 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.221 1.008 . . . . 0.0 111.471 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 p -127.64 85.04 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 125.578 1.551 . . . . 0.0 107.813 -173.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.57 148.68 31.65 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.853 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.419 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.3 pp -129.43 162.96 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.6 tt -121.66 125.77 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 124.026 0.931 . . . . 0.0 108.988 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -118.62 103.66 9.91 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.659 1.584 . . . . 0.0 109.832 -173.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.5 m-90 -85.65 117.66 24.68 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.23 0.612 . . . . 0.0 109.815 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.0 t -100.51 108.85 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 123.83 0.852 . . . . 0.0 108.978 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -78.86 164.78 24.2 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.122 0.569 . . . . 0.0 110.876 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.76 -177.88 42.13 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 124.061 0.839 . . . . 0.0 112.122 177.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -84.76 81.42 8.88 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.386 0.612 . . . . 0.0 111.066 -169.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.8 t -108.52 -44.42 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.478 1.511 . . . . 0.0 110.48 -173.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -65.9 153.8 41.02 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.117 0.567 . . . . 0.0 110.964 175.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 67.75 17.52 69.3 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 123.998 0.808 . . . . 0.0 113.722 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.6 t -104.04 -43.27 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.752 1.221 . . . . 0.0 108.828 172.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.63 32.76 2.61 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.904 1.716 . . . . 0.0 111.233 -176.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -53.5 -34.59 58.65 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.801 1.24 . . . . 0.0 112.356 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.3 53.89 0.68 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.438 1.495 . . . . 0.0 112.139 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -94.4 -75.05 0.52 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.497 1.119 . . . . 0.0 109.48 -176.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -79.99 -11.87 59.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.905 0.882 . . . . 0.0 112.016 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.6 t -44.18 -44.43 7.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.97 0.908 . . . . 0.0 112.719 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.4 mm-40 -56.41 -63.68 1.11 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.823 1.649 . . . . 0.0 110.166 172.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -50.85 -56.22 13.23 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.969 1.707 . . . . 0.0 111.75 -174.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -56.04 -54.59 43.14 Favored 'General case' 0 CA--C 1.527 0.064 0 C-N-CA 124.292 1.037 . . . . 0.0 109.852 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.47 -37.61 49.72 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.93 0.892 . . . . 0.0 111.888 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -65.32 -32.16 73.67 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.769 1.228 . . . . 0.0 112.474 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.2 mmm-85 -64.52 -45.14 88.47 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 118.464 0.574 . . . . 0.0 110.037 175.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.5 mt -73.23 -36.02 66.38 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.192 0.597 . . . . 0.0 111.311 -178.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.49 18.61 65.93 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.415 1.007 . . . . 0.0 112.475 -175.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.47 169.45 14.49 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.463 0.705 . . . . 0.0 110.713 177.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.2 p -111.87 -157.61 0.62 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -170.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.6 -155.21 16.34 Favored Glycine 0 C--N 1.339 0.711 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 166.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -166.66 154.78 10.02 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 173.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.12 96.17 5.79 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.237 1.415 . . . . 0.0 110.098 175.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -102.2 174.09 6.08 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.749 0.82 . . . . 0.0 111.321 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -125.28 132.38 52.92 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.109 0.964 . . . . 0.0 109.344 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.0 mt -71.48 171.96 10.39 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.14 1.376 . . . . 0.0 110.758 174.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -95.47 15.68 19.01 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.049 1.34 . . . . 0.0 111.763 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -117.2 -26.35 6.8 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.115 0.966 . . . . 0.0 112.043 -175.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.73 4.13 1.66 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.644 1.116 . . . . 0.0 114.307 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 p -121.11 167.51 12.56 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.002 1.321 . . . . 0.0 112.091 -165.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.7 t -123.9 128.24 74.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.578 1.151 . . . . 0.0 111.222 -170.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -101.89 111.46 23.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.165 1.386 . . . . 0.0 111.56 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.1 t -108.5 132.55 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 123.043 0.537 . . . . 0.0 110.235 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.53 143.62 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.873 0.869 . . . . 0.0 110.174 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.4 129.11 5.49 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 118.174 -0.917 . . . . 0.0 111.905 -172.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 80.8 m -95.6 -179.43 4.74 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.634 1.174 . . . . 0.0 112.441 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.43 -167.4 14.79 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 124.94 1.257 . . . . 0.0 109.978 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.98 139.79 46.92 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 170.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -53.79 -45.09 70.62 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.904 0.882 . . . . 0.0 110.587 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -42.47 -45.52 5.45 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.347 1.927 . . . . 0.0 113.202 174.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -74.21 -46.93 38.71 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.252 1.021 . . . . 0.0 111.592 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -53.34 -41.51 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.461 0.705 . . . . 0.0 110.69 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -65.14 -22.72 66.96 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.331 0.653 . . . . 0.0 112.67 -176.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -61.87 -45.23 94.67 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.366 0.53 . . . . 0.0 111.021 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.3 -28.07 61.01 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.392 0.542 . . . . 0.0 111.038 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -68.59 -26.13 65.22 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.695 -0.669 . . . . 0.0 111.277 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -44.0 -49.36 8.65 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 167.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -69.34 -37.21 77.57 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-O 118.426 -0.797 . . . . 0.0 111.69 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 mt -51.36 -42.42 61.32 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.972 0.806 . . . . 0.0 111.028 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.42 -45.43 62.72 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.1 t -58.07 -29.87 65.75 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.741 0.816 . . . . 0.0 113.101 175.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.28 -3.88 77.75 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.996 1.284 . . . . 0.0 113.022 -177.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.7 -72.64 0.71 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-N 118.188 0.994 . . . . 0.0 112.607 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -77.84 74.77 5.08 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.934 3.09 . . . . 0.0 110.767 -172.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.76 -57.11 0.73 Allowed 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.062 1.345 . . . . 0.0 109.164 -175.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.79 -45.79 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.115 1.366 . . . . 0.0 109.347 -175.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.32 154.52 10.45 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.795 1.238 . . . . 0.0 111.118 173.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.0 ttm-85 -113.08 78.37 1.13 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -177.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.8 t -71.14 102.43 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.71 0.804 . . . . 0.0 109.17 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -73.12 -52.6 13.62 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.609 0.763 . . . . 0.0 111.407 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.2 mmm-85 -168.94 166.44 11.22 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.725 1.21 . . . . 0.0 109.433 -171.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.06 133.84 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 118.838 -0.601 . . . . 0.0 111.41 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.6 tp -124.69 125.68 44.49 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.077 0.951 . . . . 0.0 112.251 -175.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.95 135.1 49.09 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.273 1.029 . . . . 0.0 111.813 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -134.17 155.98 79.5 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 125.909 1.684 . . . . 0.0 110.203 -178.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.74 126.53 11.48 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 124.244 3.296 . . . . 0.0 111.078 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -119.21 107.49 13.5 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.147 0.979 . . . . 0.0 110.371 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -110.55 74.22 0.87 Allowed Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 119.228 0.922 . . . . 0.0 111.464 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -72.97 151.5 50.47 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.179 2.586 . . . . 0.0 111.44 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.4 p -79.19 140.69 37.65 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.123 0.969 . . . . 0.0 110.624 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.8 174.26 16.57 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.028 0.823 . . . . 0.0 111.89 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -92.04 142.66 27.28 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.758 0.823 . . . . 0.0 108.975 171.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -85.98 149.01 25.49 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.1 p -75.54 -75.95 0.16 Allowed 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -134.08 163.0 30.55 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.833 0.853 . . . . 0.0 110.847 -171.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -76.52 148.63 37.0 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.848 0.859 . . . . 0.0 109.829 172.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -150.95 -177.69 6.16 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.121 0.568 . . . . 0.0 109.948 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.9 pt -132.07 152.65 37.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 C-N-CA 123.575 0.75 . . . . 0.0 109.615 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.2 mtm180 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 125.362 1.465 . . . . 0.0 113.526 174.107 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 119.025 -0.512 . . . . 0.0 109.715 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 t -168.91 -53.77 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 117.895 0.316 . . . . 0.0 110.97 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -63.06 134.71 56.52 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.709 1.204 . . . . 0.0 112.132 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.0 p -139.95 92.86 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.294 0 C-N-CA 124.603 1.161 . . . . 0.0 109.027 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.8 m -86.67 156.65 19.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.469 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.5 pp -140.46 158.48 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.073 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 tt -119.01 109.82 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.123 0.969 . . . . 0.0 109.549 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -101.99 119.77 39.33 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.298 1.039 . . . . 0.0 110.157 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.0 m-90 -97.39 112.35 24.22 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.039 0.935 . . . . 0.0 110.493 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.466 HG12 HG21 ' A' ' 14' ' ' VAL . 3.8 t -91.78 123.78 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.93 0.892 . . . . 0.0 109.063 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -94.0 174.89 6.93 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.461 1.504 . . . . 0.0 111.202 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.12 -163.56 54.15 Favored Glycine 0 C--N 1.338 0.683 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -85.93 91.8 8.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.67 0.788 . . . . 0.0 111.514 -173.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.466 HG21 HG12 ' A' ' 10' ' ' VAL . 17.6 t -123.45 -44.31 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.171 0.988 . . . . 0.0 109.771 -175.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -71.27 143.05 50.49 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.29 0.636 . . . . 0.0 110.172 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.26 18.04 79.09 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 119.214 -0.77 . . . . 0.0 113.309 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.0 t -108.78 -43.19 5.92 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 124.331 1.052 . . . . 0.0 109.686 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 116.71 25.56 3.34 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 125.185 1.374 . . . . 0.0 111.639 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -51.24 -35.09 35.33 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.891 0.876 . . . . 0.0 111.105 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.5 mtp180 -74.9 59.86 0.93 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.243 1.417 . . . . 0.0 111.36 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -114.27 -73.51 0.65 Allowed 'General case' 0 C--N 1.339 0.139 0 C-N-CA 125.389 1.475 . . . . 0.0 108.807 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.3 t -73.69 -19.96 60.68 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.229 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.5 t -45.44 -36.96 4.72 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.937 0.895 . . . . 0.0 112.163 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -69.95 -59.21 3.06 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.508 1.123 . . . . 0.0 110.208 176.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -52.33 -53.98 37.49 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.534 1.134 . . . . 0.0 111.348 -175.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.58 -52.12 64.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.643 1.177 . . . . 0.0 110.214 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.87 -31.54 59.81 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.169 0.587 . . . . 0.0 112.408 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -65.02 -34.33 78.18 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.642 1.177 . . . . 0.0 111.597 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -69.92 -48.87 56.85 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.757 0.823 . . . . 0.0 110.34 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.7 mt -71.21 -34.24 70.66 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.917 0.487 . . . . 0.0 110.779 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.09 14.08 81.1 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.319 0.962 . . . . 0.0 112.671 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.55 178.14 5.54 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.533 0.733 . . . . 0.0 111.259 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.3 p -123.79 -174.91 3.09 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 136.61 -149.3 20.11 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 170.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -169.03 165.93 11.17 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 172.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.1 101.58 7.09 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.597 0.759 . . . . 0.0 112.031 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -97.99 175.28 6.18 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.444 1.098 . . . . 0.0 111.243 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -123.77 136.54 54.48 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.837 1.255 . . . . 0.0 109.973 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.419 HD12 ' HB2' ' A' ' 43' ' ' SER . 18.6 mt -74.19 173.91 9.48 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.504 1.522 . . . . 0.0 109.981 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -97.58 13.47 29.96 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.151 0.98 . . . . 0.0 111.719 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -117.92 -11.01 10.32 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 124.044 0.938 . . . . 0.0 112.446 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.38 19.77 4.53 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 125.098 1.333 . . . . 0.0 114.061 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.419 ' HB2' HD12 ' A' ' 39' ' ' LEU . 17.1 m -118.14 166.25 12.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.546 1.538 . . . . 0.0 111.601 -171.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.2 t -129.35 118.25 45.31 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 C-N-CA 124.046 0.938 . . . . 0.0 110.575 -175.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -94.88 126.47 40.23 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.58 0.752 . . . . 0.0 110.554 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.8 t -120.38 133.95 65.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.687 0.795 . . . . 0.0 109.457 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.5 t -126.28 142.54 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 C-N-CA 124.425 1.09 . . . . 0.0 109.512 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.93 134.62 10.83 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-O 118.752 -0.642 . . . . 0.0 111.117 -173.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 51.8 m -99.77 178.44 4.83 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.211 1.404 . . . . 0.0 112.611 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.46 -153.19 20.15 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -83.77 126.63 33.12 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.832 1.253 . . . . 0.0 109.561 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -46.38 -51.48 14.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.723 1.209 . . . . 0.0 111.537 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -51.9 -44.88 56.12 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.223 1.392 . . . . 0.0 112.97 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -69.09 -44.22 72.92 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 117.33 0.565 . . . . 0.0 111.752 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.4 t -54.39 -32.66 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 122.749 0.419 . . . . 0.0 110.728 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.97 -29.97 69.98 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -57.66 -24.03 54.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.009 0.923 . . . . 0.0 112.608 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.68 -29.51 12.62 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-N 118.784 0.72 . . . . 0.0 111.483 171.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.3 mmm -65.79 -20.36 66.23 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.838 -0.601 . . . . 0.0 111.949 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -45.12 -58.18 3.39 Favored 'General case' 0 C--O 1.214 -0.791 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 172.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -62.76 -36.9 84.55 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.125 0.57 . . . . 0.0 111.833 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -58.16 -52.75 64.25 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 123.707 0.803 . . . . 0.0 110.375 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.13 -30.48 62.32 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.046 0.539 . . . . 0.0 112.234 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.7 m -75.8 -23.18 55.82 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.332 0.653 . . . . 0.0 111.946 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.79 8.85 78.27 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.38 -1.234 . . . . 0.0 113.18 -176.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.86 -103.63 0.06 OUTLIER Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.905 1.717 . . . . 0.0 112.725 -176.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.3 -174.76 1.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.838 3.025 . . . . 0.0 111.761 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -78.68 -32.89 47.26 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.688 0.795 . . . . 0.0 110.995 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.0 p -57.42 161.83 3.2 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.167 0.987 . . . . 0.0 111.155 175.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 69.79 159.46 0.19 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.32 1.448 . . . . 0.0 110.684 -171.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.82 107.94 10.3 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.5 t -88.38 80.54 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -55.31 -49.97 70.78 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 122.979 0.512 . . . . 0.0 111.21 176.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -171.26 171.13 5.75 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.67 1.188 . . . . 0.0 109.595 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.9 p -156.28 134.26 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.009 0.523 . . . . 0.0 110.212 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tp -113.91 149.63 34.9 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.989 0.916 . . . . 0.0 110.886 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.12 131.32 44.05 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.427 1.091 . . . . 0.0 111.344 -176.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -141.53 156.31 66.73 Favored Pre-proline 0 N--CA 1.468 0.431 0 C-N-CA 124.01 0.924 . . . . 0.0 111.622 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -68.63 125.28 12.53 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 124.213 3.275 . . . . 0.0 110.836 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -118.99 117.36 28.58 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.89 0.876 . . . . 0.0 109.878 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -109.34 77.67 0.97 Allowed Pre-proline 0 CA--C 1.539 0.53 0 O-C-N 121.498 -0.751 . . . . 0.0 110.344 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.63 126.58 12.23 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.656 2.904 . . . . 0.0 109.755 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.0 p -70.31 148.67 48.23 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.338 0.655 . . . . 0.0 110.688 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.25 176.7 8.84 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.973 0.796 . . . . 0.0 112.164 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -105.27 131.78 52.3 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.71 1.204 . . . . 0.0 108.872 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.2 tp -83.19 151.76 25.53 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.572 0.749 . . . . 0.0 109.55 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.5 m -74.74 -73.43 0.24 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -138.04 162.99 32.72 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.466 1.106 . . . . 0.0 110.369 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -71.83 147.21 47.4 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.673 0.789 . . . . 0.0 110.519 175.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -143.97 -177.35 5.39 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.64 1.176 . . . . 0.0 110.159 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.3 pt -146.12 78.33 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 123.628 0.771 . . . . 0.0 109.102 -177.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 35.7 mtp180 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 117.045 -1.455 . . . . 0.0 111.665 -179.647 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ptt? . . . . . 0 N--CA 1.474 0.758 0 CA-C-O 119.857 -0.116 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 t -138.17 -41.07 0.52 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.922 0.889 . . . . 0.0 110.605 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.67 152.85 44.59 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.285 1.034 . . . . 0.0 112.821 -177.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 p -138.49 88.43 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.262 1.025 . . . . 0.0 108.405 -174.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.5 m -79.55 150.49 31.1 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.584 HD11 HG11 ' A' ' 55' ' ' VAL . 1.4 pp -136.68 157.17 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.9 tt -116.35 116.35 52.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.431 1.093 . . . . 0.0 109.609 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -111.41 103.21 11.55 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.674 1.59 . . . . 0.0 109.917 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.1 m-90 -83.68 115.59 22.25 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 123.783 0.833 . . . . 0.0 109.868 176.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.466 HG13 HG22 ' A' ' 75' ' ' VAL . 4.3 t -97.92 113.24 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -87.82 172.63 9.49 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 124.487 1.115 . . . . 0.0 111.175 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.03 -169.55 55.01 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 123.632 0.634 . . . . 0.0 111.821 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -83.39 85.33 7.25 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.02 0.528 . . . . 0.0 112.124 -167.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.4 t -117.7 -43.08 2.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.845 -173.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -68.23 148.34 50.96 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.683 0.674 . . . . 0.0 110.389 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.74 -31.01 8.32 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 118.918 -0.934 . . . . 0.0 113.426 174.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 m -74.34 -0.58 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 119.018 1.409 . . . . 0.0 112.448 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.01 36.83 73.22 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.199 0.904 . . . . 0.0 110.859 -170.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -51.25 -38.84 54.86 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 123.908 0.883 . . . . 0.0 111.157 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.16 55.97 0.6 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.511 1.524 . . . . 0.0 113.095 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -110.99 -72.42 0.72 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.402 1.081 . . . . 0.0 109.465 -177.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 t -73.77 -16.93 61.15 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.213 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.2 t -40.68 -42.09 1.66 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.141 1.376 . . . . 0.0 113.021 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -64.3 -61.46 2.22 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.632 1.173 . . . . 0.0 110.411 173.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -48.97 -54.38 15.83 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.604 1.562 . . . . 0.0 111.734 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -55.69 -45.82 77.75 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.355 1.462 . . . . 0.0 112.038 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.09 -30.38 71.32 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.092 0.557 . . . . 0.0 111.999 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.8 tttt -65.3 -35.44 81.01 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.831 0.853 . . . . 0.0 111.328 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -67.51 -49.46 63.31 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.294 0.638 . . . . 0.0 110.536 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.9 mt -73.55 -34.37 65.15 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.825 0.45 . . . . 0.0 110.74 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.08 13.24 72.05 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.208 0.909 . . . . 0.0 112.866 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.21 176.28 8.9 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.775 0.83 . . . . 0.0 111.506 178.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.7 p -115.61 -160.89 0.76 Allowed 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -172.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.2 -155.25 16.27 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 118.637 0.653 . . . . 0.0 112.751 169.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -168.99 159.37 9.27 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 174.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.22 91.38 3.44 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.579 1.152 . . . . 0.0 111.5 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -93.17 174.83 7.02 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.337 0.655 . . . . 0.0 110.357 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -123.19 133.99 54.19 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 124.191 0.996 . . . . 0.0 110.539 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 30.0 mt -74.67 169.32 18.05 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.77 1.628 . . . . 0.0 110.267 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -90.0 4.5 49.96 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.391 1.076 . . . . 0.0 112.113 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -107.83 -7.57 16.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.469 1.108 . . . . 0.0 112.093 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.56 12.69 11.33 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.085 1.326 . . . . 0.0 113.963 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.36 168.06 10.31 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.637 1.575 . . . . 0.0 112.003 -170.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.9 t -129.07 118.13 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.49 1.116 . . . . 0.0 110.894 -173.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -94.97 121.71 36.87 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.407 1.003 . . . . 0.0 111.234 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.5 t -119.05 134.07 63.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 117.966 0.348 . . . . 0.0 110.532 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.43 142.55 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.412 1.085 . . . . 0.0 109.704 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.08 133.24 7.69 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 118.637 -0.697 . . . . 0.0 111.569 -171.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 96.9 m -100.18 176.44 5.39 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.808 1.243 . . . . 0.0 112.785 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.18 -159.01 20.03 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.825 1.202 . . . . 0.0 110.317 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -73.36 134.24 44.03 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.21 0.604 . . . . 0.0 110.17 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -49.01 -49.46 40.87 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.447 1.099 . . . . 0.0 111.184 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -49.91 -53.3 22.86 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.097 1.332 . . . . 0.0 112.171 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -62.22 -43.61 98.44 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.469 0.708 . . . . 0.0 111.487 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.584 HG11 HD11 ' A' ' 6' ' ' ILE . 80.7 t -58.02 -40.0 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 122.611 0.364 . . . . 0.0 110.396 175.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.46 -26.4 68.71 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -176.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -55.47 -44.72 76.71 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.609 0.764 . . . . 0.0 110.897 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.26 -30.44 48.58 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 118.177 0.444 . . . . 0.0 111.632 175.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.3 mmt -68.38 -22.72 64.63 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 119.074 -0.489 . . . . 0.0 112.096 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -43.34 -51.13 6.54 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 167.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 18.7 t90 -64.25 -40.95 97.06 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.344 0.52 . . . . 0.0 111.989 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mt -56.03 -55.07 37.28 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 123.661 0.785 . . . . 0.0 111.043 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.26 -36.77 77.47 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.769 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.7 t -61.97 -33.24 73.94 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.454 0.57 . . . . 0.0 111.718 175.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.07 16.29 76.72 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 118.932 -0.927 . . . . 0.0 112.886 -176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.99 -105.69 0.12 Allowed Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.893 1.711 . . . . 0.0 112.471 -174.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.4 -177.39 2.06 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 124.142 3.228 . . . . 0.0 112.388 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -65.62 -29.06 69.6 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.453 0.701 . . . . 0.0 111.841 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.6 p -63.75 153.41 36.49 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.402 0.681 . . . . 0.0 110.353 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 77.67 148.5 0.1 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 127.02 2.128 . . . . 0.0 111.042 -168.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -128.74 79.47 1.91 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.7 t -67.54 94.32 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 124.901 1.28 . . . . 0.0 108.039 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -62.43 -56.84 14.32 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.856 0.862 . . . . 0.0 109.988 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -166.96 158.14 12.22 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.18 0.992 . . . . 0.0 109.424 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.466 HG22 HG13 ' A' ' 10' ' ' VAL . 21.8 t -132.3 135.78 57.44 Favored 'Isoleucine or valine' 0 C--N 1.342 0.24 0 C-N-CA 123.771 0.828 . . . . 0.0 110.031 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.9 tp -117.37 108.44 15.58 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.812 0.845 . . . . 0.0 110.789 -177.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.15 127.15 46.45 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.632 1.173 . . . . 0.0 111.52 -177.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -131.0 156.51 80.04 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 126.125 1.77 . . . . 0.0 110.673 -175.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -71.24 120.14 6.78 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.232 3.288 . . . . 0.0 111.495 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -109.44 109.04 19.77 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.485 0.714 . . . . 0.0 109.616 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -109.89 74.21 0.74 Allowed Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 123.945 0.898 . . . . 0.0 110.315 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.73 146.9 30.62 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.072 2.515 . . . . 0.0 110.511 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.7 p -72.72 141.17 48.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.424 0.69 . . . . 0.0 110.485 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.7 -178.63 35.53 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 123.871 0.748 . . . . 0.0 112.132 -177.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -104.12 130.84 51.86 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.333 1.053 . . . . 0.0 108.688 172.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mp -69.54 151.84 45.52 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.836 1.254 . . . . 0.0 109.713 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.59 -77.82 0.17 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.105 0.962 . . . . 0.0 109.008 178.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -137.37 167.0 22.48 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.343 1.057 . . . . 0.0 110.536 -173.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -73.74 143.22 46.18 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.598 173.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -130.93 174.63 9.79 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.414 0.686 . . . . 0.0 110.201 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.5 tp -147.93 152.7 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 122.76 0.424 . . . . 0.0 110.727 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.7 ptt85 . . . . . 0 C--O 1.252 1.185 0 CA-C-O 116.534 -1.698 . . . . 0.0 112.415 174.015 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mtp . . . . . 0 N--CA 1.474 0.76 0 CA-C-O 119.606 -0.235 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.25 -49.89 0.15 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.13 0.572 . . . . 0.0 111.038 -178.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -61.19 135.73 57.84 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.745 1.618 . . . . 0.0 112.104 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.6 p -140.85 91.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 124.604 1.162 . . . . 0.0 108.368 -174.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.0 m -80.86 155.88 26.36 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.579 177.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.411 HD11 HG11 ' A' ' 55' ' ' VAL . 1.3 pp -143.58 158.2 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.4 tt -118.49 119.73 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 124.103 0.961 . . . . 0.0 109.329 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -109.2 106.43 16.29 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.996 1.318 . . . . 0.0 109.99 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -90.13 124.3 34.7 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.903 0.881 . . . . 0.0 110.251 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.464 HG12 HG21 ' A' ' 14' ' ' VAL . 10.4 t -101.51 104.3 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.11 0.964 . . . . 0.0 108.605 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -68.45 176.87 2.63 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 123.801 0.84 . . . . 0.0 111.69 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.72 -169.51 47.92 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -92.24 91.32 7.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.032 0.533 . . . . 0.0 110.853 -175.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.464 HG21 HG12 ' A' ' 10' ' ' VAL . 57.3 t -111.86 -31.75 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 124.106 0.962 . . . . 0.0 111.233 -178.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -69.13 150.16 47.86 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.586 0.355 . . . . 0.0 110.557 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.46 17.55 66.16 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 123.918 0.77 . . . . 0.0 113.397 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.578 HG21 ' HB2' ' A' ' 70' ' ' ALA . 71.0 t -114.94 -45.56 4.35 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 C-N-CA 124.761 1.224 . . . . 0.0 109.367 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.32 31.93 1.59 Allowed Glycine 0 C--N 1.339 0.698 0 C-N-CA 125.197 1.38 . . . . 0.0 111.434 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -50.79 -36.12 35.44 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 117.664 0.732 . . . . 0.0 110.874 177.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -74.3 56.56 0.65 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.502 1.121 . . . . 0.0 112.741 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -97.42 -71.02 0.7 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.965 0.906 . . . . 0.0 109.264 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 t -89.35 -2.99 58.64 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.71 0.804 . . . . 0.0 111.69 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.8 t -45.98 -37.78 6.93 Favored 'General case' 0 C--N 1.345 0.397 0 C-N-CA 123.84 0.856 . . . . 0.0 112.099 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -69.84 -59.51 2.89 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 124.31 1.044 . . . . 0.0 109.949 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -49.48 -55.11 14.4 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.704 1.202 . . . . 0.0 111.29 -176.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -55.78 -57.5 11.76 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.021 0.928 . . . . 0.0 109.822 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.22 -34.29 31.54 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.926 0.891 . . . . 0.0 112.121 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -62.68 -38.89 92.14 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.438 1.095 . . . . 0.0 111.71 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -68.6 -38.4 80.6 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.017 0.927 . . . . 0.0 110.527 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.87 -32.34 57.43 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.676 0.791 . . . . 0.0 111.118 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.94 15.57 80.42 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.686 0.66 . . . . 0.0 112.82 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.447 HD12 ' HB1' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -83.18 179.76 7.63 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.965 0.906 . . . . 0.0 111.217 178.269 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 46.0 p -120.29 -162.43 0.94 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -176.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.1 -151.93 17.45 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 172.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -172.57 170.39 4.85 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.844 0.458 . . . . 0.0 112.085 175.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.56 88.19 2.7 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.43 0.692 . . . . 0.0 111.697 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -88.91 173.03 8.73 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.89 0.876 . . . . 0.0 110.18 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -124.01 138.56 54.44 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.699 1.2 . . . . 0.0 108.684 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.9 mt -74.58 178.63 5.21 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.09 1.356 . . . . 0.0 110.173 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -100.94 12.3 37.92 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.806 0.842 . . . . 0.0 111.327 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -117.08 -14.67 10.56 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.401 1.08 . . . . 0.0 112.497 -176.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.13 2.6 7.69 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.171 1.367 . . . . 0.0 114.12 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.1 m -104.34 167.19 9.91 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.855 1.262 . . . . 0.0 111.679 -171.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.9 t -125.4 127.66 72.02 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 C-N-CA 124.302 1.041 . . . . 0.0 109.979 -176.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -102.33 122.73 44.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.659 1.184 . . . . 0.0 110.96 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.76 135.67 57.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -131.2 145.07 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.941 0.897 . . . . 0.0 109.578 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.447 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -158.52 138.96 12.56 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.991 -173.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.3 m -108.98 -178.6 3.62 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.053 1.341 . . . . 0.0 112.298 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.46 -161.29 26.16 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.95 121.46 23.49 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.196 0.998 . . . . 0.0 110.944 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -49.69 -45.32 48.75 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.765 1.226 . . . . 0.0 110.941 -175.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -44.47 -43.74 7.82 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 126.424 1.964 . . . . 0.0 113.423 175.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -78.4 -49.03 14.27 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.689 0.795 . . . . 0.0 110.09 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.411 HG11 HD11 ' A' ' 6' ' ' ILE . 49.4 t -52.87 -32.71 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 122.727 0.411 . . . . 0.0 111.851 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -63.25 -32.0 73.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.255 1.422 . . . . 0.0 112.149 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? -61.89 -52.87 62.35 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-O 118.625 -0.703 . . . . 0.0 110.012 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.81 -29.78 68.47 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.215 0.916 . . . . 0.0 111.091 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.537 ' HA ' HD12 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -65.87 -22.67 66.54 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.412 -0.804 . . . . 0.0 111.518 177.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -48.14 -46.63 34.59 Favored 'General case' 0 C--N 1.343 0.326 0 CA-C-N 118.632 0.651 . . . . 0.0 109.951 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -70.46 -35.94 73.62 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.113 -177.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 59' ' ' MET . 5.2 mt -57.96 -44.75 87.22 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.634 0.652 . . . . 0.0 109.957 177.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -86.67 0.44 54.57 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.0 t -115.71 -15.2 11.37 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.251 1.421 . . . . 0.0 111.367 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -56.76 -55.98 27.19 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 54.45 67.16 2.32 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.548 ' CG ' ' HB3' ' A' ' 70' ' ' ALA . 72.9 Cg_endo -69.07 136.36 34.61 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 124.686 3.59 . . . . 0.0 110.976 -174.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -80.26 -37.18 33.41 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.879 0.871 . . . . 0.0 111.717 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.39 -35.74 34.84 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.99 0.916 . . . . 0.0 110.918 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.578 ' HB2' HG21 ' A' ' 17' ' ' VAL . . . -80.89 167.62 19.67 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.844 1.258 . . . . 0.0 110.144 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.1 ttt85 -124.88 83.43 2.16 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.309 1.044 . . . . 0.0 108.57 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.3 t -70.15 90.84 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -62.92 -58.03 8.76 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.208 0.603 . . . . 0.0 110.782 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.0 tpp180 -168.38 174.07 7.23 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.931 0.892 . . . . 0.0 109.592 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.0 t -140.68 127.61 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.751 0.821 . . . . 0.0 109.982 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.13 156.08 19.18 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.695 1.198 . . . . 0.0 111.086 176.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.12 134.11 34.23 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.5 1.12 . . . . 0.0 111.556 -177.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -141.26 155.37 67.96 Favored Pre-proline 0 N--CA 1.471 0.586 0 C-N-CA 123.897 0.879 . . . . 0.0 111.503 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.9 122.24 9.13 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 124.704 3.603 . . . . 0.0 111.047 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -114.69 135.71 53.86 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.113 0.965 . . . . 0.0 110.512 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -139.66 71.42 37.13 Favored Pre-proline 0 CA--C 1.534 0.356 0 O-C-N 121.659 -0.651 . . . . 0.0 110.481 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -68.28 136.33 36.89 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.394 2.73 . . . . 0.0 110.138 -174.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.5 p -64.63 144.13 57.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.453 0.701 . . . . 0.0 110.825 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.87 170.75 5.46 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.225 0.917 . . . . 0.0 112.041 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -86.59 137.15 32.73 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mp -77.9 150.23 34.13 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.458 0.703 . . . . 0.0 109.543 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.8 -79.26 0.14 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -145.67 163.8 33.75 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.376 0.671 . . . . 0.0 110.948 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -74.22 143.99 44.91 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.258 0.623 . . . . 0.0 110.652 177.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -158.4 -179.98 8.6 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.197 0.599 . . . . 0.0 110.429 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.15 144.56 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.511 0.724 . . . . 0.0 109.296 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.103 0 CA-C-O 116.878 -1.535 . . . . 0.0 114.015 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ptm . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 119.846 -0.121 . . . . 0.0 111.321 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 m -136.42 -47.03 0.62 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.185 0.994 . . . . 0.0 110.691 -176.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.6 134.36 54.19 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.176 1.39 . . . . 0.0 112.064 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 p -139.32 90.84 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.242 0 C-N-CA 124.645 1.178 . . . . 0.0 108.63 -174.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.3 m -81.36 153.2 27.12 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.772 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pp -141.16 158.2 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.123 0.569 . . . . 0.0 109.875 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 tt -117.7 118.24 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.171 0.989 . . . . 0.0 109.724 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -107.32 108.15 19.4 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.852 1.661 . . . . 0.0 109.897 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -90.4 128.35 36.46 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 125.243 1.417 . . . . 0.0 110.296 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.463 HG12 HG21 ' A' ' 14' ' ' VAL . 10.4 t -114.45 122.44 68.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.329 1.052 . . . . 0.0 109.07 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -96.66 178.76 5.22 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.829 1.252 . . . . 0.0 110.858 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.72 -160.21 53.44 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.3 mtt-85 -85.17 92.09 8.31 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -171.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.463 HG21 HG12 ' A' ' 10' ' ' VAL . 20.9 t -131.52 -45.84 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.523 0.729 . . . . 0.0 110.487 -175.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -70.46 146.91 49.98 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 122.857 0.463 . . . . 0.0 110.539 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.23 14.72 82.27 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 119.152 -0.805 . . . . 0.0 113.373 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 75.2 t -107.79 -44.11 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.618 1.167 . . . . 0.0 109.424 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.49 28.76 2.25 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 125.194 1.378 . . . . 0.0 111.431 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -50.78 -37.61 43.3 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 123.85 0.86 . . . . 0.0 111.11 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.21 59.49 0.76 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.388 1.075 . . . . 0.0 112.621 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -111.76 -72.84 0.7 Allowed 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.108 1.363 . . . . 0.0 109.55 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.1 t -73.13 -18.13 61.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.86 -0.59 . . . . 0.0 111.45 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.2 t -45.29 -36.92 4.35 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.844 0.858 . . . . 0.0 112.009 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -71.13 -57.79 4.18 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.351 1.06 . . . . 0.0 110.317 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.15 -59.87 3.87 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.158 0.983 . . . . 0.0 110.649 -175.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -55.18 -46.17 75.8 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.368 1.067 . . . . 0.0 110.428 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.59 -36.17 71.38 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.0 tttt -62.25 -30.91 71.44 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.09 0.556 . . . . 0.0 111.572 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.2 mmm-85 -66.85 -49.54 65.39 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 122.964 0.505 . . . . 0.0 110.652 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.417 HD12 HD23 ' A' ' 58' ' ' LEU . 40.6 mt -77.16 -42.44 37.73 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 122.403 0.281 . . . . 0.0 110.855 -177.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.9 9.36 58.51 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.551 1.072 . . . . 0.0 112.953 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.01 168.1 3.44 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 117.86 0.83 . . . . 0.0 112.015 175.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.5 p -127.3 151.03 49.29 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -176.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 161.9 -148.36 15.67 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -170.45 167.83 8.05 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 122.99 0.516 . . . . 0.0 111.777 173.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.41 99.68 5.5 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 118.679 -0.676 . . . . 0.0 111.345 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -100.93 176.83 5.14 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 124.68 1.192 . . . . 0.0 111.547 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 -127.11 137.98 53.1 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.074 1.35 . . . . 0.0 109.473 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.1 mt -75.01 174.24 9.61 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 125.075 1.35 . . . . 0.0 110.552 174.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -96.69 10.33 39.01 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.708 1.203 . . . . 0.0 111.529 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.68 -2.55 12.43 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.528 1.131 . . . . 0.0 112.018 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.94 25.77 6.65 Favored Glycine 0 C--N 1.342 0.871 0 C-N-CA 124.638 1.113 . . . . 0.0 113.776 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.16 162.22 19.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.006 1.322 . . . . 0.0 111.531 -175.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.0 t -122.05 120.85 62.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.409 1.484 . . . . 0.0 110.864 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -99.11 122.37 42.25 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.906 1.282 . . . . 0.0 111.06 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.56 136.87 55.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 C-N-CA 123.554 0.741 . . . . 0.0 109.511 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 t -127.36 143.33 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 124.237 1.015 . . . . 0.0 109.425 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.43 136.71 13.96 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-O 118.819 -0.61 . . . . 0.0 110.925 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 56.4 m -104.39 -179.53 3.97 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.698 1.599 . . . . 0.0 112.652 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.52 -154.57 22.25 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -80.09 129.07 34.22 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 123.222 0.609 . . . . 0.0 110.231 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -48.73 -52.43 23.68 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.908 1.283 . . . . 0.0 111.013 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.04 -45.88 62.03 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.343 1.449 . . . . 0.0 112.693 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -66.7 -46.86 74.22 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 117.479 0.639 . . . . 0.0 111.224 177.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.3 t -54.91 -30.9 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.135 0.574 . . . . 0.0 110.955 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -59.33 -31.39 69.13 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -55.05 -36.78 65.92 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.901 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.417 HD23 HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -84.91 -31.62 23.58 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.138 0.881 . . . . 0.0 111.03 174.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.5 mmm -65.59 -19.78 66.06 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.14 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -46.31 -51.38 14.78 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -70.83 -34.04 71.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 mt -56.15 -54.21 47.85 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 123.324 0.65 . . . . 0.0 109.983 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.57 -31.21 71.98 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.948 0.499 . . . . 0.0 112.275 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.8 m -66.63 -15.03 63.17 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.696 0.68 . . . . 0.0 112.658 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.27 19.89 77.76 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 118.512 -1.16 . . . . 0.0 111.974 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.4 -103.05 0.04 OUTLIER Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.559 1.552 . . . . 0.0 112.678 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -72.28 -176.3 2.13 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.032 3.154 . . . . 0.0 111.927 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -91.33 -38.34 12.69 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.877 0.871 . . . . 0.0 110.755 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.86 -32.91 61.22 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.611 1.164 . . . . 0.0 112.056 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.18 126.75 28.42 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.621 0.768 . . . . 0.0 109.974 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -115.29 78.45 1.17 Allowed 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.6 t -71.19 92.38 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -55.75 -56.61 18.4 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 123.848 0.859 . . . . 0.0 110.775 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.8 mtm-85 -157.08 161.9 39.46 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.953 1.301 . . . . 0.0 110.001 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.06 131.03 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.353 1.061 . . . . 0.0 109.534 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 tp -113.87 148.4 36.77 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.905 1.282 . . . . 0.0 110.819 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.42 135.57 38.82 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.402 -177.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -142.64 156.69 63.01 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 123.523 0.729 . . . . 0.0 111.68 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.13 122.98 10.09 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.644 3.563 . . . . 0.0 110.737 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -110.96 113.06 25.33 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.723 0.809 . . . . 0.0 109.571 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -117.43 70.08 6.12 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 118.709 0.686 . . . . 0.0 111.171 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.91 146.34 47.33 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.249 2.633 . . . . 0.0 110.79 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.5 p -72.5 142.97 48.54 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.615 0.766 . . . . 0.0 110.726 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.79 169.65 4.78 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.362 0.982 . . . . 0.0 112.128 -176.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -95.51 135.48 37.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.5 tp -79.77 150.48 30.76 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -75.81 0.14 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.223 1.009 . . . . 0.0 108.58 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -140.97 163.64 32.43 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.341 1.056 . . . . 0.0 110.129 -173.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -69.94 146.77 50.93 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.286 0.634 . . . . 0.0 110.829 175.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -143.25 -169.81 3.13 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.672 0.789 . . . . 0.0 110.909 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.0 pt -130.65 -170.9 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 124.181 0.993 . . . . 0.0 109.109 176.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.2 mtm-85 . . . . . 0 C--O 1.251 1.165 0 C-N-CA 125.069 1.348 . . . . 0.0 112.585 178.35 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.691 0 CA-C-O 119.402 -0.333 . . . . 0.0 110.666 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 t -140.89 -52.54 0.47 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.896 0.878 . . . . 0.0 111.198 -175.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -66.48 129.48 39.97 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.449 1.5 . . . . 0.0 112.137 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 p -135.15 89.33 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.281 0 C-N-CA 125.179 1.392 . . . . 0.0 108.435 -174.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.2 m -79.96 153.94 28.58 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.558 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.422 HD11 HG11 ' A' ' 55' ' ' VAL . 1.3 pp -139.51 159.28 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.0 tt -122.83 121.08 62.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.451 1.101 . . . . 0.0 110.204 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -116.09 115.74 26.62 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.747 1.619 . . . . 0.0 111.615 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.1 m-90 -93.82 120.45 34.1 Favored 'General case' 0 C--N 1.337 0.063 0 C-N-CA 125.724 1.61 . . . . 0.0 110.906 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.1 t -109.33 123.54 65.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 124.537 1.135 . . . . 0.0 108.937 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -101.32 178.58 4.61 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 124.277 1.031 . . . . 0.0 110.846 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.59 -160.11 48.79 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -85.09 96.08 9.32 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -171.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.4 t -128.56 -46.79 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 124.036 0.835 . . . . 0.0 109.853 -176.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -67.92 145.64 54.37 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 123.558 0.743 . . . . 0.0 111.269 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.26 25.58 72.74 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 123.914 0.769 . . . . 0.0 112.98 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.7 t -119.37 -48.24 3.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 C-N-CA 124.865 1.266 . . . . 0.0 109.397 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.55 30.71 2.14 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.36 1.457 . . . . 0.0 111.392 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -55.14 -40.35 70.46 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 117.52 0.66 . . . . 0.0 109.913 173.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -89.57 23.68 2.54 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.756 1.222 . . . . 0.0 112.364 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -90.11 -57.61 2.79 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.794 0.838 . . . . 0.0 109.036 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 t -73.84 -13.82 60.99 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.003 0.921 . . . . 0.0 113.31 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.7 t -65.76 -26.77 67.87 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 118.399 0.545 . . . . 0.0 111.393 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -57.48 -53.96 52.22 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.099 0.96 . . . . 0.0 109.912 175.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.67 -49.64 72.39 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.129 0.972 . . . . 0.0 111.941 -175.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.59 -53.11 60.68 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.151 0.58 . . . . 0.0 110.835 174.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.23 -33.77 29.39 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.921 0.888 . . . . 0.0 112.647 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -63.88 -35.8 81.84 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.007 0.923 . . . . 0.0 111.72 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 -69.45 -43.73 72.71 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.694 0.797 . . . . 0.0 110.309 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.3 mt -74.7 -39.42 61.95 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.754 0.821 . . . . 0.0 111.144 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.02 16.21 72.89 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.29 0.947 . . . . 0.0 112.871 -177.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.13 172.85 10.31 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 117.575 0.688 . . . . 0.0 110.915 175.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.1 p -118.73 -162.76 0.92 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -174.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 124.18 -154.14 17.71 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 169.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -168.17 161.82 12.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.095 -0.553 . . . . 0.0 112.125 170.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.09 97.31 5.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.599 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.21 175.23 6.69 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.922 0.889 . . . . 0.0 110.603 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -123.73 138.01 54.59 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.208 1.003 . . . . 0.0 109.478 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.6 mt -76.5 172.57 12.75 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.081 1.352 . . . . 0.0 110.247 173.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -90.76 4.0 52.79 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.639 1.175 . . . . 0.0 112.184 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -108.88 -10.66 15.08 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.584 1.154 . . . . 0.0 112.397 -175.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.53 -4.44 12.04 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.274 1.416 . . . . 0.0 113.668 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.07 163.86 13.31 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.919 1.288 . . . . 0.0 111.96 -171.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.6 t -127.88 118.34 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.604 1.562 . . . . 0.0 110.723 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -100.66 119.83 39.16 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.919 0.888 . . . . 0.0 111.132 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.4 t -112.09 138.84 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.563 1.545 . . . . 0.0 109.316 -173.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 t -134.42 145.2 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.008 0.923 . . . . 0.0 109.895 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.58 137.9 12.76 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-O 118.513 -0.756 . . . . 0.0 111.604 -175.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 58.4 m -107.3 177.54 4.81 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.134 1.373 . . . . 0.0 112.442 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.31 -167.68 19.37 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -73.25 140.87 47.16 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.0 0.52 . . . . 0.0 109.741 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -53.3 -47.37 69.28 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.21 0.604 . . . . 0.0 109.799 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -46.02 -34.38 5.78 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 126.451 1.977 . . . . 0.0 114.63 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -84.61 -46.48 11.49 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.804 1.242 . . . . 0.0 111.135 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.422 HG11 HD11 ' A' ' 6' ' ' ILE . 40.5 t -59.02 -40.76 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 122.254 0.221 . . . . 0.0 110.667 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -61.51 -25.58 67.36 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.9 0.88 . . . . 0.0 111.91 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -57.41 -49.83 74.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.57 0.748 . . . . 0.0 110.998 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -73.98 -32.69 63.53 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 118.324 0.511 . . . . 0.0 110.615 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mmm -66.6 -23.03 66.13 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 118.742 -0.646 . . . . 0.0 111.341 -177.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -45.7 -49.66 14.38 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.877 0.762 . . . . 0.0 109.548 168.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -59.41 -43.98 92.93 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.461 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.77 -47.36 59.65 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 119.49 1.041 . . . . 0.0 111.533 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.83 -0.0 46.01 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.0 m -102.66 -38.04 7.66 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 124.053 0.941 . . . . 0.0 111.103 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.73 13.43 47.94 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 118.874 -0.959 . . . . 0.0 112.972 -177.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.63 -65.19 1.8 Allowed Glycine 0 CA--C 1.53 1.005 0 CA-C-N 118.647 1.223 . . . . 0.0 112.573 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.43 -13.67 25.21 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.913 2.409 . . . . 0.0 112.788 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 48.3 mtm180 -91.5 -54.58 3.84 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 123.744 0.818 . . . . 0.0 110.783 -176.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.7 148.09 38.74 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.269 1.427 . . . . 0.0 108.808 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 63.82 -168.82 0.2 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 122.915 0.486 . . . . 0.0 110.898 174.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -132.21 81.86 1.98 Allowed 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.247 0.93 . . . . 0.0 109.328 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.2 t -76.63 94.82 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 123.48 0.712 . . . . 0.0 109.153 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -64.42 -57.25 9.81 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.61 1.164 . . . . 0.0 110.979 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -154.07 153.31 31.66 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.789 0.836 . . . . 0.0 110.301 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.73 135.37 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 123.687 0.795 . . . . 0.0 111.097 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.5 tp -127.69 147.0 50.38 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.244 1.018 . . . . 0.0 112.506 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.32 141.24 50.6 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.416 1.087 . . . . 0.0 112.303 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -142.68 158.21 60.37 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 124.852 1.261 . . . . 0.0 111.922 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.51 129.47 16.86 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 124.28 3.32 . . . . 0.0 111.716 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -121.16 129.67 53.36 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.302 1.041 . . . . 0.0 110.684 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -131.81 71.77 80.33 Favored Pre-proline 0 CA--C 1.537 0.463 0 O-C-N 121.372 -0.83 . . . . 0.0 111.211 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.45 150.19 63.65 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.241 2.628 . . . . 0.0 111.11 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 75.4 p -73.73 140.23 45.84 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.681 0.792 . . . . 0.0 110.521 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.02 179.62 25.77 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 123.938 0.78 . . . . 0.0 112.131 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -98.28 131.28 44.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.938 0.895 . . . . 0.0 108.769 171.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tp -72.55 152.94 41.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.645 1.178 . . . . 0.0 109.514 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.45 -79.93 0.13 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.837 0.855 . . . . 0.0 108.998 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -134.8 163.71 29.2 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.161 0.984 . . . . 0.0 109.938 -171.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -73.62 146.61 44.49 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.196 0.598 . . . . 0.0 110.322 173.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -140.13 -171.05 3.1 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.039 0.936 . . . . 0.0 110.158 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.8 pt -131.15 -173.93 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 123.968 0.907 . . . . 0.0 109.956 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.187 0 C-N-CA 125.236 1.414 . . . . 0.0 112.297 172.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ptm . . . . . 0 N--CA 1.474 0.755 0 CA-C-O 119.263 -0.399 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 175.45 -59.2 0.01 OUTLIER 'General case' 0 C--N 1.342 0.28 0 C-N-CA 125.74 1.616 . . . . 0.0 108.927 173.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.89 111.17 4.19 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.747 0.819 . . . . 0.0 111.687 -170.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 p -112.78 79.46 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 125.708 1.603 . . . . 0.0 107.331 -174.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -76.0 144.66 40.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.474 -177.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.436 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.6 pp -117.0 163.01 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.5 tt -124.79 116.02 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 124.911 1.284 . . . . 0.0 108.228 170.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -116.04 102.51 9.7 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.633 1.173 . . . . 0.0 110.801 -173.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.2 m-90 -82.49 112.44 19.42 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.12 0.568 . . . . 0.0 109.478 176.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.6 t -91.74 106.9 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -63.75 -37.31 86.88 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.949 0.5 . . . . 0.0 111.773 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.04 165.27 7.19 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.001 1.286 . . . . 0.0 114.854 -174.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -79.87 72.4 6.61 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.522 1.129 . . . . 0.0 111.893 -174.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.3 t -100.5 -33.31 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 124.579 1.152 . . . . 0.0 111.223 -173.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -67.34 145.73 54.8 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.883 0.473 . . . . 0.0 110.693 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.62 24.49 72.45 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 123.993 0.806 . . . . 0.0 113.323 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.5 t -118.95 -40.78 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.416 1.086 . . . . 0.0 110.319 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.95 31.41 5.69 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.148 1.356 . . . . 0.0 112.05 -177.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -48.72 -33.01 9.36 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.388 1.875 . . . . 0.0 112.927 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -72.79 57.97 0.44 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.862 2.065 . . . . 0.0 111.95 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -108.22 -69.54 0.85 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.346 1.058 . . . . 0.0 109.542 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.6 t -96.22 5.57 50.73 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.342 1.057 . . . . 0.0 112.553 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.9 t -58.36 -35.62 72.23 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 122.008 -0.432 . . . . 0.0 111.31 170.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 -61.85 -58.91 6.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.445 1.098 . . . . 0.0 110.698 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -51.85 -55.35 20.51 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.69 0.796 . . . . 0.0 110.994 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -53.21 -54.43 36.18 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.536 0.734 . . . . 0.0 111.044 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.18 -32.92 56.84 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.915 0.886 . . . . 0.0 112.622 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -67.65 -32.92 73.94 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.961 0.504 . . . . 0.0 111.631 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 40.0 mtp85 -68.17 -48.12 66.16 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.386 0.539 . . . . 0.0 110.128 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.77 -30.54 59.16 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.289 0.636 . . . . 0.0 110.696 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.84 22.43 61.58 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.404 1.478 . . . . 0.0 113.352 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.418 HD22 ' C ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -81.43 167.21 19.64 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.621 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.0 p -127.84 140.78 51.82 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.477 1.511 . . . . 0.0 107.348 -171.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.04 -165.11 38.52 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.675 -1.25 . . . . 0.0 112.701 -165.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -169.34 156.44 6.87 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 171.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.61 84.6 2.05 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.646 1.178 . . . . 0.0 109.215 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -89.3 168.11 12.52 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 122.974 0.509 . . . . 0.0 110.339 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -127.31 133.36 50.13 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.646 0.778 . . . . 0.0 109.511 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.4 mt -71.2 168.21 17.74 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.12 0.968 . . . . 0.0 109.755 170.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -86.51 4.44 39.88 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.867 0.867 . . . . 0.0 111.593 175.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -90.52 -56.02 3.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.827 0.851 . . . . 0.0 109.225 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 162.64 -12.34 0.11 Allowed Glycine 0 CA--C 1.53 0.99 0 CA-C-N 114.827 -1.079 . . . . 0.0 113.192 -166.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.4 m -112.76 145.61 40.25 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.295 1.048 . . . . 0.0 112.388 -164.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 86.0 t -105.37 122.44 58.71 Favored 'Isoleucine or valine' 0 C--N 1.344 0.341 0 C-N-CA 124.759 1.224 . . . . 0.0 110.652 -173.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -94.64 103.17 15.11 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.547 1.539 . . . . 0.0 110.128 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.14 124.68 56.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.7 t -128.16 135.08 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.947 0.899 . . . . 0.0 109.428 -174.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -155.62 125.36 6.45 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.365 -169.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 95.2 m -88.86 -178.98 5.87 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.361 1.464 . . . . 0.0 112.018 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.15 -165.91 17.39 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -74.21 136.0 42.77 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -56.85 -46.09 82.0 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.294 0.638 . . . . 0.0 110.575 -174.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -47.28 -50.93 16.14 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.617 1.58 . . . . 0.0 112.56 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -62.2 -50.68 70.84 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.751 0.82 . . . . 0.0 111.294 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.3 t -55.44 -37.86 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.823 0.849 . . . . 0.0 111.12 178.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -59.11 -33.57 71.0 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.472 0.578 . . . . 0.0 111.942 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -58.12 -42.51 85.89 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.739 0.699 . . . . 0.0 112.469 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 pp -78.54 -28.19 46.04 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.928 0.785 . . . . 0.0 111.32 175.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 7.9 mmm -67.14 -34.18 77.03 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 118.425 -0.797 . . . . 0.0 111.021 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -42.25 -53.37 4.13 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 168.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -65.49 -39.97 92.55 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 118.647 -0.692 . . . . 0.0 112.261 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 42.8 mt -58.79 -49.05 79.13 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 119.813 1.188 . . . . 0.0 109.72 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -72.43 8.28 1.45 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.05 1.34 . . . . 0.0 112.751 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.6 m -146.98 29.96 0.97 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.174 1.389 . . . . 0.0 109.064 172.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.16 -46.87 4.89 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -168.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.54 116.15 8.04 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.861 -0.966 . . . . 0.0 111.074 -173.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -73.25 -47.79 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.498 2.132 . . . . 0.0 110.974 -176.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 48.5 mtt-85 -145.37 -61.44 0.34 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.214 1.006 . . . . 0.0 109.561 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.4 t -59.08 -65.82 0.61 Allowed 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.76 1.224 . . . . 0.0 111.613 -174.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.89 118.92 6.8 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.046 0.539 . . . . 0.0 109.89 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -111.6 93.08 4.29 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.466 1.106 . . . . 0.0 108.148 -173.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.8 t -76.99 94.44 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.356 1.062 . . . . 0.0 108.97 -178.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.12 -64.42 0.86 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.126 0.97 . . . . 0.0 110.5 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.53 155.84 17.82 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.532 1.133 . . . . 0.0 109.169 -173.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -129.62 123.1 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.995 1.318 . . . . 0.0 109.259 -176.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.3 tp -99.72 106.87 18.83 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.1 m -99.93 130.03 46.07 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.095 0.558 . . . . 0.0 111.401 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -130.62 164.53 40.87 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 127.585 2.354 . . . . 0.0 108.469 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.05 129.29 10.45 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.089 2.526 . . . . 0.0 111.111 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -110.4 106.66 16.09 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.741 1.216 . . . . 0.0 109.979 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -106.63 86.99 2.48 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 118.635 0.652 . . . . 0.0 111.296 177.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.91 167.29 22.33 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.107 2.538 . . . . 0.0 110.829 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.5 m -87.77 129.59 35.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.012 0.925 . . . . 0.0 109.498 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.09 -177.94 27.31 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.941 0.781 . . . . 0.0 112.509 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -100.9 126.73 47.54 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.645 1.178 . . . . 0.0 109.467 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.7 tp -72.74 143.13 48.11 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 170.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.6 p -73.43 -63.39 1.2 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.238 1.015 . . . . 0.0 111.444 -171.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -132.26 166.47 21.82 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.054 1.341 . . . . 0.0 110.087 -174.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -82.3 144.64 30.46 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.083 0.553 . . . . 0.0 109.744 168.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -155.37 178.91 9.68 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 123.069 0.547 . . . . 0.0 109.759 176.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.99 163.54 24.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 123.106 0.562 . . . . 0.0 110.626 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 116.713 -1.613 . . . . 0.0 111.287 173.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttm . . . . . 0 N--CA 1.473 0.715 0 CA-C-O 119.443 -0.313 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.4 t -137.03 -41.84 0.58 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.899 0.88 . . . . 0.0 110.785 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.24 155.11 39.67 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.235 1.014 . . . . 0.0 113.054 -176.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.34 90.99 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.304 1.042 . . . . 0.0 108.304 -174.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.7 m -78.87 153.39 30.6 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.471 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.68 149.4 18.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -176.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 tt -107.54 128.2 62.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 123.771 0.828 . . . . 0.0 109.704 176.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -121.97 101.21 7.42 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.058 1.743 . . . . 0.0 109.895 -176.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -86.37 123.52 31.7 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 124.772 1.229 . . . . 0.0 110.459 177.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.12 119.6 59.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.296 1.038 . . . . 0.0 109.292 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -92.22 175.17 6.95 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.011 1.324 . . . . 0.0 110.712 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.17 -167.52 53.43 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -84.67 84.24 7.75 Favored 'General case' 0 CA--C 1.523 -0.089 0 C-N-CA 123.083 0.553 . . . . 0.0 111.723 -169.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.94 -46.92 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 124.034 0.934 . . . . 0.0 109.442 -174.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -69.25 146.79 52.02 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-O 121.007 0.432 . . . . 0.0 111.365 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.15 20.92 73.46 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.209 0.909 . . . . 0.0 113.354 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.1 t -105.32 -42.42 7.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 C-N-CA 124.48 1.112 . . . . 0.0 109.242 175.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.48 29.07 2.81 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.653 1.597 . . . . 0.0 111.202 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -51.84 -36.55 48.61 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.483 1.113 . . . . 0.0 111.597 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.88 58.2 0.83 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.306 1.442 . . . . 0.0 112.423 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -107.24 -74.58 0.65 Allowed 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.562 1.145 . . . . 0.0 109.39 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.6 t -74.84 -18.48 60.44 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.633 -0.699 . . . . 0.0 112.002 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.4 t -43.82 -40.96 4.74 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.925 0.89 . . . . 0.0 112.286 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -67.04 -59.02 3.83 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.753 1.221 . . . . 0.0 109.675 175.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -52.76 -57.18 10.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.597 1.159 . . . . 0.0 111.343 -175.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -55.86 -51.03 68.95 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.568 0.747 . . . . 0.0 110.497 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.74 -36.55 62.43 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.807 0.443 . . . . 0.0 111.985 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -64.34 -30.97 72.0 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.365 0.666 . . . . 0.0 111.895 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 mmm-85 -67.75 -50.52 56.78 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.119 0.568 . . . . 0.0 110.597 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.9 mp -70.99 -30.05 66.19 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.827 0.451 . . . . 0.0 110.665 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.78 18.43 78.91 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.054 0.835 . . . . 0.0 112.483 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.52 175.03 10.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.705 0.802 . . . . 0.0 110.991 176.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.3 p -117.45 -161.65 0.83 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -173.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.46 -155.54 16.49 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 169.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -169.73 160.05 8.48 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 172.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.84 94.39 4.38 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.826 1.251 . . . . 0.0 110.21 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.3 174.5 6.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.506 0.722 . . . . 0.0 111.355 176.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -122.6 139.41 53.95 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.044 0.938 . . . . 0.0 109.715 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.8 mt -76.0 174.64 9.73 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 125.468 1.507 . . . . 0.0 110.258 173.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -98.67 11.7 37.72 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.968 1.307 . . . . 0.0 111.593 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -118.19 -4.54 10.96 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.806 1.242 . . . . 0.0 111.868 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.96 14.15 9.53 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.947 1.26 . . . . 0.0 114.483 176.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.8 168.57 10.1 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.504 1.522 . . . . 0.0 111.937 -170.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 73.1 t -130.7 120.99 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.312 1.045 . . . . 0.0 111.44 -174.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -101.98 118.04 36.09 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.081 0.952 . . . . 0.0 110.997 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.5 t -112.47 137.6 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 123.631 0.773 . . . . 0.0 110.027 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.22 144.31 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.689 0.796 . . . . 0.0 109.886 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.06 132.05 8.92 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-O 118.52 -0.753 . . . . 0.0 111.294 -174.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 89.7 m -100.43 -179.56 4.14 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.804 1.242 . . . . 0.0 112.365 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.2 -161.8 20.81 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -75.05 126.36 30.85 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 122.793 0.437 . . . . 0.0 110.096 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -49.18 -50.63 37.07 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 124.142 0.977 . . . . 0.0 110.594 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -48.16 -40.21 21.08 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.92 1.724 . . . . 0.0 113.652 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -77.57 -48.54 16.7 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.776 0.83 . . . . 0.0 111.132 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.0 -39.94 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 122.715 0.406 . . . . 0.0 111.114 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -61.77 -27.27 68.62 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -59.25 -48.12 82.8 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.193 0.451 . . . . 0.0 110.469 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.46 -30.74 63.37 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.889 0.313 . . . . 0.0 111.302 178.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mmt -67.55 -20.07 65.36 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-O 118.913 -0.565 . . . . 0.0 112.415 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -46.13 -50.98 14.83 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 168.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -61.27 -41.85 97.65 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.1 mt -54.39 -54.13 44.71 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 123.812 0.845 . . . . 0.0 110.6 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -70.26 -33.72 71.95 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 119.073 -0.489 . . . . 0.0 112.038 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.5 t -63.85 -31.61 72.84 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.761 0.71 . . . . 0.0 111.914 175.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.81 13.28 80.71 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 118.813 -0.993 . . . . 0.0 113.178 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.7 -105.39 0.1 OUTLIER Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.77 1.653 . . . . 0.0 112.55 -175.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -71.81 -178.88 3.36 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.133 3.222 . . . . 0.0 112.514 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -68.47 -28.32 66.93 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.436 0.694 . . . . 0.0 111.93 177.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.9 p -65.42 157.83 28.32 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.523 0.729 . . . . 0.0 110.938 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 74.25 158.4 0.21 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.518 1.927 . . . . 0.0 110.78 -166.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -129.45 107.94 9.88 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.7 t -92.65 88.3 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -60.7 -65.58 0.67 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.089 0.556 . . . . 0.0 109.892 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.6 mtm-85 -150.56 156.29 41.11 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.539 1.135 . . . . 0.0 109.6 -176.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.3 t -137.82 130.15 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 123.715 0.806 . . . . 0.0 110.522 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tp -113.38 135.35 53.96 Favored 'General case' 0 C--N 1.346 0.448 0 C-N-CA 125.21 1.404 . . . . 0.0 112.058 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.55 137.31 54.93 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.314 1.045 . . . . 0.0 111.985 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -145.27 159.06 50.17 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.645 1.178 . . . . 0.0 111.68 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.92 136.53 25.22 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.967 3.111 . . . . 0.0 111.666 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -127.13 125.43 41.18 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.672 1.189 . . . . 0.0 111.106 -175.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -129.7 70.91 82.16 Favored Pre-proline 0 CA--C 1.535 0.403 0 O-C-N 121.696 -0.627 . . . . 0.0 111.37 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.63 142.31 35.9 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.894 2.396 . . . . 0.0 110.776 -176.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.5 p -70.82 140.97 51.35 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.663 0.785 . . . . 0.0 110.85 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.99 173.04 23.95 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.106 0.86 . . . . 0.0 111.638 -175.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -96.1 135.34 38.03 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -76.25 151.99 36.65 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.3 m -80.88 -76.73 0.23 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -177.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -134.47 165.76 24.45 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.717 1.207 . . . . 0.0 110.223 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -72.88 149.79 43.17 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.711 0.804 . . . . 0.0 110.353 172.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -151.24 -169.54 3.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.005 0.922 . . . . 0.0 110.002 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.8 pt -130.77 -179.46 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.271 1.028 . . . . 0.0 109.542 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.18 0 CA-C-O 117.62 -1.181 . . . . 0.0 111.723 170.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t 79.66 -65.51 0.19 Allowed 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 125.435 1.494 . . . . 0.0 109.396 177.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.05 144.22 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.909 1.684 . . . . 0.0 111.672 176.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 p -139.44 88.2 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.199 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.7 m -81.7 152.78 26.91 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.403 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.5 146.76 19.27 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -176.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 tt -109.36 122.29 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 124.271 1.029 . . . . 0.0 109.877 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.55 116.56 28.99 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.971 1.308 . . . . 0.0 111.024 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.7 m-90 -96.56 121.99 38.99 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.768 0.827 . . . . 0.0 110.16 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.545 HG12 HG21 ' A' ' 14' ' ' VAL . 5.6 t -104.5 115.32 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.397 1.079 . . . . 0.0 108.848 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -87.49 178.56 6.77 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.76 1.224 . . . . 0.0 111.453 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.29 -159.71 50.46 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -88.37 99.49 12.29 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.114 -174.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.545 HG21 HG12 ' A' ' 10' ' ' VAL . 21.7 t -130.74 -43.71 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 123.441 0.697 . . . . 0.0 109.756 -177.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -70.4 143.77 51.76 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.596 0.758 . . . . 0.0 109.969 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.6 18.61 79.7 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 119.26 -0.745 . . . . 0.0 113.31 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 83.5 t -107.52 -43.63 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.577 1.151 . . . . 0.0 109.527 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 116.35 28.5 2.56 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 125.187 1.375 . . . . 0.0 111.446 -177.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -50.93 -32.71 21.6 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 123.627 0.771 . . . . 0.0 111.192 176.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -76.51 58.71 1.38 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.838 0.855 . . . . 0.0 112.764 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -95.18 -70.32 0.72 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 t -92.85 -2.54 55.8 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.496 -0.764 . . . . 0.0 111.656 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 t -45.48 -36.93 4.81 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.095 0.861 . . . . 0.0 112.403 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -73.72 -60.31 2.31 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.266 1.026 . . . . 0.0 109.806 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -50.3 -59.14 4.26 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.271 1.028 . . . . 0.0 111.002 -175.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.9 -53.28 34.06 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 125.589 1.556 . . . . 0.0 110.057 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.49 -37.84 70.93 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.618 0.367 . . . . 0.0 111.732 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.3 tttm -61.87 -31.72 72.02 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.249 1.019 . . . . 0.0 111.7 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.26 -52.32 48.71 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.261 0.624 . . . . 0.0 110.946 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 57' ' ' LYS . 34.6 mt -72.23 -31.11 65.54 Favored 'General case' 0 CA--C 1.528 0.124 0 O-C-N 122.849 0.093 . . . . 0.0 110.812 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.66 6.94 82.48 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.064 0.84 . . . . 0.0 112.596 -178.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.15 178.14 2.93 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.817 0.808 . . . . 0.0 111.326 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 43.7 p -125.79 -169.05 1.94 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -175.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 130.85 -151.49 19.62 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 171.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -170.91 167.48 7.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.438 -0.381 . . . . 0.0 111.421 173.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.46 ' HB3' HD12 ' A' ' 91' ' ' ILE . . . -131.69 97.07 4.11 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.793 0.683 . . . . 0.0 111.435 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.4 mttp -93.28 174.01 7.43 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.969 1.308 . . . . 0.0 110.142 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -124.24 135.25 53.28 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.431 1.092 . . . . 0.0 109.628 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.8 mt -74.95 171.82 13.38 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.077 1.351 . . . . 0.0 109.847 177.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -93.66 4.96 53.13 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.587 0.755 . . . . 0.0 111.571 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -107.25 -14.53 14.87 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.64 1.176 . . . . 0.0 111.724 -177.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.92 7.6 8.53 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.015 1.293 . . . . 0.0 113.91 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.9 168.68 8.97 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.946 1.298 . . . . 0.0 111.336 -172.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.0 t -129.01 120.25 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.391 1.077 . . . . 0.0 110.549 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -95.71 127.16 41.5 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.82 0.848 . . . . 0.0 110.232 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.27 136.22 58.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 124.389 1.075 . . . . 0.0 109.525 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.24 143.37 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 124.012 0.925 . . . . 0.0 109.356 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.69 138.23 15.98 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 118.856 -0.592 . . . . 0.0 110.668 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 61.5 m -103.0 178.5 4.54 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.867 1.267 . . . . 0.0 111.435 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.94 -159.82 18.03 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -78.76 132.54 36.97 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 124.965 1.306 . . . . 0.0 109.408 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -46.84 -55.9 7.18 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.491 1.116 . . . . 0.0 110.683 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -49.99 -43.87 40.84 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.238 1.399 . . . . 0.0 112.767 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -67.07 -46.43 74.35 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.295 1.038 . . . . 0.0 111.187 176.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 77.4 t -54.05 -41.17 49.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.163 0.585 . . . . 0.0 110.408 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.24 -26.97 68.11 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.418 ' HB2' HD21 ' A' ' 30' ' ' LEU . 29.4 mmmt -59.77 -27.12 66.26 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.259 1.024 . . . . 0.0 112.712 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.02 -29.81 13.43 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.48 0.582 . . . . 0.0 110.774 172.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.449 ' HA ' HD12 ' A' ' 62' ' ' LEU . 2.2 mmt -62.72 -23.56 67.22 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-O 118.722 -0.656 . . . . 0.0 111.418 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.48 -57.62 3.97 Favored 'General case' 0 C--O 1.248 0.985 0 C-N-CA 122.966 0.506 . . . . 0.0 110.027 173.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -65.31 -32.34 73.94 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 118.656 0.662 . . . . 0.0 112.07 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 59' ' ' MET . 12.7 mt -61.64 -51.85 66.75 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 119.054 0.843 . . . . 0.0 109.832 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -81.84 -0.05 41.7 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -178.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.6 t -108.86 -32.5 7.27 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 125.234 1.413 . . . . 0.0 110.36 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -94.62 19.85 51.58 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.391 0.996 . . . . 0.0 112.159 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.09 -78.78 0.83 Allowed Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 125.202 1.382 . . . . 0.0 110.867 175.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -67.63 -9.89 26.95 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.785 2.99 . . . . 0.0 112.634 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.01 -32.51 46.99 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.282 1.033 . . . . 0.0 112.293 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.04 -44.56 0.08 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.403 1.081 . . . . 0.0 110.275 -178.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.09 176.72 7.72 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.646 1.578 . . . . 0.0 110.509 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -122.16 74.6 1.17 Allowed 'General case' 0 C--N 1.341 0.22 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -175.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 87.8 t -70.9 96.42 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -63.05 -61.75 2.17 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.378 0.671 . . . . 0.0 109.31 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.9 mmm-85 -152.19 161.53 42.48 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.046 1.339 . . . . 0.0 109.801 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.1 t -142.24 140.38 29.28 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 124.202 1.001 . . . . 0.0 109.754 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.4 tp -129.14 157.32 42.11 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.816 0.847 . . . . 0.0 111.108 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.91 129.77 26.38 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.079 0.951 . . . . 0.0 111.221 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.31 158.83 73.16 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.112 1.365 . . . . 0.0 110.424 -177.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -71.66 130.51 17.16 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.517 3.478 . . . . 0.0 110.834 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -119.24 117.52 28.83 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.626 1.17 . . . . 0.0 109.767 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -125.55 68.2 59.76 Favored Pre-proline 0 CA--C 1.535 0.367 0 O-C-N 121.873 -0.517 . . . . 0.0 110.546 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.47 140.99 37.56 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.411 2.741 . . . . 0.0 110.432 -175.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.6 p -72.4 145.07 47.94 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.427 0.691 . . . . 0.0 110.797 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.66 170.35 3.95 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.381 0.991 . . . . 0.0 112.131 -176.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -92.21 138.13 31.79 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.8 tp -80.96 152.13 28.17 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 99.5 m -75.26 -73.96 0.23 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -146.54 167.38 23.86 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.396 0.678 . . . . 0.0 110.859 -176.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -70.39 144.72 51.48 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.951 0.501 . . . . 0.0 110.388 176.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -145.48 -176.78 5.25 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 122.999 0.52 . . . . 0.0 110.562 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.46 HD12 ' HB3' ' A' ' 36' ' ' ALA . 6.5 tt -168.65 139.8 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 123.305 0.642 . . . . 0.0 109.362 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.108 0 CA-C-O 117.158 -1.401 . . . . 0.0 110.328 174.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.09 -44.03 0.2 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.5 0.72 . . . . 0.0 110.608 -176.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.6 159.08 13.82 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.427 1.091 . . . . 0.0 112.496 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.0 p -143.83 89.63 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.6 m -75.55 153.71 37.24 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.76 174.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pp -143.13 155.82 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 123.068 0.547 . . . . 0.0 110.064 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.5 tp -112.84 118.55 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 125.004 1.322 . . . . 0.0 108.739 177.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -113.36 111.09 21.41 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.09 0.956 . . . . 0.0 110.384 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -92.41 121.02 33.47 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.801 0.84 . . . . 0.0 110.287 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.538 HG12 HG21 ' A' ' 14' ' ' VAL . 3.0 t -104.98 120.03 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.436 1.095 . . . . 0.0 108.932 -177.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -95.27 176.39 6.23 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.309 1.044 . . . . 0.0 111.559 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.25 -156.39 48.63 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.5 mtt-85 -87.96 93.16 9.39 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 123.417 0.687 . . . . 0.0 111.85 -173.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.538 HG21 HG12 ' A' ' 10' ' ' VAL . 16.9 t -127.41 -45.88 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.205 1.002 . . . . 0.0 109.974 -175.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -70.68 141.83 51.59 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.35 0.66 . . . . 0.0 110.1 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.67 15.09 80.2 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.104 -0.831 . . . . 0.0 113.371 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.1 t -111.98 -44.28 5.1 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 C-N-CA 124.561 1.145 . . . . 0.0 109.764 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.56 23.01 2.94 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.262 1.41 . . . . 0.0 111.893 -176.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -59.32 -25.34 64.08 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 117.785 0.792 . . . . 0.0 111.988 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.74 30.62 4.25 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.584 1.554 . . . . 0.0 111.687 175.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -94.46 -61.21 1.55 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.76 0.709 . . . . 0.0 109.383 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.9 t -78.21 -1.7 34.12 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 t -59.58 -26.74 65.67 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.057 0.543 . . . . 0.0 111.299 173.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -70.95 -55.64 7.93 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.224 0.61 . . . . 0.0 110.728 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -52.37 -57.03 11.07 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.027 0.531 . . . . 0.0 111.177 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -47.05 73.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.263 0.625 . . . . 0.0 110.414 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.43 -29.69 50.15 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.8 tttm -69.53 -31.53 69.81 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.231 1.012 . . . . 0.0 111.802 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.8 mmm-85 -72.84 -37.2 67.51 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.018 0.927 . . . . 0.0 111.06 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -85.9 -30.18 23.06 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.909 0.884 . . . . 0.0 111.506 178.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.67 21.21 79.63 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.47 0.557 . . . . 0.0 112.374 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.45 HD12 ' HB1' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -79.58 178.02 8.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.961 0.904 . . . . 0.0 111.111 177.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.3 p -123.18 -164.22 1.19 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -175.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.2 -151.53 18.14 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 171.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -169.22 162.91 10.83 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.05 99.79 6.41 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.1 0.96 . . . . 0.0 111.477 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -100.06 172.85 6.94 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.717 1.207 . . . . 0.0 110.936 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -124.12 135.17 53.34 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.796 1.239 . . . . 0.0 108.753 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.443 HD12 ' HB2' ' A' ' 43' ' ' SER . 21.8 mt -75.64 173.0 11.63 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.015 1.326 . . . . 0.0 110.08 175.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -95.3 8.1 44.18 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.053 0.941 . . . . 0.0 111.729 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -111.58 -2.6 15.38 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.899 1.28 . . . . 0.0 112.137 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.99 7.21 31.42 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.94 1.257 . . . . 0.0 113.949 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.443 ' HB2' HD12 ' A' ' 39' ' ' LEU . 75.4 m -102.92 165.82 10.81 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.513 1.525 . . . . 0.0 111.127 -173.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 91.4 t -128.57 122.77 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.688 1.195 . . . . 0.0 110.524 -177.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -99.32 123.43 43.59 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 124.187 0.995 . . . . 0.0 110.947 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.9 t -121.23 133.44 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.182 0.593 . . . . 0.0 109.631 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.9 t -126.01 142.79 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 124.646 1.178 . . . . 0.0 109.45 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.45 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -154.36 132.86 12.04 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-O 118.607 -0.711 . . . . 0.0 111.158 -175.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.42 178.64 4.69 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 175.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.96 -157.69 20.64 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.789 1.185 . . . . 0.0 110.201 178.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -75.94 122.43 24.16 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.67 1.188 . . . . 0.0 109.572 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -45.84 -51.82 12.32 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.472 1.109 . . . . 0.0 111.071 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.29 -47.35 56.12 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.483 1.516 . . . . 0.0 113.129 177.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -65.44 -47.76 75.06 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.395 0.598 . . . . 0.0 110.299 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.5 t -57.56 -33.06 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 122.723 0.409 . . . . 0.0 110.751 176.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.48 -32.28 73.16 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.941 0.896 . . . . 0.0 112.949 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -56.64 -27.48 58.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.004 0.922 . . . . 0.0 112.461 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.36 -30.97 13.1 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 118.622 0.646 . . . . 0.0 111.289 173.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.479 ' HA ' HD12 ' A' ' 62' ' ' LEU . 2.3 mmm -63.6 -22.45 66.9 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-O 118.624 -0.703 . . . . 0.0 112.444 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -44.27 -55.9 4.55 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.335 0.516 . . . . 0.0 110.254 173.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -61.92 -41.92 98.5 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.147 0.579 . . . . 0.0 111.782 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 59' ' ' MET . 11.4 mt -57.14 -54.25 48.93 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 123.785 0.834 . . . . 0.0 109.707 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 mppp? -66.73 -29.32 69.27 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.533 0.733 . . . . 0.0 112.314 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 t -69.56 -17.1 63.54 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.448 0.567 . . . . 0.0 112.015 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.81 5.4 89.43 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-O 118.271 -1.294 . . . . 0.0 112.716 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 43.49 -103.84 0.05 OUTLIER Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.623 1.582 . . . . 0.0 112.846 -175.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -70.64 171.06 16.16 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.422 2.748 . . . . 0.0 111.762 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.2 mtp180 -87.43 -35.0 18.53 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.45 0.7 . . . . 0.0 110.849 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -33.24 64.19 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.74 1.216 . . . . 0.0 111.965 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.35 144.39 57.2 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.736 0.814 . . . . 0.0 110.301 176.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -119.32 88.68 2.98 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.6 t -75.42 81.91 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.43 -50.89 71.57 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.251 0.621 . . . . 0.0 111.108 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -169.04 153.42 5.57 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 123.396 0.678 . . . . 0.0 109.623 -177.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.5 t -141.96 134.76 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.138 0.575 . . . . 0.0 109.537 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.5 tp -120.43 156.14 32.05 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.976 0.91 . . . . 0.0 110.928 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.12 129.5 27.68 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.853 0.861 . . . . 0.0 110.873 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -132.73 154.93 81.65 Favored Pre-proline 0 CA--C 1.539 0.558 0 C-N-CA 124.499 1.12 . . . . 0.0 110.14 -177.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.89 125.63 11.75 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 124.857 3.704 . . . . 0.0 111.067 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -117.16 127.31 54.0 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.721 0.809 . . . . 0.0 110.844 -178.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -133.63 70.49 75.91 Favored Pre-proline 0 CA--C 1.536 0.42 0 O-C-N 121.526 -0.734 . . . . 0.0 110.495 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.15 136.88 35.8 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 124.057 3.171 . . . . 0.0 109.984 -177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.6 p -61.48 143.76 55.36 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.642 0.777 . . . . 0.0 111.101 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.95 171.02 5.69 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.079 0.847 . . . . 0.0 112.112 -175.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -89.0 135.74 33.39 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mp -74.13 150.09 40.67 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.303 0.641 . . . . 0.0 109.678 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.61 -77.96 0.2 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.349 1.059 . . . . 0.0 108.625 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -143.78 164.71 29.73 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.613 0.765 . . . . 0.0 110.944 -174.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -70.96 144.86 50.39 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.973 0.509 . . . . 0.0 110.357 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -137.81 -179.35 5.71 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 124.101 0.961 . . . . 0.0 110.403 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.9 tt -142.39 153.01 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -177.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 116.598 -1.668 . . . . 0.0 111.86 177.384 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 ttm . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 110.703 -0.11 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.92 -41.77 6.04 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.579 1.152 . . . . 0.0 111.091 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.13 134.4 49.28 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.267 1.027 . . . . 0.0 111.557 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 p -140.63 94.98 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 C-N-CA 124.551 1.141 . . . . 0.0 108.484 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.4 m -92.75 153.88 18.64 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.933 -177.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pp -143.6 156.46 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -174.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 tt -116.37 119.26 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.148 0.979 . . . . 0.0 109.418 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -109.9 108.33 18.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.88 1.272 . . . . 0.0 109.951 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -91.76 123.04 34.85 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.991 0.916 . . . . 0.0 110.235 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.421 HG12 HG21 ' A' ' 14' ' ' VAL . 12.9 t -99.15 108.52 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.586 1.155 . . . . 0.0 108.768 -178.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -73.26 177.49 5.1 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.815 0.846 . . . . 0.0 111.426 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.95 -169.4 42.66 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 177.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -92.01 92.04 8.11 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.798 0.439 . . . . 0.0 110.881 -175.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.421 HG21 HG12 ' A' ' 10' ' ' VAL . 58.8 t -114.28 -31.06 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.101 0.96 . . . . 0.0 110.909 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -70.67 148.43 48.05 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.895 0.316 . . . . 0.0 110.52 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.75 22.81 54.95 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 123.753 0.692 . . . . 0.0 112.954 176.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.8 t -116.06 -48.97 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 C-N-CA 124.884 1.273 . . . . 0.0 109.41 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.67 32.29 1.23 Allowed Glycine 0 C--N 1.339 0.714 0 C-N-CA 125.251 1.405 . . . . 0.0 111.512 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -50.44 -36.81 34.96 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 123.848 0.859 . . . . 0.0 111.434 177.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.05 55.3 0.71 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.64 1.176 . . . . 0.0 112.058 177.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -94.54 -73.64 0.57 Allowed 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.337 0.655 . . . . 0.0 109.277 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.9 t -89.0 -1.59 58.18 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.435 0.694 . . . . 0.0 111.642 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.9 t -47.51 -36.93 11.03 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.752 0.821 . . . . 0.0 112.294 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -71.8 -55.96 6.64 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.442 1.097 . . . . 0.0 110.508 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -53.79 -54.15 42.27 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.677 0.791 . . . . 0.0 110.678 -176.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.15 -48.13 68.21 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.233 1.013 . . . . 0.0 110.515 177.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.42 -26.44 53.54 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -73.55 -28.28 61.79 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.806 0.843 . . . . 0.0 111.942 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.9 mtp85 -71.91 -41.89 67.38 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.321 1.049 . . . . 0.0 110.119 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -86.51 -52.67 5.43 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.558 0.743 . . . . 0.0 111.413 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.54 8.51 46.14 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.206 0.907 . . . . 0.0 112.995 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.15 167.57 2.31 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.969 0.884 . . . . 0.0 111.674 174.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.7 p -128.09 155.37 44.51 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.87 -147.95 17.38 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -169.35 166.27 10.48 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 173.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.4 100.73 5.46 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.803 0.841 . . . . 0.0 111.678 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -105.44 179.26 4.32 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.612 1.165 . . . . 0.0 110.835 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -123.51 138.99 54.46 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.673 1.189 . . . . 0.0 109.089 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.79 177.84 4.58 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.424 1.09 . . . . 0.0 110.349 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -101.14 13.31 35.54 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.296 1.038 . . . . 0.0 111.18 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -117.53 -15.46 10.24 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.863 1.265 . . . . 0.0 111.891 -177.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.0 5.66 8.02 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.012 1.292 . . . . 0.0 114.215 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 m -106.17 169.6 8.41 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.535 1.534 . . . . 0.0 111.564 -172.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.7 t -126.8 127.31 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.952 0.901 . . . . 0.0 110.448 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -105.06 122.24 45.46 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 123.725 0.81 . . . . 0.0 110.951 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.73 139.05 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 123.116 0.566 . . . . 0.0 109.632 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.2 t -130.22 142.6 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 124.276 1.031 . . . . 0.0 109.234 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.33 139.92 20.65 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.465 -176.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -111.64 -179.63 3.76 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.15 1.78 . . . . 0.0 110.911 -175.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.43 -155.05 24.69 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.85 130.57 35.12 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 117.593 0.696 . . . . 0.0 110.179 -178.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -48.63 -50.39 33.04 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.399 1.08 . . . . 0.0 111.006 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.95 -52.15 31.8 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.143 1.354 . . . . 0.0 112.335 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -61.94 -46.62 88.53 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.084 0.954 . . . . 0.0 110.601 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.9 t -56.79 -41.84 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 122.319 0.247 . . . . 0.0 110.868 176.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -60.69 -26.59 67.24 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -60.64 -28.7 68.76 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.046 0.939 . . . . 0.0 112.401 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.0 -29.7 13.5 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.001 0.521 . . . . 0.0 111.0 174.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.4 mmt -64.15 -21.42 66.55 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.99 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -46.9 -59.05 3.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 118.37 0.532 . . . . 0.0 110.167 173.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -63.02 -33.35 75.23 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.571 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt -62.49 -50.43 71.45 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.221 0.918 . . . . 0.0 110.035 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -69.65 -12.65 61.8 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.043 0.756 . . . . 0.0 113.043 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.1 m -123.36 21.13 9.58 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.317 1.047 . . . . 0.0 111.223 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -89.42 -29.25 17.3 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -176.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -39.78 101.0 0.01 OUTLIER Glycine 0 C--N 1.344 1.003 0 C-N-CA 126.857 2.17 . . . . 0.0 112.824 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.29 -176.75 2.61 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.251 1.967 . . . . 0.0 110.98 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -68.61 -34.16 75.29 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.008 0.523 . . . . 0.0 111.444 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.96 -56.24 5.18 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 123.834 0.854 . . . . 0.0 110.606 -174.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.28 153.65 9.22 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.728 1.211 . . . . 0.0 110.737 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.39 79.57 1.55 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -178.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 64.6 t -68.2 90.43 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.892 0.877 . . . . 0.0 108.665 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.35 -57.48 12.12 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.606 0.762 . . . . 0.0 110.027 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -165.66 172.88 11.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.286 1.034 . . . . 0.0 109.863 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.74 125.16 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.878 0.871 . . . . 0.0 109.663 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.86 155.85 18.91 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.609 1.163 . . . . 0.0 110.784 177.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.18 129.39 27.39 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.293 1.037 . . . . 0.0 111.113 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.37 156.59 79.61 Favored Pre-proline 0 N--CA 1.47 0.563 0 C-N-CA 124.714 1.206 . . . . 0.0 110.429 -177.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.87 124.41 11.01 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 124.873 3.715 . . . . 0.0 111.052 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -116.45 119.07 34.46 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.085 0.954 . . . . 0.0 110.895 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -124.9 69.68 57.93 Favored Pre-proline 0 CA--C 1.535 0.373 0 O-C-N 121.526 -0.733 . . . . 0.0 110.83 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.06 141.11 43.16 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.248 2.632 . . . . 0.0 110.492 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.4 m -69.81 143.36 52.94 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.587 0.755 . . . . 0.0 110.572 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.76 169.43 4.63 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.14 0.876 . . . . 0.0 112.041 -176.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -92.48 135.1 34.34 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.7 tp -78.87 150.49 32.2 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.75 -77.32 0.11 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -141.11 163.78 32.05 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.08 0.952 . . . . 0.0 110.023 -173.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -71.12 146.53 49.15 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.15 0.58 . . . . 0.0 110.767 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -140.56 -171.11 3.15 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.336 1.055 . . . . 0.0 110.437 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.8 pp -134.98 -175.26 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.55 1.14 . . . . 0.0 109.619 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 116.72 -1.61 . . . . 0.0 114.34 176.076 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 119.63 -0.224 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.5 m -140.61 -53.02 0.49 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.456 1.102 . . . . 0.0 110.701 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.26 136.03 56.11 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.84 1.256 . . . . 0.0 112.095 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 p -141.04 91.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.271 0 C-N-CA 124.576 1.151 . . . . 0.0 108.511 -174.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.4 m -81.58 156.48 25.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.7 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.451 HD11 HG11 ' A' ' 55' ' ' VAL . 1.3 pp -143.7 159.37 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 tt -118.45 118.04 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.665 1.186 . . . . 0.0 109.276 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -108.81 108.51 19.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.898 1.279 . . . . 0.0 110.341 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -90.77 124.3 35.02 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.908 0.883 . . . . 0.0 110.188 177.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.451 HG12 HG21 ' A' ' 14' ' ' VAL . 4.2 t -106.15 124.59 61.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.919 1.288 . . . . 0.0 108.379 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -96.32 179.8 4.91 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.134 1.374 . . . . 0.0 110.589 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.31 -166.09 51.01 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.1 mtt180 -86.72 93.64 9.3 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 122.696 0.398 . . . . 0.0 111.652 -171.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.451 HG21 HG12 ' A' ' 10' ' ' VAL . 18.4 t -123.25 -41.44 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 123.676 0.79 . . . . 0.0 110.398 -174.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -69.74 144.47 52.74 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.042 0.537 . . . . 0.0 109.902 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.9 12.72 83.13 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.949 -0.917 . . . . 0.0 113.578 178.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.5 t -108.76 -49.21 7.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 CA-C-N 118.374 1.087 . . . . 0.0 109.682 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.01 29.4 1.51 Allowed Glycine 0 C--N 1.338 0.663 0 C-N-CA 124.476 1.036 . . . . 0.0 112.031 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -51.66 -36.21 45.37 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.005 0.903 . . . . 0.0 111.183 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.47 56.08 0.66 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.028 1.331 . . . . 0.0 112.069 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -107.87 -71.54 0.75 Allowed 'General case' 0 C--N 1.34 0.174 0 C-N-CA 124.832 1.253 . . . . 0.0 109.47 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.6 t -70.95 -21.62 62.32 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.009 0.524 . . . . 0.0 111.486 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.4 t -47.1 -38.13 10.9 Favored 'General case' 0 C--N 1.345 0.408 0 C-N-CA 123.683 0.793 . . . . 0.0 111.695 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -69.93 -56.47 6.94 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.127 0.971 . . . . 0.0 110.189 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -51.99 -56.84 11.76 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.098 0.959 . . . . 0.0 111.018 -176.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -56.47 -51.54 68.07 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 123.367 0.667 . . . . 0.0 110.23 178.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.38 -30.13 50.97 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.088 0.555 . . . . 0.0 112.439 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -64.57 -36.57 84.67 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.649 0.779 . . . . 0.0 111.192 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -72.38 -48.92 37.84 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.334 1.054 . . . . 0.0 110.256 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.1 mp -67.88 -38.21 82.75 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.964 0.906 . . . . 0.0 110.746 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.23 12.85 83.51 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 123.874 0.749 . . . . 0.0 112.684 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.421 HD12 ' HB1' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -68.68 177.59 2.44 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.805 0.842 . . . . 0.0 110.92 176.329 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.0 p -121.91 -165.7 1.3 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.37 -151.92 16.9 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 171.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -171.77 164.65 6.56 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 123.817 0.363 . . . . 0.0 111.727 173.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.21 90.3 3.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.009 0.924 . . . . 0.0 111.898 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -92.38 178.64 5.77 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 124.534 1.134 . . . . 0.0 110.897 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -121.71 140.73 51.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.293 1.037 . . . . 0.0 110.029 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.7 mt -73.94 174.95 7.83 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.842 1.257 . . . . 0.0 110.304 174.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -99.76 13.12 34.8 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.394 1.078 . . . . 0.0 111.442 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -119.25 -9.05 10.02 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.339 1.056 . . . . 0.0 112.148 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.13 24.76 4.08 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.917 1.246 . . . . 0.0 114.159 176.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.89 170.4 11.12 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.247 1.419 . . . . 0.0 111.482 -172.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.1 t -129.79 127.31 63.95 Favored 'Isoleucine or valine' 0 C--N 1.346 0.443 0 C-N-CA 123.836 0.855 . . . . 0.0 110.6 -175.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -108.46 123.2 48.51 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.577 0.751 . . . . 0.0 110.031 -177.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.4 t -117.14 136.39 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 123.778 0.831 . . . . 0.0 109.11 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -129.53 144.26 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 124.221 1.009 . . . . 0.0 108.997 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.421 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -155.43 141.4 18.24 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 118.695 -0.669 . . . . 0.0 110.616 -176.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.6 m -111.47 179.88 3.9 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.868 1.267 . . . . 0.0 111.784 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.04 -161.32 23.43 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.79 123.64 25.95 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.152 0.981 . . . . 0.0 110.576 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.73 -46.55 59.14 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.038 0.935 . . . . 0.0 110.108 -176.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -44.61 -41.81 7.13 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 126.057 1.789 . . . . 0.0 113.332 177.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -78.78 -50.74 10.82 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.462 0.705 . . . . 0.0 110.651 174.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 6' ' ' ILE . 59.8 t -49.96 -40.76 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 118.441 0.564 . . . . 0.0 111.747 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.16 -30.8 69.56 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.71 1.604 . . . . 0.0 112.178 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -56.4 -40.79 75.24 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 124.46 1.104 . . . . 0.0 110.819 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.36 -30.53 27.35 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.672 0.669 . . . . 0.0 111.093 175.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.5 mmt -63.91 -20.18 65.65 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 118.586 -0.721 . . . . 0.0 112.02 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -45.56 -51.61 11.67 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.504 0.593 . . . . 0.0 110.411 174.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -62.29 -40.39 96.09 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.855 0.862 . . . . 0.0 111.965 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.4 mt -60.31 -49.15 78.75 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.957 0.903 . . . . 0.0 110.377 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -57.41 -28.76 63.55 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.433 0.693 . . . . 0.0 112.527 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.16 -27.36 65.59 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.276 0.63 . . . . 0.0 110.983 177.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.56 30.61 64.01 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 123.858 0.742 . . . . 0.0 112.128 174.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.48 76.2 0.21 Allowed Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -69.72 -10.98 29.94 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.413 2.075 . . . . 0.0 112.12 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -101.63 -50.71 3.64 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.626 1.171 . . . . 0.0 111.022 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.8 p -133.72 165.77 24.18 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 125.97 1.708 . . . . 0.0 108.551 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 70.04 158.67 0.18 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.537 1.135 . . . . 0.0 111.008 -176.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -124.52 74.59 1.34 Allowed 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.802 0.841 . . . . 0.0 109.014 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.4 t -71.58 106.0 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -69.71 -54.57 13.17 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.942 0.897 . . . . 0.0 110.195 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -156.81 163.67 38.95 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.65 0.78 . . . . 0.0 110.252 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.55 138.64 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.889 0.876 . . . . 0.0 109.835 -178.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.05 156.63 34.49 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.57 1.148 . . . . 0.0 110.991 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.51 129.14 26.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.035 0.934 . . . . 0.0 111.231 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.9 157.77 77.31 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 124.936 1.294 . . . . 0.0 110.491 -177.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -70.77 126.22 12.42 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 124.795 3.663 . . . . 0.0 111.003 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -118.63 135.47 54.43 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.017 0.927 . . . . 0.0 110.193 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -138.61 75.35 37.9 Favored Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 121.715 -0.616 . . . . 0.0 110.886 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.78 149.34 60.2 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.641 2.894 . . . . 0.0 110.674 -176.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.3 p -76.27 144.33 40.38 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.674 0.79 . . . . 0.0 110.597 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.3 169.99 4.41 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.401 1.0 . . . . 0.0 112.128 -176.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -88.65 137.01 32.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mp -79.02 150.55 31.89 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.527 0.731 . . . . 0.0 109.492 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -76.67 0.19 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.336 1.054 . . . . 0.0 108.448 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -143.03 162.43 35.5 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.587 0.755 . . . . 0.0 110.741 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -75.63 145.6 40.95 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.099 0.559 . . . . 0.0 110.429 177.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -144.98 148.29 33.62 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 123.713 0.805 . . . . 0.0 109.912 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -174.72 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 O-C-N 121.977 -0.452 . . . . 0.0 110.802 176.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 116.327 -1.797 . . . . 0.0 113.297 173.649 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 t -138.44 -60.9 0.6 Allowed 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.631 0.772 . . . . 0.0 109.655 -174.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -71.91 105.75 3.95 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.572 0.701 . . . . 0.0 110.537 -173.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.7 p -98.64 77.9 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.7 m -73.22 144.92 46.56 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -176.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.494 HD12 ' C ' ' A' ' 6' ' ' ILE . 2.0 pp -112.77 166.69 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.3 tt -125.89 99.44 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 166.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.29 98.16 9.45 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.416 1.087 . . . . 0.0 109.593 -174.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 20.9 m-90 -79.49 100.19 7.6 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -82.62 90.75 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -177.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -72.1 159.68 33.75 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.984 0.421 . . . . 0.0 112.002 -169.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.4 -164.85 19.14 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 124.418 1.009 . . . . 0.0 111.66 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -93.62 82.52 4.37 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.662 0.785 . . . . 0.0 110.403 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.4 t -108.63 -47.56 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.674 1.19 . . . . 0.0 111.156 -167.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -62.12 157.26 19.5 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.126 0.97 . . . . 0.0 111.958 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.64 -43.67 3.19 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.091 0.853 . . . . 0.0 112.178 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.3 t -60.17 -39.27 80.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.543 1.137 . . . . 0.0 111.356 -176.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.69 33.1 2.73 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.306 1.431 . . . . 0.0 111.458 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -47.16 -34.78 6.55 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 126.559 1.943 . . . . 0.0 112.831 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.15 36.04 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.656 1.582 . . . . 0.0 113.007 171.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -60.84 -59.41 5.42 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.973 0.909 . . . . 0.0 110.464 -170.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 t -124.58 12.0 8.6 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.785 1.234 . . . . 0.0 111.701 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.7 t -47.44 -43.46 23.99 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -62.39 -51.5 67.32 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.706 1.202 . . . . 0.0 110.702 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -53.03 -57.98 8.55 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.329 0.652 . . . . 0.0 110.322 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.32 -49.82 63.47 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.767 1.227 . . . . 0.0 110.784 178.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.25 -38.52 68.62 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.259 0.624 . . . . 0.0 111.787 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -68.44 -28.06 66.73 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.911 0.884 . . . . 0.0 111.949 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 -62.49 -47.68 82.89 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.632 0.651 . . . . 0.0 109.522 175.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 62.7 mt -77.76 -32.55 52.7 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.508 0.723 . . . . 0.0 111.05 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.47 30.99 61.46 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.986 1.279 . . . . 0.0 112.437 -176.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.444 HD22 ' C ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -81.61 169.2 17.33 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.499 0.72 . . . . 0.0 112.179 -179.266 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.4 ' N ' HD22 ' A' ' 32' ' ' LEU . 21.4 p -127.31 147.24 50.25 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.857 0.863 . . . . 0.0 109.232 -168.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.51 -145.26 15.24 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -171.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -176.26 155.49 1.5 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.314 0.645 . . . . 0.0 111.255 174.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.88 93.85 6.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.489 1.116 . . . . 0.0 109.056 166.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -93.06 173.45 7.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 170.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -124.84 148.2 48.35 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 123.727 0.811 . . . . 0.0 110.132 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 35.5 mt -84.53 175.21 9.43 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.349 1.06 . . . . 0.0 110.046 172.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -87.57 18.83 3.68 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.386 1.074 . . . . 0.0 110.632 169.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -96.1 -53.12 3.76 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 125.009 1.324 . . . . 0.0 109.499 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.87 -17.1 1.4 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.492 1.044 . . . . 0.0 112.08 -160.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.1 p -107.61 153.8 22.37 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.372 1.069 . . . . 0.0 112.427 -162.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.7 t -102.47 121.17 53.22 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 124.727 1.211 . . . . 0.0 109.237 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -90.32 97.15 11.02 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 173.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.2 t -90.51 119.79 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.5 t -114.0 126.81 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.41 ' HA ' HD23 ' A' ' 32' ' ' LEU . . . -147.81 114.34 5.98 Favored 'General case' 0 CA--C 1.522 -0.106 0 O-C-N 123.911 0.757 . . . . 0.0 110.822 -168.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 87.7 m -80.21 -176.43 5.58 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 124.659 1.184 . . . . 0.0 110.78 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.06 -176.2 21.8 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -177.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -74.87 150.09 39.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -53.82 -46.48 71.16 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.202 0.601 . . . . 0.0 110.414 -176.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -47.09 -48.89 19.32 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.062 1.792 . . . . 0.0 112.914 174.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -63.98 -54.23 37.76 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 117.501 0.65 . . . . 0.0 111.27 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.5 t -58.17 -34.77 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.132 0.973 . . . . 0.0 111.602 -177.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -53.46 -40.29 65.16 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.052 0.541 . . . . 0.0 111.101 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -65.87 -37.87 87.3 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.67 0.668 . . . . 0.0 112.347 -172.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -75.69 -35.24 60.38 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.484 0.584 . . . . 0.0 110.972 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 43.9 mtm -65.67 -39.41 91.31 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 176.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -47.93 -40.47 22.1 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.563 0.745 . . . . 0.0 111.571 173.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 28.9 t90 -78.62 -37.2 42.8 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.245 -0.884 . . . . 0.0 110.737 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.1 mt -59.41 -49.44 77.81 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 119.813 1.188 . . . . 0.0 110.911 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -71.6 4.57 3.02 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.3 t -127.79 17.87 6.79 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.249 1.419 . . . . 0.0 110.182 169.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.05 -41.8 9.24 Favored Glycine 0 C--N 1.341 0.849 0 C-N-CA 124.732 1.158 . . . . 0.0 110.867 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -124.27 72.07 0.43 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.959 1.266 . . . . 0.0 111.265 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.65 -64.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.021 2.48 . . . . 0.0 110.387 177.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -83.95 -65.4 1.01 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.232 1.013 . . . . 0.0 108.615 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 77.9 p -66.16 155.05 38.07 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.55 0.74 . . . . 0.0 110.442 173.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 57.9 171.27 0.05 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.846 1.258 . . . . 0.0 111.005 -166.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.62 81.45 2.0 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 174.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 66.7 t -72.58 91.56 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 176.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -64.84 -55.74 17.7 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.439 0.695 . . . . 0.0 111.568 -175.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -171.63 148.42 2.45 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 125.432 1.493 . . . . 0.0 107.141 -175.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 p -119.5 126.49 75.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 123.041 0.537 . . . . 0.0 110.27 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.4 tp -103.58 118.79 37.54 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 123.527 0.731 . . . . 0.0 109.175 173.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.4 m -101.74 138.34 38.86 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.621 0.769 . . . . 0.0 109.622 169.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -130.55 154.3 81.63 Favored Pre-proline 0 CA--C 1.53 0.192 0 C-N-CA 125.413 1.485 . . . . 0.0 108.525 171.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -70.51 104.24 1.41 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.212 2.608 . . . . 0.0 109.705 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -85.18 111.61 19.97 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.377 1.071 . . . . 0.0 109.482 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.71 86.71 1.02 Allowed Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 124.157 0.983 . . . . 0.0 109.754 175.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.22 165.33 32.92 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.231 1.954 . . . . 0.0 109.646 169.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.9 m -74.96 123.18 24.66 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.98 -151.91 47.13 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -173.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -126.02 147.53 49.53 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.965 1.306 . . . . 0.0 108.57 171.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 31.6 tp -72.59 156.44 38.99 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.6 p -66.05 -55.76 14.99 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.451 1.1 . . . . 0.0 111.585 -178.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -140.46 166.81 23.7 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.592 1.157 . . . . 0.0 111.547 -167.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -86.12 137.95 32.28 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 168.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -160.28 -170.63 2.88 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -167.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.1 mt 65.9 -120.12 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 126.638 1.975 . . . . 0.0 109.055 -169.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.6 mtp85 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 117.285 -1.341 . . . . 0.0 110.194 -175.394 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? . . . . . 0 N--CA 1.475 0.775 0 CA-C-O 119.258 -0.401 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 t -172.18 -42.45 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.477 0.711 . . . . 0.0 111.024 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -60.95 134.28 56.94 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.973 1.309 . . . . 0.0 112.351 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 p -138.92 91.51 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.272 0 C-N-CA 124.778 1.231 . . . . 0.0 108.707 -174.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.8 m -82.46 153.42 25.65 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.937 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.88 146.22 18.8 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -176.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.5 tt -109.22 124.11 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 124.171 0.989 . . . . 0.0 109.874 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.7 112.47 22.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.745 1.218 . . . . 0.0 110.373 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.7 m-90 -94.67 130.69 41.05 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.366 1.066 . . . . 0.0 110.289 178.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.611 HG13 HG22 ' A' ' 75' ' ' VAL . 2.9 t -111.31 101.57 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -177.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -68.16 176.63 2.61 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.611 0.765 . . . . 0.0 111.132 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.7 -162.11 54.3 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -93.34 91.71 7.33 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 123.804 0.842 . . . . 0.0 112.06 -172.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.507 HG21 HG12 ' A' ' 10' ' ' VAL . 31.9 t -122.63 -30.78 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 C-N-CA 123.991 0.916 . . . . 0.0 111.275 -175.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -72.22 148.88 45.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 121.944 -0.473 . . . . 0.0 110.018 175.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.29 -21.02 47.68 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.067 -0.851 . . . . 0.0 113.023 176.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 p -84.09 0.53 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 118.55 1.175 . . . . 0.0 112.39 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.44 52.28 54.12 Favored Glycine 0 C--N 1.34 0.791 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -176.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.36 -34.25 70.47 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.591 0.756 . . . . 0.0 111.102 176.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.84 53.95 0.78 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.905 1.682 . . . . 0.0 112.326 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -87.17 -67.61 0.81 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -177.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 t -101.81 1.9 37.69 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.17 0.988 . . . . 0.0 112.094 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.8 t -48.35 -33.82 9.62 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.421 0.688 . . . . 0.0 112.149 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -68.03 -55.19 13.49 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.965 1.306 . . . . 0.0 110.423 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -55.08 -55.3 32.62 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.749 0.819 . . . . 0.0 110.742 -175.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.22 -47.97 68.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.839 0.856 . . . . 0.0 110.3 176.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.29 -28.23 58.07 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.48 -31.14 68.15 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.024 0.929 . . . . 0.0 111.873 177.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.1 mmm-85 -67.95 -42.39 81.03 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.801 0.84 . . . . 0.0 110.869 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -84.4 -42.05 16.07 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 122.947 0.499 . . . . 0.0 111.498 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.44 6.94 63.91 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 123.932 0.777 . . . . 0.0 112.91 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.67 167.72 3.38 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.138 0.969 . . . . 0.0 111.743 174.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.7 p -131.0 156.07 45.76 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -177.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 162.51 -148.13 14.84 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -169.62 164.15 10.19 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.163 -0.519 . . . . 0.0 111.77 172.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.98 97.27 5.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.014 0.926 . . . . 0.0 111.521 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -97.12 173.09 7.43 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.399 1.08 . . . . 0.0 111.095 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -123.44 137.87 54.71 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.428 1.091 . . . . 0.0 109.219 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.1 mt -75.67 177.36 6.88 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.497 1.119 . . . . 0.0 110.447 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -101.08 9.88 41.61 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.52 1.128 . . . . 0.0 111.276 177.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -109.34 -14.12 14.5 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.528 1.131 . . . . 0.0 112.086 -176.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.61 10.65 10.11 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.17 1.366 . . . . 0.0 113.938 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.54 164.45 14.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.538 1.535 . . . . 0.0 111.537 -173.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.4 p -119.55 138.97 48.46 Favored 'Isoleucine or valine' 0 C--N 1.347 0.494 0 C-N-CA 123.674 0.79 . . . . 0.0 110.702 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -110.86 121.18 44.71 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.581 1.152 . . . . 0.0 110.823 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 64.0 t -116.17 136.55 52.78 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.17 144.01 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 124.235 1.014 . . . . 0.0 109.482 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.54 142.03 21.7 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.581 -176.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.3 m -110.73 -178.78 3.57 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 126.173 1.789 . . . . 0.0 112.471 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.47 -153.59 23.48 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.054 -1.219 . . . . 0.0 110.054 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -82.25 132.7 35.23 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.096 0.558 . . . . 0.0 109.508 -178.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -48.71 -49.89 35.97 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.25 1.02 . . . . 0.0 110.972 -178.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.83 -52.96 28.15 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.103 1.335 . . . . 0.0 112.129 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -60.85 -46.5 90.34 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 124.232 1.013 . . . . 0.0 110.771 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.6 t -55.73 -42.79 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 122.271 0.228 . . . . 0.0 110.716 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.56 -27.73 66.49 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -27.05 68.49 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.842 0.857 . . . . 0.0 112.436 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.37 -29.05 14.18 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.211 0.604 . . . . 0.0 110.829 174.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.428 ' HA ' HD12 ' A' ' 62' ' ' LEU . 1.2 mmm -64.23 -21.87 66.74 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-O 118.588 -0.72 . . . . 0.0 111.535 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -47.54 -57.76 5.03 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 118.527 0.603 . . . . 0.0 109.812 172.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 15.7 t90 -64.3 -29.31 70.4 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.649 0.78 . . . . 0.0 111.727 -178.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 59' ' ' MET . 21.1 mt -66.39 -49.14 67.82 Favored 'General case' 0 C--N 1.347 0.489 0 O-C-N 121.101 -1.0 . . . . 0.0 110.083 177.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.79 14.31 6.08 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.0 t -148.71 14.6 0.95 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.416 0.686 . . . . 0.0 111.23 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -72.81 -60.16 4.05 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -175.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.02 78.17 0.13 Allowed Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 176.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.89 -171.22 0.46 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.552 2.835 . . . . 0.0 111.068 -175.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -47.53 -37.14 11.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.45 1.1 . . . . 0.0 112.933 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.34 133.92 1.43 Allowed 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.686 0.794 . . . . 0.0 109.905 177.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -170.0 153.65 4.8 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.876 1.271 . . . . 0.0 109.027 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -122.97 73.3 1.14 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.7 t -69.41 90.68 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -58.89 -50.79 72.7 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.494 0.718 . . . . 0.0 111.301 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.9 ttm-85 -169.3 163.56 10.76 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.042 0.537 . . . . 0.0 110.377 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.611 HG22 HG13 ' A' ' 10' ' ' VAL . 8.5 t -133.35 110.33 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.763 0.825 . . . . 0.0 109.953 -176.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.0 tp -100.61 152.4 20.48 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.36 1.064 . . . . 0.0 110.283 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.52 129.51 31.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.011 0.924 . . . . 0.0 111.518 -177.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.21 158.49 74.04 Favored Pre-proline 0 N--CA 1.469 0.501 0 C-N-CA 125.358 1.463 . . . . 0.0 110.544 -176.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.73 132.26 19.91 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 124.482 3.455 . . . . 0.0 110.987 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -120.68 114.93 22.39 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.617 1.167 . . . . 0.0 109.626 -177.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -121.8 64.97 18.23 Favored Pre-proline 0 CA--C 1.536 0.426 0 O-C-N 121.656 -0.653 . . . . 0.0 110.867 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.45 142.26 44.45 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.207 2.605 . . . . 0.0 110.471 -174.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.6 p -70.44 142.46 51.98 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.372 0.669 . . . . 0.0 110.729 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.86 170.62 5.37 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.25 0.929 . . . . 0.0 112.105 -176.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -93.26 135.15 34.74 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.8 tp -77.74 149.17 34.57 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -75.53 0.15 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.217 1.007 . . . . 0.0 108.483 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -141.15 162.95 34.26 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.135 0.974 . . . . 0.0 109.926 -173.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -71.17 145.61 49.61 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.876 0.47 . . . . 0.0 110.616 174.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -142.05 -169.97 3.05 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.122 0.969 . . . . 0.0 109.964 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.2 mt -141.97 168.01 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.906 0.882 . . . . 0.0 108.706 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.168 0 CA-C-O 116.709 -1.615 . . . . 0.0 112.562 174.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 111.423 0.157 . . . . 0.0 111.423 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.9 t -137.43 -40.52 0.57 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.545 1.138 . . . . 0.0 110.598 -175.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 152.97 41.95 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.145 0.978 . . . . 0.0 112.908 -176.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 p -138.78 90.88 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 124.505 1.122 . . . . 0.0 108.435 -173.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.0 m -78.61 153.37 31.16 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.665 176.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.99 148.99 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -176.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.8 tt -111.43 125.61 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.942 0.897 . . . . 0.0 109.947 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -120.21 101.85 8.1 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.823 1.649 . . . . 0.0 109.767 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 -87.15 112.7 22.21 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 124.618 1.167 . . . . 0.0 109.895 177.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.84 121.52 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.312 1.045 . . . . 0.0 108.662 -177.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -99.27 171.35 8.04 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.048 0.939 . . . . 0.0 110.684 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.72 -165.08 49.28 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 123.375 0.512 . . . . 0.0 112.095 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.9 mtt85 -84.86 83.6 7.99 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -166.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.7 t -119.49 -47.25 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.909 0.883 . . . . 0.0 110.378 -173.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -67.68 146.64 53.61 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 120.848 0.356 . . . . 0.0 110.862 177.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.18 17.93 76.22 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.128 0.87 . . . . 0.0 113.738 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 82.4 t -102.86 -43.06 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 124.673 1.189 . . . . 0.0 109.141 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.08 29.02 3.16 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 125.884 1.707 . . . . 0.0 110.996 -175.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -50.97 -37.58 45.55 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 124.509 1.124 . . . . 0.0 111.325 177.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.0 60.09 0.96 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.848 1.259 . . . . 0.0 112.689 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -109.75 -72.94 0.7 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.684 1.194 . . . . 0.0 108.789 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.3 t -72.19 -23.26 61.24 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 118.503 -0.761 . . . . 0.0 112.053 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.5 t -41.32 -39.81 1.51 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.468 1.107 . . . . 0.0 112.667 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -71.64 -59.84 2.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.364 1.065 . . . . 0.0 110.681 176.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -49.98 -58.08 6.2 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.139 0.976 . . . . 0.0 111.771 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -53.14 -51.15 62.9 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.588 1.155 . . . . 0.0 110.849 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.46 -33.2 53.31 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 122.78 0.432 . . . . 0.0 112.079 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -68.23 -28.54 67.32 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.212 1.005 . . . . 0.0 112.234 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.6 mtp85 -70.81 -47.04 61.58 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.895 0.878 . . . . 0.0 109.926 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.5 mt -78.33 -40.71 35.78 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.013 0.525 . . . . 0.0 111.004 -177.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.27 22.31 41.62 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.195 1.379 . . . . 0.0 112.952 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.72 174.89 11.12 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.713 0.805 . . . . 0.0 111.566 177.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 51.2 p -117.69 -163.39 0.93 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.59 -155.39 16.24 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 118.534 0.606 . . . . 0.0 112.144 171.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -169.88 162.26 9.28 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.72 84.81 2.32 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.443 1.097 . . . . 0.0 111.254 -174.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -92.61 173.01 8.0 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.851 0.86 . . . . 0.0 111.281 -177.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -125.07 131.57 53.31 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.336 1.054 . . . . 0.0 109.494 -177.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 39' ' ' LEU . 16.4 mt -70.06 171.25 9.86 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 125.214 1.405 . . . . 0.0 110.897 175.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -93.82 7.33 45.33 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.872 1.269 . . . . 0.0 111.747 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -112.63 -16.83 12.74 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.515 1.126 . . . . 0.0 112.119 -175.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.6 13.97 2.98 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.122 1.344 . . . . 0.0 114.385 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.54 166.32 12.85 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.426 1.49 . . . . 0.0 111.958 -167.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.3 t -127.07 120.92 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.586 1.155 . . . . 0.0 111.404 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -98.02 115.28 27.88 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 125.168 1.387 . . . . 0.0 111.684 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.6 t -114.1 133.32 60.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 122.861 0.464 . . . . 0.0 110.43 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.33 143.26 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 123.993 0.917 . . . . 0.0 109.738 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.96 133.03 11.63 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.015 -173.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 93.7 m -101.58 179.97 4.19 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.667 1.187 . . . . 0.0 112.325 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.73 -162.6 21.34 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.337 0.97 . . . . 0.0 110.758 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -73.18 121.75 20.79 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 123.691 0.796 . . . . 0.0 109.974 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -46.88 -50.85 17.97 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.015 1.326 . . . . 0.0 111.346 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -51.96 -45.77 55.97 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.402 1.477 . . . . 0.0 112.355 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -66.7 -50.88 61.41 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 117.455 0.628 . . . . 0.0 110.714 176.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.1 t -51.39 -34.05 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 122.647 0.379 . . . . 0.0 111.055 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -57.71 -31.46 66.43 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.915 0.886 . . . . 0.0 113.192 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -54.31 -44.86 72.36 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.828 0.851 . . . . 0.0 110.766 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.63 -32.18 53.22 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 118.481 0.582 . . . . 0.0 112.118 175.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.3 mmt -67.37 -25.19 65.85 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 118.814 -0.612 . . . . 0.0 111.867 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -42.44 -49.66 5.23 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.166 0.586 . . . . 0.0 109.719 170.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -64.13 -41.86 97.06 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.7 mt -53.1 -52.94 57.01 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.667 0.787 . . . . 0.0 110.599 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -28.24 69.4 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 119.04 -0.505 . . . . 0.0 111.837 176.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 t -62.18 -31.48 72.0 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.672 0.669 . . . . 0.0 111.536 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.37 6.48 75.75 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.534 -0.592 . . . . 0.0 113.096 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.85 162.51 2.71 Favored Glycine 0 CA--C 1.539 1.56 0 C-N-CA 124.095 0.855 . . . . 0.0 112.087 -170.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.56 83.74 2.11 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.696 2.931 . . . . 0.0 110.667 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 64.75 83.07 0.17 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.787 1.235 . . . . 0.0 110.305 177.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.94 -48.0 0.1 Allowed 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.292 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.29 151.66 42.18 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.565 1.546 . . . . 0.0 110.061 -173.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -114.83 84.05 2.01 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 95.4 t -69.28 102.6 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -67.21 -55.38 14.3 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.745 0.418 . . . . 0.0 110.998 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -166.64 99.05 0.57 Allowed 'General case' 0 C--N 1.342 0.274 0 C-N-CA 122.485 0.314 . . . . 0.0 111.422 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.9 p -84.41 125.54 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.275 0.63 . . . . 0.0 111.469 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.97 137.86 45.23 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 125.694 1.598 . . . . 0.0 111.568 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.88 138.56 54.35 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.156 1.382 . . . . 0.0 112.41 -177.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -144.04 158.73 54.97 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 124.945 1.298 . . . . 0.0 111.39 -177.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.02 137.38 26.44 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 124.074 3.182 . . . . 0.0 111.792 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -128.06 124.46 37.1 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.537 1.135 . . . . 0.0 111.181 -175.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -129.02 70.01 81.32 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 121.698 -0.626 . . . . 0.0 111.431 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.2 142.63 38.12 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.864 2.376 . . . . 0.0 110.722 -176.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.3 m -66.45 140.18 58.01 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.799 0.84 . . . . 0.0 110.776 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.86 -177.91 40.85 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.755 0.693 . . . . 0.0 111.547 -176.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -108.35 131.31 54.87 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.179 0.991 . . . . 0.0 108.568 172.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -69.82 151.75 45.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.927 1.291 . . . . 0.0 109.359 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.71 -77.98 0.13 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.672 0.789 . . . . 0.0 108.943 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -137.99 161.1 37.58 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.27 1.028 . . . . 0.0 109.838 -171.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -69.19 147.82 50.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.903 0.481 . . . . 0.0 110.03 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -152.06 -167.74 2.86 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 122.905 0.482 . . . . 0.0 110.524 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.2 tt -160.29 155.21 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 123.792 0.837 . . . . 0.0 109.48 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 . . . . . 0 C--O 1.251 1.182 0 CA-C-O 116.341 -1.79 . . . . 0.0 113.088 173.72 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 mtt . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 119.934 -0.079 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.0 m -127.91 -44.05 1.49 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.062 1.345 . . . . 0.0 110.737 176.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 142.84 55.84 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -169.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.25 88.5 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -172.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.2 m -78.95 152.06 31.29 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.276 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.416 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -141.52 149.33 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -177.105 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.8 tt -110.52 122.78 65.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 O-C-N 123.81 0.693 . . . . 0.0 109.335 174.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -113.88 95.67 5.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.684 1.594 . . . . 0.0 108.873 -175.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -81.44 130.59 35.1 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.4 t -107.07 113.97 44.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.476 1.111 . . . . 0.0 109.355 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -84.47 163.71 19.28 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.698 0.799 . . . . 0.0 111.052 175.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.39 179.5 53.02 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 124.126 0.869 . . . . 0.0 111.076 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.5 mtt180 -86.5 73.61 10.07 Favored 'General case' 0 N--CA 1.457 -0.075 0 CA-C-O 121.053 0.454 . . . . 0.0 111.751 -164.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.7 t -104.73 -33.25 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.162 0.985 . . . . 0.0 112.081 -170.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -63.13 159.68 16.94 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.677 0.671 . . . . 0.0 110.851 171.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.78 -46.08 1.65 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 123.992 0.806 . . . . 0.0 111.569 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.9 p -69.63 -9.74 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 123.431 0.693 . . . . 0.0 112.817 -174.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.08 44.46 35.85 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.894 0.759 . . . . 0.0 111.306 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -48.61 -34.13 11.09 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 125.867 1.667 . . . . 0.0 112.952 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 -71.95 47.92 0.15 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.844 1.657 . . . . 0.0 112.85 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -89.34 -69.63 0.7 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.089 0.956 . . . . 0.0 109.001 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.0 t -99.84 12.29 37.08 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.203 1.401 . . . . 0.0 111.23 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.1 t -59.41 -39.75 84.46 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.027 0.376 . . . . 0.0 110.796 170.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 -53.47 -60.55 3.16 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.868 1.267 . . . . 0.0 109.852 173.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -54.8 -57.04 13.15 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.001 0.92 . . . . 0.0 110.693 -173.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -54.55 -55.22 31.52 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 123.902 0.751 . . . . 0.0 109.856 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.92 -33.95 65.14 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 118.798 -0.62 . . . . 0.0 111.958 -177.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -67.56 -36.49 81.05 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.886 -0.578 . . . . 0.0 112.191 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -60.11 -46.87 88.17 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.656 0.662 . . . . 0.0 110.861 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.63 -22.01 34.85 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.98 31.57 47.79 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.557 1.075 . . . . 0.0 113.131 -178.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.597 HD13 ' O ' ' A' ' 49' ' ' CYS . 3.3 mm? -76.21 140.77 41.81 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 117.503 0.652 . . . . 0.0 110.294 176.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.2 p -96.16 -159.89 0.76 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.484 176.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.49 -149.22 16.69 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 119.212 0.915 . . . . 0.0 112.034 172.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -169.84 158.23 7.24 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 177.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.93 97.4 5.68 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.267 1.427 . . . . 0.0 110.416 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -107.62 170.22 8.11 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.697 0.799 . . . . 0.0 111.425 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -120.66 131.46 54.59 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.386 1.075 . . . . 0.0 108.994 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.7 mt -68.04 174.84 3.49 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.228 1.411 . . . . 0.0 110.679 175.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -97.48 15.52 22.96 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.772 1.229 . . . . 0.0 111.397 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -120.09 -14.47 8.86 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 123.942 0.897 . . . . 0.0 112.778 -173.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.22 11.35 4.26 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.073 1.32 . . . . 0.0 114.325 175.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 p -126.35 162.08 26.36 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.308 1.443 . . . . 0.0 111.807 -166.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.4 t -117.06 132.91 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.785 1.234 . . . . 0.0 111.112 -174.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -106.29 113.35 26.82 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.749 1.22 . . . . 0.0 110.606 178.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.1 t -112.29 135.39 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.785 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.7 142.76 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.765 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.53 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -151.7 119.21 6.04 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 117.945 -1.026 . . . . 0.0 111.901 -171.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.597 ' O ' HD13 ' A' ' 32' ' ' LEU . 98.5 m -109.58 132.02 54.52 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 120.031 1.287 . . . . 0.0 113.376 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 156.33 -163.86 32.19 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -71.81 126.85 30.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.334 0.567 . . . . 0.0 110.406 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -54.24 -43.21 70.7 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.853 1.261 . . . . 0.0 111.668 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -42.25 -42.8 4.43 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 126.057 1.789 . . . . 0.0 112.886 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -80.76 -47.17 14.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.207 1.003 . . . . 0.0 111.476 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.488 HG22 HD11 ' A' ' 32' ' ' LEU . 77.0 t -42.75 -52.11 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 123.938 0.895 . . . . 0.0 110.892 177.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -54.01 -36.4 62.94 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.405 0.682 . . . . 0.0 112.163 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -61.29 -44.24 97.55 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.022 0.929 . . . . 0.0 110.771 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.48 -32.32 68.13 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 122.934 0.494 . . . . 0.0 110.289 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.2 mmt -66.86 -24.87 66.18 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.096 -0.954 . . . . 0.0 112.264 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -47.71 -48.42 29.47 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 119.536 1.062 . . . . 0.0 109.535 172.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -61.25 -39.05 88.9 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 118.848 -0.596 . . . . 0.0 112.205 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.94 -46.58 71.6 Favored 'General case' 0 C--N 1.347 0.5 0 CA-C-N 119.385 0.993 . . . . 0.0 111.558 177.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -12.38 56.94 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 176.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 m -124.9 20.98 8.32 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.957 1.303 . . . . 0.0 111.496 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -88.41 -34.54 9.36 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -177.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -53.87 115.74 5.32 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.127 1.346 . . . . 0.0 111.735 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -85.62 -152.27 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.029 3.153 . . . . 0.0 109.835 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -61.73 -45.51 93.65 Favored 'General case' 0 C--N 1.344 0.331 0 O-C-N 121.829 -0.545 . . . . 0.0 111.02 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.9 p -86.51 179.0 6.92 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.685 1.194 . . . . 0.0 109.686 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 73.69 131.45 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 126.329 1.852 . . . . 0.0 111.573 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -120.48 94.51 4.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.41 1.084 . . . . 0.0 108.446 -176.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.6 t -72.76 98.12 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 124.403 1.081 . . . . 0.0 108.586 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -64.93 -51.31 62.55 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -167.61 168.7 12.5 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.482 1.113 . . . . 0.0 109.142 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.1 t -132.11 125.64 54.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.148 0.979 . . . . 0.0 109.265 174.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tp -103.81 120.64 41.4 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.397 1.079 . . . . 0.0 110.965 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.6 136.35 43.47 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.05 0.94 . . . . 0.0 110.678 178.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -140.83 153.55 67.75 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 124.836 1.254 . . . . 0.0 109.937 178.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.57 136.54 28.53 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.666 2.911 . . . . 0.0 110.984 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -126.44 118.82 25.75 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.89 1.276 . . . . 0.0 110.105 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -121.2 72.34 25.18 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 119.147 0.885 . . . . 0.0 111.498 177.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.27 140.32 44.21 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.011 2.474 . . . . 0.0 110.118 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 80.9 p -75.75 143.05 42.23 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.637 0.775 . . . . 0.0 110.753 -176.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.45 -179.93 42.48 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -103.68 126.76 51.02 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.621 1.168 . . . . 0.0 108.719 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 mp -71.24 151.64 44.1 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.063 0.945 . . . . 0.0 109.797 173.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.4 p -78.65 -79.65 0.13 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.891 0.876 . . . . 0.0 108.719 173.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -141.28 164.06 31.26 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 124.119 0.968 . . . . 0.0 111.187 -168.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -75.23 148.36 39.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.904 0.882 . . . . 0.0 110.002 175.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -149.83 -172.37 4.13 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.065 0.546 . . . . 0.0 110.022 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.4 pp -129.88 173.85 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 C-N-CA 123.872 0.869 . . . . 0.0 110.66 -174.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 . . . . . 0 C--O 1.251 1.164 0 CA-C-O 116.477 -1.725 . . . . 0.0 113.563 179.582 . . . . . . . . 0 0 . 1 stop_ save_